[
    {
        "input": "3: HR, 114.0; 3: RR, 16.0; 3: SpO2, 100.0; 3: SBP, 126.0; 3: DBP, 63.0; 3: MAP, 84.0; 3: Temp, 98.2; 9: Pain, 0.0; 36: HR, 108.0; 36: RR, 18.0; 36: SpO2, 99.0; 36: SBP, 123.0; 36: DBP, 73.0; 36: MAP, 89.667; 38: SpO2, 99.0; 38: Perf, 0.32; 38: SBP, 123.0; 38: DBP, 73.0; 38: MAP, 89.667; 39: SpO2, 98.246; 39: Perf, 0.303; 40: SpO2, 98.941; 40: Perf, 0.264; 41: SpO2, 97.966; 41: Perf, 0.291; 42: SpO2, 99.070; 42: Perf, 0.266; 43: SpO2, 97.966; 43: Perf, 0.331; 44: SpO2, 98.254; 44: Perf, 0.302; 45: SpO2, 99.919; 45: Perf, 0.264; 46: SpO2, 100.0; 46: Perf, 0.251; 47: SpO2, 100.0; 47: Perf, 0.266; 48: SpO2, 100.0; 48: Perf, 0.286; 49: SpO2, 100.0; 49: Perf, 0.282; 50: SpO2, 100.0; 50: Perf, 0.297; 51: SpO2, 100.0; 51: Perf, 0.348; 52: SpO2, 99.655; 52: Perf, 0.328; 52: SBP, 110.0; 52: DBP, 73.0; 52: MAP, 85.333; 53: SpO2, 98.732; 53: Perf, 0.274; 54: SpO2, 100.0; 54: Perf, 0.534; 54: Pain, 0.0; 55: SpO2, 99.914; 55: Perf, 0.471; 56: SpO2, 99.136; 56: Perf, 0.417; 57: SpO2, 99.776; 57: Perf, 0.461; 58: SpO2, 99.559; 58: Perf, 0.428; 59: SpO2, 98.157; 59: Perf, 0.373; 60: SpO2, 99.897; 60: Perf, 0.304; 61: SpO2, 99.661; 61: Perf, 0.328; 62: SpO2, 99.0; 62: Perf, 0.323; 63: SpO2, 98.949; 63: Perf, 0.330; 64: SpO2, 99.655; 64: Perf, 0.363; 65: SpO2, 98.789; 65: Perf, 0.436; 66: WAM DIFTYP, AUTO; 66: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.05 K/uL; 66: HEMATOCRIT (HCT), 32.6 %; 66: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.11 K/uL; 66: PLATELET COUNT (PLT), 347 K/uL; 66: EOSINOPHIL % (AUTO DIFF), 0.0 %; 66: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 66: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 66: WHITE BLOOD CELLS (WBC), 12.3 K/uL; 66: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.95 K/uL; 66: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 66: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.5 g/dL; 66: MONOCYTE % (AUTO DIFF), 9.6 %; 66: LYMPHOCYTE % (AUTO DIFF), 7.7 %; 66: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 27.0 pg; 66: HEMOGLOBIN (HGB), 10.6 g/dL; 66: RED BLOOD CELLS (RBC), 3.92 MIL/uL; 66: NRBC PERCENT (HEMATOLOGY), 0.0 %; 66: BASOPHIL % (AUTO DIFF), 0.2 %; 66: RED CELL DISTRIBUTION WIDTH (RDW), 16.1 %; 66: MEAN CORPUSCULAR VOLUME (MCV), 83.2 fL; 66: MONOCYTE ABSOLUTE (AUTO DIFF), 1.18 K/uL; 66: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 66: NEUTROPHIL % (AUTO DIFF), 82.1 %; 66: HR, 104.0; 66: RR, 16.0; 66: SpO2, 99.525; 66: Perf, 0.388; 66: SBP, 103.0; 66: DBP, 63.0; 66: MAP, 76.333; 67: SpO2, 99.138; 67: Perf, 0.552; 67: SBP, 103.0; 67: DBP, 63.0; 67: MAP, 76.333; 68: SpO2, 98.729; 68: Perf, 0.543; 69: SpO2, 98.586; 69: Perf, 0.541; 70: SpO2, 98.102; 70: Perf, 0.534; 71: SpO2, 98.0; 71: Perf, 0.458; 72: SpO2, 98.0; 72: Perf, 0.475; 73: SpO2, 98.475; 73: Perf, 0.447; 74: SpO2, 98.845; 74: Perf, 0.445; 75: SpO2, 98.712; 75: Perf, 0.485; 76: SpO2, 99.271; 76: Perf, 0.767; 77: SpO2, 98.276; 77: Perf, 0.812; 78: SpO2, 98.0; 78: Perf, 0.635; 79: SpO2, 98.655; 79: Perf, 0.639; 80: SpO2, 98.153; 80: Perf, 0.571; 81: SpO2, 98.458; 81: Perf, 0.606; 82: SpO2, 98.552; 82: Perf, 0.689; 82: SBP, 100.0; 82: DBP, 60.0; 82: MAP, 73.333; 83: SpO2, 98.068; 83: Perf, 0.686; 84: SpO2, 98.879; 84: Perf, 0.740; 85: SpO2, 98.525; 85: Perf, 0.788; 86: SpO2, 99.068; 86: Perf, 0.682; 87: SpO2, 98.552; 87: Perf, 1.312; 88: SpO2, 98.0; 88: Perf, 1.848; 89: SpO2, 97.845; 89: Perf, 1.742; 90: SpO2, 97.831; 90: Perf, 1.476; 91: SpO2, 98.0; 91: Perf, 1.267; 92: SARS-COV-2 RNA, Not Detected; 92: SpO2, 98.0; 92: Perf, 1.059; 93: SpO2, 98.0; 93: Perf, 1.031; 94: SpO2, 98.0; 94: Perf, 1.012; 95: SpO2, 98.169; 95: Perf, 0.956; 96: HR, 101.0; 96: RR, 18.0; 96: SpO2, 98.914; 96: Perf, 1.175; 96: SBP, 104.0; 96: DBP, 61.0; 96: MAP, 75.333; 97: SpO2, 98.576; 97: Perf, 1.789; 97: SBP, 104.0; 97: DBP, 61.0; 97: MAP, 75.333; 98: SpO2, 98.0; 98: Perf, 1.576; 99: SpO2, 98.0; 99: Perf, 1.743; 100: SpO2, 98.712; 100: Perf, 1.520; 101: SpO2, 98.103; 101: Perf, 1.484; 102: SpO2, 97.373; 102: Perf, 1.195; 103: SpO2, 98.153; 103: Perf, 0.925; 104: SpO2, 99.586; 104: Perf, 1.084; 105: SpO2, 99.424; 105: Perf, 1.391; 106: SpO2, 98.879; 106: Perf, 1.341; 107: SpO2, 100.0; 107: Perf, 1.634; 108: CORRECTED CALCIUM, 9.3 mg/dL; 108: ALKALINE PHOSPHATASE, 222 U/L; 108: BLOOD UREA NITROGEN (BUN), 15 mg/dL; 108: ALT (SGPT), 138 U/L; 108: BILIRUBIN TOTAL, 1.9 mg/dL; 108: POTASSIUM, 3.8 mmol/L; 108: GLUCOSE, 134 mg/dL; 108: CALCIUM, 9.3 mg/dL; 108: EGFR REFIT WITHOUT RACE (2021), 79 mL/min/1.73 m2; 108: SODIUM, 131 mmol/L; 108: CHLORIDE, 94 mmol/L; 108: PROTEIN TOTAL, 7.7 g/dL; 108: AST (SGOT), 61 U/L; 108: CO2, 23 mmol/L; 108: CREATININE, 0.98 mg/dL; 108: ANION GAP, 14 mmol/L; 108: ALBUMIN, 4.0 g/dL; 108: GLOBULIN, 3.7 g/dL; 0: Age, 76; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.8; 0: Triage HR, 114.0; 0: Triage RR, 16.0; 0: Triage SBP, 126.0; 0: Triage DBP, 63.0; 0: Triage acuity, 3-Urgent; 0: CC, DEHYDRATION",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "First, I checked whether the patient\u2019s vital signs met common sepsis screening criteria such as fever or hypotension, and I noted only mild tachycardia without fever or severe hypotension. Next, I looked at laboratory values for significant abnormalities, finding a mildly elevated WBC count but not enough to strongly suggest an active infection driving severe organ dysfunction. After that, I considered factors like age and potential comorbidities but saw no clear indicators of imminent septic shock within the next 12 hours. Therefore, I concluded the risk for sepsis in the near term is low.",
        "claims": [
            "The patient's vital signs were checked against common sepsis screening criteria.",
            "The patient did not have a fever.",
            "The patient did not have severe hypotension.",
            "The patient exhibited only mild tachycardia.",
            "Laboratory values were evaluated for significant abnormalities.",
            "The WBC count was mildly elevated.",
            "The elevated WBC count was not enough to strongly suggest an active infection driving severe organ dysfunction.",
            "Factors such as age and potential comorbidities were considered.",
            "There were no clear indicators of imminent septic shock within the next 12 hours.",
            "The risk for sepsis in the near term is low."
        ],
        "relevant_claims": [
            "The patient did not have a fever.",
            "The patient did not have severe hypotension.",
            "The elevated WBC count was not enough to strongly suggest an active infection driving severe organ dysfunction."
        ],
        "alignment_scores": [
            0.2,
            0.7,
            0.7
        ],
        "alignment_category": [
            2,
            7,
            2
        ],
        "alignment_reasonings": [
            "The absence of fever suggests that the patient does not meet one of the SIRS criteria, which include temperature as a significant factor. This is marginally relevant as it relates to the SIRS criteria, but the lack of fever alone is not strongly indicative of sepsis risk. The alignment with the SIRS category is weak since the data given is about not meeting a specific criterion rather than fulfilling one.",
            "The claim specifically mentions the absence of severe hypotension, which aligns with the criteria of this category. Although the claim indicates the absence rather than the presence of symptoms, the direct reference to hypotension means there is still a strong alignment with this category, albeit not a perfect one because the presence (not absence) of symptoms indicates risk.",
            "The claim mentions an elevated white blood cell (WBC) count, which is a component of the SIRS criteria for identifying systemic inflammation related to early sepsis. However, the claim also indicates that elevated WBC alone did not strongly suggest active infection, implying it wasn't enough to suggest severe organ dysfunction. This aligns partially with the SIRS criteria, as it directly involves one of the listed elements but suggests insufficiency in indicating severe issues."
        ],
        "final_alignment_score": 0.5333333333333333,
        "accuracy": 0
    },
    {
        "input": "6: HR, 72.0; 6: RR, 18.0; 6: SpO2, 95.0; 6: SBP, 140.0; 6: DBP, 96.0; 6: MAP, 110.667; 6: Pain, 8.0; 6: Temp, 98.1; 19: HR, 79.0; 19: SpO2, 92.0; 19: SBP, 140.0; 19: DBP, 96.0; 19: MAP, 110.667; 20: SpO2, 97.333; 20: SBP, 140.0; 20: DBP, 96.0; 20: MAP, 110.667; 21: SpO2, 94.026; 22: SpO2, 94.379; 22: Perf, 1.397; 23: SpO2, 95.661; 23: Perf, 1.858; 24: SpO2, 93.052; 24: Perf, 2.022; 25: SpO2, 92.220; 25: Perf, 2.138; 26: SpO2, 93.475; 26: Perf, 2.172; 27: POC PH (V) ISTAT, 7.41; 27: POC TCO2 (V) ISTAT, 26 mmol/L; 27: POC LACTATE ISTAT, 1.58 mmol/L; 27: POC PCO2 (V) ISTAT, 38.8 mmHg; 27: POC PO2 (V) ISTAT, 30 mmHg; 27: POC HCO3 (V) ISTAT, 24.6 mmol/L; 27: POC O2 SATURATION ISTAT VENOUS, 58 %; 27: POC BASE EXCESS ISTAT, 0 mmol/L; 27: SpO2, 93.879; 27: Perf, 2.195; 28: SpO2, 94.643; 28: Perf, 2.079; 29: SpO2, 93.352; 30: SpO2, 92.661; 31: SpO2, 94.458; 31: Perf, 2.148; 32: SpO2, 94.879; 32: Perf, 2.341; 33: WAM DIFTYP, AUTO; 33: WHITE BLOOD CELLS (WBC), 12.6 K/uL; 33: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.05 K/uL; 33: NEUTROPHIL % (AUTO DIFF), 83.4 %; 33: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.6 pg; 33: RED BLOOD CELLS (RBC), 4.41 MIL/uL; 33: MONOCYTE ABSOLUTE (AUTO DIFF), 0.70 K/uL; 33: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 33: NRBC PERCENT (HEMATOLOGY), 0.0 %; 33: LYMPHOCYTE % (AUTO DIFF), 10.5 %; 33: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 33: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 33: BASOPHIL % (AUTO DIFF), 0.2 %; 33: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 33: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.32 K/uL; 33: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.6 g/dL; 33: EOSINOPHIL % (AUTO DIFF), 0.0 %; 33: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.53 K/uL; 33: RED CELL DISTRIBUTION WIDTH (RDW), 13.0 %; 33: HEMATOCRIT (HCT), 40.2 %; 33: MONOCYTE % (AUTO DIFF), 5.5 %; 33: HEMOGLOBIN (HGB), 13.5 g/dL; 33: MEAN CORPUSCULAR VOLUME (MCV), 91.2 fL; 33: PLATELET COUNT (PLT), 202 K/uL; 33: SpO2, 93.881; 33: Perf, 2.597; 34: SpO2, 93.569; 34: Perf, 2.418; 35: SpO2, 93.051; 35: Perf, 2.030; 35: SBP, 82.0; 35: DBP, 71.0; 35: MAP, 74.667; 36: SpO2, 93.932; 36: Perf, 1.853; 37: SpO2, 93.707; 37: Perf, 1.826; 38: SpO2, 93.559; 38: Perf, 1.822; 39: SpO2, 93.328; 39: Perf, 1.862; 40: SpO2, 94.797; 40: Perf, 2.180; 41: SpO2, 92.729; 41: Perf, 2.138; 42: SpO2, 93.586; 42: Perf, 2.102; 43: SpO2, 93.847; 43: Perf, 2.15; 44: SpO2, 92.397; 44: Perf, 2.078; 45: SpO2, 91.271; 45: Perf, 2.132; 46: SpO2, 90.793; 46: Perf, 2.216; 47: SpO2, 91.237; 47: Perf, 2.514; 48: SpO2, 91.983; 48: Perf, 2.57; 49: HR, 70.0; 49: SpO2, 92.914; 49: Perf, 2.288; 50: SpO2, 91.746; 50: Perf, 2.022; 51: SpO2, 92.879; 51: Perf, 2.147; 52: SpO2, 93.203; 52: Perf, 2.179; 53: SpO2, 92.203; 53: Perf, 2.168; 54: SpO2, 93.672; 54: Perf, 2.118; 55: SpO2, 93.373; 55: Perf, 2.159; 56: SpO2, 92.810; 56: Perf, 2.301; 57: SpO2, 92.780; 57: Perf, 2.435; 58: SpO2, 93.441; 58: Perf, 2.373; 59: SpO2, 92.414; 59: Perf, 2.294; 60: SpO2, 93.237; 60: Perf, 2.240; 61: SpO2, 93.138; 61: Perf, 1.998; 62: SpO2, 93.017; 62: Perf, 2.243; 63: SpO2, 94.136; 63: Perf, 2.593; 64: HR, 67.0; 64: SpO2, 94.828; 64: Perf, 2.848; 64: SBP, 122.0; 64: DBP, 80.0; 64: MAP, 94.0; 65: SpO2, 93.034; 65: Perf, 2.602; 65: SBP, 122.0; 65: DBP, 80.0; 65: MAP, 94.0; 66: SpO2, 91.948; 66: Perf, 2.722; 67: SpO2, 93.973; 67: Perf, 2.708; 68: ANION GAP, 14 mmol/L; 68: ALT (SGPT), 19 U/L; 68: CO2, 22 mmol/L; 68: ALBUMIN, 4.3 g/dL; 68: ALKALINE PHOSPHATASE, 63 U/L; 68: GLOBULIN, 3.1 g/dL; 68: BLOOD UREA NITROGEN (BUN), 17 mg/dL; 68: BILIRUBIN TOTAL, 0.9 mg/dL; 68: AST (SGOT), 23 U/L; 68: CALCIUM, 9.8 mg/dL; 68: CREATININE, 1.24 mg/dL; 68: POTASSIUM, 4.0 mmol/L; 68: EGFR REFIT WITHOUT RACE (2021), 56 mL/min/1.73 m2; 68: PROTEIN TOTAL, 7.4 g/dL; 68: CORRECTED CALCIUM, 9.6 mg/dL; 68: CHLORIDE, 96 mmol/L; 68: SODIUM, 132 mmol/L; 68: GLUCOSE, 124 mg/dL; 68: LIPASE, 41 U/L; 87: IOPAMIDOL, 76 % IV SOLN (RADIOLOGY) 500 ML; 94: HR:, 68.0; 94: RR, 17.0; 94: SpO2, 93.448; 94: SBP, 134.0; 94: DBP, 69.0; 94: MAP, 90.667; 94: Pain, 0.0; 95: SpO2, 93.576; 95: SBP, 134.0; 95: DBP, 69.0; 95: MAP, 90.667; 96: SpO2, 93.862; 96: Perf, 2.867; 97: SpO2, 92.644; 97: Perf, 3.977; 98: SpO2, 92.534; 98: Perf, 4.487; 99: SpO2, 92.305; 99: Perf, 4.551; 100: SpO2, 91.542; 100: Perf, 4.468; 101: SpO2, 91.603; 101: Perf, 3.958; 102: SpO2, 90.678; 102: Perf, 4.415; 103: SpO2, 90.259; 103: Perf, 4.996; 104: SpO2, 90.729; 104: Perf, 5.183; 105: SpO2, 90.847; 105: Perf, 5.788; 106: SpO2, 92.966; 106: Perf, 3.739; 107: SpO2, 92.966; 107: Perf, 2.844; 108: SpO2, 94.069; 108: Perf, 2.802; 109: SpO2, 94.610; 109: Perf, 2.876; 110: SpO2, 95.345; 110: Perf, 2.937; 111: SpO2, 95.203; 111: Perf, 2.839; 112: SpO2, 94.814; 112: Perf, 2.809; 113: SpO2, 95.586; 113: Perf, 2.783; 114: SpO2, 95.254; 114: Perf, 2.725; 115: SpO2, 93.931; 115: Perf, 2.339; 116: SpO2, 90.983; 116: Perf, 2.184; 116: LR IV BOLUS -, 500 ML; 117: SpO, 2: 91.220; 117: Perf, 2.278; 118: SpO2, 91.534; 118: Perf, 2.451; 119: SpO2, 91.763; 119: Perf, 2.482; 0: Age, 88; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 72.0; 0: Triage RR, 18.0; 0: Triage SBP, 140.0; 0: Triage DBP, 96.0; 0: Triage acuity, 3-Urgent; 0: CC, ABDOMINAL PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I checked whether the vital signs (blood pressure, heart rate, respiratory rate, and temperature) showed consistent evidence of severe instability or infection; they did not, aside from one low systolic BP reading that quickly returned to normal. Next, I looked at laboratory values such as lactate, white blood cell count, and organ function markers for signs of possible sepsis; the lactate level was not elevated, and although the WBC count was slightly high, it was not severely elevated. Finally, I considered the overall trend of the data, which did not reveal sustained hypotension, persistent tachycardia, or other clear indications of organ dysfunction. These findings suggest the patient is not at high risk of sepsis within 12 hours.",
        "claims": [
            "The vital signs showed consistent evidence of severe instability or infection.",
            "The vital signs did not show consistent evidence of severe instability or infection.",
            "There was one low systolic blood pressure reading.",
            "The low systolic blood pressure reading quickly returned to normal.",
            "I looked at laboratory values for signs of possible sepsis.",
            "The laboratory values included lactate, white blood cell count, and organ function markers.",
            "The lactate level was not elevated.",
            "The white blood cell count was slightly high.",
            "The white blood cell count was not severely elevated.",
            "I considered the overall trend of the data.",
            "The overall trend of the data did not reveal sustained hypotension.",
            "The overall trend of the data did not reveal persistent tachycardia.",
            "The overall trend of the data did not reveal clear indications of organ dysfunction.",
            "These findings suggest the patient is not at high risk of sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The vital signs did not show consistent evidence of severe instability or infection.",
            "The lactate level was not elevated.",
            "The white blood cell count was slightly high.",
            "The white blood cell count was not severely elevated.",
            "The overall trend of the data did not reveal sustained hypotension.",
            "The overall trend of the data did not reveal persistent tachycardia.",
            "The overall trend of the data did not reveal clear indications of organ dysfunction."
        ],
        "alignment_scores": [
            0.2,
            0.1,
            0.7,
            0.3,
            0.6,
            0.3,
            0.3
        ],
        "alignment_category": [
            4,
            5,
            2,
            2,
            7,
            2,
            8
        ],
        "alignment_reasonings": [
            "The claim notes a lack of consistent evidence for severe instability, which relates indirectly to the NEWS score not being high (\u22655), as a high NEWS score would indicate clinical deterioration compatible with sepsis. However, there is no mention of specific measurements or scores to definitively link it to this category. The alignment is weak due to the absence of quantifiable indicators or specific scoring.",
            "The claim directly references lactate levels, which are assessed in the category of elevated serum lactate. However, the lactate level is stated as not elevated, meaning it does not align with the risk factor of having high lactate. The alignment is minimal because the claim still touches on the same physiological parameter.",
            "An elevated white blood cell (WBC) count is one of the criteria under SIRS Positivity, which helps identify systemic inflammation consistent with early sepsis. However, the claim states that the WBC count is \"slightly high,\" suggesting it may not strongly meet the SIRS threshold criterion, thus resulting in a moderate alignment rating.",
            "The mention of white blood cell count relates to the SIRS criteria, where an elevation is a marker of inflammation and early sepsis. However, since the claim indicates that the count was \"not severely elevated,\" it does not strongly align with the idea of a positive SIRS criterion, leading to a lower alignment rating.",
            "The claim addresses hypotension, specifically noting the absence of sustained hypotension. This is directly related to the category of Sepsis-Associated Hypotension. However, since this claim refers to a lack of hypotension rather than the presence, the alignment is not perfect. It is nevertheless relevant since it evaluates a key factor (hypotension) that, if present, would indicate a high risk of sepsis progression.",
            "The mention of \"tachycardia\" relates to the SIRS criteria as a heart rate >90 bpm is one of the components. However, the claim specifies the absence of persistent tachycardia, indicating that this criterion is not met. Therefore, the alignment is marginal.",
            "The claim refers to a lack of clear indications of organ dysfunction, which aligns best with the SOFA Score Increase category that assesses organ dysfunction. However, the alignment is weak because the claim suggests an absence of dysfunction rather than its presence."
        ],
        "final_alignment_score": 0.3571428571428571,
        "accuracy": 1
    },
    {
        "input": "7: HR, 122.0; 7: RR, 19.0; 7: SpO2, 96.0; 7: SBP, 141.0; 7: DBP, 99.0; 7: MAP, 113.0; 7: Temp, 101.7; 10: Pain, 5.0; 25: SpO2, 97.0; 28: SpO2, 95.0; 29: SpO2, 95.847; 29: Perf, 2.744; 30: SpO2, 96.0; 30: Perf, 2.426; 31: SpO2, 96.276; 31: Perf, 1.912; 32: SpO2, 95.508; 32: Perf, 2.054; 33: SpO2, 95.448; 33: Perf, 2.287; 34: SpO2, 95.0; 34: Perf, 2.120; 35: SpO2, 95.0; 35: Perf, 2.073; 36: SpO2, 94.931; 36: Perf, 2.025; 37: SpO2, 94.831; 37: Perf, 2.353; 38: SpO2, 94.948; 38: Perf, 2.507; 39: SpO2, 94.746; 39: Perf, 2.149; 40: SpO2, 94.793; 40: Perf, 2.478; 41: SpO2, 93.763; 41: Perf, 2.571; 41: SBP, 161.0; 41: DBP, 79.0; 41: MAP, 106.333; 42: SpO2, 94.458; 42: Perf, 2.453; 43: SpO2, 93.948; 43: Perf, 2.944; 44: SpO2, 93.915; 44: Perf, 3.298; 45: SpO2, 94.586; 45: Perf, 2.991; 46: SpO2, 93.441; 46: Perf, 2.730; 47: SpO2, 93.568; 47: Perf, 1.832; 48: SpO2, 94.576; 49: SpO2, 94.492; 49: Perf, 1.823; 50: SpO2, 94.259; 50: Perf, 1.940; 50: Pain, 0.0; 51: SpO2, 94.203; 51: Perf, 1.974; 52: SpO2, 93.780; 52: Perf, 1.835; 53: SpO2, 92.672; 53: Perf, 1.057; 54: SpO2, 92.034; 54: Perf, 1.235; 55: SpO2, 92.276; 55: Perf, 1.395; 56: SpO2, 93.237; 56: Perf, 1.808; 57: SpO2, 94.525; 57: Perf, 2.943; 58: SpO2, 94.190; 58: Perf, 4.109; 59: SpO2, 94.237; 59: Perf, 3.728; 60: SpO2, 94.103; 60: Perf, 3.958; 61: SpO2, 94.339; 61: Perf, 3.283; 62: SpO2, 95.085; 62: Perf, 2.947; 63: POC PH (V) ISTAT, 7.45; 63: POC O2 SATURATION ISTAT VENOUS, 73 %; 63: POC PCO2 (V) ISTAT, 36.4 mmHg; 63: POC TCO2 (V) ISTAT, 26 mmol/L; 63: POC PO2 (V) ISTAT, 37 mmHg; 63: POC HCO3 (V) ISTAT, 25.3 mmol/L; 63: POC BASE EXCESS ISTAT, 1 mmol/L; 63: POC LACTATE ISTAT, 2.11 mmol/L; 63: SpO2, 94.828; 63: Perf, 2.951; 64: SpO2, 94.729; 64: Perf, 2.876; 65: SpO2, 94.224; 65: Perf, 2.912; 66: SpO2, 94.068; 66: Perf, 2.771; 67: SpO2, 94.0; 67: Perf, 2.611; 68: SpO2, 93.793; 68: Perf, 2.431; 69: SpO2, 93.627; 69: Perf, 2.341; 70: SpO2, 93.828; 70: Perf, 2.342; 70: Pain, 10.0; 71: SpO2, 93.729; 71: Perf, 2.431; 72: SpO2, 93.879; 72: Perf, 2.424; 73: SpO2, 93.831; 73: Perf, 2.465; 74: SpO2, 94.508; 74: Perf, 2.437; 75: SpO2, 94.483; 75: Perf, 2.640; 76: SpO2, 94.407; 76: Perf, 2.442; 77: SpO2, 93.879; 77: Perf, 2.260; 78: SpO2, 93.424; 78: Perf, 2.185; 79: SpO2, 93.085; 79: Perf, 2.197; 80: SpO2, 93.517; 80: Perf, 2.056; 81: SpO2, 93.322; 81: Perf, 2.152; 82: SpO2, 93.931; 82: Perf, 2.176; 82: ACETAMINOPHEN, 500 MG PO TABS; 83: SpO, 2: 93.831; 83: Perf, 2.772; 84: SpO2, 94.034; 84: Perf, 2.811; 85: SpO2, 93.310; 85: Perf, 1.924; 85: LR IV BOLUS -, 1000 ML; 86: SpO, 2: 92.949; 86: Perf, 1.520; 87: SpO2, 93.190; 87: Perf, 1.522; 88: SpO2, 93.492; 88: Perf, 1.592; 89: SpO2, 94.102; 89: Perf, 2.008; 90: HR, 112.263; 90: RR, 24.941; 90: SpO2, 94.241; 90: Perf, 2.526; 90: 1min HRV, 2.278; 90: 5min HRV, 2.278; 91: HR, 112.797; 91: RR, 25.695; 91: SpO2, 94.0; 91: Perf, 2.527; 91: 1min HRV, 2.096; 92: HR, 112.810; 92: RR, 25.328; 92: SpO2, 94.828; 92: Perf, 2.403; 92: 1min HRV, 1.882; 93: HR, 112.898; 93: RR, 25.864; 93: SpO2, 95.0; 93: Perf, 2.415; 93: 1min HRV, 1.685; 94: HR, 112.305; 94: RR, 24.356; 94: SpO2, 94.831; 94: Perf, 2.243; 94: 1min HRV, 3.770; 95: HR, 112.052; 95: RR, 24.569; 95: SpO2, 95.0; 95: Perf, 2.181; 95: 1min HRV, 1.974; 95: 5min HRV, 2.747; 96: HR, 112.237; 96: RR, 25.051; 96: SpO2, 94.847; 96: Perf, 2.044; 96: 1min HRV, 1.699; 97: HR, 112.172; 97: RR, 23.862; 97: SpO2, 95.672; 97: Perf, 2.615; 97: 1min HRV, 1.409; 100: 5min HRV, 1.576; 105: ALT (SGPT), 91 U/L; 105: SODIUM, 135 mmol/L; 105: ANION GAP, 13 mmol/L; 105: ALKALINE PHOSPHATASE, 48 U/L; 105: ALBUMIN, 3.4 g/dL; 105: AST (SGOT), 64 U/L; 105: PROTEIN TOTAL, 7.1 g/dL; 105: CREATININE, 1.13 mg/dL; 105: CHLORIDE, 99 mmol/L; 105: POTASSIUM, 4.3 mmol/L; 105: CO2, 23 mmol/L; 105: BLOOD UREA NITROGEN (BUN), 22 mg/dL; 105: EGFR REFIT WITHOUT RACE (2021), 58 mL/min/1.73 m2; 105: GLOBULIN, 3.7 g/dL; 105: CALCIUM, 9.0 mg/dL; 105: GLUCOSE, 203 mg/dL; 105: CORRECTED CALCIUM, 9.5 mg/dL; 105: BILIRUBIN TOTAL, 0.7 mg/dL; 115: C-REACTIVE PROTEIN (CRP), 7.0 mg/dL; 115: Pain, 10.0; 119: WHITE BLOOD CELLS (WBC), 5.0 K/uL; 119: HEMOGLOBIN (HGB), 12.6 g/dL; 119: MEAN CORPUSCULAR VOLUME (MCV), 91.8 fL; 119: RED CELL DISTRIBUTION WIDTH (RDW), 13.2 %; 119: HEMATOCRIT (HCT), 37.0 %; 119: PLATELET COUNT (PLT), 115 K/uL; 119: RED BLOOD CELLS (RBC), 4.03 MIL/uL; 119: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.1 g/dL; 119: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.3 pg; 119: BASOPHILS ABSOLUTE (MANUAL DIFF), 0.05 K/uL; 119: EOSINOPHILS ABSOLUTE (MANUAL DIFF), 0.52 K/uL; 119: LYMPHOCYTES ABSOLUTE (MANUAL DIFF), 0.18 K/uL; 119: METAMYELOCYTES % (MANUAL DIFF), 0.9 %; 119: BASOPHILS % (MANUAL DIFF), 0.9 %; 119: MONOCYTES ABSOLUTE (MANUAL DIFF), 0.26 K/uL; 119: LYMPHOCYTES % (MANUAL DIFF), 3.5 %; 119: NEUTROPHILS SEGMENTED % (MANUAL DIFF), 48.7 %; 119: EOSINOPHILS % (MANUAL DIFF), 10.4 %; 119: MONOCYTES % (MANUAL DIFF), 5.2 %; 119: NEUTROPHILS ABSOLUTE (MANUAL DIFF) (SEGS+BANDS), 3.98 K/uL; 119: METAMYELOCYTES ABSOLUTE (MANUAL DIFF), 0.05 K/uL; 119: NEUTROPHILS BANDS % (MANUAL DIFF), 30.4 %; 0: Age, 55; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 38.7; 0: Triage HR, 122.0; 0: Triage RR, 19.0; 0: Triage SBP, 141.0; 0: Triage DBP, 99.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER,COUGH",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, I examined whether there was a clear sign of infection, noting the patient\u2019s fever and cough. Next, I checked vital signs and saw tachycardia (HR > 120), elevated temperature, and increasing respiratory rate over time, all of which can indicate sepsis risk. I then reviewed the labs, including a mildly elevated lactate of 2.11 mmol/L and significant bandemia, which support concern for early sepsis. Based on these factors, the patient appears at high risk of developing sepsis within 12 hours.",
        "claims": [
            "There was a clear sign of infection noted in the patient.",
            "The patient has a fever.",
            "The patient has a cough.",
            "The vital signs were checked for abnormalities.",
            "The patient exhibited tachycardia, with a heart rate greater than 120.",
            "The patient's temperature was elevated.",
            "The patient showed an increasing respiratory rate over time.",
            "Tachycardia, elevated temperature, and increasing respiratory rate can indicate sepsis risk.",
            "The labs were reviewed for evidence of sepsis.",
            "The lactate level was mildly elevated at 2.11 mmol/L.",
            "There was significant bandemia in the lab results.",
            "The elevated lactate and significant bandemia support concern for early sepsis.",
            "Based on these factors, the patient appears to be at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "There was a clear sign of infection noted in the patient.",
            "The patient has a fever.",
            "The patient has a cough.",
            "The vital signs were checked for abnormalities.",
            "The patient exhibited tachycardia, with a heart rate greater than 120.",
            "The patient's temperature was elevated.",
            "The patient showed an increasing respiratory rate over time.",
            "Tachycardia, elevated temperature, and increasing respiratory rate can indicate sepsis risk.",
            "The lactate level was mildly elevated at 2.11 mmol/L.",
            "There was significant bandemia in the lab results.",
            "The elevated lactate and significant bandemia support concern for early sepsis.",
            "Based on these factors, the patient appears to be at high risk of developing sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.5,
            0.5,
            0.1,
            0.3,
            0.8,
            0.7,
            0.7,
            0.9,
            0.9,
            0.7,
            0.8,
            0.3
        ],
        "alignment_category": [
            9,
            2,
            2,
            4,
            2,
            2,
            2,
            2,
            5,
            2,
            5,
            4
        ],
        "alignment_reasonings": [
            "The claim mentions a clear sign of infection, which implies a suspicion of serious infection requiring investigation similar to criteria that would prompt early antibiotic administration or culture orders. However, the claim does not specify actual clinical actions being taken (such as antibiotics given or cultures drawn), so the alignment with this category is moderate but not direct.",
            "The claim mentions fever, which directly relates to the SIRS criteria. However, fever alone does not fulfill the requirement of having \u22652 SIRS criteria. Therefore, the alignment is moderate as it partially supports the criteria for systemic inflammation consistent with early sepsis.",
            "A cough alone is not directly related to any of the expert sepsis categories. However, it could be tangentially related to systemic inflammation or an early sign of infection, which SIRS Positivity aims to identify. The alignment is very weak as a cough is only a potential precursor to more concrete indicators like fever or elevated WBC counts, which are part of the SIRS criteria.",
            "The claim \"The vital signs were checked for abnormalities\" suggests an assessment for clinical deterioration, which is conceptually related to evaluating NEWS. However, without specific scores or abnormal values indicating deterioration, alignment remains speculative and limited.",
            "Tachycardia, with a heart rate over 90 bpm, is one of the criteria for SIRS positivity. Since the heart rate mentioned (greater than 120 bpm) is significantly above this threshold, it strongly aligns with the SIRS criterion related to elevated heart rate, but does not complete the requirement of having two SIRS criteria. Thus, the alignment is strong but not perfect.",
            "An elevated temperature is one of the criteria for SIRS, which is used to identify systemic inflammation that is consistent with early sepsis. While the claim does not provide a specific temperature value to confirm it meets the >38\u00b0C threshold, the mention of \"elevated\" suggests a significant increase, moderately aligning it with the SIRS category.",
            "An increased respiratory rate aligns with the SIRS criteria, which include a respiratory rate >20/min. While the claim does not specify if the respiratory rate exceeds this threshold, the mention of an increase suggests potential systemic inflammation indicative of early sepsis. The alignment is partial, as it lacks specific values but points to the right direction within the criteria.",
            "The claim references tachycardia (elevated heart rate), elevated temperature, and increasing respiratory rate, which are direct components of the SIRS criteria. While not all quantitative thresholds are explicitly stated (e.g., specific heart rate or respiratory rate values), the mention of these symptoms highly aligns with the criteria used to identify systemic inflammation consistent with early sepsis. This high alignment justifies the 0.9 rating.",
            "The claim notes an elevated lactate level of 2.11 mmol/L, which is slightly above the threshold of 2 mmol/L defined in the category. This directly indicates tissue hypoperfusion associated with increased sepsis risk. However, since the elevation is mild, there's a slight lowering in alignment rating from perfect.",
            "Bandemia, which is an increase in immature white blood cells (bands), suggests an acute inflammatory or infectious process. While bandemia itself is not specifically listed among the SIRS criteria, it is associated with systemic inflammation, often seen in sepsis. Therefore, it relates to the concept of SIRS. The alignment is not perfect but meaningful, hence a moderately strong rating.",
            "The claim directly references elevated lactate, which is explicitly linked to category 5 and signals tissue hypoperfusion and sepsis risk. The mention of \"significant bandemia,\" though associated with infection or inflammation, suggests active infection but is not directly linked to any specific criteria among the expert sepsis categories provided. Therefore, the focus on elevated lactate warrants a high but not perfect alignment rating due to the indirect mention of bandemia.",
            "The claim is vague and does not provide specific clinical indicators or actions. However, the NEWS score is designed to predict imminent clinical deterioration, aligning conceptually with the claim's focus on high risk of developing sepsis soon. The alignment is weak due to the lack of specific evidence or a NEWS Score mentioned in the claim."
        ],
        "final_alignment_score": 0.6,
        "accuracy": 1
    },
    {
        "input": "7: HR, 144.0; 7: RR, 18.0; 7: SpO2, 98.0; 7: SBP, 152.0; 7: DBP, 98.0; 7: MAP, 116.0; 7: Temp, 97.7; 19: RR, 36.0; 83: HR, 133.739; 83: RR, 22.636; 83: 1min HRV, 10.734; 83: SBP, 156.0; 83: DBP, 109.0; 83: MAP, 124.667; 83: LR IV BOLUS -, 1000 ML; 84: HR:, 132.264; 84: RR, 25.761; 84: SpO2, 96.519; 84: 1min HRV, 12.989; 85: HR, 129.170; 85: SpO2, 96.674; 85: 1min HRV, 12.830; 85: 5min HRV, 13.946; 86: HR, 131.635; 86: SpO2, 96.712; 86: 1min HRV, 16.313; 87: HR, 129.811; 87: RR, 20.0; 87: SpO2, 96.075; 87: 1min HRV, 9.957; 88: HR, 128.827; 88: RR, 21.231; 88: SpO2, 96.596; 88: 1min HRV, 12.831; 89: HR, 126.340; 89: RR, 20.057; 89: SpO2, 97.302; 89: 1min HRV, 10.653; 90: HR, 128.415; 90: RR, 17.208; 90: SpO2, 96.358; 90: 1min HRV, 11.254; 90: 5min HRV, 13.239; 91: HR, 125.577; 91: RR, 20.981; 91: SpO2, 97.0; 91: 1min HRV, 12.190; 91: SBP, 167.0; 91: DBP, 108.0; 91: MAP, 127.667; 92: HR, 124.604; 92: RR, 16.547; 92: SpO2, 97.321; 92: 1min HRV, 12.536; 93: HR, 125.811; 93: RR, 20.660; 93: SpO2, 96.755; 93: 1min HRV, 7.732; 94: HR, 122.830; 94: RR, 22.811; 94: SpO2, 97.038; 94: 1min HRV, 16.489; 95: HR, 120.717; 95: RR, 22.849; 95: SpO2, 96.755; 95: 1min HRV, 16.859; 95: 5min HRV, 15.336; 95: SBP, 167.0; 95: DBP, 108.0; 95: MAP, 127.667; 96: HR, 121.692; 96: RR, 25.192; 96: SpO2, 96.712; 96: Perf, 0.877; 96: 1min HRV, 7.205; 97: HR, 121.679; 97: RR, 22.830; 97: SpO2, 96.264; 97: Perf, 0.895; 97: 1min HRV, 13.014; 98: HR, 120.462; 98: RR, 20.635; 98: SpO2, 96.019; 98: Perf, 0.886; 98: 1min HRV, 10.239; 99: HR, 120.056; 99: RR, 26.093; 99: SpO2, 96.037; 99: Perf, 0.836; 99: 1min HRV, 10.386; 100: HR, 119.925; 100: RR, 23.943; 100: SpO2, 95.0; 100: Perf, 0.802; 100: 1min HRV, 19.736; 100: 5min HRV, 13.378; 101: HR, 123.292; 101: RR, 19.422; 101: SpO2, 96.020; 101: Perf, 0.8; 101: 1min HRV, 26.040; 102: SARS-COV-2 RNA, Not Detected; 102: HR, 129.909; 102: RR, 25.833; 102: SpO2, 97.098; 102: Perf, 0.8; 102: 1min HRV, 15.681; 103: HR, 128.442; 103: RR, 28.347; 103: SpO2, 97.75; 103: Perf, 0.757; 103: 1min HRV, 12.615; 104: HR, 125.321; 104: RR, 28.0; 104: SpO2, 98.660; 104: Perf, 0.692; 104: 1min HRV, 7.775; 105: HR, 125.537; 105: RR, 49.0; 105: SpO2, 97.444; 105: Perf, 0.71; 105: 1min HRV, 12.504; 105: 5min HRV, 17.522; 106: HR, 124.577; 106: SpO2, 98.481; 106: Perf, 0.752; 106: 1min HRV, 10.585; 106: SBP, 172.0; 106: DBP, 120.0; 106: MAP, 137.333; 107: HR, 123.264; 107: SpO2, 98.566; 107: Perf, 0.76; 107: 1min HRV, 9.122; 108: WAM DIFTYP, AUTO; 108: HEMOGLOBIN (HGB), 13.5 g/dL; 108: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.12 K/uL; 108: BASOPHIL ABSOLUTE (AUTO DIFF), 0.12 K/uL; 108: LYMPHOCYTE % (AUTO DIFF), 9.3 %; 108: NEUTROPHIL ABSOLUTE (AUTO DIFF), 11.26 K/uL; 108: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 34.2 pg; 108: MONOCYTE ABSOLUTE (AUTO DIFF), 1.10 K/uL; 108: NEUTROPHIL % (AUTO DIFF), 80.8 %; 108: EOSINOPHIL % (AUTO DIFF), 0.2 %; 108: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 108: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.9 %; 108: BASOPHIL % (AUTO DIFF), 0.9 %; 108: HEMATOCRIT (HCT), 40.8 %; 108: WHITE BLOOD CELLS (WBC), 13.9 K/uL; 108: MONOCYTE % (AUTO DIFF), 7.9 %; 108: RED BLOOD CELLS (RBC), 3.95 MIL/uL; 108: PLATELET COUNT (PLT), 215 K/uL; 108: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.29 K/uL; 108: MEAN CORPUSCULAR VOLUME (MCV), 103.3 fL; 108: RED CELL DISTRIBUTION WIDTH (RDW), 12.8 %; 108: NRBC PERCENT (HEMATOLOGY), 0.0 %; 108: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.1 g/dL; 108: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 108: HR, 123.192; 108: SpO2, 95.923; 108: Perf, 0.761; 108: 1min HRV, 11.873; 109: HR, 124.208; 109: SpO2, 96.340; 109: Perf, 0.791; 109: 1min HRV, 4.982; 110: HR, 125.692; 110: SpO2, 96.231; 110: Perf, 0.8; 110: 1min HRV, 5.283; 110: 5min HRV, 9.970; 111: HR, 126.623; 111: SpO2, 95.642; 111: Perf, 0.8; 111: 1min HRV, 5.043; 112: HR, 126.434; 112: SpO2, 97.113; 112: Perf, 0.8; 112: 1min HRV, 11.187; 113: HR, 127.231; 113: SpO2, 97.365; 113: Perf, 0.800; 113: 1min HRV, 10.667; 114: HR, 126.415; 114: SpO2, 97.868; 114: Perf, 0.876; 114: 1min HRV, 6.807; 115: HR, 126.096; 115: SpO2, 96.65; 115: Perf, 0.883; 115: 1min HRV, 6.921; 115: 5min HRV, 8.705; 116: HR, 121.943; 116: SpO2, 95.358; 116: Perf, 0.908; 116: 1min HRV, 6.774; 117: HR, 121.593; 117: SpO2, 94.630; 117: Perf, 0.94; 117: 1min HRV, 6.756; 118: HR, 122.365; 118: SpO2, 96.283; 118: Perf, 0.94; 118: 1min HRV, 3.852; 119: HR, 123.075; 119: SpO2, 97.302; 119: Perf, 0.950; 119: 1min HRV, 5.567; 0: Age, 52; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.5; 0: Triage HR, 144.0; 0: Triage RR, 18.0; 0: Triage SBP, 152.0; 0: Triage DBP, 98.0; 0: Triage acuity, 2-Emergent; 0: CC, EAR PAIN",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, I noted that the patient\u2019s heart rate and respiratory rate are both persistently elevated above normal thresholds. Next, I observed that the patient\u2019s white blood cell count is 13.9 K/uL, which is also above normal limits. Then, I considered the possible infectious source suggested by the chief complaint (ear pain) alongside these abnormal vitals and lab findings. Collectively, these factors indicate a high likelihood that the patient is at risk of developing sepsis within 12 hours.",
        "claims": [
            "The patient's heart rate is persistently elevated above normal thresholds.",
            "The patient's respiratory rate is persistently elevated above normal thresholds.",
            "The patient's white blood cell count is 13.9 K/uL.",
            "A white blood cell count of 13.9 K/uL is above normal limits.",
            "The patient's chief complaint is ear pain.",
            "The abnormal vitals and lab findings suggest a possible infectious source.",
            "Collectively, these factors indicate a high likelihood that the patient is at risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient's heart rate is persistently elevated above normal thresholds.",
            "The patient's respiratory rate is persistently elevated above normal thresholds.",
            "The patient's white blood cell count is 13.9 K/uL.",
            "A white blood cell count of 13.9 K/uL is above normal limits.",
            "The abnormal vitals and lab findings suggest a possible infectious source.",
            "Collectively, these factors indicate a high likelihood that the patient is at risk of developing sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.7,
            0.8,
            1.0,
            1.0,
            0.5,
            0.3
        ],
        "alignment_category": [
            2,
            3,
            2,
            2,
            9,
            4
        ],
        "alignment_reasonings": [
            "An elevated heart rate (>90 bpm) is one of the criteria for SIRS, which relates to systemic inflammation and early signs of sepsis. The claim mentions that the heart rate is persistently elevated, aligning quite well with this category. However, since the claim does not specify the exact heart rate or mention any additional SIRS criteria, the alignment is not perfect but quite strong.",
            "An elevated respiratory rate is one of the criteria for a high qSOFA score, which is used to flag the risk of sepsis-related organ dysfunction and mortality. While the claim specifies the respiratory rate is \"persistently elevated above normal thresholds,\" it does not specify if it meets the exact qSOFA criterion (respiratory rate\u202f\u2265\u202f22\u202f/min). However, the persistent elevation strongly suggests a potential qSOFA alignment, warranting a high alignment rating.",
            "The claim directly specifies an elevated white blood cell count, which is listed explicitly as one of the SIRS criteria (WBC\u202f>\u202f12,000/\u00b5L). This aligns perfectly with the criteria for identifying systemic inflammation consistent with early sepsis.",
            "An elevated white blood cell count (>12,000/\u00b5L) is explicitly one of the SIRS criteria, which indicates systemic inflammation and early signs of sepsis. This claim matches the SIRS criteria fully, resulting in perfect alignment.",
            "The claim points to suspicion of an infection due to abnormal vitals and lab findings, which suggests the need for further investigation, such as administering antibiotics or drawing cultures. However, it doesn't specify such actions were taken, resulting in a moderate alignment with the sepsis risk assessment category focused on early antibiotic or culture orders.",
            "The claim speaks generally about a high likelihood of sepsis risk, aligning with the concept of an early warning score predicting imminent clinical deterioration. However, there are no specific vitals or scores provided, so the alignment is weak. The A NEWS score aggregates multiple factors similar to how the claim suggests a collective assessment, albeit non-specific."
        ],
        "final_alignment_score": 0.7166666666666667,
        "accuracy": 1
    },
    {
        "input": "2: HR, 130.0; 2: RR, 18.0; 2: SpO2, 99.0; 2: SBP, 150.0; 2: DBP, 80.0; 2: MAP, 103.333; 2: Temp, 100.8; 49: POC PH (V) ISTAT, 7.43; 49: POC TCO2 (V) ISTAT, 28 mmol/L; 49: POC PO2 (V) ISTAT, 32 mmHg; 49: POC BASE EXCESS ISTAT, 2 mmol/L; 49: POC LACTATE ISTAT, 1.79 mmol/L; 49: POC O2 SATURATION ISTAT VENOUS, 63 %; 49: POC HCO3 (V) ISTAT, 26.6 mmol/L; 49: POC PCO2 (V) ISTAT, 40.5 mmHg; 57: SpO2, 98.706; 58: HR, 115.429; 58: RR, 34.846; 58: SpO2, 98.917; 58: Perf, 0.15; 58: 1min HRV, 7.583; 59: HR, 114.293; 59: RR, 21.190; 59: SpO2, 98.792; 59: Perf, 0.15; 59: 1min HRV, 10.194; 60: HR, 111.712; 60: RR, 19.220; 60: SpO2, 98.419; 60: 1min HRV, 7.770; 60: 5min HRV, 10.260; 60: Temp, 99.8; 61: HR, 113.948; 61: RR, 20.172; 61: SpO2, 97.979; 61: 1min HRV, 12.083; 62: HR, 111.25; 62: RR, 19.85; 62: SpO2, 99.909; 62: Perf, 0.12; 62: 1min HRV, 8.237; 63: HR, 112.828; 63: RR, 19.5; 63: SpO2, 100.0; 63: Perf, 0.08; 63: 1min HRV, 9.478; 64: HR, 115.017; 64: RR, 21.339; 64: SpO2, 99.333; 64: Perf, 0.087; 64: 1min HRV, 9.341; 65: HR, 113.879; 65: RR, 18.155; 65: SpO2, 98.75; 65: Perf, 0.1; 65: 1min HRV, 9.050; 65: 5min HRV, 11.233; 66: HR, 112.610; 66: RR, 19.169; 66: SpO2, 93.7; 66: 1min HRV, 7.226; 67: HR, 109.241; 67: RR, 20.914; 67: SpO2, 97.846; 67: 1min HRV, 16.590; 68: HR, 109.780; 68: RR, 25.322; 68: SpO2, 100.0; 68: 1min HRV, 6.405; 69: HR, 115.678; 69: RR, 21.390; 69: SpO2, 97.6; 69: 1min HRV, 13.991; 70: HR, 119.172; 70: RR, 24.172; 70: 1min HRV, 12.028; 70: 5min HRV, 20.794; 71: HR, 114.431; 71: RR, 19.983; 71: SpO2, 99.190; 71: 1min HRV, 6.842; 72: WAM DIFTYP, AUTO; 72: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.5 g/dL; 72: EOSINOPHIL % (AUTO DIFF), 0.4 %; 72: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 21.7 pg; 72: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.03 K/uL; 72: HEMOGLOBIN (HGB), 11.2 g/dL; 72: BASOPHIL % (AUTO DIFF), 0.4 %; 72: MEAN CORPUSCULAR VOLUME (MCV), 69.1 fL; 72: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.16 K/uL; 72: RED CELL DISTRIBUTION WIDTH (RDW), 14.6 %; 72: PLATELET COUNT (PLT), 284 K/uL; 72: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 72: HEMATOCRIT (HCT), 35.6 %; 72: NRBC PERCENT (HEMATOLOGY), 0.0 %; 72: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 72: NEUTROPHIL % (AUTO DIFF), 81.5 %; 72: RED BLOOD CELLS (RBC), 5.15 MIL/uL; 72: MONOCYTE ABSOLUTE (AUTO DIFF), 0.76 K/uL; 72: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 72: MONOCYTE % (AUTO DIFF), 6.9 %; 72: WHITE BLOOD CELLS (WBC), 11.1 K/uL; 72: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 72: NEUTROPHIL ABSOLUTE (AUTO DIFF), 9.02 K/uL; 72: LYMPHOCYTE % (AUTO DIFF), 10.5 %; 72: HR, 114.797; 72: RR, 16.220; 72: SpO2, 99.0; 72: 1min HRV, 12.736; 73: HR, 116.593; 73: RR, 22.322; 73: SpO2, 99.667; 73: 1min HRV, 10.852; 74: INR, 1.1; 74: PROTHROMBIN TIME, 13.7 seconds; 74: HR, 114.271; 74: RR, 15.136; 74: SpO2, 99.158; 74: 1min HRV, 13.033; 75: PART. THROMBOPLASTIN TIME, 26.9 seconds; 75: HR, 115.983; 75: RR, 18.569; 75: SpO2, 99.172; 75: Perf, 0.335; 75: 1min HRV, 9.179; 75: 5min HRV, 11.055; 76: HR, 117.833; 76: RR, 20.333; 76: SpO2, 98.857; 76: Perf, 0.339; 76: 1min HRV, 20.298; 77: HR, 119.635; 77: RR, 18.315; 77: SpO2, 97.810; 77: 1min HRV, 11.138; 78: HR, 118.458; 78: RR, 15.915; 78: SpO2, 98.906; 78: 1min HRV, 7.851; 78: SBP, 136.0; 78: DBP, 86.0; 78: MAP, 102.667; 79: HR, 118.390; 79: RR, 21.864; 79: SpO2, 97.0; 79: 1min HRV, 10.976; 80: HR, 116.345; 80: RR, 19.190; 80: SpO2, 92.25; 80: 1min HRV, 6.229; 80: 5min HRV, 12.280; 81: HR, 117.068; 81: RR, 16.475; 81: SpO2, 100.0; 81: 1min HRV, 9.360; 82: HR, 114.948; 82: RR, 13.672; 82: SpO2, 99.0; 82: 1min HRV, 8.781; 83: HR, 113.831; 83: RR, 17.407; 83: SpO2, 98.0; 83: 1min HRV, 9.350; 84: SPECIFIC GRAVITY, URINE (UA): 1.014; 84: PROTEIN, URINE (UA): Negative; 84: GLUCOSE, URINE (UA): Negative; 84: PH, URINE (UA): 7.0; 84: NITRITE, URINE (UA): Negative; 84: LEUKOCYTE ESTERASE, URINE (UA): Negative; 84: KETONE, URINE (UA): Negative; 84: BLOOD, URINE (UA): Negative; 84: HR, 114.525; 84: RR, 19.186; 84: SpO2, 99.111; 84: 1min HRV, 12.467; 85: HR, 112.828; 85: RR, 16.103; 85: SpO2, 98.0; 85: 1min HRV, 8.069; 85: 5min HRV, 11.248; 85: SBP, 141.0; 85: DBP, 83.0; 85: MAP, 102.333; 85: Temp, 102.6; 86: HR, 119.357; 86: RR, 19.462; 86: SpO2, 87.762; 86: 1min HRV, 11.205; 87: HR, 114.0; 87: 1min HRV, 2.966; 90: POTASSIUM, 3.7 mmol/L; 90: EGFR REFIT WITHOUT RACE (2021), 89 mL/min/1.73 m2; 90: PROTEIN TOTAL, 7.5 g/dL; 90: ALKALINE PHOSPHATASE, 167 U/L; 90: BILIRUBIN TOTAL, 0.7 mg/dL; 90: CO2, 23 mmol/L; 90: SODIUM, 138 mmol/L; 90: CREATININE, 0.82 mg/dL; 90: ALBUMIN, 4.7 g/dL; 90: CORRECTED CALCIUM, 9.0 mg/dL; 90: ALT (SGPT), 25 U/L; 90: AST (SGOT), 14 U/L; 90: CHLORIDE, 101 mmol/L; 90: GLOBULIN, 2.8 g/dL; 90: BLOOD UREA NITROGEN (BUN), 14 mg/dL; 90: ANION GAP, 14 mmol/L; 90: GLUCOSE, 111 mg/dL; 90: CALCIUM, 9.6 mg/dL; 90: 5min HRV, 15.033; 92: RSV, Not Detected; 92: INFLUENZA B, Not Detected; 92: INFLUENZA A, Not Detected; 92: SARS-COV-2 RNA, Not Detected; 95: LR IV BOLUS -, 1000 ML; 96: KETOROLAC, 30 MG/ML (1 ML) INJ SOLN; 100: HR, 103.0; 100: RR, 25.0; 100: SpO2, 97.0; 100: SBP, 126.0; 100: DBP, 80.0; 100: MAP, 95.333; 0: Age, 44; 0: Gender, F; 0: Race, Black or African American; 0: Means of arrival, Self; 0: Triage Temp, 38.2; 0: Triage HR, 130.0; 0: Triage RR, 18.0; 0: Triage SBP, 150.0; 0: Triage DBP, 80.0; 0: Triage acuity, 2-Emergent; 0: CC, HIP PAIN",
        "answer": false,
        "llm_answer": "Yes",
        "llm_explanation": "First, I checked for signs of infection, including fever and potential source (hip pain). Next, I looked for clinical indicators like tachycardia (HR > 130) and elevated temperature (>38\u00b0C), which satisfy at least two SIRS criteria. I then examined serial vitals and labs (e.g., lactate, WBC count) to see if the patient\u2019s status was worsening or stabilizing, noting ongoing tachycardia, fever, and occasional oxygen saturation drops. Finally, synthesizing these findings led to the conclusion that the patient is at high risk of developing sepsis within 12 hours.",
        "claims": [
            "I checked for signs of infection, including fever and potential source (hip pain).",
            "I looked for clinical indicators like tachycardia (HR > 130) and elevated temperature (>38\u00b0C).",
            "Tachycardia and elevated temperature satisfy at least two SIRS criteria.",
            "I examined serial vitals and labs, including lactate and WBC count.",
            "I assessed the patient's status to determine if it was worsening or stabilizing.",
            "I noted ongoing tachycardia in the patient.",
            "I noted that the patient had a fever.",
            "I noted occasional drops in oxygen saturation.",
            "Synthesizing these findings led to the conclusion that the patient is at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "I checked for signs of infection, including fever and potential source (hip pain).",
            "I looked for clinical indicators like tachycardia (HR > 130) and elevated temperature (>38\u00b0C).",
            "Tachycardia and elevated temperature satisfy at least two SIRS criteria.",
            "I examined serial vitals and labs, including lactate and WBC count.",
            "I noted ongoing tachycardia in the patient.",
            "I noted that the patient had a fever.",
            "Synthesizing these findings led to the conclusion that the patient is at high risk of developing sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.3,
            0.7,
            1.0,
            0.3,
            0.9,
            0.5,
            0.3
        ],
        "alignment_category": [
            9,
            2,
            2,
            5,
            2,
            2,
            4
        ],
        "alignment_reasonings": [
            "The claim indicates an assessment for infection through checking for fever and a potential source (hip pain). This aligns somewhat with the category of Early Antibiotic/Culture Orders, as it reflects clinical suspicion of infection. However, it does not mention concrete actions like administering antibiotics or drawing cultures, which would strengthen the alignment.",
            "The claim mentions tachycardia and elevated temperature, both of which are part of the SIRS criteria. The heart rate is significantly higher than the threshold (>90 bpm), strengthening the alignment with SIRS. However, since there are no specific values given for any of the other SIRS criteria (e.g., respiratory rate, WBC), the alignment isn't perfect but still substantial.",
            "The claim clearly states the presence of tachycardia and elevated temperature, which are both explicitly listed under the SIRS criteria. Meeting at least two SIRS criteria is used to identify systemic inflammation consistent with early sepsis. Therefore, the alignment with the SIRS Positivity category is direct and complete.",
            "The mention of lactate directly aligns with the category concerning serum lactate levels, which are significant in assessing sepsis risk. However, the claim includes multiple vitals and labs, diluting the focus on lactate alone. Hence, the alignment rating is low as it doesn't specifically indicate an elevated lactate level, which would strongly align with this category.",
            "Ongoing tachycardia (heart rate >90 bpm) is explicitly listed among the SIRS criteria, which identify systemic inflammation consistent with early sepsis. The claim directly pertains to this category. While it strongly aligns as a singular sign, SIRS generally requires at least two criteria for full positivity, hence the slight reduction in alignment rating.",
            "A fever is part of the SIRS criteria (>38\u00b0C), directly tied to systemic inflammation and an early sepsis indication. However, the claim doesn't specify the precise temperature or additional SIRS indicators, so the alignment is partial rather than complete.",
            "The claim indicates a generalized conclusion leading to a high risk of sepsis, which resonates more with a comprehensive scoring system such as the NEWS score that considers multiple deranged vital signs to predict clinical deterioration. However, it lacks specific details on individual vital sign derangements or an actual NEWS score, resulting in a low alignment rating."
        ],
        "final_alignment_score": 0.5714285714285714,
        "accuracy": 0
    },
    {
        "input": "4: HR, 95.0; 4: RR, 14.0; 4: SpO2, 100.0; 4: SBP, 142.0; 4: DBP, 87.0; 4: MAP, 105.333; 4: Pain, 5.0; 4: Temp, 99.8; 38: POC PH (V) ISTAT, 7.40; 38: POC BASE EXCESS ISTAT, 5 mmol/L; 38: POC TCO2 (V) ISTAT, 32 mmol/L; 38: POC O2 SATURATION ISTAT VENOUS, 33 %; 38: POC HCO3 (V) ISTAT, 30.1 mmol/L; 38: POC PO2 (V) ISTAT, 21 mmHg; 38: POC LACTATE ISTAT, 0.78 mmol/L; 38: POC PCO2 (V) ISTAT, 48.5 mmHg; 42: SpO2, 95.429; 42: SBP, 132.0; 42: DBP, 79.0; 42: MAP, 96.667; 43: SpO2, 97.695; 43: Perf, 1.460; 44: SpO2, 97.655; 44: Perf, 1.709; 45: SpO2, 97.847; 45: Perf, 1.616; 46: SpO2, 97.431; 46: Perf, 1.456; 47: SpO2, 97.831; 47: Perf, 1.534; 48: SpO2, 97.729; 48: Perf, 1.598; 49: SpO2, 97.690; 49: Perf, 1.836; 50: SpO2, 96.966; 50: Perf, 1.689; 51: SpO2, 96.862; 51: Perf, 1.797; 52: SpO2, 98.153; 52: Perf, 1.553; 53: SpO2, 97.085; 53: Perf, 1.476; 54: SpO2, 96.828; 54: Perf, 1.469; 55: SpO2, 97.695; 55: Perf, 1.439; 56: SpO2, 97.276; 56: Perf, 1.384; 57: SpO2, 97.237; 57: Perf, 1.219; 58: SpO2, 96.508; 58: Perf, 1.283; 59: SpO2, 96.655; 59: Perf, 1.297; 59: Pain, 5.0; 60: SpO2, 98.153; 60: Perf, 1.605; 61: SpO2, 97.793; 61: Perf, 1.55; 62: SpO2, 98.559; 62: Perf, 1.715; 63: SpO2, 97.119; 63: Perf, 1.324; 64: SpO2, 97.5; 64: Perf, 1.432; 65: SpO2, 96.983; 65: Perf, 1.462; 66: SpO2, 96.931; 66: Perf, 1.344; 67: SpO2, 95.898; 67: Perf, 1.367; 68: SpO2, 97.932; 68: Perf, 2.006; 69: SpO2, 97.828; 69: Perf, 2.007; 70: SpO2, 97.322; 70: Perf, 1.516; 70: ACETAMINOPHEN, 325 MG PO TABS; 71: SpO, 2: 98.293; 71: Perf, 2.057; 71: LR IV BOLUS -, 1000 ML; 72: SpO, 2: 96.864; 72: Perf, 1.716; 73: SpO2, 97.525; 73: Perf, 1.641; 74: SpO2, 96.810; 74: Perf, 1.119; 75: SpO2, 96.576; 75: Perf, 1.097; 76: SpO2, 96.828; 76: Perf, 0.97; 77: SpO2, 96.729; 77: Perf, 0.978; 78: SpO2, 97.103; 78: Perf, 1.133; 79: SpO2, 97.746; 79: Perf, 0.817; 80: SpO2, 97.780; 80: Perf, 0.655; 81: SpO2, 98.121; 81: Perf, 0.556; 82: SpO2, 97.407; 82: Perf, 0.713; 83: SpO2, 97.845; 83: Perf, 0.911; 84: SpO2, 97.322; 84: Perf, 1.002; 85: SpO2, 96.763; 85: Perf, 0.847; 86: SpO2, 97.310; 86: Perf, 0.828; 87: SpO2, 97.542; 87: Perf, 0.783; 88: SpO2, 97.121; 88: Perf, 0.765; 89: HR, 87.0; 89: RR, 16.0; 89: SpO2, 97.763; 89: Perf, 1.317; 89: SBP, 137.0; 89: DBP, 80.0; 89: MAP, 99.0; 90: SpO2, 98.458; 90: Perf, 1.344; 90: SBP, 137.0; 90: DBP, 80.0; 90: MAP, 99.0; 91: SpO2, 97.586; 91: Perf, 1.229; 92: SpO2, 98.424; 92: Perf, 1.203; 93: WAM DIFTYP, AUTO; 93: BASOPHIL % (AUTO DIFF), 0.0 %; 93: MEAN CORPUSCULAR VOLUME (MCV), 90.7 fL; 93: MONOCYTE ABSOLUTE (AUTO DIFF), 0.40 K/uL; 93: MONOCYTE % (AUTO DIFF), 9.4 %; 93: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 93: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.2 %; 93: NEUTROPHIL % (AUTO DIFF), 62.1 %; 93: NEUTROPHIL ABSOLUTE (AUTO DIFF), 2.65 K/uL; 93: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 93: NRBC PERCENT (HEMATOLOGY), 0.0 %; 93: EOSINOPHIL % (AUTO DIFF), 0.2 %; 93: PLATELET COUNT (PLT), 140 K/uL; 93: BASOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 93: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.01 K/uL; 93: RED BLOOD CELLS (RBC), 4.85 MIL/uL; 93: WHITE BLOOD CELLS (WBC), 4.3 K/uL; 93: HEMATOCRIT (HCT), 44.0 %; 93: LYMPHOCYTE % (AUTO DIFF), 28.1 %; 93: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.3 pg; 93: RED CELL DISTRIBUTION WIDTH (RDW), 12.1 %; 93: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.3 g/dL; 93: HEMOGLOBIN (HGB), 14.2 g/dL; 93: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.20 K/uL; 93: SpO2, 97.776; 93: Perf, 1.051; 94: SpO2, 98.390; 94: Perf, 1.286; 95: SpO2, 97.458; 95: Perf, 1.696; 96: SpO2, 97.552; 96: Perf, 1.981; 97: SpO2, 98.136; 97: Perf, 2.354; 98: SpO2, 97.741; 98: Perf, 3.455; 99: SpO2, 97.525; 99: Perf, 3.604; 100: CORRECTED CALCIUM, 8.1 mg/dL; 100: AST (SGOT), 55 U/L; 100: EGFR FOR AFRICAN AMERICAN, 135 mL/min/1.73 m2; 100: CREATININE, 0.83 mg/dL; 100: BILIRUBIN TOTAL, 0.4 mg/dL; 100: CALCIUM, 8.5 mg/dL; 100: CO2, 26 mmol/L; 100: PROTEIN TOTAL, 7.4 g/dL; 100: SODIUM, 136 mmol/L; 100: EGFR REFIT WITHOUT RACE (2021), 116 mL/min/1.73 m2; 100: CHLORIDE, 99 mmol/L; 100: GLUCOSE, 97 mg/dL; 100: ALT (SGPT), 47 U/L; 100: POTASSIUM, 3.7 mmol/L; 100: ANION GAP, 11 mmol/L; 100: ALKALINE PHOSPHATASE, 67 U/L; 100: BLOOD UREA NITROGEN (BUN), 8 mg/dL; 100: GLOBULIN, 2.9 g/dL; 100: ALBUMIN, 4.5 g/dL; 100: SpO2, 98.0; 100: Perf, 2.318; 101: SpO2, 97.431; 101: Perf, 3.629; 102: SpO2, 97.441; 102: Perf, 3.987; 103: SpO2, 97.655; 103: Perf, 4.155; 104: SpO2, 97.644; 104: Perf, 5.328; 105: SpO2, 97.627; 105: Perf, 5.882; 106: SpO2, 98.069; 106: Perf, 4.651; 107: SpO2, 98.034; 107: Perf, 3.996; 108: SpO2, 97.224; 108: Perf, 4.485; 109: SpO2, 96.847; 109: Perf, 6.229; 110: SpO2, 97.241; 110: Perf, 5.401; 111: SpO2, 97.424; 111: Perf, 5.043; 112: SpO2, 97.695; 112: Perf, 4.544; 113: SpO2, 97.897; 113: Perf, 4.034; 114: SpO2, 97.898; 114: Perf, 3.892; 115: SpO2, 97.914; 115: Perf, 3.896; 116: SpO2, 97.983; 116: Perf, 3.929; 117: SpO2, 97.593; 117: Perf, 3.813; 118: SpO2, 97.845; 118: Perf, 3.414; 119: SpO2, 98.424; 119: Perf, 2.615; 0: Age, 30; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 37.7; 0: Triage HR, 95.0; 0: Triage RR, 14.0; 0: Triage SBP, 142.0; 0: Triage DBP, 87.0; 0: Triage acuity, 3-Urgent; 0: CC, GENERALIZED BODY ACHES,FEVER,HEADACHE",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I checked the patient\u2019s vital signs to see if they are abnormal, and they appear largely stable (HR under 100, no hypotension, normal respiratory rate). Next, I examined the lab values such as lactate, WBC count, and metabolic panel, and none suggest imminent sepsis (lactate is normal, WBC is not elevated). After that, I considered the patient\u2019s presenting symptoms (fever, aches, headache) alongside the absence of concerning trends like persistent hypotension or tachycardia. Because these findings do not point towards sepsis, the patient is not at high risk within the next 12 hours.",
        "claims": [
            "The patient's vital signs were checked for abnormalities.",
            "The patient's vital signs appear largely stable.",
            "The patient's heart rate is under 100.",
            "There is no hypotension in the patient.",
            "The patient's respiratory rate is normal.",
            "Lab values such as lactate, WBC count, and metabolic panel were examined.",
            "None of the lab values suggest imminent sepsis.",
            "The patient's lactate level is normal.",
            "The patient's WBC count is not elevated.",
            "The patient's presenting symptoms include fever, aches, and headache.",
            "There are no concerning trends such as persistent hypotension or tachycardia.",
            "The findings do not point towards sepsis.",
            "The patient is not at high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "There is no hypotension in the patient.",
            "There are no concerning trends such as persistent hypotension or tachycardia."
        ],
        "alignment_scores": [
            0.2,
            0.3
        ],
        "alignment_category": [
            7,
            7
        ],
        "alignment_reasonings": [
            "The claim is about the absence of hypotension, which is directly related to the category for sepsis-associated hypotension. However, the absence of hypotension does not inform us about the presence or risk of sepsis, making the alignment quite weak. This is why the alignment rating is low.",
            "The claim mentions the absence of persistent hypotension, which aligns with the category of Sepsis-Associated Hypotension. However, the statement is about the absence of the risk factor rather than the presence, making the alignment weak but recognizable."
        ],
        "final_alignment_score": 0.25,
        "accuracy": 1
    },
    {
        "input": "5: HR, 113.0; 5: RR, 18.0; 5: SpO2, 100.0; 5: SBP, 119.0; 5: DBP, 63.0; 5: MAP, 81.667; 5: Temp, 97.9; 48: HR, 107.171; 48: RR, 21.667; 48: 1min HRV, 7.060; 48: SBP, 132.0; 48: DBP, 86.0; 48: MAP, 101.333; 49: HR, 103.707; 49: RR, 15.017; 49: 1min HRV, 7.922; 50: HR, 101.559; 50: RR, 13.593; 50: 1min HRV, 13.327; 50: 5min HRV, 15.889; 51: HR, 104.948; 51: RR, 18.052; 51: 1min HRV, 12.539; 52: HR, 108.780; 52: RR, 13.593; 52: 1min HRV, 9.291; 53: HR, 107.305; 53: RR, 16.288; 53: 1min HRV, 21.887; 54: HR, 107.741; 54: RR, 17.103; 54: 1min HRV, 9.699; 55: HR, 104.525; 55: RR, 13.729; 55: 1min HRV, 16.064; 55: 5min HRV, 16.311; 56: HR, 103.672; 56: RR, 16.586; 56: 1min HRV, 11.985; 57: HR, 98.949; 57: RR, 16.254; 57: 1min HRV, 18.393; 58: HR, 102.288; 58: RR, 15.847; 58: 1min HRV, 24.567; 59: HR, 101.603; 59: RR, 16.172; 59: 1min HRV, 14.703; 60: HR, 99.780; 60: RR, 19.017; 60: 1min HRV, 11.709; 60: 5min HRV, 18.947; 61: HR, 99.810; 61: RR, 20.776; 61: 1min HRV, 5.400; 62: HR, 100.475; 62: RR, 17.441; 62: 1min HRV, 4.773; 63: HR, 101.138; 63: RR, 17.345; 63: 1min HRV, 24.163; 64: HR, 100.864; 64: RR, 19.864; 64: 1min HRV, 14.177; 65: HR, 99.373; 65: RR, 19.254; 65: 1min HRV, 5.808; 65: 5min HRV, 13.977; 66: HR, 99.138; 66: RR, 18.052; 66: 1min HRV, 6.775; 67: HR, 101.780; 67: RR, 18.068; 67: 1min HRV, 6.950; 68: HR, 103.224; 68: RR, 16.897; 68: 1min HRV, 11.861; 69: HR, 102.525; 69: RR, 18.661; 69: 1min HRV, 25.985; 70: HR, 100.695; 70: RR, 18.576; 70: 1min HRV, 6.207; 70: 5min HRV, 16.112; 71: HR, 101.224; 71: RR, 18.5; 71: 1min HRV, 5.814; 72: HR, 101.203; 72: RR, 18.339; 72: 1min HRV, 30.666; 73: HR, 100.517; 73: RR, 18.086; 73: 1min HRV, 4.284; 74: HR, 101.390; 74: RR, 18.661; 74: 1min HRV, 4.836; 75: HR, 100.153; 75: RR, 18.356; 75: SpO2, 100.0; 75: 1min HRV, 5.396; 75: 5min HRV, 14.719; 75: SBP, 125.0; 75: DBP, 78.0; 75: MAP, 93.667; 76: HR, 100.586; 76: RR, 19.707; 76: 1min HRV, 6.736; 76: SBP, 125.0; 76: DBP, 78.0; 76: MAP, 93.667; 77: HR, 101.0; 77: RR, 19.915; 77: 1min HRV, 25.271; 78: HR, 102.207; 78: RR, 18.776; 78: 1min HRV, 7.651; 79: HR, 104.186; 79: RR, 19.339; 79: 1min HRV, 23.564; 80: HR, 99.559; 80: RR, 18.339; 80: 1min HRV, 5.302; 80: 5min HRV, 18.504; 81: HR, 99.276; 81: RR, 16.224; 81: 1min HRV, 10.391; 81: LR IV BOLUS -, 1000 ML; 82: HR:, 100.0; 82: RR, 14.407; 82: 1min HRV, 21.803; 83: POC PH (V) ISTAT, 7.41; 83: POC PCO2 (V) ISTAT, 35.4 mmHg; 83: POC TCO2 (V) ISTAT, 24 mmol/L; 83: POC HCO3 (V) ISTAT, 22.5 mmol/L; 83: POC BASE EXCESS ISTAT, -2 mmol/L; 83: POC PO2 (V) ISTAT, 37 mmHg; 83: POC O2 SATURATION ISTAT VENOUS, 72 %; 83: POC LACTATE ISTAT, 2.36 mmol/L; 83: HR, 99.948; 83: RR, 15.759; 83: 1min HRV, 10.178; 84: HR, 103.169; 84: RR, 16.407; 84: 1min HRV, 7.486; 85: HR, 100.627; 85: RR, 17.203; 85: 1min HRV, 18.625; 85: 5min HRV, 16.917; 86: HR, 100.121; 86: RR, 17.862; 86: 1min HRV, 14.181; 87: HR, 104.373; 87: RR, 16.220; 87: 1min HRV, 31.188; 88: HR, 106.397; 88: RR, 17.448; 88: 1min HRV, 25.171; 89: HR, 105.441; 89: RR, 20.017; 89: 1min HRV, 20.929; 90: HR, 103.661; 90: RR, 19.424; 90: 1min HRV, 12.967; 90: 5min HRV, 24.426; 91: HR, 102.724; 91: RR, 20.190; 91: 1min HRV, 10.363; 92: HR, 103.864; 92: RR, 19.576; 92: 1min HRV, 16.807; 93: HR, 103.259; 93: RR, 16.793; 93: 1min HRV, 26.245; 94: HR, 105.390; 94: RR, 19.475; 94: 1min HRV, 25.257; 95: SARS-COV-2 RNA, Not Detected; 95: HR, 101.914; 95: RR, 19.966; 95: 1min HRV, 6.939; 95: 5min HRV, 19.694; 96: HR, 101.814; 96: RR, 19.458; 96: 1min HRV, 6.218; 97: HR, 103.153; 97: RR, 19.356; 97: 1min HRV, 15.343; 98: HR, 103.741; 98: RR, 19.431; 98: 1min HRV, 11.374; 99: HR, 105.475; 99: RR, 18.034; 99: 1min HRV, 18.055; 100: HR, 101.655; 100: RR, 20.897; 100: 1min HRV, 14.612; 100: 5min HRV, 16.578; 101: ALKALINE PHOSPHATASE, 156 U/L; 101: GLOBULIN, 1.7 g/dL; 101: POTASSIUM, 4.1 mmol/L; 101: CHLORIDE, 102 mmol/L; 101: LIPASE, 70 U/L; 101: AST (SGOT), 36 U/L; 101: EGFR REFIT WITHOUT RACE (2021), 65 mL/min/1.73 m2; 101: ANION GAP, 13 mmol/L; 101: PROTEIN TOTAL, 5.7 g/dL; 101: CO2, 21 mmol/L; 101: ALBUMIN, 4.0 g/dL; 101: CALCIUM, 9.7 mg/dL; 101: BLOOD UREA NITROGEN (BUN), 15 mg/dL; 101: ALT (SGPT), 14 U/L; 101: BILIRUBIN TOTAL, 0.3 mg/dL; 101: SODIUM, 136 mmol/L; 101: CORRECTED CALCIUM, 9.7 mg/dL; 101: CREATININE, 1.23 mg/dL; 101: GLUCOSE, 169 mg/dL; 101: HR, 104.136; 101: RR, 22.610; 101: 1min HRV, 22.822; 102: HR, 109.593; 102: RR, 18.373; 102: 1min HRV, 24.401; 103: HR, 106.448; 103: RR, 19.793; 103: 1min HRV, 68.019; 104: HR, 106.407; 104: RR, 17.610; 104: 1min HRV, 13.481; 105: HIGH SENSITIVITY TROPONIN, 7 ng/L; 105: HR, 104.328; 105: RR, 20.259; 105: SpO2, 100.0; 105: 1min HRV, 10.131; 105: 5min HRV, 35.905; 106: HR, 107.525; 106: RR, 18.576; 106: 1min HRV, 13.288; 107: HR, 106.458; 107: RR, 18.542; 107: 1min HRV, 9.333; 108: HR, 103.862; 108: RR, 24.103; 108: 1min HRV, 5.588; 109: HR, 103.831; 109: RR, 22.441; 109: 1min HRV, 5.072; 110: HR, 105.603; 110: RR, 21.655; 110: 1min HRV, 14.536; 110: 5min HRV, 12.758; 111: HR, 108.847; 111: RR, 19.763; 111: 1min HRV, 18.562; 112: HR, 106.695; 112: RR, 21.356; 112: 1min HRV, 23.629; 113: HR, 107.224; 113: RR, 18.172; 113: 1min HRV, 12.075; 114: HR, 106.678; 114: RR, 20.932; 114: 1min HRV, 20.000; 115: HR, 106.810; 115: RR, 18.948; 115: 1min HRV, 24.795; 115: 5min HRV, 21.082; 116: HR, 108.983; 116: RR, 22.593; 116: 1min HRV, 24.284; 117: HR, 115.508; 117: RR, 21.136; 117: 1min HRV, 18.287; 118: HR, 109.741; 118: RR, 20.052; 118: 1min HRV, 14.957; 119: HR, 105.932; 119: RR, 21.271; 119: 1min HRV, 22.043; 0: Age, 65; 0: Gender, M; 0: Race, Native Hawaiian or Other Pacific Islander; 0: Means of arrival, Self; 0: Triage Temp, 36.6; 0: Triage HR, 113.0; 0: Triage RR, 18.0; 0: Triage SBP, 119.0; 0: Triage DBP, 63.0; 0: Triage acuity, 3-Urgent; 0: CC, PALPITATIONS,ABDOMINAL PAIN",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "First, I noted that the patient\u2019s temperature is not elevated and there is no persistent hypotension based on the MAP and SBP values, which addresses whether key sepsis criteria (fever or hypotension) are met. Next, I observed that the patient\u2019s lactate level is only mildly elevated at 2.36 mmol/L, so I considered whether additional signs of end-organ damage are present. Then, I checked for signs of respiratory distress and saw only mild tachypnea, which suggests no severe respiratory compromise. Finally, I integrated these findings and concluded that, overall, the patient does not appear to be at high risk of developing sepsis within 12 hours.",
        "claims": [
            "The patient's temperature is not elevated.",
            "There is no persistent hypotension based on the MAP and SBP values.",
            "Key sepsis criteria of fever or hypotension are not met.",
            "The patient's lactate level is mildly elevated at 2.36 mmol/L.",
            "I considered whether additional signs of end-organ damage are present.",
            "I checked for signs of respiratory distress.",
            "The patient only exhibits mild tachypnea.",
            "Mild tachypnea suggests no severe respiratory compromise.",
            "I integrated these findings.",
            "Overall, the patient does not appear to be at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient's temperature is not elevated.",
            "There is no persistent hypotension based on the MAP and SBP values.",
            "Key sepsis criteria of fever or hypotension are not met.",
            "The patient's lactate level is mildly elevated at 2.36 mmol/L."
        ],
        "alignment_scores": [
            0.2,
            0.5,
            0.3,
            0.9
        ],
        "alignment_category": [
            2,
            7,
            2,
            5
        ],
        "alignment_reasonings": [
            "The claim relates to temperature, which is one of the SIRS criteria. However, since the temperature is not elevated, it does not meet the required threshold for the SIRS temperature criterion. Therefore, the alignment is minimal, reflecting a lack of corroborative evidence for systemic inflammation related to early sepsis in this instance.",
            "The claim specifically mentions the absence of persistent hypotension, which directly relates to the criteria listed under Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or a \u226540 mmHg drop). Although the claim is worded in the negative (indicating the absence of risk), it nonetheless addresses the same parameters that define this category. Hence, there is moderate alignment due to the conceptual link to hypotension, albeit not indicating presence.",
            "The claim mentions the absence of fever and hypotension, which are components of SIRS criteria. This suggests a lack of evidence for systemic inflammation or shock, both important in sepsis risk assessment. However, since the claim is about criteria not being met, it's more about the absence of evidence rather than evidence of absence, resulting in a low alignment. Additionally, since multiple components of SIRS are required and only one is referenced (fever), the alignment is indirect and weak.",
            "The claim directly references an elevated lactate level of 2.36 mmol/L, which surpasses the threshold of \u22652 mmol/L mentioned in the Elevated Serum Lactate category. This elevation signals tissue hypoperfusion and increases the risk of sepsis mortality, aligning very well with the category, hence a high alignment rating. However, the term \"mildly elevated\" suggests the elevation isn't extreme, so it's slightly less than perfect alignment."
        ],
        "final_alignment_score": 0.475,
        "accuracy": 0
    },
    {
        "input": "3: HR, 74.0; 3: RR, 18.0; 3: SpO2, 94.0; 3: SBP, 113.0; 3: DBP, 71.0; 3: MAP, 85.0; 3: Pain, 4.0; 3: Temp, 99.7; 7: Pain, 3.0; 31: SpO2, 94.462; 31: SBP, 137.0; 31: DBP, 75.0; 31: MAP, 95.667; 32: SpO2, 93.0; 33: SpO2, 94.725; 33: Perf, 14.482; 34: SpO2, 94.914; 34: Perf, 18.411; 35: SpO2, 94.883; 35: Perf, 19.336; 36: SpO2, 94.982; 36: Perf, 16.918; 37: SpO2, 95.695; 37: Perf, 17.487; 38: SpO2, 95.690; 38: Perf, 17.235; 39: SpO2, 94.966; 39: Perf, 16.932; 40: SpO2, 94.559; 40: Perf, 16.699; 41: HR, 70.0; 41: RR, 18.0; 41: SpO2, 95.879; 41: Perf, 14.595; 41: SBP, 136.0; 41: DBP, 69.0; 41: MAP, 91.333; 41: Pain, 3.0; 42: SpO2, 95.7; 42: Perf, 17.597; 42: SBP, 136.0; 42: DBP, 69.0; 42: MAP, 91.333; 43: SpO2, 95.983; 43: Perf, 16.952; 44: SpO2, 96.0; 44: Perf, 18.613; 45: SpO2, 96.0; 45: Perf, 18.248; 46: SpO2, 94.881; 46: Perf, 17.846; 47: SpO2, 95.862; 47: Perf, 13.458; 48: SpO2, 96.254; 48: Perf, 14.139; 49: SpO2, 95.690; 49: Perf, 15.089; 50: SpO2, 96.153; 50: Perf, 14.664; 51: SpO2, 96.0; 51: Perf, 16.012; 52: SpO2, 96.034; 52: Perf, 16.036; 53: SpO2, 95.763; 53: Perf, 15.591; 56: SARS-COV-2 RNA, Not Detected; 56: INFLUENZA A, Not Detected; 56: RSV, Not Detected; 56: INFLUENZA B, Not Detected; 61: WAM DIFTYP, AUTO; 61: HEMATOCRIT (HCT), 41.4 %; 61: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 61: MONOCYTE ABSOLUTE (AUTO DIFF), 1.72 K/uL; 61: MEAN CORPUSCULAR VOLUME (MCV), 90.0 fL; 61: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.3 g/dL; 61: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 61: PLATELET COUNT (PLT), 222 K/uL; 61: BASOPHIL % (AUTO DIFF), 0.1 %; 61: NEUTROPHIL % (AUTO DIFF), 87.1 %; 61: NEUTROPHIL ABSOLUTE (AUTO DIFF), 17.23 K/uL; 61: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.7 %; 61: LYMPHOCYTE % (AUTO DIFF), 3.4 %; 61: RED BLOOD CELLS (RBC), 4.60 MIL/uL; 61: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.67 K/uL; 61: NRBC PERCENT (HEMATOLOGY), 0.0 %; 61: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.0 pg; 61: WHITE BLOOD CELLS (WBC), 19.8 K/uL; 61: HEMOGLOBIN (HGB), 13.8 g/dL; 61: MONOCYTE % (AUTO DIFF), 8.7 %; 61: EOSINOPHIL % (AUTO DIFF), 0.0 %; 61: RED CELL DISTRIBUTION WIDTH (RDW), 13.5 %; 61: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.13 K/uL; 61: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 71: SpO2, 95.972; 71: Perf, 19.384; 72: SpO2, 95.638; 72: Perf, 19.893; 73: SpO2, 95.593; 73: Perf, 18.497; 74: SpO2, 95.542; 74: Perf, 19.283; 75: SpO2, 95.259; 75: Perf, 19.124; 76: SpO2, 94.492; 76: Perf, 17.902; 77: POC PH (V) ISTAT, 7.44; 77: POC HCO3 (V) ISTAT, 28.5 mmol/L; 77: POC BASE EXCESS ISTAT, 4 mmol/L; 77: POC PO2 (V) ISTAT, 43 mmHg; 77: POC LACTATE ISTAT, 0.69 mmol/L; 77: POC TCO2 (V) ISTAT, 30 mmol/L; 77: POC PCO2 (V) ISTAT, 41.8 mmHg; 77: POC O2 SATURATION ISTAT VENOUS, 80 %; 77: SpO2, 94.0; 77: Perf, 15.710; 78: SpO2, 95.119; 78: Perf, 15.465; 79: SpO2, 95.136; 79: Perf, 15.434; 80: SpO2, 94.069; 80: Perf, 15.169; 81: SpO2, 94.831; 81: Perf, 14.358; 82: SpO2, 94.069; 82: Perf, 14.436; 83: SpO2, 94.0; 83: Perf, 16.667; 84: SpO2, 94.0; 84: Perf, 16.033; 85: HIGH SENSITIVITY TROPONIN, 14 ng/L; 85: SpO2, 94.0; 85: Perf, 14.911; 86: SpO2, 94.949; 86: Perf, 14.176; 87: SpO2, 95.052; 87: Perf, 15.782; 88: ALT (SGPT), 70 U/L; 88: BILIRUBIN TOTAL, 0.9 mg/dL; 88: CORRECTED CALCIUM, 9.1 mg/dL; 88: POTASSIUM, 3.2 mmol/L; 88: SODIUM, 139 mmol/L; 88: CREATININE, 1.40 mg/dL; 88: ALBUMIN, 4.1 g/dL; 88: GLOBULIN, 2.6 g/dL; 88: EGFR REFIT WITHOUT RACE (2021), 53 mL/min/1.73 m2; 88: ANION GAP, 13 mmol/L; 88: CO2, 27 mmol/L; 88: AST (SGOT), 72 U/L; 88: GLUCOSE, 156 mg/dL; 88: BLOOD UREA NITROGEN (BUN), 19 mg/dL; 88: PROTEIN TOTAL, 6.7 g/dL; 88: ALKALINE PHOSPHATASE, 133 U/L; 88: CALCIUM, 9.2 mg/dL; 88: CHLORIDE, 99 mmol/L; 88: SpO2, 95.407; 88: Perf, 13.756; 89: SpO2, 94.305; 89: Perf, 15.369; 90: SpO2, 94.103; 90: Perf, 15.427; 91: SpO2, 93.983; 91: Perf, 12.664; 92: SpO2, 93.190; 92: Perf, 15.533; 93: SpO2, 93.237; 93: Perf, 16.274; 94: SpO2, 93.407; 94: Perf, 12.725; 95: SpO2, 92.569; 95: Perf, 10.715; 96: SpO2, 94.034; 96: Perf, 13.330; 97: SpO2, 92.845; 97: Perf, 14.170; 98: SpO2, 93.254; 98: Perf, 12.813; 99: SpO2, 91.695; 99: Perf, 8.233; 100: SpO2, 92.690; 100: Perf, 13.570; 101: SpO2, 92.729; 101: Perf, 12.566; 102: SpO2, 92.448; 102: Perf, 15.272; 103: GLUCOSE, URINE (UA): Negative; 103: PH, URINE (UA): 5.0; 103: SPECIFIC GRAVITY, URINE (UA): 1.026; 103: NITRITE, URINE (UA): Negative; 103: KETONE, URINE (UA): Negative; 103: SpO2, 93.576; 103: Perf, 12.770; 104: SpO2, 91.466; 104: Perf, 12.215; 105: SpO2, 94.458; 105: Perf, 14.273; 106: SpO2, 93.458; 106: Perf, 11.702; 107: SpO2, 92.690; 107: Perf, 12.907; 108: SpO2, 92.475; 108: Perf, 12.899; 109: SpO2, 91.345; 109: Perf, 8.859; 110: SpO2, 92.492; 110: Perf, 13.471; 111: SpO2, 90.932; 111: Perf, 9.334; 112: SpO2, 95.172; 112: Perf, 14.262; 113: SpO2, 94.102; 113: Perf, 13.637; 114: SpO2, 93.0; 114: Perf, 13.566; 115: SpO2, 93.0; 115: Perf, 14.340; 116: SpO2, 93.0; 116: Perf, 13.576; 117: SpO2, 93.569; 117: Perf, 12.735; 118: SpO2, 94.407; 118: Perf, 8.632; 119: SpO2, 93.310; 119: Perf, 11.099; 0: Age, 73; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.6; 0: Triage HR, 74.0; 0: Triage RR, 18.0; 0: Triage SBP, 113.0; 0: Triage DBP, 71.0; 0: Triage acuity, 3-Urgent; 0: CC, FEVER",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I checked if the vital signs (blood pressure, heart rate, respiratory rate, temperature) showed signs of instability or shock, and they did not. Next, I examined whether the labs, especially lactate and white blood cell count, indicated severe infection or organ dysfunction: the WBC was elevated, but the lactate was normal. I then looked for additional criteria, such as altered mental status or very low oxygen saturation, and did not see clear evidence of these. Finally, given the combination of stable vitals and no marked signs of organ failure or high lactate, I did not find a high risk of sepsis within 12 hours.",
        "claims": [
            "The vital signs showed no signs of instability or shock.",
            "The labs indicated an elevated white blood cell count.",
            "The lactate level was normal.",
            "There was no evidence of altered mental status.",
            "There was no evidence of very low oxygen saturation.",
            "The combination of stable vitals and no marked signs of organ failure suggests a low risk of sepsis.",
            "I did not find a high risk of sepsis within 12 hours."
        ],
        "relevant_claims": [
            "There was no evidence of altered mental status.",
            "There was no evidence of very low oxygen saturation.",
            "The combination of stable vitals and no marked signs of organ failure suggests a low risk of sepsis."
        ],
        "alignment_scores": [
            0.3,
            0.2,
            0.7
        ],
        "alignment_category": [
            3,
            8,
            8
        ],
        "alignment_reasonings": [
            "The claim addresses the absence of altered mental status, one of the components for a high qSOFA score. While the lack of altered mentation means this specific criterion isn't met, it relates conceptually to the qSOFA assessment. However, since the claim reflects a non-confirmation rather than supporting evidence, the alignment is low.",
            "The claim about oxygen saturation indirectly relates to the SOFA criteria, which include PaO\u2082/FiO\u2082 ratio for respiratory assessment. However, the claim is about the absence of low oxygen saturation, suggesting oxygen levels are normal. While oxygen saturation itself isn't a direct SOFA measure, maintaining adequate oxygenation is relevant to avoiding SOFA criteria increases. The alignment is weak due to the lack of direct evidence of organ dysfunction shown in the claim.",
            "The claim mentions \"no marked signs of organ failure,\" which indirectly relates to the SOFA Score, as an increase in the SOFA Score is indicative of new organ dysfunction and sepsis risk. Since the claim indicates stability and lack of organ failure, it suggests a low risk of an increased SOFA Score. The alignment is indirect but meaningful, as the stability contrasts with the conditions that would elevate SOFA scores."
        ],
        "final_alignment_score": 0.39999999999999997,
        "accuracy": 1
    },
    {
        "input": "5: HR, 79.0; 5: RR, 18.0; 5: SpO2, 94.0; 5: SBP, 118.0; 5: DBP, 46.0; 5: MAP, 70.0; 5: Temp, 99.1; 69: WAM DIFTYP, AUTO; 69: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 69: WHITE BLOOD CELLS (WBC), 15.8 K/uL; 69: NEUTROPHIL ABSOLUTE (AUTO DIFF), 14.65 K/uL; 69: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.8 pg; 69: BASOPHIL % (AUTO DIFF), 0.3 %; 69: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.42 K/uL; 69: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 69: HEMOGLOBIN (HGB), 9.4 g/dL; 69: MONOCYTE ABSOLUTE (AUTO DIFF), 0.62 K/uL; 69: LYMPHOCYTE % (AUTO DIFF), 2.7 %; 69: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 69: NEUTROPHIL % (AUTO DIFF), 92.7 %; 69: EOSINOPHIL % (AUTO DIFF), 0.0 %; 69: MONOCYTE % (AUTO DIFF), 3.9 %; 69: MEAN CORPUSCULAR VOLUME (MCV), 94.9 fL; 69: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 69: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.06 K/uL; 69: HEMATOCRIT (HCT), 29.9 %; 69: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.4 g/dL; 69: RED CELL DISTRIBUTION WIDTH (RDW), 24.4 %; 69: NRBC PERCENT (HEMATOLOGY), 0.0 %; 69: PLATELET COUNT (PLT), 220 K/uL; 69: RED BLOOD CELLS (RBC), 3.15 MIL/uL; 80: HR, 79.0; 80: 1min HRV, 0.632; 80: SBP, 115.0; 80: DBP, 56.0; 80: MAP, 75.667; 81: HR, 77.627; 81: RR, 26.727; 81: SpO2, 95.828; 81: 1min HRV, 11.200; 82: HR, 74.552; 82: RR, 21.397; 82: SpO2, 90.466; 82: Perf, 1.034; 82: 1min HRV, 7.666; 83: HR, 72.559; 83: RR, 23.136; 83: SpO2, 92.373; 83: Perf, 1.478; 83: 1min HRV, 4.965; 84: HR, 71.259; 84: RR, 26.483; 84: SpO2, 92.741; 84: Perf, 1.973; 84: 1min HRV, 1.575; 84: 5min HRV, 26.452; 85: HR, 71.0; 85: RR, 24.576; 85: SpO2, 94.254; 85: Perf, 1.915; 85: 1min HRV, 4.954; 86: HR, 71.0; 86: RR, 21.237; 86: SpO2, 93.898; 86: Perf, 2.031; 86: 1min HRV, 0.982; 87: HR, 70.310; 87: RR, 21.121; 87: SpO2, 93.517; 87: Perf, 2.059; 87: 1min HRV, 4.349; 88: HR, 70.0; 88: RR, 20.712; 88: SpO2, 92.661; 88: Perf, 2.121; 88: 1min HRV, 0.977; 89: HR, 70.0; 89: RR, 20.259; 89: SpO2, 92.155; 89: Perf, 2.087; 89: 1min HRV, 7.373; 89: 5min HRV, 7.905; 90: HR, 69.949; 90: RR, 19.492; 90: SpO2, 92.610; 90: Perf, 2.144; 90: 1min HRV, 1.040; 91: HR, 70.0; 91: RR, 18.746; 91: SpO2, 92.271; 91: Perf, 2.171; 91: 1min HRV, 0.737; 92: HR, 70.0; 92: RR, 17.569; 92: SpO2, 92.379; 92: Perf, 2.239; 92: 1min HRV, 8.331; 93: HR, 70.0; 93: RR, 17.780; 93: SpO2, 91.576; 93: Perf, 2.413; 93: 1min HRV, 0.865; 94: HR, 70.0; 94: RR, 17.310; 94: SpO2, 91.724; 94: Perf, 2.581; 94: 1min HRV, 0.730; 94: 5min HRV, 3.782; 94: SBP, 102.0; 94: DBP, 57.0; 94: MAP, 72.0; 95: HR, 70.0; 95: RR, 17.797; 95: SpO2, 92.442; 95: Perf, 2.55; 95: 1min HRV, 1.324; 95: SBP, 102.0; 95: DBP, 57.0; 95: MAP, 72.0; 96: HR, 70.0; 96: RR, 23.610; 96: SpO2, 92.695; 96: Perf, 2.430; 96: 1min HRV, 1.110; 97: HR, 72.276; 97: RR, 25.0; 97: SpO2, 95.0; 97: Perf, 1.765; 97: 1min HRV, 101.809; 98: HR, 71.169; 98: RR, 26.373; 98: SpO2, 96.678; 98: Perf, 1.388; 98: 1min HRV, 20.553; 99: HR, 71.0; 99: RR, 24.466; 99: SpO2, 96.810; 99: Perf, 1.301; 99: 1min HRV, 5.030; 99: 5min HRV, 47.921; 99: NORMOSOL-R IV BOLUS -, 1000 ML; 100: HR:, 70.983; 100: RR, 26.254; 100: SpO2, 96.797; 100: Perf, 1.325; 100: 1min HRV, 31.615; 101: HR, 70.052; 101: RR, 22.190; 101: SpO2, 96.690; 101: Perf, 1.399; 101: 1min HRV, 0.887; 102: HR, 70.0; 102: RR, 24.831; 102: SpO2, 97.153; 102: Perf, 1.319; 102: 1min HRV, 0.702; 103: HR, 70.0; 103: RR, 24.237; 103: SpO2, 96.390; 103: Perf, 1.486; 103: 1min HRV, 0.833; 104: HR, 70.0; 104: RR, 21.776; 104: SpO2, 96.966; 104: Perf, 1.278; 104: 1min HRV, 0.877; 104: 5min HRV, 14.315; 105: HR, 70.0; 105: RR, 20.390; 105: SpO2, 96.508; 105: Perf, 1.329; 105: 1min HRV, 0.787; 106: HR, 70.0; 106: RR, 23.086; 106: SpO2, 96.103; 106: Perf, 1.450; 106: 1min HRV, 0.884; 107: HR, 70.0; 107: RR, 23.0; 107: SpO2, 96.305; 107: Perf, 1.023; 107: 1min HRV, 0.746; 108: HR, 70.0; 108: RR, 18.983; 108: SpO2, 96.288; 108: Perf, 1.068; 108: 1min HRV, 0.762; 109: HR, 70.0; 109: RR, 22.017; 109: SpO2, 96.517; 109: Perf, 0.975; 109: 1min HRV, 0.715; 109: 5min HRV, 0.781; 110: HR, 70.0; 110: RR, 17.712; 110: SpO2, 96.390; 110: Perf, 0.929; 110: 1min HRV, 0.772; 111: HR, 70.0; 111: RR, 21.914; 111: SpO2, 96.879; 111: Perf, 0.999; 111: 1min HRV, 0.665; 112: HR, 70.0; 112: RR, 21.915; 112: SpO2, 96.322; 112: Perf, 0.921; 112: 1min HRV, 0.640; 113: HR, 70.0; 113: RR, 22.638; 113: SpO2, 98.224; 113: Perf, 0.748; 113: 1min HRV, 0.715; 114: HR, 70.0; 114: RR, 19.017; 114: SpO2, 97.085; 114: Perf, 0.698; 114: 1min HRV, 0.565; 114: 5min HRV, 0.677; 115: HR, 70.0; 115: RR, 19.237; 115: SpO2, 97.475; 115: Perf, 0.734; 115: 1min HRV, 0.925; 116: HR, 70.0; 116: RR, 20.345; 116: SpO2, 98.155; 116: Perf, 0.717; 116: 1min HRV, 6.745; 117: HR, 70.0; 117: RR, 19.746; 117: SpO2, 95.98; 117: Perf, 0.707; 117: 1min HRV, 1.062; 118: HR, 70.0; 118: RR, 24.983; 118: SpO2, 96.436; 118: Perf, 0.771; 118: 1min HRV, 3.949; 119: HR, 70.0; 119: RR, 23.0; 119: SpO2, 97.328; 119: Perf, 0.813; 119: 1min HRV, 0.969; 119: 5min HRV, 3.700; 0: Age, 87; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.3; 0: Triage HR, 79.0; 0: Triage RR, 18.0; 0: Triage SBP, 118.0; 0: Triage DBP, 46.0; 0: Triage acuity, 3-Urgent; 0: CC, EMESIS",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, I evaluated whether the patient\u2019s WBC count was elevated and found that it was 15.8 K/uL, suggesting possible infection. Next, I checked for abnormal vitals, specifically a diastolic blood pressure of 46 mmHg and a respiratory rate frequently above 20 breaths/min, both of which raise concern. Then, I considered the patient\u2019s advanced age (87 years old) as a risk factor for sepsis. Finally, these factors together (signs of infection plus abnormal vitals in an elderly patient) indicate a high risk of sepsis within the next 12 hours.",
        "claims": [
            "The patient\u2019s WBC count was evaluated.",
            "The patient\u2019s WBC count was 15.8 K/uL.",
            "A WBC count of 15.8 K/uL suggests possible infection.",
            "The patient's diastolic blood pressure was 46 mmHg.",
            "A diastolic blood pressure of 46 mmHg is abnormal.",
            "The patient\u2019s respiratory rate was frequently above 20 breaths/min.",
            "A respiratory rate frequently above 20 breaths/min is abnormal.",
            "Both abnormal diastolic blood pressure and respiratory rate raise concern.",
            "The patient is 87 years old.",
            "The patient\u2019s advanced age of 87 years old is a risk factor for sepsis.",
            "Signs of infection and abnormal vitals in an elderly patient indicate a high risk of sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient\u2019s WBC count was evaluated.",
            "The patient\u2019s WBC count was 15.8 K/uL.",
            "A WBC count of 15.8 K/uL suggests possible infection.",
            "The patient's diastolic blood pressure was 46 mmHg.",
            "A diastolic blood pressure of 46 mmHg is abnormal.",
            "The patient\u2019s respiratory rate was frequently above 20 breaths/min.",
            "A respiratory rate frequently above 20 breaths/min is abnormal.",
            "Both abnormal diastolic blood pressure and respiratory rate raise concern.",
            "The patient is 87 years old.",
            "The patient\u2019s advanced age of 87 years old is a risk factor for sepsis.",
            "Signs of infection and abnormal vitals in an elderly patient indicate a high risk of sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            0.3,
            1.0,
            1.0,
            0.7,
            0.7,
            0.9,
            0.8,
            0.7,
            1.0,
            1.0,
            0.8
        ],
        "alignment_category": [
            2,
            2,
            2,
            7,
            7,
            2,
            2,
            3,
            1,
            1,
            1
        ],
        "alignment_reasonings": [
            "Evaluating the WBC count is a step toward assessing one of the SIRS criteria, which includes abnormal WBC levels. However, simply evaluating WBC count without specifying whether it is above or below the SIRS thresholds provides limited insight into systemic inflammation and early sepsis. The alignment is weak as it lacks direct evidence of SIRS positivity.",
            "The claim directly references an elevated white blood cell count (WBC >12,000/\u00b5L), which is one of the SIRS criteria used to identify systemic inflammation consistent with early sepsis. Therefore, it perfectly aligns with this category.",
            "The claim of an elevated white blood cell (WBC) count of 15.8 K/uL directly aligns with the SIRS criterion of WBC > 12,000/\u00b5L, which is used to identify systemic inflammation consistent with early sepsis. This alignment is strong and explicit, hence the perfect alignment rating.",
            "The claim mentions low diastolic blood pressure, which could suggest hypotension, a key identifier in the Sepsis-Associated Hypotension category. However, the claim doesn't directly mention systolic blood pressure or MAP, which are used to precisely define hypotension criteria. Therefore, the alignment is strong but not complete.",
            "While the claim discusses diastolic blood pressure specifically, hypotension is primarily assessed in the context of systolic blood pressure (SBP) or mean arterial pressure (MAP) in sepsis-related guidelines. An abnormal diastolic pressure like 46 mmHg may contribute to a low MAP, indicating haemodynamic instability. Although not a direct match to the criteria, it provides relevant context to sepsis-associated hypotension by implying potential overall hypotension.",
            "The claim directly references a respiratory rate above 20 breaths/min, which is one of the criteria for SIRS positivity. The SIRS criteria are used to identify systemic inflammation consistent with early sepsis. Since the respiratory rate alone does not confirm SIRS positivity by itself (as at least two criteria are needed), the alignment is high but not perfect.",
            "The claim references a respiratory rate frequently above 20 breaths/min, which directly correlates with one of the SIRS criteria (respiratory rate > 20/min). This indicates systemic inflammation consistent with early sepsis. The claim aligns well with the category, though it does not mention additional SIRS criteria to achieve a full alignment.",
            "The claim mentions abnormal respiratory rate, which directly aligns with a component of the qSOFA criteria (respiratory rate \u226522/min). While diastolic blood pressure isn't directly part of qSOFA, concerns around blood pressure can be relevant to assessing sepsis risk. Given only one component of qSOFA is definitively described, the alignment is moderate but not complete.",
            "The claim directly references the patient's advanced age (87 years old), which is a precise match to the Elderly Susceptibility category. This category specifically defines advanced age (\u2265\u202f65\u202fyears) as a significant risk factor for sepsis, demonstrating perfect alignment.",
            "The claim explicitly mentions the patient's advanced age of 87 years as a risk factor for sepsis. This exactly aligns with the category that identifies being age 65 or older as a significant risk factor for sepsis, hence the perfect alignment rating.",
            "The claim highlights \"an elderly patient,\" suggesting a focus on the increased risk associated with advanced age, which aligns with the \"Elderly Susceptibility\" category. While \"signs of infection and abnormal vitals\" could also pertain to other categories like SIRS or NEWS, the specific mention of \"elderly\" directly corresponds to this particular category. The alignment rating is 0.8 because the claim includes broader considerations beyond just age, such as infection signs and vitals, which somewhat dilutes the direct alignment with elderly susceptibility alone."
        ],
        "final_alignment_score": 0.8090909090909091,
        "accuracy": 1
    },
    {
        "input": "2: HR, 110.0; 2: RR, 20.0; 2: SpO2, 99.0; 2: SBP, 170.0; 2: DBP, 125.0; 2: MAP, 140.0; 2: Temp, 98.3; 7: Pain, 8.0; 23: POC, HCG, ISTAT QUALITATIVE: Negative; 23: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 35: SpO2, 96.875; 35: SBP, 166.0; 35: DBP, 133.0; 35: MAP, 144.0; 36: SpO2, 96.729; 36: Perf, 2.419; 36: SBP, 181.0; 36: DBP, 117.0; 36: MAP, 138.333; 37: SpO2, 96.793; 37: Perf, 3.050; 38: SpO2, 98.407; 38: Perf, 3.127; 39: SpO2, 97.810; 39: Perf, 3.470; 40: SpO2, 96.864; 40: Perf, 2.914; 41: SpO2, 97.305; 41: Perf, 2.716; 42: SpO2, 98.690; 42: Perf, 4.093; 43: SpO2, 99.0; 43: Perf, 4.271; 44: SpO2, 98.879; 44: Perf, 4.363; 45: SpO2, 98.898; 45: Perf, 3.121; 46: SpO2, 98.034; 46: Perf, 3.241; 47: SpO2, 98.345; 47: Perf, 5.429; 48: SpO2, 98.339; 48: Perf, 4.260; 49: SpO2, 98.121; 49: Perf, 5.469; 50: SpO2, 98.085; 50: Perf, 4.044; 51: SpO2, 98.441; 51: Perf, 3.807; 52: SpO2, 98.121; 52: Perf, 4.583; 53: SpO2, 99.086; 53: Perf, 2.823; 54: SpO2, 98.898; 54: Perf, 2.241; 55: SpO2, 98.831; 55: Perf, 2.983; 56: SpO2, 98.695; 56: Perf, 3.286; 57: SpO2, 98.0; 57: Perf, 4.375; 58: SpO2, 98.220; 58: Perf, 4.053; 59: SpO2, 97.793; 59: Perf, 4.217; 60: SpO2, 98.0; 60: Perf, 2.665; 61: SpO2, 98.712; 61: Perf, 2.182; 62: SpO2, 98.466; 62: Perf, 3.111; 63: SpO2, 98.475; 63: Perf, 2.669; 64: SpO2, 98.741; 64: Perf, 2.308; 65: SpO2, 99.0; 65: Perf, 2.785; 66: SpO2, 98.186; 66: Perf, 3.892; 67: ALT (SGPT), 79 U/L; 67: CHLORIDE, 103 mmol/L; 67: BILIRUBIN TOTAL, 0.4 mg/dL; 67: EGFR FOR AFRICAN AMERICAN, 148 mL/min/1.73 m2; 67: ALBUMIN, 4.2 g/dL; 67: CO2, 23 mmol/L; 67: EGFR REFIT WITHOUT RACE (2021), 128 mL/min/1.73 m2; 67: BLOOD UREA NITROGEN (BUN), 9 mg/dL; 67: CREATININE, 0.65 mg/dL; 67: SODIUM, 138 mmol/L; 67: PROTEIN TOTAL, 8.0 g/dL; 67: GLUCOSE, 130 mg/dL; 67: GLOBULIN, 3.8 g/dL; 67: CALCIUM, 9.5 mg/dL; 67: ANION GAP, 12 mmol/L; 67: CORRECTED CALCIUM, 9.3 mg/dL; 67: POTASSIUM, 4.3 mmol/L; 67: ALKALINE PHOSPHATASE, 109 U/L; 67: AST (SGOT), 48 U/L; 67: SpO2, 98.552; 67: Perf, 2.511; 68: SpO2, 98.458; 68: Perf, 2.268; 69: SpO2, 98.138; 69: Perf, 3.142; 70: WAM DIFTYP, AUTO; 70: LYMPHOCYTE % (AUTO DIFF), 31.8 %; 70: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.6 g/dL; 70: RED BLOOD CELLS (RBC), 5.35 MIL/uL; 70: NEUTROPHIL % (AUTO DIFF), 57.8 %; 70: RED CELL DISTRIBUTION WIDTH (RDW), 11.8 %; 70: MONOCYTE % (AUTO DIFF), 7.3 %; 70: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.05 K/uL; 70: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.0 pg; 70: PLATELET COUNT (PLT), 258 K/uL; 70: WHITE BLOOD CELLS (WBC), 12.5 K/uL; 70: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.29 K/uL; 70: NRBC PERCENT (HEMATOLOGY), 0.0 %; 70: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 70: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 70: BASOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 70: MONOCYTE ABSOLUTE (AUTO DIFF), 0.91 K/uL; 70: EOSINOPHIL % (AUTO DIFF), 2.3 %; 70: NEUTROPHIL ABSOLUTE (AUTO DIFF), 7.21 K/uL; 70: MEAN CORPUSCULAR VOLUME (MCV), 86.2 fL; 70: HEMATOCRIT (HCT), 46.1 %; 70: BASOPHIL % (AUTO DIFF), 0.4 %; 70: HEMOGLOBIN (HGB), 15.5 g/dL; 70: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 3.97 K/uL; 70: SpO2, 98.983; 70: Perf, 4.796; 71: SpO2, 98.638; 71: Perf, 4.103; 72: SpO2, 97.898; 72: Perf, 5.212; 73: SpO2, 97.949; 73: Perf, 6.655; 74: SpO2, 97.810; 74: Perf, 6.88; 75: SpO2, 97.712; 75: Perf, 7.503; 76: SpO2, 98.017; 76: Perf, 5.833; 77: SpO2, 98.068; 77: Perf, 5.273; 78: SpO2, 98.153; 78: Perf, 3.641; 79: SpO2, 97.534; 79: Perf, 4.4; 80: SpO2, 97.203; 80: Perf, 4.165; 81: SpO2, 97.569; 81: Perf, 4.237; 82: SpO2, 98.390; 82: Perf, 2.841; 83: SpO2, 98.407; 83: Perf, 1.946; 84: SpO2, 97.845; 84: Perf, 3.521; 85: SpO2, 98.017; 85: Perf, 3.399; 86: SpO2, 97.828; 86: Perf, 5.287; 87: SpO2, 97.542; 87: Perf, 5.983; 88: SpO2, 97.492; 88: Perf, 6.082; 89: SpO2, 97.534; 89: Perf, 6.151; 90: SpO2, 98.0; 90: Perf, 6.157; 91: SpO2, 98.103; 91: Perf, 4.832; 92: SpO2, 97.847; 92: Perf, 5.332; 92: ACETAMINOPHEN, 325 MG PO TABS; 92: IBUPROFEN, 400 MG PO TABS; 93: SpO2, 97.712; 93: Perf, 5.169; 93: LR IV BOLUS -, 1000 ML; 94: SpO, 2: 99.414; 94: Perf, 1.990; 94: Pain, 10.0; 94: HYDROMORPHONE, 1 MG/ML INJ SYRG; 95: SpO, 2: 99.0; 95: Perf, 3.394; 96: SpO2, 98.983; 96: Perf, 2.202; 97: SpO2, 98.305; 97: Perf, 3.937; 98: SARS-COV-2 RNA, Not Detected; 98: SpO2, 97.949; 98: Perf, 5.096; 99: SpO2, 97.810; 99: Perf, 4.267; 100: SpO2, 97.847; 100: Perf, 3.105; 101: SpO2, 97.776; 101: Perf, 2.793; 102: SpO2, 97.797; 102: Perf, 3.051; 103: SpO2, 98.328; 103: Perf, 2.511; 104: SpO2, 97.932; 104: Perf, 2.896; 105: SpO2, 97.5; 105: Perf, 2.787; 106: SpO2, 97.017; 106: Perf, 3.046; 107: SpO2, 96.797; 107: Perf, 3.829; 108: SpO2, 96.328; 108: Perf, 4.211; 109: SpO2, 96.508; 109: Perf, 4.35; 110: SpO2, 96.441; 110: Perf, 4.361; 111: SpO2, 96.914; 111: Perf, 4.117; 112: SpO2, 96.949; 112: Perf, 4.180; 113: SpO2, 97.672; 113: Perf, 3.597; 114: SpO2, 97.136; 114: Perf, 3.844; 115: SpO2, 97.793; 115: Perf, 3.008; 116: SpO2, 98.729; 116: Perf, 1.443; 117: SpO2, 99.448; 117: Perf, 1.378; 118: SpO2, 99.356; 118: Perf, 1.376; 119: SpO2, 98.627; 119: Perf, 1.548; 0: Age, 19; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.8; 0: Triage HR, 110.0; 0: Triage RR, 20.0; 0: Triage SBP, 170.0; 0: Triage DBP, 125.0; 0: Triage acuity, 3-Urgent; 0: CC, BLOOD IN URINE,ABDOMINAL PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I checked if the patient\u2019s vitals suggested systemic infection (e.g., high heart rate, fever, hypotension), and noted only mild tachycardia and no fever or hypotension. Next, I reviewed labs for clues of infection (e.g., markedly elevated WBC, high lactate), and found slightly elevated WBC but otherwise unremarkable labs. Then, I looked for clinical signs of organ dysfunction (like altered mental status, decreased urine output) and saw no evidence of those. Finally, I checked for any documented suspicion of sepsis or antibiotic administration, which was not present in the data. Consequently, the overall risk of sepsis within 12 hours does not appear elevated.",
        "claims": [
            "The patient\u2019s vitals were assessed for signs of systemic infection.",
            "The patient exhibited mild tachycardia.",
            "The patient did not have a fever.",
            "The patient did not exhibit hypotension.",
            "Laboratory tests were reviewed for evidence of infection.",
            "The white blood cell count (WBC) was slightly elevated.",
            "The laboratory results were otherwise unremarkable.",
            "Clinical signs of organ dysfunction were evaluated.",
            "There was no evidence of altered mental status.",
            "There was no evidence of decreased urine output.",
            "Documentation was checked for suspicion of sepsis.",
            "There was no documentation of suspicion of sepsis.",
            "There was no record of antibiotic administration.",
            "The overall risk of sepsis within 12 hours does not appear elevated."
        ],
        "relevant_claims": [
            "The patient did not have a fever.",
            "The patient did not exhibit hypotension.",
            "There was no evidence of decreased urine output."
        ],
        "alignment_scores": [
            0.2,
            0.7,
            0.3
        ],
        "alignment_category": [
            2,
            7,
            8
        ],
        "alignment_reasonings": [
            "The absence of fever suggests that the patient does not meet one of the SIRS criteria, which include temperature as a significant factor. This is marginally relevant as it relates to the SIRS criteria, but the lack of fever alone is not strongly indicative of sepsis risk. The alignment with the SIRS category is weak since the data given is about not meeting a specific criterion rather than fulfilling one.",
            "The claim directly addresses the absence of hypotension, which aligns with the Sepsis-Associated Hypotension category. While the claim indicates a negative finding (absence of hypotension), it still concerns the presence of a sepsis risk factor. This relevance warrants a strong alignment rating.",
            "Decreased urine output is a component of the SOFA score, which considers organ dysfunction as part of sepsis risk evaluation. The claim notes the absence of decreased urine output, which indirectly suggests no increase in SOFA score. This information is somewhat related to SOFA but does not directly support sepsis prediction, resulting in a low alignment rating."
        ],
        "final_alignment_score": 0.39999999999999997,
        "accuracy": 1
    },
    {
        "input": "6: Pain, 0.0; 16: HR, 110.0; 16: RR, 13.0; 16: SpO2, 97.0; 16: SBP, 126.0; 16: DBP, 108.0; 16: MAP, 114.0; 16: Temp, 97.7; 35: HR, 106.5; 35: RR, 24.346; 35: 1min HRV, 16.264; 36: HR, 108.483; 36: RR, 22.741; 36: SpO2, 86.5; 36: 1min HRV, 9.079; 37: HR, 106.458; 37: RR, 21.780; 37: 1min HRV, 19.289; 37: 5min HRV, 15.922; 38: HR, 104.793; 38: RR, 19.517; 38: SpO2, 97.4; 38: 1min HRV, 28.309; 39: HR, 106.237; 39: RR, 19.627; 39: SpO2, 98.0; 39: 1min HRV, 15.942; 40: HR, 101.254; 40: RR, 21.559; 40: SpO2, 99.714; 40: 1min HRV, 13.774; 41: HR, 102.086; 41: RR, 19.293; 41: SpO2, 99.459; 41: 1min HRV, 13.604; 42: HR, 102.898; 42: RR, 22.898; 42: SpO2, 99.0; 42: 1min HRV, 19.309; 42: 5min HRV, 20.796; 43: HR, 104.172; 43: RR, 20.310; 43: SpO2, 98.5; 43: Perf, 0.09; 43: 1min HRV, 13.262; 44: HR, 102.559; 44: RR, 23.898; 44: SpO2, 100.0; 44: Perf, 0.09; 44: 1min HRV, 12.124; 45: HR, 105.845; 45: RR, 22.483; 45: SpO2, 86.25; 45: Perf, 0.09; 45: 1min HRV, 8.539; 46: HR, 107.763; 46: RR, 23.237; 46: 1min HRV, 70.170; 47: HR, 101.407; 47: RR, 21.119; 47: SpO2, 96.409; 47: 1min HRV, 15.426; 47: 5min HRV, 36.245; 48: HR, 100.207; 48: RR, 20.517; 48: SpO2, 100.0; 48: 1min HRV, 27.094; 49: HR, 98.237; 49: RR, 20.119; 49: SpO2, 99.0; 49: 1min HRV, 12.805; 50: HR, 97.948; 50: RR, 24.276; 50: SpO2, 98.773; 50: Perf, 0.08; 50: 1min HRV, 16.305; 51: HR, 99.068; 51: RR, 25.390; 51: SpO2, 98.275; 51: Perf, 0.085; 51: 1min HRV, 35.372; 52: HR, 104.593; 52: RR, 19.102; 52: SpO2, 96.632; 52: Perf, 0.09; 52: 1min HRV, 10.054; 52: 5min HRV, 26.196; 53: HR, 103.931; 53: RR, 22.5; 53: SpO2, 99.390; 53: 1min HRV, 12.152; 54: HR, 103.203; 54: RR, 19.814; 54: SpO2, 100.0; 54: 1min HRV, 11.907; 55: HR, 104.259; 55: RR, 20.207; 55: SpO2, 99.933; 55: 1min HRV, 7.388; 56: HR, 105.661; 56: RR, 19.475; 56: SpO2, 99.939; 56: 1min HRV, 13.360; 57: HR, 104.724; 57: RR, 22.966; 57: SpO2, 100.0; 57: 1min HRV, 12.334; 57: 5min HRV, 12.666; 57: SBP, 99.0; 57: DBP, 65.0; 57: MAP, 76.333; 58: HR, 102.525; 58: RR, 20.220; 58: SpO2, 100.0; 58: 1min HRV, 20.083; 59: HR, 98.328; 59: RR, 16.862; 59: SpO2, 99.545; 59: Perf, 0.100; 59: 1min HRV, 34.211; 60: HR, 100.034; 60: RR, 19.203; 60: SpO2, 100.0; 60: Perf, 0.1; 60: 1min HRV, 10.732; 61: POC PH (V) ISTAT, 7.55; 61: POC HCO3 (V) ISTAT, 26.0 mmol/L; 61: POC LACTATE ISTAT, 1.13 mmol/L; 61: POC O2 SATURATION ISTAT VENOUS, 73 %; 61: POC PO2 (V) ISTAT, 33 mmHg; 61: POC PCO2 (V) ISTAT, 30.0 mmHg; 61: POC TCO2 (V) ISTAT, 27 mmol/L; 61: POC BASE EXCESS ISTAT, 4 mmol/L; 61: HR, 97.661; 61: RR, 19.508; 61: SpO2, 90.267; 61: 1min HRV, 10.219; 62: HR, 95.644; 62: RR, 20.322; 62: SpO2, 98.0; 62: 1min HRV, 17.941; 62: 5min HRV, 25.552; 63: HR, 94.483; 63: RR, 22.017; 63: SpO2, 95.0; 63: 1min HRV, 19.813; 63: SBP, 109.0; 63: DBP, 65.0; 63: MAP, 79.667; 64: HR, 95.288; 64: RR, 21.695; 64: 1min HRV, 9.077; 65: HR, 94.259; 65: RR, 21.897; 65: SpO2, 100.0; 65: 1min HRV, 35.389; 66: HR, 94.712; 66: RR, 22.814; 66: 1min HRV, 12.444; 67: HR, 95.576; 67: RR, 19.407; 67: SpO2, 99.0; 67: 1min HRV, 13.691; 67: 5min HRV, 20.499; 68: HR, 102.983; 68: RR, 21.190; 68: SpO2, 93.333; 68: 1min HRV, 29.881; 69: HR, 105.983; 69: RR, 19.759; 69: 1min HRV, 19.558; 70: HR, 105.898; 70: RR, 21.119; 70: 1min HRV, 20.311; 71: HR, 103.864; 71: RR, 19.390; 71: 1min HRV, 28.157; 72: HR, 94.831; 72: RR, 18.729; 72: SpO2, 98.946; 72: 1min HRV, 32.574; 72: 5min HRV, 38.943; 73: HR, 91.241; 73: RR, 23.483; 73: SpO2, 96.877; 73: 1min HRV, 26.875; 74: HR, 92.763; 74: RR, 23.254; 74: SpO2, 98.773; 74: 1min HRV, 27.392; 74: NORMOSOL-R IV BOLUS -, 1000 ML; 75: HR:, 87.534; 75: RR, 21.103; 75: SpO2, 95.188; 75: 1min HRV, 30.984; 76: HR, 87.237; 76: RR, 19.102; 76: SpO2, 99.25; 76: 1min HRV, 33.549; 77: HR, 88.534; 77: RR, 21.690; 77: SpO2, 99.077; 77: 1min HRV, 31.958; 77: 5min HRV, 34.560; 78: HR, 87.881; 78: RR, 22.814; 78: SpO2, 99.179; 78: 1min HRV, 14.725; 78: SBP, 103.0; 78: DBP, 61.0; 78: MAP, 75.0; 79: HR, 85.525; 79: RR, 17.0; 79: SpO2, 99.125; 79: Perf, 0.16; 79: 1min HRV, 24.524; 80: HR, 87.586; 80: RR, 21.828; 80: SpO2, 98.233; 80: Perf, 0.16; 80: 1min HRV, 23.789; 81: HR, 88.966; 81: RR, 17.322; 81: SpO2, 95.346; 81: 1min HRV, 20.920; 82: 5min HRV, 23.024; 94: EGFR FOR AFRICAN AMERICAN, 115 mL/min/1.73 m2; 94: PROTEIN TOTAL, 6.3 g/dL; 94: SODIUM, 131 mmol/L; 94: MAGNESIUM, 2.0 mg/dL; 94: AST (SGOT), 20 U/L; 94: CORRECTED CALCIUM, 9.2 mg/dL; 94: CREATININE, 0.46 mg/dL; 94: POTASSIUM, 3.8 mmol/L; 94: ANION GAP, 10 mmol/L; 94: BILIRUBIN TOTAL, 1.0 mg/dL; 94: ALBUMIN, 3.2 g/dL; 94: GLUCOSE, 124 mg/dL; 94: BLOOD UREA NITROGEN (BUN), 12 mg/dL; 94: ALKALINE PHOSPHATASE, 71 U/L; 94: ALT (SGPT), 14 U/L; 94: CO2, 25 mmol/L; 94: EGFR REFIT WITHOUT RACE (2021), 100 mL/min/1.73 m2; 94: CHLORIDE, 96 mmol/L; 94: GLOBULIN, 3.1 g/dL; 94: CALCIUM, 8.6 mg/dL; 104: SARS-COV-2 RNA, Not Detected; 113: TROPONIN I, <.017 ng/mL; 0: Age, 74; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.5; 0: Triage HR, 110.0; 0: Triage RR, 13.0; 0: Triage SBP, 126.0; 0: Triage DBP, 108.0; 0: Triage acuity, 2-Emergent; 0: CC, GENERAL WEAKNESS,COUGH",
        "answer": false,
        "llm_answer": "Yes",
        "llm_explanation": "First, I checked if there were signs or symptoms suggestive of infection, noting the patient\u2019s complaint of cough and elevated respiratory rate. Next, I looked for systemic signs, including repeated tachycardic values and intermittent low oxygen saturations, which indicate potential physiologic stress. I then considered the patient\u2019s advanced age (74 years) and triage acuity (\u201c2-Emergent\u201d), both of which increase sepsis risk. Finally, despite a normal lactate, persistent tachycardia and tachypnea in the context of a possible respiratory source of infection suggest a high likelihood of sepsis developing within 12 hours.",
        "claims": [
            "There were signs and symptoms suggestive of infection in the patient.",
            "The patient complained of a cough.",
            "The patient had an elevated respiratory rate.",
            "I looked for systemic signs of infection.",
            "The patient exhibited repeated tachycardic values.",
            "The patient experienced intermittent low oxygen saturations.",
            "Intermittent low oxygen saturations indicate potential physiologic stress.",
            "The patient is 74 years old.",
            "The patient's advanced age increases sepsis risk.",
            "The patient was triaged as \u201c2-Emergent.\u201d",
            "The triage acuity of \u201c2-Emergent\u201d increases sepsis risk.",
            "The patient had a normal lactate level.",
            "Persistent tachycardia in the context of a suspected respiratory source of infection suggests a high likelihood of sepsis developing within 12 hours.",
            "Tachypnea in the context of a suspected respiratory source of infection suggests a high likelihood of sepsis developing within 12 hours."
        ],
        "relevant_claims": [
            "There were signs and symptoms suggestive of infection in the patient.",
            "The patient had an elevated respiratory rate.",
            "The patient exhibited repeated tachycardic values.",
            "The patient experienced intermittent low oxygen saturations.",
            "Intermittent low oxygen saturations indicate potential physiologic stress.",
            "The patient is 74 years old.",
            "The patient's advanced age increases sepsis risk.",
            "The triage acuity of \u201c2-Emergent\u201d increases sepsis risk.",
            "Persistent tachycardia in the context of a suspected respiratory source of infection suggests a high likelihood of sepsis developing within 12 hours.",
            "Tachypnea in the context of a suspected respiratory source of infection suggests a high likelihood of sepsis developing within 12 hours."
        ],
        "alignment_scores": [
            0.6,
            0.7,
            0.8,
            0.7,
            0.6,
            1.0,
            1.0,
            0.3,
            0.7,
            0.8
        ],
        "alignment_category": [
            9,
            3,
            2,
            8,
            8,
            1,
            1,
            4,
            2,
            3
        ],
        "alignment_reasonings": [
            "The claim suggests the presence of infection, which aligns conceptually with clinician suspicion of serious infection. However, it does not specify concrete actions like ordering antibiotics or blood cultures, which would fully align with this category. The alignment is more suggestive of a general suspicion of infection, hence a moderate rating.",
            "An elevated respiratory rate is a component of the qSOFA score, which assesses the risk of sepsis-related organ dysfunction. While the claim doesn\u2019t specify if the respiratory rate reaches the exact criteria (\u226522/min) for a qSOFA score of 1, the alignment is relatively strong because a high respiratory rate could suggest a risk indicator for sepsis.",
            "Tachycardia (heart rate >90 bpm) is one of the criteria identified under the SIRS category. Repeated tachycardic values suggest systemic inflammation consistent with early sepsis, indicating strong alignment with SIRS. However, the claim does not mention the presence of any other SIRS criteria, hence the alignment is not perfect.",
            "Intermittent low oxygen saturations suggest possible hypoxia, which relates to impaired oxygenation\u2014a factor assessed in the SOFA score (PaO\u2082/FiO\u2082). Although intermittent low oxygen saturation is not a direct SOFA measure, it is conceptually linked to the respiratory component of the SOFA score. Therefore, while not a direct match, the connection to oxygenation makes this the most relevant category with a significant alignment.",
            "Intermittent low oxygen saturations suggest impaired oxygenation, which relates conceptually to the respiratory component of the SOFA score (e.g., PaO\u2082/FiO\u2082 <300). Although not exactly the same, it indicates potential physiologic stress related to organ dysfunction, making this category relevant with a moderate level of alignment.",
            "The claim directly references the patient's age, which is 74 years, fitting into the category of advanced age (\u2265\u202f65\u202fyears). This category highlights that advanced age significantly increases susceptibility to sepsis, showing perfect alignment with the claim.",
            "The claim explicitly references advanced age as a risk factor for sepsis, which directly aligns with the Elderly Susceptibility category that identifies individuals aged \u2265\u202f65 years as being at increased risk of sepsis progression and mortality. The alignment is perfect as the claim matches the description of the category exactly.",
            "The triage acuity of \"2-Emergent\" suggests an urgent clinical status, which is conceptually aligned with the NEWS score's use of vital signs to identify deteriorating patients. However, it is not directly equivalent to a NEWS score threshold or sepsis\u2011specific criteria, hence the lower alignment rating.",
            "The claim involves persistent tachycardia, which is related to heart rate >90 bpm, part of the SIRS criteria, indicating systemic inflammation or infection. Though the claim also suggests a suspected infection, persistent tachycardia aligns more directly with SIRS than with any other category. The claim involves a single SIRS criterion, so the alignment is moderate but not complete.",
            "Tachypnea (increased respiratory rate) is one of the criteria in the qSOFA score, which is used to identify patients at high risk of developing sepsis-related complications. Although the claim could potentially align with respiratory rate criteria under both SIRS and qSOFA, the context of suspected infection and significant likelihood of sepsis supports a stronger alignment with the qSOFA score, which indicates a high risk of sepsis with increased respiratory rate. The alignment is strong but not perfect, as the claim does not provide the specific threshold necessary for a definite qSOFA score calculation."
        ],
        "final_alignment_score": 0.72,
        "accuracy": 0
    },
    {
        "input": "5: HR, 95.0; 5: RR, 18.0; 5: SpO2, 99.0; 5: SBP, 131.0; 5: DBP, 71.0; 5: MAP, 91.0; 5: Pain, 10.0; 5: Temp, 100.0; 7: Pain, 10.0; 15: SpO2, 97.914; 15: Perf, 3.922; 15: SBP, 135.0; 15: DBP, 78.0; 15: MAP, 97.0; 16: SpO2, 97.621; 16: Perf, 4.766; 16: SBP, 128.0; 16: DBP, 76.0; 16: MAP, 93.333; 17: SpO2, 98.0; 17: Perf, 4.448; 18: SpO2, 97.431; 18: Perf, 4.878; 19: SpO2, 97.0; 19: Perf, 4.727; 20: SpO2, 97.508; 20: Perf, 4.079; 21: SpO2, 97.328; 21: Perf, 4.229; 22: SpO2, 97.831; 22: Perf, 3.967; 23: SpO2, 98.293; 23: Perf, 2.087; 24: SpO2, 97.729; 24: Perf, 3.178; 25: SpO2, 97.458; 25: Perf, 3.914; 26: SpO2, 97.759; 26: Perf, 3.689; 27: SpO2, 97.814; 27: Perf, 3.198; 28: SpO2, 97.345; 28: Perf, 3.3; 29: SpO2, 97.068; 29: Perf, 3.367; 30: SpO2, 97.0; 30: Perf, 3.384; 31: SpO2, 97.241; 31: Perf, 3.321; 32: SpO2, 97.932; 32: Perf, 3.390; 33: SpO2, 97.414; 33: Perf, 3.948; 34: SpO2, 97.119; 34: Perf, 4.267; 35: SpO2, 97.322; 35: Perf, 3.937; 36: SpO2, 97.569; 36: Perf, 3.674; 37: SpO2, 97.288; 37: Perf, 3.535; 38: SpO2, 97.845; 38: Perf, 3.626; 39: SpO2, 97.545; 39: Perf, 3.52; 40: SpO2, 97.805; 41: SpO2, 97.390; 41: Perf, 2.040; 42: SpO2, 97.542; 42: Perf, 3.324; 43: SpO2, 97.241; 43: Perf, 2.687; 44: SpO2, 97.051; 44: Perf, 2.293; 45: SpO2, 97.017; 45: Perf, 2.477; 46: SpO2, 97.0; 46: Perf, 2.558; 47: SpO2, 97.237; 47: Perf, 2.516; 48: SpO2, 97.0; 48: Perf, 2.645; 49: SpO2, 97.542; 49: Perf, 2.349; 50: SpO2, 97.328; 50: Perf, 2.295; 51: SpO2, 97.492; 51: Perf, 2.235; 52: SpO2, 97.814; 52: Perf, 2.463; 53: SpO2, 97.517; 53: Perf, 3.578; 54: SpO2, 97.153; 54: Perf, 3.237; 55: SpO2, 97.121; 55: Perf, 3.452; 56: SpO2, 97.017; 56: Perf, 4.274; 57: SpO2, 98.085; 57: Perf, 3.315; 58: SpO2, 97.379; 58: Perf, 3.838; 59: SpO2, 96.966; 59: Perf, 4.163; 60: SpO2, 96.759; 60: Perf, 3.612; 61: SpO2, 96.949; 61: Perf, 2.512; 62: SpO2, 97.0; 62: Perf, 2.677; 63: SpO2, 96.915; 63: Perf, 2.779; 64: SpO2, 97.305; 64: Perf, 2.938; 65: SpO2, 97.172; 65: Perf, 3.611; 66: SpO2, 98.932; 66: Perf, 2.547; 67: SpO2, 98.407; 67: Perf, 2.685; 68: SpO2, 97.914; 68: Perf, 2.764; 69: SpO2, 97.915; 69: Perf, 3.33; 70: SpO2, 97.862; 70: Perf, 2.763; 71: SpO2, 97.966; 71: Perf, 2.603; 72: SpO2, 97.759; 72: Perf, 3.783; 73: SpO2, 97.424; 73: Perf, 4.199; 74: SpO2, 96.746; 74: Perf, 3.387; 75: SpO2, 96.707; 75: Perf, 3.408; 76: SpO2, 96.780; 76: Perf, 3.828; 77: SpO2, 97.138; 77: Perf, 4.055; 78: SpO2, 97.271; 78: Perf, 4.364; 79: SpO2, 97.797; 79: Perf, 4.315; 80: SpO2, 98.0; 80: Perf, 4.72; 81: SpO2, 98.068; 81: Perf, 3.370; 82: SpO2, 97.914; 82: Perf, 4.015; 83: SpO2, 97.492; 83: Perf, 3.757; 84: SpO2, 97.763; 84: Perf, 3.819; 85: SpO2, 97.897; 85: Perf, 3.276; 86: SpO2, 97.864; 86: Perf, 3.438; 87: SpO2, 97.638; 87: Perf, 4.142; 88: SpO2, 97.339; 88: Perf, 3.754; 89: POC, HCG, ISTAT QUALITATIVE: Negative; 89: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 89: SpO2, 97.356; 89: Perf, 3.648; 90: SpO2, 97.759; 90: Perf, 2.604; 91: SpO2, 97.831; 91: Perf, 3.684; 91: LR IV BOLUS -, 1000 ML; 92: SpO, 2: 97.345; 92: Perf, 3.88; 93: SpO2, 97.288; 93: Perf, 3.398; 94: SpO2, 97.492; 94: Perf, 2.554; 95: SpO2, 97.259; 95: Perf, 3.043; 96: SpO2, 97.797; 96: Perf, 2.942; 97: SpO2, 97.793; 97: Perf, 2.923; 98: SpO2, 98.153; 98: Perf, 4.124; 99: SpO2, 98.190; 99: Perf, 4.331; 100: SpO2, 98.542; 100: Perf, 3.513; 101: SpO2, 98.203; 101: Perf, 3.262; 102: SpO2, 98.345; 102: Perf, 3.276; 103: SpO2, 98.305; 103: Perf, 3.638; 104: SpO2, 98.224; 104: Perf, 3.374; 105: SpO2, 98.0; 105: Perf, 3.113; 106: SpO2, 98.0; 106: Perf, 3.541; 107: SpO2, 98.0; 107: Perf, 3.784; 108: SpO2, 98.322; 108: Perf, 3.647; 109: SpO2, 98.293; 109: Perf, 2.863; 110: SpO2, 98.136; 110: Perf, 3.490; 111: WAM DIFTYP, AUTO; 111: PLATELET COUNT (PLT), 335 K/uL; 111: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.04 K/uL; 111: RED BLOOD CELLS (RBC), 4.56 MIL/uL; 111: HEMOGLOBIN (HGB), 12.0 g/dL; 111: EOSINOPHIL % (AUTO DIFF), 0.0 %; 111: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.62 K/uL; 111: MONOCYTE ABSOLUTE (AUTO DIFF), 1.12 K/uL; 111: LYMPHOCYTE % (AUTO DIFF), 11.4 %; 111: NEUTROPHIL % (AUTO DIFF), 79.7 %; 111: BASOPHIL % (AUTO DIFF), 0.2 %; 111: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 111: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 111: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 111: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.52 K/uL; 111: RED CELL DISTRIBUTION WIDTH (RDW), 15.5 %; 111: WHITE BLOOD CELLS (WBC), 13.3 K/uL; 111: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 26.3 pg; 111: MONOCYTE % (AUTO DIFF), 8.4 %; 111: HEMATOCRIT (HCT), 37.5 %; 111: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 111: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.0 g/dL; 111: MEAN CORPUSCULAR VOLUME (MCV), 82.2 fL; 111: NRBC PERCENT (HEMATOLOGY), 0.0 %; 111: SpO2, 98.034; 111: Perf, 3.432; 112: SpO2, 97.983; 112: Perf, 3.777; 113: SpO2, 98.0; 113: Perf, 4.029; 114: SpO2, 98.0; 114: Perf, 3.815; 115: SpO2, 98.034; 115: Perf, 3.668; 116: SpO2, 98.0; 116: Perf, 3.089; 117: SpO2, 98.121; 117: Perf, 3.028; 118: SpO2, 97.678; 118: Perf, 3.533; 119: SpO2, 97.086; 119: Perf, 3.043; 0: Age, 34; 0: Gender, F; 0: Race, Native Hawaiian or Other Pacific Islander; 0: Means of arrival, Self; 0: Triage Temp, 37.8; 0: Triage HR, 95.0; 0: Triage RR, 18.0; 0: Triage SBP, 131.0; 0: Triage DBP, 71.0; 0: Triage acuity, 5-Non-Urgent; 0: CC, PAIN TOOTH",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "We first considered whether the patient\u2019s vital signs showed evidence of fever or hemodynamic instability, and they did not. Next, we reviewed the lab findings for significant abnormalities, noting only a mild elevation in the white blood cell count. Finally, given the relatively stable vitals and lack of major signs of systemic infection, we concluded there is not a high risk of sepsis within the next 12 hours.",
        "claims": [
            "The patient's vital signs did not show evidence of fever.",
            "The patient's vital signs did not show evidence of hemodynamic instability.",
            "The lab findings revealed only a mild elevation in the white blood cell count.",
            "There are relatively stable vital signs observed in the patient.",
            "There are no major signs of systemic infection in the patient.",
            "The lack of major signs of systemic infection contributes to the risk assessment.",
            "There is not a high risk of sepsis for the patient within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient's vital signs did not show evidence of hemodynamic instability.",
            "There are relatively stable vital signs observed in the patient.",
            "The lack of major signs of systemic infection contributes to the risk assessment."
        ],
        "alignment_scores": [
            0.3,
            0.2,
            0.3
        ],
        "alignment_category": [
            6,
            4,
            2
        ],
        "alignment_reasonings": [
            "The claim suggests there is no evidence of hemodynamic instability, which relates to the elevated Shock Index category that denotes such instability. However, the lack of instability implies a negative finding rather than the presence of a high shock index. Therefore, the alignment is weak and indirect.",
            "The claim mentions \"relatively stable vital signs,\" implying no deranged vitals, which would lead to a low NEWS score, often used to predict clinical deterioration. The alignment is weak, as stability does not indicate a risk of sepsis but indirectly relates to the NEWS criteria for evaluating patient stability.",
            "The claim refers to the absence of major signs of systemic infection, which indirectly relates to not meeting SIRS criteria. The alignment is low because the claim does not directly specify any of the SIRS criteria or their absence but broadly concerns systemic infection signs."
        ],
        "final_alignment_score": 0.26666666666666666,
        "accuracy": 1
    },
    {
        "input": "23: HR, 110.0; 23: RR, 18.0; 23: SpO2, 99.0; 23: SBP, 108.0; 23: DBP, 51.0; 23: MAP, 70.0; 23: Pain, 0.0; 23: Temp, 100.6; 51: HR, 102.542; 51: RR, 18.780; 51: 1min HRV, 30.357; 52: HR, 101.707; 52: RR, 20.155; 52: 1min HRV, 3.753; 53: HR, 104.932; 53: RR, 20.983; 53: SpO2, 98.0; 53: 1min HRV, 30.198; 53: 5min HRV, 25.872; 54: HR, 109.966; 54: RR, 22.707; 54: 1min HRV, 9.378; 55: HR, 108.271; 55: RR, 19.339; 55: SpO2, 98.278; 55: 1min HRV, 22.000; 56: HR, 107.345; 56: RR, 19.362; 56: SpO2, 98.15; 56: 1min HRV, 31.490; 57: HR, 105.881; 57: RR, 17.458; 57: SpO2, 98.0; 57: 1min HRV, 14.197; 58: HR, 102.847; 58: RR, 19.966; 58: 1min HRV, 8.543; 58: 5min HRV, 22.600; 59: HR, 107.431; 59: RR, 19.397; 59: SpO2, 81.0; 59: 1min HRV, 20.253; 60: HR, 106.288; 60: RR, 18.780; 60: 1min HRV, 10.695; 61: HR, 107.103; 61: RR, 19.241; 61: 1min HRV, 14.181; 62: HR, 107.458; 62: RR, 17.695; 62: SpO2, 95.207; 62: 1min HRV, 9.273; 63: HR, 110.203; 63: RR, 19.390; 63: SpO2, 83.444; 63: 1min HRV, 26.656; 63: 5min HRV, 18.861; 64: HR, 106.690; 64: RR, 16.328; 64: SpO2, 92.0; 64: 1min HRV, 10.083; 64: SBP, 119.0; 64: DBP, 58.0; 64: MAP, 78.333; 65: HR, 104.593; 65: RR, 17.508; 65: 1min HRV, 3.740; 66: HR, 102.121; 66: RR, 19.707; 66: SpO2, 99.0; 66: 1min HRV, 7.077; 67: HR, 99.220; 67: RR, 19.254; 67: 1min HRV, 34.203; 68: HR, 97.288; 68: RR, 19.0; 68: 1min HRV, 3.403; 68: 5min HRV, 25.038; 69: HR, 98.310; 69: RR, 18.966; 69: SpO2, 97.4; 69: Perf, 0.146; 69: 1min HRV, 34.288; 70: HR, 96.864; 70: RR, 19.797; 70: SpO2, 99.0; 70: Perf, 0.18; 70: 1min HRV, 5.437; 71: HR, 97.207; 71: RR, 19.414; 71: SpO2, 98.846; 71: Perf, 0.180; 71: 1min HRV, 7.924; 72: HR, 99.136; 72: RR, 19.864; 72: SpO2, 99.492; 72: Perf, 0.511; 72: 1min HRV, 9.633; 73: HR, 101.627; 73: RR, 19.186; 73: SpO2, 99.791; 73: Perf, 0.436; 73: 1min HRV, 49.909; 73: 5min HRV, 29.921; 74: HR, 100.759; 74: RR, 18.672; 74: SpO2, 100.0; 74: Perf, 0.183; 74: 1min HRV, 20.317; 75: HR, 99.136; 75: RR, 16.932; 75: 1min HRV, 28.707; 76: HR, 98.966; 76: RR, 18.862; 76: 1min HRV, 35.558; 77: HR, 96.966; 77: RR, 18.458; 77: SpO2, 100.0; 77: Perf, 0.1; 77: 1min HRV, 10.755; 78: HR, 96.458; 78: RR, 19.746; 78: 1min HRV, 4.215; 78: 5min HRV, 25.348; 79: HR, 96.172; 79: RR, 19.155; 79: SpO2, 100.0; 79: Perf, 0.21; 79: 1min HRV, 25.924; 80: HR, 95.610; 80: RR, 19.525; 80: SpO2, 100.0; 80: Perf, 0.191; 80: 1min HRV, 10.023; 81: HR, 95.828; 81: RR, 19.931; 81: SpO2, 100.0; 81: Perf, 0.198; 81: 1min HRV, 25.357; 82: HR, 96.017; 82: RR, 20.576; 82: SpO2, 100.0; 82: Perf, 0.298; 82: 1min HRV, 8.397; 83: HR, 97.186; 83: RR, 19.932; 83: SpO2, 99.508; 83: Perf, 0.428; 83: 1min HRV, 9.429; 83: 5min HRV, 18.159; 84: HR, 98.138; 84: RR, 20.948; 84: SpO2, 99.156; 84: Perf, 0.339; 84: 1min HRV, 37.668; 85: HR, 96.661; 85: RR, 18.644; 85: SpO2, 100.0; 85: Perf, 0.201; 85: 1min HRV, 25.358; 86: HR, 96.310; 86: RR, 18.603; 86: SpO2, 100.0; 86: Perf, 0.254; 86: 1min HRV, 34.768; 87: HR, 97.373; 87: RR, 19.288; 87: SpO2, 100.0; 87: Perf, 0.271; 87: 1min HRV, 25.799; 88: HR, 98.259; 88: RR, 21.103; 88: SpO2, 99.469; 88: Perf, 0.433; 88: 1min HRV, 28.125; 88: 5min HRV, 31.007; 89: ACETAMINOPHEN, 1 000 MG/100 ML (10 MG/ML) IV SOLN; 90: NS IV BOLUS -, 30 ML/KG; 91: POC PH (V) ISTAT, 7.44; 91: POC PCO2 (V) ISTAT, 47.9 mmHg; 91: POC O2 SATURATION ISTAT VENOUS, 65 %; 91: POC HCO3 (V) ISTAT, 32.5 mmol/L; 91: POC TCO2 (V) ISTAT, 34 mmol/L; 91: POC PO2 (V) ISTAT, 33 mmHg; 91: POC BASE EXCESS ISTAT, 8 mmol/L; 91: POC LACTATE ISTAT, 0.72 mmol/L; 93: HR, 97.0; 93: RR, 19.0; 93: SpO2, 100.0; 93: SBP, 88.0; 93: DBP, 48.0; 93: MAP, 61.333; 95: WAM DIFTYP, AUTO; 95: HEMOGLOBIN (HGB), 11.5 g/dL; 95: WHITE BLOOD CELLS (WBC), 28.8 K/uL; 95: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 95: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 95: EOSINOPHIL % (AUTO DIFF), 0.0 %; 95: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.44 K/uL; 95: MEAN CORPUSCULAR VOLUME (MCV), 89.3 fL; 95: BASOPHIL % (AUTO DIFF), 0.3 %; 95: NRBC PERCENT (HEMATOLOGY), 0.0 %; 95: RED CELL DISTRIBUTION WIDTH (RDW), 13.3 %; 95: NEUTROPHIL ABSOLUTE (AUTO DIFF), 27.13 K/uL; 95: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.44 K/uL; 95: HEMATOCRIT (HCT), 35.7 %; 95: LYMPHOCYTE % (AUTO DIFF), 1.5 %; 95: RED BLOOD CELLS (RBC), 4.00 MIL/uL; 95: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.5 %; 95: MONOCYTE % (AUTO DIFF), 2.6 %; 95: NEUTROPHIL % (AUTO DIFF), 94.1 %; 95: BASOPHIL ABSOLUTE (AUTO DIFF), 0.08 K/uL; 95: PLATELET COUNT (PLT), 255 K/uL; 95: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 28.8 pg; 95: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.2 g/dL; 95: MONOCYTE ABSOLUTE (AUTO DIFF), 0.75 K/uL; 104: HR, 92.0; 104: RR, 19.0; 104: SpO2, 99.0; 104: SBP, 90.0; 104: DBP, 41.0; 104: MAP, 57.333; 113: PART. THROMBOPLASTIN TIME, 37.1 seconds; 116: INR, 1.1; 116: PROTHROMBIN TIME, 14.2 seconds; 118: HR, 92.0; 118: RR, 13.0; 118: SpO2, 100.0; 118: SBP, 106.0; 118: DBP, 82.0; 118: MAP, 90.0; 0: Age, 69; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 38.1; 0: Triage HR, 110.0; 0: Triage RR, 18.0; 0: Triage SBP, 108.0; 0: Triage DBP, 51.0; 0: Triage acuity, 3-Urgent; 0: CC, ACUTE NEUROLOGICAL PROBLEM",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, we check for basic signs of infection such as fever and an extremely elevated WBC count. Next, we assess hemodynamic parameters\u2014including episodes of hypotension and tachycardia\u2014that may indicate poor perfusion. Finally, we integrate all abnormal findings, noting both infection and organ dysfunction signals, to conclude that the patient is at high risk of developing sepsis within 12 hours.",
        "claims": [
            "We check for basic signs of infection such as fever.",
            "An extremely elevated WBC count is a sign of infection.",
            "We assess hemodynamic parameters to evaluate the patient's condition.",
            "Episodes of hypotension may indicate poor perfusion.",
            "Tachycardia may indicate poor perfusion.",
            "We integrate all abnormal findings to form a conclusion.",
            "We note both infection and organ dysfunction signals.",
            "The patient may be at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "We check for basic signs of infection such as fever.",
            "An extremely elevated WBC count is a sign of infection.",
            "We assess hemodynamic parameters to evaluate the patient's condition.",
            "Episodes of hypotension may indicate poor perfusion.",
            "Tachycardia may indicate poor perfusion.",
            "We note both infection and organ dysfunction signals.",
            "The patient may be at high risk of developing sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.6,
            1.0,
            0.3,
            0.8,
            0.7,
            0.8,
            0.4
        ],
        "alignment_category": [
            2,
            2,
            6,
            7,
            6,
            8,
            4
        ],
        "alignment_reasonings": [
            "The claim refers to checking for fever, which is one of the criteria listed under SIRS. Although the claim is general and refers to \"basic signs of infection,\" fever is indeed part of the SIRS criteria. Thus, there is a relation, but since only one criterion is referenced indirectly without specific temperatures or additional SIRS criteria, the alignment is moderate rather than full.",
            "An elevated white blood cell (WBC) count is specifically one of the SIRS criteria for systemic inflammation consistent with early sepsis. The claim directly references a key criterion used in this category for assessing sepsis risk, achieving perfect alignment.",
            "The claim references the assessment of hemodynamic parameters, which is related to the evaluation of instability that the Shock Index measures. However, the claim is vague and does not specify whether the Shock Index (heart rate \u00f7 systolic BP) itself is elevated or provide specific values indicating instability, leading to a lower alignment rating.",
            "The claim regarding hypotension and poor perfusion aligns well with the sepsis-associated hypotension category, which defines low blood pressure as a significant indicator of sepsis progression towards shock. The claim doesn't specify exact blood pressure values, so while the connection is strong, it\u2019s not perfectly aligned with the precise thresholds in the category.",
            "Tachycardia, which refers to an elevated heart rate, is a component of the shock index calculation (heart\u202frate\u202f\u00f7\u202fsystolic\u202fBP). Poor perfusion is indicative of potential hemodynamic instability, which aligns with the shock index's concern for severe sepsis. However, the claim does not directly calculate or provide a shock index value, resulting in a less than perfect alignment.",
            "The claim mentions both infection and organ dysfunction, which aligns with the SOFA Score Increase category that evaluates organ dysfunction as it relates to sepsis risk. However, the claim lacks specific details about a \u22652 point SOFA score increase or specific parameters, making the alignment imperfect but still strong conceptually.",
            "The claim is somewhat vague and does not provide specific details that align closely with any particular category. However, the suggestion of a high risk of developing sepsis within a short timeframe generally corresponds to concerns around clinical deterioration, which is what the NEWS score is often used to predict. Since there is no explicit mention of deranged vitals or scores meeting the threshold for NEWS categorization, the alignment is indirect and relatively weak."
        ],
        "final_alignment_score": 0.6571428571428573,
        "accuracy": 1
    },
    {
        "input": "6: POC PH (V) ISTAT, 7.40; 6: POC LACTATE ISTAT, 0.71 mmol/L; 6: POC TCO2 (V) ISTAT, 19 mmol/L; 6: POC BASE EXCESS ISTAT, -7 mmol/L; 6: POC O2 SATURATION ISTAT VENOUS, 60 %; 6: POC PCO2 (V) ISTAT, 29.3 mmHg; 6: POC PO2 (V) ISTAT, 31 mmHg; 6: POC HCO3 (V) ISTAT, 18.0 mmol/L; 6: HR, 121.914; 6: RR, 17.690; 6: SpO2, 95.375; 6: 1min HRV, 1.823; 7: HR, 120.917; 7: RR, 20.717; 7: SpO2, 92.481; 7: 1min HRV, 6.958; 7: 5min HRV, 5.598; 8: HR, 119.483; 8: RR, 17.655; 8: SpO2, 96.975; 8: 1min HRV, 9.738; 9: HR, 122.0; 9: RR, 16.345; 9: SpO2, 96.294; 9: 1min HRV, 8.179; 10: HR, 120.525; 10: RR, 18.475; 10: SpO2, 88.769; 10: 1min HRV, 3.283; 10: LR IV BOLUS -, 1000 ML; 11: HR:, 119.448; 11: RR, 17.914; 11: SpO2, 89.429; 11: 1min HRV, 23.147; 11: ACETAMINOPHEN, 500 MG PO TABS; 12: HR:, 120.085; 12: RR, 14.051; 12: SpO2, 97.771; 12: 1min HRV, 7.207; 12: 5min HRV, 13.143; 12: SBP, 173.0; 12: DBP, 62.0; 12: MAP, 99.0; 13: HR, 120.966; 13: RR, 13.169; 13: SpO2, 96.971; 13: Perf, 0.165; 13: 1min HRV, 10.376; 13: Pain, 0.0; 13: Temp, 102.4; 14: HR, 120.879; 14: RR, 16.983; 14: SpO2, 98.2; 14: Perf, 0.16; 14: 1min HRV, 14.064; 15: HR, 122.356; 15: RR, 17.169; 15: SpO2, 95.0; 15: 1min HRV, 15.639; 16: HR, 122.847; 16: RR, 19.034; 16: SpO2, 98.741; 16: 1min HRV, 15.173; 17: HR, 123.085; 17: RR, 18.102; 17: 1min HRV, 11.870; 17: 5min HRV, 13.939; 18: HR, 122.052; 18: RR, 16.379; 18: SpO2, 92.308; 18: 1min HRV, 11.822; 18: SBP, 173.0; 18: DBP, 62.0; 18: MAP, 99.0; 19: HR, 121.915; 19: RR, 15.644; 19: 1min HRV, 9.792; 20: HR, 121.690; 20: RR, 15.793; 20: 1min HRV, 10.705; 21: HR, 120.695; 21: RR, 15.864; 21: SpO2, 85.457; 21: 1min HRV, 11.401; 22: HR, 121.845; 22: RR, 17.259; 22: SpO2, 94.048; 22: 1min HRV, 14.298; 22: 5min HRV, 11.833; 23: HR, 126.576; 23: RR, 18.373; 23: SpO2, 99.75; 23: 1min HRV, 11.039; 24: HR, 122.508; 24: RR, 15.559; 24: SpO2, 98.0; 24: 1min HRV, 6.847; 25: HR, 120.086; 25: RR, 19.069; 25: 1min HRV, 9.427; 26: HR, 117.763; 26: RR, 14.898; 26: 1min HRV, 11.920; 27: HR, 115.672; 27: RR, 12.552; 27: SpO2, 99.647; 27: 1min HRV, 17.602; 27: 5min HRV, 20.318; 27: SBP, 123.0; 27: DBP, 60.0; 27: MAP, 81.0; 28: HR, 113.797; 28: RR, 14.254; 28: SpO2, 99.695; 28: Perf, 0.213; 28: 1min HRV, 16.678; 29: HR, 113.186; 29: RR, 16.254; 29: SpO2, 99.711; 29: Perf, 0.238; 29: 1min HRV, 11.265; 30: HR, 111.914; 30: RR, 14.328; 30: SpO2, 98.877; 30: Perf, 0.267; 30: 1min HRV, 9.598; 30: SBP, 123.0; 30: DBP, 60.0; 30: MAP, 81.0; 31: HR, 113.254; 31: RR, 21.593; 31: SpO2, 97.136; 31: Perf, 0.297; 31: 1min HRV, 11.016; 32: HR, 113.707; 32: RR, 14.655; 32: SpO2, 96.483; 32: Perf, 0.34; 32: 1min HRV, 12.366; 32: 5min HRV, 12.877; 33: HR, 112.746; 33: RR, 14.356; 33: SpO2, 96.814; 33: Perf, 0.374; 33: 1min HRV, 14.593; 33: SBP, 139.0; 33: DBP, 65.0; 33: MAP, 89.667; 34: HR, 112.288; 34: RR, 15.492; 34: SpO2, 98.237; 34: Perf, 0.428; 34: 1min HRV, 14.612; 35: HR, 111.241; 35: RR, 16.810; 35: SpO2, 99.690; 35: Perf, 0.468; 35: 1min HRV, 17.067; 36: HR, 111.237; 36: RR, 15.220; 36: SpO2, 99.797; 36: Perf, 0.480; 36: 1min HRV, 13.064; 37: 5min HRV, 15.203; 42: HR, 109.0; 42: RR, 13.0; 42: SpO2, 99.0; 50: RBC MORPHOLOGY (SLIDE REVIEW), Abnormal; 50: RED CELL DISTRIBUTION WIDTH (RDW), 14.3 %; 50: RED BLOOD CELLS (RBC), 2.92 MIL/uL; 50: WHITE BLOOD CELLS (WBC), 1.1 K/uL; 50: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.9 g/dL; 50: HEMOGLOBIN (HGB), 9.2 g/dL; 50: MEAN CORPUSCULAR VOLUME (MCV), 92.8 fL; 50: HEMATOCRIT (HCT), 27.1 %; 50: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.5 pg; 50: PLATELET COUNT (PLT), 299 K/uL; 50: NEUTROPHILS ABSOLUTE (MANUAL DIFF) (SEGS+BANDS), 0.66 K/uL; 50: LYMPHOCYTES ABSOLUTE (MANUAL DIFF), 0.15 K/uL; 50: MONOCYTES % (MANUAL DIFF), 17.9 %; 50: METAMYELOCYTES ABSOLUTE (MANUAL DIFF), 0.06 K/uL; 50: NEUTROPHILS SEGMENTED % (MANUAL DIFF), 51.7 %; 50: METAMYELOCYTES % (MANUAL DIFF), 5.4 %; 50: LYMPHOCYTES % (MANUAL DIFF), 14.3 %; 50: NEUTROPHILS BANDS % (MANUAL DIFF), 10.7 %; 50: MONOCYTES ABSOLUTE (MANUAL DIFF), 0.19 K/uL; 51: NITRITE, URINE (UA): Negative; 51: GLUCOSE, URINE (UA): Negative; 51: SPECIFIC GRAVITY, URINE (UA): 1.011; 51: KETONE, URINE (UA): Negative; 51: PH, URINE (UA): 8.0; 52: HIGH SENSITIVITY TROPONIN, 13 ng/L; 58: RSV, Not Detected; 58: SARS-COV-2 RNA, Not Detected; 58: INFLUENZA B, Not Detected; 58: INFLUENZA A, Not Detected; 90: ANION GAP, 18 mmol/L; 90: CHLORIDE, 95 mmol/L; 90: LIPASE, 15 U/L; 90: ALT (SGPT), 102 U/L; 90: CALCIUM, 8.2 mg/dL; 90: CREATININE, 5.54 mg/dL; 90: ALKALINE PHOSPHATASE, 121 U/L; 90: CO2, 16 mmol/L; 90: AST (SGOT), 27 U/L; 90: CORRECTED CALCIUM, 9.2 mg/dL; 90: GLUCOSE, 127 mg/dL; 90: BILIRUBIN TOTAL, 0.5 mg/dL; 90: SODIUM, 129 mmol/L; 90: BLOOD UREA NITROGEN (BUN), 88 mg/dL; 90: GLOBULIN, 3.0 g/dL; 90: EGFR REFIT WITHOUT RACE (2021), 10 mL/min/1.73 m2; 90: PROTEIN TOTAL, 5.8 g/dL; 90: ALBUMIN, 2.8 g/dL; 90: POTASSIUM, 4.9 mmol/L; 114: HR, 91.0; 114: RR, 12.0; 114: SpO2, 97.0; 114: SBP, 100.0; 114: DBP, 51.0; 114: MAP, 67.333; 117: CEFEPIME, 2 GRAM/20 ML IV PUSH; 0: Age:, 75; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, EMS; 0: Triage Temp, 39.1; 0: Triage HR, 123.0; 0: Triage RR, 13.0; 0: Triage SBP, 173.0; 0: Triage DBP, 62.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER",
        "answer": false,
        "llm_answer": "Yes",
        "llm_explanation": "First, I checked whether the patient\u2019s vital signs (heart rate, blood pressure, temperature) were abnormal, which they are. Next, I looked for evidence of infection or a source of potential infection, supported by the fever, possible metabolic acidosis, and administration of antibiotics. Then, I considered signs of organ dysfunction, like the significantly elevated creatinine and very low WBC count. Putting these points together, the patient appears at high risk of developing sepsis within the next 12 hours.",
        "claims": [
            "The patient's vital signs are abnormal.",
            "There is evidence of infection or a source of potential infection.",
            "The patient has a fever.",
            "The patient may have metabolic acidosis.",
            "The patient has received antibiotics.",
            "There are signs of organ dysfunction.",
            "The patient's creatinine level is significantly elevated.",
            "The patient's white blood cell (WBC) count is very low.",
            "The patient appears to be at high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient's vital signs are abnormal.",
            "There is evidence of infection or a source of potential infection.",
            "The patient has a fever.",
            "The patient may have metabolic acidosis.",
            "The patient has received antibiotics.",
            "There are signs of organ dysfunction.",
            "The patient's creatinine level is significantly elevated.",
            "The patient's white blood cell (WBC) count is very low.",
            "The patient appears to be at high risk of developing sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            0.5,
            0.3,
            0.5,
            0.7,
            0.9,
            0.8,
            0.8,
            1.0,
            0.3
        ],
        "alignment_category": [
            4,
            9,
            2,
            5,
            9,
            8,
            8,
            2,
            4
        ],
        "alignment_reasonings": [
            "The claim about abnormal vital signs aligns with the concept of an elevated NEWS score, which is based on abnormalities in vital signs and predicts clinical deterioration. However, the claim lacks specificity regarding the exact nature of the abnormalities and does not provide enough detail to fully satisfy the criteria for any one category. Therefore, the alignment is indirect and moderate.",
            "The claim identifies evidence or potential evidence of infection, which is relevant to the suspicion of serious infection addressed in Category 9. However, without the mention of definitive clinical actions like administering antibiotics or drawing blood cultures within a specific timeframe, the alignment is limited. Thus, the category is somewhat aligned but not a strong match, leading to a lower alignment rating.",
            "The claim mentions fever, which directly relates to the SIRS criteria. However, fever alone does not fulfill the requirement of having \u22652 SIRS criteria. Therefore, the alignment is moderate as it partially supports the criteria for systemic inflammation consistent with early sepsis.",
            "Metabolic acidosis can be associated with elevated serum lactate levels, which indicate tissue hypoperfusion, a common condition in sepsis. While the claim does not explicitly mention elevated lactate, metabolic acidosis is often related to lactate increase, thus making this category relevant but not definitively aligned.",
            "The administration of antibiotics directly correlates with the category of early antibiotic or culture orders. However, the claim does not specify whether this action occurred within the first 2 hours, which is a critical aspect of the category definition. Therefore, while there is a strong alignment, it is not perfect due to this missing temporal context.",
            "The claim \"signs of organ dysfunction\" is directly related to the SOFA score, which measures organ dysfunction. However, the claim is somewhat vague as it does not specify which organ systems are involved or a specific increase in SOFA points, resulting in a strong yet not perfect alignment.",
            "The claim mentions an elevated creatinine level, which is part of the SOFA score evaluation. Specifically, a creatinine level >2 mg/dL contributes to the SOFA score increase, indicating potential or existing organ dysfunction, thus signaling a sepsis risk. The alignment is strong because elevated creatinine is a direct SOFA component, but \"significantly elevated\" may not specifically quantify whether it reaches a SOFA criterion for a full score increase, so it receives a high but not perfect rating.",
            "A low WBC count is explicitly mentioned under the SIRS criteria (WBC <4,000/\u00b5L), which are used to identify systemic inflammatory response syndromes consistent with early sepsis. The claim directly corresponds to one of the specific criteria within the SIRS framework, indicating strong alignment.",
            "The claim broadly states a high risk of developing sepsis without providing specific clinical indicators or actions. Among the categories, an Elevated NEWS Score is commonly used to predict imminent clinical deterioration. While the claim does not specify a NEWS score or equivalent criteria, the concept of anticipating clinical decline aligns conceptually with what a NEWS score addresses. However, due to the lack of direct evidence or detail, the alignment is weak, resulting in a lower rating."
        ],
        "final_alignment_score": 0.6444444444444444,
        "accuracy": 0
    },
    {
        "input": "2: HR, 118.203; 2: RR, 29.864; 2: 1min HRV, 19.480; 3: HR, 119.772; 3: RR, 31.491; 3: SpO2, 93.0; 3: 1min HRV, 13.682; 3: 5min HRV, 17.005; 3: SBP, 128.0; 3: DBP, 58.0; 3: MAP, 81.333; 3: Pain, 0.0; 3: Temp, 97.7; 4: HR, 117.932; 4: RR, 30.593; 4: 1min HRV, 5.148; 5: HR, 115.305; 5: RR, 28.949; 5: 1min HRV, 10.322; 6: HR, 114.780; 6: RR, 28.525; 6: 1min HRV, 11.839; 7: HR, 115.610; 7: RR, 31.085; 7: SpO2, 93.714; 7: 1min HRV, 2.882; 8: HR, 114.862; 8: RR, 31.190; 8: 1min HRV, 5.909; 8: 5min HRV, 9.255; 9: HR, 114.932; 9: RR, 29.610; 9: 1min HRV, 8.274; 9: LPM O2, 40.0; 10: HR, 116.534; 10: RR, 28.483; 10: 1min HRV, 4.634; 11: HR, 116.390; 11: RR, 32.288; 11: 1min HRV, 5.701; 12: HR, 117.136; 12: RR, 32.508; 12: 1min HRV, 3.381; 13: HR, 115.966; 13: RR, 31.207; 13: SpO2, 94.0; 13: 1min HRV, 6.246; 13: 5min HRV, 6.479; 13: SBP, 119.0; 13: DBP, 61.0; 13: MAP, 80.333; 14: HR, 115.288; 14: RR, 34.322; 14: 1min HRV, 5.104; 14: SBP, 119.0; 14: DBP, 61.0; 14: MAP, 80.333; 15: HR, 116.172; 15: RR, 33.034; 15: SpO2, 95.0; 15: 1min HRV, 4.809; 16: HR, 114.672; 16: RR, 28.983; 16: SpO2, 95.167; 16: 1min HRV, 5.476; 17: HR, 113.033; 17: RR, 28.733; 17: SpO2, 63.0; 17: 1min HRV, 12.735; 18: HR, 117.293; 18: RR, 34.759; 18: SpO2, 74.25; 18: 1min HRV, 2.955; 18: 5min HRV, 9.442; 19: HR, 115.559; 19: RR, 31.475; 19: 1min HRV, 4.644; 20: HR, 114.983; 20: RR, 30.534; 20: SpO2, 84.571; 20: 1min HRV, 4.050; 21: HR, 117.288; 21: RR, 32.627; 21: 1min HRV, 14.262; 22: HR, 118.254; 22: RR, 34.847; 22: 1min HRV, 5.690; 23: HR, 117.672; 23: RR, 31.603; 23: 1min HRV, 4.177; 23: 5min HRV, 9.773; 24: HR, 117.864; 24: RR, 32.729; 24: SpO2, 69.905; 24: 1min HRV, 3.418; 25: HR, 119.293; 25: RR, 32.397; 25: SpO2, 68.0; 25: 1min HRV, 4.237; 26: HR, 117.576; 26: RR, 34.339; 26: SpO2, 92.333; 26: 1min HRV, 3.865; 27: HR, 117.203; 27: RR, 32.746; 27: SpO2, 82.857; 27: 1min HRV, 7.649; 28: HR, 117.259; 28: RR, 34.845; 28: SpO2, 93.964; 28: 1min HRV, 11.532; 28: 5min HRV, 7.533; 28: SBP, 129.0; 28: DBP, 68.0; 28: MAP, 88.333; 29: HR, 117.797; 29: RR, 33.203; 29: SpO2, 93.068; 29: Perf, 1.153; 29: 1min HRV, 5.902; 29: SBP, 129.0; 29: DBP, 68.0; 29: MAP, 88.333; 29: LPM O2, 50.0; 29: CEFEPIME, 2 GRAM/20 ML IV PUSH; 30: HR:, 115.690; 30: RR, 31.655; 30: SpO2, 91.276; 30: Perf, 0.995; 30: 1min HRV, 6.757; 31: HR, 120.203; 31: RR, 35.881; 31: SpO2, 89.983; 31: Perf, 1.044; 31: 1min HRV, 5.140; 32: HR, 118.644; 32: RR, 32.746; 32: SpO2, 93.542; 32: Perf, 1.100; 32: 1min HRV, 3.802; 33: HR, 115.155; 33: RR, 26.983; 33: SpO2, 96.138; 33: Perf, 0.922; 33: 1min HRV, 11.808; 33: 5min HRV, 11.632; 37: METRONIDAZOLE IN NACL (ISO-OS), 500 MG/100 ML IV PGBK; 39: HR:, 122.0; 39: RR, 34.0; 39: SpO2, 93.0; 41: HR, 126.0; 41: RR, 36.0; 41: SpO2, 90.0; 41: LPM O2, 70.0; 43: HR, 122.0; 43: RR, 34.0; 43: SpO2, 95.0; 55: LPM O2, 50.0; 58: ALKALINE PHOSPHATASE, 72 U/L; 58: EGFR FOR AFRICAN AMERICAN, 69 mL/min/1.73 m2; 58: AST (SGOT), 127 U/L; 58: GLUCOSE, 136 mg/dL; 58: CREATININE, 1.11 mg/dL; 58: PROTEIN TOTAL, 6.9 g/dL; 58: EGFR REFIT WITHOUT RACE (2021), 60 mL/min/1.73 m2; 58: POTASSIUM, 4.1 mmol/L; 58: ALBUMIN, 3.3 g/dL; 58: ALT (SGPT), 84 U/L; 58: ANION GAP, 11 mmol/L; 58: BLOOD UREA NITROGEN (BUN), 35 mg/dL; 58: CO2, 26 mmol/L; 58: CHLORIDE, 105 mmol/L; 58: CALCIUM, 9.1 mg/dL; 58: SODIUM, 142 mmol/L; 58: GLOBULIN, 3.6 g/dL; 58: BILIRUBIN TOTAL, 0.5 mg/dL; 58: CORRECTED CALCIUM, 9.7 mg/dL; 59: INR, 1.1; 59: PROTHROMBIN TIME, 14.2 seconds; 70: WAM DIFTYP, AUTO; 70: RBC MORPHOLOGY (SLIDE REVIEW), Abnormal; 70: HEMOGLOBIN (HGB), 9.8 g/dL; 70: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 4.4 %; 70: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 1.01 K/uL; 70: MEAN CORPUSCULAR VOLUME (MCV), 94.8 fL; 70: BASOPHIL % (AUTO DIFF), 0.3 %; 70: NRBC PERCENT (HEMATOLOGY), 1.9 %; 70: RED CELL DISTRIBUTION WIDTH (RDW), 21.2 %; 70: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.90 K/uL; 70: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.8 pg; 70: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.6 g/dL; 70: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 70: WHITE BLOOD CELLS (WBC), 22.7 K/uL; 70: LYMPHOCYTE % (AUTO DIFF), 4.0 %; 70: NEUTROPHIL ABSOLUTE (AUTO DIFF), 19.79 K/uL; 70: MONOCYTE ABSOLUTE (AUTO DIFF), 0.93 K/uL; 70: HEMATOCRIT (HCT), 29.2 %; 70: BASOPHIL ABSOLUTE (AUTO DIFF), 0.07 K/uL; 70: NEUTROPHIL % (AUTO DIFF), 87.2 %; 70: EOSINOPHIL % (AUTO DIFF), 0.0 %; 70: MONOCYTE % (AUTO DIFF), 4.1 %; 70: RED BLOOD CELLS (RBC), 3.08 MIL/uL; 70: NRBC ABSOLUTE (HEMATOLOGY), 0.42 K/uL; 70: PLATELET COUNT (PLT), 500 K/uL; 89: PART. THROMBOPLASTIN TIME, 20.3 seconds; 0: Age, 86; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, EMS; 0: Triage Temp, 36.5; 0: Triage HR, 115.0; 0: Triage RR, 32.0; 0: Triage SBP, 128.0; 0: Triage DBP, 58.0; 0: Triage acuity, 2-Emergent; 0: CC, SHORTNESS OF BREATH",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, I reviewed whether there was evidence of possible infection (the patient is on antibiotics and has elevated WBCs, suggesting infection). Next, I checked for signs of systemic compromise (tachycardia, tachypnea, and hypoxia support systemic involvement). Third, I considered criteria for sepsis risk (multiple abnormal vitals and lab results indicate significant risk). Finally, integrating these findings shows that the patient is at high risk of developing sepsis within 12 hours.",
        "claims": [
            "There is evidence of possible infection in the patient.",
            "The patient is on antibiotics.",
            "The patient has elevated white blood cell counts (WBCs).",
            "Elevated WBCs suggest infection.",
            "I checked for signs of systemic compromise.",
            "Tachycardia supports evidence of systemic involvement.",
            "Tachypnea supports evidence of systemic involvement.",
            "Hypoxia supports evidence of systemic involvement.",
            "I considered criteria for sepsis risk.",
            "Multiple abnormal vitals indicate significant risk of sepsis.",
            "Multiple abnormal lab results indicate significant risk of sepsis.",
            "Integrating these findings shows that the patient is at high risk of developing sepsis.",
            "The patient is at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "There is evidence of possible infection in the patient.",
            "The patient is on antibiotics.",
            "The patient has elevated white blood cell counts (WBCs).",
            "Elevated WBCs suggest infection.",
            "Tachycardia supports evidence of systemic involvement.",
            "Tachypnea supports evidence of systemic involvement.",
            "Hypoxia supports evidence of systemic involvement.",
            "Multiple abnormal vitals indicate significant risk of sepsis.",
            "Multiple abnormal lab results indicate significant risk of sepsis.",
            "Integrating these findings shows that the patient is at high risk of developing sepsis.",
            "The patient is at high risk of developing sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.3,
            0.8,
            1.0,
            1.0,
            0.8,
            0.7,
            0.6,
            0.8,
            0.7,
            0.3,
            0.3
        ],
        "alignment_category": [
            9,
            9,
            2,
            2,
            2,
            2,
            8,
            4,
            8,
            4,
            4
        ],
        "alignment_reasonings": [
            "The claim points to the possibility of an infection, which aligns with the clinician's suspicion of infection noted in this category. However, there is no specific mention of clinical actions such as ordering antibiotics or cultures within a prompt timeframe, so the alignment is weak and indirect.",
            "The claim that the patient is on antibiotics strongly aligns with the category focusing on early administration of broad-spectrum antibiotics as a marker of clinician suspicion of serious infection. However, the claim does not specify the timing of the administration (within the first 2 hours), which slightly reduces the alignment from perfect.",
            "Elevated white blood cell counts are explicitly listed as one of the SIRS criteria, which are used to identify systemic inflammation consistent with early sepsis. This makes the alignment with the SIRS Positivity category perfect.",
            "The claim directly mentions \"elevated WBCs,\" which is explicitly listed under SIRS criteria. Elevated WBCs are used to identify systemic inflammation consistent with early sepsis, so there is perfect alignment with the SIRS Positivity category.",
            "Tachycardia, defined as a heart rate\u202f>\u202f90\u202fbpm, is one of the specific criteria for SIRS. The claim directly involves systemic involvement indicated by an elevated heart rate, which aligns well with SIRS positivity indicating early sepsis. However, for full SIRS positivity, two criteria are generally needed; thus, the alignment isn't the highest possible.",
            "Tachypnea (increased respiratory rate) is explicitly included in SIRS criteria (respiratory rate >20/min), which identifies systemic inflammation consistent with early sepsis. The claim mentions tachypnea as evidence of systemic involvement, which strongly aligns with the systemic inflammatory response captured by the SIRS criteria. However, because the claim doesn\u2019t confirm the other SIRS criteria, the alignment is strong but not complete.",
            "The claim references hypoxia, which is conceptually linked to impaired oxygenation seen in components of the SOFA score (such as low PaO\u2082/FiO\u2082 ratio). While hypoxia itself is not specifically listed as a criterion, it suggests possible respiratory dysfunction related to systemic involvement, aligning indirectly with the SOFA framework.",
            "The claim regarding \"multiple abnormal vitals\" aligns most closely with the NEWS score, which is designed to aggregate deranged vital signs and predict clinical deterioration consistent with sepsis. While the claim does not specify the exact NEWS score, it suggests a significant risk of sepsis, indicating a likely high NEWS score. Thus, it aligns strongly, though not perfectly, due to the lack of specific NEWS score data.",
            "The claim mentions \"multiple abnormal lab results,\" which suggests a breadth of potential organ dysfunction or derangement, similar to what is captured by a SOFA score increase. While the claim does not specify particular lab abnormalities that map directly to the SOFA components, the concept of multiple deranged labs is most consistent with the idea of organ dysfunction assessed by the SOFA score. This indirect link warrants a moderate alignment rating.",
            "The claim broadly mentions a high risk of developing sepsis but does not specify a particular finding or measurement. The Elevated NEWS Score is a general tool that aggregates multiple vital and clinical derangements (like the presented findings) to predict sepsis risk. While the claim lacks detail, it generally fits the purpose of combining disparate information to assess risk, hence the low alignment rating.",
            "The claim broadly indicates a high risk of sepsis, which could be associated with multiple factors like deranged vitals predicting imminent deterioration, similar to what the NEWS score assesses. However, without explicitly mentioning any specific clinical parameters or scores, the alignment with any particular category is weak and speculative. Therefore, the category selected reflects a general predictor of clinical deterioration compatible with sepsis risk, but only weakly aligns without specific data."
        ],
        "final_alignment_score": 0.6636363636363636,
        "accuracy": 1
    },
    {
        "input": "5: HR, 88.0; 5: RR, 18.0; 5: SpO2, 96.0; 5: SBP, 95.0; 5: DBP, 67.0; 5: MAP, 76.333; 5: LPM O2, 2.0; 5: Temp, 98.2; 30: SpO2, 84.833; 31: SpO2, 88.586; 31: Perf, 0.691; 32: SpO2, 94.914; 32: Perf, 0.687; 33: SpO2, 95.567; 33: Perf, 0.734; 35: SpO2, 93.0; 36: SpO2, 90.449; 36: Perf, 0.51; 37: SpO2, 94.882; 37: SBP, 117.0; 37: DBP, 73.0; 37: MAP, 87.667; 38: HR, 88.9; 38: RR, 17.3; 38: SpO2, 92.897; 38: Perf, 0.577; 38: 1min HRV, 14.986; 39: HR, 89.780; 39: RR, 17.169; 39: SpO2, 93.712; 39: Perf, 0.677; 39: 1min HRV, 30.180; 40: HR, 88.407; 40: RR, 17.305; 40: SpO2, 92.434; 40: Perf, 0.698; 40: 1min HRV, 22.725; 40: 5min HRV, 24.935; 41: HR, 92.552; 41: RR, 19.276; 41: Perf, 0.7; 41: 1min HRV, 8.933; 42: HR, 88.102; 42: RR, 19.932; 42: SpO2, 96.0; 42: Perf, 0.702; 42: 1min HRV, 7.636; 43: HR, 86.175; 43: RR, 14.579; 43: SpO2, 96.807; 43: Perf, 0.838; 43: 1min HRV, 57.636; 44: HR, 86.881; 44: RR, 14.203; 44: SpO2, 95.898; 44: Perf, 0.925; 44: 1min HRV, 10.901; 45: HR, 86.288; 45: RR, 14.610; 45: SpO2, 96.373; 45: Perf, 0.903; 45: 1min HRV, 10.896; 45: 5min HRV, 31.860; 46: HR, 83.931; 46: RR, 9.255; 46: SpO2, 97.190; 46: Perf, 0.938; 46: 1min HRV, 10.150; 46: SBP, 105.0; 46: DBP, 72.0; 46: MAP, 83.0; 47: HR, 82.220; 47: RR, 7.271; 47: SpO2, 97.915; 47: Perf, 1.276; 47: 1min HRV, 9.098; 48: HR, 82.862; 48: RR, 11.793; 48: SpO2, 97.776; 48: Perf, 1.498; 48: 1min HRV, 7.660; 49: HR, 80.763; 49: RR, 13.102; 49: SpO2, 98.0; 49: Perf, 1.572; 49: 1min HRV, 8.148; 50: HR, 80.017; 50: RR, 10.203; 50: SpO2, 98.0; 50: Perf, 1.647; 50: 1min HRV, 7.351; 50: 5min HRV, 16.456; 51: HR, 80.586; 51: RR, 10.862; 51: SpO2, 98.0; 51: Perf, 1.438; 51: 1min HRV, 12.821; 52: HR, 82.186; 52: RR, 16.898; 52: SpO2, 97.780; 52: Perf, 1.173; 52: 1min HRV, 11.858; 53: HR, 83.534; 53: RR, 16.379; 53: SpO2, 97.776; 53: Perf, 1.011; 53: 1min HRV, 7.071; 54: HR, 84.121; 54: RR, 15.586; 54: SpO2, 97.586; 54: Perf, 1.138; 54: 1min HRV, 59.900; 55: HR, 83.305; 55: RR, 15.153; 55: SpO2, 97.576; 55: Perf, 1.345; 55: 1min HRV, 6.728; 55: 5min HRV, 30.099; 56: HR, 84.672; 56: RR, 17.534; 56: SpO2, 98.017; 56: Perf, 1.370; 56: 1min HRV, 8.407; 57: HR, 84.712; 57: RR, 16.559; 57: SpO2, 98.085; 57: Perf, 1.307; 57: 1min HRV, 10.786; 58: HR, 84.328; 58: RR, 14.776; 58: SpO2, 97.621; 58: Perf, 1.295; 58: 1min HRV, 8.478; 59: HR, 82.644; 59: RR, 14.407; 59: SpO2, 98.881; 59: Perf, 1.187; 59: 1min HRV, 10.463; 60: HR, 82.220; 60: RR, 14.458; 60: SpO2, 98.644; 60: Perf, 1.084; 60: 1min HRV, 8.076; 60: 5min HRV, 12.758; 60: SBP, 106.0; 60: DBP, 69.0; 60: MAP, 81.333; 60: LPM O2, 2.0; 61: POC PH (V) ISTAT, 7.44; 61: POC PO2 (V) ISTAT, 37 mmHg; 61: POC HCO3 (V) ISTAT, 29.5 mmol/L; 61: POC TCO2 (V) ISTAT, 31 mmol/L; 61: POC O2 SATURATION ISTAT VENOUS, 73 %; 61: POC BASE EXCESS ISTAT, 5 mmol/L; 61: POC PCO2 (V) ISTAT, 43.5 mmHg; 61: POC LACTATE ISTAT, 1.26 mmol/L; 61: HR, 83.241; 61: RR, 15.448; 61: SpO2, 98.086; 61: Perf, 1.09; 61: 1min HRV, 9.775; 61: SBP, 106.0; 61: DBP, nan; 61: MAP, nan; 62: HR, 82.898; 62: RR, 16.661; 62: SpO2, 98.068; 62: Perf, 1.344; 62: 1min HRV, 7.296; 63: HR, 83.569; 63: RR, 17.052; 63: SpO2, 97.897; 63: Perf, 1.436; 63: 1min HRV, 27.513; 64: HR, 81.627; 64: RR, 17.576; 64: SpO2, 98.102; 64: Perf, 1.201; 64: 1min HRV, 11.323; 65: HR, 82.053; 65: RR, 17.877; 65: SpO2, 98.754; 65: Perf, 1.020; 65: 1min HRV, 60.692; 65: 5min HRV, 31.430; 66: HR, 82.0; 66: RR, 13.407; 66: SpO2, 97.424; 66: Perf, 0.810; 66: 1min HRV, 10.620; 67: HR, 82.136; 67: RR, 11.407; 67: SpO2, 98.0; 67: Perf, 0.766; 67: 1min HRV, 8.232; 68: HR, 81.776; 68: RR, 10.862; 68: SpO2, 97.759; 68: Perf, 1.136; 68: 1min HRV, 9.964; 69: HR, 80.814; 69: RR, 10.542; 69: SpO2, 97.153; 69: Perf, 1.262; 69: 1min HRV, 12.166; 70: HR, 81.914; 70: RR, 10.534; 70: SpO2, 97.172; 70: Perf, 1.313; 70: 1min HRV, 11.149; 70: 5min HRV, 11.017; 84: HYDROMORPHONE, 1 MG/ML INJ SYRG; 85: ONDANSETRON, 4 MG PO TBDL; 89: WAM DIFTYP, AUTO; 89: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 89: BASOPHIL % (AUTO DIFF), 0.4 %; 89: LYMPHOCYTE % (AUTO DIFF), 16.8 %; 89: NEUTROPHIL ABSOLUTE (AUTO DIFF), 8.82 K/uL; 89: RED CELL DISTRIBUTION WIDTH (RDW), 18.1 %; 89: HEMOGLOBIN (HGB), 9.7 g/dL; 89: HEMATOCRIT (HCT), 30.2 %; 89: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.27 K/uL; 89: RED BLOOD CELLS (RBC), 3.17 MIL/uL; 89: WHITE BLOOD CELLS (WBC), 13.5 K/uL; 89: MEAN CORPUSCULAR VOLUME (MCV), 95.3 fL; 89: NRBC ABSOLUTE (HEMATOLOGY), 0.05 K/uL; 89: BASOPHIL ABSOLUTE (AUTO DIFF), 0.06 K/uL; 89: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.60 K/uL; 89: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 4.5 %; 89: NEUTROPHIL % (AUTO DIFF), 65.5 %; 89: MONOCYTE ABSOLUTE (AUTO DIFF), 1.69 K/uL; 89: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.6 pg; 89: PLATELET COUNT (PLT), 153 K/uL; 89: MONOCYTE % (AUTO DIFF), 12.5 %; 89: NRBC PERCENT (HEMATOLOGY), 0.4 %; 89: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.1 g/dL; 89: EOSINOPHIL % (AUTO DIFF), 0.3 %; 111: TROPONIN I, <.017 ng/mL; 118: BNP NT-PRO, 204 pg/mL; 0: Age, 61; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.8; 0: Triage HR, 88.0; 0: Triage RR, 18.0; 0: Triage SBP, 95.0; 0: Triage DBP, 67.0; 0: Triage acuity, 2-Emergent; 0: CC, BREAST PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I check whether the vital signs (HR, BP, RR, temp) meet standard sepsis screening criteria; they do not suggest a clear systemic inflammatory response (HR is not significantly elevated, BP improves, and RR is not consistently high). Next, I evaluate lab results for signs of sepsis, noting the normal lactate, only moderately elevated WBC, and no obvious organ dysfunction. Finally, I consider changes over time: the patient\u2019s oxygen saturation stabilizes on low-flow O2, and there is no progression toward hypotension or worsening vitals. Based on these observations, the patient does not meet high-risk criteria for sepsis within the next 12 hours.",
        "claims": [
            "The vital signs do not meet standard sepsis screening criteria.",
            "The heart rate is not significantly elevated.",
            "The blood pressure improves.",
            "The respiratory rate is not consistently high.",
            "Lab results show a normal lactate level.",
            "The white blood cell count is only moderately elevated.",
            "There is no obvious organ dysfunction.",
            "The patient\u2019s oxygen saturation stabilizes on low-flow oxygen.",
            "There is no progression toward hypotension.",
            "There is no worsening of vital signs.",
            "Based on these observations, the patient does not meet high-risk criteria for sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The vital signs do not meet standard sepsis screening criteria.",
            "The respiratory rate is not consistently high.",
            "There is no progression toward hypotension."
        ],
        "alignment_scores": [
            0.3,
            0.3,
            0.8
        ],
        "alignment_category": [
            4,
            3,
            7
        ],
        "alignment_reasonings": [
            "The claim suggests that the patient's vital signs do not indicate sepsis risk as per standard screening criteria, which often include measurements like the NEWS score. Since the claim specifically notes not meeting criteria, it marginally aligns with the NEWS category as this scoring is vital-signs based. However, it doesn't specify which criteria or scores were used, leading to a low alignment rating.",
            "The claim relates to the respiratory rate, which is a component of the qSOFA score. However, the statement indicates variability rather than a sustained high rate (\u226522/min), which directly impacts the qSOFA assessment. There is a weak alignment as occasional increases could contribute to meeting qSOFA criteria, but without consistency, it doesn't fully suggest a high qSOFA score.",
            "The claim specifically mentions the absence of hypotension progression, which directly corresponds to the category that deals with hypotension as an indicator of sepsis progression. The alignment is strong because hypotension is explicitly related to this category, although the context is the absence of it, thereby showing the patient is at a low risk under this specific criterion."
        ],
        "final_alignment_score": 0.4666666666666666,
        "accuracy": 1
    },
    {
        "input": "5: HR, 62.0; 5: RR, 30.0; 5: SpO2, 82.0; 5: SBP, 140.0; 5: DBP, 65.0; 5: MAP, 90.0; 5: LPM O2, 4.0; 5: Pain, 8.0; 5: Temp, 98.1; 6: RR, 30.0; 6: SpO2, 92.0; 6: LPM O2, 6.0; 18: Pain, 7.0; 77: SARS-COV-2 RNA, Not Detected; 77: INFLUENZA B, Not Detected; 77: RSV, Not Detected; 77: INFLUENZA A, Not Detected; 84: SpO2, 93.629; 85: HR, 50.1; 85: RR, 16.686; 85: SpO2, 93.286; 85: 1min HRV, 19.687; 86: HR, 50.326; 86: RR, 20.017; 86: SpO2, 91.745; 86: 1min HRV, 21.685; 87: HR, 54.966; 87: RR, 15.881; 87: SpO2, 88.678; 87: 1min HRV, 221.895; 88: HR, 52.723; 88: RR, 17.966; 88: SpO2, 90.534; 88: 1min HRV, 28.500; 88: 5min HRV, 125.288; 89: HR, 53.562; 89: RR, 15.322; 89: SpO2, 91.017; 89: Perf, 0.56; 89: 1min HRV, 22.452; 90: HR, 52.339; 90: RR, 16.881; 90: SpO2, 87.525; 90: Perf, 0.608; 90: 1min HRV, 169.545; 91: HR, 52.568; 91: RR, 23.552; 91: SpO2, 87.121; 91: Perf, 0.798; 91: 1min HRV, 46.723; 92: HR, 50.965; 92: RR, 19.052; 92: SpO2, 86.259; 92: Perf, 1.532; 92: 1min HRV, 32.224; 93: HR, 52.169; 93: RR, 14.305; 93: SpO2, 85.390; 93: Perf, 1.841; 93: 1min HRV, 202.136; 93: 5min HRV, 136.025; 93: LPM O2, 6.0; 94: HR, 53.276; 94: RR, 19.603; 94: SpO2, 86.707; 94: Perf, 1.810; 94: 1min HRV, 243.408; 95: HR, 51.288; 95: RR, 24.085; 95: SpO2, 88.559; 95: Perf, 1.322; 95: 1min HRV, 22.266; 96: HR, 49.678; 96: RR, 19.780; 96: SpO2, 96.712; 96: Perf, 1.31; 96: 1min HRV, 63.848; 97: HR, 50.017; 97: RR, 16.690; 97: SpO2, 97.603; 97: Perf, 1.289; 97: 1min HRV, 223.779; 98: HR, 49.254; 98: RR, 16.0; 98: SpO2, 98.746; 98: Perf, 1.253; 98: 1min HRV, 18.557; 98: 5min HRV, 161.749; 99: POC PH (V) ISTAT, 7.44; 99: POC BASE EXCESS ISTAT, 7 mmol/L; 99: POC HCO3 (V) ISTAT, 30.8 mmol/L; 99: POC TCO2 (V) ISTAT, 32 mmol/L; 99: POC PCO2 (V) ISTAT, 45.7 mmHg; 99: POC LACTATE ISTAT, 1.75 mmol/L; 99: POC O2 SATURATION ISTAT VENOUS, 47 %; 99: POC PO2 (V) ISTAT, 25 mmHg; 99: HR, 48.034; 99: RR, 16.879; 99: SpO2, 98.586; 99: Perf, 1.23; 99: 1min HRV, 20.593; 100: HR, 47.783; 100: RR, 16.35; 100: SpO2, 98.733; 100: Perf, 1.227; 100: 1min HRV, 19.668; 101: HR, 47.224; 101: RR, 18.362; 101: SpO2, 99.0; 101: Perf, 1.400; 101: 1min HRV, 11.765; 102: HR, 47.278; 102: RR, 22.390; 102: SpO2, 98.203; 102: Perf, 1.942; 102: 1min HRV, 24.580; 103: HR, 47.212; 103: RR, 21.138; 103: SpO2, 97.552; 103: Perf, 2.18; 103: 1min HRV, 29.295; 103: 5min HRV, 23.281; 104: HR, 46.424; 104: RR, 21.034; 104: SpO2, 97.220; 104: Perf, 2.167; 104: 1min HRV, 34.762; 105: HR, 47.810; 105: RR, 17.345; 105: SpO2, 97.172; 105: Perf, 1.823; 105: 1min HRV, 146.607; 106: HR, 46.407; 106: RR, 20.661; 106: SpO2, 98.525; 106: Perf, 1.007; 106: 1min HRV, 18.834; 107: HR, 45.431; 107: RR, 22.707; 107: SpO2, 97.172; 107: Perf, 1.056; 107: 1min HRV, 12.632; 108: WAM DIFTYP, AUTO; 108: NRBC PERCENT (HEMATOLOGY), 0.0 %; 108: MONOCYTE ABSOLUTE (AUTO DIFF), 0.77 K/uL; 108: NEUTROPHIL % (AUTO DIFF), 81.2 %; 108: WHITE BLOOD CELLS (WBC), 9.8 K/uL; 108: NEUTROPHIL ABSOLUTE (AUTO DIFF), 7.97 K/uL; 108: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 108: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.2 %; 108: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.9 pg; 108: HEMOGLOBIN (HGB), 16.8 g/dL; 108: EOSINOPHIL % (AUTO DIFF), 3.2 %; 108: HEMATOCRIT (HCT), 54.0 %; 108: LYMPHOCYTE % (AUTO DIFF), 6.8 %; 108: MEAN CORPUSCULAR VOLUME (MCV), 96.1 fL; 108: MONOCYTE % (AUTO DIFF), 7.8 %; 108: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.1 g/dL; 108: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.31 K/uL; 108: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.67 K/uL; 108: RED BLOOD CELLS (RBC), 5.62 MIL/uL; 108: RED CELL DISTRIBUTION WIDTH (RDW), 15.4 %; 108: BASOPHIL ABSOLUTE (AUTO DIFF), 0.08 K/uL; 108: BASOPHIL % (AUTO DIFF), 0.8 %; 108: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.02 K/uL; 108: PLATELET COUNT (PLT), 209 K/uL; 108: HR, 45.847; 108: RR, 23.475; 108: SpO2, 96.407; 108: Perf, 0.972; 108: 1min HRV, 8.665; 108: 5min HRV, 74.502; 109: HR, 46.831; 109: RR, 24.576; 109: SpO2, 95.339; 109: Perf, 1.153; 109: 1min HRV, 34.172; 110: HR, 47.483; 110: RR, 17.207; 110: SpO2, 95.138; 110: Perf, 0.853; 110: 1min HRV, 23.770; 111: HR, 47.559; 111: RR, 14.915; 111: SpO2, 97.356; 111: Perf, 0.789; 111: 1min HRV, 20.254; 112: HR, 47.897; 112: RR, 16.241; 112: SpO2, 97.724; 112: Perf, 0.800; 112: 1min HRV, 27.911; 113: HR, 45.441; 113: RR, 18.441; 113: SpO2, 97.119; 113: Perf, 0.822; 113: 1min HRV, 18.948; 113: 5min HRV, 34.415; 114: HR, 46.780; 114: RR, 20.356; 114: SpO2, 96.441; 114: Perf, 1.242; 114: 1min HRV, 177.614; 115: HR, 46.0; 115: RR, 26.828; 115: SpO2, 95.034; 115: Perf, 1.25; 115: 1min HRV, 0.0; 115: Pain, 4.0; 116: HR, 46.780; 116: RR, 19.780; 116: SpO2, 96.636; 116: Perf, 1.298; 116: 1min HRV, 177.184; 117: HR, 45.634; 117: RR, 19.305; 117: SpO2, 97.610; 117: Perf, 1.520; 117: 1min HRV, 10.559; 118: HR, 46.111; 118: RR, 17.603; 118: SpO2, 97.448; 118: Perf, 1.65; 118: 1min HRV, 0.0; 118: 5min HRV, 171.327; 119: HR, 46.958; 119: RR, 24.831; 119: SpO2, 96.695; 119: Perf, 1.619; 119: 1min HRV, 25.599; 0: Age, 62; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 62.0; 0: Triage RR, 30.0; 0: Triage SBP, 140.0; 0: Triage DBP, 65.0; 0: Triage acuity, 2-Emergent; 0: CC, SHORTNESS OF BREATH",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I assessed whether the vitals meet the criteria for concerning organ dysfunction, focusing on blood pressure, heart rate, respiratory rate, and temperature \u2013 they did not show clear shock or tachycardia. Next, I checked the lab results for signs of infection or high lactate; while the lactate was measured (1.75 mmol/L), it was not elevated beyond typical sepsis thresholds. Then, I evaluated oxygenation (O2 saturations improved, especially later in the timeline) and looked for marked changes in white blood cells or fever, which were not present. Based on these findings, the patient does not appear to be at high risk of sepsis within the next 12 hours.",
        "claims": [
            "The vitals were assessed for concerning organ dysfunction.",
            "The assessment focused on blood pressure, heart rate, respiratory rate, and temperature.",
            "The vitals did not show clear signs of shock.",
            "The vitals did not show tachycardia.",
            "Lab results were checked for signs of infection or elevated lactate.",
            "The lactate level was measured at 1.75 mmol/L.",
            "The lactate level was not elevated beyond typical sepsis thresholds.",
            "Oxygenation was evaluated and O2 saturations improved.",
            "O2 saturations particularly improved later in the timeline.",
            "Marked changes in white blood cells were not present.",
            "Fever was not present.",
            "Based on these findings, the patient does not appear to be at high risk of sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The vitals were assessed for concerning organ dysfunction.",
            "The lactate level was not elevated beyond typical sepsis thresholds.",
            "O2 saturations particularly improved later in the timeline.",
            "Marked changes in white blood cells were not present."
        ],
        "alignment_scores": [
            0.5,
            0.4,
            0.4,
            0.3
        ],
        "alignment_category": [
            8,
            5,
            8,
            2
        ],
        "alignment_reasonings": [
            "The claim about assessing vitals for organ dysfunction aligns conceptually with evaluating changes reflected in the SOFA score, which measures organ dysfunction. However, the claim is vague and lacks specificity about any concrete changes in SOFA components, resulting in a moderate alignment rating.",
            "The claim about lactate levels directly pertains to the Elevated Serum Lactate category, as it mentions lactate in relation to sepsis thresholds. However, the information provided indicates lactate levels are not elevated, which suggests no current risk based on this criterion. The alignment is partial because the claim discusses lactate, but the condition for high risk is not met.",
            "Improved O2 saturations suggest an improvement in the patient's respiratory status, which could be associated with a recovery from a condition like hypoxia that indirectly relates to the PaO\u2082/FiO\u2082 component of the SOFA score. While the improvement is mentioned, it doesn't directly address a decrease in the score itself, so the alignment is indirect and rated moderately low.",
            "The absence of marked changes in white blood cells indicates that one of the SIRS criteria (WBC >12,000/\u00b5L or <4,000/\u00b5L) is not met. While this suggests a lack of systemic inflammation indicative of early sepsis, the mention of WBC changes indirectly relates to SIRS criteria. The alignment is weak because the claim notes what is not present rather than confirming a condition that meets SIRS positivity requirements."
        ],
        "final_alignment_score": 0.4,
        "accuracy": 1
    },
    {
        "input": "6: HR, 86.0; 6: RR, 20.0; 6: SpO2, 98.0; 6: SBP, 115.0; 6: DBP, 62.0; 6: MAP, 79.667; 6: Temp, 97.3; 22: HR, 98.414; 22: RR, 31.643; 22: SpO2, 91.727; 22: 1min HRV, 110.846; 22: 5min HRV, 110.846; 23: HR, 98.136; 23: RR, 34.356; 23: SpO2, 92.0; 23: 1min HRV, 117.374; 23: SBP, 131.0; 23: DBP, 77.0; 23: MAP, 95.0; 24: HR, 95.534; 24: RR, 32.310; 24: 1min HRV, 113.171; 25: HR, 101.0; 25: RR, 29.898; 25: SpO2, 99.0; 25: 1min HRV, 162.398; 26: HR, 95.052; 26: RR, 29.517; 26: 1min HRV, 103.722; 27: HR, 100.220; 27: RR, 33.610; 27: 1min HRV, 138.512; 27: 5min HRV, 129.593; 28: HR, 95.407; 28: RR, 32.949; 28: 1min HRV, 125.817; 29: HR, 96.241; 29: RR, 34.931; 29: 1min HRV, 116.094; 30: HR, 88.407; 30: RR, 34.441; 30: 1min HRV, 109.284; 31: HR, 105.828; 31: RR, 30.397; 31: 1min HRV, 147.138; 32: HR, 98.322; 32: RR, 25.288; 32: 1min HRV, 138.014; 32: 5min HRV, 131.883; 33: HR, 90.017; 33: RR, 24.627; 33: 1min HRV, 92.595; 34: HR, 93.678; 34: RR, 29.627; 34: 1min HRV, 144.850; 35: HR, 93.828; 35: RR, 27.724; 35: 1min HRV, 120.825; 36: HR, 90.305; 36: RR, 27.576; 36: 1min HRV, 99.692; 37: HR, 92.759; 37: RR, 35.966; 37: 1min HRV, 125.839; 37: 5min HRV, 122.075; 38: HR, 92.949; 38: RR, 25.169; 38: 1min HRV, 131.881; 38: SBP, 115.0; 38: DBP, 69.0; 38: MAP, 84.333; 39: HR, 90.431; 39: RR, 28.448; 39: 1min HRV, 108.780; 40: HR, 90.356; 40: RR, 26.915; 40: 1min HRV, 135.773; 41: HR, 95.983; 41: RR, 26.407; 41: SpO2, 97.0; 41: 1min HRV, 145.704; 42: HR, 98.017; 42: RR, 33.052; 42: 1min HRV, 147.904; 42: 5min HRV, 135.808; 43: HR, 91.576; 43: RR, 32.75; 43: 1min HRV, 144.543; 44: HR, 100.644; 44: RR, 30.475; 44: 1min HRV, 99.454; 45: HR, 104.345; 45: RR, 27.672; 45: 1min HRV, 118.998; 46: HR, 102.034; 46: RR, 28.864; 46: 1min HRV, 137.662; 47: HR, 109.172; 47: RR, 29.086; 47: 1min HRV, 148.420; 47: 5min HRV, 137.077; 48: HR, 109.119; 48: RR, 23.196; 48: 1min HRV, 152.448; 49: HR, 102.559; 49: RR, 28.811; 49: 1min HRV, 167.416; 50: HR, 118.086; 50: RR, 32.224; 50: 1min HRV, 174.658; 51: HR, 96.949; 51: RR, 27.102; 51: 1min HRV, 141.684; 52: HR, 105.810; 52: RR, 23.483; 52: 1min HRV, 175.727; 52: 5min HRV, 167.496; 53: HR, 104.492; 53: RR, 22.644; 53: 1min HRV, 144.027; 53: SBP, 116.0; 53: DBP, 85.0; 53: MAP, 95.333; 54: HR, 102.931; 54: RR, 29.774; 54: 1min HRV, 146.443; 55: HR, 98.458; 55: RR, 33.310; 55: SpO2, 97.0; 55: 1min HRV, 140.776; 56: HR, 97.915; 56: RR, 35.864; 56: 1min HRV, 148.741; 57: HR, 111.828; 57: RR, 31.655; 57: 1min HRV, 154.844; 57: 5min HRV, 152.574; 58: HR, 109.508; 58: RR, 31.203; 58: 1min HRV, 160.695; 59: HR, 98.397; 59: RR, 36.534; 59: 1min HRV, 178.628; 60: HR, 91.593; 60: RR, 32.208; 60: 1min HRV, 133.466; 61: HR, 98.068; 61: RR, 40.339; 61: 1min HRV, 144.123; 62: HR, 96.810; 62: RR, 34.069; 62: 1min HRV, 146.344; 62: 5min HRV, 158.031; 63: HR, 98.593; 63: RR, 32.831; 63: 1min HRV, 156.849; 64: HR, 106.517; 64: RR, 37.741; 64: 1min HRV, 152.933; 65: HR, 97.203; 65: RR, 27.983; 65: 1min HRV, 169.895; 66: HR, 99.322; 66: RR, 29.797; 66: 1min HRV, 142.021; 67: HR, 96.966; 67: RR, 34.121; 67: 1min HRV, 128.693; 67: 5min HRV, 151.593; 68: HR, 93.492; 68: RR, 27.763; 68: 1min HRV, 119.736; 68: SBP, 103.0; 68: DBP, 67.0; 68: MAP, 79.0; 69: HR, 92.397; 69: RR, 26.690; 69: 1min HRV, 121.414; 70: HR, 88.780; 70: RR, 25.746; 70: 1min HRV, 151.117; 71: HR, 92.424; 71: RR, 29.356; 71: 1min HRV, 165.078; 72: HR, 105.810; 72: RR, 29.190; 72: 1min HRV, 177.500; 72: 5min HRV, 154.698; 73: HR, 97.508; 73: RR, 26.780; 73: 1min HRV, 174.835; 74: HR, 93.534; 74: RR, 26.534; 74: 1min HRV, 128.705; 75: HR, 97.424; 75: RR, 25.136; 75: SpO2, 98.818; 75: 1min HRV, 163.474; 76: HR, 96.661; 76: RR, 28.593; 76: SpO2, 93.4; 76: 1min HRV, 134.870; 77: ANION GAP, 12 mmol/L; 77: POTASSIUM, 4.1 mmol/L; 77: PROTEIN TOTAL, 7.2 g/dL; 77: CO2, 23 mmol/L; 77: GLUCOSE, 166 mg/dL; 77: ALBUMIN, 3.8 g/dL; 77: GLOBULIN, 3.4 g/dL; 77: ALKALINE PHOSPHATASE, 94 U/L; 77: CHLORIDE, 102 mmol/L; 77: EGFR FOR AFRICAN AMERICAN, 57 mL/min/1.73 m2; 77: AST (SGOT), 94 U/L; 77: ALT (SGPT), 76 U/L; 77: BLOOD UREA NITROGEN (BUN), 16 mg/dL; 77: CALCIUM, 9.1 mg/dL; 77: CORRECTED CALCIUM, 9.3 mg/dL; 77: EGFR REFIT WITHOUT RACE (2021), 49 mL/min/1.73 m2; 77: SODIUM, 137 mmol/L; 77: MAGNESIUM, 2.1 mg/dL; 77: CREATININE, 1.24 mg/dL; 77: BILIRUBIN TOTAL, 0.9 mg/dL; 77: BNP NT-PRO, 2309 pg/mL; 77: HR, 91.603; 77: RR, 28.534; 77: 1min HRV, 137.927; 77: 5min HRV, 149.995; 78: HR, 96.390; 78: RR, 27.424; 78: 1min HRV, 143.471; 79: HR, 94.138; 79: RR, 26.741; 79: 1min HRV, 122.539; 80: HR, 90.627; 80: RR, 30.136; 80: 1min HRV, 126.110; 81: HR, 102.305; 81: RR, 28.525; 81: 1min HRV, 138.593; 82: HR, 91.983; 82: RR, 30.379; 82: 1min HRV, 135.501; 82: 5min HRV, 135.292; 83: HR, 104.695; 83: RR, 26.305; 83: 1min HRV, 142.713; 83: SBP, 126.0; 83: DBP, 98.0; 83: MAP, 107.333; 84: TROPONIN I, <.017 ng/mL; 84: HR, 96.435; 84: RR, 41.448; 84: 1min HRV, 111.796; 85: RR, 40.085; 86: RR, 38.724; 87: HR, 124.944; 87: RR, 32.661; 87: 1min HRV, 15.413; 87: 5min HRV, 143.679; 88: HR, 113.475; 88: RR, 20.068; 88: 1min HRV, 102.226; 89: HR, 114.949; 89: RR, 36.155; 89: 1min HRV, 96.557; 90: HR, 115.356; 90: RR, 34.237; 90: 1min HRV, 130.746; 91: HR, 117.893; 91: RR, 35.038; 91: 1min HRV, 140.391; 92: 5min HRV, 126.029; 98: D-DIMER ELISA, >10000 ng/mL FEU; 100: SARS-COV-2 RNA, Not Detected; 112: SpO2, 93.0; 113: HR, 100.0; 113: RR, 33.35; 113: 1min HRV, 112.194; 114: HR, 114.0; 114: RR, 27.379; 114: 1min HRV, 134.805; 114: SBP, 128.0; 114: DBP, 81.0; 114: MAP, 96.667; 115: HR, 108.322; 115: RR, 37.034; 115: 1min HRV, 147.034; 116: HR, 98.828; 116: RR, 24.0; 116: 1min HRV, 124.792; 117: HR, 101.136; 117: RR, 23.322; 117: 1min HRV, 117.243; 117: 5min HRV, 134.779; 118: HR, 101.879; 118: RR, 33.328; 118: 1min HRV, 102.420; 119: HR, 100.644; 119: RR, 34.458; 119: 1min HRV, 105.178; 0: Age, 90; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.3; 0: Triage HR, 86.0; 0: Triage RR, 20.0; 0: Triage SBP, 115.0; 0: Triage DBP, 62.0; 0: Triage acuity, 3-Urgent; 0: CC, DIZZINESS",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, I checked whether there were sustained abnormal vital signs (e.g., elevated HR, RR), which are present. Next, I considered whether other findings, such as advanced age and borderline blood pressure, increased the likelihood of sepsis. I then examined lab values (including very high D-dimer) for any additional signs of pathology suggesting an acute systemic process. Because these factors collectively indicate a high possibility of impending organ dysfunction under an infectious or inflammatory process, sepsis risk appears high. Therefore, the patient is at high risk of developing sepsis within 12 hours.",
        "claims": [
            "Sustained abnormal vital signs are present, including elevated heart rate and respiratory rate.",
            "Advanced age may increase the likelihood of sepsis.",
            "Borderline blood pressure may increase the likelihood of sepsis.",
            "Lab values were examined for additional signs of pathology.",
            "Very high D-dimer levels were found in the lab values.",
            "High possibility of impending organ dysfunction exists under an infectious or inflammatory process.",
            "These factors collectively indicate a high risk of sepsis.",
            "The patient is at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "Sustained abnormal vital signs are present, including elevated heart rate and respiratory rate.",
            "Advanced age may increase the likelihood of sepsis.",
            "Borderline blood pressure may increase the likelihood of sepsis.",
            "Lab values were examined for additional signs of pathology.",
            "Very high D-dimer levels were found in the lab values.",
            "High possibility of impending organ dysfunction exists under an infectious or inflammatory process.",
            "These factors collectively indicate a high risk of sepsis.",
            "The patient is at high risk of developing sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.9,
            0.8,
            0.7,
            0.3,
            0.2,
            0.8,
            0.3,
            0.3
        ],
        "alignment_category": [
            2,
            1,
            7,
            9,
            5,
            8,
            4,
            4
        ],
        "alignment_reasonings": [
            "The claim specifically mentions elevated heart rate and respiratory rate, both of which are directly part of the SIRS criteria (heart rate\u202f>\u202f90\u202fbpm and respiratory\u202frate\u202f>\u202f20\u202f/min). The alignment is very strong because these indicators are critical components of the SIRS criteria used for identifying systemic inflammation and potential early sepsis. However, to fulfill the criteria completely, two or more abnormal signs are needed, so without specific thresholds or additional criteria, the rating is slightly below perfect.",
            "The claim addresses advanced age as a risk factor for sepsis, aligning with the Elderly Susceptibility category. However, the claim uses the term \"may\" without specifying whether the patient is \u226565 years, leading to uncertainty. Thus, the alignment is significant but not perfect.",
            "The claim refers to \"borderline blood pressure,\" which suggests a potential risk of hypotension. Hypotension is associated with the progression to septic shock and aligns with the category outlining the risk associated with low blood pressure in sepsis. Although the claim does not specify exact blood pressure parameters (like SBP <90 mmHg), the suggestion of increased sepsis likelihood due to low or borderline blood pressure connects conceptually to this category.",
            "The claim indicates the examination of lab values, which is a preliminary step in assessing pathology and potential infection. However, it lacks specificity regarding actions directly suggestive of a sepsis risk, such as administering antibiotics or culture orders. Therefore, while there is some alignment with the clinician\u2019s suspicion of infection, it is weak because it does not mention specific early interventions or actions typical in sepsis risk assessments.",
            "D-dimer levels themselves are not directly related to sepsis-specific criteria but are more commonly associated with coagulation disorders or thrombotic events. There is no expert category specifically for D-dimer levels in the provided list. However, D-dimer can sometimes be an indirect marker of inflammation, which can be related to sepsis physiology in a broad sense, though not explicitly addressed here. Given no direct alignment with a category, the closest indirect relationship might be with indicators of systemic stress or inflammation, if any, like elevated serum lactate which signals hypoperfusion often seen in sepsis. Therefore, this receives a low alignment rating.",
            "The claim suggests a high possibility of impending organ dysfunction, which directly relates to the SOFA score's focus on organ dysfunction in the context of sepsis. While the claim does not specify the increase in SOFA score itself, the mention of organ dysfunction under an infectious or inflammatory process aligns closely with what the SOFA score aims to capture, indicating a strong but not perfect alignment.",
            "The claim refers to a collective indication of high sepsis risk, which could involve multiple deterioration indicators. Elevated NEWS incorporates various vital signs reflecting this cumulative risk but lacks detail in the claim. The alignment is weak due to generality, but NEWS captures comprehensive clinical deterioration.",
            "The claim broadly indicates a high risk of sepsis, which could be associated with multiple factors like deranged vitals predicting imminent deterioration, similar to what the NEWS score assesses. However, without explicitly mentioning any specific clinical parameters or scores, the alignment with any particular category is weak and speculative. Therefore, the category selected reflects a general predictor of clinical deterioration compatible with sepsis risk, but only weakly aligns without specific data."
        ],
        "final_alignment_score": 0.5375000000000001,
        "accuracy": 1
    },
    {
        "input": "10: HR, 92.0; 10: RR, 16.0; 10: SpO2, 97.0; 10: SBP, 159.0; 10: DBP, 92.0; 10: MAP, 114.333; 10: Temp, 99.3; 67: POC, BHCG, ISTAT QUANTITATIVE: 6.9 IU/L; 71: POC PH (V) ISTAT, 7.32; 71: POC HCO3 (V) ISTAT, 20.7 mmol/L; 71: POC O2 SATURATION ISTAT VENOUS, 26 %; 71: POC PO2 (V) ISTAT, 19 mmHg; 71: POC BASE EXCESS ISTAT, -5 mmol/L; 71: POC TCO2 (V) ISTAT, 22 mmol/L; 71: POC LACTATE ISTAT, 0.69 mmol/L; 71: POC PCO2 (V) ISTAT, 40.5 mmHg; 76: POC POTASSIUM ISTAT, 6.6 mmol/L; 76: POC HGB (CALC) ISTAT, 12.9 g/dL; 76: POC SODIUM ISTAT, 134 mmol/L; 76: POC GLUCOSE ISTAT, 83 mg/dL; 76: POC HCT ISTAT, 38 %; 89: PART. THROMBOPLASTIN TIME, 35.2 seconds; 90: INR, 1.6; 90: PROTHROMBIN TIME, 18.5 seconds; 92: WAM DIFTYP, AUTO; 92: MONOCYTE ABSOLUTE (AUTO DIFF), 1.23 K/uL; 92: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.09 K/uL; 92: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.67 K/uL; 92: BASOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 92: LYMPHOCYTE % (AUTO DIFF), 18.7 %; 92: MEAN CORPUSCULAR VOLUME (MCV), 91.2 fL; 92: EOSINOPHIL % (AUTO DIFF), 1.5 %; 92: RED CELL DISTRIBUTION WIDTH (RDW), 17.4 %; 92: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.6 %; 92: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.21 K/uL; 92: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 92: NEUTROPHIL % (AUTO DIFF), 70.2 %; 92: MONOCYTE % (AUTO DIFF), 8.6 %; 92: RED BLOOD CELLS (RBC), 3.40 MIL/uL; 92: HEMATOCRIT (HCT), 31.0 %; 92: PLATELET COUNT (PLT), 378 K/uL; 92: BASOPHIL % (AUTO DIFF), 0.4 %; 92: NRBC PERCENT (HEMATOLOGY), 0.0 %; 92: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.1 pg; 92: WHITE BLOOD CELLS (WBC), 14.3 K/uL; 92: HEMOGLOBIN (HGB), 9.9 g/dL; 92: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.02 K/uL; 92: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.9 g/dL; 101: POC GLUCOSE BY METER, 98 mg/dL; 104: POC, BHCG, ISTAT QUANTITATIVE: 6.1 IU/L; 105: LIPASE, 11 U/L; 106: POC PH (V) ISTAT, 7.27; 106: POC PO2 (V) ISTAT, 22 mmHg; 106: POC BASE EXCESS ISTAT, -5 mmol/L; 106: POC LACTATE ISTAT, 1.44 mmol/L; 106: POC O2 SATURATION ISTAT VENOUS, 31 %; 106: POC PCO2 (V) ISTAT, 46.6 mmHg; 106: POC TCO2 (V) ISTAT, 23 mmol/L; 106: POC HCO3 (V) ISTAT, 21.6 mmol/L; 106: HR, 42.882; 106: RR, 17.5; 106: SpO2, 97.667; 106: Perf, 4.819; 106: 1min HRV, 16.461; 107: HR, 45.310; 107: RR, 16.966; 107: SpO2, 96.534; 107: Perf, 3.883; 107: 1min HRV, 27.125; 107: SBP, 139.0; 107: DBP, 84.0; 107: MAP, 102.333; 108: HR, 45.797; 108: RR, 13.712; 108: SpO2, 97.390; 108: Perf, 3.778; 108: 1min HRV, 27.967; 109: HR, 46.879; 109: RR, 15.5; 109: SpO2, 97.259; 109: Perf, 3.888; 109: 1min HRV, 41.979; 109: 5min HRV, 45.213; 110: HR, 44.864; 110: RR, 17.186; 110: SpO2, 97.780; 110: Perf, 4.039; 110: 1min HRV, 36.671; 111: HR, 44.729; 111: RR, 17.288; 111: SpO2, 97.475; 111: Perf, 6.292; 111: 1min HRV, 28.818; 112: HR, 44.172; 112: RR, 18.517; 112: SpO2, 96.914; 112: Perf, 6.863; 112: 1min HRV, 45.926; 113: HR, 44.356; 113: RR, 15.814; 113: SpO2, 96.322; 113: Perf, 5.662; 113: 1min HRV, 42.383; 114: SODIUM, 131 mmol/L; 114: SODIUM, 131 mmol/L; 114: POTASSIUM, 6.6 mmol/L; 114: BLOOD UREA NITROGEN (BUN), 46 mg/dL; 114: ALT (SGPT), 21 U/L; 114: CREATININE, 7.03 mg/dL; 114: EGFR REFIT WITHOUT RACE (2021), 7 mL/min/1.73 m2; 114: GLUCOSE, 88 mg/dL; 114: ALKALINE PHOSPHATASE, 342 U/L; 114: BLOOD UREA NITROGEN (BUN), 46 mg/dL; 114: EGFR FOR AFRICAN AMERICAN, 8 mL/min/1.73 m2; 114: ALT (SGPT), 21 U/L; 114: CORRECTED CALCIUM, 8.2 mg/dL; 114: ANION GAP, 14 mmol/L; 114: ALKALINE PHOSPHATASE, 342 U/L; 114: GLUCOSE, 88 mg/dL; 114: CHLORIDE, 98 mmol/L; 114: PROTEIN TOTAL, 8.2 g/dL; 114: CHLORIDE, 98 mmol/L; 114: GLOBULIN, 4.3 g/dL; 114: CALCIUM, 8.1 mg/dL; 114: CO2, 19 mmol/L; 114: AST (SGOT), 21 U/L; 114: EGFR REFIT WITHOUT RACE (2021), 7 mL/min/1.73 m2; 114: PROTEIN TOTAL, 8.2 g/dL; 114: CO2, 19 mmol/L; 114: ALBUMIN, 3.9 g/dL; 114: CALCIUM, 8.1 mg/dL; 114: GLOBULIN, 4.3 g/dL; 114: EGFR FOR AFRICAN AMERICAN, 8 mL/min/1.73 m2; 114: BILIRUBIN TOTAL, 0.7 mg/dL; 114: ANION GAP, 14 mmol/L; 114: POTASSIUM, 6.6 mmol/L; 114: AST (SGOT), 21 U/L; 114: CREATININE, 7.03 mg/dL; 114: CORRECTED CALCIUM, 8.2 mg/dL; 114: BILIRUBIN TOTAL, 0.7 mg/dL; 114: ALBUMIN, 3.9 g/dL; 114: HR, 42.052; 114: RR, 16.552; 114: SpO2, 96.707; 114: Perf, 4.959; 114: 1min HRV, 39.438; 114: 5min HRV, 47.285; 115: HR, 42.102; 115: RR, 16.525; 115: SpO2, 96.0; 115: Perf, 4.387; 115: 1min HRV, 29.882; 115: SBP, 121.0; 115: DBP, 77.0; 115: MAP, 91.667; 116: HR, 43.305; 116: RR, 15.729; 116: SpO2, 96.254; 116: Perf, 4.035; 116: 1min HRV, 46.183; 117: HR, 41.845; 117: RR, 16.276; 117: SpO2, 96.276; 117: Perf, 4.256; 117: 1min HRV, 22.321; 118: HR, 41.373; 118: RR, 17.102; 118: SpO2, 96.458; 118: Perf, 4.405; 118: 1min HRV, 38.386; 119: HR, 44.534; 119: RR, 17.276; 119: SpO2, 96.5; 119: Perf, 4.310; 119: 1min HRV, 124.121; 119: 5min HRV, 73.300; 0: Age, 28; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 37.4; 0: Triage HR, 92.0; 0: Triage RR, 16.0; 0: Triage SBP, 159.0; 0: Triage DBP, 92.0; 0: Triage acuity, 3-Urgent; 0: CC, LEG SWELLING,EMESIS,FEVER",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "First, I considered whether there were clear signs of infection such as high fever, hypotension, or markedly elevated lactate; the patient has only mild fever and normal-to-high blood pressure with low-normal lactates. Next, I assessed whether there was evidence of significant organ dysfunction due to infection; although the creatinine is high, there is no strong indication of an infectious process driving this acute kidney issue. Finally, I compared the available indicators of infection (e.g., WBC count, vital signs) with typical sepsis criteria and found insufficient support for a high sepsis risk at this time.",
        "claims": [
            "There were clear signs of infection considered.",
            "The patient has only mild fever.",
            "The patient has normal-to-high blood pressure.",
            "The patient has low-normal lactates.",
            "There was an assessment of significant organ dysfunction due to infection.",
            "The creatinine level is high.",
            "There is no strong indication of an infectious process driving the acute kidney issue.",
            "Available indicators of infection were compared with typical sepsis criteria.",
            "There is insufficient support for a high sepsis risk at this time."
        ],
        "relevant_claims": [
            "The patient has normal-to-high blood pressure.",
            "The creatinine level is high.",
            "There is no strong indication of an infectious process driving the acute kidney issue."
        ],
        "alignment_scores": [
            0.2,
            0.7,
            0.3
        ],
        "alignment_category": [
            7,
            8,
            8
        ],
        "alignment_reasonings": [
            "The claim refers to blood pressure, which is pertinent to the category of \"Sepsis-Associated Hypotension.\" However, normal-to-high blood pressure does not indicate hypotension and thus is the opposite of what this category highlights. The alignment is minimal, as normal-to-high blood pressure might suggest that the patient is less likely to have progressed to severe sepsis-related hypotension.",
            "Creatinine level is directly related to renal function, and an increase is a component in the SOFA score, which assesses organ dysfunction. A high creatinine could suggest renal impairment, which correlates with an increase in SOFA score. However, the claim does not specify whether the increase is sufficient to amount to a SOFA score increase of \u22652 points. Thus, the alignment is moderate but relevant.",
            "The claim mentions an \"acute kidney issue,\" which can be associated with organ dysfunction\u2014a component of the SOFA score assessment for sepsis risk. However, there is no mention of an infection driving this dysfunction, reducing the chance of it being sepsis-related. Thus, while there is a weak link to the SOFA criteria because of the organ dysfunction, the absence of an infectious indication lowers the alignment significantly."
        ],
        "final_alignment_score": 0.39999999999999997,
        "accuracy": 0
    },
    {
        "input": "10: HR, 125.0; 10: RR, 20.0; 10: SpO2, 96.0; 10: SBP, 116.0; 10: DBP, 66.0; 10: MAP, 82.667; 10: Pain, 8.0; 10: Temp, 99.1; 55: SpO2, 96.364; 56: SpO2, 97.814; 56: Perf, 3.785; 57: POC PH (V) ISTAT, 7.47; 57: POC PCO2 (V) ISTAT, 38.9 mmHg; 57: POC BASE EXCESS ISTAT, 5 mmol/L; 57: POC LACTATE ISTAT, 1.53 mmol/L; 57: POC PO2 (V) ISTAT, 44 mmHg; 57: POC HCO3 (V) ISTAT, 28.4 mmol/L; 57: POC TCO2 (V) ISTAT, 30 mmol/L; 57: POC O2 SATURATION ISTAT VENOUS, 83 %; 57: SpO2, 97.75; 57: Perf, 4.13; 58: SpO2, 97.545; 60: SpO2, 97.5; 62: SpO2, 97.892; 62: Perf, 2.504; 63: HR, 120.688; 63: RR, 29.0; 63: SpO2, 97.482; 63: Perf, 2.431; 63: 1min HRV, 4.649; 63: SBP, 115.0; 63: DBP, 74.0; 63: MAP, 87.667; 64: HR, 121.288; 64: RR, 23.593; 64: SpO2, 96.966; 64: Perf, 2.527; 64: 1min HRV, 5.019; 65: HR, 120.914; 65: RR, 23.207; 65: SpO2, 96.724; 65: Perf, 2.408; 65: 1min HRV, 5.123; 65: LR IV BOLUS -, 1000 ML; 66: HR:, 120.983; 66: RR, 24.475; 66: SpO2, 96.898; 66: Perf, 2.540; 66: 1min HRV, 9.017; 66: 5min HRV, 6.528; 66: SBP, 115.0; 66: DBP, 74.0; 66: MAP, 87.667; 67: HR, 120.172; 67: RR, 19.828; 67: SpO2, 96.603; 67: Perf, 2.773; 67: 1min HRV, 4.176; 68: HR, 117.847; 68: RR, 26.475; 68: SpO2, 96.169; 68: Perf, 3.083; 68: 1min HRV, 3.796; 69: HR, 116.424; 69: RR, 27.881; 69: SpO2, 96.763; 69: Perf, 3.132; 69: 1min HRV, 3.793; 70: HR, 115.586; 70: RR, 30.172; 70: SpO2, 96.724; 70: Perf, 2.924; 70: 1min HRV, 3.025; 71: HR, 115.458; 71: RR, 31.322; 71: SpO2, 96.508; 71: Perf, 3.087; 71: 1min HRV, 4.311; 71: 5min HRV, 7.879; 72: HR, 116.759; 72: RR, 27.810; 72: SpO2, 96.603; 72: Perf, 2.989; 72: 1min HRV, 4.088; 73: HR, 116.203; 73: RR, 26.763; 73: SpO2, 97.203; 73: Perf, 2.665; 73: 1min HRV, 7.695; 74: HR, 115.644; 74: RR, 30.881; 74: SpO2, 97.373; 74: Perf, 2.693; 74: 1min HRV, 3.287; 75: HR, 114.672; 75: RR, 31.397; 75: SpO2, 97.172; 75: Perf, 2.736; 75: 1min HRV, 3.565; 76: HR, 115.237; 76: RR, 27.085; 76: SpO2, 96.966; 76: Perf, 2.905; 76: 1min HRV, 3.617; 76: 5min HRV, 5.477; 77: HR, 115.086; 77: RR, 28.845; 77: SpO2, 96.948; 77: Perf, 2.516; 77: 1min HRV, 3.056; 78: HR, 115.169; 78: RR, 29.356; 78: SpO2, 97.492; 78: Perf, 2.126; 78: 1min HRV, 5.350; 79: HR, 114.381; 79: RR, 35.0; 79: SpO2, 97.107; 79: Perf, 1.866; 79: 1min HRV, 2.431; 81: 5min HRV, 4.226; 90: IOPAMIDOL, 76 % IV SOLN (RADIOLOGY) 500 ML; 94: INR:, 1.1; 94: PROTHROMBIN TIME, 15.1 seconds; 102: SpO2, 95.962; 103: WHITE BLOOD CELLS (WBC), 8.3 K/uL; 103: RED BLOOD CELLS (RBC), 3.10 MIL/uL; 103: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 26.8 pg; 103: MEAN CORPUSCULAR VOLUME (MCV), 84.8 fL; 103: HEMOGLOBIN (HGB), 8.3 g/dL; 103: RED CELL DISTRIBUTION WIDTH (RDW), 13.0 %; 103: HEMATOCRIT (HCT), 26.3 %; 103: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.6 g/dL; 103: PLATELET COUNT (PLT), 331 K/uL; 103: LYMPHOCYTES ABSOLUTE (MANUAL DIFF), 0.51 K/uL; 103: NEUTROPHILS ABSOLUTE (MANUAL DIFF) (SEGS+BANDS), 7.49 K/uL; 103: MONOCYTES % (MANUAL DIFF), 0.0 %; 103: EOSINOPHILS ABSOLUTE (MANUAL DIFF), 0.29 K/uL; 103: NEUTROPHILS BANDS % (MANUAL DIFF), 7.8 %; 103: EOSINOPHILS % (MANUAL DIFF), 3.5 %; 103: NEUTROPHILS SEGMENTED % (MANUAL DIFF), 82.6 %; 103: LYMPHOCYTES % (MANUAL DIFF), 6.1 %; 103: HR, 112.581; 103: RR, 18.032; 103: SpO2, 97.559; 103: 1min HRV, 7.885; 104: PART. THROMBOPLASTIN TIME, 32.3 seconds; 104: HR, 112.707; 104: RR, 28.879; 104: SpO2, 97.466; 104: Perf, 1.069; 104: 1min HRV, 5.442; 105: HR, 113.780; 105: RR, 24.034; 105: SpO2, 97.305; 105: Perf, 1.174; 105: 1min HRV, 2.973; 106: HR, 113.797; 106: RR, 22.712; 106: SpO2, 97.0; 106: Perf, 1.143; 106: 1min HRV, 4.693; 106: 5min HRV, 5.928; 107: HR, 112.448; 107: RR, 27.672; 107: SpO2, 97.707; 107: Perf, 1.229; 107: 1min HRV, 4.238; 108: HR, 113.186; 108: RR, 24.390; 108: SpO2, 97.678; 108: Perf, 1.205; 108: 1min HRV, 5.694; 109: HR, 112.638; 109: RR, 26.672; 109: SpO2, 97.534; 109: Perf, 1.260; 109: 1min HRV, 4.334; 110: HR, 112.661; 110: RR, 24.373; 110: SpO2, 98.0; 110: Perf, 1.144; 110: 1min HRV, 4.286; 111: HR, 115.448; 111: RR, 21.397; 111: SpO2, 98.0; 111: Perf, 1.383; 111: 1min HRV, 4.708; 111: 5min HRV, 7.053; 112: HR, 114.949; 112: RR, 20.220; 112: SpO2, 98.339; 112: Perf, 1.131; 112: 1min HRV, 9.737; 113: HR, 114.305; 113: RR, 25.542; 113: SpO2, 97.627; 113: Perf, 1.18; 113: 1min HRV, 9.114; 114: BLOOD, URINE (UA): Negative; 114: KETONE, URINE (UA): Negative; 114: SPECIFIC GRAVITY, URINE (UA): 1.003; 114: NITRITE, URINE (UA): Negative; 114: LEUKOCYTE ESTERASE, URINE (UA): Negative; 114: PROTEIN, URINE (UA): Negative; 114: GLUCOSE, URINE (UA): Negative; 114: PH, URINE (UA): 6.0; 114: HR, 114.259; 114: RR, 24.845; 114: SpO2, 97.155; 114: Perf, 1.245; 114: 1min HRV, 7.585; 115: HR, 114.068; 115: RR, 28.017; 115: SpO2, 97.102; 115: Perf, 1.962; 115: 1min HRV, 9.362; 116: HR, 113.914; 116: RR, 25.431; 116: SpO2, 96.948; 116: Perf, 1.619; 116: 1min HRV, 5.658; 116: 5min HRV, 8.827; 117: HR, 113.034; 117: RR, 22.119; 117: SpO2, 97.797; 117: Perf, 1.397; 117: 1min HRV, 6.426; 118: HR, 112.983; 118: RR, 25.729; 118: SpO2, 97.898; 118: Perf, 1.529; 118: 1min HRV, 4.914; 119: HR, 113.845; 119: RR, 24.638; 119: SpO2, 98.0; 119: Perf, 1.743; 119: 1min HRV, 9.732; 0: Age, 45; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 37.3; 0: Triage HR, 125.0; 0: Triage RR, 20.0; 0: Triage SBP, 116.0; 0: Triage DBP, 66.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I checked if the patient\u2019s vital signs fulfill heightened sepsis screening criteria (e.g., qSOFA or SIRS). Next, I reviewed",
        "claims": [
            "the patient's vital signs.",
            "The patient's vital signs were checked.",
            "Heightened sepsis screening criteria include qSOFA or SIRS.",
            "The patient's vital signs were assessed against heightened sepsis screening criteria."
        ],
        "relevant_claims": [
            "The patient's vital signs were assessed against heightened sepsis screening criteria."
        ],
        "alignment_scores": [
            0.5
        ],
        "alignment_category": [
            4
        ],
        "alignment_reasonings": [
            "The claim refers to assessing vital signs, which can include several measurements such as respiratory rate, blood pressure, and heart rate. These are components of the National Early Warning Score (NEWS) used for sepsis screening. However, the claim does not indicate specific results or scores, so it lacks specificity that directly marks an elevated NEWS score. Hence, the alignment is moderate but not definitive."
        ],
        "final_alignment_score": 0.5,
        "accuracy": 1
    },
    {
        "input": "3: HR, 87.0; 3: RR, 16.0; 3: SpO2, 90.0; 3: SBP, 134.0; 3: DBP, 80.0; 3: MAP, 98.0; 3: Temp, 99.5; 6: Pain, 0.0; 29: POC PH (V) ISTAT, 7.42; 29: POC HCO3 (V) ISTAT, 37.4 mmol/L; 29: POC PCO2 (V) ISTAT, 58.4 mmHg; 29: POC TCO2 (V) ISTAT, 39 mmol/L; 29: POC PO2 (V) ISTAT, 49 mmHg; 29: POC O2 SATURATION ISTAT VENOUS, 83 %; 29: POC BASE EXCESS ISTAT, 13 mmol/L; 29: POC LACTATE ISTAT, 1.38 mmol/L; 61: INR, 1.2; 61: WAM DIFTYP, AUTO; 61: PROTHROMBIN TIME, 15.4 seconds; 61: NEUTROPHIL ABSOLUTE (AUTO DIFF), 23.28 K/uL; 61: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 61: WHITE BLOOD CELLS (WBC), 26.0 K/uL; 61: NEUTROPHIL % (AUTO DIFF), 89.4 %; 61: BASOPHIL % (AUTO DIFF), 0.2 %; 61: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 18.8 pg; 61: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 61: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.9 %; 61: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.38 K/uL; 61: HEMOGLOBIN (HGB), 9.5 g/dL; 61: MEAN CORPUSCULAR VOLUME (MCV), 66.1 fL; 61: NRBC PERCENT (HEMATOLOGY), 0.0 %; 61: MONOCYTE % (AUTO DIFF), 4.2 %; 61: RED CELL DISTRIBUTION WIDTH (RDW), 15.3 %; 61: RED BLOOD CELLS (RBC), 5.05 MIL/uL; 61: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 61: LYMPHOCYTE % (AUTO DIFF), 5.3 %; 61: PLATELET COUNT (PLT), 365 K/uL; 61: HEMATOCRIT (HCT), 33.4 %; 61: EOSINOPHIL % (AUTO DIFF), 0.0 %; 61: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 28.4 g/dL; 61: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.23 K/uL; 61: MONOCYTE ABSOLUTE (AUTO DIFF), 1.10 K/uL; 62: CHLORIDE, 94 mmol/L; 62: GLUCOSE, 129 mg/dL; 62: CALCIUM, 9.1 mg/dL; 62: ANION GAP, 7 mmol/L; 62: BLOOD UREA NITROGEN (BUN), 19 mg/dL; 62: ALBUMIN, 3.7 g/dL; 62: AST (SGOT), 15 U/L; 62: BILIRUBIN TOTAL, 0.3 mg/dL; 62: SODIUM, 136 mmol/L; 62: PROTEIN TOTAL, 7.5 g/dL; 62: CORRECTED CALCIUM, 9.3 mg/dL; 62: CREATININE, 0.33 mg/dL; 62: CO2, 35 mmol/L; 62: PART. THROMBOPLASTIN TIME, 36.4 seconds; 62: GLOBULIN, 3.8 g/dL; 62: ALKALINE PHOSPHATASE, 101 U/L; 62: EGFR FOR AFRICAN AMERICAN, 135 mL/min/1.73 m2; 62: ALT (SGPT), 12 U/L; 62: EGFR REFIT WITHOUT RACE (2021), 117 mL/min/1.73 m2; 62: POTASSIUM, 4.3 mmol/L; 85: HR, 161.0; 85: RR, 23.0; 85: SpO2, 97.0; 85: SBP, 127.0; 85: DBP, 90.0; 85: MAP, 102.333; 85: LPM O2, 2.0; 88: WAM DIFTYP, AUTO; 88: RED BLOOD CELLS (RBC), 4.88 MIL/uL; 88: HEMOGLOBIN (HGB), 9.2 g/dL; 88: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 88: NRBC PERCENT (HEMATOLOGY), 0.0 %; 88: MONOCYTE ABSOLUTE (AUTO DIFF), 1.17 K/uL; 88: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 28.6 g/dL; 88: EOSINOPHIL % (AUTO DIFF), 0.0 %; 88: MONOCYTE % (AUTO DIFF), 4.6 %; 88: MEAN CORPUSCULAR VOLUME (MCV), 66.0 fL; 88: LYMPHOCYTE % (AUTO DIFF), 5.8 %; 88: WHITE BLOOD CELLS (WBC), 25.6 K/uL; 88: PLATELET COUNT (PLT), 346 K/uL; 88: BASOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 88: BASOPHIL % (AUTO DIFF), 0.2 %; 88: NEUTROPHIL % (AUTO DIFF), 88.7 %; 88: RED CELL DISTRIBUTION WIDTH (RDW), 15.3 %; 88: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.18 K/uL; 88: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 88: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.7 %; 88: HEMATOCRIT (HCT), 32.2 %; 88: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 18.9 pg; 88: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.49 K/uL; 88: NEUTROPHIL ABSOLUTE (AUTO DIFF), 22.66 K/uL; 96: PHOSPHORUS, 2.9 mg/dL; 96: MAGNESIUM, 2.2 mg/dL; 102: LR IV BOLUS -, 500 ML; 105: CEFEPIME, 2 GRAM/20 ML IV PUSH; 110: GLUCOSE, 118 mg/dL; 110: CO2, 33 mmol/L; 110: MAGNESIUM, 2.3 mg/dL; 110: CREATININE, 0.31 mg/dL; 110: ANION GAP, 8 mmol/L; 110: EGFR FOR AFRICAN AMERICAN, 137 mL/min/1.73 m2; 110: ALKALINE PHOSPHATASE, 95 U/L; 110: CALCIUM, 9.0 mg/dL; 110: PHOSPHORUS, 2.9 mg/dL; 110: EGFR REFIT WITHOUT RACE (2021), 119 mL/min/1.73 m2; 110: PROTEIN TOTAL, 7.2 g/dL; 110: BILIRUBIN TOTAL, 0.3 mg/dL; 110: POTASSIUM, 4.1 mmol/L; 110: CORRECTED CALCIUM, 9.3 mg/dL; 110: CHLORIDE, 95 mmol/L; 110: AST (SGOT), 14 U/L; 110: SODIUM, 136 mmol/L; 110: ALBUMIN, 3.6 g/dL; 110: ALT (SGPT), 9 U/L; 110: GLOBULIN, 3.6 g/dL; 110: BLOOD UREA NITROGEN (BUN), 19 mg/dL; 110: HR, 94.0; 110: RR, 21.0; 110: SpO2, 95.0; 110: SBP, 128.0; 110: DBP, 87.0; 110: MAP, 100.667; 110: LPM O2, 2.0; 111: TROPONIN I, <.017 ng/mL; 114: MAGNESIUM SULFATE IN WATER, 2 GRAM/50 ML (4 %) IV PGBK; 0: Age:, 66; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.5; 0: Triage HR, 87.0; 0: Triage RR, 16.0; 0: Triage SBP, 134.0; 0: Triage DBP, 80.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, I checked the clinical signs and found that the patient has markedly high heart rate (161 bpm) and elevated WBC counts (over 25 K/uL), suggesting a probable acute inflammatory response. Next, I examined the respiratory rate and blood pressure to confirm any other systemic signs, noting mild tachypnea (RR in the 20s) and largely normal systolic blood pressure. Then, I confirmed that the patient was being given broad-spectrum antibiotics (cefepime), which supports suspicion of a serious infection. These findings together indicate a high risk of sepsis within 12 hours.",
        "claims": [
            "The patient has a markedly high heart rate of 161 bpm.",
            "A heart rate of 161 bpm suggests a probable acute inflammatory response.",
            "The patient has elevated WBC counts over 25 K/uL.",
            "Elevated WBC counts further suggest a probable acute inflammatory response.",
            "The respiratory rate is noted to be mild tachypnea in the 20s.",
            "The blood pressure is largely normal.",
            "The patient is being given broad-spectrum antibiotics, specifically cefepime.",
            "The administration of cefepime supports suspicion of a serious infection.",
            "These findings together indicate a high risk of sepsis within 12 hours."
        ],
        "relevant_claims": [
            "A heart rate of 161 bpm suggests a probable acute inflammatory response.",
            "The patient has elevated WBC counts over 25 K/uL.",
            "Elevated WBC counts further suggest a probable acute inflammatory response.",
            "The respiratory rate is noted to be mild tachypnea in the 20s.",
            "The patient is being given broad-spectrum antibiotics, specifically cefepime.",
            "The administration of cefepime supports suspicion of a serious infection.",
            "These findings together indicate a high risk of sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.8,
            1.0,
            1.0,
            0.7,
            1.0,
            0.9,
            0.3
        ],
        "alignment_category": [
            2,
            2,
            2,
            2,
            9,
            9,
            4
        ],
        "alignment_reasonings": [
            "The claim highlights a heart rate (HR) of 161 bpm, which significantly exceeds the SIRS criterion threshold (>90 bpm) for identifying systemic inflammation. This heart rate is a strong indicator of an inflammatory or stress response, typical in early sepsis detection. However, SIRS requires meeting at least two criteria, so while the heart rate strongly aligns with one element of SIRS, it doesn\u2019t encompass the complete criteria, hence a slightly less than perfect alignment rating.",
            "The elevated white blood cell count (WBC > 12,000/\u00b5L) is one of the explicit criteria listed under SIRS. The given WBC count is significantly above the SIRS threshold, indicating systemic inflammation consistent with early sepsis. This makes the alignment with the category perfect.",
            "The claim explicitly mentions \"elevated WBC counts,\" which is directly listed as part of the SIRS criteria for identifying systemic inflammation consistent with early sepsis. This indicates a perfect alignment with the mentioned category.",
            "A respiratory rate of >20 breaths per minute meets one of the criteria for SIRS positivity. Although \"mild tachypnea in the 20s\" precisely aligns with the SIRS threshold for respiratory rate, it is only one component and does not cover the full SIRS criteria. Therefore, the alignment is significant but not complete.",
            "The claim specifies the administration of broad-spectrum antibiotics, which is a direct indication of clinical suspicion of serious infection. This action is a key component of category 9, indicating strong alignment and relevance to sepsis risk assessment.",
            "The claim indicates that cefepime, a broad-spectrum antibiotic, was administered. This action strongly aligns with the category which focuses on early administration of antibiotics as a sign of clinician suspicion of serious infection that warrants a sepsis risk assessment. The strong alignment merits a high rating, though the exact timing within the first 2 hours is not detailed, hence slightly less than perfect alignment.",
            "The claim suggests a general assessment of high sepsis risk, which most closely aligns with the idea of a scoring system predicting imminent clinical deterioration. While not directly mentioned, the NEWS score is designed to assess overall clinical risk, aligning conceptually. However, the claim lacks specificity about actual vitals or scoring components, so the alignment is somewhat weak."
        ],
        "final_alignment_score": 0.8142857142857143,
        "accuracy": 1
    },
    {
        "input": "10: HR, 77.0; 10: RR, 26.0; 10: SpO2, 94.0; 10: SBP, 124.0; 10: DBP, 62.0; 10: MAP, 82.667; 10: Temp, 96.5; 82: SpO2, 89.0; 83: SpO2, 90.429; 84: SpO2, 90.492; 84: Perf, 4.452; 84: SBP, 154.0; 84: DBP, 70.0; 84: MAP, 98.0; 85: SpO2, 96.466; 85: Perf, 4.148; 86: HR, 71.381; 86: RR, 16.0; 86: SpO2, 97.593; 86: Perf, 2.966; 86: 1min HRV, 16.155; 86: SBP, 154.0; 86: DBP, 70.0; 86: MAP, 98.0; 86: LPM O2, 4.0; 87: HR, 71.517; 87: RR, 16.621; 87: SpO2, 97.845; 87: Perf, 2.527; 87: 1min HRV, 66.844; 88: HR, 71.068; 88: RR, 18.305; 88: SpO2, 99.102; 88: Perf, 6.147; 88: 1min HRV, 88.071; 88: 5min HRV, 71.322; 89: HR, 69.712; 89: RR, 17.373; 89: SpO2, 99.0; 89: Perf, 6.267; 89: 1min HRV, 99.938; 89: SBP, 144.0; 89: DBP, 77.0; 89: MAP, 99.333; 90: HR, 68.655; 90: RR, 19.638; 90: SpO2, 98.931; 90: Perf, 5.382; 90: 1min HRV, 93.795; 91: HR, 68.068; 91: RR, 18.051; 91: SpO2, 99.0; 91: Perf, 3.774; 91: 1min HRV, 108.446; 92: HR, 67.914; 92: RR, 19.621; 92: SpO2, 99.207; 92: Perf, 2.366; 92: 1min HRV, 144.427; 93: HR, 66.576; 93: RR, 22.169; 93: SpO2, 99.339; 93: Perf, 2.173; 93: 1min HRV, 110.827; 93: 5min HRV, 113.988; 94: HR, 65.627; 94: RR, 18.288; 94: SpO2, 98.881; 94: Perf, 2.096; 94: 1min HRV, 110.571; 95: HR, 65.172; 95: RR, 19.759; 95: SpO2, 99.379; 95: Perf, 3.281; 95: 1min HRV, 77.063; 96: POC PH (V) ISTAT, 7.31; 96: POC TCO2 (V) ISTAT, 30 mmol/L; 96: POC BASE EXCESS ISTAT, 2 mmol/L; 96: POC O2 SATURATION ISTAT VENOUS, 64 %; 96: POC PCO2 (V) ISTAT, 57.5 mmHg; 96: POC LACTATE ISTAT, 0.93 mmol/L; 96: POC PO2 (V) ISTAT, 37 mmHg; 96: POC HCO3 (V) ISTAT, 28.7 mmol/L; 96: HR, 65.542; 96: RR, 19.153; 96: SpO2, 99.102; 96: Perf, 1.754; 96: 1min HRV, 27.516; 97: HR, 68.948; 97: RR, 24.897; 97: SpO2, 98.621; 97: Perf, 1.487; 97: 1min HRV, 45.742; 98: HR, 67.034; 98: RR, 21.712; 98: SpO2, 99.085; 98: Perf, 1.493; 98: 1min HRV, 104.683; 98: 5min HRV, 81.792; 99: HR, 67.932; 99: RR, 20.525; 99: SpO2, 99.0; 99: Perf, 1.597; 99: 1min HRV, 120.171; 100: HR, 66.862; 100: RR, 19.621; 100: SpO2, 99.052; 100: Perf, 1.658; 100: 1min HRV, 94.356; 101: HR, 66.831; 101: RR, 23.169; 101: SpO2, 99.136; 101: Perf, 1.661; 101: 1min HRV, 75.248; 102: HR, 65.862; 102: RR, 19.448; 102: SpO2, 99.138; 102: Perf, 1.378; 102: 1min HRV, 32.203; 103: HR, 65.492; 103: RR, 18.424; 103: SpO2, 99.237; 103: Perf, 1.368; 103: 1min HRV, 22.240; 103: 5min HRV, 79.378; 104: HR, 66.552; 104: RR, 26.276; 104: SpO2, 99.224; 104: Perf, 1.556; 104: 1min HRV, 102.855; 105: HR, 64.949; 105: RR, 19.288; 105: SpO2, 99.237; 105: Perf, 1.84; 105: 1min HRV, 23.225; 106: HR, 65.729; 106: RR, 21.475; 106: SpO2, 99.0; 106: Perf, 1.560; 106: 1min HRV, 19.443; 107: HR, 64.603; 107: RR, 24.466; 107: SpO2, 99.776; 107: Perf, 1.227; 107: 1min HRV, 85.820; 108: HR, 63.339; 108: RR, 23.695; 108: SpO2, 99.847; 108: Perf, 1.352; 108: 1min HRV, 26.607; 108: 5min HRV, 65.054; 109: HR, 63.138; 109: RR, 25.052; 109: SpO2, 100.0; 109: Perf, 1.304; 109: 1min HRV, 111.949; 110: HR, 62.695; 110: RR, 22.966; 110: SpO2, 100.0; 110: Perf, 1.205; 110: 1min HRV, 34.180; 111: HR, 65.424; 111: RR, 24.898; 111: SpO2, 99.831; 111: Perf, 1.268; 111: 1min HRV, 76.669; 112: HR, 66.448; 112: RR, 21.948; 112: SpO2, 99.897; 112: Perf, 1.413; 112: 1min HRV, 123.017; 112: Temp, 97.9; 113: HR, 64.915; 113: RR, 23.797; 113: SpO2, 100.0; 113: Perf, 1.788; 113: 1min HRV, 99.817; 113: 5min HRV, 98.123; 114: HR, 64.741; 114: RR, 21.103; 114: SpO2, 99.828; 114: Perf, 1.588; 114: 1min HRV, 154.840; 115: HR, 64.305; 115: RR, 24.051; 115: SpO2, 99.864; 115: Perf, 1.443; 115: 1min HRV, 156.988; 116: HR, 64.797; 116: RR, 22.0; 116: SpO2, 99.949; 116: Perf, 1.362; 116: 1min HRV, 112.948; 117: HR, 64.759; 117: RR, 24.741; 117: SpO2, 99.828; 117: Perf, 1.498; 117: 1min HRV, 138.767; 117: LPM O2, 2.0; 118: SARS-COV-2 RNA, Not Detected; 118: HR, 62.881; 118: RR, 23.424; 118: SpO2, 100.0; 118: Perf, 1.646; 118: 1min HRV, 122.625; 118: 5min HRV, 139.282; 119: WAM DIFTYP, AUTO; 119: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.7 g/dL; 119: MONOCYTE ABSOLUTE (AUTO DIFF), 0.63 K/uL; 119: NRBC PERCENT (HEMATOLOGY), 0.0 %; 119: HEMATOCRIT (HCT), 35.3 %; 119: NEUTROPHIL ABSOLUTE (AUTO DIFF), 6.30 K/uL; 119: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 119: NEUTROPHIL % (AUTO DIFF), 76.3 %; 119: RED CELL DISTRIBUTION WIDTH (RDW), 14.0 %; 119: MONOCYTE % (AUTO DIFF), 7.6 %; 119: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.26 K/uL; 119: RED BLOOD CELLS (RBC), 3.82 MIL/uL; 119: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.94 K/uL; 119: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.3 pg; 119: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.08 K/uL; 119: BASOPHIL % (AUTO DIFF), 0.5 %; 119: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 119: LYMPHOCYTE % (AUTO DIFF), 11.4 %; 119: MEAN CORPUSCULAR VOLUME (MCV), 92.4 fL; 119: PLATELET COUNT (PLT), 147 K/uL; 119: EOSINOPHIL % (AUTO DIFF), 3.2 %; 119: HEMOGLOBIN (HGB), 11.2 g/dL; 119: WHITE BLOOD CELLS (WBC), 8.3 K/uL; 119: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.0 %; 119: HR, 62.966; 119: RR, 23.138; 119: SpO2, 99.603; 119: Perf, 1.539; 119: 1min HRV, 132.912; 0: Age, 72; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 35.8; 0: Triage HR, 77.0; 0: Triage RR, 26.0; 0: Triage SBP, 124.0; 0: Triage DBP, 62.0; 0: Triage acuity, 3-Urgent; 0: CC, MULTIPLE COMPLAINTS",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I checked the vital signs for red flags such as hypotension or persistently high respiratory rate, and they were relatively stable. Next, I reviewed the lab results for indicators of sepsis (e.g., elevated lactate or abnormal WBC), which were normal. Then, I considered whether there was any apparent organ dysfunction or strong evidence of infection, and these were not identified. Based on these findings, the patient does not appear to be at high risk of developing sepsis within 12 hours.",
        "claims": [
            "The vital signs were checked for red flags such as hypotension or persistently high respiratory rate.",
            "The vital signs were relatively stable.",
            "Lab results were reviewed for indicators of sepsis.",
            "Indicators of sepsis include elevated lactate or abnormal white blood cell count (WBC).",
            "The lab results were normal.",
            "There was consideration of any apparent organ dysfunction.",
            "No apparent organ dysfunction was identified.",
            "Strong evidence of infection was considered.",
            "No strong evidence of infection was identified.",
            "Based on these findings, the patient does not appear to be at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The vital signs were checked for red flags such as hypotension or persistently high respiratory rate.",
            "Indicators of sepsis include elevated lactate or abnormal white blood cell count (WBC).",
            "There was consideration of any apparent organ dysfunction.",
            "Based on these findings, the patient does not appear to be at high risk of developing sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.6,
            0.5,
            0.7,
            0.3
        ],
        "alignment_category": [
            4,
            5,
            8,
            4
        ],
        "alignment_reasonings": [
            "The claim focuses on checking vital signs for red flags like hypotension or a high respiratory rate, which are components considered in the NEWS score. However, it is not specific regarding the results or thresholds needed for NEWS, making the alignment more general than direct. Nevertheless, checking for these signs is conceptually related to monitoring for changes that could elevate a NEWS score.",
            "The claim simultaneously references two indicators",
            "The claim discusses organ dysfunction consideration, which aligns with the SOFA score, designed to track organ dysfunction. However, the claim does not specify an actual increase in the SOFA score or specific organ dysfunction, leading to a partial but relevant alignment.",
            "The claim suggests that the patient is not at high risk for developing sepsis, implying stable vitals and no severe derangements suggesting imminent clinical deterioration. The NEWS score, which predicts clinical deterioration, would likely be low. Although the claim does not directly mention a NEWS score, it aligns conceptually with what a low NEWS score would indicate. The alignment is indirect and inferred, so the rating is moderate."
        ],
        "final_alignment_score": 0.525,
        "accuracy": 1
    },
    {
        "input": "12: HR, 131.0; 12: RR, 26.0; 12: SpO2, 97.0; 12: SBP, 112.0; 12: DBP, 63.0; 12: MAP, 79.333; 12: Pain, 8.0; 12: Temp, 99.1; 16: HR, 130.224; 16: RR, 31.759; 16: SpO2, 96.810; 16: Perf, 2.298; 16: 1min HRV, 2.130; 17: HR, 130.271; 17: RR, 30.661; 17: SpO2, 96.169; 17: Perf, 2.430; 17: 1min HRV, 2.049; 18: HR, 129.879; 18: RR, 29.517; 18: SpO2, 96.328; 18: Perf, 2.537; 18: 1min HRV, 4.819; 19: HR, 129.661; 19: RR, 33.458; 19: SpO2, 97.0; 19: Perf, 2.426; 19: 1min HRV, 3.290; 20: HR, 128.695; 20: RR, 30.390; 20: SpO2, 96.373; 20: Perf, 2.076; 20: 1min HRV, 2.228; 20: 5min HRV, 3.789; 21: HR, 128.810; 21: RR, 30.638; 21: SpO2, 96.931; 21: Perf, 2.043; 21: 1min HRV, 2.866; 22: HR, 127.407; 22: RR, 31.864; 22: SpO2, 96.814; 22: Perf, 1.983; 22: 1min HRV, 2.082; 23: HR, 127.414; 23: RR, 31.052; 23: SpO2, 95.845; 23: Perf, 1.876; 23: 1min HRV, 2.009; 24: POC PH (V) ISTAT, 7.47; 24: POC PO2 (V) ISTAT, 47 mmHg; 24: POC LACTATE ISTAT, 1.31 mmol/L; 24: POC TCO2 (V) ISTAT, 15 mmol/L; 24: POC PCO2 (V) ISTAT, 19.9 mmHg; 24: POC O2 SATURATION ISTAT VENOUS, 87 %; 24: POC BASE EXCESS ISTAT, -9 mmol/L; 24: POC HCO3 (V) ISTAT, 14.4 mmol/L; 24: HR, 127.051; 24: RR, 32.576; 24: SpO2, 96.288; 24: Perf, 2.031; 24: 1min HRV, 2.624; 25: HR, 127.328; 25: RR, 31.345; 25: SpO2, 95.914; 25: Perf, 1.939; 25: 1min HRV, 2.888; 25: 5min HRV, 3.467; 26: HR, 127.407; 26: RR, 26.644; 26: SpO2, 95.593; 26: Perf, 1.900; 26: 1min HRV, 7.509; 27: HR, 127.932; 27: RR, 29.983; 27: SpO2, 95.780; 27: Perf, 1.887; 27: 1min HRV, 3.685; 28: HR, 127.983; 28: RR, 31.793; 28: SpO2, 94.569; 28: Perf, 2.606; 28: 1min HRV, 1.864; 29: HR, 127.542; 29: RR, 29.492; 29: SpO2, 94.0; 29: Perf, 2.147; 29: 1min HRV, 2.224; 30: 5min HRV, 4.540; 67: PROTEIN TOTAL, 7.2 g/dL; 67: ALKALINE PHOSPHATASE, 91 U/L; 67: ALT (SGPT), 13 U/L; 67: EGFR REFIT WITHOUT RACE (2021), 9 mL/min/1.73 m2; 67: CHLORIDE, 99 mmol/L; 67: GLOBULIN, 3.9 g/dL; 67: CO2, 12 mmol/L; 67: AST (SGOT), 14 U/L; 67: SODIUM, 133 mmol/L; 67: BILIRUBIN TOTAL, 0.8 mg/dL; 67: ANION GAP, 22 mmol/L; 67: ALBUMIN, 3.3 g/dL; 67: CALCIUM, 8.9 mg/dL; 67: EGFR FOR AFRICAN AMERICAN, 11 mL/min/1.73 m2; 67: GLUCOSE, 164 mg/dL; 67: CREATININE, 5.68 mg/dL; 67: CORRECTED CALCIUM, 9.5 mg/dL; 67: POTASSIUM, 4.7 mmol/L; 67: BLOOD UREA NITROGEN (BUN), 79 mg/dL; 72: INR, 1.3; 72: PROTHROMBIN TIME, 16.1 seconds; 73: PART. THROMBOPLASTIN TIME, 49.0 seconds; 73: CEFEPIME, 2 GRAM/20 ML IV PUSH; 82: HR:, 113.0; 82: RR, 27.0; 82: SpO2, 97.0; 82: Temp, 102.4; 85: VANCOMYCIN-WATER INJECT (PEG), 1.25 GRAM/250 ML IV PGBK; 86: WAM, DIFTYP: AUTO; 86: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 86: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.65 K/uL; 86: NEUTROPHIL ABSOLUTE (AUTO DIFF), 29.65 K/uL; 86: BASOPHIL % (AUTO DIFF), 0.3 %; 86: RED BLOOD CELLS (RBC), 3.66 MIL/uL; 86: EOSINOPHIL % (AUTO DIFF), 0.0 %; 86: HEMATOCRIT (HCT), 32.2 %; 86: LYMPHOCYTE % (AUTO DIFF), 2.1 %; 86: HEMOGLOBIN (HGB), 10.4 g/dL; 86: NRBC PERCENT (HEMATOLOGY), 0.0 %; 86: PLATELET COUNT (PLT), 420 K/uL; 86: MONOCYTE % (AUTO DIFF), 1.6 %; 86: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.1 %; 86: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 86: BASOPHIL ABSOLUTE (AUTO DIFF), 0.08 K/uL; 86: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.3 g/dL; 86: MONOCYTE ABSOLUTE (AUTO DIFF), 0.49 K/uL; 86: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 28.4 pg; 86: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.34 K/uL; 86: NEUTROPHIL % (AUTO DIFF), 94.9 %; 86: WHITE BLOOD CELLS (WBC), 31.2 K/uL; 86: MEAN CORPUSCULAR VOLUME (MCV), 88.0 fL; 86: RED CELL DISTRIBUTION WIDTH (RDW), 14.8 %; 86: METAMYELOCYTE/MYELOCYTE/PROMYELOCYTE (SLIDE REVIEW), 54 %; 86: LR IV BOLUS -, 30 ML/KG (ED FOR BMI <= 30); 90: HR:, 116.0; 90: RR, 26.0; 90: SpO2, 97.0; 90: SBP, 95.0; 90: DBP, 56.0; 90: MAP, 69.0; 110: HR, 110.0; 110: RR, 29.0; 110: SpO2, 95.0; 110: SBP, 96.0; 110: DBP, 58.0; 110: MAP, 70.667; 0: Age, 73; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, EMS; 0: Triage Temp, 37.3; 0: Triage HR, 131.0; 0: Triage RR, 26.0; 0: Triage SBP, 112.0; 0: Triage DBP, 63.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER,ABDOMINAL PAIN,NAUSEA",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, I check whether the vital signs are abnormal, and see persistent tachycardia (HR > 130), tachypnea (RR in the high 20s), and later hypotension (SBP < 100). Next, I look at labs and note significantly elevated WBC (31.2 K/uL) and acute kidney injury (creatinine 5.68 mg/dL), indicating likely infection plus organ dysfunction. Finally, given the clinical picture (fever, broad-spectrum antibiotics started, high WBC, and hemodynamic instability), the patient appears at high risk for sepsis within 12 hours.",
        "claims": [
            "I check whether the vital signs are abnormal.",
            "I observe persistent tachycardia with a heart rate greater than 130 beats per minute.",
            "I observe tachypnea with a respiratory rate in the high 20s.",
            "I later observe hypotension with a systolic blood pressure less than 100 mmHg.",
            "I look at labs and note significantly elevated white blood cell count.",
            "The white blood cell count is 31.2 K/uL.",
            "I note acute kidney injury with a creatinine level of 5.68 mg/dL.",
            "The elevated white blood cell count and acute kidney injury indicate likely infection and organ dysfunction.",
            "Given the clinical picture that includes fever, broad-spectrum antibiotics started, high white blood cell count, and hemodynamic instability,",
            "the patient appears at high risk for sepsis within 12 hours."
        ],
        "relevant_claims": [
            "I observe persistent tachycardia with a heart rate greater than 130 beats per minute.",
            "I observe tachypnea with a respiratory rate in the high 20s.",
            "I later observe hypotension with a systolic blood pressure less than 100 mmHg.",
            "I look at labs and note significantly elevated white blood cell count.",
            "The white blood cell count is 31.2 K/uL.",
            "I note acute kidney injury with a creatinine level of 5.68 mg/dL.",
            "The elevated white blood cell count and acute kidney injury indicate likely infection and organ dysfunction.",
            "Given the clinical picture that includes fever, broad-spectrum antibiotics started, high white blood cell count, and hemodynamic instability,",
            "the patient appears at high risk for sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.7,
            0.9,
            0.7,
            1.0,
            1.0,
            1.0,
            0.9,
            0.8,
            0.3
        ],
        "alignment_category": [
            6,
            3,
            7,
            2,
            2,
            8,
            8,
            9,
            4
        ],
        "alignment_reasonings": [
            "A heart rate over 130 bpm indicates tachycardia, which contributes to the shock index assessment (heart rate \u00f7 systolic BP). While the claim does not directly mention systolic blood pressure, persistent tachycardia reflects haemodynamic instability, which is key to this category. The elevated heart rate strongly suggests a high shock index, but lacks specific data for full alignment.",
            "The claim of tachypnea with a respiratory rate in the high 20s closely aligns with the qSOFA criteria, which identifies a respiratory rate \u226522/min as one of its components. This strongly suggests potential high risk of sepsis-related organ dysfunction and mortality, making the alignment strong though not perfect (since other components of qSOFA are not mentioned).",
            "The claim mentions hypotension with a systolic blood pressure less than 100 mmHg, which suggests a drop in blood pressure that could indicate sepsis-associated hypotension. However, the threshold specified in the category is SBP < 90 mmHg, which means the alignment isn't perfect, but it is closely related. Hence, the alignment rating is 0.7 because the observed hypotension is a strong but not exact indicator as per the category definition.",
            "The claim explicitly mentions an elevated white blood cell count, which is directly listed as one of the SIRS criteria. Elevated WBC is used to identify systemic inflammation consistent with early sepsis, resulting in a perfect alignment with this category.",
            "The claim involves an elevated white blood cell count (31.2 K/uL), which fits directly into the SIRS criteria for leukocytosis (WBC > 12,000/\u00b5L). This indicates systemic inflammation, making the claim perfectly aligned with SIRS positivity as part of early sepsis identification.",
            "A creatinine level >2 mg/dL is directly listed as a criterion for a SOFA score increase. The claim's creatinine level of 5.68 mg/dL clearly indicates new organ dysfunction, precisely aligning with this category. Therefore, the alignment is perfect.",
            "The claim mentions both an elevated white blood cell count and acute kidney injury. While elevated WBC is directly linked to SIRS criteria, acute kidney injury (which may be associated with increased creatinine levels) is directly relevant to the SOFA criteria, which measures renal dysfunction as part of its organ dysfunction assessment. The combination of organ dysfunction and symptoms of infection strongly suggest an increased SOFA score, making this category most relevant to the claim. The alignment is strong because the claim involves likely organ dysfunction consistent with an increase in the SOFA score, but not a perfect alignment since the elevated WBC aligns more closely with SIRS Positivity criteria.",
            "The claim indicates that broad-spectrum antibiotics were started, which directly ties to clinician suspicion of serious infection as noted in this category. While the claim also references fever and high white blood cell count (which align with the SIRS category), the initiation of antibiotics within the context suggests the strongest alignment with clinician intervention aimed at a serious infection. The inclusion of hemodynamic instability does suggest possible shock, but lacks specific details to fully align with the Shock Index or Sepsis-Associated Hypotension categories, which prevents a higher rating.",
            "The claim generally suggests a high risk of sepsis without specifying which clinical indicators or criteria led to this assessment. While not directly stating a specific criterion, the notion of being at high risk within a short time period closely aligns with the idea of imminent clinical deterioration predicted by an elevated NEWS score. However, the lack of specific vital sign deviations limits the alignment strength, resulting in an indirect and weak association."
        ],
        "final_alignment_score": 0.8111111111111111,
        "accuracy": 1
    },
    {
        "input": "2: SpO2, 97.0; 2: SBP, 206.0; 2: DBP, 115.0; 2: MAP, 145.333; 3: SpO2, 97.185; 4: SpO2, 97.019; 4: Perf, 0.720; 5: SpO2, 97.491; 5: Perf, 0.742; 6: SpO2, 97.208; 6: Perf, 0.717; 7: SpO2, 98.0; 7: Perf, 0.701; 8: HR, 103.0; 8: RR, 18.0; 8: SpO2, 97.623; 8: Perf, 0.68; 8: SBP, 206.0; 8: DBP, 115.0; 8: MAP, 145.333; 8: Pain, 10.0; 9: SpO2, 97.615; 9: Perf, 0.680; 10: SpO2, 97.604; 10: Perf, 0.69; 11: SpO2, 98.0; 11: Perf, 0.772; 12: SpO2, 97.830; 12: Perf, 0.758; 13: SpO2, 97.566; 13: Perf, 0.740; 14: SpO2, 98.154; 14: Perf, 0.769; 15: SpO2, 98.189; 15: Perf, 0.763; 16: SpO2, 97.846; 16: Perf, 0.704; 17: SpO2, 97.283; 17: Perf, 0.726; 18: SpO2, 97.0; 18: Perf, 0.831; 19: SpO2, 97.242; 20: SpO2, 97.115; 20: Perf, 0.737; 21: SpO2, 96.923; 21: Perf, 0.927; 22: SpO2, 97.0; 23: SpO2, 97.586; 23: Perf, 1.114; 24: HR, 100.0; 24: RR, 18.0; 24: SpO2, 94.111; 24: SBP, 197.0; 24: DBP, 103.0; 24: MAP, 134.333; 25: SpO2, 97.0; 25: SBP, 197.0; 25: DBP, 103.0; 25: MAP, 134.333; 27: SpO2, 97.364; 28: SpO2, 97.623; 28: Perf, 1.001; 29: SpO2, 97.0; 29: Perf, 1.053; 31: SpO2, 88.0; 33: WAM DIFTYP, AUTO; 33: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.3 %; 33: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.39 K/uL; 33: LYMPHOCYTE % (AUTO DIFF), 14.0 %; 33: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.7 g/dL; 33: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.18 K/uL; 33: MEAN CORPUSCULAR VOLUME (MCV), 99.5 fL; 33: BASOPHIL % (AUTO DIFF), 0.2 %; 33: PLATELET COUNT (PLT), 376 K/uL; 33: MONOCYTE % (AUTO DIFF), 7.3 %; 33: HEMOGLOBIN (HGB), 12.5 g/dL; 33: HEMATOCRIT (HCT), 39.4 %; 33: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 33: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 33: NEUTROPHIL % (AUTO DIFF), 77.1 %; 33: RED CELL DISTRIBUTION WIDTH (RDW), 14.2 %; 33: MONOCYTE ABSOLUTE (AUTO DIFF), 0.98 K/uL; 33: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.6 pg; 33: NRBC PERCENT (HEMATOLOGY), 0.0 %; 33: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.89 K/uL; 33: EOSINOPHIL % (AUTO DIFF), 0.1 %; 33: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 33: WHITE BLOOD CELLS (WBC), 13.5 K/uL; 33: RED BLOOD CELLS (RBC), 3.96 MIL/uL; 33: SpO2, 94.0; 34: ACETAMINOPHEN, 325 MG PO TABS; 35: SpO, 2: 97.917; 36: SpO2, 97.308; 36: Perf, 0.873; 36: AMPICILLIN-SULBACTAM, 3 GRAM/100 ML MINIBAG PLUS; 37: SpO, 2: 97.170; 37: Perf, 0.920; 38: SpO2, 97.0; 38: Perf, 0.895; 39: SpO2, 97.0; 39: Perf, 0.892; 40: SpO2, 97.0; 40: Perf, 0.86; 41: SpO2, 97.0; 41: Perf, 0.827; 42: SpO2, 97.744; 43: SpO2, 98.0; 43: Perf, 0.891; 44: SpO2, 97.588; 44: Perf, 1.045; 45: SpO2, 97.0; 45: Perf, 0.975; 46: SpO2, 96.731; 46: Perf, 1.045; 47: SpO2, 96.302; 47: Perf, 1.191; 48: SpO2, 96.654; 48: Perf, 1.225; 49: SpO2, 97.0; 49: Perf, 1.303; 50: SpO2, 97.0; 50: Perf, 1.328; 51: SpO2, 97.0; 51: Perf, 1.327; 52: SpO2, 97.0; 52: Perf, 1.391; 53: SpO2, 97.0; 53: Perf, 1.318; 54: SpO2, 96.868; 54: Perf, 1.406; 55: SpO2, 96.0; 55: Perf, 1.390; 56: SpO2, 96.226; 56: Perf, 1.419; 57: SpO2, 96.327; 57: Perf, 1.422; 58: SpO2, 96.0; 58: Perf, 1.384; 59: SpO2, 95.774; 59: Perf, 1.254; 60: SpO2, 96.096; 60: Perf, 1.303; 61: SpO2, 96.264; 61: Perf, 1.389; 62: SpO2, 96.0; 62: Perf, 1.226; 63: SpO2, 95.340; 63: Perf, 1.125; 64: SpO2, 96.962; 64: Perf, 1.310; 65: SpO2, 97.0; 65: Perf, 1.818; 66: AST (SGOT), 33 U/L; 66: GLUCOSE, 102 mg/dL; 66: ALBUMIN, 4.3 g/dL; 66: PROTEIN TOTAL, 7.3 g/dL; 66: BLOOD UREA NITROGEN (BUN), 12 mg/dL; 66: BILIRUBIN TOTAL, 1.5 mg/dL; 66: EGFR FOR AFRICAN AMERICAN, 78 mL/min/1.73 m2; 66: SODIUM, 138 mmol/L; 66: CREATININE, 0.76 mg/dL; 66: GLOBULIN, 3.0 g/dL; 66: EGFR REFIT WITHOUT RACE (2021), 67 mL/min/1.73 m2; 66: ALKALINE PHOSPHATASE, 150 U/L; 66: ANION GAP, 13 mmol/L; 66: CO2, 23 mmol/L; 66: CALCIUM, 9.4 mg/dL; 66: CHLORIDE, 102 mmol/L; 66: CORRECTED CALCIUM, 9.2 mg/dL; 66: POTASSIUM, 4.3 mmol/L; 66: ALT (SGPT), 28 U/L; 66: SpO2, 96.943; 66: Perf, 1.860; 67: SpO2, 96.827; 67: Perf, 1.841; 68: SpO2, 96.0; 68: Perf, 1.759; 69: SpO2, 96.113; 69: Perf, 1.695; 70: SpO2, 95.951; 70: Perf, 1.700; 71: SpO2, 96.0; 71: Perf, 1.540; 72: SpO2, 96.173; 72: Perf, 1.488; 73: SpO2, 96.0; 73: Perf, 1.600; 74: SpO2, 95.151; 74: Perf, 1.457; 75: SpO2, 95.904; 75: Perf, 1.517; 76: SpO2, 95.925; 76: Perf, 1.477; 77: SpO2, 95.058; 77: Perf, 1.363; 78: SpO2, 96.0; 78: Perf, 1.658; 79: SpO2, 95.642; 79: Perf, 1.595; 80: SpO2, 95.327; 80: Perf, 1.426; 81: SpO2, 95.226; 81: Perf, 1.360; 82: SARS-COV-2 RNA, Not Detected; 82: SpO2, 95.0; 82: Perf, 1.314; 83: SpO2, 94.509; 83: Perf, 1.301; 84: SpO2, 94.538; 84: Perf, 1.324; 85: SpO2, 94.725; 85: Perf, 1.390; 104: SpO2, 96.365; 104: Perf, 1.140; 105: SpO2, 96.0; 105: Perf, 1.179; 106: SpO2, 96.0; 106: Perf, 1.165; 107: SpO2, 96.0; 108: SpO2, 96.721; 108: Perf, 1.267; 109: SpO2, 96.635; 109: Perf, 1.278; 110: SpO2, 96.245; 110: Perf, 1.290; 111: SpO2, 96.0; 111: Perf, 1.262; 112: SpO2, 96.282; 112: Perf, 1.303; 112: IOPAMIDOL, 76 % IV SOLN (RADIOLOGY) 500 ML; 113: SpO, 2: 97.0; 113: Perf, 1.497; 114: SpO2, 97.0; 114: Perf, 1.674; 115: SpO2, 97.189; 115: Perf, 1.635; 116: SpO2, 96.942; 116: Perf, 1.490; 117: SpO2, 97.377; 117: Perf, 1.634; 118: SpO2, 97.226; 118: Perf, 1.614; 119: SpO2, 96.635; 119: Perf, 1.432; 0: Age, 90; 0: Gender, F; 0: Race, White; 0: Means of arrival, EMS; 0: Triage Temp, 37.4; 0: Triage HR, 103.0; 0: Triage RR, 18.0; 0: Triage SBP, 206.0; 0: Triage DBP, 115.0; 0: Triage acuity, 3-Urgent; 0: CC, JAW SWELLING",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I asked whether there were clear signs of infection, and the elevated WBC plus antibiotics administration suggests possible infection. Second, I considered whether there was any evidence of organ dysfunction or severe abnormal vitals (fever, hypotension, or hypoxia) and found them largely unremarkable aside from mild tachycardia. Lastly, I evaluated whether the patient met sepsis criteria or showed strong risk factors for progression within 12 hours, and the data did not indicate such progression. Therefore, based on these observations, the sepsis risk prediction is low.",
        "claims": [
            "There are clear signs of infection.",
            "The elevated WBC suggests possible infection.",
            "Antibiotics administration suggests possible infection.",
            "There is evidence of organ dysfunction or severe abnormal vitals.",
            "The vital signs are largely unremarkable aside from mild tachycardia.",
            "The patient has mild tachycardia.",
            "I evaluated whether the patient met sepsis criteria.",
            "The data did not indicate strong risk factors for progression within 12 hours.",
            "The sepsis risk prediction is low based on these observations."
        ],
        "relevant_claims": [
            "The elevated WBC suggests possible infection.",
            "Antibiotics administration suggests possible infection.",
            "There is evidence of organ dysfunction or severe abnormal vitals."
        ],
        "alignment_scores": [
            0.9,
            0.7,
            0.7
        ],
        "alignment_category": [
            2,
            9,
            8
        ],
        "alignment_reasonings": [
            "An elevated WBC count is one of the criteria under SIRS, which is used to identify systemic inflammation consistent with early sepsis. However, the claim suggests a \"possible infection\" rather than meeting multiple SIRS criteria explicitly. Therefore, while there is a strong correlation, the presence of one component of the SIRS criteria without other accompanying elements slightly reduces the alignment strength.",
            "The administration of antibiotics is a critical action reflecting clinician suspicion of a serious infection, which is significant for sepsis risk assessment. However, the claim does not specify if the administration occurred within the first 2 hours, which prevents a perfect alignment rating.",
            "The claim refers to evidence of organ dysfunction or severe abnormal vitals. The SOFA Score Increase category addresses organ dysfunction explicitly, which aligns moderately well with the claim. However, \"severe abnormal vitals\" is not fully captured by this category alone, hence the score of 0.7 instead of a perfect alignment."
        ],
        "final_alignment_score": 0.7666666666666666,
        "accuracy": 1
    },
    {
        "input": "4: HR, 106.0; 4: RR, 18.0; 4: SpO2, 95.0; 4: SBP, 118.0; 4: DBP, 57.0; 4: MAP, 77.333; 4: Temp, 100.6; 11: Pain, 10.0; 78: INFLUENZA B, Not Detected; 78: RSV, Not Detected; 78: SARS-COV-2 RNA, Not Detected; 78: INFLUENZA A, Not Detected; 86: WAM DIFTYP, AUTO; 86: MONOCYTE % (AUTO DIFF), 3.2 %; 86: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.0 %; 86: NRBC PERCENT (HEMATOLOGY), 0.0 %; 86: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.37 K/uL; 86: NEUTROPHIL ABSOLUTE (AUTO DIFF), 21.89 K/uL; 86: BASOPHIL % (AUTO DIFF), 0.2 %; 86: MONOCYTE ABSOLUTE (AUTO DIFF), 0.74 K/uL; 86: NEUTROPHIL % (AUTO DIFF), 93.9 %; 86: HEMOGLOBIN (HGB), 12.1 g/dL; 86: BASOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 86: RED CELL DISTRIBUTION WIDTH (RDW), 14.1 %; 86: PLATELET COUNT (PLT), 296 K/uL; 86: EOSINOPHIL % (AUTO DIFF), 0.1 %; 86: MEAN CORPUSCULAR VOLUME (MCV), 83.9 fL; 86: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.2 g/dL; 86: LYMPHOCYTE % (AUTO DIFF), 1.6 %; 86: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.23 K/uL; 86: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 86: WHITE BLOOD CELLS (WBC), 23.3 K/uL; 86: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 27.9 pg; 86: HEMATOCRIT (HCT), 36.4 %; 86: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 86: RED BLOOD CELLS (RBC), 4.34 MIL/uL; 89: SpO2, 96.0; 89: Perf, 4.079; 90: AST (SGOT), 114 U/L; 90: PROTEIN TOTAL, 6.9 g/dL; 90: ALT (SGPT), 110 U/L; 90: CREATININE, 0.54 mg/dL; 90: GLOBULIN, 2.9 g/dL; 90: BILIRUBIN TOTAL, 0.6 mg/dL; 90: ALBUMIN, 4.0 g/dL; 90: ALKALINE PHOSPHATASE, 96 U/L; 90: BLOOD UREA NITROGEN (BUN), 15 mg/dL; 90: POTASSIUM, 3.9 mmol/L; 90: CHLORIDE, 101 mmol/L; 90: GLUCOSE, 133 mg/dL; 90: SODIUM, 137 mmol/L; 90: ANION GAP, 15 mmol/L; 90: CO2, 21 mmol/L; 90: CORRECTED CALCIUM, 9.4 mg/dL; 90: EGFR REFIT WITHOUT RACE (2021), 101 mL/min/1.73 m2; 90: CALCIUM, 9.4 mg/dL; 90: HR, 84.517; 90: RR, 21.292; 90: SpO2, 95.458; 90: Perf, 4.041; 90: 1min HRV, 10.199; 91: HR, 83.949; 91: RR, 23.932; 91: SpO2, 95.590; 91: Perf, 3.659; 91: 1min HRV, 11.842; 91: 5min HRV, 11.409; 91: SBP, 116.0; 91: DBP, 50.0; 91: MAP, 72.0; 92: HR, 83.879; 92: RR, 27.276; 92: SpO2, 94.408; 92: Perf, 4.016; 92: 1min HRV, 9.479; 93: HR, 83.644; 93: RR, 26.017; 93: SpO2, 95.0; 93: Perf, 5.217; 93: 1min HRV, 10.131; 94: HR, 85.362; 94: RR, 23.397; 94: SpO2, 94.207; 94: Perf, 5.130; 94: 1min HRV, 10.629; 95: HR, 85.017; 95: RR, 22.847; 95: SpO2, 93.881; 95: Perf, 5.692; 95: 1min HRV, 11.154; 96: HR, 86.103; 96: RR, 22.017; 96: SpO2, 93.172; 96: Perf, 6.053; 96: 1min HRV, 6.565; 96: 5min HRV, 12.675; 97: HR, 88.797; 97: RR, 23.356; 97: SpO2, 91.763; 97: Perf, 5.578; 97: 1min HRV, 7.669; 98: HR, 88.475; 98: RR, 24.407; 98: SpO2, 92.407; 98: Perf, 5.426; 98: 1min HRV, 9.469; 99: HR, 89.207; 99: RR, 25.948; 99: SpO2, 92.172; 99: Perf, 5.348; 99: 1min HRV, 6.386; 100: HR, 86.966; 100: RR, 25.237; 100: SpO2, 92.068; 100: Perf, 5.777; 100: 1min HRV, 9.830; 101: HR, 86.914; 101: RR, 23.397; 101: SpO2, 94.155; 101: Perf, 6.101; 101: 1min HRV, 9.211; 101: 5min HRV, 11.822; 102: HR, 86.542; 102: RR, 24.0; 102: SpO2, 92.156; 102: Perf, 5.225; 102: 1min HRV, 5.188; 102: SBP, 110.0; 102: DBP, 58.0; 102: MAP, 75.333; 103: HR, 87.780; 103: RR, 23.678; 103: SpO2, 91.780; 103: Perf, 4.880; 103: 1min HRV, 7.196; 104: HR, 87.845; 104: RR, 25.397; 104: SpO2, 91.707; 104: Perf, 4.783; 104: 1min HRV, 8.222; 105: HR, 88.525; 105: RR, 26.814; 105: SpO2, 92.051; 105: Perf, 4.338; 105: 1min HRV, 7.789; 106: HIGH SENSITIVITY TROPONIN, 4 ng/L; 106: HR, 88.931; 106: RR, 25.759; 106: SpO2, 92.517; 106: Perf, 4.301; 106: 1min HRV, 8.454; 106: 5min HRV, 10.096; 107: HR, 88.847; 107: RR, 28.763; 107: SpO2, 92.712; 107: Perf, 4.237; 107: 1min HRV, 8.968; 108: HR, 88.322; 108: RR, 27.695; 108: SpO2, 94.831; 108: Perf, 4.0; 108: 1min HRV, 12.599; 109: HR, 88.897; 109: RR, 25.276; 109: SpO2, 96.0; 109: Perf, 4.164; 109: 1min HRV, 19.491; 110: HR, 86.797; 110: RR, 25.288; 110: SpO2, 96.0; 110: Perf, 4.062; 110: 1min HRV, 18.006; 111: HR, 85.241; 111: RR, 25.534; 111: SpO2, 95.534; 111: Perf, 4.561; 111: 1min HRV, 11.685; 111: 5min HRV, 18.796; 112: HR, 86.254; 112: RR, 25.847; 112: SpO2, 95.0; 112: Perf, 4.068; 112: 1min HRV, 14.892; 113: HR, 85.492; 113: RR, 26.373; 113: SpO2, 94.492; 113: Perf, 4.149; 113: 1min HRV, 12.022; 114: HR, 85.155; 114: RR, 23.362; 114: SpO2, 94.759; 114: Perf, 4.107; 114: 1min HRV, 17.338; 114: CEFTRIAXONE, 1 GRAM/10 ML IV PUSH (VIAL ONLY); 115: HR:, 85.966; 115: RR, 25.119; 115: SpO2, 94.932; 115: Perf, 3.909; 115: 1min HRV, 18.567; 115: SBP, 110.0; 115: DBP, 58.0; 115: MAP, 75.333; 115: Pain, 10.0; 116: HR, 94.586; 116: RR, 23.483; 116: SpO2, 95.224; 116: Perf, 2.791; 116: 1min HRV, 9.841; 116: 5min HRV, 32.305; 117: HR, 93.407; 117: RR, 20.458; 117: SpO2, 95.912; 117: Perf, 2.549; 117: 1min HRV, 28.365; 117: SBP, 132.0; 117: DBP, 60.0; 117: MAP, 84.0; 118: HR, 85.695; 118: RR, 26.695; 118: SpO2, 96.424; 118: Perf, 3.112; 118: 1min HRV, 16.910; 119: HR, 88.931; 119: RR, 22.603; 119: SpO2, 97.362; 119: Perf, 4.151; 119: 1min HRV, 14.827; 0: Age, 68; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 38.1; 0: Triage HR, 106.0; 0: Triage RR, 18.0; 0: Triage SBP, 118.0; 0: Triage DBP, 57.0; 0: Triage acuity, 3-Urgent; 0: CC, CHEST PAIN",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, I checked whether the patient\u2019s vital signs showed abnormal values (fever of 38.1\u00b0C, tachycardia around 106 bpm). Next, I examined lab findings demonstrating leukocytosis (WBC 23.3 K/uL) with neutrophil predominance, markers of potential bacterial infection. Then, I noted that ceftriaxone was given, indicating clinical concern for a serious infection. Putting these findings together supports a high risk of sepsis within 12 hours.",
        "claims": [
            "The patient's vital signs showed abnormal values.",
            "The patient has a fever of 38.1\u00b0C.",
            "The patient has tachycardia around 106 bpm.",
            "Lab findings demonstrate leukocytosis.",
            "The white blood cell count (WBC) is 23.3 K/uL.",
            "There is neutrophil predominance in the lab findings.",
            "Neutrophil predominance is a marker of potential bacterial infection.",
            "Ceftriaxone was given to the patient.",
            "Administering ceftriaxone indicates clinical concern for a serious infection.",
            "The combination of these findings supports a high risk of sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient's vital signs showed abnormal values.",
            "The patient has a fever of 38.1\u00b0C.",
            "The patient has tachycardia around 106 bpm.",
            "Lab findings demonstrate leukocytosis.",
            "The white blood cell count (WBC) is 23.3 K/uL.",
            "There is neutrophil predominance in the lab findings.",
            "Neutrophil predominance is a marker of potential bacterial infection.",
            "Ceftriaxone was given to the patient.",
            "Administering ceftriaxone indicates clinical concern for a serious infection.",
            "The combination of these findings supports a high risk of sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.5,
            0.5,
            0.9,
            1.0,
            1.0,
            0.7,
            0.7,
            1.0,
            0.8,
            0.4
        ],
        "alignment_category": [
            4,
            2,
            2,
            2,
            2,
            2,
            2,
            9,
            9,
            4
        ],
        "alignment_reasonings": [
            "The claim mentions \"abnormal values\" in vital signs, which aligns with how an elevated NEWS score is derived from multiple deranged vitals. However, since the claim is vague and doesn't provide specific vital sign details, the alignment with any particular prediction category is moderate. If the claim specified more details indicating significant derangements or specific thresholds, it could increase alignment with a particular category.",
            "The patient's fever of 38.1\u00b0C meets one of the SIRS criteria (temperature\u202f>\u202f38\u202f\u00b0C), indicating the presence of systemic inflammation. However, since SIRS positivity requires the presence of\u202f\u2265\u202f2 criteria, the alignment is partial but relevant.",
            "Tachycardia with a heart rate >90 bpm is specifically listed as one of the SIRS criteria. The claim meets this criterion, indicating systemic inflammation consistent with early sepsis. The alignment is strong since the heart rate value clearly exceeds the threshold, though it's worth noting that complete SIRS positivity requires at least two criteria, so the evaluation would be stronger with additional supporting criteria.",
            "Leukocytosis directly corresponds to an elevated white blood cell count, which is explicitly included in the SIRS criteria. SIRS criteria are used to identify systemic inflammation consistent with early sepsis, and leukocytosis is a concrete finding that aligns strongly with this category.",
            "The claim directly references an elevated white blood cell count, which is explicitly listed as a criterion under SIRS. According to the SIRS criteria, a white blood cell count (WBC) >12,000/\u00b5L is an indicator of systemic inflammation, making the alignment with the category perfect.",
            "Neutrophil predominance is indicative of infection and systemic inflammation, aligning with the concept of identifying systemic inflammatory response (SIRS) in early sepsis. While not explicitly a SIRS criterion on its own, it suggests elevated WBC could be present, indirectly supporting a SIRS diagnosis. Therefore, the alignment is reasonably strong but not perfect.",
            "Neutrophil predominance indicates a possible bacterial infection and relates to the systemic inflammation that SIRS criteria identify. While it's not explicitly listed like elevated WBC, it aligns with the context of an inflammatory response, reflecting moderate alignment with the SIRS criteria's focus on infection-related systemic inflammation.",
            "The administration of ceftriaxone, an antibiotic, indicates a direct clinical action in response to potential infection and aligns strongly with the category of early antibiotic orders. The prescribing of an antibiotic suggests suspicion of infection, which is central to the sepsis risk assessment criteria in this category.",
            "The claim indicates the administration of ceftriaxone, a broad-spectrum antibiotic, which aligns well with the category of early antibiotic/culture orders. This category highlights early administration of broad-spectrum antibiotics within the first 2 hours as a sign of clinician suspicion of a serious infection. While the timing (\"within 2 hours\") is not specified, the action of administering antibiotics directly relates to the category\u2019s intent of addressing suspected serious infections, resulting in a high alignment rating.",
            "The claim mentions a combination of findings supporting a high risk of sepsis, which is a general and nonspecific statement. An elevated NEWS score reflects the aggregation of various physiological parameters to predict clinical deterioration like sepsis, aligning conceptually with the notion of \"findings\" indicating risk. However, without specific metrics mentioned, the alignment is fairly indirect and hence rated at 0.4."
        ],
        "final_alignment_score": 0.75,
        "accuracy": 1
    },
    {
        "input": "5: HR, 89.0; 5: RR, 26.0; 5: SpO2, 99.422; 5: SBP, 134.0; 5: DBP, 89.0; 5: MAP, 104.0; 5: Temp, 98.0; 6: HR, 82.0; 6: RR, 25.0; 6: SpO2, 100.0; 6: Perf, 1.743; 6: 1min HRV, 8.815; 7: HR, 82.441; 7: RR, 24.983; 7: SpO2, 100.0; 7: Perf, 1.750; 7: 1min HRV, 13.853; 8: HR, 87.914; 8: RR, 19.672; 8: SpO2, 100.0; 8: Perf, 1.710; 8: 1min HRV, 19.853; 9: HR, 87.593; 9: RR, 24.797; 9: SpO2, 100.0; 9: Perf, 1.685; 9: 1min HRV, 11.920; 10: HR, 86.186; 10: RR, 20.915; 10: SpO2, 100.0; 10: Perf, 1.863; 10: 1min HRV, 15.067; 10: 5min HRV, 23.610; 11: HR, 82.586; 11: RR, 28.431; 11: SpO2, 100.0; 11: Perf, 2.261; 11: 1min HRV, 49.671; 12: HR, 84.254; 12: RR, 25.051; 12: SpO2, 100.0; 12: Perf, 2.640; 12: 1min HRV, 23.906; 13: HR, 82.707; 13: RR, 27.845; 13: SpO2, 100.0; 13: Perf, 2.562; 13: 1min HRV, 14.888; 14: HR, 83.051; 14: RR, 23.678; 14: SpO2, 100.0; 14: Perf, 2.033; 14: 1min HRV, 64.432; 15: HR, 81.288; 15: RR, 24.712; 15: SpO2, 100.0; 15: Perf, 1.790; 15: 1min HRV, 14.575; 15: 5min HRV, 40.136; 15: SBP, 127.0; 15: DBP, 77.0; 15: MAP, 93.667; 16: HR, 81.0; 16: RR, 24.5; 16: SpO2, 100.0; 16: Perf, 1.82; 16: 1min HRV, 0.0; 18: POC PH (V) ISTAT, 7.29; 18: POC PO2 (V) ISTAT, 19 mmHg; 18: POC PCO2 (V) ISTAT, 68.2 mmHg; 18: POC LACTATE ISTAT, 0.77 mmol/L; 18: POC HCO3 (V) ISTAT, 33.0 mmol/L; 18: POC TCO2 (V) ISTAT, 35 mmol/L; 18: POC BASE EXCESS ISTAT, 6 mmol/L; 18: POC O2 SATURATION ISTAT VENOUS, 22 %; 20: HR, 83.0; 20: RR, 27.0; 20: SpO2, 100.0; 20: 5min HRV, 0.0; 20: SBP, 132.0; 20: DBP, 77.0; 20: MAP, 95.333; 23: HR, 81.0; 23: RR, 22.0; 23: SpO2, 100.0; 23: SBP, 132.0; 23: DBP, 77.0; 23: MAP, 95.333; 23: LPM O2, 15.0; 24: METHYLPREDNISOLONE SOD SUC(PF), 125 MG/2 ML INJ SOLR; 25: HR:, 85.0; 25: RR, 27.0; 25: SpO2, 100.0; 59: ALBUTEROL SULFATE, 90 MCG/ACTUATION INH HFAA; 66: RR:, 25.0; 66: SpO2, 100.0; 66: LPM O2, 12.0; 80: HR, 81.0; 80: RR, 23.0; 80: SpO2, 100.0; 80: LPM O2, 3.0; 90: INR, 1.1; 90: PROTHROMBIN TIME, 13.6 seconds; 91: PART. THROMBOPLASTIN TIME, 29.2 seconds; 99: WAM DIFTYP, AUTO; 99: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.5 pg; 99: NEUTROPHIL ABSOLUTE (AUTO DIFF), 5.43 K/uL; 99: MEAN CORPUSCULAR VOLUME (MCV), 95.1 fL; 99: RED CELL DISTRIBUTION WIDTH (RDW), 13.6 %; 99: EOSINOPHIL % (AUTO DIFF), 2.0 %; 99: PLATELET COUNT (PLT), 136 K/uL; 99: MONOCYTE ABSOLUTE (AUTO DIFF), 0.87 K/uL; 99: MONOCYTE % (AUTO DIFF), 9.3 %; 99: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 99: HEMOGLOBIN (HGB), 14.2 g/dL; 99: BASOPHIL % (AUTO DIFF), 0.4 %; 99: NEUTROPHIL % (AUTO DIFF), 58.2 %; 99: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.03 K/uL; 99: LYMPHOCYTE % (AUTO DIFF), 29.8 %; 99: WHITE BLOOD CELLS (WBC), 9.3 K/uL; 99: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.78 K/uL; 99: NRBC PERCENT (HEMATOLOGY), 0.0 %; 99: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 99: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.19 K/uL; 99: HEMATOCRIT (HCT), 44.3 %; 99: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.1 g/dL; 99: RED BLOOD CELLS (RBC), 4.66 MIL/uL; 99: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 105: D-DIMER ELISA, 522 ng/mL FEU; 105: HR, 82.0; 105: RR, 20.0; 105: SpO2, 100.0; 105: SBP, 119.0; 105: DBP, 74.0; 105: MAP, 89.0; 105: LPM O2, 3.0; 107: POTASSIUM, 3.9 mmol/L; 107: ALT (SGPT), 23 U/L; 107: BLOOD UREA NITROGEN (BUN), 12 mg/dL; 107: EGFR REFIT WITHOUT RACE (2021), 92 mL/min/1.73 m2; 107: EGFR FOR AFRICAN AMERICAN, 106 mL/min/1.73 m2; 107: GLOBULIN, 2.6 g/dL; 107: ANION GAP, 9 mmol/L; 107: SODIUM, 144 mmol/L; 107: BILIRUBIN TOTAL, 0.6 mg/dL; 107: MAGNESIUM, 2.1 mg/dL; 107: AST (SGOT), 25 U/L; 107: CALCIUM, 9.0 mg/dL; 107: ALBUMIN, 4.4 g/dL; 107: CORRECTED CALCIUM, 8.7 mg/dL; 107: ALKALINE PHOSPHATASE, 65 U/L; 107: CREATININE, 0.88 mg/dL; 107: CHLORIDE, 103 mmol/L; 107: PROTEIN TOTAL, 7.0 g/dL; 107: GLUCOSE, 128 mg/dL; 107: CO2, 32 mmol/L; 107: HR, 70.55; 107: RR, 20.2; 107: SpO2, 98.0; 107: 1min HRV, 16.197; 108: HR, 69.717; 108: RR, 21.483; 108: SpO2, 98.45; 108: Perf, 10.850; 108: 1min HRV, 18.305; 108: SBP, 162.0; 108: DBP, 70.0; 108: MAP, 100.667; 109: HR, 70.741; 109: RR, 23.603; 109: SpO2, 98.0; 109: Perf, 10.095; 109: 1min HRV, 14.727; 110: HR, 70.525; 110: RR, 23.678; 110: SpO2, 97.729; 110: Perf, 10.250; 110: 1min HRV, 18.191; 110: 5min HRV, 17.916; 111: HR, 69.593; 111: RR, 21.678; 111: SpO2, 98.0; 111: Perf, 11.894; 111: 1min HRV, 17.194; 112: HR, 68.845; 112: RR, 22.069; 112: SpO2, 98.172; 112: Perf, 11.066; 112: 1min HRV, 18.784; 113: HR, 68.932; 113: RR, 23.898; 113: SpO2, 98.0; 113: Perf, 11.114; 113: 1min HRV, 17.758; 114: HR, 68.983; 114: RR, 19.983; 114: SpO2, 98.034; 114: Perf, 9.912; 114: 1min HRV, 17.644; 115: HR, 68.881; 115: RR, 21.441; 115: SpO2, 98.0; 115: Perf, 10.051; 115: 1min HRV, 14.015; 115: 5min HRV, 17.415; 116: HR, 67.797; 116: RR, 21.915; 116: SpO2, 97.881; 116: Perf, 10.571; 116: 1min HRV, 19.510; 117: HR, 68.259; 117: RR, 23.586; 117: SpO2, 98.0; 117: Perf, 10.108; 117: 1min HRV, 37.164; 118: HR, 68.525; 118: RR, 23.627; 118: SpO2, 98.0; 118: Perf, 9.978; 118: 1min HRV, 14.901; 119: HR, 68.138; 119: RR, 17.828; 119: SpO2, 98.362; 119: Perf, 9.379; 119: 1min HRV, 11.541; 0: Age, 64; 0: Gender, M; 0: Race, Other; 0: Means of arrival, EMS; 0: Triage Temp, 36.7; 0: Triage HR, 89.0; 0: Triage RR, 26.0; 0: Triage SBP, 134.0; 0: Triage DBP, 89.0; 0: Triage acuity, 2-Emergent; 0: CC, SHORTNESS OF BREATH",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I looked at the patient\u2019s vital signs (heart rate, blood pressure, temperature) and saw that none strongly indicated shock or severe infection. Then, I reviewed lab results (including lactate and white blood cell count) and found no major signs of systemic infection or tissue hypoperfusion. Finally, I compared these findings to standard sepsis criteria, noting an elevated respiratory rate but otherwise stable values and normal lactate, suggesting low likelihood of sepsis development within the next 12 hours.",
        "claims": [
            "The patient's vital signs were assessed, including heart rate, blood pressure, and temperature.",
            "None of the vital signs strongly indicated shock.",
            "None of the vital signs strongly indicated severe infection.",
            "Lab results, including lactate and white blood cell count, were reviewed.",
            "There were no major signs of systemic infection in the lab results.",
            "There were no signs of tissue hypoperfusion in the lab results.",
            "The findings were compared to standard sepsis criteria.",
            "The respiratory rate was elevated.",
            "All other vital signs were stable.",
            "The lactate level was normal.",
            "The findings suggest a low likelihood of sepsis development within the next 12 hours."
        ],
        "relevant_claims": [
            "None of the vital signs strongly indicated shock.",
            "None of the vital signs strongly indicated severe infection.",
            "There were no major signs of systemic infection in the lab results.",
            "The respiratory rate was elevated.",
            "The findings suggest a low likelihood of sepsis development within the next 12 hours."
        ],
        "alignment_scores": [
            0.3,
            0.2,
            0.3,
            0.7,
            0.2
        ],
        "alignment_category": [
            6,
            4,
            2,
            2,
            4
        ],
        "alignment_reasonings": [
            "The claim suggests that vital signs do not strongly indicate shock, which is related to the concept of haemodynamic instability assessed by the shock index. Since none of the vital signs indicated shock, it implies that the shock index might not be elevated, thus providing only a slight relevance to this category. The alignment is weak as the absence of an indication does not strongly relate to the presence of an elevated shock index.",
            "The claim that none of the vital signs strongly indicated severe infection indirectly pertains to the NEWS score, which aggregates deranged vitals to predict deterioration due to sepsis. While no strong vital sign abnormalities suggest a low NEWS, the connection is weak, warranting a low alignment rating.",
            "This claim implies an absence of evidence for systemic inflammation or infection markers. While it doesn't directly reference the SIRS criteria, it indirectly suggests that no conditions (e.g., abnormal temperature, elevated WBCs) necessary to meet SIRS positivity were present. The alignment is weak since it is based on the absence rather than the presence of criteria.",
            "An elevated respiratory rate is directly mentioned in the SIRS criteria (respiratory rate > 20/min). The claim aligns with one aspect of the SIRS Positivity category; however, without additional information on accompanying criteria (such as temperature, heart rate, or WBC count), it does not fully meet the threshold for SIRS positivity. The alignment is strong enough due to its direct relevance to the category but not complete.",
            "The claim indicates a low likelihood of sepsis development, which could imply stable vitals and a low NEWS score. Although it does not provide specific indicators or scores, the inverse relationship between elevated NEWS scores and low sepsis risk aligns conceptually. Thus, the alignment is weak and indirect."
        ],
        "final_alignment_score": 0.33999999999999997,
        "accuracy": 1
    },
    {
        "input": "5: HR, 116.0; 5: RR, 18.0; 5: SpO2, 99.0; 5: SBP, 100.0; 5: DBP, 53.0; 5: MAP, 68.667; 5: Temp, 98.8; 10: Pain, 0.0; 51: SpO2, 97.0; 51: Perf, 4.984; 52: SpO2, 97.089; 52: Perf, 4.915; 53: SpO2, 98.595; 54: SpO2, 96.5; 54: Perf, 4.248; 55: SpO2, 96.102; 55: Perf, 4.384; 55: SBP, 131.0; 55: DBP, 110.0; 55: MAP, 117.0; 56: HR, 131.0; 56: RR, 18.0; 56: SpO2, 94.517; 56: Perf, 4.223; 57: SpO2, 97.086; 57: Perf, 4.379; 58: SpO2, 96.390; 58: Perf, 5.404; 58: SBP, 136.0; 58: DBP, 73.0; 58: MAP, 94.0; 59: SpO2, 96.397; 59: Perf, 5.06; 60: SpO2, 95.729; 60: Perf, 5.474; 61: SpO2, 95.542; 61: Perf, 5.584; 62: SpO2, 94.190; 62: Perf, 6.141; 63: SpO2, 93.339; 63: Perf, 6.243; 64: SpO2, 92.707; 64: Perf, 6.196; 65: SpO2, 92.831; 65: Perf, 5.624; 66: SpO2, 93.655; 66: Perf, 5.275; 67: SpO2, 93.466; 67: Perf, 5.632; 68: SpO2, 92.0; 68: Perf, 5.250; 69: SpO2, 94.483; 69: Perf, 5.079; 70: SpO2, 95.644; 70: Perf, 4.544; 71: WAM DIFTYP, AUTO; 71: MONOCYTE % (AUTO DIFF), 12.4 %; 71: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.17 K/uL; 71: HEMATOCRIT (HCT), 29.4 %; 71: NEUTROPHIL ABSOLUTE (AUTO DIFF), 13.60 K/uL; 71: EOSINOPHIL % (AUTO DIFF), 0.7 %; 71: PLATELET COUNT (PLT), 194 K/uL; 71: MEAN CORPUSCULAR VOLUME (MCV), 90.2 fL; 71: BASOPHIL % (AUTO DIFF), 0.2 %; 71: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.0 %; 71: LYMPHOCYTE % (AUTO DIFF), 7.3 %; 71: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 71: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.13 K/uL; 71: RED CELL DISTRIBUTION WIDTH (RDW), 19.4 %; 71: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 35.0 g/dL; 71: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.27 K/uL; 71: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.6 pg; 71: NRBC PERCENT (HEMATOLOGY), 0.0 %; 71: HEMOGLOBIN (HGB), 10.3 g/dL; 71: MONOCYTE ABSOLUTE (AUTO DIFF), 2.16 K/uL; 71: WHITE BLOOD CELLS (WBC), 17.4 K/uL; 71: RED BLOOD CELLS (RBC), 3.26 MIL/uL; 71: NEUTROPHIL % (AUTO DIFF), 78.4 %; 71: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 71: SpO2, 96.627; 71: Perf, 3.934; 72: HR, 128.0; 72: RR, 15.0; 72: SpO2, 96.948; 72: Perf, 3.796; 72: SBP, 111.0; 72: DBP, 58.0; 72: MAP, 75.667; 73: SpO2, 95.169; 73: Perf, 3.323; 74: SpO2, 95.862; 74: Perf, 3.46; 75: SpO2, 95.949; 75: Perf, 4.404; 76: SpO2, 96.424; 76: Perf, 4.125; 77: SpO2, 95.386; 77: Perf, 4.499; 78: SpO2, 95.847; 78: Perf, 4.029; 79: SpO2, 93.931; 79: Perf, 5.616; 80: SpO2, 93.712; 80: Perf, 5.950; 81: SpO2, 92.576; 81: Perf, 6.079; 82: SpO2, 91.5; 82: Perf, 6.108; 83: SpO2, 91.288; 83: Perf, 5.687; 84: SpO2, 92.759; 84: Perf, 4.941; 85: SpO2, 91.695; 85: Perf, 4.881; 86: SpO2, 94.155; 86: Perf, 4.166; 87: SpO2, 92.356; 87: Perf, 5.018; 88: SpO2, 92.017; 88: Perf, 4.251; 89: SARS-COV-2 RNA, Not Detected; 89: SpO2, 92.678; 89: Perf, 4.758; 90: SpO2, 93.431; 90: Perf, 4.360; 91: SpO2, 93.085; 91: Perf, 4.184; 92: SpO2, 92.138; 92: Perf, 4.353; 93: SpO2, 93.15; 93: Perf, 3.918; 94: SpO2, 92.982; 94: Perf, 4.616; 95: SpO2, 91.458; 95: Perf, 4.198; 96: SpO2, 92.508; 96: Perf, 3.947; 97: SpO2, 95.017; 97: Perf, 2.862; 98: SpO2, 95.172; 98: Perf, 3.838; 99: SpO2, 95.103; 99: Perf, 4.120; 100: SpO2, 95.155; 100: Perf, 3.586; 101: SpO2, 95.847; 101: Perf, 3.316; 102: SpO2, 96.483; 102: Perf, 3.631; 103: SpO2, 96.525; 103: Perf, 4.056; 104: SpO2, 95.339; 104: Perf, 4.778; 105: SpO2, 95.741; 105: Perf, 4.193; 106: SpO2, 95.305; 106: Perf, 4.879; 107: SpO2, 95.390; 107: Perf, 4.927; 108: HIGH SENSITIVITY TROPONIN, 12 ng/L; 108: SpO2, 94.627; 108: Perf, 5.704; 117: HR, 129.0; 117: RR, 17.0; 117: SpO2, 98.0; 117: SBP, 131.0; 117: DBP, 69.0; 117: MAP, 89.667; 119: ALKALINE PHOSPHATASE, 557 U/L; 119: ALBUMIN, 1.9 g/dL; 119: CALCIUM, 7.5 mg/dL; 119: EGFR REFIT WITHOUT RACE (2021), 92 mL/min/1.73 m2; 119: ANION GAP, 13 mmol/L; 119: ALT (SGPT), 63 U/L; 119: BLOOD UREA NITROGEN (BUN), 15 mg/dL; 119: CHLORIDE, 92 mmol/L; 119: POTASSIUM, 4.0 mmol/L; 119: PROTEIN TOTAL, 4.6 g/dL; 119: GLUCOSE, 110 mg/dL; 119: CORRECTED CALCIUM, 9.2 mg/dL; 119: SODIUM, 128 mmol/L; 119: GLOBULIN, 2.7 g/dL; 119: AST (SGOT), 64 U/L; 119: CO2, 23 mmol/L; 119: BILIRUBIN TOTAL, 5.7 mg/dL; 119: CREATININE, 0.72 mg/dL; 119: LIPASE, 48 U/L; 0: Age, 66; 0: Gender, F; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 37.1; 0: Triage HR, 116.0; 0: Triage RR, 18.0; 0: Triage SBP, 100.0; 0: Triage DBP, 53.0; 0: Triage acuity, 2-Emergent; 0: CC, SHORTNESS OF BREATH",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, we check vitals and see tachycardia (HR\u2265116) and borderline hypotension (SBP\u2248100, DBP\u224853). Next, we look at labs that reveal an elevated WBC (17.4) and high bilirubin (5.7), suggesting infection with possible organ dysfunction. Then, we account for the patient\u2019s shortness of breath and continued signs of hemodynamic instability. Putting these findings together, we determine that the patient is at high risk for developing sepsis within 12 hours.",
        "claims": [
            "We check vitals and see tachycardia.",
            "The heart rate (HR) is \u2265116.",
            "We see borderline hypotension.",
            "The systolic blood pressure (SBP) is approximately 100.",
            "The diastolic blood pressure (DBP) is approximately 53.",
            "We look at labs that reveal an elevated white blood cell count (WBC).",
            "The elevated WBC is 17.4.",
            "We find high bilirubin levels.",
            "The bilirubin level is 5.7.",
            "The elevated WBC and high bilirubin suggest infection with possible organ dysfunction.",
            "We account for the patient\u2019s shortness of breath.",
            "The patient shows continued signs of hemodynamic instability.",
            "Putting these findings together, we determine that the patient is at high risk for developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "We check vitals and see tachycardia.",
            "The heart rate (HR) is \u2265116.",
            "We see borderline hypotension.",
            "The systolic blood pressure (SBP) is approximately 100.",
            "The diastolic blood pressure (DBP) is approximately 53.",
            "We look at labs that reveal an elevated white blood cell count (WBC).",
            "The elevated WBC is 17.4.",
            "The elevated WBC and high bilirubin suggest infection with possible organ dysfunction.",
            "We account for the patient\u2019s shortness of breath.",
            "The patient shows continued signs of hemodynamic instability.",
            "Putting these findings together, we determine that the patient is at high risk for developing sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.7,
            0.7,
            0.7,
            0.8,
            0.3,
            1.0,
            1.0,
            0.8,
            0.8,
            0.8,
            0.3
        ],
        "alignment_category": [
            2,
            2,
            7,
            3,
            7,
            2,
            2,
            8,
            3,
            6,
            4
        ],
        "alignment_reasonings": [
            "Tachycardia (elevated heart rate >90 bpm) is one of the criteria listed under SIRS. The claim about checking vitals and observing tachycardia directly aligns with the SIRS criteria used to identify systemic inflammation indicative of early sepsis. However, since the presence of one SIRS criterion alone is insufficient for a positive SIRS diagnosis (requires \u22652), the alignment is strong but not perfect.",
            "The heart rate being \u2265116 bpm exceeds the SIRS criterion of HR >90 bpm, indicating systemic inflammation that is consistent with early sepsis detection. The alignment is strong because the elevated heart rate is explicitly covered under the SIRS criteria, although complete confirmation of SIRS positivity requires at least one additional criterion to be met.",
            "The claim mentions \"borderline hypotension,\" which conceptually relates to hypotension\u2014a key part of category 7. While the claim does not specify whether SBP is <90 mmHg or MAP is <70 mmHg, the term \"borderline\" suggests low blood pressure that could lead to hypotensive states defined in this category. Given the indirectness of the term \"borderline,\" the alignment is moderate but significant.",
            "The claim mentions a systolic blood pressure (SBP) that is approximately 100 mmHg. This aligns with one of the components of the qSOFA score (SBP \u2264 100 mmHg), which indicates a high risk of sepsis-related organ dysfunction and mortality. The connection is strong but not perfect since the exact value for qSOFA is 100 mmHg or less, not \"approximately\" 100. Therefore, the alignment rating is 0.8.",
            "The claim mentions diastolic blood pressure (DBP), which is not directly part of the criteria for sepsis-associated hypotension that focuses on systolic blood pressure (SBP) and mean arterial pressure (MAP). However, a low DBP can imply potential hemodynamic instability. This relationship to hypotension leads to a weak but tangible connection to sepsis risk.",
            "The claim directly mentions an elevated white blood cell count, which is one of the explicit criteria listed under the SIRS (Systemic Inflammatory Response Syndrome) criteria. This is used to identify systemic inflammation consistent with early sepsis. Therefore, there is perfect alignment with this category.",
            "An elevated white blood cell (WBC) count is explicitly listed as one of the SIRS criteria, which are used to identify systemic inflammation consistent with early sepsis. The WBC count of 17.4 is well above the SIRS threshold of >12,000/\u00b5L, indicating a perfect alignment with this category.",
            "The claim references elevated WBC and high bilirubin, which suggests infection and potential organ dysfunction. Elevated bilirubin is explicitly noted as a component of the SOFA score, which helps assess organ dysfunction risk in sepsis. Although WBC elevation is more closely associated with SIRS, the overall concern about organ dysfunction aligns strongly with the SOFA criteria. The alignment is high, but not absolute due to the mixed nature of the indicators, hence a rating of 0.8.",
            "Shortness of breath is indicative of a high respiratory rate, which is directly related to one of the criteria for a qSOFA score (respiratory rate\u202f\u2265\u202f22/min). While shortness of breath itself doesn't confirm a qSOFA score of 2 or more, it is closely aligned, indicating potential for organ dysfunction and sepsis risk. The alignment is strong but indirect, as we do not have the exact rate.",
            "Hemodynamic instability suggests an imbalance in blood flow or pressure, which is characteristic of a high shock index, a predictor of severe sepsis. While the claim doesn\u2019t specify heart rate or blood pressure data needed to calculate the shock index, \u201chemodynamic instability\u201d is most closely aligned with this category. The alignment isn't absolute due to the lack of explicit metrics, hence a slightly lower rating.",
            "The claim talks about the patient being at high risk for developing sepsis, which usually integrates multiple clinical parameters and observations. While the claim itself is vague without specific details, an elevated NEWS score involves multiple deranged vitals leading to deterioration prediction, which aligns conceptually. However, due to the lack of specific vital signs or NEWS score figures in the claim, the alignment rating is moderate."
        ],
        "final_alignment_score": 0.7181818181818181,
        "accuracy": 1
    },
    {
        "input": "2: HR, 84.0; 2: RR, 18.0; 2: SpO2, 100.0; 2: SBP, 149.0; 2: DBP, 90.0; 2: MAP, 109.667; 2: Temp, 97.5; 9: Pain, 7.0; 29: SpO2, 99.615; 29: SBP, 133.0; 29: DBP, 66.0; 29: MAP, 88.333; 30: SpO2, 99.052; 30: Perf, 1.447; 31: SpO2, 99.136; 31: Perf, 1.132; 32: SpO2, 98.864; 32: Perf, 1.162; 33: SpO2, 98.678; 33: Perf, 1.168; 34: SpO2, 98.172; 34: Perf, 1.263; 35: SpO2, 97.729; 35: Perf, 1.112; 36: SpO2, 98.793; 36: Perf, 1.055; 37: SpO2, 99.932; 37: Perf, 2.007; 38: SpO2, 99.475; 38: Perf, 1.981; 39: SpO2, 100.0; 39: Perf, 1.991; 40: SpO2, 100.0; 40: Perf, 2.05; 40: SBP, 134.0; 40: DBP, 64.0; 40: MAP, 87.333; 41: SpO2, 100.0; 41: Perf, 1.834; 42: SpO2, 100.0; 42: Perf, 2.230; 43: SpO2, 100.0; 43: Perf, 2.98; 44: SpO2, 100.0; 44: Perf, 2.706; 45: SpO2, 100.0; 45: Perf, 2.465; 46: SpO2, 100.0; 46: Perf, 1.636; 47: SpO2, 100.0; 47: Perf, 1.171; 48: SpO2, 100.0; 48: Perf, 1.506; 49: SpO2, 100.0; 49: Perf, 1.302; 50: SpO2, 100.0; 50: Perf, 1.425; 51: SpO2, 100.0; 51: Perf, 1.422; 52: SpO2, 100.0; 52: Perf, 1.737; 53: SpO2, 99.949; 53: Perf, 1.718; 54: HR, 89.0; 54: SpO2, 99.776; 54: Perf, 2.102; 54: SBP, 149.0; 54: DBP, 87.0; 54: MAP, 107.667; 55: SpO2, 100.0; 55: Perf, 2.118; 55: SBP, 149.0; 55: DBP, 87.0; 55: MAP, 107.667; 56: SpO2, 99.948; 56: Perf, 1.947; 57: SpO2, 100.0; 57: Perf, 1.568; 58: SpO2, 100.0; 58: Perf, 1.255; 59: SpO2, 100.0; 59: Perf, 1.162; 60: SpO2, 100.0; 60: Perf, 1.636; 61: SpO2, 100.0; 61: Perf, 2.113; 62: SpO2, 100.0; 62: Perf, 2.164; 63: SpO2, 100.0; 63: Perf, 2.545; 64: SpO2, 100.0; 64: Perf, 1.976; 65: SpO2, 100.0; 65: Perf, 2.252; 66: SpO2, 100.0; 66: Perf, 2.494; 67: SpO2, 100.0; 67: Perf, 3.019; 68: SpO2, 100.0; 68: Perf, 2.882; 69: SpO2, 100.0; 69: Perf, 2.967; 70: SpO2, 100.0; 70: Perf, 2.846; 70: SBP, 161.0; 70: DBP, 59.0; 70: MAP, 93.0; 71: SpO2, 100.0; 71: Perf, 3.402; 72: SpO2, 100.0; 72: Perf, 3.417; 73: SpO2, 100.0; 73: Perf, 4.680; 74: SpO2, 100.0; 74: Perf, 4.734; 75: SpO2, 100.0; 75: Perf, 4.657; 76: SpO2, 100.0; 76: Perf, 4.039; 77: SpO2, 100.0; 77: Perf, 5.079; 78: SpO2, 100.0; 78: Perf, 6.706; 79: SpO2, 100.0; 79: Perf, 6.602; 80: SpO2, 100.0; 80: Perf, 2.713; 81: SpO2, 100.0; 81: Perf, 2.343; 82: SpO2, 100.0; 82: Perf, 4.020; 83: SARS-COV-2 RNA, Not Detected; 83: SpO2, 100.0; 83: Perf, 4.951; 84: SpO2, 100.0; 84: Perf, 4.196; 85: SpO2, 100.0; 85: Perf, 3.677; 85: SBP, 143.0; 85: DBP, 68.0; 85: MAP, 93.0; 85: HYDROMORPHONE, 1 MG/ML INJ SYRG; 85: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 86: SpO2, 100.0; 86: Perf, 4.171; 87: SpO2, 100.0; 87: Perf, 4.629; 88: SpO2, 100.0; 88: Perf, 6.049; 89: SpO2, 100.0; 89: Perf, 6.075; 90: HIGH SENSITIVITY TROPONIN, <4 ng/L; 90: SpO2, 100.0; 90: Perf, 5.209; 91: SpO2, 100.0; 91: Perf, 4.779; 92: SpO2, 100.0; 92: Perf, 4.859; 93: SpO2, 100.0; 93: Perf, 6.634; 94: SpO2, 100.0; 94: Perf, 5.851; 95: SpO2, 99.966; 95: Perf, 6.213; 96: SpO2, 99.797; 96: Perf, 5.211; 97: GLOBULIN, 4.5 g/dL; 97: CORRECTED CALCIUM, 9.1 mg/dL; 97: CALCIUM, 8.4 mg/dL; 97: EGFR REFIT WITHOUT RACE (2021), 79 mL/min/1.73 m2; 97: PROTEIN TOTAL, 7.6 g/dL; 97: CREATININE, 0.78 mg/dL; 97: ALT (SGPT), 92 U/L; 97: ALBUMIN, 3.1 g/dL; 97: GLUCOSE, 88 mg/dL; 97: CO2, 24 mmol/L; 97: AST (SGOT), 182 U/L; 97: SODIUM, 139 mmol/L; 97: BLOOD UREA NITROGEN (BUN), 15 mg/dL; 97: ALKALINE PHOSPHATASE, 593 U/L; 97: BILIRUBIN TOTAL, 3.1 mg/dL; 97: POTASSIUM, 3.9 mmol/L; 97: CHLORIDE, 103 mmol/L; 97: ANION GAP, 12 mmol/L; 97: C-REACTIVE PROTEIN (CRP), 2.4 mg/dL; 97: SpO2, 100.0; 97: Perf, 3.267; 98: SpO2, 100.0; 98: Perf, 4.380; 99: HR, 89.0; 99: RR, 17.0; 99: SpO2, 100.0; 99: Perf, 3.140; 99: SBP, 148.0; 99: DBP, 75.0; 99: MAP, 99.333; 100: SpO2, 100.0; 100: Perf, 2.549; 100: SBP, 148.0; 100: DBP, 75.0; 100: MAP, 99.333; 101: SpO2, 100.0; 101: Perf, 2.340; 102: SpO2, 100.0; 102: Perf, 3.034; 103: SpO2, 99.897; 103: Perf, 3.312; 104: SpO2, 100.0; 104: Perf, 3.47; 115: Pain, 4.0; 118: WAM DIFTYP, AUTO; 118: LYMPHOCYTE % (AUTO DIFF), 31.0 %; 118: HEMATOCRIT (HCT), 34.7 %; 118: BASOPHIL % (AUTO DIFF), 1.0 %; 118: PLATELET COUNT (PLT), 65 K/uL; 118: NEUTROPHIL % (AUTO DIFF), 51.8 %; 118: WHITE BLOOD CELLS (WBC), 2.9 K/uL; 118: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 118: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.0 g/dL; 118: MEAN CORPUSCULAR VOLUME (MCV), 97.2 fL; 118: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.1 pg; 118: RED BLOOD CELLS (RBC), 3.57 MIL/uL; 118: NEUTROPHIL ABSOLUTE (AUTO DIFF), 1.50 K/uL; 118: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 118: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 118: NRBC PERCENT (HEMATOLOGY), 0.0 %; 118: HEMOGLOBIN (HGB), 11.1 g/dL; 118: EOSINOPHIL % (AUTO DIFF), 3.8 %; 118: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.90 K/uL; 118: MONOCYTE ABSOLUTE (AUTO DIFF), 0.35 K/uL; 118: RED CELL DISTRIBUTION WIDTH (RDW), 15.2 %; 118: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.01 K/uL; 118: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.11 K/uL; 118: MONOCYTE % (AUTO DIFF), 12.1 %; 0: Age, 78; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.4; 0: Triage HR, 84.0; 0: Triage RR, 18.0; 0: Triage SBP, 149.0; 0: Triage DBP, 90.0; 0: Triage acuity, 3-Urgent; 0: CC, KNEE PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I checked the patient\u2019s vital signs for classic signs of systemic infection or shock (such as fever, tachycardia, or hypotension), and they appear stable (e.g., heart rate around 84-89, MAP well above 65, and temperature near normal). Next, I inspected the lab results for glaring signs of serious infection or organ dysfunction, noting the low white blood cell count and elevated liver enzymes but no clear pattern indicative of acute sepsis. Finally, I considered the overall clinical picture, including the patient\u2019s primary complaint of knee pain and lack of new concerning symptoms, which suggests that sepsis within the next 12 hours is unlikely.",
        "claims": [
            "The patient's vital signs were checked for classic signs of systemic infection or shock.",
            "The patient\u2019s heart rate is around 84-89.",
            "The patient\u2019s mean arterial pressure (MAP) is well above 65.",
            "The patient\u2019s temperature is near normal.",
            "The lab results were inspected for signs of serious infection or organ dysfunction.",
            "The patient has a low white blood cell count.",
            "The patient has elevated liver enzymes.",
            "There is no clear pattern in the lab results indicative of acute sepsis.",
            "The overall clinical picture was considered in the assessment.",
            "The patient\u2019s primary complaint is knee pain.",
            "The patient lacks new concerning symptoms.",
            "The assessment suggests that sepsis within the next 12 hours is unlikely."
        ],
        "relevant_claims": [
            "The patient\u2019s mean arterial pressure (MAP) is well above 65.",
            "There is no clear pattern in the lab results indicative of acute sepsis."
        ],
        "alignment_scores": [
            0.3,
            0.3
        ],
        "alignment_category": [
            7,
            8
        ],
        "alignment_reasonings": [
            "The claim states that the patient's mean arterial pressure (MAP) is well above 65, which indirectly relates to sepsis-associated hypotension as this category involves assessing low MAP (<70 mmHg) to identify risk. However, since the MAP is well above this threshold, the claim does not indicate a risk of hypotension related to sepsis, leading to a low alignment rating.",
            "The claim lacks specific references to any defined sepsis criteria or measurement but suggests an absence of acute clinical signs that could align with worsening organ dysfunction typical in SOFA score increases. Therefore, the correlation is weak and indirect, reflecting merely the lack of new organ dysfunction as could be quantified by a lack of SOFA score increase."
        ],
        "final_alignment_score": 0.3,
        "accuracy": 1
    },
    {
        "input": "8: HR, 112.0; 8: RR, 22.0; 8: SpO2, 92.0; 8: SBP, 120.0; 8: DBP, 73.0; 8: MAP, 88.667; 8: Pain, 10.0; 8: Temp, 102.4; 17: SpO2, 96.0; 17: LPM O2, 2.0; 66: SpO2, 98.478; 67: SpO2, 98.387; 67: SBP, 117.0; 67: DBP, 82.0; 67: MAP, 93.667; 68: SpO2, 98.891; 68: Perf, 0.407; 69: HR, 108.325; 69: RR, 44.0; 69: SpO2, 98.638; 69: Perf, 0.381; 69: 1min HRV, 41.156; 70: HR, 108.559; 70: RR, 45.661; 70: SpO2, 98.915; 70: Perf, 0.297; 70: 1min HRV, 5.363; 70: 5min HRV, 28.514; 71: HR, 108.068; 71: RR, 37.729; 71: SpO2, 98.780; 71: Perf, 0.294; 71: 1min HRV, 13.637; 72: POC PH (V) ISTAT, 7.36; 72: POC TCO2 (V) ISTAT, 23 mmol/L; 72: POC O2 SATURATION ISTAT VENOUS, 19 %; 72: POC PCO2 (V) ISTAT, 38.5 mmHg; 72: POC BASE EXCESS ISTAT, -4 mmol/L; 72: POC HCO3 (V) ISTAT, 21.5 mmol/L; 72: POC LACTATE ISTAT, 1.65 mmol/L; 72: POC PO2 (V) ISTAT, 15 mmHg; 72: HR, 109.293; 72: RR, 37.052; 72: SpO2, 98.310; 72: Perf, 0.303; 72: 1min HRV, 11.081; 73: HR, 108.983; 73: RR, 40.966; 73: SpO2, 98.593; 73: Perf, 0.307; 73: 1min HRV, 6.493; 74: HR, 109.741; 74: RR, 38.379; 74: SpO2, 98.603; 74: Perf, 0.296; 74: 1min HRV, 18.011; 75: HR, 110.949; 75: RR, 37.576; 75: SpO2, 98.475; 75: Perf, 0.286; 75: 1min HRV, 9.440; 75: 5min HRV, 13.032; 76: HR, 109.644; 76: RR, 36.441; 76: SpO2, 97.741; 76: Perf, 0.28; 76: 1min HRV, 7.183; 77: HR, 110.276; 77: RR, 35.690; 77: SpO2, 98.448; 77: Perf, 0.281; 77: 1min HRV, 7.025; 78: HR, 110.237; 78: RR, 43.407; 78: SpO2, 98.525; 78: Perf, 0.269; 78: 1min HRV, 7.783; 79: HR, 111.241; 79: RR, 38.638; 79: SpO2, 98.482; 79: Perf, 0.259; 79: 1min HRV, 10.516; 80: HR, 110.592; 80: RR, 37.695; 80: SpO2, 99.352; 80: Perf, 0.258; 80: 1min HRV, 10.900; 80: 5min HRV, 8.904; 81: HR, 109.362; 81: RR, 39.776; 81: SpO2, 99.583; 81: Perf, 0.230; 81: 1min HRV, 13.018; 81: Pain, 0.0; 82: HR, 110.339; 82: RR, 40.542; 82: SpO2, 99.814; 82: Perf, 0.247; 82: 1min HRV, 8.560; 83: HR, 109.763; 83: RR, 39.017; 83: SpO2, 100.0; 83: Perf, 0.238; 83: 1min HRV, 13.194; 84: HR, 111.088; 84: RR, 36.879; 84: SpO2, 99.878; 84: Perf, 0.246; 84: 1min HRV, 10.999; 85: HR, 113.475; 85: RR, 38.644; 85: SpO2, 99.508; 85: Perf, 0.278; 85: 1min HRV, 9.971; 85: 5min HRV, 12.858; 86: HR, 111.155; 86: RR, 33.845; 86: SpO2, 99.259; 86: Perf, 0.383; 86: 1min HRV, 14.009; 87: HR, 110.508; 87: RR, 41.932; 87: SpO2, 99.254; 87: Perf, 0.294; 87: 1min HRV, 5.862; 88: HR, 111.424; 88: RR, 40.847; 88: SpO2, 98.966; 88: Perf, 0.262; 88: 1min HRV, 4.613; 89: HR, 110.741; 89: RR, 41.483; 89: SpO2, 98.414; 89: Perf, 0.271; 89: 1min HRV, 2.881; 90: HR, 110.458; 90: RR, 40.831; 90: SpO2, 98.322; 90: Perf, 0.288; 90: 1min HRV, 4.093; 90: 5min HRV, 7.499; 91: HR, 111.466; 91: RR, 39.552; 91: SpO2, 98.155; 91: Perf, 0.272; 91: 1min HRV, 4.415; 92: HR, 111.220; 92: RR, 39.102; 92: SpO2, 98.356; 92: Perf, 0.274; 92: 1min HRV, 12.221; 93: HR, 111.627; 93: RR, 39.915; 93: SpO2, 98.966; 93: Perf, 0.280; 93: 1min HRV, 2.886; 94: HR, 111.414; 94: RR, 41.983; 94: SpO2, 99.448; 94: Perf, 0.296; 94: 1min HRV, 2.454; 95: HR, 110.814; 95: RR, 40.644; 95: SpO2, 98.966; 95: Perf, 0.308; 95: 1min HRV, 3.129; 95: 5min HRV, 6.370; 96: HR, 111.224; 96: RR, 39.759; 96: SpO2, 99.483; 96: Perf, 0.332; 96: 1min HRV, 2.579; 97: HR, 110.932; 97: RR, 39.932; 97: SpO2, 99.695; 97: Perf, 0.334; 97: 1min HRV, 49.577; 98: HR, 111.559; 98: RR, 39.983; 98: SpO2, 99.780; 98: Perf, 0.330; 98: 1min HRV, 3.696; 99: HR, 113.172; 99: RR, 42.103; 99: SpO2, 98.707; 99: Perf, 0.323; 99: 1min HRV, 5.145; 99: PIPERACILLIN-TAZOBACTAM-DEXTRS, 3.375 GRAM/50 ML IV PGBK; 100: HR:, 112.746; 100: RR, 43.661; 100: SpO2, 99.102; 100: Perf, 0.328; 100: 1min HRV, 6.513; 100: 5min HRV, 23.550; 101: HR, 114.190; 101: RR, 41.603; 101: SpO2, 99.190; 101: Perf, 0.33; 101: 1min HRV, 5.972; 102: HR, 114.695; 102: RR, 41.492; 102: SpO2, 98.552; 102: Perf, 0.33; 102: 1min HRV, 11.769; 103: HR, 114.373; 103: RR, 44.847; 103: SpO2, 99.843; 103: Perf, 0.338; 103: 1min HRV, 10.364; 104: HR, 114.310; 104: RR, 42.603; 104: SpO2, 99.862; 104: Perf, 0.327; 104: 1min HRV, 8.266; 105: INR, 1.3; 105: PROTHROMBIN TIME, 16.5 seconds; 105: HR, 114.186; 105: RR, 38.407; 105: SpO2, 99.169; 105: Perf, 0.3; 105: 1min HRV, 13.973; 105: 5min HRV, 10.070; 106: PART. THROMBOPLASTIN TIME, 34.9 seconds; 106: HR, 113.776; 106: RR, 42.138; 106: SpO2, 99.172; 106: Perf, 0.3; 106: 1min HRV, 7.621; 107: HR, 112.085; 107: RR, 39.305; 107: SpO2, 98.746; 107: Perf, 0.306; 107: 1min HRV, 54.041; 108: HR, 113.746; 108: RR, 41.508; 108: SpO2, 99.169; 108: Perf, 0.313; 108: 1min HRV, 54.108; 109: HR, 111.966; 109: RR, 40.017; 109: SpO2, 99.143; 109: Perf, 0.32; 109: 1min HRV, 9.468; 110: HR, 113.746; 110: RR, 39.746; 110: SpO2, 98.562; 110: Perf, 0.318; 110: 1min HRV, 4.468; 110: 5min HRV, 35.284; 111: HR, 113.897; 111: RR, 42.293; 111: SpO2, 99.103; 111: Perf, 0.327; 111: 1min HRV, 4.217; 112: HR, 112.932; 112: RR, 42.305; 112: SpO2, 98.831; 112: Perf, 0.343; 112: 1min HRV, 4.204; 113: HR, 112.207; 113: RR, 41.569; 113: SpO2, 99.466; 113: Perf, 0.396; 113: 1min HRV, 5.945; 114: HR, 112.831; 114: RR, 41.407; 114: SpO2, 99.305; 114: Perf, 0.383; 114: 1min HRV, 3.358; 115: HR, 113.017; 115: RR, 42.136; 115: SpO2, 99.475; 115: Perf, 0.405; 115: 1min HRV, 6.819; 115: 5min HRV, 5.540; 116: HR, 112.155; 116: RR, 41.862; 116: SpO2, 99.569; 116: Perf, 0.380; 116: 1min HRV, 3.962; 117: HR, 112.797; 117: RR, 42.576; 117: SpO2, 99.847; 117: Perf, 0.382; 117: 1min HRV, 2.799; 118: HR, 112.224; 118: RR, 41.310; 118: SpO2, 99.517; 118: Perf, 0.397; 118: 1min HRV, 4.919; 119: HR, 112.254; 119: RR, 44.492; 119: SpO2, 99.593; 119: Perf, 0.429; 119: 1min HRV, 2.948; 0: Age, 75; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 39.1; 0: Triage HR, 112.0; 0: Triage RR, 22.0; 0: Triage SBP, 120.0; 0: Triage DBP, 73.0; 0: Triage acuity, 2-Emergent; 0: CC, FATIGUE",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, we check if the patient's vital signs meet SIRS criteria, which they do (fever above 38\u00b0C, heart rate above 90 bpm, and respiratory rate above 20 breaths/min). Next, we confirm signs of possible infection, noting that broad-spectrum antibiotics have been administered. Finally, the patient\u2019s advanced age and high acuity triage further increase the likelihood of sepsis, indicating a \u201cYes\u201d label.",
        "claims": [
            "The patient's vital signs meet SIRS criteria.",
            "The SIRS criteria include a fever above 38\u00b0C.",
            "The SIRS criteria include a heart rate above 90 bpm.",
            "The SIRS criteria include a respiratory rate above 20 breaths/min.",
            "Signs of possible infection are confirmed.",
            "Broad-spectrum antibiotics have been administered to the patient.",
            "The patient\u2019s advanced age increases the likelihood of sepsis.",
            "The patient is categorized as having high acuity triage.",
            "The combination of factors indicates a \u201cYes\u201d label for the likelihood of sepsis."
        ],
        "relevant_claims": [
            "The patient's vital signs meet SIRS criteria.",
            "The SIRS criteria include a fever above 38\u00b0C.",
            "The SIRS criteria include a heart rate above 90 bpm.",
            "The SIRS criteria include a respiratory rate above 20 breaths/min.",
            "Signs of possible infection are confirmed.",
            "Broad-spectrum antibiotics have been administered to the patient.",
            "The patient\u2019s advanced age increases the likelihood of sepsis.",
            "The patient is categorized as having high acuity triage.",
            "The combination of factors indicates a \u201cYes\u201d label for the likelihood of sepsis."
        ],
        "alignment_scores": [
            1.0,
            1.0,
            0.9,
            1.0,
            0.6,
            1.0,
            1.0,
            0.7,
            0.3
        ],
        "alignment_category": [
            2,
            2,
            2,
            2,
            9,
            9,
            1,
            4,
            4
        ],
        "alignment_reasonings": [
            "The claim explicitly states that the patient's vital signs meet the SIRS criteria, which are used to identify systemic inflammation consistent with early sepsis. This directly aligns with the description of the SIRS Positivity category, leading to a perfect alignment rating.",
            "The claim directly references one of the specific conditions listed under the SIRS criteria, which are used to identify systemic inflammation consistent with early sepsis. The mention of fever above 38\u00b0C is precisely aligned with the SIRS criteria definition.",
            "The claim directly references one of the SIRS criteria",
            "The claim directly cites one of the SIRS criteria (respiratory rate >20 breaths/min), which identifies systemic inflammation associated with early sepsis. This is a precise and complete alignment with the category.",
            "The claim indicates the confirmation of possible infection, which aligns with the suspicion of a serious infection\u2014a reason to consider early antibiotics or cultures. However, without specific mention of clinical actions, the alignment is not complete, resulting in a moderate alignment rating.",
            "The administration of broad-spectrum antibiotics is directly indicative of clinician suspicion of a serious infection, which is exactly what this category addresses. There is perfect alignment between the claim and the category, as the claim involves a concrete clinical action associated with sepsis risk assessment.",
            "The claim directly references advanced age as increasing the likelihood of sepsis. This aligns perfectly with the \"Elderly Susceptibility\" category, which considers advanced age (\u226565 years) as a significant risk factor for sepsis progression and higher mortality.",
            "\"High acuity triage\" suggests that the patient's condition is considered urgent or severe, which often correlates with a high NEWS score. The NEWS score is a tool to assess clinical acuity, and a higher score indicates a need for urgent medical intervention due to potential clinical deterioration, such as that seen in sepsis. While not a perfect match, the concept of high acuity aligns reasonably well with an elevated NEWS score.",
            "The claim refers to a combination of factors leading to a positive sepsis prediction, which could align with a scoring system like the NEWS, designed to evaluate multiple vital signs and their deviations. However, the claim does not specify which factors are involved, making the alignment speculative and weak. Hence, the alignment rating reflects minor relevance due to a lack of detailed correspondence."
        ],
        "final_alignment_score": 0.8333333333333333,
        "accuracy": 1
    },
    {
        "input": "6: HR, 118.0; 6: RR, 22.0; 6: SpO2, 100.0; 6: SBP, 132.0; 6: DBP, 94.0; 6: MAP, 106.667; 6: Pain, 5.0; 6: Temp, 98.1; 43: METOCLOPRAMIDE HCL, 5 MG/ML INJ SOLN; 52: SpO, 2: 95.903; 53: SpO2, 100.0; 53: SBP, 144.0; 53: DBP, 114.0; 53: MAP, 124.0; 54: SpO2, 100.0; 54: Perf, 0.382; 55: SpO2, 100.0; 55: Perf, 0.570; 56: SpO2, 100.0; 56: Perf, 1.475; 56: LR IV BOLUS -, 1000 ML; 57: SpO, 2: 99.898; 57: Perf, 1.808; 57: Pain, 0.0; 58: SpO2, 99.707; 58: Perf, 1.647; 59: SpO2, 100.0; 59: Perf, 1.412; 60: SpO2, 100.0; 60: Perf, 1.091; 61: SpO2, 100.0; 61: Perf, 0.924; 61: SBP, 125.0; 61: DBP, nan; 61: MAP, nan; 62: HR, 87.0; 62: RR, 18.0; 62: SpO2, 100.0; 62: Perf, 0.791; 62: SBP, 133.0; 62: DBP, 92.0; 62: MAP, 105.667; 62: Pain, 5.0; 63: SpO2, 100.0; 63: Perf, 0.720; 63: SBP, 133.0; 63: DBP, 92.0; 63: MAP, 105.667; 64: SARS-COV-2 RNA, Not Detected; 64: SpO2, 99.690; 64: Perf, 0.582; 65: SpO2, 99.897; 65: Perf, 0.660; 66: POC PH (V) ISTAT, 7.43; 66: POC LACTATE ISTAT, 2.70 mmol/L; 66: POC O2 SATURATION ISTAT VENOUS, 55 %; 66: POC PO2 (V) ISTAT, 28 mmHg; 66: POC HCO3 (V) ISTAT, 23.1 mmol/L; 66: POC TCO2 (V) ISTAT, 24 mmol/L; 66: POC PCO2 (V) ISTAT, 35.1 mmHg; 66: POC BASE EXCESS ISTAT, -1 mmol/L; 66: SpO2, 99.915; 66: Perf, 0.674; 67: SpO2, 100.0; 67: Perf, 0.690; 68: SpO2, 99.879; 68: Perf, 0.710; 69: SpO2, 100.0; 69: Perf, 0.765; 70: SpO2, 99.878; 70: Perf, 0.725; 71: SpO2, 99.830; 71: Perf, 0.598; 72: WAM DIFTYP, AUTO; 72: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 72: NEUTROPHIL % (AUTO DIFF), 83.7 %; 72: RED CELL DISTRIBUTION WIDTH (RDW), 12.3 %; 72: MONOCYTE % (AUTO DIFF), 4.1 %; 72: NRBC PERCENT (HEMATOLOGY), 0.0 %; 72: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.05 K/uL; 72: RED BLOOD CELLS (RBC), 4.89 MIL/uL; 72: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 72: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 72: HEMATOCRIT (HCT), 42.2 %; 72: NEUTROPHIL ABSOLUTE (AUTO DIFF), 9.84 K/uL; 72: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.7 pg; 72: PLATELET COUNT (PLT), 323 K/uL; 72: EOSINOPHIL % (AUTO DIFF), 0.1 %; 72: MONOCYTE ABSOLUTE (AUTO DIFF), 0.48 K/uL; 72: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 72: MEAN CORPUSCULAR VOLUME (MCV), 86.3 fL; 72: BASOPHIL % (AUTO DIFF), 0.3 %; 72: WHITE BLOOD CELLS (WBC), 11.8 K/uL; 72: LYMPHOCYTE % (AUTO DIFF), 11.4 %; 72: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.34 K/uL; 72: HEMOGLOBIN (HGB), 14.5 g/dL; 72: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.4 g/dL; 72: SpO2, 100.0; 72: Perf, 0.590; 73: SpO2, 100.0; 73: Perf, 0.597; 74: SpO2, 100.0; 74: Perf, 0.607; 75: SpO2, 100.0; 75: Perf, 0.565; 76: SpO2, 100.0; 76: Perf, 0.524; 77: SpO2, 100.0; 77: Perf, 0.508; 78: SpO2, 100.0; 78: Perf, 0.520; 78: SBP, 114.0; 78: DBP, 75.0; 78: MAP, 88.0; 79: SpO2, 100.0; 79: Perf, 0.482; 80: SpO2, 100.0; 80: Perf, 0.443; 81: SpO2, 100.0; 81: Perf, 0.402; 82: HR, 100.0; 82: RR, 17.0; 82: SpO2, 100.0; 82: Perf, 0.384; 82: SBP, 114.0; 82: DBP, 75.0; 82: MAP, 88.0; 82: Pain, 5.0; 82: ACETAMINOPHEN, 500 MG PO TABS; 83: SpO, 2: 100.0; 83: Perf, 0.38; 84: SpO2, 100.0; 84: Perf, 0.38; 85: SpO2, 100.0; 85: Perf, 0.389; 86: Perf, 0.39; 87: SpO2, 100.0; 87: Perf, 0.39; 88: SpO2, 100.0; 88: Perf, 0.39; 89: Perf, 0.39; 90: Perf, 0.396; 91: Perf, 0.401; 92: SpO2, 100.0; 92: Perf, 0.375; 93: SpO2, 100.0; 93: Perf, 0.38; 93: SBP, 133.0; 93: DBP, 91.0; 93: MAP, 105.0; 94: SpO2, 100.0; 94: Perf, 0.384; 95: SpO2, 100.0; 95: Perf, 0.397; 96: SpO2, 100.0; 96: Perf, 0.4; 97: SpO2, 100.0; 97: Perf, 0.392; 98: SpO2, 100.0; 98: Perf, 0.361; 99: ALT (SGPT), 17 U/L; 99: BLOOD UREA NITROGEN (BUN), 11 mg/dL; 99: SODIUM, 137 mmol/L; 99: CHLORIDE, 102 mmol/L; 99: AST (SGOT), 19 U/L; 99: BILIRUBIN TOTAL, 0.6 mg/dL; 99: GLUCOSE, 110 mg/dL; 99: CREATININE, 0.61 mg/dL; 99: CO2, 21 mmol/L; 99: ANION GAP, 14 mmol/L; 99: ALBUMIN, 4.3 g/dL; 99: POTASSIUM, 3.9 mmol/L; 99: GLOBULIN, 3.0 g/dL; 99: EGFR REFIT WITHOUT RACE (2021), 127 mL/min/1.73 m2; 99: CORRECTED CALCIUM, 9.0 mg/dL; 99: CALCIUM, 9.2 mg/dL; 99: EGFR FOR AFRICAN AMERICAN, 147 mL/min/1.73 m2; 99: PROTEIN TOTAL, 7.3 g/dL; 99: ALKALINE PHOSPHATASE, 57 U/L; 99: MAGNESIUM, 1.9 mg/dL; 99: SpO2, 100.0; 99: Perf, 0.359; 100: SpO2, 100.0; 100: Perf, 0.337; 101: SpO2, 100.0; 101: Perf, 0.28; 102: SpO2, 100.0; 102: Perf, 0.252; 103: SpO2, 100.0; 103: Perf, 0.26; 104: Perf, 0.26; 105: Perf, 0.26; 106: Perf, 0.26; 107: SpO2, 97.575; 107: Perf, 0.391; 108: SpO2, 100.0; 108: Perf, 0.39; 108: SBP, 115.0; 108: DBP, 70.0; 108: MAP, 85.0; 108: LR IV BOLUS -, 1000 ML; 109: SpO, 2: 100.0; 109: Perf, 0.398; 110: SpO2, 100.0; 110: Perf, 0.407; 111: SpO2, 100.0; 111: Perf, 0.396; 112: HR, 85.0; 112: RR, 16.0; 112: SpO2, 100.0; 112: Perf, 0.473; 112: SBP, 115.0; 112: DBP, 70.0; 112: MAP, 85.0; 112: Pain, 3.0; 113: SpO2, 100.0; 113: Perf, 0.453; 114: SpO2, 100.0; 114: Perf, 0.429; 115: SpO2, 100.0; 115: Perf, 0.413; 116: SpO2, 100.0; 116: Perf, 0.377; 117: SpO2, 100.0; 117: Perf, 0.364; 118: BETA HCG, 50897 mIU/mL; 118: SpO2, 100.0; 118: Perf, 0.364; 119: SpO2, 100.0; 119: Perf, 0.559; 0: Age, 26; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 118.0; 0: Triage RR, 22.0; 0: Triage SBP, 132.0; 0: Triage DBP, 94.0; 0: Triage acuity, 3-Urgent; 0: CC, EMESIS,HEADACHE",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I checked whether the initial vital signs and labs suggest systemic infection (e.g., abnormal temperature, elevated HR, or elevated WBC). Next, I looked for signs of organ dysfunction or hypotension to indicate severe infection or sepsis. Then, I noted the lactate level and vital trends to see if there was a concerning rise suggesting poor perfusion. Finally, I confirmed that the patient\u2019s pressures, labs, and clinical presentation remained stable over time. Based on these observations, the patient is not at high risk of sepsis within the next 12 hours.",
        "claims": [
            "The initial vital signs and labs were checked for signs of systemic infection.",
            "Abnormal temperature, elevated heart rate, or elevated white blood cell count suggest systemic infection.",
            "Signs of organ dysfunction or hypotension were looked for to indicate severe infection or sepsis.",
            "The lactate level and vital trends were noted to assess for a concerning rise suggesting poor perfusion.",
            "The patient's pressures, labs, and clinical presentation were confirmed to remain stable over time.",
            "Based on these observations, the patient is not at high risk of sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The initial vital signs and labs were checked for signs of systemic infection.",
            "Abnormal temperature, elevated heart rate, or elevated white blood cell count suggest systemic infection.",
            "Signs of organ dysfunction or hypotension were looked for to indicate severe infection or sepsis.",
            "The lactate level and vital trends were noted to assess for a concerning rise suggesting poor perfusion."
        ],
        "alignment_scores": [
            0.3,
            1.0,
            0.8,
            0.7
        ],
        "alignment_category": [
            9,
            2,
            8,
            5
        ],
        "alignment_reasonings": [
            "The claim mentions checking vital signs and labs for systemic infection, suggesting initial evaluation for possible sepsis. However, it does not specifically mention ordering antibiotics or cultures, which are more direct indicators of clinician suspicion of serious infection as per this category. Hence, the alignment is only somewhat relevant.",
            "The claim references abnormal temperature, elevated heart rate, and elevated white blood cell count, which are specific criteria listed under SIRS. The presence of any two of these indicators confirms systemic inflammation consistent with early sepsis, making the alignment with the SIRS Positivity category direct and strong.",
            "The claim mentions \"signs of organ dysfunction,\" which directly aligns with the SOFA score\u2014a metric used to evaluate organ dysfunction. Although the claim does not provide specifics on which SOFA components are affected, the search for organ dysfunction is closely related. The mention of \"hypotension\" also suggests some relevance to Category 7 (\"Sepsis-Associated Hypotension\"), but since the focus is on signs indicative of infection or sepsis through organ function assessment, Category 8 is the better fit. The absence of explicit SOFA score criteria limits the alignment to 0.8 rather than a perfect score.",
            "The claim references assessing lactate levels and vital signs to check for poor perfusion, which is directly related to the measurement of serum lactate levels. Elevated serum lactate is indicative of tissue hypoperfusion, making it relevant to this category. However, because the claim does not specify an exact lactate level or provide concrete measurements, the alignment is strong but not complete, thus the score of 0.7."
        ],
        "final_alignment_score": 0.7,
        "accuracy": 1
    },
    {
        "input": "5: HR, 104.0; 5: RR, 18.0; 5: SpO2, 98.0; 5: SBP, 126.0; 5: DBP, 78.0; 5: MAP, 94.0; 5: Pain, 7.0; 5: Temp, 99.9; 18: SBP, 126.0; 18: DBP, 86.0; 18: MAP, 99.333; 20: HR, 129.333; 20: 1min HRV, 10.333; 21: HR, 124.169; 21: RR, 20.098; 21: SpO2, 99.711; 21: 1min HRV, 33.530; 22: HR, 122.707; 22: RR, 11.466; 22: SpO2, 98.571; 22: 1min HRV, 17.122; 23: HR, 122.085; 23: RR, 14.085; 23: SpO2, 97.219; 23: 1min HRV, 24.052; 24: HR, 117.914; 24: RR, 17.724; 24: SpO2, 100.0; 24: 1min HRV, 21.285; 24: 5min HRV, 25.823; 25: HR, 122.220; 25: RR, 16.627; 25: SpO2, 99.808; 25: Perf, 0.192; 25: 1min HRV, 24.577; 25: SBP, 116.0; 25: DBP, 78.0; 25: MAP, 90.667; 26: HR, 117.746; 26: RR, 18.153; 26: SpO2, 99.679; 26: Perf, 0.206; 26: 1min HRV, 20.401; 27: HR, 124.672; 27: RR, 26.879; 27: SpO2, 99.552; 27: Perf, 0.2; 27: 1min HRV, 26.780; 28: HR, 123.627; 28: RR, 25.542; 28: SpO2, 96.894; 28: Perf, 0.2; 28: 1min HRV, 23.114; 29: HR, 123.052; 29: RR, 20.724; 29: SpO2, 99.707; 29: 1min HRV, 29.700; 29: 5min HRV, 26.483; 30: HR, 124.593; 30: RR, 16.186; 30: SpO2, 99.949; 30: 1min HRV, 22.922; 31: HR, 125.559; 31: RR, 19.305; 31: SpO2, 99.909; 31: 1min HRV, 28.814; 32: HR, 129.931; 32: RR, 28.155; 32: SpO2, 99.875; 32: Perf, 0.214; 32: 1min HRV, 28.843; 33: HR, 129.712; 33: RR, 26.254; 33: SpO2, 99.947; 33: Perf, 0.22; 33: 1min HRV, 25.706; 34: HR, 146.724; 34: RR, 30.155; 34: Perf, 0.22; 34: 1min HRV, 32.094; 34: 5min HRV, 35.024; 35: HR, 133.554; 35: RR, 27.847; 35: 1min HRV, 32.280; 36: HR, 123.441; 36: RR, 15.797; 36: 1min HRV, 35.801; 37: HR, 128.879; 37: RR, 24.828; 37: 1min HRV, 28.475; 38: HR, 132.051; 38: RR, 20.542; 38: 1min HRV, 16.376; 39: HR, 128.603; 39: RR, 20.069; 39: 1min HRV, 16.487; 39: 5min HRV, 30.643; 40: HR, 128.610; 40: RR, 16.712; 40: 1min HRV, 15.154; 40: SBP, 107.0; 40: DBP, 84.0; 40: MAP, 91.667; 41: HR, 121.483; 41: RR, 21.397; 41: 1min HRV, 19.597; 42: HR, 124.068; 42: RR, 20.373; 42: 1min HRV, 22.711; 43: HR, 116.780; 43: RR, 21.153; 43: 1min HRV, 16.104; 44: HR, 116.379; 44: RR, 19.914; 44: 1min HRV, 15.746; 44: 5min HRV, 25.775; 45: HR, 114.356; 45: RR, 20.746; 45: 1min HRV, 14.980; 46: HR, 113.724; 46: RR, 20.293; 46: 1min HRV, 22.211; 47: HR, 111.797; 47: RR, 21.017; 47: 1min HRV, 12.082; 48: HR, 111.288; 48: RR, 19.559; 48: 1min HRV, 19.268; 49: HR, 109.017; 49: RR, 18.345; 49: 1min HRV, 23.235; 49: 5min HRV, 20.667; 50: HR, 110.898; 50: RR, 18.576; 50: 1min HRV, 14.002; 51: HR, 115.966; 51: RR, 16.397; 51: 1min HRV, 18.354; 52: HR, 113.254; 52: RR, 19.898; 52: 1min HRV, 30.575; 53: HR, 111.898; 53: RR, 24.644; 53: 1min HRV, 22.842; 54: HR, 111.172; 54: RR, 23.534; 54: 1min HRV, 20.992; 54: 5min HRV, 24.145; 55: HR, 111.644; 55: RR, 17.237; 55: 1min HRV, 16.907; 56: HR, 115.121; 56: RR, 21.845; 56: 1min HRV, 29.425; 57: HR, 113.305; 57: RR, 19.746; 57: 1min HRV, 21.649; 58: HR, 116.712; 58: RR, 24.169; 58: 1min HRV, 28.961; 59: HR, 112.948; 59: RR, 21.069; 59: 1min HRV, 33.231; 59: 5min HRV, 27.756; 60: HR, 112.576; 60: RR, 22.441; 60: 1min HRV, 27.150; 61: HR, 114.328; 61: RR, 18.259; 61: 1min HRV, 29.118; 62: HR, 107.780; 62: RR, 18.492; 62: 1min HRV, 21.263; 63: HR, 105.661; 63: RR, 17.847; 63: 1min HRV, 15.294; 64: HR, 107.259; 64: RR, 17.793; 64: 1min HRV, 17.259; 64: 5min HRV, 29.527; 65: HR, 103.119; 65: RR, 20.339; 65: 1min HRV, 13.472; 66: HR, 104.931; 66: RR, 18.5; 66: 1min HRV, 11.080; 67: HR, 105.661; 67: RR, 19.186; 67: 1min HRV, 11.420; 68: HR, 104.678; 68: RR, 19.373; 68: 1min HRV, 12.364; 69: HR, 104.5; 69: RR, 17.828; 69: 1min HRV, 12.741; 69: 5min HRV, 13.261; 70: HR, 103.593; 70: RR, 16.898; 70: 1min HRV, 15.759; 71: HR, 103.172; 71: RR, 19.5; 71: 1min HRV, 18.602; 72: HR, 103.0; 72: RR, 18.203; 72: 1min HRV, 23.638; 73: HR, 102.190; 73: RR, 15.741; 73: 1min HRV, 18.132; 74: HR, 102.305; 74: RR, 20.254; 74: 1min HRV, 32.681; 74: 5min HRV, 23.049; 75: HR, 101.475; 75: RR, 16.881; 75: 1min HRV, 21.624; 76: HR, 100.534; 76: RR, 19.810; 76: 1min HRV, 16.212; 77: HR, 100.017; 77: RR, 17.949; 77: 1min HRV, 17.357; 78: HR, 102.121; 78: RR, 18.190; 78: 1min HRV, 13.711; 79: HR, 99.153; 79: RR, 17.661; 79: 1min HRV, 17.442; 79: 5min HRV, 18.412; 80: HR, 99.102; 80: RR, 18.763; 80: 1min HRV, 14.854; 81: HR, 97.5; 81: RR, 20.966; 81: 1min HRV, 12.589; 82: HR, 98.814; 82: RR, 18.475; 82: 1min HRV, 18.978; 83: HR, 96.672; 83: RR, 19.0; 83: 1min HRV, 13.628; 84: HR, 101.678; 84: RR, 21.288; 84: 1min HRV, 22.110; 84: 5min HRV, 20.979; 85: HR, 102.508; 85: RR, 20.085; 85: 1min HRV, 18.928; 85: LR IV BOLUS -, 1000 ML; 86: SARS-COV-, 2 RNA: Not Detected; 86: HR, 102.397; 86: RR, 17.707; 86: 1min HRV, 24.139; 87: HR, 101.610; 87: RR, 19.661; 87: 1min HRV, 30.701; 88: HR, 110.259; 88: RR, 19.207; 88: 1min HRV, 29.053; 89: HR, 115.8; 89: RR, 19.870; 89: 1min HRV, 31.107; 89: 5min HRV, 35.486; 0: Age, 25; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 37.7; 0: Triage HR, 104.0; 0: Triage RR, 18.0; 0: Triage SBP, 126.0; 0: Triage DBP, 78.0; 0: Triage acuity, 3-Urgent; 0: CC, FEVER,FEMALE GENITAL PROBLEM",
        "answer": false,
        "llm_answer": "Yes",
        "llm_explanation": "First, we check for signs of possible infection based on the chief complaints and mild fever. Next, we review whether the patient meets criteria for concerning vitals, noting repeated tachycardia (HR above 120 and at times exceeding 140) and elevated respiratory rates (frequently above 20). Then, we consider that fluid bolus administration indicates clinical concern for hemodynamic instability. Putting these findings together points to a high likelihood of developing sepsis within 12 hours.",
        "claims": [
            "Signs of possible infection are checked based on the chief complaints and mild fever.",
            "The patient meets criteria for concerning vitals.",
            "Repeated tachycardia is noted, with heart rate (HR) above 120 and at times exceeding 140.",
            "Elevated respiratory rates are frequently observed, often above 20.",
            "Fluid bolus administration indicates clinical concern for hemodynamic instability.",
            "The combination of these findings points to a high likelihood of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "Signs of possible infection are checked based on the chief complaints and mild fever.",
            "The patient meets criteria for concerning vitals.",
            "Repeated tachycardia is noted, with heart rate (HR) above 120 and at times exceeding 140.",
            "Elevated respiratory rates are frequently observed, often above 20.",
            "Fluid bolus administration indicates clinical concern for hemodynamic instability.",
            "The combination of these findings points to a high likelihood of developing sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.3,
            0.7,
            0.9,
            0.9,
            0.7,
            0.6
        ],
        "alignment_category": [
            9,
            4,
            2,
            2,
            6,
            4
        ],
        "alignment_reasonings": [
            "The claim refers to checking for signs of infection based on symptoms and mild fever, indicating an initial investigation phase without specific clinical actions like ordering antibiotics or cultures, which is the criterion for this category. Alignment is weak since it focuses more on observation than concrete actions indicative of heightened sepsis risk.",
            "The claim refers to concerning vitals, which indicates a general area of risk assessment. The Elevated NEWS Score is specifically derived from deranged vital signs and is directly tied to predicting clinical deterioration relevant to sepsis. Although the claim doesn't specify the NEWS score or its components, the connection to vitals suggests a focused alignment with this category due to its use of vital signs as indicators for sepsis risk. However, the lack of specific details slightly reduces the alignment rating.",
            "The claim highlights repeated tachycardia, with heart rate frequently above 120 bpm, which exceeds the SIRS criterion of heart rate >90 bpm. This criterion is part of SIRS positivity, which identifies systemic inflammation and potential early sepsis. The frequent elevated heart rate aligns well with the criteria, though not addressing other SIRS factors. Therefore, the alignment rating is very strong but not perfect.",
            "The claim mentions an elevated respiratory rate, specifically noted as frequently being above 20. This directly relates to the SIRS criteria, where a respiratory rate >20/min is one of the indicators of systemic inflammation and possible early sepsis. Although the claim does not indicate other SIRS criteria, the reference to elevated respiratory rates aligns strongly with the category. The alignment rating is high because one specific SIRS criterion is clearly met.",
            "The administration of a fluid bolus typically signifies a response to hemodynamic instability, which correlates with the concept of an elevated shock index. While the claim doesn\u2019t provide specific values for heart rate or blood pressure, suggesting an elevated shock index, the alignment with addressing hemodynamic instability is strong but not entirely direct without precise measurements.",
            "The claim regarding a high likelihood of developing sepsis generally aligns with the idea that certain aggregate findings, like those contributing to an Elevated NEWS Score, can predict imminent clinical deterioration compatible with sepsis. The claim is non-specific and doesn't reference any particular clinical finding or numerical threshold, making the alignment moderate but not definitive."
        ],
        "final_alignment_score": 0.6833333333333332,
        "accuracy": 0
    },
    {
        "input": "7: HR, 100.0; 7: RR, 16.0; 7: SpO2, 93.364; 7: Pain, 10.0; 7: Temp, 97.5; 8: SpO2, 96.0; 9: HR, 97.714; 9: 1min HRV, 46.887; 9: 5min HRV, 46.887; 9: SBP, 80.0; 9: DBP, 56.0; 9: MAP, 64.0; 10: HR, 99.339; 10: 1min HRV, 38.734; 11: HR, 98.414; 11: SpO2, 98.476; 11: 1min HRV, 37.015; 12: HR, 97.763; 12: 1min HRV, 37.484; 13: HR, 97.458; 13: SpO2, 100.0; 13: Perf, 0.11; 13: 1min HRV, 27.611; 14: HR, 97.018; 14: SpO2, 100.0; 14: Perf, 0.11; 14: 1min HRV, 22.578; 14: 5min HRV, 33.647; 15: HR, 97.034; 15: 1min HRV, 29.255; 16: HR, 95.672; 16: 1min HRV, 29.521; 17: HR, 94.644; 17: SpO2, 95.667; 17: 1min HRV, 20.008; 18: HR, 97.034; 18: SpO2, 97.474; 18: 1min HRV, 39.668; 19: HR, 95.75; 19: SpO2, 98.733; 19: 1min HRV, 26.890; 19: 5min HRV, 30.244; 19: SBP, 93.0; 19: DBP, 67.0; 19: MAP, 75.667; 20: HR, 96.153; 20: SpO2, 85.5; 20: 1min HRV, 29.099; 20: SBP, 93.0; 20: DBP, 67.0; 20: MAP, 75.667; 21: HR, 98.155; 21: SpO2, 100.0; 21: 1min HRV, 16.114; 22: HR, 95.508; 22: SpO2, 99.966; 22: 1min HRV, 19.910; 23: HR, 95.424; 23: SpO2, 100.0; 23: 1min HRV, 23.032; 24: HR, 94.810; 24: SpO2, 100.0; 24: 1min HRV, 13.884; 24: 5min HRV, 22.364; 25: HR, 92.966; 25: SpO2, 100.0; 25: 1min HRV, 9.650; 26: HR, 93.138; 26: SpO2, 100.0; 26: 1min HRV, 5.931; 27: HR, 94.695; 27: 1min HRV, 32.017; 28: HR, 93.5; 28: SpO2, 99.4; 28: 1min HRV, 36.406; 29: HR, 96.881; 29: SpO2, 99.0; 29: 1min HRV, 39.831; 29: 5min HRV, 30.991; 30: HR, 96.627; 30: SpO2, 100.0; 30: 1min HRV, 28.922; 31: HR, 95.796; 31: SpO2, 100.0; 31: 1min HRV, 28.161; 32: HR, 95.746; 32: SpO2, 96.556; 32: 1min HRV, 15.114; 33: HR, 95.293; 33: SpO2, 91.8; 33: 1min HRV, 18.812; 34: HR, 97.448; 34: SpO2, 93.95; 34: 1min HRV, 10.198; 34: 5min HRV, 22.786; 35: HR, 97.085; 35: SpO2, 94.5; 35: 1min HRV, 15.337; 35: ASPIRIN, 81 MG PO CHEW; 35: ACETAMINOPHEN, 500 MG PO TABS; 36: HR, 98.241; 36: SpO2, 95.518; 36: 1min HRV, 24.382; 37: HR, 97.492; 37: SpO2, 93.096; 37: 1min HRV, 45.606; 38: HR, 97.310; 38: SpO2, 93.85; 38: Perf, 0.24; 38: 1min HRV, 44.786; 39: HR, 97.305; 39: SpO2, 95.474; 39: Perf, 0.24; 39: 1min HRV, 40.561; 39: 5min HRV, 38.341; 40: HR, 97.0; 40: SpO2, 99.2; 40: Perf, 0.24; 40: 1min HRV, 39.062; 41: HR, 96.983; 41: SpO2, 100.0; 41: 1min HRV, 48.266; 42: HR, 97.356; 42: SpO2, 99.0; 42: 1min HRV, 40.408; 43: HR, 95.621; 43: SpO2, 100.0; 43: 1min HRV, 42.188; 44: HR, 96.5; 44: SpO2, 100.0; 44: 1min HRV, 37.516; 44: 5min HRV, 42.290; 45: HR, 92.847; 45: SpO2, 100.0; 45: 1min HRV, 23.501; 46: HR, 94.397; 46: SpO2, 100.0; 46: 1min HRV, 29.513; 47: HR, 93.034; 47: SpO2, 98.647; 47: 1min HRV, 32.125; 48: HR, 95.667; 48: SpO2, 99.143; 48: 1min HRV, 14.480; 49: HR, 93.831; 49: SpO2, 99.531; 49: 1min HRV, 16.465; 49: 5min HRV, 25.851; 50: HR, 93.661; 50: SpO2, 98.571; 50: 1min HRV, 13.106; 51: HR, 93.207; 51: 1min HRV, 11.248; 52: HR, 92.525; 52: 1min HRV, 12.237; 53: HR, 92.534; 53: SpO2, 100.0; 53: 1min HRV, 11.557; 54: HR, 92.508; 54: SpO2, 96.143; 54: 1min HRV, 6.789; 54: 5min HRV, 11.654; 54: Pain, 10.0; 55: HR, 92.559; 55: SpO2, 100.0; 55: 1min HRV, 9.271; 56: HR, 92.862; 56: SpO2, 99.853; 56: 1min HRV, 8.397; 57: HR, 92.237; 57: SpO2, 100.0; 57: 1min HRV, 9.517; 58: HR, 92.655; 58: SpO2, 99.955; 58: Perf, 0.15; 58: 1min HRV, 9.605; 59: HR, 93.0; 59: SpO2, 100.0; 59: Perf, 0.15; 59: 1min HRV, 6.399; 59: 5min HRV, 8.951; 60: HR, 92.897; 60: SpO2, 100.0; 60: Perf, 0.2; 60: 1min HRV, 7.052; 61: HR, 92.949; 61: SpO2, 100.0; 61: Perf, 0.21; 61: 1min HRV, 6.408; 62: HR, 92.492; 62: SpO2, 100.0; 62: Perf, 0.229; 62: 1min HRV, 7.471; 63: HR, 92.138; 63: 1min HRV, 8.428; 64: HR, 93.305; 64: SpO2, 100.0; 64: Perf, 0.216; 64: 1min HRV, 18.790; 64: 5min HRV, 10.843; 65: HR, 88.298; 65: SpO2, 100.0; 65: Perf, 0.23; 65: 1min HRV, 14.646; 66: HR, 91.559; 66: SpO2, 100.0; 66: 1min HRV, 13.013; 67: HR, 92.644; 67: SpO2, 100.0; 67: 1min HRV, 24.961; 68: HR, 91.724; 68: SpO2, 100.0; 68: 1min HRV, 43.105; 69: HR, 92.655; 69: SpO2, 96.95; 69: 1min HRV, 33.333; 69: 5min HRV, 28.986; 70: HR, 91.552; 70: SpO2, 93.75; 70: 1min HRV, 51.283; 71: HR, 90.492; 71: SpO2, 99.933; 71: Perf, 0.15; 71: 1min HRV, 22.465; 72: HR, 91.153; 72: SpO2, 99.867; 72: Perf, 0.155; 72: 1min HRV, 5.308; 73: HR, 91.741; 73: SpO2, 99.848; 73: Perf, 0.159; 73: 1min HRV, 22.532; 74: HR, 89.729; 74: SpO2, 99.595; 74: Perf, 0.160; 74: 1min HRV, 24.310; 74: 5min HRV, 26.494; 75: HR, 90.667; 75: SpO2, 100.0; 75: Perf, 0.165; 75: 1min HRV, 23.716; 76: HR, 91.729; 76: SpO2, 100.0; 76: Perf, 0.178; 76: 1min HRV, 22.482; 77: HR, 93.135; 77: SpO2, 97.852; 77: Perf, 0.18; 77: 1min HRV, 3.623; 78: HR, 97.52; 78: SpO2, 97.167; 78: 1min HRV, 37.103; 78: SBP, 72.0; 78: DBP, 54.0; 78: MAP, 60.0; 79: HR, 98.288; 79: SpO2, 98.667; 79: 1min HRV, 25.253; 79: 5min HRV, 35.545; 79: SBP, 72.0; 79: DBP, nan; 79: MAP, nan; 80: HR, 98.034; 80: SpO2, 100.0; 80: Perf, 0.22; 80: 1min HRV, 30.413; 80: SBP, 69.0; 80: DBP, 52.0; 80: MAP, 57.667; 81: HR, 97.949; 81: SpO2, 100.0; 81: Perf, 0.255; 81: 1min HRV, 28.517; 81: SBP, 69.0; 81: DBP, 52.0; 81: MAP, 57.667; 82: HR, 98.068; 82: SpO2, 100.0; 82: Perf, 0.279; 82: 1min HRV, 31.266; 83: HR, 97.621; 83: SpO2, 100.0; 83: Perf, 0.299; 83: 1min HRV, 23.406; 84: 5min HRV, 28.597; 86: NS IV BOLUS -, 250 ML; 94: HR:, 93.0; 94: SpO2, 100.0; 94: SBP, 86.0; 94: DBP, 68.0; 94: MAP, 74.0; 100: SARS-COV-2 RNA, Not Detected; 109: HR, 87.0; 109: SpO2, 100.0; 109: SBP, 76.0; 109: DBP, 48.0; 109: MAP, 57.333; 117: INR, 1.2; 117: PROTHROMBIN TIME, 15.1 seconds; 118: PART. THROMBOPLASTIN TIME, 47.1 seconds; 118: NS IV BOLUS -, 250 ML; 0: Age:, 65; 0: Gender, F; 0: Race, Black or African American; 0: Means of arrival, EMS; 0: Triage Temp, 36.4; 0: Triage HR, 100.0; 0: Triage RR, 16.0; 0: Triage SBP, 93.0; 0: Triage DBP, 67.0; 0: Triage acuity, 3-Urgent; 0: CC, CHEST PAIN",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "First, check for clear signs of infection (e.g., fever or elevated labs), and note that neither fever nor labs indicate infection. Next, evaluate whether vital signs (heart rate, blood pressure, oxygen saturation) show a consistent pattern of sepsis-related instability, but here the pattern more closely aligns with possible cardiogenic or other shock rather than a systemic infection. Finally, assess therapies: while the patient receives IV fluids, there is no indication of targeted antibiotic therapy or other sepsis-specific interventions. Taken together, these factors suggest the patient is not at high risk of sepsis within 12 hours.",
        "claims": [
            "Clear signs of infection should be checked first.",
            "Examples of clear signs of infection include fever and elevated labs.",
            "Neither fever nor elevated labs indicate infection in this case.",
            "Vital signs should be evaluated for a consistent pattern of sepsis-related instability.",
            "In this case, the pattern of vital signs aligns more closely with possible cardiogenic shock or other types of shock.",
            "The pattern of vital signs does not indicate a systemic infection.",
            "Therapies being administered should be assessed.",
            "The patient is receiving IV fluids.",
            "There is no indication of targeted antibiotic therapy for the patient.",
            "There are no sepsis-specific interventions being administered.",
            "These factors suggest the patient is not at high risk of sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "Vital signs should be evaluated for a consistent pattern of sepsis-related instability.",
            "In this case, the pattern of vital signs aligns more closely with possible cardiogenic shock or other types of shock.",
            "The pattern of vital signs does not indicate a systemic infection.",
            "There is no indication of targeted antibiotic therapy for the patient."
        ],
        "alignment_scores": [
            0.6,
            0.8,
            0.3,
            0.3
        ],
        "alignment_category": [
            4,
            6,
            4,
            9
        ],
        "alignment_reasonings": [
            "The claim implies the need for monitoring vital signs for patterns of instability related to sepsis. Evaluating vital signs aligns with the NEWS scoring system, which predicts clinical deterioration that could indicate sepsis. While it mentions evaluating vital signs, it doesn't specifically state elevated scores or point thresholds, leading to a moderate rather than a high alignment rating.",
            "The claim mentions a pattern of vital signs consistent with shock. Elevated Shock Index, a measure indicating haemodynamic instability, aligns closely with any assessment of shock, including cardiogenic shock. While the claim does not provide a specific shock index value, the conceptual alignment with assessing types of shock is strong. Thus, the alignment rating is high but not perfect due to the lack of specific details directly referencing the Shock Index.",
            "The claim implies that the patient\u2019s vital signs do not suggest sepsis or systemic infection. This is related to the NEWS score, which evaluates vital signs to predict deterioration. Although this signifies a lack of elevated NEWS, there\u2019s only minimal alignment since the claim doesn\u2019t involve a NEWS score or specific thresholds\u2014it's an indirect reference.",
            "The absence of targeted antibiotic therapy suggests a lack of clinician suspicion for serious infection, which somewhat aligns with the category concerning early action on antibiotics or cultures. However, since the claim is about an absence of action rather than presence, the alignment is weak."
        ],
        "final_alignment_score": 0.5,
        "accuracy": 0
    },
    {
        "input": "3: HR, 121.0; 3: RR, 22.0; 3: SpO2, 97.0; 3: SBP, 129.0; 3: DBP, 87.0; 3: MAP, 101.0; 3: Temp, 99.3; 16: SpO2, 96.45; 16: Perf, 0.6; 17: HR, 133.538; 17: RR, 22.158; 17: SpO2, 97.130; 17: Perf, 0.471; 17: 1min HRV, 16.532; 18: HR, 133.305; 18: RR, 21.966; 18: SpO2, 96.625; 18: Perf, 0.406; 18: 1min HRV, 19.165; 18: SBP, 114.0; 18: DBP, 76.0; 18: MAP, 88.667; 19: HR, 139.339; 19: RR, 18.746; 19: SpO2, 97.186; 19: Perf, 0.443; 19: 1min HRV, 20.527; 19: 5min HRV, 20.534; 20: HR, 131.103; 20: RR, 23.862; 20: SpO2, 96.793; 20: Perf, 0.505; 20: 1min HRV, 16.418; 21: HR, 130.086; 21: RR, 22.190; 21: SpO2, 97.138; 21: Perf, 0.542; 21: 1min HRV, 12.962; 22: HR, 129.103; 22: RR, 20.5; 22: SpO2, 96.931; 22: Perf, 0.499; 22: 1min HRV, 9.228; 23: HR, 131.356; 23: RR, 21.898; 23: SpO2, 97.356; 23: Perf, 0.426; 23: 1min HRV, 11.118; 24: HR, 131.390; 24: RR, 21.932; 24: SpO2, 97.441; 24: Perf, 0.427; 24: 1min HRV, 12.103; 24: 5min HRV, 13.005; 25: HR, 131.948; 25: RR, 21.914; 25: SpO2, 97.276; 25: Perf, 0.387; 25: 1min HRV, 10.485; 26: HR, 133.322; 26: RR, 22.390; 26: SpO2, 97.695; 26: Perf, 0.369; 26: 1min HRV, 13.968; 27: HR, 133.121; 27: RR, 22.517; 27: SpO2, 98.034; 27: Perf, 0.367; 27: 1min HRV, 16.834; 28: HR, 130.119; 28: RR, 22.068; 28: SpO2, 97.279; 28: Perf, 0.408; 28: 1min HRV, 10.430; 29: HR, 129.169; 29: RR, 20.814; 29: SpO2, 97.424; 29: Perf, 0.623; 29: 1min HRV, 5.235; 29: 5min HRV, 13.384; 29: SBP, 113.0; 29: DBP, 72.0; 29: MAP, 85.667; 30: HR, 129.017; 30: RR, 21.931; 30: SpO2, 98.023; 30: Perf, 0.61; 30: 1min HRV, 8.060; 30: SBP, 113.0; 30: DBP, 72.0; 30: MAP, 85.667; 31: HR, 130.0; 31: RR, 22.655; 31: SpO2, 98.0; 31: Perf, 0.628; 31: 1min HRV, 7.261; 32: HR, 130.810; 32: RR, 21.621; 32: SpO2, 98.0; 32: Perf, 0.555; 32: 1min HRV, 5.514; 33: HR, 130.661; 33: RR, 25.169; 33: SpO2, 98.0; 33: Perf, 0.507; 33: 1min HRV, 10.328; 34: 5min HRV, 8.431; 61: POC PH (V) ISTAT, 7.41; 61: POC LACTATE ISTAT, 1.49 mmol/L; 61: POC O2 SATURATION ISTAT VENOUS, 77 %; 61: POC PO2 (V) ISTAT, 41 mmHg; 61: POC TCO2 (V) ISTAT, 24 mmol/L; 61: POC BASE EXCESS ISTAT, -2 mmol/L; 61: POC PCO2 (V) ISTAT, 36.8 mmHg; 61: POC HCO3 (V) ISTAT, 23.1 mmol/L; 66: POC CREATININE ISTAT, 0.2 mg/dL; 66: POC EGFR REFIT WITHOUT RACE (2021), 169 mL/min/1.73 m2; 78: RSV, Not Detected; 78: INFLUENZA B, Not Detected; 78: SARS-COV-2 RNA, Not Detected; 78: INFLUENZA A, Not Detected; 84: WAM DIFTYP, AUTO; 84: NEUTROPHIL % (AUTO DIFF), 70.3 %; 84: PLATELET COUNT (PLT), 275 K/uL; 84: WHITE BLOOD CELLS (WBC), 7.6 K/uL; 84: EOSINOPHIL % (AUTO DIFF), 1.1 %; 84: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.3 g/dL; 84: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.02 K/uL; 84: BASOPHIL % (AUTO DIFF), 0.4 %; 84: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 84: NRBC PERCENT (HEMATOLOGY), 0.0 %; 84: MONOCYTE ABSOLUTE (AUTO DIFF), 0.52 K/uL; 84: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.60 K/uL; 84: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 84: HEMATOCRIT (HCT), 47.6 %; 84: NEUTROPHIL ABSOLUTE (AUTO DIFF), 5.35 K/uL; 84: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 84: LYMPHOCYTE % (AUTO DIFF), 21.1 %; 84: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.08 K/uL; 84: RED BLOOD CELLS (RBC), 5.91 MIL/uL; 84: MONOCYTE % (AUTO DIFF), 6.8 %; 84: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 25.2 pg; 84: RED CELL DISTRIBUTION WIDTH (RDW), 17.4 %; 84: HEMOGLOBIN (HGB), 14.9 g/dL; 84: MEAN CORPUSCULAR VOLUME (MCV), 80.5 fL; 97: INR, 1.0; 97: PROTHROMBIN TIME, 13.8 seconds; 98: PART. THROMBOPLASTIN TIME, 32.9 seconds; 111: HIGH SENSITIVITY TROPONIN, <4 ng/L; 112: SODIUM, 137 mmol/L; 112: AST (SGOT), 57 U/L; 112: PROTEIN TOTAL, 8.1 g/dL; 112: BILIRUBIN TOTAL, 0.5 mg/dL; 112: BLOOD UREA NITROGEN (BUN), 16 mg/dL; 112: ALKALINE PHOSPHATASE, 165 U/L; 112: GLUCOSE, 146 mg/dL; 112: CHLORIDE, 107 mmol/L; 112: GLOBULIN, 4.1 g/dL; 112: ANION GAP, 10 mmol/L; 112: POTASSIUM, 4.1 mmol/L; 112: EGFR REFIT WITHOUT RACE (2021), 181 mL/min/1.73 m2; 112: CREATININE, 0.16 mg/dL; 112: CALCIUM, 9.4 mg/dL; 112: CORRECTED CALCIUM, 9.4 mg/dL; 112: ALBUMIN, 4.0 g/dL; 112: ALT (SGPT), 122 U/L; 112: C-REACTIVE PROTEIN (CRP), 2.1 mg/dL; 112: CO2, 20 mmol/L; 119: HR, 120.0; 119: RR, 20.0; 119: SpO2, 96.0; 119: SBP, 120.0; 119: DBP, 90.0; 119: MAP, 100.0; 119: Pain, 0.0; 0: Age, 47; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.4; 0: Triage HR, 121.0; 0: Triage RR, 22.0; 0: Triage SBP, 129.0; 0: Triage DBP, 87.0; 0: Triage acuity, 3-Urgent; 0: CC, VASCULAR ACCESS PROBLEM",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "First, I check if the patient\u2019s heart rate is persistently high: it is elevated but not extreme. Next, I look at other vital signs (BP, RR, and Temp) to see if they indicate possible sepsis: the blood pressure is stable, the respiratory rate is only slightly elevated, and there is no sustained fever. Then, I inspect the lab results (including lactate, WBC, and organ function markers) for signs of infection or organ dysfunction: they remain largely within normal ranges. Therefore, given these findings, the patient is not at high risk for sepsis within the next 12 hours.",
        "claims": [
            "The patient's heart rate is persistently high.",
            "The patient's heart rate is elevated but not extreme.",
            "Other vital signs are checked to assess for possible sepsis.",
            "The blood pressure is stable.",
            "The respiratory rate is only slightly elevated.",
            "There is no sustained fever.",
            "Lab results are inspected for signs of infection or organ dysfunction.",
            "The lab results include lactate, white blood cell count (WBC), and organ function markers.",
            "The lab results remain largely within normal ranges.",
            "Given these findings, the patient is not at high risk for sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient's heart rate is persistently high.",
            "There is no sustained fever."
        ],
        "alignment_scores": [
            0.5,
            0.3
        ],
        "alignment_category": [
            6,
            2
        ],
        "alignment_reasonings": [
            "A persistently high heart rate is a component of the shock index (calculated as heart rate \u00f7 systolic BP), indicating potential haemodynamic instability. However, without information on systolic BP, it cannot fully establish the shock index threshold. Therefore, the alignment is partial, capturing potential relevance to sepsis risk.",
            "The lack of sustained fever suggests the absence of one of the criteria for systemic inflammation, which is part of the SIRS criteria. Although the claim does not confirm the presence of SIRS, it makes partial reference to one of its components, resulting in a weak alignment."
        ],
        "final_alignment_score": 0.4,
        "accuracy": 0
    },
    {
        "input": "4: HR, 95.0; 4: RR, 18.0; 4: SpO2, 97.0; 4: SBP, 92.0; 4: DBP, 64.0; 4: MAP, 73.333; 4: Temp, 97.5; 5: SBP, 86.0; 5: DBP, 59.0; 5: MAP, 68.0; 8: Pain, 2.0; 38: POC PH (V) ISTAT, 7.36; 38: POC LACTATE ISTAT, 2.34 mmol/L; 38: POC TCO2 (V) ISTAT, 31 mmol/L; 38: POC HCO3 (V) ISTAT, 29.3 mmol/L; 38: POC BASE EXCESS ISTAT, 4 mmol/L; 38: POC PO2 (V) ISTAT, 24 mmHg; 38: POC PCO2 (V) ISTAT, 51.6 mmHg; 38: POC O2 SATURATION ISTAT VENOUS, 40 %; 44: WAM DIFTYP, AUTO; 44: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 44: NEUTROPHIL % (AUTO DIFF), 58.6 %; 44: MONOCYTE ABSOLUTE (AUTO DIFF), 0.46 K/uL; 44: RED CELL DISTRIBUTION WIDTH (RDW), 15.0 %; 44: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.38 K/uL; 44: HEMOGLOBIN (HGB), 11.4 g/dL; 44: EOSINOPHIL % (AUTO DIFF), 4.4 %; 44: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 44: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 44: NRBC PERCENT (HEMATOLOGY), 0.0 %; 44: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.66 K/uL; 44: NEUTROPHIL ABSOLUTE (AUTO DIFF), 5.03 K/uL; 44: MONOCYTE % (AUTO DIFF), 5.3 %; 44: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 25.7 pg; 44: BASOPHIL % (AUTO DIFF), 0.5 %; 44: HEMATOCRIT (HCT), 38.3 %; 44: MEAN CORPUSCULAR VOLUME (MCV), 86.5 fL; 44: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 29.8 g/dL; 44: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.03 K/uL; 44: LYMPHOCYTE % (AUTO DIFF), 30.9 %; 44: PLATELET COUNT (PLT), 425 K/uL; 44: WHITE BLOOD CELLS (WBC), 8.6 K/uL; 44: RED BLOOD CELLS (RBC), 4.43 MIL/uL; 45: SpO2, 97.435; 46: SpO2, 95.0; 46: Perf, 0.797; 47: SpO2, 94.949; 47: Perf, 0.570; 48: SpO2, 97.222; 48: Perf, 0.413; 48: SBP, 106.0; 48: DBP, 63.0; 48: MAP, 77.333; 49: SpO2, 96.627; 49: Perf, 0.574; 50: SpO2, 95.379; 50: Perf, 0.486; 51: SpO2, 95.356; 51: Perf, 0.394; 52: SpO2, 95.759; 52: Perf, 0.377; 53: SpO2, 96.949; 53: Perf, 0.411; 54: SpO2, 97.0; 54: Perf, 0.439; 55: SpO2, 96.586; 55: Perf, 0.461; 56: SpO2, 97.0; 56: Perf, 0.387; 57: INR, 1.0; 57: PROTHROMBIN TIME, 13.5 seconds; 57: PART. THROMBOPLASTIN TIME, 27.1 seconds; 57: SpO2, 97.0; 57: Perf, 0.376; 58: HR, 79.0; 58: SpO2, 96.475; 58: Perf, 0.393; 59: HR, 79.0; 59: SpO2, 97.0; 59: Perf, 0.442; 59: SBP, 102.0; 59: DBP, 64.0; 59: MAP, 76.667; 60: SpO2, 97.333; 60: Perf, 0.45; 60: SBP, 102.0; 60: DBP, 64.0; 60: MAP, 76.667; 61: SpO2, 96.627; 61: Perf, 0.591; 62: SpO2, 96.207; 62: Perf, 0.531; 63: SpO2, 97.017; 63: Perf, 0.563; 64: SpO2, 96.678; 64: Perf, 0.502; 65: SpO2, 96.860; 65: Perf, 0.598; 66: SpO2, 96.483; 66: Perf, 0.573; 67: SpO2, 95.759; 67: Perf, 0.473; 68: SpO2, 94.576; 68: Perf, 0.374; 69: SpO2, 95.136; 69: Perf, 0.384; 70: SpO2, 95.397; 70: Perf, 0.361; 71: SpO2, 96.644; 71: Perf, 0.393; 72: SpO2, 96.879; 72: Perf, 0.448; 73: SpO2, 96.898; 73: Perf, 0.455; 74: SpO2, 97.0; 74: Perf, 0.478; 75: EGFR REFIT WITHOUT RACE (2021), 76 mL/min/1.73 m2; 75: CALCIUM, 9.7 mg/dL; 75: GLUCOSE, 133 mg/dL; 75: CO2, 26 mmol/L; 75: AST (SGOT), 24 U/L; 75: ALBUMIN, 4.1 g/dL; 75: CORRECTED CALCIUM, 9.6 mg/dL; 75: PROTEIN TOTAL, 7.8 g/dL; 75: ANION GAP, 10 mmol/L; 75: BLOOD UREA NITROGEN (BUN), 18 mg/dL; 75: CREATININE, 0.74 mg/dL; 75: GLOBULIN, 3.7 g/dL; 75: ALT (SGPT), 11 U/L; 75: BILIRUBIN TOTAL, 0.3 mg/dL; 75: SODIUM, 136 mmol/L; 75: ALKALINE PHOSPHATASE, 86 U/L; 75: CHLORIDE, 100 mmol/L; 75: POTASSIUM, 4.9 mmol/L; 75: SpO2, 97.190; 75: Perf, 0.538; 76: SpO2, 97.305; 76: Perf, 0.482; 77: SpO2, 96.897; 77: Perf, 0.432; 78: SpO2, 97.155; 78: Perf, 0.404; 79: SpO2, 97.661; 79: Perf, 0.421; 80: SARS-COV-2 RNA, Not Detected; 80: SpO2, 96.525; 80: Perf, 0.404; 81: SpO2, 96.695; 81: Perf, 0.383; 82: SpO2, 96.603; 82: Perf, 0.349; 82: LR IV BOLUS -, 1000 ML; 83: SpO, 2: 96.704; 83: Perf, 0.351; 84: SpO2, 96.604; 85: SpO2, 95.845; 86: SpO2, 96.576; 86: Perf, 0.305; 87: SpO2, 96.707; 87: Perf, 0.307; 88: SpO2, 96.522; 88: Perf, 0.3; 89: SpO2, 97.537; 89: Perf, 0.3; 90: SpO2, 97.0; 90: Perf, 0.382; 91: SpO2, 96.288; 91: Perf, 0.401; 92: SpO2, 94.915; 92: Perf, 0.369; 93: SpO2, 96.949; 93: Perf, 0.290; 94: SpO2, 95.310; 94: Perf, 0.277; 95: SpO2, 96.644; 95: Perf, 0.301; 96: SpO2, 95.537; 96: Perf, 0.269; 97: SpO2, 96.064; 97: Perf, 0.260; 98: SpO2, 97.091; 98: Perf, 0.255; 99: SpO2, 96.612; 99: Perf, 0.264; 100: SpO2, 96.409; 100: Perf, 0.242; 101: SpO2, 96.231; 101: Perf, 0.246; 102: SpO2, 96.735; 102: Perf, 0.238; 103: SpO2, 97.0; 103: Perf, 0.235; 104: SpO2, 97.217; 104: Perf, 0.236; 105: SpO2, 96.6; 105: Perf, 0.217; 106: SpO2, 96.675; 106: Perf, 0.224; 107: SpO2, 96.081; 107: Perf, 0.240; 108: SpO2, 96.806; 108: Perf, 0.232; 109: SpO2, 96.25; 109: Perf, 0.225; 110: SpO2, 96.759; 110: Perf, 0.220; 111: SpO2, 96.379; 111: Perf, 0.216; 112: SpO2, 96.455; 112: Perf, 0.222; 113: SpO2, 97.125; 113: Perf, 0.221; 114: SpO2, 96.318; 114: Perf, 0.227; 115: SpO2, 96.241; 115: Perf, 0.227; 116: SpO2, 96.714; 116: Perf, 0.216; 117: SpO2, 97.135; 117: Perf, 0.224; 118: SpO2, 97.318; 118: Perf, 0.227; 119: SpO2, 97.467; 119: Perf, 0.21; 0: Age, 90; 0: Gender, F; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 36.4; 0: Triage HR, 95.0; 0: Triage RR, 18.0; 0: Triage SBP, 92.0; 0: Triage DBP, 64.0; 0: Triage acuity, 2-Emergent; 0: CC, WOUND CHECK",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I checked if there were strong signs of infection, such as significantly elevated white blood cell counts or fever, and found none. Next, I looked for persistent hypotension or tachycardia across the time series and noted that, after a brief drop in blood pressure, the patient\u2019s vitals stabilized. Then, I examined the lactate level, which was mildly elevated but not high enough to strongly indicate sepsis. Given normalizing hemodynamics and the lack of clear infection markers, the risk of sepsis within 12 hours appears low.",
        "claims": [
            "There were no strong signs of infection present.",
            "Significantly elevated white blood cell counts or fever were not found.",
            "Persistent hypotension was examined.",
            "Tachycardia was examined across the time series.",
            "After a brief drop in blood pressure, the patient\u2019s vitals stabilized.",
            "The lactate level was mildly elevated.",
            "The mildly elevated lactate level was not high enough to strongly indicate sepsis.",
            "The risk of sepsis within 12 hours appears low.",
            "Normalizing hemodynamics contribute to the low risk of sepsis.",
            "The lack of clear infection markers contributes to the low risk of sepsis."
        ],
        "relevant_claims": [
            "Significantly elevated white blood cell counts or fever were not found.",
            "The lactate level was mildly elevated.",
            "The mildly elevated lactate level was not high enough to strongly indicate sepsis.",
            "The lack of clear infection markers contributes to the low risk of sepsis."
        ],
        "alignment_scores": [
            0.3,
            0.7,
            0.3,
            0.3
        ],
        "alignment_category": [
            2,
            5,
            5,
            9
        ],
        "alignment_reasonings": [
            "The claim references the absence of significantly elevated white blood cell counts or fever, which are part of the SIRS criteria used to flag systemic inflammation related to early sepsis. Therefore, it indirectly relates to SIRS criteria by noting their absence, which provides minimal alignment.",
            "The claim indicates an elevated lactate level, which aligns with Category 5 that associates serum lactate levels of \u22652 mmol/L with increased risk of sepsis. However, the use of \"mildly elevated\" suggests the level may not be significantly high, so the alignment is strong but not perfect.",
            "The claim references an elevated lactate level, which directly pertains to this category. However, the wording indicates that the elevation is mild and not conclusively indicative of sepsis. This suggests a weak alignment with the criteria that require a serum lactate level of \u22652 mmol/L for a strong indication of sepsis risk.",
            "The claim suggests that there is a low suspicion of infection due to the absence of clear infection markers. While not directly mentioning the absence of early antibiotic orders or culture draws, it implies a lower clinical suspicion of serious infection, which is conceptually related to this category. The alignment is weak but somewhat relevant to the absence of criteria that would prompt rapid intervention consistent with sepsis risk."
        ],
        "final_alignment_score": 0.4,
        "accuracy": 1
    },
    {
        "input": "4: HR, 94.0; 4: RR, 18.0; 4: SpO2, 99.0; 4: SBP, 141.0; 4: DBP, 92.0; 4: MAP, 108.333; 4: Pain, 6.0; 4: Temp, 97.9; 9: Pain, 7.0; 28: HR, 97.0; 28: RR, 15.0; 28: SpO2, 99.0; 28: SBP, 149.0; 28: DBP, 99.0; 28: MAP, 115.667; 28: Pain, 7.0; 29: SBP, 149.0; 29: DBP, 99.0; 29: MAP, 115.667; 30: SpO2, 98.833; 30: Perf, 2.51; 31: SpO2, 98.847; 31: Perf, 2.238; 32: SpO2, 98.103; 32: Perf, 1.899; 33: SpO2, 96.763; 33: Perf, 2.299; 34: SpO2, 97.034; 34: Perf, 2.379; 35: SpO2, 96.593; 35: Perf, 2.486; 36: SpO2, 98.322; 36: Perf, 2.368; 37: SpO2, 98.569; 37: Perf, 2.020; 38: SpO2, 97.0; 38: Perf, 2.242; 39: SpO2, 96.793; 39: Perf, 2.375; 40: SpO2, 97.814; 40: Perf, 2.22; 41: SpO2, 98.898; 41: Perf, 1.982; 42: SpO2, 98.983; 42: Perf, 1.713; 43: SpO2, 99.034; 43: Perf, 1.991; 44: SpO2, 97.5; 44: Perf, 2.662; 45: SpO2, 97.814; 45: Perf, 2.922; 46: SpO2, 98.322; 46: Perf, 2.619; 47: SpO2, 98.793; 47: Perf, 2.243; 48: SpO2, 97.407; 48: Perf, 1.931; 49: SpO2, 97.724; 49: Perf, 1.593; 50: SpO2, 97.898; 50: Perf, 1.594; 51: SpO2, 97.915; 51: Perf, 1.571; 52: SpO2, 98.776; 52: Perf, 1.957; 53: SpO2, 98.661; 53: Perf, 2.086; 54: SpO2, 98.328; 54: Perf, 1.897; 55: SpO2, 98.102; 55: Perf, 1.603; 56: SpO2, 98.322; 56: Perf, 1.592; 57: SpO2, 98.534; 57: Perf, 1.642; 58: SpO2, 99.237; 58: Perf, 1.675; 59: SpO2, 97.810; 59: Perf, 1.644; 60: SpO2, 97.729; 60: Perf, 1.421; 61: SpO2, 97.729; 61: Perf, 1.236; 62: SpO2, 98.103; 62: Perf, 1.116; 63: SpO2, 98.102; 63: Perf, 1.111; 64: SpO2, 98.862; 64: Perf, 1.314; 65: SpO2, 98.288; 65: Perf, 1.637; 66: SpO2, 98.810; 66: Perf, 1.958; 67: SpO2, 98.780; 67: Perf, 1.529; 68: SpO2, 97.831; 68: Perf, 1.272; 69: SpO2, 98.379; 69: Perf, 1.351; 70: SpO2, 98.254; 70: Perf, 1.663; 71: SpO2, 97.879; 71: Perf, 1.607; 72: SpO2, 98.746; 72: Perf, 1.151; 73: SpO2, 97.475; 73: Perf, 1.061; 74: SpO2, 97.466; 74: Perf, 1.162; 75: SpO2, 97.661; 75: Perf, 1.278; 76: SpO2, 98.155; 76: Perf, 1.366; 77: SpO2, 98.0; 77: Perf, 1.219; 78: SpO2, 99.034; 78: Perf, 0.794; 79: SpO2, 98.707; 79: Perf, 0.774; 80: SpO2, 97.254; 80: Perf, 1.277; 81: SpO2, 97.138; 81: Perf, 1.397; 82: SpO2, 96.949; 82: Perf, 1.276; 83: SpO2, 97.254; 83: Perf, 0.825; 84: SpO2, 97.483; 84: Perf, 1.056; 85: SpO2, 98.441; 85: Perf, 1.759; 86: SpO2, 98.086; 86: Perf, 1.750; 87: SpO2, 98.627; 87: Perf, 1.313; 88: SpO2, 98.051; 88: Perf, 1.599; 89: SpO2, 98.672; 89: Perf, 1.206; 89: SBP, 151.0; 89: DBP, 87.0; 89: MAP, 108.333; 90: SpO2, 98.864; 90: Perf, 1.203; 91: SpO2, 99.431; 91: Perf, 1.215; 92: SpO2, 98.881; 92: Perf, 1.043; 93: CHLORIDE, 105 mmol/L; 93: GLOBULIN, 2.6 g/dL; 93: ALKALINE PHOSPHATASE, 89 U/L; 93: CREATININE, 1.25 mg/dL; 93: BLOOD UREA NITROGEN (BUN), 16 mg/dL; 93: ALT (SGPT), 29 U/L; 93: EGFR REFIT WITHOUT RACE (2021), 68 mL/min/1.73 m2; 93: AST (SGOT), 29 U/L; 93: CO2, 21 mmol/L; 93: POTASSIUM, 3.6 mmol/L; 93: GLUCOSE, 109 mg/dL; 93: ALBUMIN, 4.3 g/dL; 93: CORRECTED CALCIUM, 8.6 mg/dL; 93: PROTEIN TOTAL, 6.9 g/dL; 93: CALCIUM, 8.8 mg/dL; 93: ANION GAP, 13 mmol/L; 93: SODIUM, 139 mmol/L; 93: BILIRUBIN TOTAL, 0.6 mg/dL; 93: LIPASE, 23 U/L; 93: SpO2, 99.136; 93: Perf, 0.841; 94: SpO2, 98.931; 94: Perf, 0.738; 95: SpO2, 98.203; 95: Perf, 1.045; 96: SpO2, 98.293; 96: Perf, 1.207; 97: SARS-COV-2 RNA, Not Detected; 97: SpO2, 99.458; 97: Perf, 1.211; 98: SpO2, 99.259; 98: Perf, 1.108; 99: SpO2, 100.0; 99: Perf, 0.684; 100: SpO2, 99.932; 100: Perf, 0.549; 101: SpO2, 99.276; 101: Perf, 0.588; 102: SpO2, 98.780; 102: Perf, 0.494; 103: SpO2, 99.052; 103: Perf, 0.49; 104: SpO2, 98.424; 104: Perf, 0.535; 105: SpO2, 98.305; 105: Perf, 0.428; 106: SpO2, 98.897; 106: Perf, 0.391; 107: SpO2, 97.763; 107: Perf, 0.546; 108: SpO2, 98.483; 108: Perf, 0.491; 109: SpO2, 96.593; 109: Perf, 0.523; 110: SpO2, 97.627; 110: Perf, 0.64; 111: SpO2, 97.707; 111: Perf, 0.719; 112: SpO2, 98.525; 112: Perf, 0.737; 113: SpO2, 98.155; 113: Perf, 0.561; 114: SpO2, 97.525; 114: Perf, 0.627; 115: SpO2, 98.085; 115: Perf, 0.650; 116: PLATELET COUNT (PLT), 215 K/uL; 116: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.0 g/dL; 116: RED CELL DISTRIBUTION WIDTH (RDW), 12.6 %; 116: HEMATOCRIT (HCT), 37.6 %; 116: WHITE BLOOD CELLS (WBC), 3.3 K/uL; 116: RED BLOOD CELLS (RBC), 4.01 MIL/uL; 116: MEAN CORPUSCULAR VOLUME (MCV), 93.8 fL; 116: HEMOGLOBIN (HGB), 12.8 g/dL; 116: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.9 pg; 116: NEUTROPHILS BANDS % (MANUAL DIFF), 10.4 %; 116: NEUTROPHILS ABSOLUTE (MANUAL DIFF) (SEGS+BANDS), 2.68 K/uL; 116: LYMPHOCYTES % (MANUAL DIFF), 8.7 %; 116: MONOCYTES ABSOLUTE (MANUAL DIFF), 0.17 K/uL; 116: EOSINOPHILS ABSOLUTE (MANUAL DIFF), 0.09 K/uL; 116: BASOPHILS % (MANUAL DIFF), 1.7 %; 116: NEUTROPHILS SEGMENTED % (MANUAL DIFF), 71.4 %; 116: LYMPHOCYTES ABSOLUTE (MANUAL DIFF), 0.29 K/uL; 116: MONOCYTES % (MANUAL DIFF), 5.2 %; 116: EOSINOPHILS % (MANUAL DIFF), 2.6 %; 116: BASOPHILS ABSOLUTE (MANUAL DIFF), 0.06 K/uL; 116: SpO2, 99.069; 116: Perf, 0.680; 117: SpO2, 98.864; 117: Perf, 0.548; 118: SpO2, 99.439; 118: Perf, 0.634; 119: SpO2, 98.75; 119: Perf, 0.77; 0: Age, 54; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 36.6; 0: Triage HR, 94.0; 0: Triage RR, 18.0; 0: Triage SBP, 141.0; 0: Triage DBP, 92.0; 0: Triage acuity, 3-Urgent; 0: CC, FLANK PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I checked if there were obvious abnormal vital signs such as high fever or hypotension, and found they were largely within normal ranges. Next, I looked at key labs (like WBC count) to see if they suggested infection or organ dysfunction, but the mild leukopenia, normal creatinine, and other lab values did not strongly indicate sepsis. Then, I evaluated the patient\u2019s clinical presentation\u2014flank pain and stable vital signs\u2014along with stable oxygen saturations that did not suggest acute deterioration. Based on these findings, there is no compelling evidence for high sepsis risk in the next 12 hours.",
        "claims": [
            "Obvious abnormal vital signs such as high fever or hypotension were checked.",
            "The vital signs were largely within normal ranges.",
            "Key labs were evaluated to see if they suggested infection or organ dysfunction.",
            "The WBC count showed mild leukopenia.",
            "The creatinine level was normal.",
            "Other lab values did not strongly indicate sepsis.",
            "The patient\u2019s clinical presentation included flank pain.",
            "The patient had stable vital signs.",
            "Stable oxygen saturations did not suggest acute deterioration.",
            "There is no compelling evidence for high sepsis risk in the next 12 hours."
        ],
        "relevant_claims": [
            "Other lab values did not strongly indicate sepsis.",
            "The patient\u2019s clinical presentation included flank pain.",
            "There is no compelling evidence for high sepsis risk in the next 12 hours."
        ],
        "alignment_scores": [
            0.3,
            0.2,
            0.5
        ],
        "alignment_category": [
            8,
            9,
            9
        ],
        "alignment_reasonings": [
            "The claim refers to lab values not strongly indicating sepsis, which indirectly relates to the assessment of organ dysfunction through lab measures in the SOFA score context. While it doesn't explicitly mention specific lab changes that align with SOFA criteria (like changes in bilirubin, creatinine, etc.), it hints at an evaluation process. This connection is quite indirect and weak, warranting a low alignment rating.",
            "Flank pain itself is not directly aligned with any specific sepsis prediction category. It could, however, suggest a potential underlying infection such as a kidney infection, which may prompt a clinician to investigate further or anticipate treatment. This is only slightly related to the category involving actions taken based on suspicion of infection, hence the low alignment rating.",
            "The claim suggests an absence of immediate intervention or clinical suspicion for serious infection, indirectly relating to the category that involves proactive measures (antibiotics or cultures). While it doesn't discuss the potential for action, the lack of compelling evidence aligns moderately with the rationale for not initiating early treatment or diagnostic measures."
        ],
        "final_alignment_score": 0.3333333333333333,
        "accuracy": 1
    },
    {
        "input": "7: Pain, 7.0; 32: HR, 117.0; 32: RR, 32.0; 32: SpO2, 86.0; 32: SBP, 109.0; 32: DBP, 68.0; 32: MAP, 81.667; 32: Pain, 10.0; 32: Temp, 100.9; 36: SpO2, 96.0; 36: LPM O2, 4.0; 68: WAM DIFTYP, AUTO; 68: RED BLOOD CELLS (RBC), 5.46 MIL/uL; 68: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 24.9 pg; 68: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.1 %; 68: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 68: NEUTROPHIL % (AUTO DIFF), 80.3 %; 68: NEUTROPHIL ABSOLUTE (AUTO DIFF), 6.20 K/uL; 68: MONOCYTE ABSOLUTE (AUTO DIFF), 0.40 K/uL; 68: RED CELL DISTRIBUTION WIDTH (RDW), 14.6 %; 68: MONOCYTE % (AUTO DIFF), 5.2 %; 68: MEAN CORPUSCULAR VOLUME (MCV), 74.0 fL; 68: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.05 K/uL; 68: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 68: EOSINOPHIL % (AUTO DIFF), 0.4 %; 68: NRBC PERCENT (HEMATOLOGY), 0.0 %; 68: HEMOGLOBIN (HGB), 13.6 g/dL; 68: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 68: PLATELET COUNT (PLT), 312 K/uL; 68: HEMATOCRIT (HCT), 40.4 %; 68: LYMPHOCYTE % (AUTO DIFF), 13.6 %; 68: BASOPHIL % (AUTO DIFF), 0.4 %; 68: WHITE BLOOD CELLS (WBC), 7.7 K/uL; 68: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.7 g/dL; 68: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.01 K/uL; 85: SpO2, 98.0; 86: SpO2, 98.625; 86: Perf, 2.463; 86: SBP, 109.0; 86: DBP, 73.0; 86: MAP, 85.0; 87: HR, 113.469; 87: RR, 27.0; 87: SpO2, 99.155; 87: Perf, 2.662; 87: 1min HRV, 19.790; 87: 5min HRV, 19.790; 88: HR, 112.390; 88: RR, 21.492; 88: SpO2, 98.644; 88: Perf, 2.950; 88: 1min HRV, 20.380; 89: HR, 110.603; 89: RR, 27.207; 89: SpO2, 98.586; 89: Perf, 2.988; 89: 1min HRV, 18.547; 90: HR, 107.508; 90: RR, 27.237; 90: SpO2, 98.797; 90: Perf, 4.969; 90: 1min HRV, 11.911; 91: HR, 106.559; 91: RR, 22.780; 91: SpO2, 99.0; 91: Perf, 5.491; 91: 1min HRV, 7.818; 92: HR, 107.448; 92: RR, 21.603; 92: SpO2, 98.931; 92: Perf, 5.781; 92: 1min HRV, 17.544; 92: 5min HRV, 19.342; 92: SBP, 105.0; 92: DBP, 77.0; 92: MAP, 86.333; 92: LPM O2, 4.0; 93: HR, 106.458; 93: RR, 27.153; 93: SpO2, 99.152; 93: Perf, 5.267; 93: 1min HRV, 9.148; 93: SBP, 105.0; 93: DBP, 77.0; 93: MAP, 86.333; 94: HR, 105.397; 94: RR, 27.448; 94: SpO2, 98.931; 94: Perf, 4.354; 94: 1min HRV, 11.650; 95: HR, 105.983; 95: RR, 24.458; 95: SpO2, 98.475; 95: Perf, 5.262; 95: 1min HRV, 7.859; 96: HR, 104.966; 96: RR, 26.254; 96: SpO2, 98.0; 96: Perf, 5.722; 96: 1min HRV, 9.993; 97: HR, 104.759; 97: RR, 28.569; 97: SpO2, 98.345; 97: Perf, 5.849; 97: 1min HRV, 26.592; 97: 5min HRV, 15.220; 98: HR, 106.051; 98: RR, 28.017; 98: SpO2, 98.475; 98: Perf, 4.902; 98: 1min HRV, 13.398; 99: POC PH (V) ISTAT, 7.44; 99: POC LACTATE ISTAT, 0.97 mmol/L; 99: POC TCO2 (V) ISTAT, 36 mmol/L; 99: POC PCO2 (V) ISTAT, 51.2 mmHg; 99: POC O2 SATURATION ISTAT VENOUS, 86 %; 99: POC BASE EXCESS ISTAT, 10 mmol/L; 99: POC HCO3 (V) ISTAT, 34.4 mmol/L; 99: POC PO2 (V) ISTAT, 51 mmHg; 99: HR, 102.362; 99: RR, 23.259; 99: SpO2, 98.0; 99: Perf, 5.626; 99: 1min HRV, 9.641; 100: HR, 103.119; 100: RR, 26.407; 100: SpO2, 98.0; 100: Perf, 6.064; 100: 1min HRV, 9.006; 101: HR, 105.552; 101: RR, 21.793; 101: SpO2, 98.017; 101: Perf, 6.432; 101: 1min HRV, 26.363; 102: HR, 105.746; 102: RR, 21.576; 102: SpO2, 98.492; 102: Perf, 6.412; 102: 1min HRV, 15.509; 102: 5min HRV, 18.497; 103: LIPASE, 7 U/L; 103: HR, 103.559; 103: RR, 21.322; 103: SpO2, 97.966; 103: Perf, 7.953; 103: 1min HRV, 10.207; 103: HYDROMORPHONE, 1 MG/ML INJ SYRG; 104: HR:, 103.966; 104: RR, 22.931; 104: SpO2, 98.190; 104: Perf, 6.394; 104: 1min HRV, 12.384; 105: HR, 102.797; 105: RR, 22.898; 105: SpO2, 98.0; 105: Perf, 7.407; 105: 1min HRV, 9.324; 106: HR, 106.552; 106: RR, 26.207; 106: SpO2, 97.638; 106: Perf, 6.102; 106: 1min HRV, 22.177; 107: HR, 105.051; 107: RR, 20.458; 107: SpO2, 97.542; 107: Perf, 7.189; 107: 1min HRV, 15.540; 107: 5min HRV, 16.297; 108: HR, 102.203; 108: RR, 26.271; 108: SpO2, 98.0; 108: Perf, 8.579; 108: 1min HRV, 8.521; 108: SBP, 104.0; 108: DBP, 68.0; 108: MAP, 80.0; 109: HR, 102.862; 109: RR, 19.431; 109: SpO2, 98.0; 109: Perf, 7.502; 109: 1min HRV, 7.261; 110: HR, 102.322; 110: RR, 22.508; 110: SpO2, 98.0; 110: Perf, 8.154; 110: 1min HRV, 11.387; 111: HR, 100.224; 111: RR, 23.552; 111: SpO2, 98.0; 111: Perf, 7.929; 111: 1min HRV, 13.069; 112: HR, 100.729; 112: RR, 22.237; 112: SpO2, 98.0; 112: Perf, 7.754; 112: 1min HRV, 10.293; 112: 5min HRV, 11.824; 113: HR, 99.966; 113: RR, 24.864; 113: SpO2, 98.0; 113: Perf, 7.96; 113: 1min HRV, 13.281; 114: HR, 99.586; 114: RR, 24.603; 114: SpO2, 98.0; 114: Perf, 8.212; 114: 1min HRV, 12.548; 115: HR, 98.763; 115: RR, 22.390; 115: SpO2, 98.0; 115: Perf, 8.311; 115: 1min HRV, 10.531; 116: HR, 100.362; 116: RR, 22.362; 116: SpO2, 98.0; 116: Perf, 7.152; 116: 1min HRV, 24.455; 117: HR, 98.441; 117: RR, 21.373; 117: SpO2, 98.0; 117: Perf, 7.441; 117: 1min HRV, 13.903; 117: 5min HRV, 16.747; 118: HR, 97.034; 118: RR, 24.085; 118: SpO2, 98.0; 118: Perf, 7.582; 118: 1min HRV, 11.218; 119: HR, 96.879; 119: RR, 22.638; 119: SpO2, 98.0; 119: Perf, 8.531; 119: 1min HRV, 11.097; 0: Age, 23; 0: Gender, M; 0: Race, Black or African American; 0: Means of arrival, Self; 0: Triage Temp, 38.3; 0: Triage HR, 117.0; 0: Triage RR, 32.0; 0: Triage SBP, 109.0; 0: Triage DBP, 68.0; 0: Triage acuity, 3-Urgent; 0: CC, CHEST PAIN,ABDOMINAL PAIN",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, consider whether the patient has signs of systemic infection (fever, tachycardia, tachypnea). Next, determine if there is any indication of end-organ dysfunction (initially low oxygen saturation improved by supplemental O2, plus a higher-than-normal respiratory rate that could signal evolving compromise). Then, check laboratory values like normal lactate to see if they confirm or discount severe sepsis markers (normal lactate alone does not rule out progressive infection). Finally, note that the sustained abnormal vitals (fever, high HR, high RR) combined with possible acute changes in oxygenation raise a concern for infection that could escalate to sepsis. Together, these considerations support a high risk of sepsis within 12 hours.",
        "claims": [
            "The patient should be assessed for signs of systemic infection, such as fever, tachycardia, and tachypnea.",
            "Indications of end-organ dysfunction should be evaluated.",
            "An initial low oxygen saturation that improves with supplemental oxygen may suggest end-organ dysfunction.",
            "A higher-than-normal respiratory rate could signal evolving compromise.",
            "Laboratory values, such as normal lactate, should be checked to confirm or discount severe sepsis markers.",
            "Normal lactate levels alone do not rule out progressive infection.",
            "Sustained abnormal vital signs, including fever, high heart rate, and high respiratory rate, raise concern for infection.",
            "Possible acute changes in oxygenation can indicate an escalating risk of sepsis.",
            "These considerations collectively support a high risk of sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient should be assessed for signs of systemic infection, such as fever, tachycardia, and tachypnea.",
            "Indications of end-organ dysfunction should be evaluated.",
            "An initial low oxygen saturation that improves with supplemental oxygen may suggest end-organ dysfunction.",
            "A higher-than-normal respiratory rate could signal evolving compromise.",
            "Sustained abnormal vital signs, including fever, high heart rate, and high respiratory rate, raise concern for infection.",
            "Possible acute changes in oxygenation can indicate an escalating risk of sepsis.",
            "These considerations collectively support a high risk of sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            0.8,
            0.8,
            0.7,
            0.7,
            1.0,
            0.7,
            0.3
        ],
        "alignment_category": [
            2,
            8,
            8,
            3,
            2,
            8,
            4
        ],
        "alignment_reasonings": [
            "The claim suggests assessing the patient for signs of systemic infection, specifically referencing fever, tachycardia, and tachypnea, which are part of the SIRS criteria. This aligns well with the category as it lists these signs as key indicators of systemic inflammation consistent with early sepsis. However, since the claim refers to an assessment rather than a confirmed presence of these criteria, the alignment is strong but not complete, hence a rating of 0.8.",
            "The claim about evaluating indications of end-organ dysfunction aligns with the SOFA score, which assesses organ dysfunction. The SOFA score tracks changes in organ function, including respiration, coagulation, liver, cardiovascular, central nervous, and renal systems. The focus on end-organ dysfunction strongly suggests a connection to this category, but without specific details on the organ systems involved or the exact score change, it rates at 0.8.",
            "The claim refers to low oxygen saturation and its improvement with supplemental oxygen, which suggests concern for end-organ dysfunction related to oxygenation. While pulse oximetry itself isn't directly a SOFA measure, it conceptually relates to impaired oxygenation, such as the PaO\u2082/FiO\u2082 ratio, which is part of SOFA. This makes the alignment indirect but relevant and meaningful, warranting a moderately strong alignment rating.",
            "The claim mentions a higher-than-normal respiratory rate, which is one of the parameters in the qSOFA score (respiratory rate \u226522/min) used to flag risk of sepsis-related organ dysfunction. While the claim doesn't specify if the respiratory rate meets the threshold required for qSOFA, its mention of evolving compromise suggests concern for significant clinical deterioration. Therefore, it's reasonably aligned with the category, although not perfectly aligned due to the lack of specific values.",
            "The claim mentions \"fever, high heart rate, and high respiratory rate,\" which align directly with the SIRS criteria (temperature >38\u00b0C, heart rate >90 bpm, respiratory rate >20/min). These are key components used to identify systemic inflammation consistent with early sepsis. The reference to multiple criteria strongly matches the SIRS framework, resulting in a perfect alignment.",
            "The claim of \"possible acute changes in oxygenation\" is conceptually tied to impaired oxygenation, similar to PaO\u2082/FiO\u2082 ratios that are included in the SOFA score. While not a direct match, the statement aligns well with the implications of oxygenation-related measurements affecting SOFA scoring, and, by extension, potential sepsis risk. Thus, it moderately aligns with this category.",
            "The claim about a high risk of sepsis within the next 12 hours is vague and could potentially relate to several categories, as it doesn't specify any particular clinical indicator. However, the Elevated NEWS Score specifically predicts imminent clinical deterioration compatible with sepsis, which aligns conceptually with the claim of predicting sepsis risk in a specified timeframe. The alignment is weak due to the lack of specific details in the claim."
        ],
        "final_alignment_score": 0.7142857142857143,
        "accuracy": 1
    },
    {
        "input": "12: SpO2, 98.026; 13: HR, 117.0; 13: RR, 18.0; 13: SpO2, 97.0; 13: SBP, 148.0; 13: DBP, 99.0; 13: MAP, 115.333; 13: Pain, 0.0; 13: Temp, 97.9; 14: SpO2, 96.877; 14: SBP, 148.0; 14: DBP, 99.0; 14: MAP, 115.333; 15: SpO2, 96.559; 15: Perf, 0.549; 16: SpO2, 96.121; 16: Perf, 0.543; 17: SpO2, 95.717; 17: Perf, 0.54; 18: SpO2, 96.339; 18: Perf, 0.569; 19: SpO2, 96.155; 19: Perf, 0.618; 20: SpO2, 94.929; 20: Perf, 0.62; 21: SpO2, 94.312; 21: Perf, 0.62; 22: SpO2, 94.214; 22: Perf, 0.631; 23: SpO2, 95.489; 23: Perf, 0.899; 24: SpO2, 94.466; 24: Perf, 0.986; 25: SpO2, 95.390; 25: Perf, 0.890; 26: SpO2, 95.707; 26: Perf, 0.893; 27: SpO2, 95.339; 27: Perf, 0.886; 28: SpO2, 95.932; 28: Perf, 0.794; 29: SpO2, 95.476; 29: Perf, 0.73; 30: SpO2, 95.695; 31: SpO2, 95.121; 31: Perf, 0.726; 32: SpO2, 95.881; 32: Perf, 0.751; 33: SpO2, 95.593; 33: Perf, 0.769; 34: SpO2, 95.828; 34: Perf, 0.635; 35: SpO2, 95.932; 35: Perf, 0.645; 36: SpO2, 96.517; 36: Perf, 0.65; 37: SpO2, 95.746; 37: Perf, 0.65; 37: Temp, 99.9; 38: SpO2, 95.1; 38: Perf, 0.65; 39: SpO2, 97.0; 39: Perf, 0.65; 40: Perf, 0.65; 41: SpO2, 95.769; 41: Perf, 0.654; 42: SpO2, 97.0; 42: Perf, 0.67; 43: SpO2, 95.35; 43: Perf, 0.704; 44: SpO2, 94.288; 44: Perf, 0.715; 45: SpO2, 93.421; 45: Perf, 0.72; 46: SpO2, 94.0; 46: Perf, 0.727; 47: SpO2, 94.458; 47: Perf, 0.74; 48: SpO2, 94.379; 48: Perf, 0.741; 49: SpO2, 94.153; 49: Perf, 0.844; 50: SpO2, 94.356; 50: Perf, 1.115; 51: SpO2, 94.524; 51: Perf, 1.12; 51: LR IV BOLUS -, 500 ML; 52: SpO, 2: 94.373; 52: Perf, 1.12; 53: SpO2, 94.569; 53: Perf, 1.139; 54: SpO2, 93.830; 54: Perf, 1.238; 55: SpO2, 93.714; 55: Perf, 1.176; 56: SpO2, 95.190; 56: Perf, 0.968; 57: SpO2, 94.169; 57: Perf, 0.96; 58: SpO2, 94.466; 58: Perf, 0.96; 59: SpO2, 93.712; 59: Perf, 0.946; 60: SpO2, 95.0; 60: Perf, 0.894; 61: SpO2, 95.017; 61: Perf, 0.882; 62: SpO2, 95.441; 62: Perf, 0.883; 63: SpO2, 94.707; 63: Perf, 0.87; 64: SpO2, 95.017; 64: Perf, 0.861; 65: SpO2, 94.644; 65: Perf, 0.857; 66: SpO2, 95.310; 66: Perf, 0.742; 67: SpO2, 94.824; 67: Perf, 0.69; 68: INR, 1.9; 68: PROTHROMBIN TIME, 21.2 seconds; 68: SpO2, 94.655; 69: PART. THROMBOPLASTIN TIME, 79.5 seconds; 69: SpO2, 96.525; 69: Perf, 0.725; 70: SpO2, 96.822; 70: Perf, 0.7; 71: SpO2, 95.085; 72: SpO2, 94.644; 72: Perf, 0.757; 73: WAM DIFTYP, AUTO; 73: POTASSIUM, 5.2 mmol/L; 73: CO2, 21 mmol/L; 73: GLUCOSE, 115 mg/dL; 73: BLOOD UREA NITROGEN (BUN), 51 mg/dL; 73: CALCIUM, 8.8 mg/dL; 73: CHLORIDE, 103 mmol/L; 73: EGFR REFIT WITHOUT RACE (2021), 55 mL/min/1.73 m2; 73: ANION GAP, 14 mmol/L; 73: SODIUM, 138 mmol/L; 73: CREATININE, 1.15 mg/dL; 73: EGFR FOR AFRICAN AMERICAN, 64 mL/min/1.73 m2; 73: MONOCYTE ABSOLUTE (AUTO DIFF), 0.02 K/uL; 73: NRBC PERCENT (HEMATOLOGY), 0.0 %; 73: RED CELL DISTRIBUTION WIDTH (RDW), 15.8 %; 73: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 73: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 28.4 pg; 73: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 73: WHITE BLOOD CELLS (WBC), 7.1 K/uL; 73: NEUTROPHIL ABSOLUTE (AUTO DIFF), 6.15 K/uL; 73: EOSINOPHIL % (AUTO DIFF), 0.1 %; 73: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.03 K/uL; 73: MONOCYTE % (AUTO DIFF), 0.3 %; 73: NEUTROPHIL % (AUTO DIFF), 87.1 %; 73: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.1 g/dL; 73: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 73: PLATELET COUNT (PLT), 106 K/uL; 73: RED BLOOD CELLS (RBC), 3.70 MIL/uL; 73: LYMPHOCYTE % (AUTO DIFF), 11.8 %; 73: BASOPHIL % (AUTO DIFF), 0.3 %; 73: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 73: HEMATOCRIT (HCT), 33.8 %; 73: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.83 K/uL; 73: MEAN CORPUSCULAR VOLUME (MCV), 91.4 fL; 73: HEMOGLOBIN (HGB), 10.5 g/dL; 73: SpO2, 94.759; 73: Perf, 0.619; 74: SpO2, 95.083; 74: Perf, 0.627; 74: SBP, 127.0; 74: DBP, 67.0; 74: MAP, 87.0; 75: Perf, 0.63; 76: SpO2, 93.6; 76: Perf, 0.617; 77: SpO2, 94.621; 77: Perf, 0.6; 78: SpO2, 95.179; 78: Perf, 0.6; 79: SpO2, 95.542; 79: Perf, 0.6; 80: SpO2, 92.625; 80: Perf, 0.6; 81: SpO2, 91.722; 82: SpO2, 92.1; 83: SpO2, 95.957; 84: SpO2, 94.797; 85: SpO2, 95.552; 86: SpO2, 96.4; 87: SpO2, 99.4; 88: SpO2, 97.308; 90: SpO2, 95.739; 91: SpO2, 94.356; 92: SpO2, 94.293; 93: SpO2, 94.831; 94: SpO2, 95.220; 95: SpO2, 94.5; 95: Perf, 0.516; 96: SpO2, 94.780; 96: Perf, 0.531; 97: SpO2, 95.172; 97: Perf, 0.547; 98: SpO2, 95.390; 98: Perf, 0.573; 99: SpO2, 95.085; 99: Perf, 0.603; 100: SpO2, 94.845; 100: Perf, 0.638; 101: SpO2, 94.525; 101: Perf, 0.655; 102: SpO2, 93.333; 102: Perf, 0.66; 111: SpO2, 83.875; 112: SpO2, 94.931; 112: Perf, 0.38; 113: SpO2, 95.0; 113: Perf, 0.352; 114: SpO2, 95.746; 114: Perf, 0.358; 115: SpO2, 95.897; 115: Perf, 0.361; 116: SpO2, 94.830; 116: Perf, 0.274; 117: HR, 130.0; 117: SpO2, 94.0; 117: Temp, 103.1; 0: Age, 90; 0: Gender, M; 0: Race, Other; 0: Means of arrival, EMS; 0: Triage Temp, 36.6; 0: Triage HR, 117.0; 0: Triage RR, 18.0; 0: Triage SBP, 148.0; 0: Triage DBP, 99.0; 0: Triage acuity, 3-Urgent; 0: CC, MALE GENITAL PROBLEM",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, I checked whether the patient\u2019s vital signs showed potential sepsis indicators, such as tachycardia (heart rate of 130) and fever (temperature of 103.1). Next, I looked for organ dysfunction, noting the low platelet count (106 K/uL) and prolonged coagulation times. Then, I assessed for possible infection, given the elevated temperature and labs suggestive of an inflammatory process. Combining these findings, the patient appears to be at high risk of developing sepsis within 12 hours.",
        "claims": [
            "The patient's vital signs showed potential sepsis indicators.",
            "The patient has tachycardia with a heart rate of 130.",
            "The patient has a fever with a temperature of 103.1.",
            "I noted low platelet count in the patient at 106 K/uL.",
            "The patient has prolonged coagulation times.",
            "I assessed for possible infection in the patient.",
            "The patient's elevated temperature suggests a possible infection.",
            "Laboratory results suggest an inflammatory process in the patient.",
            "Combining these findings indicates the patient is at high risk of developing sepsis.",
            "The patient is at high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient's vital signs showed potential sepsis indicators.",
            "The patient has tachycardia with a heart rate of 130.",
            "The patient has a fever with a temperature of 103.1.",
            "I noted low platelet count in the patient at 106 K/uL.",
            "The patient's elevated temperature suggests a possible infection.",
            "Laboratory results suggest an inflammatory process in the patient.",
            "Combining these findings indicates the patient is at high risk of developing sepsis.",
            "The patient is at high risk of developing sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            0.5,
            0.7,
            0.6,
            0.9,
            0.8,
            0.7,
            0.3,
            0.5
        ],
        "alignment_category": [
            4,
            2,
            2,
            8,
            2,
            2,
            4,
            4
        ],
        "alignment_reasonings": [
            "The claim referring to \"vital signs showing potential sepsis indicators\" loosely aligns with the concept of an elevated NEWS score, which is derived from deranged vital signs. However, since it lacks specific details (such as exact values or a NEWS point total), the alignment is not direct or comprehensive. Therefore, while there is a conceptual connection, the specific connection is moderate.",
            "Tachycardia, defined as a heart rate >90 bpm, is directly listed as a SIRS criterion indicating systemic inflammation and early sepsis. The alignment is strong as tachycardia is an explicit part of the SIRS criteria, but the claim only addresses one component of the \u22652 needed for full SIRS positivity, hence the rating of 0.7.",
            "A fever with a temperature of 103.1\u00b0F (39.5\u00b0C) exceeds the SIRS criterion of temperature >38\u00b0C. While only one SIRS criterion is identified in the claim (fever), it strongly aligns with systemic inflammation as described in the SIRS criteria. However, to fully satisfy the SIRS positivity condition, at least two criteria are needed, thus explaining the rating of 0.6 rather than a perfect score.",
            "A low platelet count (below 100\u202f\u00d7\u202f10\u2079/L) is a specific component of the SOFA score indicating potential organ dysfunction. The patient's platelet count is slightly above the specific threshold but still sufficiently low to suggest a risk factor for sepsis. The alignment is strong, though not absolute, as it does not completely meet the threshold.",
            "An elevated temperature is one of the criteria under SIRS, which is used to identify systemic inflammation consistent with early sepsis. Although the temperature is not specified in relation to the exact threshold (>38\u00b0C), the mention of it as \"elevated\" strongly suggests SIRS relevance, thus the high alignment rating.",
            "The claim refers to an inflammatory process, which aligns with the SIRS criteria as they are designed to identify systemic inflammation potentially indicative of early sepsis. However, the claim is not specific about which SIRS criteria (e.g., elevated WBC) apply, so while there is a distinct connection, it's not as direct as it could be.",
            "The claim refers generally to a combination of findings that suggests high sepsis risk. The Elevated NEWS Score category captures the idea of synthesizing various deranged vital signs into a single risk assessment value, although the claim does not specify any criteria or quantitative score. The indirect relationship to NEWS leads to a moderate but not strong alignment.",
            "The claim broadly states a high risk of developing sepsis soon, without specifying particular clinical indicators. The NEWS score aligns with predicting imminent deterioration, similar to \"high risk,\" but the claim doesn't directly mention any typical NEWS parameters or scores, resulting in moderate rather than strong alignment."
        ],
        "final_alignment_score": 0.625,
        "accuracy": 1
    },
    {
        "input": "11: HR, 124.0; 11: RR, 24.0; 11: SpO2, 96.0; 11: SBP, 110.0; 11: DBP, 65.0; 11: MAP, 80.0; 11: Temp, 97.9; 32: HR, 123.588; 32: RR, 18.0; 32: SpO2, 96.067; 32: Perf, 0.2; 32: 1min HRV, 6.990; 32: SBP, 117.0; 32: DBP, 73.0; 32: MAP, 87.667; 33: HR, 120.208; 33: RR, 19.604; 33: 1min HRV, 2.968; 34: HR, 119.173; 34: RR, 17.942; 34: SpO2, 97.0; 34: Perf, 0.15; 34: 1min HRV, 4.574; 35: HR, 117.981; 35: RR, 16.547; 35: SpO2, 96.5; 35: Perf, 0.14; 35: 1min HRV, 2.616; 35: 5min HRV, 7.779; 35: SBP, 113.0; 35: DBP, 69.0; 35: MAP, 83.667; 36: HR, 118.132; 36: RR, 15.736; 36: 1min HRV, 5.070; 36: SBP, 113.0; 36: DBP, 69.0; 36: MAP, 83.667; 37: HR, 117.0; 37: RR, 16.0; 37: 1min HRV, 1.732; 38: HR, 117.113; 38: RR, 15.434; 38: SpO2, 95.0; 38: Perf, 0.207; 38: 1min HRV, 2.010; 39: HR, 116.019; 39: RR, 15.038; 39: SpO2, 95.0; 39: Perf, 0.21; 39: 1min HRV, 2.276; 40: HR, 116.075; 40: RR, 15.642; 40: 1min HRV, 2.121; 40: 5min HRV, 4.496; 41: HR, 115.623; 41: RR, 15.415; 41: SpO2, 95.0; 41: Perf, 0.233; 41: 1min HRV, 1.634; 42: HR, 115.717; 42: RR, 15.396; 42: SpO2, 95.333; 42: Perf, 0.22; 42: 1min HRV, 2.719; 43: HR, 115.755; 43: RR, 15.717; 43: SpO2, 95.963; 43: Perf, 0.226; 43: 1min HRV, 1.995; 44: HR, 115.462; 44: RR, 15.0; 44: SpO2, 94.288; 44: Perf, 0.281; 44: 1min HRV, 2.2; 45: HR, 115.340; 45: RR, 14.075; 45: SpO2, 94.472; 45: Perf, 0.278; 45: 1min HRV, 1.998; 45: 5min HRV, 2.160; 46: HR, 115.340; 46: RR, 13.660; 46: SpO2, 94.038; 46: Perf, 0.276; 46: 1min HRV, 2.547; 47: HR, 115.0; 47: RR, 13.923; 47: SpO2, 94.135; 47: Perf, 0.275; 47: 1min HRV, 3.042; 48: HR, 115.245; 48: RR, 14.019; 48: SpO2, 94.617; 48: Perf, 0.266; 48: 1min HRV, 2.396; 49: HR, 117.808; 49: RR, 17.981; 49: SpO2, 95.432; 49: Perf, 0.238; 49: 1min HRV, 5.660; 50: HR, 119.849; 50: RR, 18.453; 50: SpO2, 96.208; 50: Perf, 0.328; 50: 1min HRV, 2.571; 50: 5min HRV, 9.206; 51: HR, 119.170; 51: RR, 17.321; 51: SpO2, 95.264; 51: Perf, 0.421; 51: 1min HRV, 2.345; 52: HR, 118.288; 52: RR, 17.577; 52: SpO2, 95.08; 52: Perf, 0.331; 52: 1min HRV, 2.746; 53: HR, 118.519; 53: RR, 18.759; 53: SpO2, 95.630; 53: Perf, 0.334; 53: 1min HRV, 3.235; 54: HR, 118.519; 54: RR, 19.385; 54: SpO2, 94.212; 54: Perf, 0.363; 54: 1min HRV, 1.890; 55: HR, 117.547; 55: RR, 18.566; 55: SpO2, 95.0; 55: Perf, 0.332; 55: 1min HRV, 2.645; 55: 5min HRV, 3.315; 56: HR, 116.769; 56: RR, 18.385; 56: SpO2, 95.0; 56: Perf, 0.333; 56: 1min HRV, 4.047; 57: HR, 118.472; 57: RR, 21.830; 57: SpO2, 95.774; 57: Perf, 0.297; 57: 1min HRV, 8.639; 58: HR, 118.321; 58: RR, 20.208; 58: SpO2, 96.302; 58: Perf, 0.278; 58: 1min HRV, 4.660; 59: HR, 117.5; 59: RR, 16.981; 59: SpO2, 95.865; 59: Perf, 0.261; 59: 1min HRV, 4.249; 60: HR, 115.981; 60: RR, 15.962; 60: SpO2, 94.604; 60: Perf, 0.295; 60: 1min HRV, 1.728; 60: 5min HRV, 6.621; 61: HR, 115.558; 61: RR, 16.077; 61: SpO2, 94.404; 61: Perf, 0.293; 61: 1min HRV, 3.394; 62: HR, 115.509; 62: RR, 16.547; 62: SpO2, 95.0; 62: Perf, 0.267; 62: 1min HRV, 1.862; 63: HR, 115.981; 63: RR, 16.792; 63: SpO2, 95.115; 63: Perf, 0.258; 63: 1min HRV, 1.911; 64: HR, 116.654; 64: RR, 17.404; 64: SpO2, 95.654; 64: Perf, 0.279; 64: 1min HRV, 3.281; 65: HR, 118.889; 65: RR, 18.037; 65: SpO2, 95.0; 65: Perf, 0.319; 65: 1min HRV, 8.971; 65: 5min HRV, 7.523; 66: HR, 119.481; 66: RR, 19.615; 66: SpO2, 95.385; 66: Perf, 0.316; 66: 1min HRV, 3.115; 66: SBP, 108.0; 66: DBP, 76.0; 66: MAP, 86.667; 67: HR, 118.943; 67: RR, 18.264; 67: SpO2, 95.264; 67: Perf, 0.389; 67: 1min HRV, 2.462; 68: HR, 118.868; 68: RR, 18.019; 68: SpO2, 95.0; 68: Perf, 0.353; 68: 1min HRV, 3.067; 69: HR, 117.904; 69: RR, 18.192; 69: SpO2, 95.0; 69: Perf, 0.343; 69: 1min HRV, 2.331; 70: HR, 117.415; 70: RR, 17.057; 70: SpO2, 95.0; 70: Perf, 0.326; 70: 1min HRV, 2.257; 70: 5min HRV, 3.951; 71: HR, 118.788; 71: RR, 18.25; 71: SpO2, 95.0; 71: Perf, 0.294; 71: 1min HRV, 5.300; 72: HR, 120.094; 72: RR, 18.377; 72: SpO2, 95.340; 72: Perf, 0.285; 72: 1min HRV, 1.663; 73: HR, 119.283; 73: RR, 18.094; 73: SpO2, 95.528; 73: Perf, 0.277; 73: 1min HRV, 6.112; 74: HR, 118.692; 74: RR, 16.962; 74: SpO2, 95.385; 74: Perf, 0.294; 74: 1min HRV, 4.186; 75: HR, 118.075; 75: RR, 16.528; 75: SpO2, 95.811; 75: Perf, 0.311; 75: 1min HRV, 3.037; 75: 5min HRV, 5.208; 76: HR, 119.308; 76: RR, 17.538; 76: SpO2, 94.173; 76: Perf, 0.370; 76: 1min HRV, 5.686; 77: HR, 117.396; 77: RR, 15.623; 77: SpO2, 93.925; 77: Perf, 0.396; 77: 1min HRV, 2.105; 78: HR, 118.321; 78: RR, 16.755; 78: SpO2, 94.0; 78: Perf, 0.371; 78: 1min HRV, 3.661; 79: HR, 118.151; 79: RR, 16.623; 79: SpO2, 94.0; 79: Perf, 0.396; 79: 1min HRV, 2.929; 80: HR, 117.463; 80: RR, 15.056; 80: SpO2, 94.0; 80: Perf, 0.372; 80: 1min HRV, 1.731; 80: 5min HRV, 4.406; 81: HR, 117.5; 81: RR, 15.0; 81: SpO2, 93.923; 81: Perf, 0.317; 81: 1min HRV, 2.825; 82: HR, 119.370; 82: RR, 15.630; 82: SpO2, 93.833; 82: Perf, 0.315; 82: 1min HRV, 6.033; 83: HR, 117.679; 83: RR, 15.830; 83: SpO2, 94.0; 83: Perf, 0.320; 83: 1min HRV, 2.040; 84: HR, 116.788; 84: RR, 15.077; 84: SpO2, 93.423; 84: Perf, 0.391; 84: 1min HRV, 2.008; 85: 5min HRV, 5.663; 95: HR, 119.0; 95: RR, 17.0; 95: SpO2, 95.0; 95: SBP, 115.0; 95: DBP, 73.0; 95: MAP, 87.0; 116: POC PH (V) ISTAT, 7.43; 116: POC PCO2 (V) ISTAT, 46.2 mmHg; 116: POC LACTATE ISTAT, 2.90 mmol/L; 116: POC HCO3 (V) ISTAT, 30.7 mmol/L; 116: POC PO2 (V) ISTAT, 38 mmHg; 116: POC TCO2 (V) ISTAT, 32 mmol/L; 116: POC BASE EXCESS ISTAT, 6 mmol/L; 116: POC O2 SATURATION ISTAT VENOUS, 73 %; 118: POC, HCG, ISTAT QUALITATIVE: Negative; 118: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 0: Age, 52; 0: Gender, F; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 36.6; 0: Triage HR, 124.0; 0: Triage RR, 24.0; 0: Triage SBP, 110.0; 0: Triage DBP, 65.0; 0: Triage acuity, 2-Emergent; 0: CC, EDEMA,JAUNDICE,ABNORMAL LAB",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, I identified SIRS criteria by checking the patient\u2019s heart rate (consistently above 90) and respiratory rate (above 20). Next, I noted possible organ dysfunction from the elevated lactate level (2.9 mmol/L) and persistent hemodynamic changes. Then, I assessed accompanying clinical factors such as potential jaundice and abnormal labs raising concern for infection. These elements combined suggest a high risk for sepsis within 12 hours.",
        "claims": [
            "The patient's heart rate is consistently above 90.",
            "The patient's respiratory rate is above 20.",
            "I identified SIRS criteria by checking the patient\u2019s heart rate and respiratory rate.",
            "The elevated lactate level is 2.9 mmol/L.",
            "There are persistent hemodynamic changes in the patient.",
            "There are possible signs of organ dysfunction indicated by the elevated lactate level and hemodynamic changes.",
            "I assessed accompanying clinical factors such as potential jaundice.",
            "There are abnormal labs raising concern for infection.",
            "These elements combined suggest a high risk for sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient's heart rate is consistently above 90.",
            "The patient's respiratory rate is above 20.",
            "I identified SIRS criteria by checking the patient\u2019s heart rate and respiratory rate.",
            "The elevated lactate level is 2.9 mmol/L.",
            "There are persistent hemodynamic changes in the patient.",
            "There are possible signs of organ dysfunction indicated by the elevated lactate level and hemodynamic changes.",
            "I assessed accompanying clinical factors such as potential jaundice.",
            "There are abnormal labs raising concern for infection.",
            "These elements combined suggest a high risk for sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.7,
            0.9,
            1.0,
            1.0,
            0.7,
            1.0,
            0.5,
            0.3,
            0.3
        ],
        "alignment_category": [
            2,
            2,
            2,
            5,
            6,
            5,
            8,
            9,
            4
        ],
        "alignment_reasonings": [
            "A heart rate consistently above 90 bpm is one of the criteria listed under SIRS, which are used to identify systemic inflammation consistent with early sepsis. However, since only one SIRS criterion is mentioned and two are required for a full SIRS positivity assessment, the alignment is strong but not complete, leading to a rating less than perfect.",
            "The claim indicates a respiratory rate above 20, which satisfies one of the SIRS criteria. This directly relates to the systemic inflammatory response often seen in early sepsis. However, SIRS requires the presence of two or more criteria, so while this demonstrates alignment with early sepsis indication, it isn't sufficient alone to confirm SIRS positivity, thus the alignment rating of 0.9.",
            "The claim explicitly mentions checking the heart rate and respiratory rate, both of which are components of the SIRS criteria. The presence of \u22652 SIRS criteria indicates systemic inflammation consistent with early sepsis. Since the claim refers directly to considerations used to identify SIRS, the alignment is perfect.",
            "The claim specifically mentions an elevated serum lactate level of 2.9 mmol/L, which aligns perfectly with the category of Elevated Serum Lactate (\u22652 mmol/L). The category identifies a lactate level equal to or exceeding 2 mmol/L as a strong indicator of tissue hypoperfusion and elevated sepsis risk. The claim meets and surpasses this threshold, resulting in a perfect alignment.",
            "Hemodynamic changes often refer to alterations in heart rate and blood pressure, which directly relate to the shock index. The shock index is a key indicator of hemodynamic instability, a critical factor in assessing sepsis severity. While the claim doesn't quantify changes needed to determine an elevated shock index, the reference to \"persistent hemodynamic changes\" suggests a significant alteration that aligns closely with this category.",
            "The claim explicitly mentions an elevated lactate level, which directly corresponds to the category of Elevated Serum Lactate. The reference to hemodynamic changes strengthens the association with systemic issues related to sepsis. Elevated lactate is a key indicator of tissue hypoperfusion and sepsis risk, making the alignment perfect.",
            "Jaundice may indicate elevated bilirubin levels, which is a component of the SOFA score. Although the claim does not explicitly state elevated bilirubin or a specific SOFA score increase, the mention of jaundice connects conceptually to organ dysfunction criteria used in the SOFA score. The alignment is moderate as it implies potential organ-related issues without direct evidence of a SOFA score change.",
            "The claim mentions \"abnormal labs raising concern for infection,\" which suggests suspicion of infection. However, it lacks specific concrete actions such as administering antibiotics or drawing blood cultures, which are directly mentioned in this category. The alignment is minimal as it alludes to, but does not explicitly include, the actions that the category emphasizes.",
            "The claim broadly suggests a high risk of sepsis without specific details. The NEWS score, which assesses overall clinical risk and deterioration, is most conceptually aligned with the notion of an imminent high sepsis risk. However, due to the vague nature of \"these elements,\" the alignment is weak and indirect. Other categories might also align loosely, but none better fit the context given."
        ],
        "final_alignment_score": 0.711111111111111,
        "accuracy": 1
    },
    {
        "input": "4: SBP, 87.0; 4: DBP, 67.0; 4: MAP, 73.667; 5: HR, 122.0; 5: RR, 20.0; 5: SpO2, 96.0; 5: 1min HRV, 35.0; 5: SBP, 87.0; 5: DBP, 67.0; 5: MAP, 73.667; 5: Pain, 0.0; 5: Temp, 97.6; 6: HR, 120.811; 6: 1min HRV, 27.447; 7: HR, 122.915; 7: SpO2, 100.0; 7: Perf, 0.11; 7: 1min HRV, 14.483; 7: 5min HRV, 22.525; 8: HR, 121.707; 8: SpO2, 100.0; 8: Perf, 0.087; 8: 1min HRV, 18.467; 9: HR, 121.949; 9: SpO2, 100.0; 9: Perf, 0.08; 9: 1min HRV, 20.872; 10: HR, 122.724; 10: SpO2, 100.0; 10: Perf, 0.08; 10: 1min HRV, 14.636; 11: POC GLUCOSE BY METER, 93 mg/dL; 11: HR, 124.707; 11: SpO2, 99.8; 11: Perf, 0.073; 11: 1min HRV, 16.397; 12: 5min HRV, 18.206; 18: POC, BHCG, ISTAT QUANTITATIVE: 7.1 IU/L; 20: POC PH (V) ISTAT, 7.47; 20: POC LACTATE ISTAT, 0.77 mmol/L; 20: POC PCO2 (V) ISTAT, 23.4 mmHg; 20: POC PO2 (V) ISTAT, 47 mmHg; 20: POC HCO3 (V) ISTAT, 16.9 mmol/L; 20: POC TCO2 (V) ISTAT, 18 mmol/L; 20: POC BASE EXCESS ISTAT, -7 mmol/L; 20: POC O2 SATURATION ISTAT VENOUS, 86 %; 27: HR, 59.0; 27: RR, 16.0; 27: SpO2, 71.0; 27: SBP, 94.0; 27: DBP, 70.0; 27: MAP, 78.0; 27: Pain, 0.0; 30: LR IV BOLUS -, 1000 ML; 40: ABO/RH, (AUTOMATION): B Positive; 40: ANTIBODY SCREEN 3, NEG; 46: METRONIDAZOLE IN NACL (ISO-OS), 500 MG/100 ML IV PGBK; 47: PART. THROMBOPLASTIN TIME:, 37.6 seconds; 47: LEVOFLOXACIN IN D, 5W 750 MG/150 ML IV PGBK; 54: INR:, 1.7; 54: PROTHROMBIN TIME, 19.5 seconds; 64: LIPASE, 5 U/L; 83: DIPHENHYDRAMINE HCL, 50 MG/ML INJ SOLN; 86: TROPONIN I: <., 017 ng/mL; 92: NEUTROPHILS SEGMENTED % (MANUAL DIFF), 86.9 %; 92: NEUTROPHILS ABSOLUTE (MANUAL DIFF) (SEGS+BANDS), 11.57 K/uL; 92: MONOCYTES % (MANUAL DIFF), 2.6 %; 92: LYMPHOCYTES % (MANUAL DIFF), 0.9 %; 92: MONOCYTES ABSOLUTE (MANUAL DIFF), 0.31 K/uL; 92: NEUTROPHILS BANDS % (MANUAL DIFF), 9.6 %; 92: LYMPHOCYTES ABSOLUTE (MANUAL DIFF), 0.11 K/uL; 94: HEMOGLOBIN (HGB), 4.2 g/dL; 94: HEMATOCRIT (HCT), 12.2 %; 94: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.4 g/dL; 94: MEAN CORPUSCULAR VOLUME (MCV), 84.7 fL; 94: HEMOGLOBIN (HGB), 4.2 g/dL; 94: RED CELL DISTRIBUTION WIDTH (RDW), 14.5 %; 94: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.4 g/dL; 94: WHITE BLOOD CELLS (WBC), 12.0 K/uL; 94: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.2 pg; 94: MEAN CORPUSCULAR VOLUME (MCV), 84.7 fL; 94: PLATELET COUNT (PLT), 27 K/uL; 94: RED BLOOD CELLS (RBC), 1.44 MIL/uL; 94: WHITE BLOOD CELLS (WBC), 12.0 K/uL; 94: RED CELL DISTRIBUTION WIDTH (RDW), 14.5 %; 94: HEMATOCRIT (HCT), 12.2 %; 94: RED BLOOD CELLS (RBC), 1.44 MIL/uL; 94: PLATELET COUNT (PLT), 27 K/uL; 94: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.2 pg; 95: HR, 103.0; 95: RR, 24.0; 95: SpO2, 100.0; 95: SBP, 96.0; 95: DBP, 59.0; 95: MAP, 71.333; 95: Temp, 97.6; 102: HR, 123.0; 102: SpO2, 100.0; 102: SBP, 96.0; 102: DBP, 59.0; 102: MAP, 71.333; 111: HR, 114.0; 111: RR, 28.0; 111: SpO2, 100.0; 111: SBP, 94.0; 111: DBP, 55.0; 111: MAP, 68.0; 111: Temp, 97.7; 117: HR, 127.0; 117: SpO2, 100.0; 119: BLOOD UREA NITROGEN (BUN), 35 mg/dL; 119: GLUCOSE, 89 mg/dL; 119: GLUCOSE, 89 mg/dL; 119: AST (SGOT), 15 U/L; 119: ALT (SGPT), 10 U/L; 119: ANION GAP, 15 mmol/L; 119: EGFR REFIT WITHOUT RACE (2021), 17 mL/min/1.73 m2; 119: PROTEIN TOTAL, 5.3 g/dL; 119: POTASSIUM, 3.1 mmol/L; 119: BILIRUBIN TOTAL, 0.3 mg/dL; 119: CORRECTED CALCIUM, 8.8 mg/dL; 119: ALBUMIN, 2.4 g/dL; 119: CHLORIDE, 88 mmol/L; 119: EGFR REFIT WITHOUT RACE (2021), 17 mL/min/1.73 m2; 119: CHLORIDE, 88 mmol/L; 119: PROTEIN TOTAL, 5.3 g/dL; 119: GLOBULIN, 2.9 g/dL; 119: AST (SGOT), 15 U/L; 119: CORRECTED CALCIUM, 8.8 mg/dL; 119: POTASSIUM, 3.1 mmol/L; 119: BLOOD UREA NITROGEN (BUN), 35 mg/dL; 119: ALT (SGPT), 10 U/L; 119: SODIUM, 119 mmol/L; 119: ANION GAP, 15 mmol/L; 119: SODIUM, 119 mmol/L; 119: CALCIUM, 7.5 mg/dL; 119: CO2, 16 mmol/L; 119: ALKALINE PHOSPHATASE, 129 U/L; 119: CO2, 16 mmol/L; 119: GLOBULIN, 2.9 g/dL; 119: BILIRUBIN TOTAL, 0.3 mg/dL; 119: EGFR FOR AFRICAN AMERICAN, 20 mL/min/1.73 m2; 119: CREATININE, 3.12 mg/dL; 119: ALBUMIN, 2.4 g/dL; 119: EGFR FOR AFRICAN AMERICAN, 20 mL/min/1.73 m2; 119: ALKALINE PHOSPHATASE, 129 U/L; 119: CALCIUM, 7.5 mg/dL; 119: CREATININE, 3.12 mg/dL; 0: Age, 44; 0: Gender, F; 0: Race, Other; 0: Means of arrival, EMS; 0: Triage Temp, 36.4; 0: Triage HR, 122.0; 0: Triage RR, 20.0; 0: Triage SBP, 87.0; 0: Triage DBP, 67.0; 0: Triage acuity, 1-Resuscitation; 0: CC, BLOOD IN URINE",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, I reviewed the initial vital signs (hypotension, tachycardia, tachypnea) to see if they met early sepsis criteria. Next, I examined lab results (thrombocytopenia, elevated creatinine, abnormal WBC) for evidence of organ dysfunction. Then, I noted the initiation of broad-spectrum antibiotic therapy, which suggests a suspicion of infection. Putting these facts together, the patient appears to be at high risk of sepsis within 12 hours.",
        "claims": [
            "I reviewed the initial vital signs.",
            "The initial vital signs included hypotension, tachycardia, and tachypnea.",
            "I examined lab results for evidence of organ dysfunction.",
            "The lab results indicated thrombocytopenia, elevated creatinine, and abnormal WBC.",
            "The initiation of broad-spectrum antibiotic therapy was noted.",
            "The initiation of broad-spectrum antibiotic therapy suggests a suspicion of infection.",
            "Putting these facts together, the patient appears to be at high risk of sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The initial vital signs included hypotension, tachycardia, and tachypnea.",
            "I examined lab results for evidence of organ dysfunction.",
            "The lab results indicated thrombocytopenia, elevated creatinine, and abnormal WBC.",
            "The initiation of broad-spectrum antibiotic therapy was noted.",
            "The initiation of broad-spectrum antibiotic therapy suggests a suspicion of infection.",
            "Putting these facts together, the patient appears to be at high risk of sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.9,
            0.7,
            0.9,
            1.0,
            0.8,
            0.3
        ],
        "alignment_category": [
            2,
            8,
            8,
            9,
            9,
            4
        ],
        "alignment_reasonings": [
            "The claim mentions tachycardia and tachypnea, which are both part of the SIRS criteria (heart rate\u202f>\u202f90\u202fbpm and respiratory rate\u202f>\u202f20\u202f/min). Hypotension is not included in the SIRS definition, but the presence of two other aspects make it largely aligned with SIRS Positivity. Since all conditions meet or exceed the defined thresholds, it's a strong, albeit not purely exclusive, fit.",
            "The claim mentions examining lab results for evidence of organ dysfunction. The SOFA score is specifically designed to assess organ dysfunction through lab-based criteria like PaO\u2082/FiO\u2082, platelets, bilirubin, and creatinine levels. While the claim does not explicitly mention any specific SOFA criteria or point changes, the focus on organ dysfunction suggests a notable, though not perfect, alignment with the SOFA category.",
            "The claim directly mentions thrombocytopenia and elevated creatinine, both of which are specific components of the SOFA score (platelets <100 \u00d7 10\u2079/L, creatinine >2 mg/dL), indicating new organ dysfunction. Although abnormal WBC is not part of the SOFA criteria, the presence of two SOFA components aligns closely with the identified category, suggesting a higher risk of sepsis due to multi-organ involvement. The high alignment rating reflects the strong relevance of the claim to the category.",
            "The claim directly mentions the initiation of broad-spectrum antibiotic therapy, which is explicitly identified in this category as an indicator of clinician suspicion of serious infection. This perfectly aligns with the criteria outlined for making a sepsis risk assessment.",
            "The claim mentions the initiation of broad-spectrum antibiotic therapy, which pertains directly to actions taken due to a clinical suspicion of infection. This aligns well with the category focused on early intervention through antibiotics or culture orders, however, because the claim doesn't specify the timing of the administration (within 2 hours), the alignment is strong but not perfect.",
            "The claim is vague and includes no specific measurements or clinical criteria. However, \"the patient appears to be at high risk of sepsis\" generally aligns with what an elevated NEWS score tries to accomplish\u2014assessing imminent deterioration. Without specific indicators or criteria, alignment is quite weak."
        ],
        "final_alignment_score": 0.7666666666666666,
        "accuracy": 1
    },
    {
        "input": "4: HR, 97.746; 4: RR, 22.186; 4: SpO2, 94.559; 4: Perf, 0.646; 4: 1min HRV, 11.968; 4: SBP, 92.0; 4: DBP, 66.0; 4: MAP, 74.667; 5: HR, 98.759; 5: RR, 23.724; 5: SpO2, 94.862; 5: Perf, 0.741; 5: 1min HRV, 8.708; 6: HR, 100.746; 6: RR, 26.729; 6: SpO2, 90.763; 6: Perf, 0.651; 6: 1min HRV, 5.674; 7: HR, 100.644; 7: RR, 28.102; 7: SpO2, 89.068; 7: Perf, 0.558; 7: 1min HRV, 12.144; 8: HR, 99.017; 8: RR, 27.690; 8: SpO2, 90.66; 8: Perf, 0.624; 8: 1min HRV, 8.066; 8: 5min HRV, 11.353; 9: HR, 97.288; 9: RR, 24.424; 9: SpO2, 91.576; 9: Perf, 0.602; 9: 1min HRV, 7.119; 9: SBP, 83.0; 9: DBP, 64.0; 9: MAP, 70.333; 10: HR, 96.627; 10: RR, 26.712; 10: SpO2, 92.0; 10: Perf, 0.704; 10: 1min HRV, 9.393; 10: SBP, 83.0; 10: DBP, 64.0; 10: MAP, 70.333; 10: Temp, 100.9; 11: HR, 96.776; 11: RR, 22.207; 11: SpO2, 92.621; 11: Perf, 0.637; 11: 1min HRV, 9.644; 12: HR, 97.034; 12: RR, 22.847; 12: SpO2, 92.017; 12: Perf, 0.600; 12: 1min HRV, 5.245; 13: HR, 96.879; 13: RR, 22.034; 13: SpO2, 92.088; 13: Perf, 0.632; 13: 1min HRV, 14.753; 13: 5min HRV, 9.971; 14: HR, 96.339; 14: RR, 21.119; 14: SpO2, 94.339; 14: Perf, 0.657; 14: 1min HRV, 10.121; 14: SBP, 90.0; 14: DBP, 60.0; 14: MAP, 70.0; 15: HR, 95.949; 15: RR, 22.492; 15: SpO2, 94.763; 15: Perf, 0.840; 15: 1min HRV, 4.013; 15: SBP, 90.0; 15: DBP, 60.0; 15: MAP, 70.0; 16: HR, 96.845; 16: RR, 22.259; 16: SpO2, 94.569; 16: Perf, 0.876; 16: 1min HRV, 3.703; 17: HR, 96.237; 17: RR, 22.627; 17: SpO2, 94.881; 17: Perf, 0.765; 17: 1min HRV, 6.290; 18: HR, 96.690; 18: RR, 21.793; 18: SpO2, 94.795; 18: Perf, 0.773; 18: 1min HRV, 4.852; 18: 5min HRV, 6.426; 19: HR, 97.254; 19: RR, 22.339; 19: SpO2, 94.526; 19: Perf, 0.814; 19: 1min HRV, 3.623; 19: SBP, 85.0; 19: DBP, 61.0; 19: MAP, 69.0; 20: HR, 96.186; 20: RR, 20.678; 20: SpO2, 94.0; 20: Perf, 0.843; 20: 1min HRV, 4.718; 21: HR, 96.052; 21: RR, 22.172; 21: SpO2, 94.0; 21: Perf, 0.719; 21: 1min HRV, 5.543; 22: HR, 96.593; 22: RR, 25.831; 22: SpO2, 94.0; 22: Perf, 0.723; 22: 1min HRV, 6.151; 23: HR, 97.552; 23: RR, 25.569; 23: SpO2, 95.672; 23: Perf, 0.807; 23: 1min HRV, 44.425; 23: 5min HRV, 20.809; 24: HR, 95.424; 24: RR, 24.492; 24: SpO2, 92.644; 24: Perf, 0.812; 24: 1min HRV, 4.431; 24: SBP, 94.0; 24: DBP, 84.0; 24: MAP, 87.333; 25: HR, 95.932; 25: RR, 23.441; 25: SpO2, 90.424; 25: Perf, 0.442; 25: 1min HRV, 7.390; 26: HR, 96.586; 26: RR, 23.5; 26: SpO2, 92.793; 26: Perf, 0.369; 26: 1min HRV, 7.642; 27: HR, 95.898; 27: RR, 22.407; 27: SpO2, 92.542; 27: Perf, 0.37; 27: 1min HRV, 10.837; 28: HR, 95.948; 28: RR, 23.241; 28: SpO2, 92.086; 28: Perf, 0.37; 28: 1min HRV, 2.685; 28: 5min HRV, 7.882; 29: SBP, 82.0; 29: DBP, 67.0; 29: MAP, 72.0; 44: POC PH (V) ISTAT, 7.45; 44: POC LACTATE ISTAT, 0.79 mmol/L; 44: POC PCO2 (V) ISTAT, 49.2 mmHg; 44: POC HCO3 (V) ISTAT, 34.0 mmol/L; 44: POC O2 SATURATION ISTAT VENOUS, 72 %; 44: POC BASE EXCESS ISTAT, 10 mmol/L; 44: POC TCO2 (V) ISTAT, 35 mmol/L; 44: POC PO2 (V) ISTAT, 37 mmHg; 47: SpO2, 94.0; 47: LPM O2, 15.0; 53: HR, 86.0; 53: RR, 34.0; 53: SpO2, 98.0; 53: SBP, 102.0; 53: DBP, 61.0; 53: MAP, 74.667; 57: LR IV BOLUS -, 500 ML; 58: HR:, 88.0; 58: RR, 20.0; 58: SpO2, 98.0; 58: SBP, 86.0; 58: DBP, 61.0; 58: MAP, 69.333; 58: Temp, 100.2; 68: HR, 87.0; 68: RR, 27.0; 68: SpO2, 93.0; 68: SBP, 92.0; 68: DBP, 66.0; 68: MAP, 74.667; 68: Temp, 100.2; 83: HR, 85.0; 83: RR, 20.0; 83: SpO2, 94.0; 83: Temp, 100.2; 88: HR, 85.0; 88: RR, 20.0; 88: SpO2, 96.0; 88: SBP, 84.0; 88: DBP, 59.0; 88: MAP, 67.333; 88: Temp, 100.2; 88: LR IV BOLUS -, 500 ML; 94: SODIUM:, 131 mmol/L; 94: GLOBULIN, 4.0 g/dL; 94: EGFR REFIT WITHOUT RACE (2021), 116 mL/min/1.73 m2; 94: GLUCOSE, 128 mg/dL; 94: POTASSIUM, 4.3 mmol/L; 94: ALKALINE PHOSPHATASE, 159 U/L; 94: ALT (SGPT), 31 U/L; 94: CALCIUM, 8.5 mg/dL; 94: PROTEIN TOTAL, 7.1 g/dL; 94: ANION GAP, 10 mmol/L; 94: CREATININE, 0.55 mg/dL; 94: AST (SGOT), 51 U/L; 94: CHLORIDE, 94 mmol/L; 94: ALBUMIN, 3.1 g/dL; 94: CO2, 27 mmol/L; 94: BILIRUBIN TOTAL, 0.3 mg/dL; 94: BLOOD UREA NITROGEN (BUN), 5 mg/dL; 94: CORRECTED CALCIUM, 9.2 mg/dL; 94: ACETAMINOPHEN, 1 000 MG/100 ML (10 MG/ML) IV SOLN; 98: HR:, 84.0; 98: RR, 22.0; 98: SpO2, 96.0; 98: SBP, 86.0; 98: DBP, 58.0; 98: MAP, 67.333; 98: Temp, 100.0; 113: HR, 80.0; 113: RR, 17.0; 113: SpO2, 96.0; 113: SBP, 84.0; 113: DBP, 57.0; 113: MAP, 66.0; 113: Temp, 99.7; 0: Age, 56; 0: Gender, M; 0: Race, Other; 0: Means of arrival, EMS; 0: Triage Temp, 38.3; 0: Triage HR, 97.0; 0: Triage RR, 21.0; 0: Triage SBP, 83.0; 0: Triage DBP, 64.0; 0: Triage acuity, 2-Emergent; 0: CC, SHORTNESS OF BREATH",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, I check whether there is a suspicion of infection based on the patient\u2019s fever and respiratory complaints. Next, I assess for organ dysfunction by noting the persistently low blood pressure and elevated respiratory rates, both of which indicate hemodynamic compromise. The combination of suspected infection and hemodynamic instability supports a high risk for sepsis within 12 hours.",
        "claims": [
            "There is a suspicion of infection based on the patient\u2019s fever and respiratory complaints.",
            "I assess for organ dysfunction by noting persistently low blood pressure.",
            "Persistently low blood pressure indicates hemodynamic compromise.",
            "I assess for organ dysfunction by noting elevated respiratory rates.",
            "Elevated respiratory rates indicate hemodynamic compromise.",
            "The combination of suspected infection and hemodynamic instability supports a high risk for sepsis within 12 hours."
        ],
        "relevant_claims": [
            "There is a suspicion of infection based on the patient\u2019s fever and respiratory complaints.",
            "I assess for organ dysfunction by noting persistently low blood pressure.",
            "Persistently low blood pressure indicates hemodynamic compromise.",
            "I assess for organ dysfunction by noting elevated respiratory rates.",
            "Elevated respiratory rates indicate hemodynamic compromise.",
            "The combination of suspected infection and hemodynamic instability supports a high risk for sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.7,
            0.8,
            1.0,
            0.8,
            0.4,
            0.8
        ],
        "alignment_category": [
            9,
            7,
            7,
            3,
            6,
            6
        ],
        "alignment_reasonings": [
            "The claim indicates suspicion of infection due to fever and respiratory complaints, which aligns with the motivation for early antibiotic/culture orders. However, since the claim doesn't mention specific actions like administering antibiotics or drawing cultures, the alignment isn't perfect but is still strongly suggestive of sepsis risk assessment action.",
            "The claim focuses on persistently low blood pressure, which aligns closely with the definition of sepsis-associated hypotension in this category (SBP <90 mmHg, MAP <70 mmHg, or a drop of \u226540 mmHg). This indicates significant progression towards septic shock and thus is a major factor in assessing for organ dysfunction, strongly aligning with this category, though the exact BP values aren't specified, so it's not a perfect match.",
            "The claim highlights \"persistently low blood pressure,\" which directly relates to hypotension\u2014a key indicator in the Sepsis-Associated Hypotension category. This category includes specific criteria for blood pressure, and persistent hypotension strongly suggests progression toward septic shock, aligning perfectly with the category.",
            "The claim mentions assessing elevated respiratory rates to identify organ dysfunction. A respiratory rate\u202f\u2265\u202f22\u202f/min is a component of the qSOFA score, which helps flag the risk of sepsis-related organ dysfunction. The alignment is strong since the claim focuses on using respiratory rate as an indicator, which is a direct element of the qSOFA score. However, the claim doesn't provide further specifics on whether the respiratory rate meets the exact threshold, hence a slightly less than perfect alignment rating.",
            "The claim discusses elevated respiratory rates in the context of hemodynamic compromise, which is related to the concept of shock. While the Shock Index includes heart rate and blood pressure, it implicitly links to overall circulatory and respiratory interdependence. The connection is not direct or explicit but suggests a related underlying concern about hemodynamics, granting a moderate alignment.",
            "The claim mentions \"hemodynamic instability,\" which aligns closely with the Elevated Shock Index category due to its focus on hemodynamic instability and sepsis risk. While the claim also indicates a suspected infection, the central focus on hemodynamic instability matches well with the Shock Index criteria, but it doesn't specify the exact measure like heart rate or blood pressure required for a perfect alignment. Therefore, the alignment rating is slightly reduced but still strong."
        ],
        "final_alignment_score": 0.75,
        "accuracy": 1
    },
    {
        "input": "5: HR, 106.0; 5: RR, 32.0; 5: SpO2, 99.0; 5: SBP, 123.0; 5: DBP, 78.0; 5: MAP, 93.0; 5: Pain, 0.0; 5: Temp, 98.8; 27: SpO2, 95.804; 27: Perf, 0.518; 28: SpO2, 95.915; 28: Perf, 0.875; 29: SpO2, 93.810; 29: Perf, 0.93; 30: SpO2, 93.731; 30: Perf, 0.93; 31: HR, 105.0; 31: SpO2, 95.5; 31: Perf, 0.921; 31: SBP, 118.0; 31: DBP, 88.0; 31: MAP, 98.0; 32: SpO2, 94.926; 32: Perf, 0.769; 33: SpO2, 94.895; 33: Perf, 0.76; 34: SpO2, 95.0; 34: Perf, 0.76; 35: SpO2, 97.0; 35: Perf, 0.603; 36: HR, 101.952; 36: SpO2, 97.103; 36: Perf, 0.532; 36: 1min HRV, 35.120; 37: HR, 105.542; 37: SpO2, 96.441; 37: Perf, 0.586; 37: 1min HRV, 22.801; 38: HR, 104.845; 38: SpO2, 95.776; 38: Perf, 0.601; 38: 1min HRV, 17.379; 39: HR, 103.475; 39: SpO2, 95.881; 39: Perf, 0.698; 39: 1min HRV, 21.945; 39: 5min HRV, 25.526; 40: HR, 104.776; 40: SpO2, 95.259; 40: Perf, 0.889; 40: 1min HRV, 23.186; 41: HR, 107.186; 41: SpO2, 94.458; 41: Perf, 0.937; 41: 1min HRV, 27.290; 42: HR, 102.814; 42: SpO2, 94.712; 42: Perf, 1.16; 42: 1min HRV, 26.491; 43: HR, 104.983; 43: SpO2, 93.897; 43: Perf, 1.168; 43: 1min HRV, 19.577; 44: HR, 106.0; 44: SpO2, 95.085; 44: Perf, 0.625; 44: 1min HRV, 22.391; 44: 5min HRV, 24.972; 45: HR, 101.517; 45: SpO2, 94.690; 45: Perf, 0.590; 45: 1min HRV, 36.524; 46: HR, 106.186; 46: SpO2, 96.339; 46: Perf, 0.64; 46: 1min HRV, 41.338; 47: HR, 106.034; 47: SpO2, 95.576; 47: Perf, 0.64; 47: 1min HRV, 24.015; 48: HR, 101.431; 48: SpO2, 97.017; 48: Perf, 0.638; 48: 1min HRV, 27.987; 49: HR, 105.271; 49: SpO2, 96.026; 49: Perf, 0.623; 49: 1min HRV, 27.465; 49: 5min HRV, 36.044; 50: HR, 105.475; 50: SpO2, 95.458; 50: Perf, 0.709; 50: 1min HRV, 32.442; 51: HR, 104.569; 51: SpO2, 95.414; 51: Perf, 0.74; 51: 1min HRV, 29.709; 52: HR, 104.508; 52: SpO2, 94.0; 52: Perf, 0.74; 52: 1min HRV, 29.782; 53: HR, 109.086; 53: Perf, 0.74; 53: 1min HRV, 21.648; 54: HR, 108.237; 54: Perf, 0.74; 54: 1min HRV, 29.355; 54: 5min HRV, 30.426; 55: HR, 106.305; 55: SpO2, 91.417; 55: Perf, 0.74; 55: 1min HRV, 28.756; 56: HR, 100.034; 56: SpO2, 90.0; 56: 1min HRV, 30.972; 57: HR, 103.593; 57: 1min HRV, 26.173; 58: HR, 100.0; 58: 1min HRV, 36.792; 59: HR, 109.305; 59: 1min HRV, 33.558; 59: 5min HRV, 36.879; 60: HR, 102.017; 60: 1min HRV, 32.222; 61: HR, 107.780; 61: 1min HRV, 25.075; 62: HR, 109.136; 62: 1min HRV, 18.568; 63: HR, 107.483; 63: 1min HRV, 39.046; 64: HR, 109.356; 64: 1min HRV, 32.715; 64: 5min HRV, 33.510; 65: HR, 96.627; 65: SpO2, 91.484; 65: 1min HRV, 30.208; 66: HR, 102.293; 66: SpO2, 94.64; 66: 1min HRV, 31.751; 67: HR, 100.339; 67: SpO2, 96.913; 67: Perf, 0.65; 67: 1min HRV, 34.148; 68: HR, 106.034; 68: SpO2, 96.833; 68: Perf, 0.65; 68: 1min HRV, 31.407; 69: HR, 101.153; 69: SpO2, 97.0; 69: Perf, 0.402; 69: 1min HRV, 29.794; 69: 5min HRV, 36.688; 70: HR, 98.627; 70: SpO2, 96.949; 70: Perf, 0.405; 70: 1min HRV, 26.562; 71: HR, 111.034; 71: SpO2, 97.25; 71: Perf, 0.41; 71: 1min HRV, 20.913; 72: HR, 109.644; 72: SpO2, 94.857; 72: 1min HRV, 36.253; 73: POC, HCG, ISTAT QUALITATIVE: Negative; 73: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 73: HR, 101.759; 73: 1min HRV, 34.292; 74: HR, 105.780; 74: 1min HRV, 41.076; 74: 5min HRV, 41.376; 75: POC PH (V) ISTAT, 7.38; 75: POC LACTATE ISTAT, <.30 mmol/L; 75: POC HCO3 (V) ISTAT, 19.6 mmol/L; 75: POC O2 SATURATION ISTAT VENOUS, 86 %; 75: POC PCO2 (V) ISTAT, 33.3 mmHg; 75: POC TCO2 (V) ISTAT, 21 mmol/L; 75: POC PO2 (V) ISTAT, 53 mmHg; 75: POC BASE EXCESS ISTAT, -6 mmol/L; 75: HR, 107.724; 75: SpO2, 96.0; 75: 1min HRV, 29.352; 76: HR, 109.695; 76: SpO2, 96.0; 76: 1min HRV, 30.434; 77: HR, 106.627; 77: SpO2, 96.2; 77: 1min HRV, 24.569; 78: HR, 104.724; 78: SpO2, 96.0; 78: 1min HRV, 28.498; 79: HR, 110.661; 79: 1min HRV, 27.035; 79: 5min HRV, 30.151; 80: HR, 108.207; 80: 1min HRV, 18.073; 81: HR, 108.407; 81: SpO2, 99.0; 81: 1min HRV, 21.980; 82: HR, 106.983; 82: SpO2, 98.0; 82: 1min HRV, 26.322; 83: HR, 110.776; 83: 1min HRV, 24.902; 84: HR, 105.169; 84: 1min HRV, 25.793; 84: 5min HRV, 24.952; 85: HR, 107.724; 85: 1min HRV, 25.418; 86: HR, 107.661; 86: 1min HRV, 29.177; 87: HR, 107.220; 87: 1min HRV, 22.764; 88: SARS-COV-2 RNA, Not Detected; 88: HR, 108.845; 88: 1min HRV, 34.501; 89: HR, 105.915; 89: SpO2, 100.0; 89: 1min HRV, 23.263; 89: 5min HRV, 27.878; 90: HR, 105.138; 90: SpO2, 100.0; 90: 1min HRV, 21.307; 91: HR, 106.068; 91: SpO2, 99.0; 91: Perf, 1.246; 91: 1min HRV, 39.280; 92: HR, 107.915; 92: SpO2, 99.0; 92: Perf, 0.983; 92: 1min HRV, 27.151; 93: HR, 106.810; 93: SpO2, 99.0; 93: Perf, 0.870; 93: 1min HRV, 21.717; 94: HR, 107.0; 94: SpO2, 99.0; 94: Perf, 0.943; 94: 1min HRV, 17.297; 94: 5min HRV, 27.470; 118: WAM DIFTYP, AUTO; 118: BASOPHIL % (AUTO DIFF), 0.3 %; 118: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 118: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.26 K/uL; 118: RED CELL DISTRIBUTION WIDTH (RDW), 13.3 %; 118: MONOCYTE ABSOLUTE (AUTO DIFF), 0.70 K/uL; 118: PLATELET COUNT (PLT), 279 K/uL; 118: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.2 pg; 118: HEMOGLOBIN (HGB), 10.6 g/dL; 118: RED BLOOD CELLS (RBC), 3.40 MIL/uL; 118: MONOCYTE % (AUTO DIFF), 7.3 %; 118: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.6 g/dL; 118: NEUTROPHIL % (AUTO DIFF), 76.0 %; 118: EOSINOPHIL % (AUTO DIFF), 2.7 %; 118: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 118: HEMATOCRIT (HCT), 33.5 %; 118: WHITE BLOOD CELLS (WBC), 9.6 K/uL; 118: LYMPHOCYTE % (AUTO DIFF), 13.3 %; 118: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.04 K/uL; 118: MEAN CORPUSCULAR VOLUME (MCV), 98.5 fL; 118: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.28 K/uL; 118: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 118: NEUTROPHIL ABSOLUTE (AUTO DIFF), 7.31 K/uL; 118: NRBC PERCENT (HEMATOLOGY), 0.0 %; 0: Age, 23; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.1; 0: Triage HR, 106.0; 0: Triage RR, 32.0; 0: Triage SBP, 123.0; 0: Triage DBP, 78.0; 0: Triage acuity, 2-Emergent; 0: CC, COUGH",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "First, we determine whether the patient's vital signs suggest severe infection or hemodynamic instability. Next, we check if the laboratory values, especially lactate and white blood cell count, point to significant organ dysfunction. While the patient is tachycardic and tachypneic, her blood pressure and labs (including a normal lactate) do not indicate severe sepsis. Therefore, the patient is not at high risk of developing sepsis in the next 12 hours.",
        "claims": [
            "The patient's vital signs are assessed for signs of severe infection or hemodynamic instability.",
            "Laboratory values, particularly lactate and white blood cell count, are evaluated for indicators of significant organ dysfunction.",
            "The patient is tachycardic.",
            "The patient is tachypneic.",
            "The patient's blood pressure does not indicate severe sepsis.",
            "The patient's laboratory values include a normal lactate.",
            "The presence of tachycardia and tachypnea does not mean the patient is at high risk of developing sepsis.",
            "The patient is not at high risk of developing sepsis in the next 12 hours."
        ],
        "relevant_claims": [
            "The patient is tachycardic.",
            "The patient is tachypneic.",
            "The presence of tachycardia and tachypnea does not mean the patient is at high risk of developing sepsis."
        ],
        "alignment_scores": [
            0.8,
            0.7,
            0.8
        ],
        "alignment_category": [
            2,
            3,
            2
        ],
        "alignment_reasonings": [
            "Tachycardia (heart rate > 90 bpm) is one of the specific criteria mentioned under the SIRS category used to identify systemic inflammation consistent with early sepsis. The alignment rating is high because tachycardia is directly listed as a SIRS criterion, but the final SIRS positivity requires meeting at least two criteria, so it is not a perfect alignment by itself.",
            "Tachypnea (increased respiratory rate) is a component of the qSOFA score, which flags high risk of sepsis-related organ dysfunction and mortality when the score is high. Although tachypnea alone does not confirm a high qSOFA score (requires \u22652 criteria), it strongly aligns because it is a direct component. However, it doesn't perfectly fit the criterion by itself, so the alignment rating is less than 1.0.",
            "Tachycardia (elevated heart rate) and tachypnea (elevated respiratory rate) are two criteria of SIRS, used to identify systemic inflammation consistent with early sepsis. While the claim states that these signs are present, it concludes that the patient is not at high risk for sepsis. The alignment is fairly strong because both signs are directly related to the SIRS criteria, even if the conclusion in the claim is negative. Therefore, despite disputing high risk in the claim, the signs align well with the SIRS category's clinical considerations."
        ],
        "final_alignment_score": 0.7666666666666666,
        "accuracy": 0
    },
    {
        "input": "3: SpO2, 95.566; 3: Perf, 1.128; 4: SpO2, 94.811; 4: Perf, 0.859; 5: RR, 28.667; 5: SpO2, 88.321; 5: Perf, 0.710; 5: 1min HRV, 192.045; 6: HR, 87.510; 6: RR, 18.358; 6: SpO2, 86.736; 6: Perf, 0.617; 6: 1min HRV, 190.778; 7: HR, 84.615; 7: RR, 24.756; 7: SpO2, 94.173; 7: Perf, 0.719; 7: 1min HRV, 151.921; 7: 5min HRV, 200.315; 8: HR, 79.667; 8: RR, 17.333; 8: SpO2, 97.551; 8: Perf, 0.640; 8: SBP, 81.0; 8: DBP, 67.0; 8: MAP, 71.667; 8: LPM O2, 15.0; 8: Pain, 0.0; 8: Temp, 95.5; 9: HR, 80.896; 9: SpO2, 97.698; 9: Perf, 0.721; 9: 1min HRV, 123.937; 10: HR, 73.521; 10: SpO2, 95.0; 10: Perf, 0.766; 10: 1min HRV, 345.717; 10: SBP, 103.0; 10: DBP, 61.0; 10: MAP, 75.0; 11: HR, 54.913; 11: SpO2, 95.887; 11: Perf, 0.672; 11: 1min HRV, 55.263; 12: HR, 0.0; 12: SpO2, 96.472; 12: Perf, 0.808; 12: 5min HRV, 222.786; 13: POC PH (V) ISTAT, 7.34; 13: POC PO2 (V) ISTAT, 26 mmHg; 13: POC TCO2 (V) ISTAT, 39 mmol/L; 13: POC LACTATE ISTAT, 1.75 mmol/L; 13: POC HCO3 (V) ISTAT, 36.6 mmol/L; 13: POC PCO2 (V) ISTAT, 68.0 mmHg; 13: POC O2 SATURATION ISTAT VENOUS, 40 %; 13: POC BASE EXCESS ISTAT, 11 mmol/L; 13: HR, 0.0; 13: SpO2, 96.623; 13: Perf, 0.706; 13: 1min HRV, 178.75; 14: HR, 0.0; 14: SpO2, 97.852; 14: Perf, 0.518; 14: 1min HRV, 3.583; 15: HR, 0.0; 15: SpO2, 97.135; 15: Perf, 0.586; 15: 1min HRV, 8.225; 16: HR, 0.0; 16: SpO2, 97.585; 16: Perf, 0.585; 17: HR, 0.0; 17: SpO2, 97.774; 17: Perf, 0.55; 17: 1min HRV, 133.625; 17: 5min HRV, 125.316; 18: HR, 0.0; 18: SpO2, 96.925; 18: Perf, 0.553; 18: 1min HRV, 213.992; 19: HR, 6.276; 19: SpO2, 97.132; 19: Perf, 0.56; 19: 1min HRV, 93.679; 20: HR, 0.0; 20: SpO2, 97.596; 20: Perf, 0.56; 20: 1min HRV, 0.0; 21: HR, 0.0; 21: SpO2, 98.0; 21: Perf, 0.564; 21: 1min HRV, 0.0; 22: HR, 0.0; 22: SpO2, 97.269; 22: Perf, 0.574; 22: 5min HRV, 167.366; 23: HR, 0.0; 23: SpO2, 96.415; 23: Perf, 0.59; 23: SBP, 103.0; 23: DBP, 74.0; 23: MAP, 83.667; 24: HR, 0.0; 24: SpO2, 97.811; 24: Perf, 0.619; 25: HR, 0.0; 25: SpO2, 98.0; 25: Perf, 0.63; 26: HR, 0.0; 26: SpO2, 97.755; 26: Perf, 0.675; 27: HR, 0.0; 27: SpO2, 97.442; 27: Perf, 0.749; 28: HR, 14.6; 28: RR, 7.286; 28: SpO2, 98.113; 28: Perf, 0.786; 28: 1min HRV, 126.031; 29: HR, 0.0; 29: RR, 13.510; 29: SpO2, 98.019; 29: Perf, 0.809; 29: 1min HRV, 100.75; 30: HR, 0.0; 30: RR, 18.885; 30: SpO2, 97.885; 30: Perf, 0.8; 30: 1min HRV, 258.922; 31: HR, 33.793; 31: RR, 15.574; 31: SpO2, 97.704; 31: Perf, 0.790; 31: 1min HRV, 99.035; 32: HR, 15.778; 32: RR, 17.615; 32: SpO2, 96.942; 32: Perf, 0.688; 32: 1min HRV, 79.568; 32: 5min HRV, 173.597; 33: HR, 63.727; 33: RR, 32.547; 33: SpO2, 97.642; 33: Perf, 0.56; 33: 1min HRV, 59.396; 34: HR, 23.1; 34: RR, 23.788; 34: SpO2, 97.0; 34: Perf, 0.635; 34: 1min HRV, 20.603; 35: HR, 0.0; 35: RR, 24.767; 35: SpO2, 96.870; 35: Perf, 0.611; 36: HR, 16.818; 36: RR, 16.923; 36: SpO2, 96.717; 36: Perf, 0.6; 36: 1min HRV, 56.853; 37: HR, 31.882; 37: RR, 27.673; 37: SpO2, 95.308; 37: Perf, 0.601; 37: 1min HRV, 53.233; 37: 5min HRV, 56.500; 38: HR, 41.0; 38: RR, 28.075; 38: SpO2, 96.522; 38: Perf, 0.61; 38: 1min HRV, 65.923; 38: SBP, 100.0; 38: DBP, 63.0; 38: MAP, 75.333; 42: 5min HRV, 65.923; 46: WAM DIFTYP, AUTO; 46: NEUTROPHIL % (AUTO DIFF), 88.2 %; 46: HEMATOCRIT (HCT), 44.5 %; 46: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 46: BASOPHIL % (AUTO DIFF), 0.3 %; 46: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.6 pg; 46: NRBC PERCENT (HEMATOLOGY), 0.0 %; 46: RED BLOOD CELLS (RBC), 4.53 MIL/uL; 46: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 46: HEMOGLOBIN (HGB), 14.3 g/dL; 46: MONOCYTE % (AUTO DIFF), 3.2 %; 46: EOSINOPHIL % (AUTO DIFF), 0.3 %; 46: WHITE BLOOD CELLS (WBC), 11.8 K/uL; 46: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.1 g/dL; 46: LYMPHOCYTE % (AUTO DIFF), 7.6 %; 46: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.90 K/uL; 46: MEAN CORPUSCULAR VOLUME (MCV), 98.2 fL; 46: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 46: RED CELL DISTRIBUTION WIDTH (RDW), 16.1 %; 46: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.05 K/uL; 46: PLATELET COUNT (PLT), 113 K/uL; 46: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.43 K/uL; 46: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 46: MONOCYTE ABSOLUTE (AUTO DIFF), 0.38 K/uL; 54: RR, 30.0; 54: SpO2, 97.0; 61: PROTEIN TOTAL, 7.9 g/dL; 61: CREATININE, 0.64 mg/dL; 61: ALT (SGPT), 17 U/L; 61: EGFR FOR AFRICAN AMERICAN, 111 mL/min/1.73 m2; 61: BILIRUBIN TOTAL, 0.3 mg/dL; 61: SODIUM, 138 mmol/L; 61: CORRECTED CALCIUM, 9.8 mg/dL; 61: ANION GAP, 8 mmol/L; 61: GLUCOSE, 78 mg/dL; 61: AST (SGOT), 40 U/L; 61: POTASSIUM, 5.2 mmol/L; 61: CO2, 27 mmol/L; 61: BLOOD UREA NITROGEN (BUN), 19 mg/dL; 61: ALBUMIN, 2.6 g/dL; 61: GLOBULIN, 5.3 g/dL; 61: BNP NT-PRO, 2199 pg/mL; 61: CHLORIDE, 103 mmol/L; 61: EGFR REFIT WITHOUT RACE (2021), 96 mL/min/1.73 m2; 61: CALCIUM, 8.7 mg/dL; 61: ALKALINE PHOSPHATASE, 115 U/L; 67: HR, 71.0; 67: RR, 28.0; 67: SpO2, 99.0; 67: SBP, 104.0; 67: DBP, 51.0; 67: MAP, 68.667; 72: TROPONIN I, <.017 ng/mL; 83: SARS-COV-2 RNA, Not Detected; 105: METHYLPREDNISOLONE SOD SUC(PF), 125 MG/2 ML INJ SOLR; 110: NORMOSOL-R IV BOLUS -, 500 ML; 0: Age, 75; 0: Gender, M; 0: Race, White; 0: Means of arrival, EMS; 0: Triage Temp, 35.3; 0: Triage HR, 72.0; 0: Triage RR, 28.0; 0: Triage SBP, 103.0; 0: Triage DBP, 61.0; 0: Triage acuity, 2-Emergent; 0: CC, RESPIRATORY DISTRESS",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, I checked for signs of infection and found that the patient presented with respiratory distress and abnormal vital signs (notably a low temperature and prolonged tachypnea). Next, I confirmed increased sepsis risk by noting possible organ dysfunction (mild hypotension, altered platelets, and high neutrophil counts). Finally, I looked at the labs indicating potential metabolic compensation and the administration of IV fluids and steroids, which further supports concern for a serious condition. Based on these findings, the patient appears high-risk for sepsis.",
        "claims": [
            "The patient presented with respiratory distress.",
            "The patient had abnormal vital signs.",
            "The patient had a low temperature.",
            "The patient experienced prolonged tachypnea.",
            "I noted possible organ dysfunction in the patient.",
            "The patient exhibited mild hypotension.",
            "The patient's platelets were altered.",
            "The patient had high neutrophil counts.",
            "Labs indicated potential metabolic compensation.",
            "IV fluids were administered to the patient.",
            "Steroids were administered to the patient.",
            "The administration of IV fluids and steroids supports concern for a serious condition.",
            "Based on these findings, the patient appears high-risk for sepsis."
        ],
        "relevant_claims": [
            "The patient presented with respiratory distress.",
            "The patient had abnormal vital signs.",
            "The patient experienced prolonged tachypnea.",
            "I noted possible organ dysfunction in the patient.",
            "The patient exhibited mild hypotension.",
            "The patient's platelets were altered.",
            "The patient had high neutrophil counts.",
            "Labs indicated potential metabolic compensation.",
            "IV fluids were administered to the patient.",
            "Steroids were administered to the patient.",
            "The administration of IV fluids and steroids supports concern for a serious condition.",
            "Based on these findings, the patient appears high-risk for sepsis."
        ],
        "alignment_scores": [
            0.7,
            0.3,
            0.7,
            0.7,
            0.7,
            0.8,
            0.7,
            0.3,
            0.3,
            0.3,
            0.4,
            0.3
        ],
        "alignment_category": [
            3,
            4,
            3,
            8,
            7,
            8,
            2,
            8,
            7,
            9,
            9,
            4
        ],
        "alignment_reasonings": [
            "Respiratory distress implies an elevated respiratory rate, which is a component of the qSOFA score. While the specific respiratory rate is not given, the presence of respiratory distress suggests a high likelihood of meeting the qSOFA criterion for respiratory rate, thus indicating potential sepsis-related risk. The alignment is significant but not direct without specific measurements.",
            "While \"abnormal vital signs\" is a vague claim, it suggests that there could be multiple deranged vital parameters, which could relate to an elevated NEWS score indicating clinical deterioration. However, without specific details on which vital signs are abnormal and to what extent, the alignment is weak and indirect.",
            "Tachypnea, defined as an abnormally high respiratory rate, is directly a part of the qSOFA criteria (respiratory rate\u202f\u2265\u202f22\u202f/min). If the patient's tachypnea meets or exceeds this threshold, it could contribute to a high qSOFA score, signaling a heightened sepsis risk. While the claim notes prolonged tachypnea, which suggests chronic elevated respiratory rate, it doesn't specify if it meets the exact qSOFA threshold, so the alignment is meaningful but not fully confirmed.",
            "The claim about possible organ dysfunction aligns conceptually with an increase in the SOFA score, which is used to confirm new organ dysfunction and assess sepsis risk. However, without details on specific SOFA components or point increases, the alignment is inferred but not direct, warranting a strong but not full alignment rating.",
            "The claim mentions mild hypotension, which is relevant to sepsis-associated hypotension in the context of sepsis progression. However, the claim lacks specifics on whether the hypotension meets the exact thresholds specified in the category (SBP <90 mmHg, MAP <70 mmHg, or a \u226540 mmHg drop). Thus, while there is a meaningful alignment with the criteria, it is partial and not definitive.",
            "The claim about altered platelets directly relates to the SOFA criteria, which includes platelet count as a factor. While the claim does not specify the exact value or change, altered platelets suggest potential organ dysfunction relevant to the SOFA score, resulting in a strong alignment.",
            "High neutrophil counts are indicative of an inflammatory or infectious process, which aligns with the systemic inflammation criteria noted in SIRS. Although neutrophil count itself isn't specified under SIRS, elevated white blood cell count is a relevant criterion, hence the strong but not complete alignment.",
            "Metabolic compensation may suggest a physiological response to maintain homeostasis under stress, potentially signaling organ dysfunction. However, the claim is not directly linked to any specific SOFA component increase, resulting in indirect and relatively weak alignment.",
            "The administration of IV fluids can be indicative of addressing hypotension, which is a relevant concern in sepsis associated with low blood pressure. While IV fluids are a common response to hypotension, the claim does not specify the patient's blood pressure details to confirm whether it aligns completely with sepsis-associated hypotension criteria. The alignment is indirect and suggests a precaution toward potential hypotension rather than confirming its presence.",
            "The claim mentions the administration of steroids, which doesn't directly align with any of the specified sepsis categories. Early sepsis management often involves rapid intervention like antibiotics based on infection suspicion. However, while steroids might be given for inflammatory responses, they are not a direct indication for suspicion of infection leading to antibiotic or culture orders. The alignment is somewhat relevant to systemic inflammatory responses but weakly associated with the specific category of early antibiotic or culture orders.",
            "The administration of IV fluids and steroids suggests concern for a serious condition, possibly sepsis. While not directly related to the administration of antibiotics or drawing cultures, it does reflect clinical suspicion and treatment of a critical condition, aligning indirectly with the need for prompt management of potential sepsis. The alignment is moderate, as it doesn't directly meet the criteria of antibiotic or culture actions but still indicates concern for serious illness.",
            "The claim broadly states a high risk for sepsis based on unspecified findings. The National Early Warning Score (NEWS) is designed to indicate imminent clinical deterioration in a general sense, which can include sepsis risk. Although the claim lacks specific details or metrics for concrete alignment with any one category, the broad assessment of high risk is somewhat captured by the purpose of a NEWS score, making this category the closest match, albeit with low alignment strength due to the absence of specifics."
        ],
        "final_alignment_score": 0.5166666666666667,
        "accuracy": 1
    },
    {
        "input": "4: HR, 152.0; 4: RR, 16.0; 4: SpO2, 100.0; 4: SBP, 150.0; 4: DBP, 102.0; 4: MAP, 118.0; 4: Temp, 97.2; 24: Pain, 5.0; 57: SpO2, 100.0; 57: Perf, 0.247; 58: SpO2, 100.0; 58: Perf, 0.346; 59: SpO2, 100.0; 59: Perf, 0.383; 60: SpO2, 100.0; 60: Perf, 0.339; 61: SpO2, 100.0; 61: Perf, 0.721; 62: SpO2, 100.0; 62: Perf, 1.018; 63: SpO2, 100.0; 63: Perf, 0.941; 64: SpO2, 100.0; 64: Perf, 0.551; 65: SpO2, 100.0; 65: Perf, 0.336; 66: HR, 142.0; 66: RR, 11.0; 66: SpO2, 100.0; 66: Perf, 0.311; 67: SpO2, 100.0; 67: Perf, 0.243; 68: HR, 142.444; 68: RR, 30.6; 68: SpO2, 100.0; 68: Perf, 0.229; 68: 1min HRV, 12.486; 69: HR, 143.678; 69: RR, 14.271; 69: SpO2, 100.0; 69: Perf, 0.249; 69: 1min HRV, 7.575; 70: HR, 142.069; 70: RR, 20.431; 70: SpO2, 100.0; 70: Perf, 0.267; 70: 1min HRV, 5.002; 71: HR, 143.068; 71: RR, 16.136; 71: SpO2, 100.0; 71: Perf, 0.304; 71: 1min HRV, 6.348; 71: 5min HRV, 7.438; 72: HR, 141.569; 72: RR, 15.552; 72: SpO2, 100.0; 72: Perf, 0.481; 72: 1min HRV, 5.429; 73: HR, 141.559; 73: RR, 15.983; 73: SpO2, 100.0; 73: Perf, 0.340; 73: 1min HRV, 11.586; 74: HR, 146.741; 74: RR, 19.931; 74: SpO2, 100.0; 74: Perf, 0.334; 74: 1min HRV, 7.123; 75: HR, 142.169; 75: RR, 17.186; 75: SpO2, 100.0; 75: Perf, 0.285; 75: 1min HRV, 16.123; 76: HR, 148.475; 76: RR, 22.847; 76: SpO2, 100.0; 76: Perf, 0.271; 76: 1min HRV, 10.443; 76: 5min HRV, 12.894; 77: HR, 143.0; 77: RR, 18.241; 77: SpO2, 100.0; 77: Perf, 0.218; 77: 1min HRV, 8.013; 78: HR, 141.678; 78: RR, 13.186; 78: SpO2, 100.0; 78: Perf, 0.204; 78: 1min HRV, 7.869; 79: HR, 143.322; 79: RR, 17.186; 79: SpO2, 100.0; 79: Perf, 0.191; 79: 1min HRV, 5.016; 80: HR, 145.862; 80: RR, 21.483; 80: SpO2, 100.0; 80: Perf, 0.19; 80: 1min HRV, 14.273; 81: HR, 150.593; 81: RR, 24.136; 81: SpO2, 100.0; 81: Perf, 0.220; 81: 1min HRV, 4.908; 81: 5min HRV, 12.638; 82: HR, 147.724; 82: RR, 20.155; 82: SpO2, 100.0; 82: Perf, 0.193; 82: 1min HRV, 6.422; 83: HR, 145.864; 83: RR, 19.610; 83: SpO2, 100.0; 83: Perf, 0.198; 83: 1min HRV, 16.707; 84: HR, 146.103; 84: RR, 15.379; 84: SpO2, 100.0; 84: Perf, 0.203; 84: 1min HRV, 5.428; 85: HR, 146.881; 85: RR, 19.746; 85: SpO2, 100.0; 85: Perf, 0.2; 85: 1min HRV, 5.309; 86: HR, 147.690; 86: RR, 17.586; 86: SpO2, 100.0; 86: Perf, 0.2; 86: 1min HRV, 6.579; 86: 5min HRV, 9.290; 87: HR, 147.831; 87: RR, 16.932; 87: 1min HRV, 6.513; 88: HR, 146.373; 88: RR, 17.644; 88: 1min HRV, 5.914; 89: HR, 146.345; 89: RR, 18.966; 89: SpO2, 100.0; 89: Perf, 0.19; 89: 1min HRV, 4.308; 90: HR, 144.763; 90: RR, 19.559; 90: SpO2, 100.0; 90: Perf, 0.172; 90: 1min HRV, 6.645; 91: HR, 143.510; 91: RR, 16.830; 91: SpO2, 100.0; 91: Perf, 0.177; 91: 1min HRV, 6.265; 91: 5min HRV, 7.416; 92: HR, 143.94; 92: RR, 16.6; 92: SpO2, 100.0; 92: Perf, 0.177; 92: 1min HRV, 5.722; 93: HR, 145.458; 93: RR, 19.203; 93: SpO2, 100.0; 93: Perf, 0.179; 93: 1min HRV, 12.575; 94: HR, 145.466; 94: RR, 19.914; 94: SpO2, 100.0; 94: Perf, 0.276; 94: 1min HRV, 3.769; 95: HR, 140.983; 95: RR, 28.966; 95: SpO2, 100.0; 95: Perf, 0.435; 95: 1min HRV, 7.861; 96: HR, 141.915; 96: RR, 19.475; 96: SpO2, 100.0; 96: Perf, 0.645; 96: 1min HRV, 7.151; 96: 5min HRV, 9.919; 97: HR, 141.207; 97: RR, 15.810; 97: SpO2, 100.0; 97: Perf, 0.418; 97: 1min HRV, 8.263; 98: HR, 141.441; 98: RR, 15.542; 98: SpO2, 100.0; 98: Perf, 0.271; 98: 1min HRV, 5.571; 99: HR, 140.879; 99: RR, 16.121; 99: SpO2, 100.0; 99: Perf, 0.212; 99: 1min HRV, 6.727; 100: HR, 141.542; 100: RR, 17.492; 100: SpO2, 100.0; 100: Perf, 0.225; 100: 1min HRV, 6.407; 101: HR, 141.831; 101: RR, 17.068; 101: SpO2, 100.0; 101: Perf, 0.186; 101: 1min HRV, 8.050; 101: 5min HRV, 7.225; 102: HR, 135.224; 102: RR, 22.741; 102: SpO2, 100.0; 102: Perf, 0.207; 102: 1min HRV, 18.650; 103: HR, 137.288; 103: RR, 17.932; 103: SpO2, 100.0; 103: Perf, 0.205; 103: 1min HRV, 10.367; 104: HR, 139.483; 104: RR, 18.828; 104: SpO2, 100.0; 104: Perf, 0.205; 104: 1min HRV, 10.576; 105: HR, 139.983; 105: RR, 19.322; 105: SpO2, 100.0; 105: Perf, 0.185; 105: 1min HRV, 6.975; 106: SARS-COV-2 RNA, Not Detected; 106: HR, 139.864; 106: RR, 19.203; 106: SpO2, 100.0; 106: Perf, 0.192; 106: 1min HRV, 7.106; 106: 5min HRV, 12.724; 107: HR, 137.103; 107: RR, 15.759; 107: SpO2, 100.0; 107: Perf, 0.256; 107: 1min HRV, 6.563; 108: HR, 139.525; 108: RR, 18.593; 108: SpO2, 100.0; 108: Perf, 0.316; 108: 1min HRV, 5.620; 109: HR, 142.172; 109: RR, 19.672; 109: SpO2, 100.0; 109: Perf, 0.279; 109: 1min HRV, 7.703; 110: HR, 143.797; 110: RR, 15.898; 110: SpO2, 100.0; 110: Perf, 0.261; 110: 1min HRV, 5.670; 111: HR, 142.763; 111: RR, 17.085; 111: SpO2, 100.0; 111: Perf, 0.269; 111: 1min HRV, 6.064; 111: 5min HRV, 9.558; 112: HR, 143.172; 112: RR, 24.379; 112: SpO2, 100.0; 112: Perf, 0.222; 112: 1min HRV, 6.416; 113: HR, 146.136; 113: RR, 20.525; 113: SpO2, 100.0; 113: Perf, 0.214; 113: 1min HRV, 10.223; 114: HR, 142.983; 114: RR, 21.0; 114: SpO2, 100.0; 114: Perf, 0.235; 114: 1min HRV, 6.139; 115: HR, 146.153; 115: RR, 21.203; 115: SpO2, 100.0; 115: Perf, 0.246; 115: 1min HRV, 4.909; 116: HR, 148.845; 116: RR, 28.776; 116: SpO2, 100.0; 116: Perf, 0.22; 116: 1min HRV, 5.657; 116: 5min HRV, 9.084; 117: HR, 149.305; 117: RR, 22.729; 117: SpO2, 100.0; 117: Perf, 0.22; 117: 1min HRV, 4.460; 118: HR, 145.949; 118: RR, 20.814; 118: SpO2, 100.0; 118: Perf, 0.213; 118: 1min HRV, 5.542; 119: HR, 149.362; 119: RR, 19.431; 119: SpO2, 100.0; 119: Perf, 0.245; 119: 1min HRV, 6.651; 0: Age, 32; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.2; 0: Triage HR, 152.0; 0: Triage RR, 16.0; 0: Triage SBP, 150.0; 0: Triage DBP, 102.0; 0: Triage acuity, 2-Emergent; 0: CC, EMESIS,DIZZINESS,CHEST PRESSURE",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "First, I considered whether the patient\u2019s vitals met common criteria for sepsis, such as fever or hypotension, and noted that the patient\u2019s temperature was not elevated and blood pressure remained stable. Next, I looked at respiratory rate and heart rate; the patient\u2019s heart rate is consistently high, but the respiratory rate is not persistently above thresholds indicative of severe illness. I then checked for any lab evidence of infection (e.g., abnormal WBC count or lactate), but such data were not present. Finally, no clear clinical indicators of potential infection are seen in the short timeframe given. Therefore, there is insufficient information to indicate a high risk of sepsis within 12 hours.",
        "claims": [
            "The patient's vitals were assessed for common criteria for sepsis.",
            "The common criteria for sepsis include fever or hypotension.",
            "The patient\u2019s temperature was not elevated.",
            "The patient\u2019s blood pressure remained stable.",
            "The patient's heart rate is consistently high.",
            "The patient's respiratory rate is not persistently above thresholds indicative of severe illness.",
            "Lab evidence of infection, such as abnormal WBC count or lactate, was checked.",
            "No lab evidence of infection was present.",
            "No clear clinical indicators of potential infection were seen in the short timeframe given.",
            "There is insufficient information to indicate a high risk of sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient\u2019s temperature was not elevated.",
            "The patient's heart rate is consistently high."
        ],
        "alignment_scores": [
            0.3,
            0.3
        ],
        "alignment_category": [
            2,
            6
        ],
        "alignment_reasonings": [
            "The claim stating that the patient's temperature was not elevated is indirectly related to the SIRS criteria, as an elevated temperature is one component of these criteria. The absence of fever does not support SIRS positivity. However, since temperature evaluation is part of the SIRS criteria, there is minimal alignment.",
            "While the claim indicates a consistently high heart rate, it does not provide information about systolic BP, which is necessary to directly calculate a shock index. The elevated heart rate alone suggests potential hemodynamic instability associated with sepsis but doesn't fully meet the shock index criterion or any other listed category. The alignment is indirect and limited."
        ],
        "final_alignment_score": 0.3,
        "accuracy": 0
    },
    {
        "input": "3: HR, 106.0; 3: RR, 18.0; 3: SpO2, 99.0; 3: SBP, 133.0; 3: DBP, 83.0; 3: MAP, 99.667; 3: Temp, 97.9; 6: Pain, 8.0; 6: Pain, 5.0; 38: POC PH (V) ISTAT, 7.36; 38: POC PO2 (V) ISTAT, 34 mmHg; 38: POC PCO2 (V) ISTAT, 53.4 mmHg; 38: POC O2 SATURATION ISTAT VENOUS, 61 %; 38: POC BASE EXCESS ISTAT, 4 mmol/L; 38: POC LACTATE ISTAT, 0.90 mmol/L; 38: POC HCO3 (V) ISTAT, 29.9 mmol/L; 38: POC TCO2 (V) ISTAT, 31 mmol/L; 40: SpO2, 98.9; 40: Perf, 2.592; 40: HYDROMORPHONE, 1 MG/ML INJ SYRG; 41: SpO, 2: 99.224; 41: Perf, 2.862; 42: SpO2, 98.948; 42: Perf, 2.541; 43: SpO2, 98.966; 43: Perf, 2.984; 44: SpO2, 98.436; 44: Perf, 2.976; 45: SpO2, 98.322; 45: Perf, 3.164; 46: SpO2, 98.310; 46: Perf, 3.478; 47: WAM DIFTYP, AUTO; 47: BASOPHIL ABSOLUTE (AUTO DIFF), 0.09 K/uL; 47: PLATELET COUNT (PLT), 370 K/uL; 47: NEUTROPHIL % (AUTO DIFF), 63.1 %; 47: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.43 K/uL; 47: NEUTROPHIL ABSOLUTE (AUTO DIFF), 5.80 K/uL; 47: MONOCYTE ABSOLUTE (AUTO DIFF), 0.62 K/uL; 47: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 47: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 28.3 pg; 47: BASOPHIL % (AUTO DIFF), 1.0 %; 47: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.23 K/uL; 47: MEAN CORPUSCULAR VOLUME (MCV), 89.0 fL; 47: EOSINOPHIL % (AUTO DIFF), 2.5 %; 47: HEMOGLOBIN (HGB), 13.9 g/dL; 47: RED BLOOD CELLS (RBC), 4.91 MIL/uL; 47: HEMATOCRIT (HCT), 43.7 %; 47: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.8 g/dL; 47: WHITE BLOOD CELLS (WBC), 9.2 K/uL; 47: LYMPHOCYTE % (AUTO DIFF), 26.4 %; 47: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.03 K/uL; 47: NRBC PERCENT (HEMATOLOGY), 0.0 %; 47: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 47: MONOCYTE % (AUTO DIFF), 6.7 %; 47: RED CELL DISTRIBUTION WIDTH (RDW), 12.9 %; 47: SpO2, 98.797; 47: Perf, 3.236; 48: SpO2, 98.138; 48: Perf, 3.093; 49: SpO2, 97.780; 49: Perf, 3.111; 50: SpO2, 98.271; 50: Perf, 3.193; 51: SpO2, 97.914; 51: Perf, 3.141; 52: SpO2, 97.881; 52: Perf, 2.574; 53: SpO2, 98.655; 53: Perf, 1.647; 54: SpO2, 99.2; 54: Perf, 1.737; 55: SpO2, 98.875; 55: Perf, 1.658; 56: SpO2, 98.763; 56: Perf, 0.683; 57: SpO2, 98.831; 57: Perf, 0.945; 58: SpO2, 98.552; 58: Perf, 0.899; 59: SpO2, 98.705; 59: Perf, 1.609; 60: SpO2, 98.086; 60: Perf, 2.193; 61: SpO2, 98.475; 61: Perf, 1.659; 62: SpO2, 98.0; 62: Perf, 1.693; 63: SpO2, 97.345; 63: Perf, 1.119; 64: SpO2, 97.0; 64: Perf, 0.674; 65: SpO2, 96.466; 65: Perf, 0.71; 66: SpO2, 95.971; 66: Perf, 0.729; 67: SpO2, 98.138; 67: Perf, 1.856; 68: SpO2, 97.818; 68: Perf, 2.067; 69: SpO2, 98.780; 69: Perf, 2.496; 70: SpO2, 98.155; 70: Perf, 3.193; 71: SpO2, 98.186; 71: Perf, 2.602; 72: SpO2, 98.271; 72: Perf, 2.089; 73: SpO2, 98.517; 73: Perf, 1.809; 74: SpO2, 97.831; 74: Perf, 1.508; 75: SpO2, 97.897; 75: Perf, 1.814; 76: HR, 79.0; 76: SpO2, 98.322; 76: Perf, 1.851; 76: Pain, 2.0; 77: CREATININE, 0.97 mg/dL; 77: ALT (SGPT), 37 U/L; 77: CHLORIDE, 102 mmol/L; 77: ALKALINE PHOSPHATASE, 115 U/L; 77: GLOBULIN, 3.1 g/dL; 77: POTASSIUM, 4.1 mmol/L; 77: EGFR REFIT WITHOUT RACE (2021), 93 mL/min/1.73 m2; 77: SODIUM, 142 mmol/L; 77: BILIRUBIN TOTAL, 0.3 mg/dL; 77: CALCIUM, 9.8 mg/dL; 77: ANION GAP, 11 mmol/L; 77: ALBUMIN, 4.9 g/dL; 77: CO2, 29 mmol/L; 77: GLUCOSE, 121 mg/dL; 77: AST (SGOT), 30 U/L; 77: PROTEIN TOTAL, 8.0 g/dL; 77: CORRECTED CALCIUM, 9.1 mg/dL; 77: EGFR FOR AFRICAN AMERICAN, 107 mL/min/1.73 m2; 77: BLOOD UREA NITROGEN (BUN), 16 mg/dL; 77: SpO2, 98.661; 77: Perf, 1.894; 78: SpO2, 98.155; 78: Perf, 1.599; 79: SpO2, 98.288; 79: Perf, 1.339; 80: SpO2, 98.649; 80: Perf, 1.626; 81: SpO2, 99.271; 81: Perf, 0.797; 82: SpO2, 99.576; 82: Perf, 0.516; 83: SpO2, 99.431; 83: Perf, 0.709; 84: SpO2, 99.814; 84: Perf, 0.594; 85: SpO2, 99.483; 85: Perf, 1.451; 86: SpO2, 98.847; 86: Perf, 1.900; 87: SpO2, 98.931; 87: Perf, 2.788; 88: SpO2, 98.847; 88: Perf, 3.167; 89: SpO2, 98.780; 89: Perf, 3.262; 90: SpO2, 98.776; 90: Perf, 3.402; 91: SpO2, 98.845; 91: Perf, 2.487; 92: SpO2, 98.729; 92: Perf, 2.223; 93: SpO2, 98.534; 93: Perf, 2.077; 94: SpO2, 98.783; 94: Perf, 1.206; 95: SpO2, 98.810; 95: Perf, 1.407; 96: SpO2, 98.864; 96: Perf, 1.919; 97: SpO2, 99.121; 97: Perf, 1.476; 98: SpO2, 98.797; 98: Perf, 1.537; 99: SpO2, 98.983; 99: Perf, 1.331; 100: SpO2, 98.0; 100: Perf, 1.937; 101: SpO2, 98.390; 101: Perf, 1.659; 102: SpO2, 98.466; 102: Perf, 1.656; 103: SpO2, 98.0; 103: Perf, 1.959; 104: SpO2, 98.567; 104: Perf, 1.748; 105: SpO2, 99.035; 105: Perf, 1.988; 106: SpO2, 99.0; 106: Perf, 2.469; 107: SpO2, 99.0; 107: Perf, 2.539; 108: SpO2, 99.0; 108: Perf, 1.821; 109: SpO2, 98.898; 109: Perf, 2.148; 110: SpO2, 99.0; 110: Perf, 1.34; 111: NITRITE, URINE (UA): Positive; 111: PH, URINE (UA): 6.0; 111: KETONE, URINE (UA): Negative; 111: SPECIFIC GRAVITY, URINE (UA): 1.028; 111: GLUCOSE, URINE (UA): Negative; 111: SpO2, 99.0; 111: Perf, 1.149; 112: SpO2, 99.0; 112: Perf, 1.797; 113: SpO2, 99.0; 113: Perf, 1.614; 114: SpO2, 99.0; 114: Perf, 1.840; 115: SpO2, 99.0; 115: Perf, 1.343; 116: SpO2, 99.0; 116: Perf, 1.33; 117: SpO2, 98.845; 117: Perf, 1.616; 118: SpO2, 98.932; 118: Perf, 1.644; 119: SpO2, 99.0; 119: Perf, 2.028; 0: Age, 49; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 36.6; 0: Triage HR, 106.0; 0: Triage RR, 18.0; 0: Triage SBP, 133.0; 0: Triage DBP, 83.0; 0: Triage acuity, 3-Urgent; 0: CC, ABDOMINAL PAIN,NEPHROSTOMY",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I look at the vital signs for instability (e.g., hypotension or very high heart rate), and they are mostly within normal limits aside from a slightly elevated heart rate. Next, I check for signs of infection or organ dysfunction, including lactate level and WBC count, and these values do not suggest significant infection or dysfunction. Finally, I confirm that the patient\u2019s overall clinical picture and labs do not meet typical sepsis criteria, indicating a low risk of sepsis within 12 hours.",
        "claims": [
            "The vital signs are mostly within normal limits.",
            "The vital signs show a slightly elevated heart rate.",
            "I check for signs of infection or organ dysfunction.",
            "The lactate level does not suggest significant infection or dysfunction.",
            "The WBC count does not suggest significant infection or dysfunction.",
            "The patient\u2019s overall clinical picture does not meet typical sepsis criteria.",
            "The patient's labs do not meet typical sepsis criteria.",
            "There is a low risk of sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The vital signs show a slightly elevated heart rate.",
            "The patient's labs do not meet typical sepsis criteria."
        ],
        "alignment_scores": [
            0.3,
            0.3
        ],
        "alignment_category": [
            2,
            8
        ],
        "alignment_reasonings": [
            "An elevated heart rate is one of the criteria for SIRS, which is used to identify systemic inflammation consistent with early sepsis. However, the claim does not specify if the heart rate exceeds the SIRS threshold (heart rate >90 bpm), hence the alignment is weak, reflecting some relevance to the SIRS criteria but lacking specific details to fully meet the criterion.",
            "The claim suggests that the patient does not exhibit typical sepsis criteria, implying a lack of organ dysfunction or systemic inflammation commonly associated with sepsis. The SOFA score is a comprehensive measure of organ dysfunction, and if a patient does not meet these sepsis criteria, it likely means there wasn't a significant SOFA score increase. The alignment is indirect but highlights the absence of key organ dysfunction markers used in SOFA, making this category slightly relevant."
        ],
        "final_alignment_score": 0.3,
        "accuracy": 1
    },
    {
        "input": "5: HR, 109.0; 5: RR, 18.0; 5: SpO2, 100.0; 5: SBP, 127.0; 5: DBP, 69.0; 5: MAP, 88.333; 5: Pain, 6.0; 5: Temp, 98.2; 81: WAM DIFTYP, AUTO; 81: RED CELL DISTRIBUTION WIDTH (RDW), 14.9 %; 81: NEUTROPHIL ABSOLUTE (AUTO DIFF), 4.34 K/uL; 81: BASOPHIL % (AUTO DIFF), 0.9 %; 81: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 81: MONOCYTE ABSOLUTE (AUTO DIFF), 0.53 K/uL; 81: HEMATOCRIT (HCT), 43.5 %; 81: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 81: PLATELET COUNT (PLT), 241 K/uL; 81: NEUTROPHIL % (AUTO DIFF), 64.0 %; 81: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.78 K/uL; 81: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 81: MONOCYTE % (AUTO DIFF), 7.8 %; 81: MEAN CORPUSCULAR VOLUME (MCV), 104.6 fL; 81: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.02 K/uL; 81: NRBC PERCENT (HEMATOLOGY), 0.0 %; 81: EOSINOPHIL % (AUTO DIFF), 0.7 %; 81: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.3 pg; 81: RED BLOOD CELLS (RBC), 4.16 MIL/uL; 81: LYMPHOCYTE % (AUTO DIFF), 26.3 %; 81: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 29.9 g/dL; 81: BASOPHIL ABSOLUTE (AUTO DIFF), 0.06 K/uL; 81: HEMOGLOBIN (HGB), 13.0 g/dL; 81: WHITE BLOOD CELLS (WBC), 6.8 K/uL; 86: SpO2, 99.32; 87: SpO2, 99.552; 87: Perf, 2.687; 88: HR, 98.8; 88: RR, 19.467; 88: SpO2, 99.525; 88: Perf, 1.823; 88: 1min HRV, 17.223; 89: HR, 103.483; 89: RR, 18.948; 89: SpO2, 98.983; 89: Perf, 1.419; 89: 1min HRV, 28.598; 90: HR, 99.322; 90: RR, 22.068; 90: SpO2, 98.862; 90: Perf, 2.159; 90: 1min HRV, 16.204; 90: 5min HRV, 24.694; 91: HR, 96.356; 91: RR, 15.966; 91: SpO2, 98.983; 91: Perf, 2.292; 91: 1min HRV, 22.544; 91: SBP, 115.0; 91: DBP, 79.0; 91: MAP, 91.0; 92: HR, 95.0; 92: RR, 19.052; 92: SpO2, 98.879; 92: Perf, 3.058; 92: 1min HRV, 14.133; 93: HR, 95.932; 93: RR, 16.966; 93: SpO2, 98.746; 93: Perf, 4.128; 93: 1min HRV, 18.879; 94: HR, 96.397; 94: RR, 17.466; 94: SpO2, 98.052; 94: Perf, 4.146; 94: 1min HRV, 17.535; 95: HR, 96.424; 95: RR, 15.492; 95: SpO2, 98.627; 95: Perf, 3.096; 95: 1min HRV, 40.939; 95: 5min HRV, 25.220; 96: HR, 91.881; 96: RR, 11.475; 96: SpO2, 98.441; 96: Perf, 4.773; 96: 1min HRV, 19.820; 97: HR, 93.448; 97: RR, 13.672; 97: SpO2, 98.517; 97: Perf, 4.844; 97: 1min HRV, 17.150; 98: HR, 95.034; 98: RR, 9.695; 98: SpO2, 98.627; 98: Perf, 3.999; 98: 1min HRV, 20.632; 99: HR, 93.207; 99: RR, 12.017; 99: SpO2, 98.414; 99: Perf, 4.606; 99: 1min HRV, 19.888; 100: HR, 95.136; 100: RR, 11.525; 100: SpO2, 98.085; 100: Perf, 4.079; 100: 1min HRV, 21.264; 100: 5min HRV, 21.607; 101: HR, 94.678; 101: RR, 11.169; 101: SpO2, 98.729; 101: Perf, 2.924; 101: 1min HRV, 17.756; 102: HR, 94.517; 102: RR, 12.276; 102: SpO2, 98.741; 102: Perf, 3.257; 102: 1min HRV, 18.186; 103: HR, 94.288; 103: RR, 16.644; 103: SpO2, 98.797; 103: Perf, 2.705; 103: 1min HRV, 12.102; 104: HR, 95.414; 104: RR, 15.724; 104: SpO2, 98.207; 104: Perf, 1.763; 104: 1min HRV, 8.317; 105: HR, 94.797; 105: RR, 14.169; 105: SpO2, 99.068; 105: Perf, 1.365; 105: 1min HRV, 17.161; 105: 5min HRV, 15.655; 106: HR, 93.729; 106: RR, 13.593; 106: SpO2, 98.729; 106: Perf, 1.404; 106: 1min HRV, 12.790; 106: SBP, 126.0; 106: DBP, nan; 106: MAP, nan; 107: HR, 94.759; 107: RR, 13.276; 107: SpO2, 98.776; 107: Perf, 2.192; 107: 1min HRV, 34.534; 108: HR, 93.305; 108: RR, 16.305; 108: SpO2, 98.893; 108: Perf, 2.48; 108: 1min HRV, 38.104; 109: HR, 94.155; 109: RR, 11.897; 109: SpO2, 98.522; 109: Perf, 1.763; 109: 1min HRV, 21.272; 110: HR, 96.153; 110: RR, 11.661; 110: SpO2, 98.305; 110: Perf, 1.962; 110: 1min HRV, 20.947; 110: 5min HRV, 28.704; 111: HR, 98.356; 111: RR, 17.695; 111: SpO2, 98.627; 111: Perf, 1.963; 111: 1min HRV, 19.384; 112: HR, 98.379; 112: RR, 15.914; 112: SpO2, 98.534; 112: Perf, 1.66; 112: 1min HRV, 23.370; 113: HR, 96.068; 113: RR, 13.627; 113: SpO2, 98.661; 113: Perf, 1.335; 113: 1min HRV, 19.161; 114: CHLORIDE, 105 mmol/L; 114: GLOBULIN, 3.0 g/dL; 114: CO2, 23 mmol/L; 114: GLUCOSE, 126 mg/dL; 114: ALKALINE PHOSPHATASE, 91 U/L; 114: SODIUM, 140 mmol/L; 114: ALT (SGPT), 32 U/L; 114: BLOOD UREA NITROGEN (BUN), 9 mg/dL; 114: PROTEIN TOTAL, 6.8 g/dL; 114: ANION GAP, 12 mmol/L; 114: CREATININE, 0.82 mg/dL; 114: EGFR REFIT WITHOUT RACE (2021), 89 mL/min/1.73 m2; 114: POTASSIUM, 4.6 mmol/L; 114: CORRECTED CALCIUM, 9.2 mg/dL; 114: CALCIUM, 9.0 mg/dL; 114: AST (SGOT), 40 U/L; 114: BILIRUBIN TOTAL, 0.3 mg/dL; 114: ALBUMIN, 3.8 g/dL; 114: HR, 94.655; 114: RR, 13.293; 114: SpO2, 99.241; 114: Perf, 1.235; 114: 1min HRV, 19.096; 115: HR, 94.017; 115: RR, 14.356; 115: SpO2, 99.322; 115: Perf, 1.177; 115: 1min HRV, 19.983; 115: 5min HRV, 23.273; 116: HR, 94.881; 116: RR, 19.356; 116: SpO2, 99.288; 116: Perf, 1.171; 116: 1min HRV, 23.524; 117: HR, 94.241; 117: RR, 14.534; 117: SpO2, 99.138; 117: Perf, 1.404; 117: 1min HRV, 19.643; 118: HR, 94.339; 118: RR, 19.746; 118: SpO2, 98.051; 118: Perf, 1.309; 118: 1min HRV, 33.339; 119: HR, 93.017; 119: RR, 15.897; 119: SpO2, 97.857; 119: Perf, 1.16; 119: 1min HRV, 24.704; 0: Age, 48; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.8; 0: Triage HR, 109.0; 0: Triage RR, 18.0; 0: Triage SBP, 127.0; 0: Triage DBP, 69.0; 0: Triage acuity, 3-Urgent; 0: CC, DIZZINESS",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I checked whether the patient\u2019s vital signs (blood pressure, heart rate, respiratory rate, and temperature) showed critical abnormalities, and they remained relatively stable with only mild tachycardia. Next, I looked at the laboratory results (white blood cell count, lactate if available, and other metabolic indicators) to see if there were any major signs of infection or end-organ dysfunction, and the labs appeared within normal limits. Then, I checked for ongoing concerning trends in heart rate variability and respiratory rate, and they did not escalate in a manner consistent with imminent sepsis. Based on these observations, there is no clear indication of high sepsis risk within 12 hours.",
        "claims": [
            "The patient's vital signs showed critical abnormalities.",
            "The patient's blood pressure remained relatively stable.",
            "The patient's heart rate showed mild tachycardia.",
            "The patient's respiratory rate remained relatively stable.",
            "The patient's temperature remained relatively stable.",
            "Laboratory results were checked for major signs of infection or end-organ dysfunction.",
            "The white blood cell count appeared within normal limits.",
            "The lactate levels were checked if available.",
            "Other metabolic indicators appeared within normal limits.",
            "Ongoing trends in heart rate variability were assessed.",
            "The trends in heart rate variability did not escalate in a manner consistent with imminent sepsis.",
            "Ongoing trends in respiratory rate were assessed.",
            "The trends in respiratory rate did not escalate in a manner consistent with imminent sepsis.",
            "Based on these observations, there is no clear indication of high sepsis risk within 12 hours."
        ],
        "relevant_claims": [
            "The patient's heart rate showed mild tachycardia.",
            "The trends in heart rate variability did not escalate in a manner consistent with imminent sepsis."
        ],
        "alignment_scores": [
            0.6,
            0.3
        ],
        "alignment_category": [
            2,
            6
        ],
        "alignment_reasonings": [
            "Mild tachycardia is related to the heart rate criterion (>90 bpm) in SIRS Positivity. Although \"mild\" implies it might not be significantly above 90 bpm, it still relates directly to one aspect of identifying systemic inflammation in early sepsis. The alignment is not complete because a single SIRS criterion does not fulfill the full requirement (\u22652 criteria), hence the moderate rating.",
            "The claim involves heart rate variability, which is related to hemodynamic stability. The \"Elevated Shock Index\" category involves heart rate divided by systolic BP, and a rise may indicate hemodynamic instability and severe sepsis risk. Since the claim suggests that heart rate variability trends did not escalate, the alignment is weak, especially since the claim does not provide specific heart rate or blood pressure data or mention the shock index directly. Thus, there is only a marginal and indirect correlation with this category."
        ],
        "final_alignment_score": 0.44999999999999996,
        "accuracy": 1
    },
    {
        "input": "8: HR, 114.0; 8: RR, 18.0; 8: SpO2, 98.0; 8: SBP, 100.0; 8: DBP, 62.0; 8: MAP, 74.667; 8: Temp, 101.9; 54: POC PH (V) ISTAT, 7.45; 54: POC PCO2 (V) ISTAT, 41.3 mmHg; 54: POC TCO2 (V) ISTAT, 30 mmol/L; 54: POC PO2 (V) ISTAT, 28 mmHg; 54: POC BASE EXCESS ISTAT, 5 mmol/L; 54: POC O2 SATURATION ISTAT VENOUS, 55 %; 54: POC HCO3 (V) ISTAT, 28.8 mmol/L; 54: POC LACTATE ISTAT, 1.14 mmol/L; 61: SpO2, 96.667; 61: SBP, 106.0; 61: DBP, 75.0; 61: MAP, 85.333; 62: SpO2, 95.780; 63: SpO2, 96.729; 63: Perf, 1.77; 64: SpO2, 97.0; 64: Perf, 1.786; 64: NORMOSOL-R IV BOLUS -, 1000 ML; 65: HR:, 112.0; 65: SpO2, 97.271; 65: Perf, 1.638; 65: SBP, 115.0; 65: DBP, 84.0; 65: MAP, 94.333; 65: ACETAMINOPHEN, 500 MG PO TABS; 66: SpO, 2: 98.293; 66: Perf, 1.373; 66: SBP, 115.0; 66: DBP, 84.0; 66: MAP, 94.333; 67: SpO2, 96.085; 67: Perf, 1.177; 68: SpO2, 95.678; 68: Perf, 1.127; 69: SpO2, 96.5; 69: Perf, 0.956; 70: SpO2, 95.356; 70: Perf, 0.855; 71: SpO2, 95.828; 71: Perf, 0.802; 72: SpO2, 95.559; 72: Perf, 0.764; 73: SpO2, 96.254; 73: Perf, 0.803; 74: SpO2, 96.931; 74: Perf, 0.899; 74: AMOXICILLIN, 500 MG PO CAPS; 74: AZITHROMYCIN, 250 MG PO TABS; 75: SpO2, 96.339; 75: Perf, 0.968; 76: SpO2, 96.052; 76: Perf, 0.902; 77: HR, 110.528; 77: RR, 13.625; 77: SpO2, 95.780; 77: Perf, 0.899; 77: 1min HRV, 2.757; 78: HR, 109.741; 78: RR, 19.190; 78: SpO2, 95.638; 78: Perf, 0.769; 78: 1min HRV, 3.116; 79: HR, 109.322; 79: RR, 23.814; 79: SpO2, 96.0; 79: Perf, 0.738; 79: 1min HRV, 2.266; 80: HR, 111.475; 80: RR, 21.068; 80: SpO2, 96.153; 80: Perf, 0.685; 80: 1min HRV, 3.989; 80: 5min HRV, 5.418; 80: SBP, 102.0; 80: DBP, 90.0; 80: MAP, 94.0; 81: HR, 114.534; 81: RR, 21.552; 81: SpO2, 95.455; 81: Perf, 0.641; 81: 1min HRV, 5.618; 81: SBP, 102.0; 81: DBP, 90.0; 81: MAP, 94.0; 82: HR, 117.169; 82: RR, 25.864; 82: SpO2, 95.508; 82: Perf, 0.54; 82: 1min HRV, 9.593; 83: HR, 121.276; 83: RR, 26.914; 83: SpO2, 94.328; 83: Perf, 0.548; 83: 1min HRV, 5.129; 84: HR, 124.678; 84: RR, 30.169; 84: SpO2, 93.492; 84: Perf, 0.55; 84: 1min HRV, 7.047; 85: HR, 127.04; 85: RR, 26.220; 85: SpO2, 93.136; 85: Perf, 0.55; 85: 1min HRV, 7.672; 85: 5min HRV, 18.936; 86: HR, 132.0; 86: RR, 28.845; 86: SpO2, 94.103; 86: Perf, 0.55; 86: 1min HRV, 9.623; 87: RR, 31.966; 87: SpO2, 94.0; 87: Perf, 0.55; 88: HR, 136.0; 88: RR, 35.690; 88: SpO2, 94.897; 88: Perf, 0.55; 88: 1min HRV, 0.0; 89: HR, 133.906; 89: RR, 30.373; 89: SpO2, 94.085; 89: Perf, 0.55; 89: 1min HRV, 173.207; 90: HR, 125.0; 90: RR, 33.390; 90: SpO2, 95.05; 90: Perf, 0.55; 90: 5min HRV, 97.885; 91: HR, 149.054; 91: RR, 31.534; 91: SpO2, 97.679; 91: Perf, 0.55; 91: 1min HRV, 10.808; 92: HR, 156.712; 92: RR, 30.0; 92: SpO2, 98.271; 92: Perf, 0.55; 92: 1min HRV, 60.644; 93: HR, 161.025; 93: RR, 33.034; 93: SpO2, 98.6; 93: Perf, 0.55; 93: 1min HRV, 22.283; 94: HR, 156.370; 94: RR, 36.712; 94: SpO2, 98.2; 94: Perf, 0.55; 94: 1min HRV, 94.293; 95: HR, 157.196; 95: RR, 34.339; 95: SpO2, 96.737; 95: Perf, 0.55; 95: 1min HRV, 16.234; 95: 5min HRV, 49.010; 95: SBP, 111.0; 95: DBP, 53.0; 95: MAP, 72.333; 96: PROTEIN, URINE (UA): Negative; 96: SPECIFIC GRAVITY, URINE (UA): 1.001; 96: NITRITE, URINE (UA): Negative; 96: KETONE, URINE (UA): Negative; 96: LEUKOCYTE ESTERASE, URINE (UA): Negative; 96: PH, URINE (UA): 7.0; 96: HR, 164.089; 96: RR, 36.5; 96: SpO2, 97.32; 96: Perf, 0.55; 96: 1min HRV, 26.799; 97: INR, 1.2; 97: PART. THROMBOPLASTIN TIME, 38.8 seconds; 97: PROTHROMBIN TIME, 15.3 seconds; 97: HR, 163.871; 97: RR, 36.424; 97: SpO2, 96.475; 97: Perf, 0.55; 97: 1min HRV, 13.300; 98: HR, 153.0; 98: RR, 40.224; 98: SpO2, 96.771; 98: Perf, 0.55; 98: 1min HRV, 124.873; 99: HR, 144.982; 99: RR, 34.576; 99: SpO2, 95.875; 99: Perf, 0.55; 99: 1min HRV, 12.892; 100: HR, 162.524; 100: RR, 33.407; 100: SpO2, 96.271; 100: Perf, 0.55; 100: 1min HRV, 1.961; 100: 5min HRV, 75.241; 101: HR, 165.897; 101: RR, 36.362; 101: SpO2, 97.0; 101: Perf, 0.55; 101: 1min HRV, 13.371; 102: HR, 166.962; 102: RR, 41.898; 102: SpO2, 96.746; 102: Perf, 0.55; 102: 1min HRV, 15.235; 103: HR, 164.707; 103: RR, 34.897; 103: SpO2, 97.155; 103: Perf, 0.55; 103: 1min HRV, 13.524; 104: HR, 166.322; 104: RR, 36.576; 104: SpO2, 97.492; 104: Perf, 0.55; 104: 1min HRV, 16.295; 105: HR, 165.821; 105: RR, 37.136; 105: SpO2, 97.0; 105: Perf, 0.55; 105: 1min HRV, 16.144; 105: 5min HRV, 15.305; 106: CREATININE, 1.17 mg/dL; 106: ALT (SGPT), 56 U/L; 106: BILIRUBIN TOTAL, 0.7 mg/dL; 106: AST (SGOT), 53 U/L; 106: CALCIUM, 8.8 mg/dL; 106: SODIUM, 129 mmol/L; 106: EGFR FOR AFRICAN AMERICAN, 93 mL/min/1.73 m2; 106: ALBUMIN, 3.9 g/dL; 106: GLOBULIN, 3.0 g/dL; 106: GLUCOSE, 298 mg/dL; 106: POTASSIUM, 3.1 mmol/L; 106: ALKALINE PHOSPHATASE, 76 U/L; 106: CORRECTED CALCIUM, 8.9 mg/dL; 106: CHLORIDE, 96 mmol/L; 106: CO2, 24 mmol/L; 106: ANION GAP, 9 mmol/L; 106: EGFR REFIT WITHOUT RACE (2021), 80 mL/min/1.73 m2; 106: BLOOD UREA NITROGEN (BUN), 7 mg/dL; 106: PROTEIN TOTAL, 6.9 g/dL; 106: HR, 166.759; 106: RR, 37.879; 106: SpO2, 97.741; 106: Perf, 0.55; 106: 1min HRV, 18.752; 107: HR, 166.305; 107: RR, 35.915; 107: SpO2, 97.339; 107: Perf, 0.55; 107: 1min HRV, 13.251; 108: HR, 161.741; 108: RR, 39.034; 108: SpO2, 97.190; 108: Perf, 0.55; 108: 1min HRV, 70.909; 109: HR, 159.644; 109: RR, 38.186; 109: SpO2, 97.254; 109: Perf, 0.55; 109: 1min HRV, 59.905; 110: HR, 165.724; 110: RR, 34.431; 110: SpO2, 97.310; 110: Perf, 0.55; 110: 1min HRV, 11.562; 110: 5min HRV, 46.894; 111: HR, 164.068; 111: RR, 31.051; 111: SpO2, 97.085; 111: Perf, 0.55; 111: 1min HRV, 8.139; 112: HR, 161.678; 112: RR, 32.475; 112: SpO2, 97.533; 112: Perf, 0.55; 112: 1min HRV, 10.966; 113: HR, 161.448; 113: RR, 36.655; 113: SpO2, 98.0; 113: 1min HRV, 34.426; 114: HR, 159.678; 114: RR, 29.136; 114: SpO2, 97.683; 114: 1min HRV, 11.619; 115: HR, 155.552; 115: RR, 22.431; 115: SpO2, 98.0; 115: 1min HRV, 13.881; 115: 5min HRV, 19.683; 116: HR, 153.390; 116: RR, 21.559; 116: SpO2, 98.0; 116: 1min HRV, 15.817; 117: HR, 151.356; 117: RR, 20.356; 117: SpO2, 98.0; 117: 1min HRV, 17.470; 117: CEFTRIAXONE, 1 GRAM/10 ML IV PUSH (VIAL ONLY); 118: HR:, 150.379; 118: RR, 20.672; 118: SpO2, 97.845; 118: 1min HRV, 17.041; 119: HR, 149.695; 119: RR, 23.661; 119: SpO2, 97.0; 119: 1min HRV, 18.899; 0: Age, 33; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 38.8; 0: Triage HR, 114.0; 0: Triage RR, 18.0; 0: Triage SBP, 100.0; 0: Triage DBP, 62.0; 0: Triage acuity, 3-Urgent; 0: CC, FEVER",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, I checked for signs of systemic infection by looking at fever, tachycardia, and tachypnea, all of which were present. Next, I noted that the patient is receiving broad-spectrum antibiotics and IV fluids, suggesting that clinicians suspect an infection requiring aggressive management. Finally, the persistent elevation in heart rate and respiratory rate over time points toward a high likelihood of sepsis developing within 12 hours.",
        "claims": [
            "Signs of systemic infection were checked for by looking at fever, tachycardia, and tachypnea.",
            "Fever was present in the patient.",
            "Tachycardia was present in the patient.",
            "Tachypnea was present in the patient.",
            "The patient is receiving broad-spectrum antibiotics.",
            "The patient is receiving IV fluids.",
            "The administration of broad-spectrum antibiotics suggests that clinicians suspect an infection.",
            "The administration of IV fluids suggests that clinicians suspect an infection requiring aggressive management.",
            "There is a persistent elevation in heart rate over time.",
            "There is a persistent elevation in respiratory rate over time.",
            "The persistent elevation in heart rate and respiratory rate points toward a high likelihood of sepsis developing within 12 hours."
        ],
        "relevant_claims": [
            "Signs of systemic infection were checked for by looking at fever, tachycardia, and tachypnea.",
            "Fever was present in the patient.",
            "Tachycardia was present in the patient.",
            "Tachypnea was present in the patient.",
            "The patient is receiving broad-spectrum antibiotics.",
            "The patient is receiving IV fluids.",
            "The administration of broad-spectrum antibiotics suggests that clinicians suspect an infection.",
            "The administration of IV fluids suggests that clinicians suspect an infection requiring aggressive management.",
            "There is a persistent elevation in heart rate over time.",
            "There is a persistent elevation in respiratory rate over time.",
            "The persistent elevation in heart rate and respiratory rate points toward a high likelihood of sepsis developing within 12 hours."
        ],
        "alignment_scores": [
            0.9,
            0.7,
            0.7,
            0.7,
            1.0,
            0.3,
            0.8,
            0.6,
            0.7,
            0.6,
            0.9
        ],
        "alignment_category": [
            2,
            2,
            2,
            3,
            9,
            7,
            9,
            7,
            6,
            3,
            2
        ],
        "alignment_reasonings": [
            "The claim refers to fever, tachycardia, and tachypnea, which are all components of the SIRS criteria. Checking for these signs directly relates to identifying systemic inflammation consistent with early sepsis. While the claim doesn't confirm the presence of all these criteria, it reflects the direct evaluation of relevant SIRS criteria, making the alignment very strong but not absolute.",
            "The presence of fever aligns with the SIRS criteria, which includes a temperature >38\u00b0C as a marker of systemic inflammation. However, the claim does not specify whether the fever exceeds this threshold, so the alignment isn't complete, but it is nonetheless strongly suggestive of the SIRS criterion related to temperature.",
            "Tachycardia, defined as a heart rate > 90 bpm, is one of the criteria listed under SIRS. This directly ties to identifying systemic inflammation consistent with early sepsis, but since SIRS requires at least two criteria and no other criteria are mentioned, the alignment is strong but not complete.",
            "Tachypnea, which refers to rapid breathing, corresponds directly with one element of the qSOFA score (respiratory rate\u202f\u2265\u202f22\u202f/min). While the claim alone doesn\u2019t provide enough information to confirm a qSOFA score of 2 or more, tachypnea is a specific qSOFA component, which makes the alignment fairly strong but not complete, hence the rating of 0.7.",
            "The claim explicitly mentions the administration of broad-spectrum antibiotics, which directly corresponds to this category. This is a strong indicator of clinician suspicion of a serious infection and aligns perfectly with the specified sepsis risk assessment criteria.",
            "IV fluid administration can be a response to hypotension, commonly associated with sepsis, to improve circulatory volume. The claim does not explicitly mention hypotension but suggests a potential alignment with fluid resuscitation typically used in cases where low blood pressure or hypoperfusion may be a concern. The alignment is indirect and not explicitly stated, resulting in a lower alignment rating.",
            "The claim directly mentions the administration of broad-spectrum antibiotics, which is a concrete action indicating clinician suspicion of a serious infection. This aligns well with the expert category concerning the early initiation of antibiotics, though it does not specify the timing (within 2 hours). The connection to the category is strong, but the lack of explicit timing reduces the alignment from perfect.",
            "The administration of IV fluids often indicates a response to low blood pressure or hypoperfusion, which can be consistent with sepsis-associated hypotension. Although the claim does not explicitly state hypotension, the treatment is commonly applied when there's a concern for fluid depletion or low blood pressure typically associated with sepsis. Hence, there is a moderate alignment due to this indirect connection.",
            "A persistent elevation in heart rate suggests potential haemodynamic instability, which is a key component of the Shock Index. While the claim does not directly mention systolic blood pressure, the elevated heart rate is directly related to this category, indicating a high probability of severe sepsis. The alignment is strong but not complete due to the absence of specific blood pressure data.",
            "Although the claim concerning persistent elevation in respiratory rate suggests a condition of potential clinical concern, it doesn\u2019t specify whether it meets the qSOFA criterion of respiratory rate\u202f\u2265\u202f22/min necessary for sepsis risk categorization. However, an elevated respiratory rate is indeed a consideration in qSOFA scores. Thus, there is a moderate alignment, though not explicitly detailed in the claim.",
            "The claim references the persistent elevation in both heart rate and respiratory rate, which directly relates to the criteria for SIRS, where a heart rate >90 bpm and a respiratory rate >20/min are indicators. Since both elevations are mentioned as persistent and suggest a high likelihood of sepsis, it strongly aligns with the SIRS category, though it does not cite exact numbers to fully confirm the criteria."
        ],
        "final_alignment_score": 0.7181818181818183,
        "accuracy": 1
    },
    {
        "input": "4: HR, 77.0; 4: RR, 16.0; 4: SpO2, 100.0; 4: SBP, 111.0; 4: DBP, 62.0; 4: MAP, 78.333; 4: Temp, 98.1; 30: SpO2, 95.364; 31: SpO2, 98.15; 31: Perf, 1.224; 31: SBP, 141.0; 31: DBP, 64.0; 31: MAP, 89.667; 32: SpO2, 99.776; 32: Perf, 0.976; 33: SpO2, 99.847; 33: Perf, 0.968; 34: SpO2, 98.625; 34: SBP, 126.0; 34: DBP, 74.0; 34: MAP, 91.333; 35: SpO2, 99.086; 35: Perf, 0.972; 36: SpO2, 99.542; 36: Perf, 0.932; 37: SpO2, 99.086; 37: Perf, 0.882; 38: SpO2, 99.172; 38: Perf, 0.910; 39: SpO2, 99.917; 39: Perf, 0.988; 40: SpO2, 99.707; 40: Perf, 0.895; 41: SpO2, 99.271; 41: Perf, 0.855; 42: SpO2, 99.517; 42: Perf, 0.907; 43: POC, HCG, ISTAT QUALITATIVE: Negative; 43: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 43: SpO2, 100.0; 43: Perf, 0.995; 44: SpO2, 98.831; 44: Perf, 0.989; 45: SpO2, 98.034; 45: Perf, 0.958; 46: SpO2, 99.305; 46: Perf, 0.772; 47: SpO2, 98.897; 47: Perf, 0.843; 48: SpO2, 99.593; 48: Perf, 0.885; 49: SpO2, 99.0; 49: SBP, 122.0; 49: DBP, 85.0; 49: MAP, 97.333; 50: SpO2, 98.831; 50: Perf, 0.945; 51: SpO2, 99.310; 51: Perf, 0.891; 52: SpO2, 99.237; 52: Perf, 0.859; 53: SpO2, 99.644; 53: Perf, 0.846; 54: SpO2, 97.429; 54: Perf, 0.83; 55: SpO2, 99.322; 55: Perf, 0.887; 56: SpO2, 99.305; 56: Perf, 0.819; 57: SpO2, 99.379; 57: Perf, 0.925; 58: SpO2, 98.271; 58: Perf, 0.880; 59: SpO2, 97.727; 59: Perf, 0.86; 60: SpO2, 98.362; 60: Perf, 0.852; 61: SpO2, 99.085; 61: Perf, 0.805; 62: SpO2, 97.741; 62: Perf, 0.81; 63: SpO2, 97.636; 63: Perf, 0.811; 64: SpO2, 98.1; 64: SBP, 120.0; 64: DBP, 100.0; 64: MAP, 106.667; 65: SpO2, 96.872; 66: SpO2, 98.068; 66: Perf, 0.520; 67: SpO2, 98.707; 67: Perf, 0.486; 68: SpO2, 98.559; 68: Perf, 0.544; 69: WAM DIFTYP, AUTO; 69: RED BLOOD CELLS (RBC), 4.54 MIL/uL; 69: HEMATOCRIT (HCT), 43.4 %; 69: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.01 K/uL; 69: HEMOGLOBIN (HGB), 14.1 g/dL; 69: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 69: MONOCYTE ABSOLUTE (AUTO DIFF), 0.32 K/uL; 69: RED CELL DISTRIBUTION WIDTH (RDW), 12.2 %; 69: MEAN CORPUSCULAR VOLUME (MCV), 95.6 fL; 69: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 69: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.06 K/uL; 69: NRBC PERCENT (HEMATOLOGY), 0.0 %; 69: PLATELET COUNT (PLT), 241 K/uL; 69: BASOPHIL % (AUTO DIFF), 0.9 %; 69: MONOCYTE % (AUTO DIFF), 9.2 %; 69: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.1 pg; 69: LYMPHOCYTE % (AUTO DIFF), 38.6 %; 69: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.5 g/dL; 69: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 69: EOSINOPHIL % (AUTO DIFF), 1.7 %; 69: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.34 K/uL; 69: NEUTROPHIL % (AUTO DIFF), 49.3 %; 69: WHITE BLOOD CELLS (WBC), 3.5 K/uL; 69: NEUTROPHIL ABSOLUTE (AUTO DIFF), 1.71 K/uL; 69: SpO2, 98.724; 69: Perf, 0.638; 70: SARS-COV-2 RNA, Not Detected; 70: SpO2, 97.845; 70: Perf, 0.540; 71: SpO2, 98.0; 71: Perf, 0.48; 72: SpO2, 96.611; 72: Perf, 0.48; 73: SpO2, 94.722; 73: Perf, 0.48; 74: SpO2, 98.588; 74: Perf, 0.488; 75: SpO2, 95.053; 75: Perf, 0.52; 76: GLUCOSE, URINE (UA): Negative; 76: PROTEIN, URINE (UA): Negative; 76: NITRITE, URINE (UA): Negative; 76: PH, URINE (UA): 6.0; 76: KETONE, URINE (UA): Negative; 76: SPECIFIC GRAVITY, URINE (UA): 1.013; 76: SpO2, 97.562; 77: SpO2, 88.5; 78: SpO2, 95.889; 79: SpO2, 94.88; 79: SBP, 115.0; 79: DBP, 75.0; 79: MAP, 88.333; 80: SpO2, 97.727; 80: Perf, 0.173; 81: SpO2, 94.140; 83: SpO2, 91.75; 84: SpO2, 91.464; 86: SpO2, 90.294; 87: SpO2, 92.613; 88: SpO2, 97.147; 89: SpO2, 96.1; 90: SpO2, 91.103; 91: SpO2, 93.606; 92: SpO2, 92.714; 93: CREATININE, 0.85 mg/dL; 93: POTASSIUM, 4.1 mmol/L; 93: GLUCOSE, 100 mg/dL; 93: CORRECTED CALCIUM, 8.8 mg/dL; 93: ALBUMIN, 4.8 g/dL; 93: CALCIUM, 9.4 mg/dL; 93: ANION GAP, 9 mmol/L; 93: BLOOD UREA NITROGEN (BUN), 12 mg/dL; 93: EGFR REFIT WITHOUT RACE (2021), 80 mL/min/1.73 m2; 93: BILIRUBIN TOTAL, 0.5 mg/dL; 93: LIPASE, 46 U/L; 93: ALKALINE PHOSPHATASE, 70 U/L; 93: AST (SGOT), 23 U/L; 93: CHLORIDE, 103 mmol/L; 93: SODIUM, 137 mmol/L; 93: EGFR FOR AFRICAN AMERICAN, 92 mL/min/1.73 m2; 93: CO2, 25 mmol/L; 93: PROTEIN TOTAL, 7.6 g/dL; 93: GLOBULIN, 2.8 g/dL; 93: ALT (SGPT), 18 U/L; 93: TSH, 2.77 uIU/mL; 93: SpO2, 88.762; 94: SpO2, 98.105; 94: SBP, 125.0; 94: DBP, 98.0; 94: MAP, 107.0; 95: SpO2, 95.966; 95: Perf, 0.92; 96: SpO2, 98.672; 96: Perf, 0.845; 97: SpO2, 98.169; 97: Perf, 0.894; 98: SpO2, 96.966; 98: Perf, 0.907; 99: SpO2, 96.175; 99: Perf, 0.898; 100: SpO2, 97.276; 100: Perf, 0.873; 101: SpO2, 98.288; 101: Perf, 0.865; 102: SpO2, 96.390; 102: Perf, 0.899; 103: SpO2, 98.508; 103: Perf, 1.044; 104: SpO2, 98.086; 104: Perf, 0.951; 105: SpO2, 96.68; 105: Perf, 0.95; 106: SpO2, 96.0; 106: Perf, 0.95; 107: SpO2, 97.746; 107: Perf, 0.898; 108: SpO2, 96.929; 108: Perf, 0.859; 109: SpO2, 96.611; 109: SBP, 114.0; 109: DBP, 72.0; 109: MAP, 86.0; 110: SpO2, 96.525; 110: Perf, 1.736; 111: SpO2, 98.786; 111: Perf, 1.821; 112: SpO2, 98.017; 112: Perf, 2.042; 113: SpO2, 98.153; 113: Perf, 1.672; 114: SpO2, 97.581; 114: Perf, 1.112; 0: Age, 48; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 77.0; 0: Triage RR, 16.0; 0: Triage SBP, 111.0; 0: Triage DBP, 62.0; 0: Triage acuity, 3-Urgent; 0: CC, ABDOMINAL PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I checked the patient\u2019s vital signs for major abnormalities (e.g., fever, hypotension, tachycardia) and noted they are mostly within normal limits. Next, I reviewed the laboratory results for signs of infection or organ dysfunction, such as significantly abnormal white blood cell count or elevated inflammatory markers, and did not find concerning trends. Although the WBC is slightly low, there are no other indicators of sepsis risk. Therefore, the patient does not appear to be at high risk of developing sepsis within the next 12 hours.",
        "claims": [
            "The patient\u2019s vital signs were checked for major abnormalities.",
            "The vital signs are mostly within normal limits.",
            "Laboratory results were reviewed for signs of infection or organ dysfunction.",
            "There were no concerning trends in the laboratory results.",
            "The white blood cell (WBC) count is slightly low.",
            "There are no other indicators of sepsis risk.",
            "The patient does not appear to be at high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The vital signs are mostly within normal limits."
        ],
        "alignment_scores": [
            0.2
        ],
        "alignment_category": [
            4
        ],
        "alignment_reasonings": [
            "The claim indicates that vital signs are mostly within normal limits, which indirectly suggests that it is unlikely for the NEWS score to be elevated (as an elevated NEWS score is based on deranged vitals). This provides only a weak alignment, as the claim negates the possibility of fulfilling the criteria for an elevated NEWS score, which is a predictor of clinical deterioration compatible with sepsis."
        ],
        "final_alignment_score": 0.2,
        "accuracy": 1
    },
    {
        "input": "15: HR, 100.0; 15: RR, 22.0; 15: SpO2, 94.0; 15: SBP, 107.0; 15: DBP, 55.0; 15: MAP, 72.333; 15: Pain, 3.0; 15: Temp, 101.8; 28: SpO2, 87.0; 29: SpO2, 87.898; 30: HR, 101.765; 30: RR, 20.889; 30: SpO2, 90.632; 30: 1min HRV, 4.830; 30: SBP, 123.0; 30: DBP, 62.0; 30: MAP, 82.333; 31: HR, 101.333; 31: RR, 19.233; 31: SpO2, 92.1; 31: 1min HRV, 4.776; 32: HR, 100.138; 32: RR, 17.362; 32: SpO2, 91.483; 32: 1min HRV, 4.689; 32: 5min HRV, 6.331; 33: HR, 99.0; 33: RR, 17.983; 33: SpO2, 92.593; 33: 1min HRV, 3.153; 34: HR, 98.475; 34: RR, 23.085; 34: SpO2, 91.780; 34: 1min HRV, 7.334; 35: HR, 98.310; 35: RR, 19.121; 35: SpO2, 91.259; 35: 1min HRV, 6.017; 35: ACETAMINOPHEN, 325 MG PO TABS; 36: HR:, 97.169; 36: RR, 21.034; 36: SpO2, 91.119; 36: 1min HRV, 2.545; 37: HR, 96.707; 37: RR, 19.052; 37: SpO2, 90.759; 37: 1min HRV, 9.207; 37: 5min HRV, 7.719; 38: HR, 95.881; 38: RR, 21.695; 38: SpO2, 91.661; 38: 1min HRV, 13.105; 39: HR, 97.339; 39: RR, 26.017; 39: SpO2, 90.305; 39: 1min HRV, 6.039; 40: HR, 97.776; 40: RR, 20.672; 40: SpO2, 91.034; 40: 1min HRV, 4.908; 41: HR, 96.390; 41: RR, 18.407; 41: SpO2, 91.661; 41: 1min HRV, 9.422; 42: HR, 96.828; 42: RR, 20.569; 42: SpO2, 91.190; 42: 1min HRV, 8.440; 42: 5min HRV, 9.844; 43: HR, 96.466; 43: RR, 19.569; 43: SpO2, 90.586; 43: 1min HRV, 3.590; 44: HR, 96.339; 44: RR, 23.763; 44: SpO2, 91.542; 44: 1min HRV, 5.054; 45: HR, 95.831; 45: RR, 28.254; 45: SpO2, 90.932; 45: 1min HRV, 2.598; 46: HR, 95.525; 46: RR, 26.932; 46: SpO2, 90.136; 46: 1min HRV, 5.323; 47: HR, 95.483; 47: RR, 22.931; 47: SpO2, 90.621; 47: 1min HRV, 5.140; 47: 5min HRV, 5.528; 48: HR, 95.339; 48: RR, 27.0; 48: SpO2, 90.153; 48: 1min HRV, 4.641; 49: HR, 94.879; 49: RR, 24.948; 49: SpO2, 89.810; 49: 1min HRV, 4.375; 50: HR, 94.780; 50: RR, 22.0; 50: SpO2, 90.627; 50: 1min HRV, 2.481; 51: HR, 95.203; 51: RR, 27.576; 51: SpO2, 90.068; 51: 1min HRV, 2.493; 52: HR, 95.431; 52: RR, 23.103; 52: SpO2, 89.914; 52: 1min HRV, 4.808; 52: 5min HRV, 4.417; 53: HR, 94.864; 53: RR, 23.237; 53: SpO2, 90.610; 53: 1min HRV, 6.341; 54: HR, 95.655; 54: RR, 26.397; 54: SpO2, 91.241; 54: 1min HRV, 4.805; 55: HR, 96.431; 55: RR, 20.586; 55: SpO2, 91.345; 55: 1min HRV, 3.885; 56: POC PH (V) ISTAT, 7.40; 56: POC BASE EXCESS ISTAT, 9 mmol/L; 56: POC O2 SATURATION ISTAT VENOUS, 69 %; 56: POC PO2 (V) ISTAT, 37 mmHg; 56: POC HCO3 (V) ISTAT, 33.7 mmol/L; 56: POC LACTATE ISTAT, 1.52 mmol/L; 56: POC PCO2 (V) ISTAT, 53.9 mmHg; 56: POC TCO2 (V) ISTAT, 35 mmol/L; 56: HR, 95.881; 56: RR, 16.627; 56: SpO2, 91.695; 56: 1min HRV, 4.064; 57: HR, 95.966; 57: RR, 17.305; 57: SpO2, 92.153; 57: 1min HRV, 6.730; 57: 5min HRV, 6.051; 58: HR, 94.763; 58: RR, 16.831; 58: SpO2, 92.356; 58: 1min HRV, 16.739; 58: SBP, 134.0; 58: DBP, 72.0; 58: MAP, 92.667; 59: HR, 96.897; 59: RR, 19.690; 59: SpO2, 93.0; 59: 1min HRV, 4.855; 60: HR, 95.915; 60: RR, 19.458; 60: SpO2, 92.915; 60: 1min HRV, 8.370; 61: HR, 101.542; 61: RR, 22.881; 61: SpO2, 93.729; 61: 1min HRV, 16.173; 62: HR, 106.879; 62: RR, 23.190; 62: SpO2, 91.534; 62: Perf, 2.954; 62: 1min HRV, 17.762; 62: 5min HRV, 30.337; 72: WAM DIFTYP, AUTO; 72: EOSINOPHIL % (AUTO DIFF), 0.5 %; 72: MONOCYTE % (AUTO DIFF), 4.3 %; 72: HEMATOCRIT (HCT), 45.1 %; 72: NEUTROPHIL % (AUTO DIFF), 84.7 %; 72: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.06 K/uL; 72: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.7 pg; 72: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 72: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.6 %; 72: PLATELET COUNT (PLT), 283 K/uL; 72: MEAN CORPUSCULAR VOLUME (MCV), 93.6 fL; 72: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.9 g/dL; 72: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 72: HEMOGLOBIN (HGB), 15.3 g/dL; 72: RED CELL DISTRIBUTION WIDTH (RDW), 12.8 %; 72: NRBC PERCENT (HEMATOLOGY), 0.0 %; 72: MONOCYTE ABSOLUTE (AUTO DIFF), 0.45 K/uL; 72: LYMPHOCYTE % (AUTO DIFF), 9.5 %; 72: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 72: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.99 K/uL; 72: WHITE BLOOD CELLS (WBC), 10.4 K/uL; 72: RED BLOOD CELLS (RBC), 4.82 MIL/uL; 72: NEUTROPHIL ABSOLUTE (AUTO DIFF), 8.84 K/uL; 72: BASOPHIL % (AUTO DIFF), 0.4 %; 86: DEXAMETHASONE SODIUM PHOSPHATE, 4 MG/ML INJ SOLN; 87: HR:, 93.0; 87: RR, 26.0; 87: SpO2, 92.0; 87: SBP, 114.0; 87: DBP, 49.0; 87: MAP, 70.667; 88: INR, 1.0; 88: PROTHROMBIN TIME, 12.5 seconds; 89: PART. THROMBOPLASTIN TIME, 27.9 seconds; 110: TROPONIN I, <.017 ng/mL; 113: CREATININE, 0.80 mg/dL; 113: SODIUM, 137 mmol/L; 113: BLOOD UREA NITROGEN (BUN), 14 mg/dL; 113: EGFR FOR AFRICAN AMERICAN, 134 mL/min/1.73 m2; 113: BILIRUBIN TOTAL, 0.5 mg/dL; 113: EGFR REFIT WITHOUT RACE (2021), 116 mL/min/1.73 m2; 113: POTASSIUM, 5.0 mmol/L; 113: PROTEIN TOTAL, 7.5 g/dL; 113: CO2, 25 mmol/L; 113: GLUCOSE, 127 mg/dL; 113: CHLORIDE, 99 mmol/L; 113: ANION GAP, 13 mmol/L; 113: ALBUMIN, 4.2 g/dL; 113: CORRECTED CALCIUM, 9.3 mg/dL; 113: ALT (SGPT), 74 U/L; 113: CALCIUM, 9.5 mg/dL; 113: AST (SGOT), 47 U/L; 113: ALKALINE PHOSPHATASE, 66 U/L; 113: GLOBULIN, 3.3 g/dL; 0: Age, 34; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 38.8; 0: Triage HR, 100.0; 0: Triage RR, 22.0; 0: Triage SBP, 107.0; 0: Triage DBP, 55.0; 0: Triage acuity, 2-Emergent; 0: CC, CHEST PAIN",
        "answer": false,
        "llm_answer": "Yes",
        "llm_explanation": "First, I checked whether the patient met systemic inflammatory response criteria, noting fever (38.8\u00b0C), tachycardia (HR ~100), and tachypnea (RR > 20). Next, I considered whether there was a suspicion of infection (the patient presents with possible respiratory issues and abnormal vital signs). Then, I looked for signs of organ dysfunction (e.g., borderline hypotension and reduced oxygen saturations) to further assess sepsis risk. Combining these findings, the patient\u2019s vital signs and clinical picture suggest a high likelihood of developing sepsis within 12 hours.",
        "claims": [
            "The patient met systemic inflammatory response criteria.",
            "The patient has a fever of 38.8\u00b0C.",
            "The patient has tachycardia with a heart rate of approximately 100 beats per minute.",
            "The patient has tachypnea with a respiratory rate greater than 20 breaths per minute.",
            "There is a suspicion of infection based on the patient's presentation.",
            "The patient presents with possible respiratory issues.",
            "The patient's vital signs are abnormal.",
            "There are signs of organ dysfunction in the patient.",
            "The patient exhibits borderline hypotension.",
            "The patient has reduced oxygen saturations.",
            "Combining these findings suggests a high likelihood of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient met systemic inflammatory response criteria.",
            "The patient has a fever of 38.8\u00b0C.",
            "The patient has tachycardia with a heart rate of approximately 100 beats per minute.",
            "The patient has tachypnea with a respiratory rate greater than 20 breaths per minute.",
            "There is a suspicion of infection based on the patient's presentation.",
            "The patient presents with possible respiratory issues.",
            "The patient's vital signs are abnormal.",
            "There are signs of organ dysfunction in the patient.",
            "The patient exhibits borderline hypotension.",
            "The patient has reduced oxygen saturations.",
            "Combining these findings suggests a high likelihood of developing sepsis within 12 hours."
        ],
        "alignment_scores": [
            1.0,
            0.8,
            0.6,
            0.9,
            0.3,
            0.4,
            0.5,
            0.8,
            0.6,
            0.6,
            0.3
        ],
        "alignment_category": [
            2,
            2,
            2,
            2,
            9,
            3,
            4,
            8,
            7,
            8,
            4
        ],
        "alignment_reasonings": [
            "The claim explicitly states that the patient met systemic inflammatory response criteria, which directly corresponds to the SIRS criteria. Meeting these criteria indicates systemic inflammation consistent with early sepsis, perfectly aligning with this category.",
            "A fever of 38.8\u00b0C meets one of the SIRS criteria (temperature\u202f>\u202f38\u202f\u00b0C), indicating systemic inflammation consistent with early sepsis. However, SIRS positivity requires at least two criteria to be met. This alignment is strong for one SIRS criterion but doesn't fully meet the SIRS positivity requirement, hence the rating of 0.8.",
            "Tachycardia with a heart rate exceeding 90 beats per minute is one of the criteria for SIRS (Systemic Inflammatory Response Syndrome). Although the patient's heart rate does meet the threshold for tachycardia, only one SIRS criterion is specified in the claim, aligning partially with the category's requirements for systemic inflammation indicative of early sepsis.",
            "Tachypnea with a respiratory rate greater than 20 breaths per minute is directly part of the SIRS criteria. The patient meets one of the required criteria for diagnosing systemic inflammation consistent with early sepsis, but since the SIRS Positivity requires the presence of \u22652 criteria, the alignment is strong but not perfect.",
            "The claim suggests a suspicion of infection based on the patient's presentation. While this aligns with the rationale behind administering early antibiotics or obtaining cultures, there is no mention of actual clinical actions undertaken to support the suspicion. Thus, the connection is weak, as it refers to suspicion without concrete steps such as ordering antibiotics or cultures.",
            "The claim mentions possible respiratory issues, which could relate to the respiratory rate component of the qSOFA score. However, without specific details, such as a respiratory rate meeting the qSOFA threshold (\u226522/min), the alignment remains speculative and indirect. Thus, it only slightly aligns with the criteria of a high qSOFA score.",
            "The claim about abnormal vital signs aligns with the concept of an elevated NEWS score, which is based on abnormalities in vital signs and predicts clinical deterioration. However, the claim lacks specificity regarding the exact nature of the abnormalities and does not provide enough detail to fully satisfy the criteria for any one category. Therefore, the alignment is indirect and moderate.",
            "The claim about signs of organ dysfunction aligns well with the SOFA score, which measures new organ dysfunctions, a key indicator of sepsis risk. However, the claim does not provide specific details or quantify the dysfunction to confirm an increase in SOFA score by \u22652 points, resulting in less than perfect alignment.",
            "The claim mentions \"borderline hypotension,\" which directly relates to the concept of hypotension associated with sepsis. Although it does not specify whether the systolic blood pressure is below 90 mmHg, the mention of hypotension suggests a potential progression towards a critical condition highlighted by this category. The alignment is not perfect, as specific blood pressure measurements are not provided, but it is still relevant.",
            "Reduced oxygen saturations can imply a lower PaO\u2082/FiO\u2082 ratio, which is a component of the SOFA score criteria used to assess organ dysfunction in sepsis. Although oxygen saturation is not directly measured by the SOFA criteria, it is conceptually related to the impaired oxygenation aspect. Therefore, there is a moderate alignment with the SOFA score increase category.",
            "The claim is vague and does not specify any particular metric or finding that directly corresponds to the expert categories such as SIRS criteria, qSOFA scores, or others. However, it suggests an imminent risk of sepsis, which aligns moderately with the spirit of an Elevated NEWS Score indicating imminent clinical deterioration. The rating is kept low due to lack of specific parameters or scores mentioned in the claim."
        ],
        "final_alignment_score": 0.618181818181818,
        "accuracy": 0
    },
    {
        "input": "4: HR, 98.0; 4: RR, 20.0; 4: SpO2, 98.0; 4: SBP, 156.0; 4: DBP, 91.0; 4: MAP, 112.667; 4: Pain, 9.0; 4: Temp, 97.3; 17: Pain, 9.0; 47: SpO2, 99.815; 47: Perf, 5.65; 48: SpO2, 99.698; 48: Perf, 4.866; 49: SpO2, 99.654; 49: Perf, 6.326; 50: SpO2, 98.283; 50: Perf, 6.188; 51: SpO2, 98.692; 51: Perf, 4.329; 52: SpO2, 99.887; 52: Perf, 5.396; 53: SpO2, 98.698; 53: Perf, 6.652; 54: SpO2, 97.788; 54: Perf, 6.915; 55: SpO2, 98.321; 55: Perf, 5.774; 56: SpO2, 98.769; 56: Perf, 5.436; 57: SpO2, 99.796; 57: Perf, 3.147; 58: SpO2, 99.981; 58: Perf, 5.669; 59: SpO2, 98.852; 59: Perf, 6.074; 60: SpO2, 98.962; 60: Perf, 5.853; 61: SpO2, 98.327; 61: Perf, 6.366; 62: SpO2, 97.887; 62: Perf, 4.309; 63: WAM DIFTYP, AUTO; 63: WHITE BLOOD CELLS (WBC), 9.2 K/uL; 63: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.0 %; 63: PLATELET COUNT (PLT), 111 K/uL; 63: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.11 K/uL; 63: RED BLOOD CELLS (RBC), 3.36 MIL/uL; 63: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.8 pg; 63: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.8 g/dL; 63: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.09 K/uL; 63: MONOCYTE ABSOLUTE (AUTO DIFF), 0.60 K/uL; 63: MONOCYTE % (AUTO DIFF), 6.5 %; 63: LYMPHOCYTE % (AUTO DIFF), 23.5 %; 63: NEUTROPHIL % (AUTO DIFF), 67.4 %; 63: MEAN CORPUSCULAR VOLUME (MCV), 90.8 fL; 63: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 63: HEMATOCRIT (HCT), 30.5 %; 63: NEUTROPHIL ABSOLUTE (AUTO DIFF), 6.21 K/uL; 63: BASOPHIL % (AUTO DIFF), 0.4 %; 63: EOSINOPHIL % (AUTO DIFF), 1.2 %; 63: HEMOGLOBIN (HGB), 10.0 g/dL; 63: NRBC PERCENT (HEMATOLOGY), 0.0 %; 63: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.17 K/uL; 63: RED CELL DISTRIBUTION WIDTH (RDW), 14.5 %; 63: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 63: SpO2, 98.472; 63: Perf, 5.038; 64: SpO2, 97.75; 64: Perf, 5.482; 65: SpO2, 98.811; 65: Perf, 4.566; 66: SpO2, 100.0; 66: Perf, 4.300; 67: SpO2, 99.679; 67: Perf, 4.146; 68: SpO2, 98.453; 68: Perf, 3.965; 69: SpO2, 97.692; 69: Perf, 3.954; 70: SpO2, 98.604; 70: Perf, 4.070; 71: SpO2, 98.963; 71: Perf, 3.789; 72: SpO2, 99.208; 72: Perf, 3.189; 73: SpO2, 99.226; 73: Perf, 3.142; 74: SpO2, 98.731; 74: Perf, 4.288; 75: SpO2, 99.830; 75: Perf, 4.364; 76: SpO2, 99.212; 76: Perf, 3.890; 77: SpO2, 99.358; 77: Perf, 2.905; 78: SpO2, 99.192; 78: Perf, 3.487; 79: SpO2, 100.0; 79: Perf, 2.814; 80: SpO2, 99.302; 80: Perf, 2.529; 81: SpO2, 99.827; 81: Perf, 2.478; 82: SpO2, 99.679; 82: Perf, 2.804; 83: SpO2, 99.358; 83: Perf, 3.397; 84: SpO2, 99.660; 84: Perf, 2.971; 85: SpO2, 99.722; 85: Perf, 3.593; 86: SpO2, 98.462; 86: Perf, 2.956; 87: SpO2, 99.094; 87: Perf, 2.975; 88: SpO2, 98.731; 88: Perf, 4.379; 89: SpO2, 99.226; 89: Perf, 7.745; 90: SpO2, 98.717; 90: Perf, 7.697; 91: SpO2, 98.885; 91: Perf, 5.139; 92: ANION GAP, 8 mmol/L; 92: PROTEIN TOTAL, 6.5 g/dL; 92: CREATININE, 1.69 mg/dL; 92: ALKALINE PHOSPHATASE, 204 U/L; 92: BLOOD UREA NITROGEN (BUN), 19 mg/dL; 92: GLUCOSE, 194 mg/dL; 92: AST (SGOT), 103 U/L; 92: BILIRUBIN TOTAL, 1.9 mg/dL; 92: POTASSIUM, 4.2 mmol/L; 92: CHLORIDE, 107 mmol/L; 92: GLOBULIN, 3.7 g/dL; 92: CALCIUM, 8.2 mg/dL; 92: EGFR REFIT WITHOUT RACE (2021), 41 mL/min/1.73 m2; 92: CORRECTED CALCIUM, 9.2 mg/dL; 92: SODIUM, 137 mmol/L; 92: ALT (SGPT), 35 U/L; 92: CO2, 22 mmol/L; 92: LIPASE, 7 U/L; 92: ALBUMIN, 2.8 g/dL; 92: SpO2, 99.585; 92: Perf, 5.095; 93: SpO2, 100.0; 93: Perf, 4.939; 93: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 94: SpO, 2: 100.0; 94: Perf, 6.090; 95: SpO2, 99.547; 95: Perf, 7.254; 96: SpO2, 99.698; 96: Perf, 3.639; 96: HYDROMORPHONE, 1 MG/ML INJ SYRG; 97: SpO, 2: 100.0; 97: Perf, 2.333; 98: SpO2, 100.0; 98: Perf, 1.970; 99: SpO2, 100.0; 99: Perf, 1.992; 100: SpO2, 100.0; 100: Perf, 2.358; 101: SpO2, 100.0; 101: Perf, 2.456; 102: SpO2, 100.0; 102: Perf, 2.726; 103: SpO2, 100.0; 103: Perf, 2.592; 104: SpO2, 100.0; 104: Perf, 2.425; 105: SpO2, 100.0; 105: Perf, 2.096; 106: SpO2, 100.0; 106: Perf, 2.291; 107: SpO2, 99.679; 107: Perf, 2.310; 108: POC PH (V) ISTAT, 7.54; 108: POC PCO2 (V) ISTAT, 23.5 mmHg; 108: POC O2 SATURATION ISTAT VENOUS, 77 %; 108: POC PO2 (V) ISTAT, 35 mmHg; 108: POC BASE EXCESS ISTAT, -2 mmol/L; 108: POC LACTATE ISTAT, 1.68 mmol/L; 108: POC TCO2 (V) ISTAT, 21 mmol/L; 108: POC HCO3 (V) ISTAT, 20.3 mmol/L; 108: SpO2, 99.792; 108: Perf, 2.784; 109: SpO2, 100.0; 109: Perf, 2.668; 110: POC, HCG, ISTAT QUALITATIVE: Negative; 110: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 110: SpO2, 99.788; 110: Perf, 2.271; 110: LR IV BOLUS -, 500 ML; 111: SpO, 2: 100.0; 111: Perf, 2.174; 112: SpO2, 100.0; 112: Perf, 2.461; 113: SpO2, 99.925; 113: Perf, 2.120; 114: SpO2, 98.736; 114: Perf, 2.366; 114: SBP, 125.0; 114: DBP, 72.0; 114: MAP, 89.667; 115: SpO2, 94.868; 115: Perf, 2.387; 116: SpO2, 99.302; 116: Perf, 2.58; 117: HR, 94.0; 117: RR, 18.0; 117: SpO2, 99.642; 117: Perf, 2.295; 117: SBP, 125.0; 117: DBP, 72.0; 117: MAP, 89.667; 117: Pain, 9.0; 118: SpO2, 97.231; 118: Perf, 2.053; 119: SpO2, 90.167; 119: Perf, 2.086; 0: Age, 31; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.3; 0: Triage HR, 98.0; 0: Triage RR, 20.0; 0: Triage SBP, 156.0; 0: Triage DBP, 91.0; 0: Triage acuity, 2-Emergent; 0: CC, ABDOMINAL PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, we review the vital signs to see if they suggest significant hemodynamic instability, but they remain relatively stable. Next, we check the lab results for marked infection or metabolic derangements, finding only mild abnormalities and no elevated lactate. Then, we evaluate signs of organ dysfunction to see if they point toward sepsis, noting that while creatinine is high, other indicators are not dramatically abnormal. Overall, these findings do not suggest a high risk of sepsis within the next 12 hours.",
        "claims": [
            "The vital signs are reviewed to assess for significant hemodynamic instability.",
            "The vital signs remain relatively stable.",
            "Lab results are checked for marked infection or metabolic derangements.",
            "Only mild abnormalities are found in the lab results.",
            "No elevated lactate is present in the lab results.",
            "Signs of organ dysfunction are evaluated to assess for sepsis.",
            "Creatinine levels are high.",
            "Other indicators of organ dysfunction are not dramatically abnormal.",
            "Overall findings do not suggest a high risk of sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "No elevated lactate is present in the lab results."
        ],
        "alignment_scores": [
            0.9
        ],
        "alignment_category": [
            5
        ],
        "alignment_reasonings": [
            "The claim explicitly mentions lactate levels, which directly correspond to the Elevated Serum Lactate category. However, since the claim states there is no elevation, it indicates the absence of a high risk of sepsis from this specific factor. Still, the reference is clear and specific to the criterion."
        ],
        "final_alignment_score": 0.9,
        "accuracy": 1
    },
    {
        "input": "8: HR, 120.0; 8: RR, 25.0; 8: SpO2, 86.0; 8: SBP, 105.0; 8: DBP, 77.0; 8: MAP, 86.333; 8: LPM O2, 2.0; 8: Pain, 0.0; 8: Temp, 98.8; 17: HR, 108.0; 17: SpO2, 91.538; 17: 1min HRV, 7.040; 18: HR, 112.138; 18: SpO2, 92.966; 18: Perf, 0.71; 18: 1min HRV, 6.005; 19: HR, 110.915; 19: RR, 24.2; 19: SpO2, 94.932; 19: Perf, 0.629; 19: 1min HRV, 24.315; 20: HR, 111.190; 20: RR, 17.7; 20: SpO2, 96.203; 20: Perf, 0.600; 20: 1min HRV, 4.859; 21: SpO2, 96.224; 21: Perf, 0.638; 21: 5min HRV, 16.412; 22: SpO2, 95.661; 22: Perf, 0.788; 23: HR, 110.6; 23: RR, 28.25; 23: SpO2, 96.310; 23: Perf, 0.871; 23: 1min HRV, 3.451; 24: HR, 110.644; 24: RR, 25.492; 24: SpO2, 95.441; 24: Perf, 0.802; 24: 1min HRV, 8.795; 25: POC PH (V) ISTAT, 7.33; 25: POC PCO2 (V) ISTAT, 34.3 mmHg; 25: POC HCO3 (V) ISTAT, 17.9 mmol/L; 25: POC O2 SATURATION ISTAT VENOUS, 63 %; 25: POC LACTATE ISTAT, 1.94 mmol/L; 25: POC PO2 (V) ISTAT, 35 mmHg; 25: POC TCO2 (V) ISTAT, 19 mmol/L; 25: POC BASE EXCESS ISTAT, -8 mmol/L; 25: HR, 110.576; 25: RR, 28.034; 25: SpO2, 92.746; 25: Perf, 0.727; 25: 1min HRV, 4.456; 26: HR, 109.914; 26: RR, 26.052; 26: SpO2, 92.931; 26: Perf, 0.758; 26: 1min HRV, 4.512; 26: 5min HRV, 6.624; 27: HR, 110.644; 27: RR, 27.237; 27: SpO2, 93.0; 27: Perf, 0.727; 27: 1min HRV, 6.069; 28: HR, 110.793; 28: RR, 24.707; 28: SpO2, 92.052; 28: Perf, 0.718; 28: 1min HRV, 5.125; 29: HR, 110.508; 29: RR, 24.441; 29: SpO2, 91.678; 29: Perf, 0.881; 29: 1min HRV, 24.560; 30: HR, 109.712; 30: RR, 27.068; 30: SpO2, 90.322; 30: Perf, 1.013; 30: 1min HRV, 7.817; 31: HR, 108.431; 31: RR, 26.759; 31: SpO2, 92.638; 31: Perf, 1.119; 31: 1min HRV, 6.071; 31: 5min HRV, 13.418; 31: LPM O2, 3.0; 32: HR, 106.271; 32: RR, 25.339; 32: SpO2, 94.542; 32: Perf, 1.045; 32: 1min HRV, 6.875; 32: SBP, 106.0; 32: DBP, 73.0; 32: MAP, 84.0; 33: HR, 107.586; 33: RR, 25.397; 33: SpO2, 95.0; 33: Perf, 1.158; 33: 1min HRV, 7.604; 35: POC, HCG, ISTAT QUALITATIVE: Negative; 35: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 36: 5min HRV, 7.778; 46: WAM DIFTYP, AUTO; 46: LYMPHOCYTE % (AUTO DIFF), 18.4 %; 46: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.6 g/dL; 46: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 46: PLATELET COUNT (PLT), 209 K/uL; 46: MEAN CORPUSCULAR VOLUME (MCV), 78.8 fL; 46: RED BLOOD CELLS (RBC), 3.86 MIL/uL; 46: RED CELL DISTRIBUTION WIDTH (RDW), 18.5 %; 46: MONOCYTE % (AUTO DIFF), 11.2 %; 46: NRBC ABSOLUTE (HEMATOLOGY), 0.02 K/uL; 46: NEUTROPHIL ABSOLUTE (AUTO DIFF), 9.77 K/uL; 46: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.5 %; 46: HEMATOCRIT (HCT), 30.4 %; 46: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 25.6 pg; 46: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.63 K/uL; 46: MONOCYTE ABSOLUTE (AUTO DIFF), 1.60 K/uL; 46: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.22 K/uL; 46: WHITE BLOOD CELLS (WBC), 14.3 K/uL; 46: BASOPHIL % (AUTO DIFF), 0.3 %; 46: HEMOGLOBIN (HGB), 9.9 g/dL; 46: NEUTROPHIL % (AUTO DIFF), 68.5 %; 46: EOSINOPHIL % (AUTO DIFF), 0.1 %; 46: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 46: NRBC PERCENT (HEMATOLOGY), 0.1 %; 74: CEFEPIME, 2 GRAM/20 ML IV PUSH; 80: SARS-COV-, 2 RNA: Not Detected; 80: VANCOMYCIN-WATER INJECT (PEG), 1 GRAM/200 ML IV PGBK; 83: ALT (SGPT):, 33 U/L; 83: ALKALINE PHOSPHATASE, 300 U/L; 83: AST (SGOT), 27 U/L; 83: BLOOD UREA NITROGEN (BUN), 35 mg/dL; 83: PROTEIN TOTAL, 4.8 g/dL; 83: CALCIUM, 10.9 mg/dL; 83: CORRECTED CALCIUM, 12.3 mg/dL; 83: CREATININE, 1.40 mg/dL; 83: GLOBULIN, 2.5 g/dL; 83: ALBUMIN, 2.3 g/dL; 83: BILIRUBIN TOTAL, 1.2 mg/dL; 83: GLUCOSE, 117 mg/dL; 83: SODIUM, 125 mmol/L; 83: CHLORIDE, 98 mmol/L; 83: EGFR FOR AFRICAN AMERICAN, 56 mL/min/1.73 m2; 83: ANION GAP, 9 mmol/L; 83: POTASSIUM, 4.3 mmol/L; 83: EGFR REFIT WITHOUT RACE (2021), 48 mL/min/1.73 m2; 83: CO2, 18 mmol/L; 92: TROPONIN I, <.017 ng/mL; 99: GLUCOSE, URINE (UA): Negative; 99: NITRITE, URINE (UA): Negative; 99: SPECIFIC GRAVITY, URINE (UA): 1.009; 99: KETONE, URINE (UA): Negative; 99: PH, URINE (UA): 6.0; 117: BNP NT-PRO, 363 pg/mL; 0: Age, 35; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 37.1; 0: Triage HR, 120.0; 0: Triage RR, 25.0; 0: Triage SBP, 105.0; 0: Triage DBP, 77.0; 0: Triage acuity, 2-Emergent; 0: CC, BREATHING PROBLEM",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "The first subquestion is whether the patient\u2019s vital signs (e.g., tachycardia and tachypnea) meet criteria suggesting sepsis risk. Next, we consider whether the lab tests indicate potential infection or organ dysfunction (e.g., elevated WBC count and renal impairment). Finally, we assess whether the clinical management (e.g., broad-spectrum antibiotics) suggests a serious concern for sepsis. These factors together support a high risk for sepsis within 12 hours.",
        "claims": [
            "The first subquestion is whether the patient\u2019s vital signs meet criteria suggesting sepsis risk.",
            "The patient\u2019s vital signs include tachycardia and tachypnea.",
            "The lab tests are considered to determine potential infection or organ dysfunction.",
            "Elevated WBC count is a lab test result that may indicate potential infection.",
            "Renal impairment is a lab test result that may indicate organ dysfunction.",
            "Clinical management is assessed to suggest a serious concern for sepsis.",
            "Broad-spectrum antibiotics may indicate a serious concern for sepsis.",
            "These factors together support a high risk for sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The first subquestion is whether the patient\u2019s vital signs meet criteria suggesting sepsis risk.",
            "The patient\u2019s vital signs include tachycardia and tachypnea.",
            "The lab tests are considered to determine potential infection or organ dysfunction.",
            "Elevated WBC count is a lab test result that may indicate potential infection.",
            "Renal impairment is a lab test result that may indicate organ dysfunction.",
            "Clinical management is assessed to suggest a serious concern for sepsis.",
            "Broad-spectrum antibiotics may indicate a serious concern for sepsis."
        ],
        "alignment_scores": [
            0.7,
            0.9,
            0.4,
            0.9,
            0.7,
            0.6,
            0.7
        ],
        "alignment_category": [
            4,
            2,
            9,
            2,
            8,
            9,
            9
        ],
        "alignment_reasonings": [
            "The claim is focused on evaluating vital signs to assess sepsis risk. The Elevated NEWS Score criterion relates directly to using deranged vital signs to predict clinical deterioration compatible with sepsis. While the claim does not specify the NEWS score or exact vital sign values, it suggests an assessment process similar to computing a NEWS score. Thus, the alignment is moderate but not direct, warranting a 0.7 rating.",
            "The claim references tachycardia and tachypnea, which directly correspond to two of the SIRS criteria",
            "The claim mentions lab tests being considered to assess infection or organ dysfunction. While these actions align with the intention behind early antibiotic or culture orders, the claim does not explicitly state that antibiotics were administered or cultures drawn, both of which are concrete clinical actions. Therefore, although related, the alignment is not strong, resulting in a moderate rating.",
            "An elevated white blood cell (WBC) count is a key component of the SIRS criteria, which are used to recognize systemic inflammation consistent with early sepsis. This claim ties directly to the concept of identifying potential infection. While the claim is less explicit about matching all SIRS criteria, the presence of an elevated WBC aligns strongly with the sepsis prediction category, warranting a high alignment rating.",
            "Renal impairment is related to organ dysfunction, which aligns with the SOFA Score, specifically the component related to creatinine levels (>\u202f2\u202fmg/dL) indicating renal dysfunction. However, the claim does not specify the exact measurement or increase required by the SOFA score, so the alignment is indirect but still significant.",
            "The claim suggests a significant concern for sepsis, indicating a higher likelihood that clinicians would order early antibiotics or cultures, aligning with the action-driven nature of this category. However, the claim lacks specific actions taken (e.g., antibiotic administration) to fully align, resulting in a moderate rating.",
            "The claim suggests that prescribing broad-spectrum antibiotics signals a serious concern for sepsis, which aligns with the category of early antibiotic orders reflecting clinician suspicion of a serious infection. However, the claim is somewhat general and lacks specifics about the timing or context of the antibiotic use (e.g., within the first two hours), which slightly reduces the alignment. Thus, the alignment rating is less than perfect but still strong."
        ],
        "final_alignment_score": 0.7,
        "accuracy": 1
    },
    {
        "input": "5: HR, 136.0; 5: RR, 16.0; 5: SpO2, 98.0; 5: SBP, 122.0; 5: DBP, 79.0; 5: MAP, 93.333; 5: Temp, 100.8; 14: SpO2, 96.089; 15: HR, 129.462; 15: RR, 20.722; 15: SpO2, 97.431; 15: 1min HRV, 7.348; 16: HR, 127.492; 16: RR, 21.695; 16: SpO2, 97.356; 16: 1min HRV, 3.740; 17: HR, 129.172; 17: RR, 20.086; 17: SpO2, 97.517; 17: 1min HRV, 4.378; 18: HR, 128.814; 18: RR, 21.169; 18: SpO2, 97.864; 18: 1min HRV, 3.746; 18: 5min HRV, 5.221; 19: HR, 126.881; 19: RR, 26.492; 19: SpO2, 97.576; 19: 1min HRV, 9.624; 20: POC PH (V) ISTAT, 7.44; 20: POC LACTATE ISTAT, 1.52 mmol/L; 20: POC TCO2 (V) ISTAT, 26 mmol/L; 20: POC BASE EXCESS ISTAT, 1 mmol/L; 20: POC O2 SATURATION ISTAT VENOUS, 78 %; 20: POC HCO3 (V) ISTAT, 25.2 mmol/L; 20: POC PO2 (V) ISTAT, 41 mmHg; 20: POC PCO2 (V) ISTAT, 37.1 mmHg; 20: HR, 125.397; 20: RR, 25.517; 20: SpO2, 97.310; 20: 1min HRV, 6.978; 21: HR, 127.136; 21: RR, 26.424; 21: SpO2, 97.559; 21: 1min HRV, 4.623; 22: HR, 127.121; 22: RR, 24.828; 22: SpO2, 97.328; 22: 1min HRV, 16.265; 23: HR, 128.102; 23: RR, 21.220; 23: SpO2, 97.864; 23: 1min HRV, 17.616; 23: 5min HRV, 12.635; 24: HR, 126.051; 24: RR, 24.424; 24: SpO2, 97.729; 24: 1min HRV, 5.951; 25: HR, 126.776; 25: RR, 24.155; 25: SpO2, 97.362; 25: 1min HRV, 4.675; 26: HR, 127.0; 26: RR, 23.508; 26: SpO2, 97.966; 26: 1min HRV, 4.440; 26: SBP, 116.0; 26: DBP, 77.0; 26: MAP, 90.0; 27: HR, 125.879; 27: RR, 27.259; 27: SpO2, 97.466; 27: 1min HRV, 5.543; 28: HR, 126.508; 28: RR, 25.475; 28: SpO2, 97.712; 28: 1min HRV, 7.168; 28: 5min HRV, 6.036; 28: SBP, 124.0; 28: DBP, 74.0; 28: MAP, 90.667; 28: Temp, 101.1; 29: HR, 124.603; 29: RR, 24.052; 29: SpO2, 98.0; 29: 1min HRV, 8.227; 29: SBP, 124.0; 29: DBP, 74.0; 29: MAP, 90.667; 30: HR, 126.407; 30: RR, 21.610; 30: SpO2, 97.949; 30: 1min HRV, 5.456; 31: HR, 126.0; 31: RR, 27.0; 31: SpO2, 97.322; 31: 1min HRV, 4.318; 32: HR, 124.552; 32: RR, 27.586; 32: SpO2, 97.552; 32: 1min HRV, 18.025; 33: HR, 125.746; 33: RR, 27.695; 33: SpO2, 97.610; 33: 1min HRV, 4.128; 33: 5min HRV, 9.856; 34: HR, 125.310; 34: RR, 27.845; 34: SpO2, 97.621; 34: 1min HRV, 4.438; 35: HR, 124.068; 35: RR, 25.729; 35: SpO2, 97.576; 35: 1min HRV, 5.781; 36: HR, 124.966; 36: RR, 25.814; 36: SpO2, 97.864; 36: 1min HRV, 6.834; 37: HR, 124.621; 37: RR, 23.603; 37: SpO2, 97.983; 37: 1min HRV, 6.626; 38: HR, 128.559; 38: RR, 27.322; 38: SpO2, 97.542; 38: 1min HRV, 11.386; 38: 5min HRV, 10.032; 38: ACETAMINOPHEN, 500 MG PO TABS; 39: HR:, 125.466; 39: RR, 23.931; 39: SpO2, 98.586; 39: 1min HRV, 13.072; 40: HR, 125.305; 40: RR, 18.831; 40: SpO2, 98.068; 40: Perf, 1.216; 40: 1min HRV, 22.549; 41: HR, 123.034; 41: RR, 23.966; 41: SpO2, 97.966; 41: Perf, 1.656; 41: 1min HRV, 10.291; 42: HR, 127.224; 42: RR, 23.828; 42: SpO2, 97.862; 42: Perf, 1.72; 42: 1min HRV, 8.718; 43: HR, 124.763; 43: RR, 24.034; 43: SpO2, 97.475; 43: Perf, 1.72; 43: 1min HRV, 5.967; 43: 5min HRV, 13.759; 44: HR, 123.293; 44: RR, 24.672; 44: SpO2, 97.121; 44: Perf, 1.72; 44: 1min HRV, 6.401; 44: SBP, 130.0; 44: DBP, 76.0; 44: MAP, 94.0; 45: HR, 123.475; 45: RR, 26.712; 45: SpO2, 97.237; 45: Perf, 1.72; 45: 1min HRV, 4.158; 46: HR, 123.492; 46: RR, 27.729; 46: SpO2, 97.305; 46: Perf, 1.72; 46: 1min HRV, 4.571; 47: HR, 125.310; 47: RR, 25.017; 47: SpO2, 97.5; 47: Perf, 1.72; 47: 1min HRV, 8.107; 48: HR, 122.814; 48: RR, 24.271; 48: SpO2, 97.831; 48: Perf, 1.72; 48: 1min HRV, 4.364; 48: 5min HRV, 6.794; 49: HR, 123.655; 49: RR, 24.121; 49: SpO2, 97.862; 49: Perf, 1.72; 49: 1min HRV, 4.398; 53: 5min HRV, 4.398; 57: ANTIBODY SCREEN 3, NEG; 57: ABO/RH (AUTOMATION), A Positive; 61: LR IV BOLUS -, 1000 ML; 62: INR:, 1.0; 62: PROTHROMBIN TIME, 13.3 seconds; 63: PART. THROMBOPLASTIN TIME, 36.0 seconds; 71: GLOBULIN, 2.3 g/dL; 71: CALCIUM, 9.5 mg/dL; 71: EGFR FOR AFRICAN AMERICAN, 111 mL/min/1.73 m2; 71: ALT (SGPT), 58 U/L; 71: BILIRUBIN TOTAL, 1.3 mg/dL; 71: CO2, 24 mmol/L; 71: ALKALINE PHOSPHATASE, 89 U/L; 71: AST (SGOT), 35 U/L; 71: BLOOD UREA NITROGEN (BUN), 14 mg/dL; 71: PROTEIN TOTAL, 6.5 g/dL; 71: ALBUMIN, 4.2 g/dL; 71: GLUCOSE, 120 mg/dL; 71: CHLORIDE, 102 mmol/L; 71: POTASSIUM, 4.0 mmol/L; 71: ANION GAP, 11 mmol/L; 71: CREATININE, 0.79 mg/dL; 71: EGFR REFIT WITHOUT RACE (2021), 96 mL/min/1.73 m2; 71: SODIUM, 137 mmol/L; 71: CORRECTED CALCIUM, 9.3 mg/dL; 95: SARS-COV-2 RNA, Not Detected; 116: CEFEPIME, 2 GRAM/20 ML IV PUSH; 118: HR:, 111.0; 118: RR, 20.0; 118: SpO2, 98.0; 118: SBP, 116.0; 118: DBP, 71.0; 118: MAP, 86.0; 118: Temp, 99.5; 0: Age, 62; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 38.2; 0: Triage HR, 136.0; 0: Triage RR, 16.0; 0: Triage SBP, 122.0; 0: Triage DBP, 79.0; 0: Triage acuity, 2-Emergent; 0: CC, CHILLS",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, we check whether the patient meets criteria for infection and systemic involvement by looking at fever (\u226538\u00b0C) and tachycardia (heart rate >100). Next, we note they also exhibit elevated respiratory rates, pointing toward multiple SIRS criteria. Then, we see the administration of broad-spectrum antibiotics (cefepime) and IV fluid bolus, suggesting clinical concern for possible sepsis. Putting these findings together, they indicate a high risk of sepsis within the next 12 hours.",
        "claims": [
            "The patient is checked for criteria indicating infection and systemic involvement.",
            "Fever is defined as a temperature of \u226538\u00b0C.",
            "A heart rate of >100 is classified as tachycardia.",
            "The patient exhibits elevated respiratory rates.",
            "Elevated respiratory rates point toward meeting multiple SIRS criteria.",
            "The patient has received broad-spectrum antibiotics, specifically cefepime.",
            "The administration of cefepime suggests clinical concern for possible sepsis.",
            "The patient has received an IV fluid bolus.",
            "The administration of an IV fluid bolus also suggests clinical concern for possible sepsis.",
            "The collective findings indicate a high risk of sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient is checked for criteria indicating infection and systemic involvement.",
            "Fever is defined as a temperature of \u226538\u00b0C.",
            "A heart rate of >100 is classified as tachycardia.",
            "The patient exhibits elevated respiratory rates.",
            "Elevated respiratory rates point toward meeting multiple SIRS criteria.",
            "The patient has received broad-spectrum antibiotics, specifically cefepime.",
            "The administration of cefepime suggests clinical concern for possible sepsis.",
            "The patient has received an IV fluid bolus.",
            "The administration of an IV fluid bolus also suggests clinical concern for possible sepsis.",
            "The collective findings indicate a high risk of sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            0.7,
            0.7,
            0.7,
            0.7,
            0.7,
            1.0,
            0.9,
            0.3,
            0.7,
            0.4
        ],
        "alignment_category": [
            2,
            2,
            2,
            2,
            2,
            9,
            9,
            7,
            7,
            4
        ],
        "alignment_reasonings": [
            "The claim mentions checking for criteria indicating infection and systemic involvement, which aligns with the SIRS criteria that use clinical measures like temperature, heart rate, respiratory rate, and WBC count to identify systemic inflammation in early sepsis. While the claim doesn't specify whether two or more SIRS criteria are met, it suggests a consideration of those aspects, thus moderately aligning with the category.",
            "The claim provides a definition of fever in terms of temperature (\u226538\u00b0C), which aligns with one of the SIRS criteria but not with a complete symptom profile for SIRS positivity. It strongly relates to sepsis assessment through systemic inflammatory response, making the alignment more than marginal but not fully complete without additional SIRS criteria.",
            "The claim refers to tachycardia, which aligns with one of the SIRS criteria (heart rate >90 bpm). Since the heart rate of >100 bpm exceeds the threshold for the SIRS criterion, this indicates a significant alignment with the category, but not complete because only one SIRS criterion is mentioned, not two.",
            "An elevated respiratory rate is explicitly listed under the SIRS criteria (respiratory rate > 20/min) used to identify systemic inflammation consistent with early sepsis. While the claim does not specify whether this is the only criterion met, it aligns well with SIRS as a risk factor for sepsis. However, without additional SIRS criteria, the alignment is not perfect.",
            "The claim refers to elevated respiratory rates, which are part of the SIRS criteria (respiratory rate > 20/min or PaCO\u2082\u202f<\u202f32\u202fmm\u202fHg). This criterion directly aligns with one of the specified SIRS parameters, suggesting systemic inflammation. However, since the claim doesn't explicitly state the fulfillment of two or more SIRS criteria, the alignment isn't perfect but still notably relevant.",
            "The claim directly mentions the administration of broad-spectrum antibiotics (cefepime), which aligns perfectly with this category's criterion of taking action within 2 hours as a sign of sepsis suspicion.",
            "The claim indicates that cefepime, a broad-spectrum antibiotic, is being administered. This action suggests strong clinical suspicion of a serious infection, which aligns with criteria for early antibiotic administration indicating sepsis risk. However, without explicit timing (within two hours), it slightly falls short of perfect alignment.",
            "The administration of an IV fluid bolus is often used to address low blood pressure or hypoperfusion, which is related to sepsis-associated hypotension. While the claim does not provide specific blood pressure values, the treatment implies potential hemodynamic instability associated with sepsis. The alignment is indirect and speculative without further context.",
            "The administration of an IV fluid bolus can indicate an attempt to manage hypotension, which aligns with concerns about sepsis-associated hypotension. While not explicitly mentioned in the definition, hypotension often prompts fluid resuscitation to maintain blood pressure, fitting within the broader context of managing sepsis-related shock symptoms. Thus, there is a moderate-to-strong alignment with category 7.",
            "The claim suggests a generalized assessment leading to the conclusion of high sepsis risk within the next 12 hours. The Elevated NEWS Score category encompasses the synthesis of different vital sign abnormalities, which aligns conceptually with an assessment pointing to imminent clinical deterioration and therefore at increased risk of sepsis. However, it's not specified if the exact criteria for the NEWS Score are fulfilled, so the alignment is speculative rather than definitive."
        ],
        "final_alignment_score": 0.6799999999999999,
        "accuracy": 1
    },
    {
        "input": "3: HR, 113.0; 3: RR, 16.0; 3: SpO2, 99.0; 3: SBP, 100.0; 3: DBP, 53.0; 3: MAP, 68.667; 3: Pain, 9.0; 3: Temp, 97.7; 63: HR, 108.259; 63: RR, 23.222; 63: 1min HRV, 2.271; 64: HR, 107.390; 64: RR, 18.0; 64: SpO2, 98.5; 64: 1min HRV, 20.909; 65: HR, 104.797; 65: RR, 18.288; 65: SpO2, 99.0; 65: Perf, 0.282; 65: 1min HRV, 3.347; 66: HR, 104.569; 66: RR, 20.379; 66: SpO2, 99.589; 66: Perf, 0.233; 66: 1min HRV, 3.413; 66: 5min HRV, 13.865; 66: SBP, 99.0; 66: DBP, 60.0; 66: MAP, 73.0; 67: HR, 105.220; 67: RR, 20.559; 67: SpO2, 99.305; 67: Perf, 0.468; 67: 1min HRV, 3.043; 68: HR, 104.862; 68: RR, 17.431; 68: SpO2, 99.138; 68: Perf, 0.607; 68: 1min HRV, 19.816; 69: HR, 103.508; 69: RR, 17.339; 69: SpO2, 98.746; 69: Perf, 0.731; 69: 1min HRV, 5.278; 70: HR, 103.397; 70: RR, 18.759; 70: SpO2, 98.276; 70: Perf, 0.855; 70: 1min HRV, 4.453; 71: HR, 105.220; 71: RR, 16.814; 71: SpO2, 97.672; 71: Perf, 0.354; 71: 1min HRV, 3.284; 71: 5min HRV, 10.753; 72: HR, 106.254; 72: RR, 19.525; 72: SpO2, 98.0; 72: Perf, 0.328; 72: 1min HRV, 3.043; 73: HR, 105.086; 73: RR, 17.379; 73: SpO2, 97.966; 73: Perf, 0.460; 73: 1min HRV, 4.894; 74: HR, 105.169; 74: RR, 19.407; 74: SpO2, 98.475; 74: Perf, 0.698; 74: 1min HRV, 5.951; 75: HR, 103.897; 75: RR, 20.086; 75: SpO2, 98.431; 75: Perf, 0.831; 75: 1min HRV, 2.929; 76: HR, 101.593; 76: RR, 22.356; 76: SpO2, 98.115; 76: Perf, 0.738; 76: 1min HRV, 5.040; 76: 5min HRV, 10.054; 76: SBP, 99.0; 76: DBP, 60.0; 76: MAP, 73.0; 77: HR, 101.475; 77: RR, 23.559; 77: SpO2, 98.891; 77: Perf, 0.798; 77: 1min HRV, 7.057; 78: HR, 102.517; 78: RR, 18.845; 78: SpO2, 99.25; 78: Perf, 0.83; 78: 1min HRV, 6.585; 79: HR, 102.220; 79: RR, 18.034; 79: 1min HRV, 15.981; 80: HR, 101.448; 80: RR, 17.914; 80: 1min HRV, 3.591; 81: HR, 101.763; 81: RR, 19.525; 81: 1min HRV, 4.064; 81: 5min HRV, 9.065; 82: HR, 102.237; 82: RR, 19.847; 82: 1min HRV, 4.790; 82: SBP, 93.0; 82: DBP, 60.0; 82: MAP, 71.0; 83: HR, 103.759; 83: RR, 21.017; 83: 1min HRV, 2.918; 84: HR, 103.458; 84: RR, 22.153; 84: 1min HRV, 25.080; 85: HR, 102.741; 85: RR, 17.431; 85: 1min HRV, 3.035; 86: HR, 102.763; 86: RR, 20.508; 86: SpO2, 97.707; 86: 1min HRV, 16.972; 86: 5min HRV, 14.220; 87: HR, 102.932; 87: RR, 16.169; 87: SpO2, 96.898; 87: Perf, 0.732; 87: 1min HRV, 2.928; 88: HR, 102.310; 88: RR, 15.914; 88: SpO2, 97.379; 88: Perf, 0.589; 88: 1min HRV, 2.836; 89: HR, 101.136; 89: RR, 20.339; 89: SpO2, 96.407; 89: Perf, 0.467; 89: 1min HRV, 28.272; 90: HR, 102.690; 90: RR, 18.552; 90: SpO2, 97.052; 90: Perf, 0.338; 90: 1min HRV, 2.962; 91: HR, 102.186; 91: RR, 20.288; 91: SpO2, 97.789; 91: Perf, 0.322; 91: 1min HRV, 2.993; 91: 5min HRV, 13.305; 92: HR, 101.017; 92: RR, 19.271; 92: SpO2, 97.741; 92: Perf, 0.298; 92: 1min HRV, 3.328; 93: HR, 100.914; 93: RR, 20.259; 93: SpO2, 98.328; 93: Perf, 0.307; 93: 1min HRV, 4.303; 94: HR, 100.254; 94: RR, 19.305; 94: SpO2, 98.542; 94: Perf, 0.392; 94: 1min HRV, 16.879; 95: BLOOD UREA NITROGEN (BUN), 44 mg/dL; 95: EGFR REFIT WITHOUT RACE (2021), 22 mL/min/1.73 m2; 95: AST (SGOT), 66 U/L; 95: SODIUM, 130 mmol/L; 95: ANION GAP, 18 mmol/L; 95: CO2, 24 mmol/L; 95: ALKALINE PHOSPHATASE, 67 U/L; 95: ALT (SGPT), 19 U/L; 95: CREATININE, 2.50 mg/dL; 95: CHLORIDE, 88 mmol/L; 95: GLOBULIN, 5.0 g/dL; 95: PROTEIN TOTAL, 8.7 g/dL; 95: POTASSIUM, 5.6 mmol/L; 95: CALCIUM, 9.9 mg/dL; 95: CORRECTED CALCIUM, 10.1 mg/dL; 95: BILIRUBIN TOTAL, 0.5 mg/dL; 95: ALBUMIN, 3.7 g/dL; 95: GLUCOSE, 158 mg/dL; 95: HR, 100.638; 95: RR, 20.466; 95: SpO2, 99.0; 95: Perf, 0.416; 95: 1min HRV, 8.345; 96: SARS-COV-2 RNA, Not Detected; 96: HR, 100.288; 96: RR, 17.864; 96: SpO2, 99.169; 96: Perf, 0.434; 96: 1min HRV, 7.287; 96: 5min HRV, 9.559; 96: Pain, 10.0; 97: HR, 97.322; 97: RR, 15.288; 97: SpO2, 99.339; 97: Perf, 0.489; 97: 1min HRV, 6.903; 98: HR, 95.603; 98: RR, 12.103; 98: SpO2, 98.121; 98: Perf, 0.430; 98: 1min HRV, 5.772; 99: HR, 97.0; 99: RR, 14.576; 99: SpO2, 97.356; 99: Perf, 0.417; 99: 1min HRV, 27.925; 100: HR, 95.448; 100: RR, 18.810; 100: SpO2, 98.241; 100: Perf, 0.445; 100: 1min HRV, 7.272; 101: HR, 96.712; 101: RR, 21.085; 101: SpO2, 98.0; 101: Perf, 0.409; 101: 1min HRV, 5.961; 101: 5min HRV, 14.265; 102: HR, 96.845; 102: RR, 18.397; 102: SpO2, 98.948; 102: Perf, 0.392; 102: 1min HRV, 5.895; 103: HR, 95.492; 103: RR, 19.153; 103: SpO2, 98.814; 103: Perf, 0.334; 103: 1min HRV, 5.351; 104: HR, 95.305; 104: RR, 19.644; 104: SpO2, 98.780; 104: Perf, 0.324; 104: 1min HRV, 8.790; 105: HR, 94.190; 105: RR, 18.190; 105: SpO2, 99.475; 105: Perf, 0.292; 105: 1min HRV, 3.851; 106: HR, 95.220; 106: RR, 18.983; 106: SpO2, 99.282; 106: Perf, 0.21; 106: 1min HRV, 7.364; 106: 5min HRV, 8.084; 107: HR, 92.397; 107: RR, 20.379; 107: SpO2, 99.394; 107: Perf, 0.216; 107: 1min HRV, 8.601; 108: HR, 92.254; 108: RR, 16.695; 108: SpO2, 98.947; 108: Perf, 0.201; 108: 1min HRV, 8.056; 108: MORPHINE, 4 MG/ML IV SYRG; 109: HR:, 92.678; 109: RR, 18.356; 109: SpO2, 98.814; 109: Perf, 0.276; 109: 1min HRV, 9.551; 110: HR, 93.259; 110: RR, 19.069; 110: SpO2, 97.509; 110: Perf, 0.314; 110: 1min HRV, 5.623; 111: HR, 93.763; 111: RR, 19.864; 111: SpO2, 98.807; 111: Perf, 0.306; 111: 1min HRV, 5.628; 111: 5min HRV, 8.911; 111: LR IV BOLUS -, 1000 ML; 112: HR:, 95.345; 112: RR, 19.483; 112: SpO2, 98.879; 112: Perf, 0.294; 112: 1min HRV, 6.629; 112: SBP, 79.0; 112: DBP, 59.0; 112: MAP, 65.667; 113: HR, 95.373; 113: RR, 18.051; 113: SpO2, 99.356; 113: Perf, 0.352; 113: 1min HRV, 6.753; 114: HR, 93.881; 114: RR, 19.763; 114: SpO2, 99.407; 114: Perf, 0.336; 114: 1min HRV, 7.098; 115: HR, 93.741; 115: RR, 18.879; 115: SpO2, 98.912; 115: Perf, 0.289; 115: 1min HRV, 7.738; 116: HR, 94.119; 116: RR, 17.847; 116: SpO2, 99.0; 116: Perf, 0.26; 116: 1min HRV, 8.469; 116: 5min HRV, 9.063; 117: HR, 91.983; 117: RR, 20.207; 117: SpO2, 99.316; 117: Perf, 0.245; 117: 1min HRV, 6.011; 118: HR, 92.186; 118: RR, 18.119; 118: SpO2, 100.0; 118: Perf, 0.156; 118: 1min HRV, 7.891; 119: HR, 94.458; 119: RR, 18.220; 119: SpO2, 100.0; 119: Perf, 0.13; 119: 1min HRV, 23.407; 119: SBP, 84.0; 119: DBP, 53.0; 119: MAP, 63.333; 0: Age, 59; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.5; 0: Triage HR, 113.0; 0: Triage RR, 16.0; 0: Triage SBP, 100.0; 0: Triage DBP, 53.0; 0: Triage acuity, 3-Urgent; 0: CC, WOUND CHECK",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, I check if there are abnormal vital signs consistent with sepsis, and indeed the patient demonstrates hypotension (SBP dipping below 90 mmHg), tachycardia (HR consistently over 100 bpm), and periods of elevated respiratory rate. Next, I verify whether there is evidence of organ dysfunction: the significantly elevated BUN and creatinine suggest impaired renal function. Then I note potential infection risk, given the presenting complaint of a \u201cwound check\u201d and the administration of IV fluids/medications indicating concern for sepsis. Putting these findings together strongly indicates a high risk of developing sepsis within 12 hours.",
        "claims": [
            "There are abnormal vital signs consistent with sepsis.",
            "The patient demonstrates hypotension with a systolic blood pressure (SBP) dipping below 90 mmHg.",
            "The patient shows tachycardia with a heart rate (HR) consistently over 100 bpm.",
            "The patient experiences periods of elevated respiratory rate.",
            "There is evidence of organ dysfunction indicated by significantly elevated blood urea nitrogen (BUN) and creatinine levels.",
            "Elevated BUN and creatinine suggest impaired renal function.",
            "The patient has a presenting complaint of a \u201cwound check.\u201d",
            "The administration of IV fluids and medications indicates concern for sepsis.",
            "The findings strongly indicate a high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "There are abnormal vital signs consistent with sepsis.",
            "The patient shows tachycardia with a heart rate (HR) consistently over 100 bpm.",
            "The patient experiences periods of elevated respiratory rate.",
            "There is evidence of organ dysfunction indicated by significantly elevated blood urea nitrogen (BUN) and creatinine levels.",
            "Elevated BUN and creatinine suggest impaired renal function.",
            "The administration of IV fluids and medications indicates concern for sepsis.",
            "The findings strongly indicate a high risk of developing sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            0.6,
            0.8,
            0.7,
            0.9,
            0.8,
            0.7,
            0.6
        ],
        "alignment_category": [
            4,
            2,
            2,
            8,
            8,
            9,
            4
        ],
        "alignment_reasonings": [
            "The claim mentions abnormal vital signs, which are covered under the NEWS scoring system. Elevated NEWS scores reflect deranged vitals and predict clinical deterioration compatible with sepsis. However, without specifics about the severity or combination of the abnormalities, the alignment is partial rather than complete, thus a 0.6 rating.",
            "Tachycardia, with a heart rate of over 90 bpm, is explicitly listed as one of the SIRS criteria. The claim states that the heart rate is consistently over 100 bpm, which meets the criterion for systemic inflammation that can signal early sepsis. The alignment is strong since it directly references one of the SIRS components, but it's not a complete match to a complete SIRS positivity, which requires two criteria.",
            "The claim of elevated respiratory rate relates directly to one of the SIRS criteria, which includes a respiratory rate >20/min. While it does not specify the exact rate, the mention of elevated respiratory rate suggests possible systemic inflammation and early sepsis, making this category the most relevant. However, because the exact rate isn't provided, the alignment is strong but not perfect.",
            "The claim references organ dysfunction through elevated creatinine levels, which is a component of the SOFA score used to assess organ dysfunction. The mention of blood urea nitrogen (BUN) supports kidney function assessment, though BUN itself is not a direct SOFA component. The alignment is strong due to the direct mention of creatinine, which is a specific measure in the SOFA score for renal dysfunction.",
            "Elevated BUN and creatinine are indicative of impaired renal function. In the context of sepsis risk assessment, an increase in creatinine is directly mentioned as part of the SOFA criteria (creatinine >2 mg/dL). This suggests new organ dysfunction, which aligns closely with the SOFA score increase criterion. While BUN is not explicitly mentioned in the SOFA criteria, it is a related measure of kidney function, so there is a strong alignment but not perfect.",
            "The administration of IV fluids and medications suggests an active response to a suspected infection, akin to the ordering of antibiotics or cultures. While not direct evidence of antibiotic administration, it strongly implies concern for a serious infection like sepsis. Therefore, it partially aligns with clinicians suspecting sepsis and acting accordingly, thus garnering a strong but not perfect alignment rating.",
            "The claim suggests a high risk of developing sepsis soon, which aligns generally with predictive categories. Elevated NEWS scores are specifically designed to forecast imminent clinical deterioration, including sepsis. However, the claim lacks explicit reference to deranged vitals or a specific NEWS score, hence the alignment is moderate."
        ],
        "final_alignment_score": 0.7285714285714285,
        "accuracy": 1
    },
    {
        "input": "14: HR, 142.0; 14: RR, 20.0; 14: SpO2, 94.0; 14: SBP, 105.0; 14: DBP, 72.0; 14: MAP, 83.0; 14: Pain, 0.0; 14: Temp, 97.9; 36: POC PH (V) ISTAT, 7.30; 36: POC LACTATE ISTAT, 1.08 mmol/L; 36: POC TCO2 (V) ISTAT, 27 mmol/L; 36: POC HCO3 (V) ISTAT, 25.2 mmol/L; 36: POC PCO2 (V) ISTAT, 51.6 mmHg; 36: POC PO2 (V) ISTAT, 29 mmHg; 36: POC BASE EXCESS ISTAT, -1 mmol/L; 36: POC O2 SATURATION ISTAT VENOUS, 48 %; 37: HR, 126.719; 37: RR, 25.732; 37: 1min HRV, 13.425; 37: SBP, 121.0; 37: DBP, 73.0; 37: MAP, 89.0; 37: LR IV BOLUS -, 1000 ML; 38: HR:, 126.638; 38: RR, 22.397; 38: SpO2, 96.0; 38: 1min HRV, 14.436; 38: SBP, 121.0; 38: DBP, 73.0; 38: MAP, 89.0; 39: HR, 129.441; 39: RR, 16.407; 39: 1min HRV, 10.516; 40: HR, 126.203; 40: RR, 19.780; 40: 1min HRV, 21.605; 40: 5min HRV, 16.186; 41: HR, 124.534; 41: RR, 19.672; 41: 1min HRV, 15.972; 42: HR, 124.169; 42: RR, 23.763; 42: 1min HRV, 13.252; 42: Pain, 6.0; 43: HR, 121.569; 43: RR, 16.466; 43: 1min HRV, 23.672; 44: HR, 122.220; 44: RR, 19.169; 44: 1min HRV, 26.307; 45: HR, 120.678; 45: RR, 19.627; 45: SpO2, 96.0; 45: 1min HRV, 16.388; 45: 5min HRV, 20.748; 45: SBP, 114.0; 45: DBP, 88.0; 45: MAP, 96.667; 46: HR, 117.397; 46: RR, 17.362; 46: 1min HRV, 21.886; 46: SBP, 114.0; 46: DBP, nan; 46: MAP, nan; 47: HR, 115.661; 47: RR, 17.085; 47: 1min HRV, 45.698; 48: HR, 120.776; 48: RR, 20.293; 48: 1min HRV, 21.509; 49: HR, 119.339; 49: RR, 20.898; 49: 1min HRV, 19.138; 50: HR, 117.356; 50: RR, 19.220; 50: 1min HRV, 21.795; 50: 5min HRV, 28.716; 51: HR, 116.655; 51: RR, 17.638; 51: 1min HRV, 40.855; 52: HR, 116.390; 52: RR, 19.119; 52: 1min HRV, 20.976; 53: HR, 114.414; 53: RR, 21.828; 53: 1min HRV, 22.699; 54: HR, 111.559; 54: RR, 20.797; 54: 1min HRV, 23.915; 55: HR, 112.424; 55: RR, 20.881; 55: 1min HRV, 37.342; 55: 5min HRV, 31.574; 56: HR, 113.276; 56: RR, 17.328; 56: 1min HRV, 19.370; 57: HR, 110.576; 57: RR, 20.203; 57: 1min HRV, 38.104; 58: HR, 105.931; 58: RR, 22.845; 58: 1min HRV, 14.892; 59: HR, 107.576; 59: RR, 23.864; 59: 1min HRV, 16.178; 60: HR, 109.724; 60: RR, 23.914; 60: 1min HRV, 33.069; 60: 5min HRV, 29.141; 61: HR, 109.492; 61: RR, 21.271; 61: 1min HRV, 36.478; 62: HR, 107.949; 62: RR, 23.068; 62: 1min HRV, 28.136; 63: HR, 109.397; 63: RR, 25.552; 63: 1min HRV, 31.885; 64: HR, 105.881; 64: RR, 21.712; 64: 1min HRV, 45.909; 65: HR, 105.052; 65: RR, 20.966; 65: 1min HRV, 35.182; 65: 5min HRV, 37.445; 66: HR, 107.271; 66: RR, 23.085; 66: 1min HRV, 36.498; 67: HR, 103.695; 67: RR, 20.864; 67: 1min HRV, 40.807; 68: POC HGB (CALC) ISTAT, 17.7 g/dL; 68: POC HCT ISTAT, 52 %; 68: POC POTASSIUM ISTAT, 7.0 mmol/L; 68: POC SODIUM ISTAT, 128 mmol/L; 68: POC GLUCOSE ISTAT, 97 mg/dL; 68: HR, 102.897; 68: RR, 21.103; 68: 1min HRV, 42.232; 69: WAM DIFTYP, AUTO; 69: MEAN CORPUSCULAR VOLUME (MCV), 85.0 fL; 69: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 69: RED CELL DISTRIBUTION WIDTH (RDW), 14.6 %; 69: HEMATOCRIT (HCT), 54.4 %; 69: BASOPHIL % (AUTO DIFF), 0.6 %; 69: LYMPHOCYTE % (AUTO DIFF), 12.2 %; 69: NEUTROPHIL ABSOLUTE (AUTO DIFF), 13.58 K/uL; 69: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.1 pg; 69: WHITE BLOOD CELLS (WBC), 17.6 K/uL; 69: RED BLOOD CELLS (RBC), 6.40 MIL/uL; 69: NRBC PERCENT (HEMATOLOGY), 0.0 %; 69: HEMOGLOBIN (HGB), 18.6 g/dL; 69: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.5 %; 69: EOSINOPHIL % (AUTO DIFF), 1.6 %; 69: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.09 K/uL; 69: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.2 g/dL; 69: MONOCYTE ABSOLUTE (AUTO DIFF), 1.42 K/uL; 69: MONOCYTE % (AUTO DIFF), 8.0 %; 69: PLATELET COUNT (PLT), 520 K/uL; 69: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.16 K/uL; 69: NEUTROPHIL % (AUTO DIFF), 77.1 %; 69: BASOPHIL ABSOLUTE (AUTO DIFF), 0.11 K/uL; 69: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.28 K/uL; 69: HR, 106.203; 69: RR, 22.695; 69: 1min HRV, 24.347; 70: 5min HRV, 38.258; 78: CALCIUM GLUC IN NACL ISO-OSM, 1 GRAM/50 ML IV SOLN; 82: HIGH SENSITIVITY TROPONIN: <, 4 ng/L; 94: INFLUENZA A, Not Detected; 94: RSV, Not Detected; 94: SARS-COV-2 RNA, Not Detected; 94: INFLUENZA B, Not Detected; 98: RR, 23.0; 98: SpO2, 97.0; 98: LPM O2, 15.0; 98: ALBUTEROL CONTINUOUS NEBULIZER SOLUTION, 15 MG/HR (RT MIXTURE); 116: POC GLUCOSE BY METER:, 88 mg/dL; 119: DEXTROSE, 20 % IN WATER (D20W) IVPB BOLUS; 0: Age:, 18; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.6; 0: Triage HR, 142.0; 0: Triage RR, 20.0; 0: Triage SBP, 105.0; 0: Triage DBP, 72.0; 0: Triage acuity, 2-Emergent; 0: CC, RAPID HEART RATE",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "First, note whether the patient meets basic SIRS or qSOFA criteria (e.g., tachycardia or tachypnea). Next, review lactate and blood pressure values for signs of shock or hypoperfusion (the lactate is normal, and the blood pressure remains relatively stable). Then, check for fever or other strong indicators of infection (the temperature is normal, and there are no clear signs of severe infection). Based on these findings, the data do not strongly suggest imminent sepsis.",
        "claims": [
            "The patient should be evaluated for basic SIRS or qSOFA criteria.",
            "Tachycardia is one of the SIRS or qSOFA criteria.",
            "Tachypnea is one of the SIRS or qSOFA criteria.",
            "Lactate and blood pressure values should be reviewed for signs of shock or hypoperfusion.",
            "The lactate value is normal.",
            "The blood pressure remains relatively stable.",
            "Fever or other strong indicators of infection should be checked.",
            "The temperature is normal.",
            "There are no clear signs of severe infection.",
            "The data do not strongly suggest imminent sepsis based on these findings."
        ],
        "relevant_claims": [
            "The patient should be evaluated for basic SIRS or qSOFA criteria.",
            "Tachycardia is one of the SIRS or qSOFA criteria.",
            "Lactate and blood pressure values should be reviewed for signs of shock or hypoperfusion.",
            "There are no clear signs of severe infection.",
            "The data do not strongly suggest imminent sepsis based on these findings."
        ],
        "alignment_scores": [
            0.5,
            0.8,
            0.6,
            0.2,
            0.2
        ],
        "alignment_category": [
            2,
            2,
            5,
            9,
            4
        ],
        "alignment_reasonings": [
            "The claim suggests evaluation for basic SIRS or qSOFA criteria, indicating a consideration of systemic inflammation and organ dysfunction risk. While it mentions both categories, it doesn't specify whether any criteria are actually met, and evaluation alone doesn't confirm these criteria. Thus, there is moderate alignment with the SIRS criteria, which is the more basic and direct assessment tool in early sepsis risk evaluation.",
            "The claim references tachycardia, which is explicitly part of the SIRS criteria (heart rate\u202f>\u202f90\u202fbpm). While tachycardia is also part of the qSOFA criteria, it is more directly aligned with SIRS as it is one of the specific markers for systemic inflammation. The strong alignment with the SIRS criteria justifies a high rating.",
            "The claim mentions the review of lactate levels, suggesting a concern for hypoperfusion, directly related to the Elevated Serum Lactate category. Blood pressure review suggests an assessment of haemodynamic status, aligning tangentially with shock index or hypotension, but given lactate's specific mention and relevance to hypoperfusion risk in sepsis, it is the stronger fit. Direct lactate value evaluation indicates significant, albeit indirect, alignment with potential elevated lactate concerns.",
            "The claim implies a lack of clear signs of infection, which contrasts with sepsis suspicion prompting early antibiotics or cultures. However, the consideration of infection is indirectly related to this category, suggesting minimal alignment.",
            "The claim indicates that the findings do not strongly suggest imminent sepsis, which could imply that the NEWS score is likely below the threshold of \u22655 points that predicts imminent deterioration compatible with sepsis. However, no specific details are provided about NEWS scores or similar metrics, so the alignment is indirect and not strong. Hence, a low rating of 0.2 is assigned."
        ],
        "final_alignment_score": 0.4600000000000001,
        "accuracy": 0
    },
    {
        "input": "8: HR, 70.0; 8: RR, 18.0; 8: SpO2, 100.0; 8: SBP, 159.0; 8: DBP, 83.0; 8: MAP, 108.333; 12: Pain, 9.0; 33: SpO2, 100.0; 34: HR, 82.0; 34: RR, 20.0; 34: SpO2, 100.0; 34: Perf, 1.700; 34: SBP, 138.0; 34: DBP, 81.0; 34: MAP, 100.0; 34: Temp, 97.9; 35: SpO2, 100.0; 35: Perf, 2.154; 36: SpO2, 100.0; 36: Perf, 2.221; 37: SpO2, 100.0; 37: Perf, 1.998; 38: SpO2, 100.0; 38: Perf, 1.810; 39: SpO2, 100.0; 39: Perf, 1.716; 40: SpO2, 99.915; 40: Perf, 1.645; 41: SpO2, 99.627; 41: Perf, 1.527; 42: SpO2, 99.897; 42: Perf, 1.582; 43: SpO2, 99.424; 43: Perf, 1.827; 44: HR, 80.0; 44: RR, 22.0; 44: SpO2, 99.328; 44: Perf, 1.891; 44: SBP, 159.0; 44: DBP, 92.0; 44: MAP, 114.333; 44: Pain, 9.0; 45: SpO2, 99.492; 45: Perf, 1.696; 45: SBP, 159.0; 45: DBP, 92.0; 45: MAP, 114.333; 46: SpO2, 99.898; 46: Perf, 1.302; 47: SpO2, 99.895; 47: Perf, 1.316; 48: SpO2, 100.0; 48: Perf, 1.239; 49: SpO2, 100.0; 49: Perf, 1.162; 50: SpO2, 99.932; 50: Perf, 1.170; 51: SpO2, 100.0; 51: Perf, 1.271; 52: SpO2, 100.0; 52: Perf, 1.272; 53: SpO2, 99.898; 53: Perf, 1.299; 54: POC, HCG, ISTAT QUALITATIVE: Negative; 54: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 54: SpO2, 99.914; 54: Perf, 1.518; 55: SpO2, 99.881; 55: Perf, 1.807; 56: SpO2, 99.776; 56: Perf, 1.771; 57: SpO2, 100.0; 57: Perf, 1.647; 58: SpO2, 100.0; 58: Perf, 1.594; 59: SpO2, 99.879; 59: Perf, 1.747; 60: SpO2, 99.814; 60: Perf, 1.711; 61: SpO2, 99.879; 61: Perf, 1.805; 62: SpO2, 99.831; 62: Perf, 2.869; 63: SpO2, 99.881; 63: Perf, 2.230; 64: SpO2, 100.0; 64: Perf, 1.868; 65: SpO2, 100.0; 65: Perf, 1.737; 66: SpO2, 100.0; 66: Perf, 1.750; 67: SpO2, 100.0; 67: Perf, 2.172; 68: SpO2, 99.475; 68: Perf, 3.406; 69: SpO2, 99.776; 69: Perf, 2.376; 70: SpO2, 99.593; 70: Perf, 1.955; 71: SpO2, 100.0; 71: Perf, 3.23; 72: SpO2, 99.288; 72: Perf, 7.179; 73: SpO2, 99.525; 73: Perf, 5.067; 74: SpO2, 98.741; 74: Perf, 1.804; 75: SpO2, 98.797; 75: Perf, 1.396; 76: SpO2, 99.0; 76: Perf, 1.391; 77: SpO2, 98.586; 77: Perf, 1.382; 78: SpO2, 98.458; 78: Perf, 1.414; 78: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 78: ACETAMINOPHEN 1,000 MG/100 ML (10 MG/ML) IV SOLN; 79: WAM DIFTYP, AUTO; 79: RED CELL DISTRIBUTION WIDTH (RDW), 18.6 %; 79: LYMPHOCYTE % (AUTO DIFF), 8.2 %; 79: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 79: PLATELET COUNT (PLT), 238 K/uL; 79: MONOCYTE ABSOLUTE (AUTO DIFF), 0.91 K/uL; 79: BASOPHIL % (AUTO DIFF), 0.8 %; 79: HEMOGLOBIN (HGB), 13.2 g/dL; 79: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 24.9 pg; 79: BASOPHIL ABSOLUTE (AUTO DIFF), 0.13 K/uL; 79: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.08 K/uL; 79: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 29.9 g/dL; 79: EOSINOPHIL % (AUTO DIFF), 0.1 %; 79: NRBC PERCENT (HEMATOLOGY), 0.0 %; 79: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.38 K/uL; 79: MEAN CORPUSCULAR VOLUME (MCV), 83.1 fL; 79: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.5 %; 79: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 79: WHITE BLOOD CELLS (WBC), 16.9 K/uL; 79: MONOCYTE % (AUTO DIFF), 5.4 %; 79: HEMATOCRIT (HCT), 44.1 %; 79: RED BLOOD CELLS (RBC), 5.31 MIL/uL; 79: NEUTROPHIL ABSOLUTE (AUTO DIFF), 14.42 K/uL; 79: NEUTROPHIL % (AUTO DIFF), 85.0 %; 79: SpO2, 99.897; 79: Perf, 1.471; 79: KETOROLAC, 30 MG/ML (1 ML) INJ SOLN; 79: LR IV BOLUS -, 1000 ML; 80: SpO2, 99.864; 80: Perf, 1.835; 81: SpO2, 98.345; 81: Perf, 1.771; 82: SpO2, 98.356; 82: Perf, 1.736; 83: SpO2, 99.621; 83: Perf, 1.849; 84: SpO2, 99.475; 84: Perf, 1.761; 85: SpO2, 100.0; 85: Perf, 1.923; 86: SpO2, 99.707; 86: Perf, 1.697; 87: SpO2, 99.0; 87: Perf, 1.564; 88: SpO2, 99.0; 88: Perf, 1.585; 89: SpO2, 98.831; 89: Perf, 1.430; 90: INFLUENZA A, Not Detected; 90: SARS-COV-2 RNA, Not Detected; 90: RSV, Not Detected; 90: INFLUENZA B, Not Detected; 90: SpO2, 99.322; 90: Perf, 1.201; 91: SpO2, 99.845; 91: Perf, 1.121; 92: SpO2, 98.729; 92: Perf, 1.032; 93: SpO2, 98.276; 93: Perf, 1.166; 94: SpO2, 98.966; 94: Perf, 1.158; 95: SpO2, 98.712; 95: Perf, 1.161; 96: SpO2, 97.772; 96: Perf, 1.171; 97: SpO2, 99.068; 97: Perf, 1.172; 98: SpO2, 98.879; 98: Perf, 1.252; 99: SpO2, 98.695; 99: Perf, 1.220; 100: SpO2, 98.407; 100: Perf, 1.230; 101: SpO2, 99.0; 101: Perf, 1.339; 102: SpO2, 99.0; 102: Perf, 1.359; 103: SpO2, 99.0; 103: Perf, 1.370; 104: SpO2, 99.0; 104: Perf, 1.355; 105: SpO2, 99.0; 105: Perf, 1.396; 106: SpO2, 99.0; 106: Perf, 1.319; 107: SpO2, 99.0; 107: Perf, 1.301; 108: SpO2, 98.948; 108: Perf, 1.274; 109: SpO2, 99.0; 109: Perf, 1.318; 110: SpO2, 99.0; 110: Perf, 1.316; 111: SpO2, 99.0; 111: Perf, 1.387; 112: LIPASE, 22 U/L; 112: SpO2, 99.0; 112: Perf, 1.382; 113: SpO2, 99.0; 113: Perf, 1.321; 114: SpO2, 99.0; 114: Perf, 1.407; 115: SpO2, 99.0; 115: Perf, 1.360; 116: SpO2, 99.103; 116: Perf, 1.299; 117: SpO2, 99.576; 117: Perf, 1.475; 118: HR, 83.786; 118: SpO2, 99.517; 118: Perf, 1.436; 118: 1min HRV, 62.269; 119: HR, 83.746; 119: RR, 22.0; 119: SpO2, 99.610; 119: Perf, 1.606; 119: 1min HRV, 55.335; 119: 5min HRV, 60.184; 0: Age, 44; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.6; 0: Triage HR, 70.0; 0: Triage RR, 18.0; 0: Triage SBP, 159.0; 0: Triage DBP, 83.0; 0: Triage acuity, 2-Emergent; 0: CC, ABDOMINAL PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I check whether there is evidence of an infection, which is suggested by the elevated WBC count. Next, I assess whether the SIRS or qSOFA criteria are met; the patient has an elevated WBC and slightly increased RR but does not have tachycardia or hypotension. Then, I consider whether there are any signs of end-organ dysfunction; none are evident given stable blood pressures, relatively normal temperatures, and normal SpO2. Thus, the patient is not at high risk of developing sepsis within 12 hours.",
        "claims": [
            "There is evidence of an infection suggested by the elevated WBC count.",
            "The SIRS criteria are assessed.",
            "The qSOFA criteria are assessed.",
            "The patient has an elevated WBC.",
            "The patient has a slightly increased respiratory rate.",
            "The patient does not have tachycardia.",
            "The patient does not have hypotension.",
            "There are no signs of end-organ dysfunction evident.",
            "The blood pressures are stable.",
            "The temperatures are relatively normal.",
            "The SpO2 levels are normal.",
            "The patient is not at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient does not have hypotension."
        ],
        "alignment_scores": [
            0.2
        ],
        "alignment_category": [
            7
        ],
        "alignment_reasonings": [
            "The claim explicitly mentions the absence of hypotension, which is directly related to the Sepsis-Associated Hypotension category. However, since the claim states an absence of this sepsis risk factor rather than its presence, the alignment is weak but still relevant as it involves assessing a specific criterion from the category."
        ],
        "final_alignment_score": 0.2,
        "accuracy": 1
    },
    {
        "input": "3: HR, 112.0; 3: RR, 18.0; 3: SpO2, 100.0; 3: SBP, 120.0; 3: DBP, 90.0; 3: MAP, 100.0; 3: Pain, 8.0; 3: Temp, 99.1; 8: Pain, 8.0; 38: POC PH (V) ISTAT, 7.38; 38: POC O2 SATURATION ISTAT VENOUS, 46 %; 38: POC PCO2 (V) ISTAT, 51.6 mmHg; 38: POC BASE EXCESS ISTAT, 5 mmol/L; 38: POC LACTATE ISTAT, 0.87 mmol/L; 38: POC TCO2 (V) ISTAT, 32 mmol/L; 38: POC HCO3 (V) ISTAT, 30.3 mmol/L; 38: POC PO2 (V) ISTAT, 26 mmHg; 53: WAM DIFTYP, AUTO; 53: RED BLOOD CELLS (RBC), 4.87 MIL/uL; 53: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 53: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 53: NRBC PERCENT (HEMATOLOGY), 0.0 %; 53: MEAN CORPUSCULAR VOLUME (MCV), 87.1 fL; 53: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.2 %; 53: HEMOGLOBIN (HGB), 14.6 g/dL; 53: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 53: RED CELL DISTRIBUTION WIDTH (RDW), 11.9 %; 53: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.4 g/dL; 53: WHITE BLOOD CELLS (WBC), 8.6 K/uL; 53: MONOCYTE ABSOLUTE (AUTO DIFF), 0.94 K/uL; 53: NEUTROPHIL % (AUTO DIFF), 70.5 %; 53: PLATELET COUNT (PLT), 235 K/uL; 53: BASOPHIL % (AUTO DIFF), 0.2 %; 53: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.02 K/uL; 53: MONOCYTE % (AUTO DIFF), 10.9 %; 53: HEMATOCRIT (HCT), 42.4 %; 53: EOSINOPHIL % (AUTO DIFF), 0.5 %; 53: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.52 K/uL; 53: LYMPHOCYTE % (AUTO DIFF), 17.7 %; 53: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.0 pg; 53: NEUTROPHIL ABSOLUTE (AUTO DIFF), 6.06 K/uL; 81: ALKALINE PHOSPHATASE, 52 U/L; 81: CORRECTED CALCIUM, 9.3 mg/dL; 81: CALCIUM, 9.5 mg/dL; 81: CREATININE, 1.22 mg/dL; 81: POTASSIUM, 3.5 mmol/L; 81: GLUCOSE, 91 mg/dL; 81: ALT (SGPT), 15 U/L; 81: EGFR REFIT WITHOUT RACE (2021), 78 mL/min/1.73 m2; 81: GLOBULIN, 2.8 g/dL; 81: ANION GAP, 13 mmol/L; 81: BILIRUBIN TOTAL, 0.5 mg/dL; 81: BLOOD UREA NITROGEN (BUN), 12 mg/dL; 81: AST (SGOT), 17 U/L; 81: CO2, 28 mmol/L; 81: ALBUMIN, 4.3 g/dL; 81: CHLORIDE, 98 mmol/L; 81: SODIUM, 139 mmol/L; 81: PROTEIN TOTAL, 7.1 g/dL; 90: SpO2, 97.667; 91: SpO2, 97.766; 92: SpO2, 98.676; 93: HR, 117.189; 93: RR, 17.417; 93: SpO2, 98.339; 93: 1min HRV, 35.892; 94: HR, 118.897; 94: RR, 19.397; 94: SpO2, 99.052; 94: Perf, 0.651; 94: 1min HRV, 36.582; 94: SBP, 110.0; 94: DBP, 70.0; 94: MAP, 83.333; 95: HR, 112.356; 95: RR, 14.763; 95: SpO2, 98.949; 95: Perf, 0.622; 95: 1min HRV, 23.354; 95: SBP, 110.0; 95: DBP, 70.0; 95: MAP, 83.333; 95: Temp, 100.3; 96: HR, 117.103; 96: RR, 16.034; 96: SpO2, 97.828; 96: Perf, 0.617; 96: 1min HRV, 12.359; 96: 5min HRV, 30.311; 97: SARS-COV-2 RNA, Not Detected; 97: HR, 114.542; 97: RR, 19.729; 97: SpO2, 96.661; 97: Perf, 0.561; 97: 1min HRV, 10.839; 98: HR, 115.746; 98: RR, 16.831; 98: SpO2, 97.271; 98: Perf, 0.554; 98: 1min HRV, 70.725; 99: HR, 112.448; 99: RR, 14.552; 99: SpO2, 99.638; 99: Perf, 0.597; 99: 1min HRV, 15.210; 99: SBP, 111.0; 99: DBP, 73.0; 99: MAP, 85.667; 99: Pain, 9.0; 100: HR, 115.424; 100: RR, 14.949; 100: SpO2, 97.814; 100: Perf, 0.601; 100: 1min HRV, 7.647; 101: HR, 115.259; 101: RR, 17.172; 101: SpO2, 97.328; 101: Perf, 0.575; 101: 1min HRV, 18.362; 101: 5min HRV, 33.974; 102: HR, 113.593; 102: RR, 14.017; 102: SpO2, 97.797; 102: Perf, 0.537; 102: 1min HRV, 29.787; 102: SBP, 111.0; 102: DBP, 73.0; 102: MAP, 85.667; 103: HR, 116.407; 103: RR, 19.034; 103: SpO2, 99.0; 103: Perf, 0.519; 103: 1min HRV, 21.083; 103: HYDROMORPHONE, 1 MG/ML INJ SYRG; 104: HR:, 116.672; 104: RR, 18.190; 104: SpO2, 98.207; 104: Perf, 0.492; 104: 1min HRV, 17.796; 105: HR, 114.729; 105: RR, 15.881; 105: SpO2, 98.119; 105: Perf, 0.471; 105: 1min HRV, 30.473; 105: LR IV BOLUS -, 1000 ML; 106: HR:, 116.379; 106: RR, 17.379; 106: SpO2, 97.638; 106: Perf, 0.471; 106: 1min HRV, 16.924; 106: 5min HRV, 24.392; 106: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 107: HR:, 115.593; 107: RR, 21.797; 107: SpO2, 97.881; 107: Perf, 0.519; 107: 1min HRV, 13.793; 108: HR, 116.288; 108: RR, 20.780; 108: SpO2, 97.746; 108: Perf, 0.519; 108: 1min HRV, 14.276; 109: HR, 114.776; 109: RR, 11.345; 109: SpO2, 98.931; 109: Perf, 0.505; 109: 1min HRV, 13.103; 110: HR, 115.254; 110: RR, 16.0; 110: SpO2, 97.424; 110: Perf, 0.498; 110: 1min HRV, 21.313; 111: HR, 116.034; 111: RR, 17.034; 111: SpO2, 97.310; 111: Perf, 0.484; 111: 1min HRV, 19.157; 111: 5min HRV, 16.964; 112: HR, 112.034; 112: RR, 18.373; 112: SpO2, 96.559; 112: Perf, 0.524; 112: 1min HRV, 14.941; 113: HR, 113.983; 113: RR, 18.586; 113: SpO2, 97.466; 113: Perf, 0.536; 113: 1min HRV, 11.433; 114: HR, 112.271; 114: RR, 20.407; 114: SpO2, 96.780; 114: Perf, 0.540; 114: 1min HRV, 15.690; 115: HR, 112.051; 115: RR, 15.034; 115: SpO2, 95.356; 115: Perf, 0.529; 115: 1min HRV, 20.846; 116: HR, 111.948; 116: RR, 16.379; 116: SpO2, 95.914; 116: Perf, 0.514; 116: 1min HRV, 13.143; 116: 5min HRV, 15.961; 117: HR, 112.644; 117: RR, 14.203; 117: SpO2, 97.339; 117: Perf, 0.507; 117: 1min HRV, 16.865; 118: HR, 113.810; 118: RR, 16.741; 118: SpO2, 95.983; 118: Perf, 0.52; 118: 1min HRV, 11.521; 119: HR, 114.186; 119: RR, 17.254; 119: SpO2, 96.119; 119: Perf, 0.52; 119: 1min HRV, 13.682; 0: Age, 38; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.3; 0: Triage HR, 112.0; 0: Triage RR, 18.0; 0: Triage SBP, 120.0; 0: Triage DBP, 90.0; 0: Triage acuity, 3-Urgent; 0: CC, WOUND CHECK",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I check whether the patient\u2019s lactate level is elevated; it is normal at 0.87 mmol/L. Next, I look at vital signs (e.g., blood pressure, heart rate, respiratory rate) for sepsis criteria and find no significant hypotension or abnormally high respiratory rate, although the heart",
        "claims": [
            "The patient\u2019s lactate level is normal at 0.87 mmol/L.",
            "The lactate level is not elevated.",
            "I check the patient\u2019s vital signs for sepsis criteria.",
            "I find no significant hypotension in the patient.",
            "I find no abnormally high respiratory rate in the patient.",
            "I check the heart rate as part of the vital signs assessment."
        ],
        "relevant_claims": [
            "The lactate level is not elevated."
        ],
        "alignment_scores": [
            0.2
        ],
        "alignment_category": [
            5
        ],
        "alignment_reasonings": [
            "The claim refers to lactate levels, which align with the category concerning Elevated Serum Lactate, a known indicator for sepsis risk. However, since the lactate level is not elevated, the claim does not affirm a risk factor for sepsis, resulting in a low alignment rating."
        ],
        "final_alignment_score": 0.2,
        "accuracy": 1
    },
    {
        "input": "11: HR, 128.0; 11: RR, 22.0; 11: SpO2, 100.0; 11: SBP, 135.0; 11: DBP, 95.0; 11: MAP, 108.333; 11: LPM O2, 4.0; 11: Temp, 99.2; 20: Pain, 2.0; 46: HR, 122.0; 46: RR, 23.0; 46: SpO2, 100.0; 46: SBP, 150.0; 46: DBP, 110.0; 46: MAP, 123.333; 52: HR, 122.939; 52: RR, 23.25; 52: SpO2, 100.0; 52: 1min HRV, 5.704; 53: HR, 122.845; 53: RR, 21.517; 53: SpO2, 99.914; 53: Perf, 2.808; 53: 1min HRV, 5.565; 53: SBP, 150.0; 53: DBP, 110.0; 53: MAP, 123.333; 54: HR, 123.831; 54: RR, 24.644; 54: SpO2, 99.661; 54: Perf, 2.638; 54: 1min HRV, 10.795; 55: HR, 121.0; 55: RR, 25.508; 55: SpO2, 99.915; 55: Perf, 2.988; 55: 1min HRV, 10.056; 56: HR, 122.84; 56: RR, 26.149; 56: SpO2, 99.948; 56: Perf, 3.283; 56: 1min HRV, 8.571; 56: 5min HRV, 8.940; 57: HR, 122.576; 57: RR, 19.769; 57: SpO2, 99.864; 57: Perf, 3.919; 57: 1min HRV, 7.105; 58: HR, 122.879; 58: RR, 22.517; 58: SpO2, 99.879; 58: Perf, 4.124; 58: 1min HRV, 8.843; 59: HR, 123.034; 59: RR, 25.678; 59: SpO2, 100.0; 59: Perf, 3.976; 59: 1min HRV, 4.672; 60: HR, 122.508; 60: RR, 24.169; 60: SpO2, 100.0; 60: Perf, 3.974; 60: 1min HRV, 7.319; 61: HR, 120.776; 61: RR, 25.017; 61: SpO2, 100.0; 61: Perf, 3.710; 61: 1min HRV, 9.472; 61: 5min HRV, 8.257; 62: HR, 122.085; 62: RR, 21.136; 62: SpO2, 99.729; 62: Perf, 3.300; 62: 1min HRV, 5.797; 63: HR, 121.190; 63: RR, 22.569; 63: SpO2, 100.0; 63: Perf, 3.961; 63: 1min HRV, 6.137; 64: HR, 121.492; 64: RR, 23.712; 64: SpO2, 99.864; 64: Perf, 3.505; 64: 1min HRV, 7.056; 65: HR, 121.475; 65: RR, 21.966; 65: SpO2, 100.0; 65: Perf, 3.676; 65: 1min HRV, 5.555; 66: HR, 124.069; 66: RR, 25.638; 66: SpO2, 100.0; 66: Perf, 3.285; 66: 1min HRV, 6.096; 66: 5min HRV, 7.719; 67: HR, 122.441; 67: RR, 20.119; 67: SpO2, 99.932; 67: Perf, 3.020; 67: 1min HRV, 10.566; 68: POC PH (V) ISTAT, 7.27; 68: POC LACTATE ISTAT, <.30 mmol/L; 68: POC PO2 (V) ISTAT, 52 mmHg; 68: POC O2 SATURATION ISTAT VENOUS, 79 %; 68: POC BASE EXCESS ISTAT, 16 mmol/L; 68: POC TCO2 (V) ISTAT, 46 mmol/L; 68: POC PCO2 (V) ISTAT, 93.1 mmHg; 68: POC HCO3 (V) ISTAT, 43.1 mmol/L; 68: HR, 122.759; 68: RR, 22.862; 68: SpO2, 100.0; 68: Perf, 3.085; 68: 1min HRV, 6.594; 69: HR, 122.220; 69: RR, 24.593; 69: SpO2, 99.763; 69: Perf, 3.244; 69: 1min HRV, 11.331; 70: HR, 120.983; 70: RR, 23.356; 70: SpO2, 99.847; 70: Perf, 2.363; 70: 1min HRV, 7.587; 71: HR, 121.017; 71: RR, 22.431; 71: SpO2, 100.0; 71: Perf, 2.784; 71: 1min HRV, 9.820; 71: 5min HRV, 9.871; 72: HR, 120.864; 72: RR, 21.915; 72: SpO2, 99.915; 72: Perf, 3.830; 72: 1min HRV, 16.374; 73: HR, 120.103; 73: RR, 24.759; 73: SpO2, 100.0; 73: Perf, 3.610; 73: 1min HRV, 10.152; 74: HR, 118.492; 74: RR, 18.559; 74: SpO2, 99.492; 74: Perf, 3.811; 74: 1min HRV, 18.415; 75: HR, 101.776; 75: RR, 24.276; 75: SpO2, 98.810; 75: Perf, 3.638; 75: 1min HRV, 60.252; 76: HR, 112.729; 76: RR, 25.119; 76: SpO2, 97.441; 76: Perf, 4.093; 76: 1min HRV, 62.110; 76: 5min HRV, 53.036; 77: HR, 129.0; 77: RR, 21.203; 77: SpO2, 96.847; 77: Perf, 3.652; 77: 1min HRV, 4.517; 78: HR, 127.362; 78: RR, 21.466; 78: SpO2, 97.672; 78: Perf, 2.806; 78: 1min HRV, 9.283; 79: HR, 125.898; 79: RR, 30.441; 79: SpO2, 99.186; 79: Perf, 3.482; 79: 1min HRV, 7.209; 80: HR, 125.207; 80: RR, 27.448; 80: SpO2, 99.552; 80: Perf, 4.992; 80: 1min HRV, 7.198; 81: HR, 124.119; 81: RR, 25.729; 81: SpO2, 99.661; 81: Perf, 4.143; 81: 1min HRV, 4.572; 81: 5min HRV, 9.969; 82: HR, 122.712; 82: RR, 22.220; 82: SpO2, 99.814; 82: Perf, 4.987; 82: 1min HRV, 8.090; 83: HR, 121.931; 83: RR, 21.862; 83: SpO2, 99.621; 83: Perf, 2.813; 83: 1min HRV, 10.376; 86: 5min HRV, 9.461; 89: WAM DIFTYP, AUTO; 89: HEMATOCRIT (HCT), 40.8 %; 89: PLATELET COUNT (PLT), 327 K/uL; 89: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 27.0 pg; 89: HEMOGLOBIN (HGB), 12.1 g/dL; 89: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 29.7 g/dL; 89: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.04 K/uL; 89: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 89: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.84 K/uL; 89: MEAN CORPUSCULAR VOLUME (MCV), 91.1 fL; 89: LYMPHOCYTE % (AUTO DIFF), 6.7 %; 89: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 89: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.29 K/uL; 89: MONOCYTE % (AUTO DIFF), 8.5 %; 89: MONOCYTE ABSOLUTE (AUTO DIFF), 1.06 K/uL; 89: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 89: RED CELL DISTRIBUTION WIDTH (RDW), 12.4 %; 89: EOSINOPHIL % (AUTO DIFF), 2.3 %; 89: NRBC PERCENT (HEMATOLOGY), 0.0 %; 89: NEUTROPHIL % (AUTO DIFF), 81.9 %; 89: WHITE BLOOD CELLS (WBC), 12.5 K/uL; 89: RED BLOOD CELLS (RBC), 4.48 MIL/uL; 89: BASOPHIL % (AUTO DIFF), 0.3 %; 89: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.20 K/uL; 95: NS IV BOLUS -, 1000 ML; 97: INR:, 1.0; 97: PROTHROMBIN TIME, 13.2 seconds; 97: PART. THROMBOPLASTIN TIME, 29.0 seconds; 100: POC, BHCG, ISTAT QUANTITATIVE: 5.0 IU/L; 106: HR, 113.0; 106: RR, 17.0; 106: SpO2, 98.0; 106: SBP, 159.0; 106: DBP, 103.0; 106: MAP, 121.667; 106: LPM O2, 4.0; 110: CO2, 37 mmol/L; 110: CREATININE, 0.59 mg/dL; 110: BLOOD UREA NITROGEN (BUN), 25 mg/dL; 110: ANION GAP, 7 mmol/L; 110: EGFR FOR AFRICAN AMERICAN, 137 mL/min/1.73 m2; 110: GLUCOSE, 247 mg/dL; 110: CHLORIDE, 94 mmol/L; 110: CORRECTED CALCIUM, 9.9 mg/dL; 110: GLOBULIN, 3.4 g/dL; 110: AST (SGOT), 22 U/L; 110: ALKALINE PHOSPHATASE, 122 U/L; 110: SODIUM, 138 mmol/L; 110: PROTEIN TOTAL, 7.3 g/dL; 110: BILIRUBIN TOTAL, <.2 mg/dL; 110: EGFR REFIT WITHOUT RACE (2021), 119 mL/min/1.73 m2; 110: POTASSIUM, 4.4 mmol/L; 110: CALCIUM, 9.8 mg/dL; 110: ALBUMIN, 3.9 g/dL; 110: ALT (SGPT), 25 U/L; 111: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 0: Age:, 37; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.3; 0: Triage HR, 128.0; 0: Triage RR, 22.0; 0: Triage SBP, 135.0; 0: Triage DBP, 95.0; 0: Triage acuity, 2-Emergent; 0: CC, COUGH",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, I checked for possible signs of infection, such as the patient\u2019s presenting complaint of cough. Next, I determined",
        "claims": [
            "the patient has a cough.",
            "The patient\u2019s presenting complaint includes a cough.",
            "Signs of infection were checked for in the patient."
        ],
        "relevant_claims": [
            "The patient\u2019s presenting complaint includes a cough."
        ],
        "alignment_scores": [
            0.2
        ],
        "alignment_category": [
            9
        ],
        "alignment_reasonings": [
            "A presenting complaint of a cough suggests a potential respiratory infection, which might lead to suspicion of sepsis. However, the claim does not mention any specific clinical actions such as ordering antibiotics or cultures within 2 hours. The alignment is weak as the information is too generic and does not directly indicate high or low sepsis risk without further actions."
        ],
        "final_alignment_score": 0.2,
        "accuracy": 1
    },
    {
        "input": "12: HR, 105.0; 12: RR, 28.0; 12: SpO2, 95.0; 12: SBP, 140.0; 12: DBP, 63.0; 12: MAP, 88.667; 12: Temp, 99.7; 74: HR, 95.688; 74: SpO2, 93.758; 74: 1min HRV, 8.974; 74: SBP, 144.0; 74: DBP, 63.0; 74: MAP, 90.0; 75: HR, 98.203; 75: SpO2, 94.966; 75: 1min HRV, 12.323; 75: 5min HRV, 14.276; 76: HR, 96.569; 76: SpO2, 94.776; 76: Perf, 6.578; 76: 1min HRV, 12.903; 77: SARS-COV-2 RNA, Not Detected; 77: HR, 99.102; 77: SpO2, 94.339; 77: Perf, 4.638; 77: 1min HRV, 15.613; 78: HR, 96.879; 78: SpO2, 94.431; 78: Perf, 4.077; 78: 1min HRV, 7.583; 79: HR, 97.881; 79: SpO2, 94.153; 79: Perf, 4.416; 79: 1min HRV, 18.735; 80: HR, 100.508; 80: SpO2, 94.322; 80: Perf, 4.084; 80: 1min HRV, 15.058; 80: 5min HRV, 16.596; 81: HR, 97.052; 81: SpO2, 94.138; 81: Perf, 3.874; 81: 1min HRV, 9.255; 82: HR, 98.153; 82: SpO2, 94.0; 82: Perf, 4.344; 82: 1min HRV, 8.571; 83: HR, 95.810; 83: SpO2, 93.724; 83: Perf, 4.399; 83: 1min HRV, 9.797; 84: HR, 95.508; 84: SpO2, 92.881; 84: Perf, 4.271; 84: 1min HRV, 15.169; 85: HR, 95.610; 85: SpO2, 93.0; 85: Perf, 4.012; 85: 1min HRV, 7.541; 85: 5min HRV, 12.341; 86: POC PH (V) ISTAT, 7.51; 86: POC LACTATE ISTAT, 1.04 mmol/L; 86: POC BASE EXCESS ISTAT, 7 mmol/L; 86: POC PO2 (V) ISTAT, 45 mmHg; 86: POC O2 SATURATION ISTAT VENOUS, 85 %; 86: POC HCO3 (V) ISTAT, 29.9 mmol/L; 86: POC PCO2 (V) ISTAT, 37.9 mmHg; 86: POC TCO2 (V) ISTAT, 31 mmol/L; 86: HR, 95.086; 86: SpO2, 93.397; 86: Perf, 4.21; 86: 1min HRV, 3.706; 87: HR, 95.525; 87: SpO2, 93.254; 87: Perf, 4.314; 87: 1min HRV, 10.295; 88: HR, 95.793; 88: SpO2, 94.0; 88: Perf, 4.491; 88: 1min HRV, 10.727; 89: HR, 94.186; 89: SpO2, 93.661; 89: Perf, 4.244; 89: 1min HRV, 6.677; 90: HR, 93.763; 90: SpO2, 93.542; 90: Perf, 4.679; 90: 1min HRV, 10.949; 90: 5min HRV, 9.909; 91: HR, 94.793; 91: SpO2, 93.207; 91: Perf, 4.523; 91: 1min HRV, 11.560; 92: HR, 92.186; 92: SpO2, 92.729; 92: Perf, 4.081; 92: 1min HRV, 10.722; 93: HR, 93.310; 93: SpO2, 93.259; 93: Perf, 4.575; 93: 1min HRV, 11.295; 93: LIDOCAINE, 5 % TP PTMD; 94: HR:, 94.041; 94: SpO2, 93.407; 94: Perf, 5.464; 94: 1min HRV, 18.225; 95: HR, 93.862; 95: SpO2, 94.276; 95: Perf, 4.087; 95: 1min HRV, 23.162; 95: 5min HRV, 16.508; 96: HR, 95.847; 96: SpO2, 93.898; 96: Perf, 3.660; 96: 1min HRV, 19.795; 97: HR, 95.288; 97: SpO2, 94.085; 97: Perf, 3.631; 97: 1min HRV, 26.480; 98: WAM DIFTYP, AUTO; 98: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.54 K/uL; 98: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.08 K/uL; 98: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 98: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.7 %; 98: PLATELET COUNT (PLT), 363 K/uL; 98: MONOCYTE ABSOLUTE (AUTO DIFF), 1.35 K/uL; 98: RED CELL DISTRIBUTION WIDTH (RDW), 13.0 %; 98: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 98: BASOPHIL % (AUTO DIFF), 0.3 %; 98: WHITE BLOOD CELLS (WBC), 11.6 K/uL; 98: RED BLOOD CELLS (RBC), 4.05 MIL/uL; 98: EOSINOPHIL % (AUTO DIFF), 0.3 %; 98: LYMPHOCYTE % (AUTO DIFF), 4.7 %; 98: HEMOGLOBIN (HGB), 13.1 g/dL; 98: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 32.3 pg; 98: MONOCYTE % (AUTO DIFF), 11.7 %; 98: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.7 g/dL; 98: NEUTROPHIL ABSOLUTE (AUTO DIFF), 9.52 K/uL; 98: NRBC PERCENT (HEMATOLOGY), 0.0 %; 98: MEAN CORPUSCULAR VOLUME (MCV), 96.0 fL; 98: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 98: NEUTROPHIL % (AUTO DIFF), 82.3 %; 98: HEMATOCRIT (HCT), 38.9 %; 98: HR, 93.810; 98: SpO2, 94.017; 98: Perf, 4.691; 98: 1min HRV, 23.968; 99: HR, 96.339; 99: SpO2, 94.203; 99: Perf, 5.558; 99: 1min HRV, 18.059; 100: HR, 94.052; 100: SpO2, 93.862; 100: Perf, 4.896; 100: 1min HRV, 20.223; 100: 5min HRV, 22.715; 101: HR, 92.797; 101: SpO2, 94.136; 101: Perf, 4.679; 101: 1min HRV, 18.505; 102: HR, 94.102; 102: SpO2, 93.356; 102: Perf, 4.308; 102: 1min HRV, 24.808; 103: HR, 90.397; 103: SpO2, 93.552; 103: Perf, 3.735; 103: 1min HRV, 21.601; 104: HR, 91.458; 104: SpO2, 94.0; 104: Perf, 3.391; 104: 1min HRV, 19.831; 105: HR, 90.362; 105: SpO2, 93.690; 105: Perf, 3.608; 105: 1min HRV, 19.193; 105: 5min HRV, 22.761; 106: HR, 88.695; 106: SpO2, 93.322; 106: Perf, 3.818; 106: 1min HRV, 30.647; 107: HR, 87.864; 107: SpO2, 93.102; 107: Perf, 6.080; 107: 1min HRV, 21.781; 108: HR, 91.793; 108: SpO2, 93.379; 108: Perf, 4.790; 108: 1min HRV, 20.482; 109: HR, 90.068; 109: SpO2, 93.627; 109: Perf, 5.224; 109: 1min HRV, 9.640; 110: HR, 90.690; 110: SpO2, 92.448; 110: Perf, 5.879; 110: 1min HRV, 10.436; 110: 5min HRV, 22.487; 111: HR, 91.017; 111: SpO2, 92.424; 111: Perf, 5.972; 111: 1min HRV, 13.902; 112: HR, 90.203; 112: SpO2, 93.0; 112: Perf, 6.482; 112: 1min HRV, 8.039; 113: HR, 90.483; 113: SpO2, 92.810; 113: Perf, 6.112; 113: 1min HRV, 9.718; 114: HR, 90.051; 114: SpO2, 92.864; 114: Perf, 5.358; 114: 1min HRV, 8.979; 115: HR, 90.879; 115: SpO2, 92.845; 115: Perf, 5.083; 115: 1min HRV, 16.757; 115: 5min HRV, 12.244; 116: HR, 88.525; 116: SpO2, 93.932; 116: Perf, 4.567; 116: 1min HRV, 22.357; 117: HR, 89.746; 117: SpO2, 93.814; 117: Perf, 4.894; 117: 1min HRV, 12.992; 118: HR, 91.879; 118: SpO2, 93.362; 118: Perf, 5.772; 118: 1min HRV, 13.784; 119: HR, 88.525; 119: SpO2, 93.661; 119: Perf, 4.697; 119: 1min HRV, 14.209; 0: Age, 81; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.6; 0: Triage HR, 105.0; 0: Triage RR, 28.0; 0: Triage SBP, 140.0; 0: Triage DBP, 63.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, we check whether there are strong indications of infection by looking at temperature, heart rate, respiratory rate, and white blood cell count. Next, we note that although the patient\u2019s heart rate and respiratory rate are elevated, the patient\u2019s blood pressure remains stable and their lactate level is normal. Then, we assess whether these indicators suggest a high likelihood of sepsis risk in the next 12 hours. Because the patient\u2019s perfusion measures and lab results remain relatively stable, we conclude there is not a high risk of developing sepsis within that timeframe.",
        "claims": [
            "We check for strong indications of infection by examining temperature, heart rate, respiratory rate, and white blood cell count.",
            "The patient\u2019s heart rate is elevated.",
            "The patient\u2019s respiratory rate is elevated.",
            "The patient\u2019s blood pressure remains stable.",
            "The patient\u2019s lactate level is normal.",
            "We assess if these indicators suggest a high likelihood of sepsis risk in the next 12 hours.",
            "The patient\u2019s perfusion measures remain relatively stable.",
            "The patient\u2019s lab results remain relatively stable.",
            "We conclude there is not a high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient\u2019s heart rate is elevated.",
            "The patient\u2019s respiratory rate is elevated."
        ],
        "alignment_scores": [
            0.3,
            0.7
        ],
        "alignment_category": [
            6,
            3
        ],
        "alignment_reasonings": [
            "An elevated heart rate can be a part of the shock index calculation (heart\u202frate\u202f\u00f7\u202fsystolic\u202fBP), which is used to denote haemodynamic instability and high sepsis risk. However, since the claim only mentions an elevated heart rate without reference to BP or a specific calculation, the alignment is indirect and weak. Other categories related to heart rate (such as SIRS) require more specific additional criteria to be met, so alignment with the Elevated Shock Index category is more relevant, albeit not strong.",
            "An elevated respiratory rate is directly related to the qSOFA criterion, as a respiratory rate of \u226522 /min contributes to a high qSOFA score, indicating a higher risk of sepsis-related complications. Without the exact respiratory rate, it is assumed to likely be relevant to qSOFA, but without full compliance to the threshold given, hence a slightly less than perfect alignment."
        ],
        "final_alignment_score": 0.5,
        "accuracy": 1
    },
    {
        "input": "2: SpO2, 95.604; 2: SBP, 73.0; 2: DBP, nan; 2: MAP, nan; 3: SpO2, 97.633; 3: Perf, 0.510; 4: SpO2, 98.0; 4: Perf, 0.485; 4: SBP, 71.0; 4: DBP, 48.0; 4: MAP, 55.667; 5: HR, 115.0; 5: RR, 19.0; 5: SpO2, 96.729; 5: Perf, 0.322; 5: SBP, 79.0; 5: DBP, 48.0; 5: MAP, 58.333; 5: Pain, 3.0; 5: Temp, 98.0; 6: SpO2, 95.264; 6: Perf, 0.711; 7: SpO2, 96.038; 7: Perf, 0.838; 8: SpO2, 97.849; 8: Perf, 0.911; 9: SpO2, 99.0; 9: Perf, 1.024; 10: SpO2, 98.212; 10: Perf, 0.978; 10: SBP, 73.0; 10: DBP, 43.0; 10: MAP, 53.0; 11: SpO2, 98.642; 11: Perf, 0.448; 12: SpO2, 98.712; 12: Perf, 0.979; 13: SpO2, 99.245; 13: Perf, 1.204; 14: SpO2, 99.212; 14: Perf, 1.499; 15: SpO2, 99.887; 15: Perf, 1.369; 16: SpO2, 99.478; 16: Perf, 1.329; 17: SpO2, 94.333; 17: Perf, 1.36; 19: SpO2, 93.769; 19: Perf, 0.170; 20: SpO2, 93.0; 20: Perf, 0.23; 20: SBP, 63.0; 20: DBP, 45.0; 20: MAP, 51.0; 21: SpO2, 94.0; 21: Perf, 0.286; 22: SpO2, 98.423; 22: Perf, 0.689; 23: SpO2, 98.0; 23: Perf, 0.410; 24: SpO2, 98.875; 24: Perf, 0.394; 24: LR IV BOLUS -, 500 ML; 25: SpO, 2: 96.395; 25: Perf, 0.432; 26: SpO2, 98.288; 26: Perf, 1.126; 27: SpO2, 95.981; 27: Perf, 1.025; 28: SpO2, 98.415; 28: Perf, 1.452; 28: SBP, 71.0; 28: DBP, 32.0; 28: MAP, 45.0; 29: SpO2, 99.192; 29: Perf, 0.813; 30: SpO2, 99.509; 30: Perf, 0.659; 31: POC PH (V) ISTAT, 7.63; 31: POC O2 SATURATION ISTAT VENOUS, 92 %; 31: POC TCO2 (V) ISTAT, 34 mmol/L; 31: POC BASE EXCESS ISTAT, 12 mmol/L; 31: POC PCO2 (V) ISTAT, 32.1 mmHg; 31: POC PO2 (V) ISTAT, 51 mmHg; 31: POC LACTATE ISTAT, 1.99 mmol/L; 31: POC HCO3 (V) ISTAT, 33.5 mmol/L; 31: SpO2, 99.385; 31: Perf, 0.763; 32: SpO2, 96.385; 32: Perf, 0.773; 33: SpO2, 96.094; 33: Perf, 0.739; 34: SpO2, 97.231; 34: Perf, 0.936; 35: SpO2, 99.094; 35: Perf, 1.320; 35: SBP, 76.0; 35: DBP, 54.0; 35: MAP, 61.333; 36: SpO2, 98.596; 36: Perf, 0.990; 37: SpO2, 98.094; 37: Perf, 0.757; 38: SpO2, 96.283; 38: Perf, 0.687; 39: SpO2, 95.712; 39: Perf, 0.747; 40: SpO2, 97.755; 40: Perf, 1.372; 41: SpO2, 97.923; 41: Perf, 1.720; 42: SpO2, 95.585; 42: Perf, 1.869; 43: SpO2, 94.72; 43: Perf, 1.339; 44: SpO2, 95.667; 44: Perf, 0.698; 45: SpO2, 96.019; 45: Perf, 0.370; 46: WAM DIFTYP, AUTO; 46: RED CELL DISTRIBUTION WIDTH (RDW), 16.2 %; 46: HEMATOCRIT (HCT), 30.5 %; 46: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 46: MONOCYTE ABSOLUTE (AUTO DIFF), 0.63 K/uL; 46: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 46: PLATELET COUNT (PLT), 250 K/uL; 46: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 32.1 pg; 46: NEUTROPHIL % (AUTO DIFF), 75.4 %; 46: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.8 g/dL; 46: HEMOGLOBIN (HGB), 10.0 g/dL; 46: MEAN CORPUSCULAR VOLUME (MCV), 97.8 fL; 46: LYMPHOCYTE % (AUTO DIFF), 12.8 %; 46: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 46: NRBC PERCENT (HEMATOLOGY), 0.0 %; 46: NEUTROPHIL ABSOLUTE (AUTO DIFF), 4.82 K/uL; 46: RED BLOOD CELLS (RBC), 3.12 MIL/uL; 46: WHITE BLOOD CELLS (WBC), 6.4 K/uL; 46: BASOPHIL % (AUTO DIFF), 0.5 %; 46: EOSINOPHIL % (AUTO DIFF), 0.6 %; 46: MONOCYTE % (AUTO DIFF), 9.9 %; 46: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.8 %; 46: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.82 K/uL; 46: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.05 K/uL; 46: SpO2, 98.75; 46: Perf, 1.011; 47: SpO2, 99.585; 47: Perf, 0.703; 48: SpO2, 98.830; 48: Perf, 0.596; 49: SpO2, 98.462; 49: Perf, 0.741; 50: SpO2, 97.868; 50: Perf, 0.314; 51: SpO2, 99.0; 51: Perf, 0.335; 52: SpO2, 99.82; 52: Perf, 0.290; 53: SpO2, 98.733; 53: Perf, 0.208; 54: SpO2, 99.442; 54: Perf, 0.407; 55: SpO2, 98.698; 55: Perf, 0.510; 56: SpO2, 97.885; 56: Perf, 0.373; 57: SpO2, 97.717; 57: Perf, 0.412; 58: SpO2, 99.5; 58: Perf, 0.699; 59: SpO2, 99.019; 59: Perf, 0.417; 60: SpO2, 99.226; 60: Perf, 0.292; 61: SpO2, 99.154; 61: Perf, 0.311; 62: SpO2, 99.434; 62: Perf, 0.488; 63: SpO2, 100.0; 63: Perf, 0.649; 63: SBP, 103.0; 63: DBP, 54.0; 63: MAP, 70.333; 67: ALT (SGPT), 20 U/L; 67: PROTEIN TOTAL, 7.8 g/dL; 67: BILIRUBIN TOTAL, 0.5 mg/dL; 67: ALKALINE PHOSPHATASE, 81 U/L; 67: SODIUM, 131 mmol/L; 67: CALCIUM, 8.9 mg/dL; 67: ANION GAP, 14 mmol/L; 67: ALBUMIN, 4.1 g/dL; 67: POTASSIUM, 4.5 mmol/L; 67: CO2, 28 mmol/L; 67: EGFR REFIT WITHOUT RACE (2021), 14 mL/min/1.73 m2; 67: AST (SGOT), 54 U/L; 67: BLOOD UREA NITROGEN (BUN), 18 mg/dL; 67: GLUCOSE, 118 mg/dL; 67: GLOBULIN, 3.7 g/dL; 67: CHLORIDE, 89 mmol/L; 67: CREATININE, 3.37 mg/dL; 67: CORRECTED CALCIUM, 8.8 mg/dL; 69: HR, 89.0; 69: SpO2, 99.0; 69: SBP, 87.0; 69: DBP, 58.0; 69: MAP, 67.667; 87: HR, 82.0; 87: RR, 18.0; 87: SpO2, 99.0; 87: SBP, 85.0; 87: DBP, 69.0; 87: MAP, 74.333; 95: INR, 1.1; 95: PROTHROMBIN TIME, 15.0 seconds; 96: PART. THROMBOPLASTIN TIME, 28.3 seconds; 114: SARS-COV-2 RNA, Not Detected; 114: INFLUENZA B, Not Detected; 114: RSV, Not Detected; 114: INFLUENZA A, Not Detected; 0: Age, 67; 0: Gender, F; 0: Race, Native Hawaiian or Other Pacific Islander; 0: Means of arrival, EMS; 0: Triage Temp, 36.7; 0: Triage HR, 115.0; 0: Triage RR, 19.0; 0: Triage SBP, 101.0; 0: Triage DBP, 57.0; 0: Triage acuity, 3-Urgent; 0: CC, GENERAL WEAKNESS",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, I checked whether the patient\u2019s blood pressure was low over time, which it was (with multiple SBP readings in the 70s). Next, I looked for signs of organ dysfunction, noting the elevated creatinine of 3.37 mg/dL. Then, I considered whether there were indicators of possible infection or inflammatory response, such as an elevated heart rate of 115. Putting these findings together, the combination of persistent hypotension and organ dysfunction suggests a high risk for sepsis.",
        "claims": [
            "The patient\u2019s blood pressure was low over time.",
            "There were multiple systolic blood pressure readings in the 70s.",
            "The patient had elevated creatinine of 3.37 mg/dL.",
            "The elevated creatinine indicates signs of organ dysfunction.",
            "The patient had an elevated heart rate of 115.",
            "The elevated heart rate may indicate possible infection or inflammatory response.",
            "The combination of persistent hypotension and organ dysfunction suggests a high risk for sepsis."
        ],
        "relevant_claims": [
            "The patient\u2019s blood pressure was low over time.",
            "There were multiple systolic blood pressure readings in the 70s.",
            "The patient had elevated creatinine of 3.37 mg/dL.",
            "The elevated creatinine indicates signs of organ dysfunction.",
            "The patient had an elevated heart rate of 115.",
            "The elevated heart rate may indicate possible infection or inflammatory response.",
            "The combination of persistent hypotension and organ dysfunction suggests a high risk for sepsis."
        ],
        "alignment_scores": [
            0.8,
            1.0,
            1.0,
            0.9,
            0.8,
            0.8,
            0.8
        ],
        "alignment_category": [
            7,
            7,
            8,
            8,
            2,
            2,
            7
        ],
        "alignment_reasonings": [
            "The claim about low blood pressure over time suggests a progressive decline, aligning closely with sepsis-associated hypotension criteria, which involve sustained low blood pressure. However, without specific BP values presented, the alignment is strong but not absolute.",
            "The claim mentions multiple systolic blood pressure readings in the 70s, which directly aligns with the criterion of having a systolic blood pressure reading under 90 mmHg. This indicates sepsis-associated hypotension, which is a key indicator of progression toward septic shock as detailed in this category. The alignment is strong and direct.",
            "The claim directly references elevated creatinine levels, specifically greater than 2 mg/dL, which is a criterion for SOFA Score increase indicating new organ dysfunction and a high risk of sepsis. This aligns perfectly with the SOFA Score criterion.",
            "Elevated creatinine levels are directly related to kidney function and are part of the SOFA score criteria for assessing organ dysfunction. An increase in creatinine suggests renal impairment, which is used to calculate the SOFA score, aligning well with this category. While the claim doesn't specify how much the creatinine is elevated, the reference to organ dysfunction is a strong indicator of potential sepsis risk according to SOFA score guidelines.",
            "The elevated heart rate of 115 bpm is directly relevant to one of the SIRS criteria (heart rate >90 bpm). While it meets one criterion associated with systemic inflammation and early sepsis indication, it does not address the presence of a second SIRS criterion, which is required for confirmed SIRS positivity. Therefore, the alignment is strong but not complete, leading to an alignment rating of 0.8.",
            "An elevated heart rate (>90 bpm) is one of the explicit SIRS criteria, which indicates systemic inflammation potentially consistent with early sepsis. The mention of an elevated heart rate aligns directly with the SIRS criteria. However, since only one criterion is mentioned, and SIRS requires at least two, the alignment rating is not perfect but still strong.",
            "The claim discusses persistent hypotension and organ dysfunction, both of which are critical features of sepsis and are directly relevant to this category. The persisting hypotension aligns well with the description of hypotension associated with sepsis, but organ dysfunction itself could also relate to other categories like SOFA. Despite this, the reference to hypotension is very relevant to Category 7, but since it does not explicitly mention the defined thresholds (e.g., SBP\u202f<\u202f90\u202fmmHg), the alignment is not perfect."
        ],
        "final_alignment_score": 0.8714285714285713,
        "accuracy": 1
    },
    {
        "input": "2: SpO2, 92.286; 3: HR, 108.0; 3: RR, 18.0; 3: SpO2, 94.712; 3: SBP, 104.0; 3: DBP, 58.0; 3: MAP, 73.333; 3: Pain, 10.0; 3: Temp, 98.4; 4: SpO2, 94.424; 4: 1min HRV, 3.128; 5: HR, 105.679; 5: RR, 22.017; 5: SpO2, 95.345; 5: 1min HRV, 12.321; 5: 5min HRV, 12.071; 5: SBP, 104.0; 5: DBP, 58.0; 5: MAP, 73.333; 6: HR, 100.898; 6: RR, 14.288; 6: SpO2, 94.881; 6: 1min HRV, 13.117; 7: HR, 99.603; 7: RR, 16.103; 7: SpO2, 94.172; 7: 1min HRV, 11.406; 8: HR, 98.797; 8: RR, 15.797; 8: SpO2, 93.305; 8: Perf, 3.430; 8: 1min HRV, 10.144; 9: HR, 97.695; 9: RR, 22.237; 9: SpO2, 93.932; 9: Perf, 3.684; 9: 1min HRV, 4.646; 10: HR, 97.810; 10: RR, 27.793; 10: SpO2, 94.672; 10: Perf, 4.924; 10: 1min HRV, 6.557; 10: 5min HRV, 11.750; 11: HR, 98.678; 11: RR, 18.847; 11: SpO2, 96.0; 11: Perf, 4.99; 11: 1min HRV, 6.099; 12: HR, 101.091; 12: RR, 18.091; 12: SpO2, 95.455; 12: Perf, 4.99; 12: 1min HRV, 1.898; 14: HR, 101.0; 14: RR, 27.0; 14: SpO2, 95.0; 14: Perf, 4.99; 15: HR, 103.562; 15: RR, 26.562; 15: SpO2, 93.55; 15: Perf, 4.75; 15: 1min HRV, 2.806; 15: 5min HRV, 11.961; 16: HR, 102.559; 16: RR, 21.864; 16: SpO2, 93.712; 16: Perf, 3.154; 16: 1min HRV, 9.604; 16: SBP, 92.0; 16: DBP, 53.0; 16: MAP, 66.0; 17: HR, 101.559; 17: RR, 21.627; 17: SpO2, 94.424; 17: Perf, 1.920; 17: 1min HRV, 14.599; 18: HR, 96.690; 18: RR, 29.897; 18: SpO2, 94.741; 18: Perf, 2.758; 18: 1min HRV, 11.359; 19: HR, 93.864; 19: RR, 25.746; 19: SpO2, 94.542; 19: Perf, 3.453; 19: 1min HRV, 14.594; 20: HR, 96.052; 20: RR, 28.724; 20: SpO2, 95.0; 20: Perf, 3.637; 20: 1min HRV, 4.509; 20: 5min HRV, 23.489; 21: HR, 97.441; 21: RR, 32.508; 21: SpO2, 94.271; 21: Perf, 3.552; 21: 1min HRV, 4.268; 22: HR, 97.814; 22: RR, 31.441; 22: SpO2, 93.136; 22: Perf, 3.410; 22: 1min HRV, 4.070; 23: HR, 96.862; 23: RR, 30.345; 23: SpO2, 92.362; 23: Perf, 3.15; 23: 1min HRV, 6.574; 24: HR, 97.898; 24: RR, 29.271; 24: SpO2, 94.362; 24: Perf, 3.041; 24: 1min HRV, 6.397; 25: HR, 96.931; 25: RR, 33.103; 25: SpO2, 94.034; 25: 1min HRV, 2.760; 25: 5min HRV, 5.875; 26: HR, 98.356; 26: RR, 32.441; 26: SpO2, 93.780; 26: 1min HRV, 3.452; 27: HR, 99.542; 27: RR, 33.661; 27: SpO2, 94.0; 27: 1min HRV, 2.319; 28: HR, 100.103; 28: RR, 33.569; 28: SpO2, 93.810; 28: 1min HRV, 1.990; 29: HR, 100.729; 29: RR, 33.407; 29: SpO2, 94.0; 29: 1min HRV, 2.201; 30: HR, 100.879; 30: RR, 32.776; 30: SpO2, 93.931; 30: 1min HRV, 4.129; 30: 5min HRV, 5.757; 31: HR, 100.186; 31: RR, 32.424; 31: SpO2, 92.273; 31: 1min HRV, 9.024; 31: SBP, 99.0; 31: DBP, 47.0; 31: MAP, 64.333; 32: HR, 101.525; 32: RR, 33.542; 32: SpO2, 93.932; 32: 1min HRV, 2.930; 33: HR, 102.655; 33: RR, 32.517; 33: SpO2, 93.914; 33: 1min HRV, 2.312; 34: HR, 101.373; 34: RR, 28.576; 34: SpO2, 93.390; 34: 1min HRV, 9.428; 35: HR, 101.241; 35: RR, 22.172; 35: SpO2, 93.621; 35: Perf, 3.324; 35: 1min HRV, 8.231; 35: 5min HRV, 8.377; 36: HR, 102.712; 36: RR, 20.797; 36: SpO2, 94.254; 36: Perf, 3.239; 36: 1min HRV, 6.205; 37: HR, 101.576; 37: RR, 32.373; 37: SpO2, 93.322; 37: Perf, 2.84; 37: 1min HRV, 4.236; 38: HR, 102.293; 38: RR, 26.017; 38: SpO2, 93.638; 38: Perf, 2.84; 38: 1min HRV, 3.312; 39: HR, 101.237; 39: RR, 20.508; 39: SpO2, 94.149; 39: Perf, 2.84; 39: 1min HRV, 9.369; 40: HR, 100.190; 40: RR, 20.034; 40: SpO2, 93.845; 40: 1min HRV, 9.251; 40: 5min HRV, 9.019; 41: HR, 98.085; 41: RR, 22.288; 41: SpO2, 95.475; 41: 1min HRV, 11.561; 42: HR, 98.559; 42: RR, 28.881; 42: SpO2, 95.034; 42: 1min HRV, 3.942; 43: HR, 98.621; 43: RR, 28.138; 43: SpO2, 94.966; 43: 1min HRV, 5.115; 44: HR, 98.322; 44: RR, 32.017; 44: SpO2, 94.136; 44: 1min HRV, 8.521; 45: HR, 98.879; 45: RR, 33.534; 45: SpO2, 92.586; 45: Perf, 2.88; 45: 1min HRV, 4.662; 45: 5min HRV, 7.515; 46: HR, 98.966; 46: RR, 31.475; 46: SpO2, 92.0; 46: Perf, 3.082; 46: 1min HRV, 8.390; 46: SBP, 89.0; 46: DBP, 44.0; 46: MAP, 59.0; 47: HR, 101.818; 47: RR, 21.762; 47: SpO2, 92.535; 47: Perf, 2.787; 47: 1min HRV, 4.126; 47: SBP, 94.0; 47: DBP, 56.0; 47: MAP, 68.667; 50: HR, 102.0; 50: RR, 19.0; 50: SpO2, 94.0; 50: 5min HRV, 10.895; 50: SBP, 94.0; 50: DBP, 56.0; 50: MAP, 68.667; 77: SpO2, 95.176; 78: SpO2, 95.932; 78: Perf, 3.047; 79: SpO2, 95.397; 79: Perf, 2.886; 80: SpO2, 95.576; 80: Perf, 2.753; 81: SpO2, 95.153; 81: Perf, 2.917; 82: SpO2, 94.759; 82: Perf, 3.042; 83: SpO2, 95.0; 83: Perf, 2.844; 84: SpO2, 95.0; 84: Perf, 2.474; 85: SpO2, 95.0; 85: Perf, 2.152; 86: SpO2, 95.138; 86: Perf, 2.112; 87: SpO2, 95.492; 87: Perf, 2.163; 88: SpO2, 95.763; 88: Perf, 2.362; 89: SpO2, 95.586; 89: Perf, 2.067; 90: SpO2, 95.763; 90: Perf, 1.954; 91: SpO2, 95.644; 91: Perf, 1.944; 92: SpO2, 95.603; 92: Perf, 1.77; 93: SpO2, 94.932; 93: Perf, 1.731; 94: SpO2, 95.207; 94: Perf, 1.576; 95: SpO2, 95.0; 95: Perf, 1.505; 96: SpO2, 95.390; 96: Perf, 1.500; 97: SpO2, 95.759; 97: Perf, 1.497; 98: SpO2, 95.379; 98: Perf, 1.476; 99: SpO2, 95.780; 99: Perf, 1.509; 100: SpO2, 95.492; 100: Perf, 1.502; 101: SpO2, 95.593; 101: Perf, 1.464; 102: SpO2, 94.931; 102: Perf, 1.498; 103: SpO2, 95.576; 103: Perf, 1.543; 104: SpO2, 95.845; 104: Perf, 1.474; 105: SpO2, 95.644; 105: Perf, 1.305; 106: SpO2, 96.151; 106: Perf, 0.808; 107: SpO2, 97.207; 107: Perf, 0.534; 108: SpO2, 97.271; 108: Perf, 0.505; 109: SpO2, 95.793; 109: Perf, 0.665; 110: SpO2, 93.414; 110: Perf, 0.695; 111: SpO2, 96.983; 111: Perf, 0.61; 112: SpO2, 97.169; 112: Perf, 0.61; 113: SpO2, 97.525; 113: Perf, 0.61; 114: SpO2, 97.345; 114: Perf, 0.61; 115: SpO2, 96.644; 115: Perf, 0.61; 116: SpO2, 96.034; 116: Perf, 0.61; 117: SpO2, 95.932; 117: Perf, 0.61; 118: SpO2, 95.576; 118: Perf, 0.61; 118: SBP, 93.0; 118: DBP, nan; 118: MAP, nan; 119: SpO2, 96.172; 119: Perf, 0.612; 0: Age, 46; 0: Gender, M; 0: Race, White; 0: Means of arrival, EMS; 0: Triage Temp, 36.9; 0: Triage HR, 108.0; 0: Triage RR, 18.0; 0: Triage SBP, 104.0; 0: Triage DBP, 58.0; 0: Triage acuity, 3-Urgent; 0: CC, KNEE PAIN",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, I checked whether the patient\u2019s vital signs show concerning trends, such as low blood pressure and high heart rate. Next, I noted that the patient\u2019s respiratory rate frequently exceeds normal limits. I then observed that these abnormalities persist over time and are associated with reduced perfusion, suggesting a systemic process. Finally, I concluded that these findings, when taken together, place the patient at high risk for sepsis within 12 hours.",
        "claims": [
            "The patient's vital signs show concerning trends.",
            "Concerning trends include low blood pressure.",
            "Concerning trends also include high heart rate.",
            "The patient\u2019s respiratory rate frequently exceeds normal limits.",
            "The observed abnormalities persist over time.",
            "The observed abnormalities are associated with reduced perfusion.",
            "The association with reduced perfusion suggests a systemic process.",
            "These findings place the patient at high risk for sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient's vital signs show concerning trends.",
            "Concerning trends also include high heart rate.",
            "The patient\u2019s respiratory rate frequently exceeds normal limits.",
            "The observed abnormalities persist over time.",
            "The observed abnormalities are associated with reduced perfusion.",
            "The association with reduced perfusion suggests a systemic process.",
            "These findings place the patient at high risk for sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.3,
            0.8,
            0.7,
            0.5,
            0.7,
            0.7,
            0.3
        ],
        "alignment_category": [
            4,
            2,
            2,
            8,
            5,
            5,
            4
        ],
        "alignment_reasonings": [
            "The claim mentions concerning trends in vital signs, which is related to the National Early Warning Score (NEWS) that uses vital sign changes to predict clinical deterioration. However, without specific details or a NEWS score provided, the alignment is indirect and weak.",
            "A high heart rate is one of the SIRS criteria, indicating systemic inflammation consistent with early sepsis. While the claim does not specify the exact heart rate or other SIRS criteria, the mention of a high heart rate alone significantly aligns with SIRS Positivity, warranting an alignment rating of 0.8.",
            "The claim notes that the patient's respiratory rate frequently exceeds normal limits, which relates to the SIRS criteria specifying a respiratory rate > 20/min as an indicator of systemic inflammation and potential early sepsis. While the claim does not specify an exact rate, the implication of elevated respiratory rate aligns reasonably well with this category, leading to a strong but not perfect alignment.",
            "Persistent abnormalities could signify organ dysfunction or clinical deterioration, both aspects of the SOFA Score used for assessing sepsis risk. However, the claim is vague and doesn't specify the types of abnormalities or quantify any changes, thus the alignment with this category is suggestive but not definitive.",
            "The claim mentions \"reduced perfusion,\" which directly relates to the concept of tissue hypoperfusion. Elevated serum lactate is a clinical marker indicative of hypoperfusion and increased sepsis mortality risk. Although the claim doesn't explicitly mention lactate levels, the association with reduced perfusion provides a moderate level of alignment with this category.",
            "Reduced perfusion is indicative of potential tissue hypoperfusion, which is closely related to elevated serum lactate levels (\u22652\u202fmmol/L) known to signal hypoperfusion and sepsis risk. While the connection isn't direct since serum lactate isn't mentioned, reduced perfusion strongly suggests this category. Therefore, the alignment with \"Elevated Serum Lactate\" is significant but not complete, warranting a rating of 0.7.",
            "The claim references a high risk for sepsis within 12 hours, which suggests imminent clinical deterioration. This aligns somewhat with the Elevated NEWS Score category, as scores of \u22655 predict clinical deterioration. However, the claim lacks specific reference to deranged vital signs or a specific NEWS score, limiting the alignment strength. The reference to a general \"high risk\" could also relate to other categories, but Elevated NEWS Score is chosen based on its focus on imminent deterioration."
        ],
        "final_alignment_score": 0.5714285714285714,
        "accuracy": 1
    },
    {
        "input": "5: SBP, 156.0; 5: DBP, 80.0; 5: MAP, 105.333; 6: SpO2, 97.265; 7: SpO2, 96.695; 7: Perf, 0.607; 8: HR, 76.163; 8: RR, 21.787; 8: SpO2, 97.0; 8: Perf, 0.360; 8: 1min HRV, 18.003; 9: HR, 75.259; 9: RR, 20.603; 9: SpO2, 96.897; 9: Perf, 0.341; 9: 1min HRV, 20.634; 10: HR, 73.373; 10: RR, 18.593; 10: SpO2, 96.525; 10: Perf, 0.417; 10: 1min HRV, 9.648; 11: HR, 73.397; 11: RR, 18.828; 11: SpO2, 97.0; 11: Perf, 1.269; 11: 1min HRV, 13.256; 12: HR, 73.542; 12: RR, 18.068; 12: SpO2, 97.0; 12: Perf, 1.663; 12: 1min HRV, 9.717; 12: 5min HRV, 18.442; 12: SBP, 131.0; 12: DBP, 61.0; 12: MAP, 84.333; 13: HR, 74.542; 13: RR, 18.576; 13: SpO2, 96.508; 13: Perf, 1.742; 13: 1min HRV, 13.443; 13: SBP, 131.0; 13: DBP, 61.0; 13: MAP, 84.333; 14: HR, 74.414; 14: RR, 18.241; 14: SpO2, 96.655; 14: Perf, 1.770; 14: 1min HRV, 12.028; 15: HR, 76.310; 15: RR, 19.621; 15: SpO2, 96.466; 15: Perf, 1.963; 15: 1min HRV, 25.404; 16: HR, 80.407; 16: RR, 16.797; 16: SpO2, 96.763; 16: Perf, 1.335; 16: 1min HRV, 12.899; 17: HR, 79.448; 17: RR, 21.034; 17: SpO2, 96.983; 17: Perf, 1.158; 17: 1min HRV, 21.785; 17: 5min HRV, 30.540; 18: HR, 77.05; 18: RR, 22.217; 18: SpO2, 97.283; 18: Perf, 1.249; 18: 1min HRV, 13.935; 19: HR, 81.018; 19: RR, 18.386; 19: SpO2, 97.386; 19: Perf, 1.181; 19: 1min HRV, 20.072; 20: HR, 79.898; 20: RR, 22.593; 20: SpO2, 97.390; 20: Perf, 1.124; 20: 1min HRV, 20.390; 21: HR, 81.655; 21: RR, 23.069; 21: SpO2, 97.517; 21: Perf, 1.018; 21: 1min HRV, 15.768; 22: HR, 81.136; 22: RR, 22.102; 22: SpO2, 97.390; 22: Perf, 1.014; 22: 1min HRV, 27.226; 22: 5min HRV, 25.597; 23: HR, 81.217; 23: RR, 23.167; 23: SpO2, 97.05; 23: Perf, 1.053; 23: 1min HRV, 23.937; 23: Pain, 10.0; 24: HR, 81.018; 24: RR, 21.123; 24: SpO2, 96.877; 24: Perf, 1.125; 24: 1min HRV, 38.289; 25: HR, 83.017; 25: RR, 21.8; 25: SpO2, 97.233; 25: Perf, 1.119; 25: 1min HRV, 20.266; 26: HR, 81.404; 26: RR, 19.947; 26: SpO2, 96.912; 26: Perf, 1.140; 26: 1min HRV, 21.604; 27: HR, 80.864; 27: RR, 23.169; 27: SpO2, 97.203; 27: Perf, 1.119; 27: 1min HRV, 14.880; 27: 5min HRV, 25.481; 27: SBP, 154.0; 27: DBP, 79.0; 27: MAP, 104.0; 28: HR, 81.3; 28: RR, 21.967; 28: SpO2, 97.1; 28: Perf, 1.037; 28: 1min HRV, 17.820; 28: SBP, 154.0; 28: DBP, 79.0; 28: MAP, 104.0; 29: HR, 82.175; 29: RR, 24.035; 29: SpO2, 97.228; 29: Perf, 0.969; 29: 1min HRV, 21.252; 30: HR, 80.458; 30: RR, 22.508; 30: SpO2, 97.237; 30: Perf, 1.003; 30: 1min HRV, 19.101; 31: HR, 78.441; 31: RR, 19.797; 31: SpO2, 97.508; 31: Perf, 1.016; 31: 1min HRV, 22.356; 32: HR, 83.845; 32: RR, 16.293; 32: SpO2, 96.276; 32: Perf, 0.984; 32: 1min HRV, 16.489; 32: 5min HRV, 24.109; 33: HR, 79.475; 33: RR, 22.864; 33: SpO2, 96.915; 33: Perf, 0.929; 33: 1min HRV, 18.395; 34: HR, 79.814; 34: RR, 22.051; 34: SpO2, 97.254; 34: Perf, 0.933; 34: 1min HRV, 27.613; 35: HR, 76.172; 35: RR, 21.293; 35: SpO2, 96.914; 35: Perf, 1.011; 35: 1min HRV, 34.719; 36: HR, 78.847; 36: RR, 20.881; 36: SpO2, 96.932; 36: Perf, 1.105; 36: 1min HRV, 25.498; 37: HR, 79.638; 37: RR, 22.5; 37: SpO2, 97.448; 37: Perf, 0.987; 37: 1min HRV, 10.071; 37: 5min HRV, 27.434; 38: HR, 80.0; 38: RR, 21.220; 38: SpO2, 97.441; 38: Perf, 1.018; 38: 1min HRV, 14.389; 39: HR, 79.138; 39: RR, 23.638; 39: SpO2, 97.586; 39: Perf, 1.066; 39: 1min HRV, 13.513; 40: HR, 80.763; 40: RR, 21.729; 40: SpO2, 97.593; 40: Perf, 1.016; 40: 1min HRV, 11.630; 41: HR, 80.932; 41: RR, 22.169; 41: SpO2, 97.915; 41: Perf, 1.100; 41: 1min HRV, 13.254; 42: HR, 82.051; 42: RR, 20.322; 42: SpO2, 97.373; 42: Perf, 1.055; 42: 1min HRV, 29.948; 42: 5min HRV, 20.107; 43: HR, 79.724; 43: RR, 21.259; 43: SpO2, 97.276; 43: Perf, 1.029; 43: 1min HRV, 30.056; 43: SBP, 181.0; 43: DBP, 167.0; 43: MAP, 171.667; 44: HR, 80.712; 44: RR, 21.814; 44: SpO2, 97.593; 44: Perf, 0.926; 44: 1min HRV, 15.547; 45: HR, 80.661; 45: RR, 22.203; 45: SpO2, 97.407; 45: Perf, 1.028; 45: 1min HRV, 13.599; 47: 5min HRV, 21.117; 57: HR, 74.0; 57: RR, 18.0; 57: SpO2, 97.0; 57: SBP, 136.0; 57: DBP, 76.0; 57: MAP, 96.0; 81: WAM DIFTYP, AUTO; 81: RED BLOOD CELLS (RBC), 2.72 MIL/uL; 81: MONOCYTE ABSOLUTE (AUTO DIFF), 0.43 K/uL; 81: NRBC PERCENT (HEMATOLOGY), 0.0 %; 81: BASOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 81: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.6 g/dL; 81: BASOPHIL % (AUTO DIFF), 0.3 %; 81: MONOCYTE % (AUTO DIFF), 12.4 %; 81: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.02 K/uL; 81: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 81: NEUTROPHIL ABSOLUTE (AUTO DIFF), 2.32 K/uL; 81: HEMOGLOBIN (HGB), 8.4 g/dL; 81: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.9 pg; 81: NEUTROPHIL % (AUTO DIFF), 66.8 %; 81: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.68 K/uL; 81: LYMPHOCYTE % (AUTO DIFF), 19.6 %; 81: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.6 %; 81: RED CELL DISTRIBUTION WIDTH (RDW), 16.4 %; 81: MEAN CORPUSCULAR VOLUME (MCV), 94.9 fL; 81: PLATELET COUNT (PLT), 176 K/uL; 81: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 81: HEMATOCRIT (HCT), 25.8 %; 81: EOSINOPHIL % (AUTO DIFF), 0.3 %; 81: WHITE BLOOD CELLS (WBC), 3.5 K/uL; 111: HIGH SENSITIVITY TROPONIN, 14 ng/L; 0: Age, 90; 0: Gender, M; 0: Race, White; 0: Means of arrival, EMS; 0: Triage Temp, 36.7; 0: Triage HR, 74.0; 0: Triage RR, 18.0; 0: Triage SBP, 131.0; 0: Triage DBP, 61.0; 0: Triage acuity, 3-Urgent; 0: CC, RIB PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, we check the patient\u2019s vital signs for fever or hypotension and do not find any strong indicators of either. Next, we look for tachycardia or persistently elevated respiratory rate, but these values remain relatively stable. Then, we examine the lab results, which do not show elevated white blood cells or other markers typically associated with active infection. Based on these findings, the patient does not appear to be at high",
        "claims": [
            "risk of developing sepsis within the next 12 hours.",
            "The patient's vital signs are checked for fever or hypotension.",
            "There are no strong indicators of fever in the patient's vital signs.",
            "There are no strong indicators of hypotension in the patient's vital signs.",
            "Tachycardia is not observed in the patient.",
            "The patient's respiratory rate remains relatively stable.",
            "Lab results do not show elevated white blood cells.",
            "Lab results do not show other markers typically associated with active infection.",
            "Based on these findings, the patient does not appear to be at high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "There are no strong indicators of fever in the patient's vital signs.",
            "Lab results do not show other markers typically associated with active infection."
        ],
        "alignment_scores": [
            0.3,
            0.3
        ],
        "alignment_category": [
            2,
            9
        ],
        "alignment_reasonings": [
            "The claim refers to the absence of fever, which is one of the indicators used for determining SIRS positivity. However, the statement is about the lack of fever rather than the presence of a specific SIRS criterion. This makes the alignment weak but somewhat relevant since fever is part of the SIRS criteria.",
            "The claim suggests a lack of markers for infection, which might influence the decision not to initiate early antibiotic therapy or culture orders. While this indirectly ties to the category's focus on prompt clinical action reflecting suspicion of serious infection, it indicates the opposite scenario where such actions might not be pursued. Thus, the alignment is weak and indirect."
        ],
        "final_alignment_score": 0.3,
        "accuracy": 1
    },
    {
        "input": "10: HR, 96.0; 10: RR, 26.0; 10: SpO2, 98.0; 10: SBP, 133.0; 10: DBP, 76.0; 10: MAP, 95.0; 10: Temp, 99.1; 27: SpO2, 97.156; 27: SBP, 131.0; 27: DBP, nan; 27: MAP, nan; 28: SpO2, 97.357; 29: SpO2, 98.341; 30: SpO2, 97.492; 31: SpO2, 95.793; 31: SBP, 119.0; 31: DBP, 58.0; 31: MAP, 78.333; 32: SpO2, 95.237; 33: SpO2, 97.308; 34: SpO2, 97.517; 35: SpO2, 97.932; 36: SpO2, 97.569; 37: SpO2, 97.655; 38: SpO2, 97.367; 39: SpO2, 97.263; 40: SpO2, 97.914; 41: SpO2, 97.644; 42: SpO2, 97.724; 43: SpO2, 96.5; 44: SpO2, 99.0; 44: Perf, 3.644; 45: SpO2, 97.983; 45: Perf, 3.672; 46: HR, 69.0; 46: RR, 30.0; 46: SpO2, 96.958; 46: Perf, 3.73; 46: SBP, 130.0; 46: DBP, 116.0; 46: MAP, 120.667; 46: Temp, 98.3; 47: HR, 62.0; 47: SpO2, 95.103; 47: SBP, 130.0; 47: DBP, 116.0; 47: MAP, 120.667; 48: SpO2, 99.375; 49: SpO2, 97.864; 50: SpO2, 95.862; 51: SpO2, 95.644; 52: SpO2, 95.949; 53: SpO2, 96.712; 54: SpO2, 97.052; 55: SpO2, 97.102; 56: SpO2, 96.810; 57: SpO2, 96.276; 57: Perf, 3.434; 58: SpO2, 96.780; 58: Perf, 3.367; 59: SpO2, 96.276; 59: Perf, 3.348; 60: SpO2, 96.831; 60: Perf, 3.294; 61: SpO2, 96.879; 61: Perf, 3.28; 62: HR, 106.809; 62: RR, 19.659; 62: SpO2, 97.203; 62: Perf, 3.316; 62: 1min HRV, 66.908; 63: HR, 107.776; 63: RR, 20.328; 63: SpO2, 97.034; 63: Perf, 3.291; 63: 1min HRV, 64.980; 64: HR, 107.103; 64: RR, 23.525; 64: SpO2, 97.729; 64: Perf, 3.29; 64: 1min HRV, 61.610; 65: HR, 108.610; 65: RR, 14.053; 65: SpO2, 97.847; 65: Perf, 3.232; 65: 1min HRV, 71.515; 65: 5min HRV, 66.948; 66: HR, 107.789; 66: SpO2, 97.333; 66: Perf, 3.108; 66: 1min HRV, 64.832; 67: HR, 109.559; 67: SpO2, 97.305; 67: Perf, 3.065; 67: 1min HRV, 66.942; 68: HR, 111.069; 68: SpO2, 96.810; 68: Perf, 3.06; 68: 1min HRV, 67.297; 69: HR, 105.695; 69: SpO2, 96.085; 69: Perf, 3.204; 69: 1min HRV, 65.368; 70: WAM DIFTYP, AUTO; 70: MEAN CORPUSCULAR VOLUME (MCV), 91.1 fL; 70: HEMOGLOBIN (HGB), 16.0 g/dL; 70: HEMATOCRIT (HCT), 48.3 %; 70: RED BLOOD CELLS (RBC), 5.30 MIL/uL; 70: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.2 pg; 70: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 70: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.6 %; 70: MONOCYTE % (AUTO DIFF), 7.3 %; 70: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 70: WHITE BLOOD CELLS (WBC), 6.5 K/uL; 70: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.1 g/dL; 70: MONOCYTE ABSOLUTE (AUTO DIFF), 0.47 K/uL; 70: LYMPHOCYTE % (AUTO DIFF), 9.7 %; 70: NEUTROPHIL % (AUTO DIFF), 81.6 %; 70: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.63 K/uL; 70: RED CELL DISTRIBUTION WIDTH (RDW), 12.9 %; 70: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.04 K/uL; 70: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 70: NEUTROPHIL ABSOLUTE (AUTO DIFF), 5.29 K/uL; 70: NRBC PERCENT (HEMATOLOGY), 0.0 %; 70: BASOPHIL % (AUTO DIFF), 0.5 %; 70: PLATELET COUNT (PLT), 203 K/uL; 70: EOSINOPHIL % (AUTO DIFF), 0.3 %; 70: HR, 107.627; 70: SpO2, 96.424; 70: Perf, 3.251; 70: 1min HRV, 60.198; 70: 5min HRV, 65.907; 71: HR, 104.517; 71: SpO2, 97.621; 71: Perf, 3.208; 71: 1min HRV, 76.915; 72: HR, 107.390; 72: SpO2, 97.119; 72: Perf, 3.320; 72: 1min HRV, 64.587; 73: HR, 105.534; 73: SpO2, 96.966; 73: Perf, 3.356; 73: 1min HRV, 65.170; 74: GLUCOSE, URINE (UA): Negative; 74: KETONE, URINE (UA): Negative; 74: PH, URINE (UA): 5.0; 74: LEUKOCYTE ESTERASE, URINE (UA): Negative; 74: NITRITE, URINE (UA): Negative; 74: SPECIFIC GRAVITY, URINE (UA): 1.027; 74: HR, 106.881; 74: SpO2, 96.153; 74: Perf, 3.34; 74: 1min HRV, 67.444; 75: HR, 109.949; 75: SpO2, 96.542; 75: Perf, 3.34; 75: 1min HRV, 64.928; 75: 5min HRV, 68.501; 76: HR, 106.569; 76: SpO2, 97.0; 76: Perf, 3.365; 76: 1min HRV, 66.408; 77: HR, 108.746; 77: SpO2, 97.203; 77: Perf, 3.376; 77: 1min HRV, 59.347; 78: HR, 111.0; 78: SpO2, 97.466; 78: Perf, 3.38; 78: 1min HRV, 72.866; 79: HR, 108.351; 79: RR, 29.957; 79: SpO2, 97.458; 79: Perf, 3.38; 79: 1min HRV, 69.164; 80: HR, 113.881; 80: RR, 28.872; 80: SpO2, 95.746; 80: Perf, 3.38; 80: 1min HRV, 56.213; 80: 5min HRV, 66.186; 81: HR, 111.0; 81: RR, 21.552; 81: SpO2, 97.931; 81: Perf, 3.390; 81: 1min HRV, 54.996; 82: HR, 109.322; 82: RR, 19.471; 82: SpO2, 97.864; 82: Perf, 3.436; 82: 1min HRV, 58.811; 83: HR, 110.707; 83: RR, 22.382; 83: SpO2, 97.810; 83: Perf, 3.44; 83: 1min HRV, 50.588; 84: HR, 110.203; 84: RR, 31.25; 84: SpO2, 97.085; 84: Perf, 3.44; 84: 1min HRV, 57.078; 85: HR, 104.948; 85: RR, 21.397; 85: SpO2, 97.0; 85: Perf, 3.421; 85: 1min HRV, 63.378; 85: 5min HRV, 57.972; 86: HR, 105.455; 86: RR, 19.75; 86: SpO2, 97.103; 86: Perf, 3.377; 86: 1min HRV, 62.959; 87: HR, 104.224; 87: RR, 21.069; 87: SpO2, 97.0; 87: Perf, 3.37; 87: 1min HRV, 65.987; 88: HR, 107.471; 88: RR, 25.810; 88: SpO2, 97.845; 88: Perf, 3.351; 88: 1min HRV, 59.549; 89: HR, 107.932; 89: RR, 13.639; 89: SpO2, 97.593; 89: Perf, 3.289; 89: 1min HRV, 63.945; 90: HR, 109.508; 90: RR, 16.552; 90: SpO2, 96.831; 90: Perf, 3.182; 90: 1min HRV, 64.924; 90: 5min HRV, 64.664; 91: HR, 107.0; 91: SpO2, 96.0; 91: Perf, 2.889; 93: INR, 1.2; 93: PROTHROMBIN TIME, 15.0 seconds; 94: PART. THROMBOPLASTIN TIME, 36.6 seconds; 102: BNP NT-PRO, 2531 pg/mL; 102: CEFTRIAXONE, 1 GRAM/10 ML IV PUSH (VIAL ONLY); 109: TROPONIN I: ., 030 ng/mL; 0: Age, 48; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.3; 0: Triage HR, 96.0; 0: Triage RR, 26.0; 0: Triage SBP, 133.0; 0: Triage DBP, 76.0; 0: Triage acuity, 3-Urgent; 0: CC, URINARY PAIN,FEVER",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I check if the patient\u2019s labs show evidence of significant infection, such as an elevated WBC count\u2014here, the WBC is normal at 6.5 K/uL. Next, I examine vital signs for sepsis indicators including persistent high heart rate or",
        "claims": [
            "elevated respiratory rate. The patient's heart rate is 78 beats per minute, which is within the normal range. The patient's respiratory rate is 16 breaths per minute, also within the normal range. I then review any recent history of infection that may increase suspicion of sepsis. The patient has no reported recent infections. Overall, the absence of high heart rate, elevated respiratory rate, and recent infections suggests a low risk of developing sepsis.",
            "The patient's labs show no evidence of significant infection.",
            "The patient's WBC count is normal at 6.5 K/uL.",
            "I examine vital signs for sepsis indicators.",
            "Persistent high heart rate is an indicator of sepsis.",
            "Elevated respiratory rate is an indicator of sepsis.",
            "The patient's heart rate is 78 beats per minute.",
            "A heart rate of 78 beats per minute is within the normal range.",
            "The patient's respiratory rate is 16 breaths per minute.",
            "A respiratory rate of 16 breaths per minute is within the normal range.",
            "I review any recent history of infection.",
            "The patient has no reported recent infections.",
            "The absence of high heart rate suggests a low risk of developing sepsis.",
            "The absence of elevated respiratory rate suggests a low risk of developing sepsis.",
            "The absence of recent infections suggests a low risk of developing sepsis.",
            "Overall, these factors suggest a low risk of developing sepsis."
        ],
        "relevant_claims": [
            "Elevated respiratory rate is an indicator of sepsis."
        ],
        "alignment_scores": [
            0.8
        ],
        "alignment_category": [
            3
        ],
        "alignment_reasonings": [
            "The claim mentions an elevated respiratory rate, which is one of the criteria used in calculating the qSOFA score. A respiratory rate of \u226522/min is specifically part of the qSOFA criteria for identifying high sepsis risk due to potential organ dysfunction. The alignment is strong because the respiratory rate is explicitly used in qSOFA, but the claim does not indicate the exact respiratory rate, so it's reasonable but slightly less than perfect alignment."
        ],
        "final_alignment_score": 0.8,
        "accuracy": 1
    },
    {
        "input": "12: HR, 71.0; 12: RR, 14.0; 12: SpO2, 95.0; 12: SBP, 101.0; 12: DBP, 53.0; 12: MAP, 69.0; 12: Temp, 95.5; 15: Pain, 0.0; 21: POC GLUCOSE BY METER, 110 mg/dL; 23: Temp, 98.4; 68: HR, 71.048; 68: RR, 21.216; 68: 1min HRV, 118.647; 68: 5min HRV, 118.647; 69: HR, 68.203; 69: RR, 22.881; 69: SpO2, 94.054; 69: Perf, 8.043; 69: 1min HRV, 25.429; 70: HR, 69.0; 70: RR, 20.069; 70: SpO2, 95.190; 70: Perf, 7.138; 70: 1min HRV, 23.513; 71: HR, 68.661; 71: RR, 21.051; 71: SpO2, 94.983; 71: Perf, 6.486; 71: 1min HRV, 22.759; 72: HR, 66.881; 72: RR, 20.169; 72: SpO2, 94.729; 72: Perf, 6.701; 72: 1min HRV, 13.082; 73: HR, 66.293; 73: RR, 20.914; 73: SpO2, 93.914; 73: Perf, 6.633; 73: 1min HRV, 10.359; 73: 5min HRV, 24.827; 74: HR, 67.627; 74: RR, 20.729; 74: SpO2, 94.017; 74: Perf, 6.500; 74: 1min HRV, 14.015; 75: HR, 68.741; 75: RR, 20.983; 75: SpO2, 94.776; 75: Perf, 6.494; 75: 1min HRV, 23.017; 76: HR, 68.051; 76: RR, 18.847; 76: SpO2, 93.915; 76: Perf, 6.348; 76: 1min HRV, 24.286; 77: HR, 66.864; 77: RR, 20.542; 77: SpO2, 94.458; 77: Perf, 6.000; 77: 1min HRV, 17.775; 78: HR, 67.270; 78: RR, 20.324; 78: SpO2, 93.625; 78: Perf, 5.996; 78: 1min HRV, 22.862; 78: 5min HRV, 21.776; 93: HR, 67.0; 93: RR, 21.0; 93: SpO2, 96.0; 93: Pain, 0.0; 94: HR, 66.0; 94: RR, 15.412; 94: SpO2, 95.077; 94: 1min HRV, 9.971; 95: HR, 66.724; 95: RR, 19.362; 95: SpO2, 95.534; 95: Perf, 5.150; 95: 1min HRV, 20.369; 96: HR, 67.949; 96: RR, 18.458; 96: SpO2, 95.305; 96: Perf, 5.37; 96: 1min HRV, 19.084; 97: INFLUENZA A, Not Detected; 97: INFLUENZA B, Not Detected; 97: SARS-COV-2 RNA, Not Detected; 97: RSV, Not Detected; 97: HR, 66.534; 97: RR, 18.845; 97: SpO2, 94.328; 97: Perf, 5.031; 97: 1min HRV, 18.682; 98: HR, 67.153; 98: RR, 19.746; 98: SpO2, 94.153; 98: Perf, 4.881; 98: 1min HRV, 13.253; 98: 5min HRV, 18.928; 99: HR, 66.932; 99: RR, 18.373; 99: SpO2, 94.627; 99: Perf, 4.283; 99: 1min HRV, 22.392; 100: HR, 65.966; 100: RR, 18.293; 100: SpO2, 94.328; 100: Perf, 4.909; 100: 1min HRV, 11.049; 101: HR, 66.356; 101: RR, 17.458; 101: SpO2, 94.661; 101: Perf, 4.382; 101: 1min HRV, 21.931; 102: HR, 68.517; 102: RR, 19.534; 102: SpO2, 96.828; 102: Perf, 4.202; 102: 1min HRV, 41.638; 103: HR, 66.881; 103: RR, 19.356; 103: SpO2, 94.627; 103: Perf, 3.830; 103: 1min HRV, 27.780; 103: 5min HRV, 28.206; 104: HR, 66.881; 104: RR, 18.220; 104: SpO2, 93.169; 104: Perf, 3.421; 104: 1min HRV, 24.512; 105: HR, 67.310; 105: RR, 19.190; 105: SpO2, 94.345; 105: Perf, 2.697; 105: 1min HRV, 26.227; 106: HR, 66.102; 106: RR, 19.136; 106: SpO2, 94.373; 106: Perf, 2.676; 106: 1min HRV, 26.542; 107: HR, 65.897; 107: RR, 19.172; 107: SpO2, 94.431; 107: Perf, 2.753; 107: 1min HRV, 27.196; 108: HR, 66.034; 108: RR, 18.949; 108: SpO2, 94.220; 108: Perf, 2.97; 108: 1min HRV, 28.092; 108: 5min HRV, 27.770; 109: POC HCT ISTAT, 30 %; 109: POC GLUCOSE ISTAT, 119 mg/dL; 109: POC HGB (CALC) ISTAT, 10.2 g/dL; 109: POC SODIUM ISTAT, 133 mmol/L; 109: POC POTASSIUM ISTAT, 3.3 mmol/L; 109: HR, 65.356; 109: RR, 17.559; 109: SpO2, 94.322; 109: Perf, 2.850; 109: 1min HRV, 27.110; 110: POC PH (V) ISTAT, 7.48; 110: POC BASE EXCESS ISTAT, 9 mmol/L; 110: POC PCO2 (V) ISTAT, 44.2 mmHg; 110: POC TCO2 (V) ISTAT, 34 mmol/L; 110: POC O2 SATURATION ISTAT VENOUS, 85 %; 110: POC PO2 (V) ISTAT, 47 mmHg; 110: POC LACTATE ISTAT, 0.50 mmol/L; 110: POC HCO3 (V) ISTAT, 33.0 mmol/L; 110: HR, 67.259; 110: RR, 20.552; 110: SpO2, 94.793; 110: Perf, 2.956; 110: 1min HRV, 30.449; 111: HR, 68.034; 111: RR, 19.203; 111: SpO2, 95.0; 111: Perf, 3.131; 111: 1min HRV, 23.808; 112: HR, 67.879; 112: RR, 19.293; 112: SpO2, 94.052; 112: Perf, 3.301; 112: 1min HRV, 28.090; 113: HR, 68.339; 113: RR, 20.508; 113: SpO2, 94.542; 113: Perf, 3.465; 113: 1min HRV, 20.705; 113: 5min HRV, 29.870; 114: HR, 68.542; 114: RR, 20.186; 114: SpO2, 94.458; 114: Perf, 3.305; 114: 1min HRV, 25.128; 115: HR, 66.586; 115: RR, 20.552; 115: SpO2, 93.776; 115: Perf, 4.752; 115: 1min HRV, 23.213; 116: HR, 66.525; 116: RR, 18.508; 116: SpO2, 95.983; 116: Perf, 3.87; 116: 1min HRV, 24.671; 117: HR, 67.793; 117: RR, 19.276; 117: SpO2, 94.345; 117: Perf, 4.154; 117: 1min HRV, 28.839; 118: HR, 67.475; 118: RR, 18.322; 118: SpO2, 94.203; 118: Perf, 4.330; 118: 1min HRV, 31.003; 118: 5min HRV, 28.383; 119: ABO/RH (AUTOMATION), O Positive; 119: HR, 67.932; 119: RR, 20.203; 119: SpO2, 93.966; 119: Perf, 4.078; 119: 1min HRV, 32.047; 0: Age, 69; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 35.3; 0: Triage HR, 71.0; 0: Triage RR, 14.0; 0: Triage SBP, 101.0; 0: Triage DBP, 53.0; 0: Triage acuity, 3-Urgent; 0: CC, FALL",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "First, I examined whether the patient exhibited significantly abnormal vitals, such as markedly low blood pressure or high heart rate, and found these values to be relatively stable. Next, I checked for elevated lactate or fever, both of which can indicate sepsis, but the lactate was normal and temperature did not sustain a fever range. Then, I reviewed lab results for infection indicators (like a positive influenza, RSV, or SARS-COV-2 test), all of which were negative. Finally, I integrated these findings\u2014normal lactate, no clear infection, and relatively stable vitals\u2014which led me to conclude that the patient\u2019s risk of sepsis within 12 hours is low.",
        "claims": [
            "The patient's vitals were examined for abnormalities.",
            "The patient exhibited relatively stable vitals.",
            "The examination included checking for markedly low blood pressure or high heart rate.",
            "Elevated lactate and fever can indicate sepsis.",
            "The patient's lactate was normal.",
            "The patient's temperature did not sustain a fever range.",
            "Lab results were reviewed for indicators of infection.",
            "The indicators of infection included positive tests for influenza, RSV, or SARS-COV-2.",
            "All infection indicator tests were negative.",
            "The findings included normal lactate, no clear infection, and relatively stable vitals.",
            "These findings led to the conclusion that the patient's risk of sepsis within 12 hours is low."
        ],
        "relevant_claims": [
            "All infection indicator tests were negative.",
            "The findings included normal lactate, no clear infection, and relatively stable vitals."
        ],
        "alignment_scores": [
            0.3,
            0.3
        ],
        "alignment_category": [
            9,
            4
        ],
        "alignment_reasonings": [
            "The claim suggests a low suspicion of infection given the negative test results. While this indirectly relates to sepsis risk assessment (by implying a low risk), there is no direct link to the early interventions typical of this category. Hence, the alignment is weak but present due to the context of infection indicators which are typically assessed when considering antibiotics or cultures.",
            "The claim discusses stable vitals and normal lactate, which suggests less concern for parameters that would elevate the NEWS score, as that score is derived from deranged vitals to predict deterioration. While no particular category shows strong alignment due to the lack of concerning findings, the assessment of stable vitals suggests indirect relevance to systemic stability, thus somewhat aligning with the notion behind NEWS, albeit weakly."
        ],
        "final_alignment_score": 0.3,
        "accuracy": 0
    },
    {
        "input": "8: HR, 122.0; 8: 1min HRV, 6.485; 9: HR, 119.949; 9: 1min HRV, 5.774; 10: HR, 119.431; 10: RR, 25.0; 10: SpO2, 99.0; 10: 1min HRV, 7.438; 10: SBP, 157.0; 10: DBP, 111.0; 10: MAP, 126.333; 10: Pain, 10.0; 10: Temp, 97.7; 11: HR, 125.864; 11: 1min HRV, 5.985; 12: HR, 128.552; 12: 1min HRV, 12.354; 12: 5min HRV, 15.326; 13: HR, 132.763; 13: 1min HRV, 5.476; 14: HR, 128.237; 14: 1min HRV, 5.782; 15: HR, 127.052; 15: 1min HRV, 6.009; 16: HR, 129.576; 16: 1min HRV, 3.205; 17: HR, 131.397; 17: SpO2, 81.0; 17: 1min HRV, 3.718; 17: 5min HRV, 8.351; 18: HR, 134.780; 18: SpO2, 81.6; 18: 1min HRV, 3.966; 19: HR, 134.322; 19: 1min HRV, 3.130; 20: HR, 134.966; 20: 1min HRV, 2.578; 21: HR, 136.186; 21: 1min HRV, 3.903; 22: HR, 135.621; 22: 1min HRV, 2.507; 22: 5min HRV, 3.855; 23: HR, 135.915; 23: 1min HRV, 3.906; 24: HR, 138.593; 24: 1min HRV, 12.697; 25: HR, 137.172; 25: 1min HRV, 2.892; 26: HR, 137.729; 26: 1min HRV, 5.677; 27: HR, 141.534; 27: 1min HRV, 10.735; 27: 5min HRV, 9.730; 28: HR, 140.305; 28: 1min HRV, 3.041; 29: HR, 136.603; 29: 1min HRV, 7.352; 30: HR, 136.898; 30: SpO2, 72.030; 30: 1min HRV, 3.811; 31: HR, 141.288; 31: SpO2, 71.5; 31: 1min HRV, 10.722; 32: HR, 141.086; 32: 1min HRV, 6.121; 32: 5min HRV, 10.326; 33: HR, 140.068; 33: 1min HRV, 3.493; 34: HR, 140.362; 34: 1min HRV, 3.298; 35: HR, 145.552; 35: SpO2, 84.059; 35: 1min HRV, 11.218; 36: HR, 143.617; 36: 1min HRV, 12.918; 37: HR, 147.948; 37: 1min HRV, 17.235; 37: 5min HRV, 13.856; 38: HR, 145.186; 38: SpO2, 80.0; 38: 1min HRV, 11.901; 39: HR, 143.362; 39: SpO2, 80.611; 39: 1min HRV, 5.209; 40: HR, 141.119; 40: 1min HRV, 4.706; 41: HR, 143.576; 41: 1min HRV, 15.462; 42: HR, 143.431; 42: 1min HRV, 5.235; 42: 5min HRV, 10.431; 43: HR, 143.085; 43: 1min HRV, 16.664; 44: HR, 142.431; 44: 1min HRV, 3.801; 44: HYDROMORPHONE, 1 MG/ML INJ SYRG; 45: HR:, 141.322; 45: 1min HRV, 3.006; 46: HR, 140.729; 46: 1min HRV, 6.007; 47: HR, 144.759; 47: 1min HRV, 5.140; 47: 5min HRV, 9.141; 48: HR, 140.534; 48: 1min HRV, 12.333; 49: HR, 137.186; 49: 1min HRV, 2.207; 50: HR, 137.153; 50: 1min HRV, 3.967; 51: HR, 135.915; 51: 1min HRV, 3.492; 52: HR, 137.448; 52: 1min HRV, 5.259; 52: 5min HRV, 7.911; 53: HR, 140.576; 53: 1min HRV, 7.635; 54: HR, 140.586; 54: 1min HRV, 3.035; 55: HR, 139.763; 55: 1min HRV, 2.794; 56: HR, 136.746; 56: 1min HRV, 4.514; 57: HR, 136.224; 57: 1min HRV, 5.090; 57: 5min HRV, 7.816; 58: HR, 135.525; 58: 1min HRV, 2.689; 59: HR, 136.483; 59: 1min HRV, 3.506; 60: HR, 136.569; 60: 1min HRV, 2.851; 61: HR, 136.915; 61: 1min HRV, 15.564; 62: HR, 136.068; 62: 1min HRV, 2.720; 62: 5min HRV, 7.596; 63: HR, 135.356; 63: 1min HRV, 3.134; 64: HR, 136.552; 64: 1min HRV, 4.518; 65: HR, 139.661; 65: 1min HRV, 7.439; 66: HR, 133.0; 66: 1min HRV, 19.097; 67: HR, 132.492; 67: 1min HRV, 3.197; 67: 5min HRV, 12.820; 68: HR, 133.186; 68: 1min HRV, 4.656; 69: HR, 134.966; 69: 1min HRV, 3.943; 70: HR, 134.712; 70: 1min HRV, 2.937; 71: HR, 134.983; 71: 1min HRV, 3.785; 72: HR, 133.879; 72: 1min HRV, 2.891; 72: 5min HRV, 4.401; 73: HR, 133.85; 73: 1min HRV, 3.464; 74: HR, 135.828; 74: 1min HRV, 5.596; 75: HR, 139.271; 75: 1min HRV, 5.174; 76: HR, 142.5; 76: 1min HRV, 0.740; 77: SARS-COV-2 RNA, Not Detected; 77: 5min HRV, 9.243; 79: HR, 143.0; 79: 1min HRV, 1.797; 80: HR, 140.949; 80: 1min HRV, 16.120; 81: HR, 136.966; 81: 1min HRV, 3.455; 82: HR, 135.542; 82: 1min HRV, 2.452; 82: 5min HRV, 12.124; 83: HR, 134.797; 83: 1min HRV, 2.825; 84: HR, 135.483; 84: 1min HRV, 2.503; 84: LR IV BOLUS -, 1000 ML; 85: HR:, 135.068; 85: 1min HRV, 3.966; 86: HR, 135.310; 86: 1min HRV, 4.188; 87: HR, 135.288; 87: 1min HRV, 3.515; 87: 5min HRV, 3.577; 88: HR, 136.417; 88: 1min HRV, 2.231; 92: 5min HRV, 2.231; 93: SpO2, 94.778; 97: Pain, 8.0; 110: SpO2, 92.444; 0: Age, 40; 0: Gender, F; 0: Race, Black or African American; 0: Means of arrival, EMS; 0: Triage Temp, 36.5; 0: Triage HR, 120.0; 0: Triage RR, 25.0; 0: Triage SBP, 157.0; 0: Triage DBP, 111.0; 0: Triage acuity, 2-Emergent; 0: CC, ABDOMINAL PAIN,FLANK PAIN",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, we check if the patient\u2019s vital signs meet SIRS criteria, noting the persistent tachycardia (HR often above 120) and tachypnea (RR of 25). Next, we observe the repeatedly low oxygen saturation (SpO2 dropping below 85%), which demonstrates potential organ dysfunction. Then, we consider the severe abdominal/flank pain as a possible source of infection. Given these findings, the patient appears to be at high risk for developing sepsis within the next 12 hours.",
        "claims": [
            "The patient's vital signs are checked to see if they meet SIRS criteria.",
            "The patient has persistent tachycardia.",
            "The patient's heart rate (HR) is often above 120.",
            "The patient has tachypnea.",
            "The patient's respiratory rate (RR) is 25.",
            "The patient has repeatedly low oxygen saturation.",
            "The patient's SpO2 drops below 85%.",
            "Low oxygen saturation demonstrates potential organ dysfunction.",
            "The patient has severe abdominal or flank pain.",
            "The severe abdominal or flank pain may be a source of infection.",
            "Given these findings, the patient appears to be at high risk for developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient's vital signs are checked to see if they meet SIRS criteria.",
            "The patient has persistent tachycardia.",
            "The patient's heart rate (HR) is often above 120.",
            "The patient has tachypnea.",
            "The patient's respiratory rate (RR) is 25.",
            "The patient has repeatedly low oxygen saturation.",
            "The patient's SpO2 drops below 85%.",
            "Low oxygen saturation demonstrates potential organ dysfunction.",
            "The patient has severe abdominal or flank pain.",
            "The severe abdominal or flank pain may be a source of infection.",
            "Given these findings, the patient appears to be at high risk for developing sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            0.8,
            0.8,
            0.8,
            0.7,
            1.0,
            0.7,
            0.7,
            0.7,
            0.3,
            0.3,
            0.3
        ],
        "alignment_category": [
            2,
            2,
            2,
            3,
            3,
            8,
            8,
            8,
            9,
            9,
            4
        ],
        "alignment_reasonings": [
            "The claim pertains to assessing whether the patient's vital signs meet the SIRS criteria, which directly relates to identifying systemic inflammation consistent with early sepsis. Although the claim indicates the action of checking, it does not confirm that the criteria are met; hence, it's not a perfect alignment.",
            "Tachycardia is defined as a heart rate greater than 90 bpm, which is one of the criteria for SIRS. While the claim does not mention other SIRS criteria, the presence of tachycardia alone is strongly aligned with SIRS positivity. Therefore, the alignment is high, but not perfect, as the claim does not specify meeting the other criterion needed for SIRS positivity.",
            "A heart rate of over 90 bpm is a criterion within the SIRS framework, and a heart rate frequently above 120 bpm strongly aligns with this category. However, since the claim highlights just one of the SIRS criteria, rather than multiple, the alignment isn\u2019t perfect but still substantial.",
            "Tachypnea, or rapid breathing, is directly aligned with one of the criteria for a high qSOFA score (respiratory rate \u226522/min). While the claim doesn't specify the exact respiratory rate, tachypnea suggests an alignment, though not a full match without further details. Therefore, the alignment rating is moderate to high.",
            "The claim specifies a respiratory rate (RR) of 25, which is higher than the qSOFA threshold of \u226522/min. This directly aligns with the criteria for a high qSOFA score indicating a high risk of sepsis-related complications. Therefore, the alignment is strong and rated at 1.0.",
            "Repeatedly low oxygen saturation suggests hypoxemia, which is conceptually related to impaired oxygenation metrics like the PaO\u2082/FiO\u2082 ratio used in the SOFA score. Although not directly stated, frequent low oxygen saturation aligns significantly with the respiratory component of the SOFA score, indicating a potential risk for organ dysfunction.",
            "A drop in SpO2 below 85% indicates significant hypoxia and potential organ dysfunction, which conceptually aligns with impaired oxygenation (PaO\u2082/FiO\u2082 < 300) in the SOFA criteria. Although SpO2 is not a direct SOFA measure, the hypoxia it represents is relevant to the assessment of respiratory dysfunction in the context of sepsis. Given its indirect but relevant connection to the SOFA score, I rated the alignment as 0.7.",
            "Low oxygen saturation is indicative of potential organ dysfunction, particularly related to impaired oxygenation, which aligns with the SOFA component for respiratory assessment (e.g., PaO\u2082/FiO\u2082). While the claim does not specify a direct link to the PaO\u2082/FiO\u2082 ratio, it conceptually suggests a similar concern about respiratory compromise. Therefore, the alignment is relevant but not explicitly detailed, resulting in a strong but not perfect alignment rating.",
            "Severe abdominal or flank pain is commonly associated with suspicion of an intra-abdominal infection or other serious conditions requiring investigation; however, the claim does not provide specific information about diagnostic criteria or intervention (such as antibiotic administration or culture orders) that more directly align with the categories. Therefore, it relates only generally to suspicion that might lead to prompt investigation or intervention.",
            "The claim suggests suspicion of an infection source based on severe pain, which could prompt actions like ordering antibiotics or cultures, aligning with this category. However, the claim does not directly mention any actual clinical actions taken, such as ordering antibiotics or cultures, which are crucial to fulfilling this category's criteria. Therefore, the alignment is weak but relevant.",
            "The claim broadly states a high risk for developing sepsis without specific indicators. This aligns loosely with the notion of \"imminent clinical deterioration,\" which the NEWS score predicts. However, because no direct criteria or measurements are given, the alignment is weak. The claim suggests an overall assessment rather than a specific indicator."
        ],
        "final_alignment_score": 0.6454545454545454,
        "accuracy": 1
    },
    {
        "input": "9: HR, 95.0; 9: RR, 18.0; 9: SpO2, 77.0; 9: SBP, 112.0; 9: DBP, 84.0; 9: MAP, 93.333; 9: LPM O2, nan; 9: Temp, 98.1; 14: SpO2, 96.0; 14: LPM O2, 4.0; 45: HR, 82.0; 45: SpO2, 96.0; 45: SBP, 122.0; 45: DBP, 80.0; 45: MAP, 94.0; 45: LPM O2, 4.0; 49: SpO2, 96.0; 50: SpO2, 95.109; 50: Perf, 1.92; 51: SpO2, 94.774; 51: Perf, 1.96; 75: SpO2, 97.0; 76: SpO2, 96.566; 77: SpO2, 96.358; 78: SpO2, 96.808; 79: SpO2, 97.245; 80: SpO2, 97.135; 81: SpO2, 97.093; 82: SpO2, 97.321; 82: Perf, 0.838; 83: SpO2, 98.115; 83: Perf, 1.027; 84: SpO2, 98.811; 84: Perf, 1.008; 85: HR, 83.152; 85: RR, 23.25; 85: SpO2, 98.962; 85: Perf, 0.881; 85: 1min HRV, 92.396; 85: 5min HRV, 92.396; 86: HR, 83.981; 86: RR, 22.811; 86: SpO2, 99.415; 86: Perf, 0.951; 86: 1min HRV, 91.875; 87: HR, 83.189; 87: RR, 18.151; 87: SpO2, 98.906; 87: Perf, 0.996; 87: 1min HRV, 99.886; 88: HR, 84.346; 88: RR, 20.596; 88: SpO2, 98.904; 88: Perf, 0.978; 88: 1min HRV, 98.378; 89: HR, 87.698; 89: RR, 23.340; 89: SpO2, 98.684; 89: Perf, 0.97; 89: 1min HRV, 103.759; 90: HR, 86.269; 90: RR, 19.558; 90: SpO2, 98.0; 90: Perf, 0.974; 90: 1min HRV, 87.281; 90: 5min HRV, 97.058; 91: HR, 86.170; 91: RR, 24.434; 91: SpO2, 97.830; 91: Perf, 0.982; 91: 1min HRV, 114.745; 92: HR, 86.547; 92: RR, 20.755; 92: SpO2, 98.377; 92: Perf, 0.993; 92: 1min HRV, 96.649; 93: HR, 87.887; 93: RR, 25.377; 93: SpO2, 98.509; 93: Perf, 1.400; 93: 1min HRV, 128.835; 94: HR, 88.094; 94: RR, 23.755; 94: SpO2, 98.377; 94: Perf, 1.707; 94: 1min HRV, 115.796; 95: HR, 85.423; 95: RR, 20.481; 95: SpO2, 98.0; 95: Perf, 1.755; 95: 1min HRV, 87.944; 95: 5min HRV, 109.781; 96: HR, 84.811; 96: RR, 19.170; 96: SpO2, 98.308; 96: Perf, 1.494; 96: 1min HRV, 107.870; 97: HR, 83.887; 97: RR, 18.962; 97: SpO2, 98.0; 97: Perf, 1.488; 97: 1min HRV, 96.765; 98: HR, 83.654; 98: RR, 19.212; 98: SpO2, 98.269; 98: Perf, 1.531; 98: 1min HRV, 106.380; 99: HR, 83.415; 99: RR, 16.887; 99: SpO2, 98.576; 99: Perf, 1.367; 99: 1min HRV, 102.632; 100: HR, 83.846; 100: RR, 17.75; 100: SpO2, 97.923; 100: Perf, 1.313; 100: 1min HRV, 83.002; 100: 5min HRV, 99.817; 101: WAM DIFTYP, AUTO; 101: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 101: NEUTROPHIL ABSOLUTE (AUTO DIFF), 4.80 K/uL; 101: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.4 g/dL; 101: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.01 K/uL; 101: MONOCYTE ABSOLUTE (AUTO DIFF), 0.69 K/uL; 101: WHITE BLOOD CELLS (WBC), 7.0 K/uL; 101: MONOCYTE % (AUTO DIFF), 9.9 %; 101: LYMPHOCYTE % (AUTO DIFF), 15.4 %; 101: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 101: NRBC PERCENT (HEMATOLOGY), 0.0 %; 101: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.35 K/uL; 101: EOSINOPHIL % (AUTO DIFF), 5.0 %; 101: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.07 K/uL; 101: MEAN CORPUSCULAR VOLUME (MCV), 114.1 fL; 101: NEUTROPHIL % (AUTO DIFF), 69.2 %; 101: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 35.9 pg; 101: RED BLOOD CELLS (RBC), 2.90 MIL/uL; 101: HEMOGLOBIN (HGB), 10.4 g/dL; 101: HEMATOCRIT (HCT), 33.1 %; 101: PLATELET COUNT (PLT), 197 K/uL; 101: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.1 %; 101: RED CELL DISTRIBUTION WIDTH (RDW), 14.4 %; 101: BASOPHIL % (AUTO DIFF), 0.4 %; 101: HR, 84.057; 101: RR, 19.132; 101: SpO2, 98.453; 101: Perf, 1.311; 101: 1min HRV, 120.978; 102: HR, 83.396; 102: RR, 17.943; 102: SpO2, 97.566; 102: Perf, 1.299; 102: 1min HRV, 100.458; 103: HR, 84.192; 103: RR, 21.981; 103: SpO2, 98.0; 103: Perf, 1.255; 103: 1min HRV, 117.417; 104: HR, 83.981; 104: RR, 19.226; 104: SpO2, 97.906; 104: Perf, 1.149; 104: 1min HRV, 95.129; 105: HR, 82.942; 105: RR, 17.558; 105: SpO2, 98.327; 105: Perf, 1.450; 105: 1min HRV, 86.174; 105: 5min HRV, 103.831; 105: LPM O2, 4.0; 106: HR, 83.509; 106: RR, 19.019; 106: SpO2, 97.566; 106: Perf, 1.604; 106: 1min HRV, 98.076; 107: HR, 83.472; 107: RR, 20.075; 107: SpO2, 98.019; 107: Perf, 1.633; 107: 1min HRV, 81.495; 108: HR, 82.925; 108: RR, 20.679; 108: SpO2, 98.245; 108: Perf, 0.948; 108: 1min HRV, 121.444; 109: HR, 83.075; 109: RR, 21.132; 109: SpO2, 98.434; 109: Perf, 0.889; 109: 1min HRV, 102.718; 110: HR, 81.923; 110: RR, 22.231; 110: SpO2, 97.962; 110: Perf, 1.283; 110: 1min HRV, 85.795; 110: 5min HRV, 99.079; 111: HR, 82.642; 111: RR, 20.585; 111: SpO2, 98.830; 111: Perf, 1.488; 111: 1min HRV, 84.665; 112: HR, 84.712; 112: RR, 20.635; 112: SpO2, 98.769; 112: Perf, 1.543; 112: 1min HRV, 110.879; 113: HR, 82.283; 113: RR, 25.396; 113: SpO2, 98.434; 113: Perf, 1.144; 113: 1min HRV, 86.141; 114: HR, 83.222; 114: RR, 20.778; 114: SpO2, 98.611; 114: Perf, 0.899; 114: 1min HRV, 84.949; 115: HR, 82.423; 115: RR, 21.827; 115: SpO2, 98.365; 115: Perf, 0.94; 115: 1min HRV, 89.629; 115: 5min HRV, 91.965; 116: HR, 82.755; 116: RR, 20.811; 116: SpO2, 98.755; 116: Perf, 1.107; 116: 1min HRV, 102.620; 117: HR, 83.712; 117: RR, 18.865; 117: SpO2, 98.308; 117: Perf, 1.218; 117: 1min HRV, 88.153; 118: HR, 83.094; 118: RR, 20.962; 118: SpO2, 97.792; 118: Perf, 1.218; 118: 1min HRV, 102.102; 119: HR, 85.111; 119: RR, 22.0; 119: SpO2, 98.0; 119: Perf, 1.23; 119: 1min HRV, 109.427; 0: Age, 66; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 95.0; 0: Triage RR, 18.0; 0: Triage SBP, 112.0; 0: Triage DBP, 84.0; 0: Triage acuity, 2-Emergent; 0: CC, BREATHING PROBLEM",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, we evaluated the patient\u2019s vital signs at presentation and found no significant abnormalities (mildly elevated heart rate, but normal temperature and blood pressure). Next, we reviewed the laboratory data, noting a normal white blood cell count and no clear indicators of bacterial infection. We then examined trends in oxygen saturation and respiratory rate, which improved with supplemental oxygen and remained fairly stable. Based on these findings, the patient does not appear to be at high risk of sepsis within the next 12 hours.",
        "claims": [
            "The patient's vital signs at presentation were evaluated.",
            "There were no significant abnormalities in the patient's vital signs.",
            "The patient had a mildly elevated heart rate.",
            "The patient had a normal temperature.",
            "The patient had a normal blood pressure.",
            "Laboratory data were reviewed.",
            "The patient had a normal white blood cell count.",
            "There were no clear indicators of bacterial infection in the laboratory data.",
            "Trends in oxygen saturation were examined.",
            "The patient's oxygen saturation improved with supplemental oxygen.",
            "The patient's respiratory rate was stable.",
            "Based on these findings, the patient does not appear to be at high risk of sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "There were no clear indicators of bacterial infection in the laboratory data.",
            "The patient's oxygen saturation improved with supplemental oxygen."
        ],
        "alignment_scores": [
            0.3,
            0.5
        ],
        "alignment_category": [
            9,
            8
        ],
        "alignment_reasonings": [
            "The claim mentions the absence of clear laboratory indicators of bacterial infection, which indirectly relates to this category as it implies that no strong suspicion of infection was present to warrant early antibiotic administration or culture orders. While this suggests a decreased perception of sepsis risk, it aligns with the concept of assessing the need for early clinical interventions, but without specific actions cited, the alignment is weak.",
            "The claim about improved oxygen saturation with supplemental oxygen indirectly relates to the respiratory component of the SOFA score, which considers the PaO\u2082/FiO\u2082 ratio. While the specific metrics for a direct SOFA score increase aren't provided in the claim, the implication of improved oxygenation signifies a concern for respiratory function, which aligns with organ dysfunction as assessed by the SOFA score. The alignment is moderate due to the indirect connection and lack of specific data, like PaO\u2082/FiO\u2082 values, needed for a definitive SOFA score assessment."
        ],
        "final_alignment_score": 0.4,
        "accuracy": 1
    },
    {
        "input": "7: HR, 96.0; 7: RR, 16.0; 7: SpO2, 99.0; 7: SBP, 130.0; 7: DBP, 92.0; 7: MAP, 104.667; 7: Temp, 98.1; 20: Pain, 7.0; 45: SpO2, 96.406; 45: Perf, 1.377; 45: SBP, 128.0; 45: DBP, 97.0; 45: MAP, 107.333; 46: SpO2, 97.155; 46: Perf, 1.579; 47: SpO2, 96.644; 47: Perf, 2.137; 48: SpO2, 97.627; 48: Perf, 2.492; 49: SpO2, 97.831; 49: Perf, 2.683; 50: HR, 93.0; 50: RR, 19.0; 50: SpO2, 97.724; 50: Perf, 2.751; 50: SBP, 125.0; 50: DBP, 105.0; 50: MAP, 111.667; 51: SpO2, 97.797; 51: Perf, 3.935; 51: SBP, 125.0; 51: DBP, 105.0; 51: MAP, 111.667; 52: SpO2, 98.0; 52: Perf, 4.613; 53: SpO2, 98.0; 53: Perf, 4.703; 54: SpO2, 97.793; 54: Perf, 4.382; 55: SpO2, 97.712; 55: Perf, 3.319; 56: SpO2, 97.492; 56: Perf, 2.563; 57: SpO2, 97.414; 57: Perf, 2.518; 58: SpO2, 97.797; 58: Perf, 2.62; 59: SpO2, 97.655; 59: Perf, 2.570; 60: SpO2, 98.458; 60: Perf, 2.374; 61: SpO2, 98.746; 61: Perf, 1.605; 62: SpO2, 98.621; 62: Perf, 2.178; 63: SpO2, 98.119; 63: Perf, 3.291; 64: SpO2, 97.724; 64: Perf, 3.941; 65: SpO2, 97.898; 65: Perf, 4.344; 66: SpO2, 97.932; 66: Perf, 4.513; 66: SBP, 129.0; 66: DBP, 102.0; 66: MAP, 111.0; 67: SpO2, 97.379; 67: Perf, 4.306; 68: SpO2, 97.525; 68: Perf, 3.781; 69: SpO2, 97.466; 69: Perf, 2.854; 70: SpO2, 97.458; 70: Perf, 2.605; 71: SpO2, 98.203; 71: Perf, 2.407; 72: SpO2, 98.397; 72: Perf, 2.168; 73: SpO2, 98.746; 73: Perf, 2.085; 74: SpO2, 98.759; 74: Perf, 2.311; 75: SpO2, 97.814; 75: Perf, 2.402; 76: SpO2, 98.0; 76: Perf, 2.832; 77: SpO2, 98.0; 77: Perf, 3.784; 78: SpO2, 97.576; 78: Perf, 3.755; 79: INFLUENZA B, Not Detected; 79: RSV, Not Detected; 79: INFLUENZA A, Not Detected; 79: SARS-COV-2 RNA, Not Detected; 79: SpO2, 98.0; 79: Perf, 3.552; 80: SpO2, 97.373; 80: Perf, 3.137; 81: SpO2, 97.576; 81: Perf, 2.871; 81: SBP, 132.0; 81: DBP, 103.0; 81: MAP, 112.667; 82: SpO2, 97.931; 82: Perf, 2.412; 83: SpO2, 97.661; 83: Perf, 1.794; 84: SpO2, 97.603; 84: Perf, 2.579; 85: SpO2, 97.932; 85: Perf, 2.144; 86: SpO2, 97.879; 86: Perf, 2.266; 87: SpO2, 97.407; 87: Perf, 3.087; 88: SpO2, 97.525; 88: Perf, 2.095; 89: SpO2, 97.914; 89: Perf, 1.692; 90: SpO2, 98.644; 90: Perf, 1.534; 91: SpO2, 98.431; 91: Perf, 1.664; 92: SpO2, 97.915; 92: Perf, 2.03; 93: SpO2, 98.305; 93: Perf, 2.03; 94: SpO2, 98.052; 94: Perf, 2.03; 95: SpO2, 98.915; 95: Perf, 2.03; 96: HR, 50.0; 96: RR, 22.0; 96: SpO2, 99.0; 96: Perf, 1.996; 96: SBP, 137.0; 96: DBP, 110.0; 96: MAP, 119.0; 96: Pain, 3.0; 96: Temp, 98.9; 97: SpO2, 99.339; 97: Perf, 1.919; 98: SpO2, 99.034; 98: Perf, 1.779; 99: SpO2, 99.0; 99: Perf, 2.056; 100: WAM DIFTYP, AUTO; 100: BASOPHIL ABSOLUTE (AUTO DIFF), 0.06 K/uL; 100: MONOCYTE % (AUTO DIFF), 8.8 %; 100: NRBC PERCENT (HEMATOLOGY), 0.0 %; 100: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.15 K/uL; 100: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 100: HEMATOCRIT (HCT), 41.4 %; 100: PLATELET COUNT (PLT), 241 K/uL; 100: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.5 pg; 100: RED BLOOD CELLS (RBC), 4.47 MIL/uL; 100: RED CELL DISTRIBUTION WIDTH (RDW), 13.7 %; 100: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.34 K/uL; 100: LYMPHOCYTE % (AUTO DIFF), 27.8 %; 100: BASOPHIL % (AUTO DIFF), 0.7 %; 100: EOSINOPHIL % (AUTO DIFF), 1.8 %; 100: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.9 g/dL; 100: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.5 %; 100: NEUTROPHIL % (AUTO DIFF), 60.4 %; 100: HEMOGLOBIN (HGB), 13.2 g/dL; 100: MONOCYTE ABSOLUTE (AUTO DIFF), 0.74 K/uL; 100: WHITE BLOOD CELLS (WBC), 8.4 K/uL; 100: NEUTROPHIL ABSOLUTE (AUTO DIFF), 5.09 K/uL; 100: MEAN CORPUSCULAR VOLUME (MCV), 92.6 fL; 100: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.04 K/uL; 100: SpO2, 98.475; 100: Perf, 2.900; 101: INR, 1.4; 101: PROTHROMBIN TIME, 16.5 seconds; 101: SpO2, 98.310; 101: Perf, 3.327; 102: SpO2, 98.424; 102: Perf, 3.066; 103: SpO2, 98.169; 103: Perf, 2.855; 104: SpO2, 98.897; 104: Perf, 2.206; 105: SpO2, 98.220; 105: Perf, 2.655; 106: SpO2, 97.983; 106: Perf, 2.997; 107: SpO2, 98.271; 107: Perf, 2.789; 108: SpO2, 97.966; 108: Perf, 2.631; 109: SpO2, 98.690; 109: Perf, 2.325; 110: SpO2, 98.576; 110: Perf, 2.028; 110: SBP, 129.0; 110: DBP, 103.0; 110: MAP, 111.667; 111: SpO2, 97.983; 111: Perf, 2.424; 111: SBP, 129.0; 111: DBP, 103.0; 111: MAP, 111.667; 112: LACTIC ACID, 1.2 mmol/L; 112: SpO2, 97.508; 112: Perf, 2.367; 113: SpO2, 98.831; 113: Perf, 2.098; 114: SpO2, 98.845; 114: Perf, 2.181; 115: SpO2, 98.169; 115: Perf, 2.054; 116: SpO2, 98.069; 116: Perf, 1.825; 117: SpO2, 99.0; 117: Perf, 1.891; 118: MAGNESIUM, 1.9 mg/dL; 118: AST (SGOT), 51 U/L; 118: ALBUMIN, 3.7 g/dL; 118: BILIRUBIN TOTAL, 0.2 mg/dL; 118: ALKALINE PHOSPHATASE, 57 U/L; 118: GLOBULIN, 3.1 g/dL; 118: EGFR REFIT WITHOUT RACE (2021), 92 mL/min/1.73 m2; 118: SODIUM, 137 mmol/L; 118: PROTEIN TOTAL, 6.8 g/dL; 118: ALT (SGPT), 48 U/L; 118: BLOOD UREA NITROGEN (BUN), 21 mg/dL; 118: CORRECTED CALCIUM, 8.8 mg/dL; 118: ANION GAP, 10 mmol/L; 118: CREATININE, 1.03 mg/dL; 118: CALCIUM, 8.6 mg/dL; 118: CO2, 20 mmol/L; 118: CHLORIDE, 107 mmol/L; 118: POTASSIUM, 4.1 mmol/L; 118: GLUCOSE, 101 mg/dL; 118: SpO2, 98.017; 118: Perf, 2.516; 119: SpO2, 97.915; 119: Perf, 2.765; 0: Age, 43; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 96.0; 0: Triage RR, 16.0; 0: Triage SBP, 130.0; 0: Triage DBP, 92.0; 0: Triage acuity, 3-Urgent; 0: CC, COUGH",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I check whether the patient\u2019s vital signs (heart rate, respiratory rate, temperature, and blood pressure) meet sepsis clinical criteria. Next, I look for organ dysfunction indicators in labs (e.g., lactate, WBC count) or signs of significant infection. Then, I note the normal lactate, normal WBC, and negative viral tests, all of which do not suggest a high risk of sepsis. Given this information, the patient is not at high risk of developing sepsis within 12 hours.",
        "claims": [
            "I check whether the patient\u2019s vital signs meet sepsis clinical criteria.",
            "The vital signs I check include heart rate, respiratory rate, temperature, and blood pressure.",
            "I look for organ dysfunction indicators in laboratory tests.",
            "Organ dysfunction indicators may include lactate levels and white blood cell (WBC) count.",
            "I also check for signs of significant infection.",
            "The patient has normal lactate levels.",
            "The patient has a normal WBC count.",
            "The patient has negative viral tests.",
            "The normal lactate, normal WBC, and negative viral tests do not suggest a high risk of sepsis.",
            "Given this information, the patient is not at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The normal lactate, normal WBC, and negative viral tests do not suggest a high risk of sepsis."
        ],
        "alignment_scores": [
            0.7
        ],
        "alignment_category": [
            5
        ],
        "alignment_reasonings": [
            "The claim specifically mentions a normal lactate level, which directly relates to the Elevated Serum Lactate category that identifies high sepsis risk through an elevated lactate level. The normal lactate level suggests a lower risk of sepsis. The claim indirectly addresses the other part by mentioning a normal WBC, which pertains to the SIRS criteria, but the explicit mention of lactate provides a clearer alignment with category 5. The rating reflects this alignment considering that the claim presents normal rather than elevated values, indicating a lower risk scenario."
        ],
        "final_alignment_score": 0.7,
        "accuracy": 1
    },
    {
        "input": "10: HR, 124.0; 10: RR, 18.0; 10: SBP, 123.0; 10: DBP, 85.0; 10: MAP, 97.667; 10: Temp, 99.3; 34: SpO2, 98.474; 35: SpO2, 99.169; 35: Perf, 2.224; 36: SpO2, 98.948; 36: Perf, 2.137; 37: SpO2, 99.119; 37: Perf, 2.362; 38: SpO2, 98.603; 38: Perf, 1.824; 39: SpO2, 97.678; 39: Perf, 1.582; 40: SpO2, 98.458; 40: Perf, 1.283; 41: SpO2, 98.534; 41: Perf, 1.659; 42: SpO2, 98.746; 42: Perf, 1.824; 43: SpO2, 98.379; 43: Perf, 1.852; 44: SpO2, 98.441; 44: Perf, 1.785; 45: SpO2, 98.220; 45: Perf, 1.027; 46: SpO2, 98.690; 46: Perf, 1.103; 47: SpO2, 99.678; 47: Perf, 1.772; 48: SpO2, 99.810; 48: Perf, 2.277; 49: SpO2, 99.780; 49: Perf, 2.665; 50: SpO2, 98.661; 50: Perf, 2.874; 51: SpO2, 98.810; 51: Perf, 2.65; 52: SpO2, 99.0; 52: Perf, 1.746; 53: SpO2, 98.414; 53: Perf, 1.777; 54: SpO2, 98.237; 54: Perf, 1.994; 55: SpO2, 97.678; 55: Perf, 2.447; 56: SpO2, 99.017; 56: Perf, 2.373; 57: SpO2, 98.203; 57: Perf, 2.956; 58: SpO2, 98.914; 58: Perf, 3.224; 59: SpO2, 99.186; 59: Perf, 2.435; 60: SpO2, 98.271; 60: Perf, 1.618; 61: SpO2, 97.224; 61: Perf, 1.683; 62: SpO2, 96.339; 62: Perf, 0.938; 63: SpO2, 96.724; 63: Perf, 0.922; 64: SpO2, 97.153; 64: Perf, 0.700; 65: SpO2, 97.0; 65: Perf, 0.776; 66: SpO2, 97.186; 66: Perf, 1.047; 67: SpO2, 97.237; 67: Perf, 1.001; 68: SpO2, 96.845; 68: Perf, 0.894; 69: SpO2, 97.085; 69: Perf, 0.953; 70: POC, HCG, ISTAT QUALITATIVE: Negative; 70: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 70: SpO2, 99.138; 70: Perf, 1.017; 71: SpO2, 97.661; 71: Perf, 1.419; 72: POC PH (V) ISTAT, 7.40; 72: POC PCO2 (V) ISTAT, 40.6 mmHg; 72: POC PO2 (V) ISTAT, 36 mmHg; 72: POC O2 SATURATION ISTAT VENOUS, 69 %; 72: POC HCO3 (V) ISTAT, 25.0 mmol/L; 72: POC LACTATE ISTAT, 0.93 mmol/L; 72: POC BASE EXCESS ISTAT, 0 mmol/L; 72: POC TCO2 (V) ISTAT, 26 mmol/L; 72: SpO2, 98.0; 72: Perf, 1.794; 73: SpO2, 98.0; 73: Perf, 1.956; 74: SpO2, 98.0; 74: Perf, 2.021; 74: LR IV BOLUS -, 1000 ML; 75: SpO, 2: 97.293; 75: Perf, 1.599; 76: SpO2, 97.492; 76: Perf, 2.369; 77: SpO2, 97.424; 77: Perf, 2.6; 78: SpO2, 99.207; 78: Perf, 2.413; 79: SpO2, 98.678; 79: Perf, 2.122; 80: SpO2, 98.879; 80: Perf, 1.586; 81: SpO2, 98.898; 81: Perf, 1.792; 82: SpO2, 98.237; 82: Perf, 1.856; 83: SpO2, 98.897; 83: Perf, 1.813; 84: SpO2, 98.814; 84: Perf, 1.436; 85: SpO2, 99.138; 85: Perf, 1.005; 86: SpO2, 98.356; 86: Perf, 1.135; 87: SpO2, 98.034; 87: Perf, 1.147; 88: SpO2, 99.0; 88: Perf, 1.075; 89: SpO2, 98.712; 89: Perf, 1.979; 90: SpO2, 98.966; 90: Perf, 1.538; 91: SpO2, 97.746; 91: Perf, 0.917; 92: SpO2, 97.559; 92: Perf, 0.788; 93: SpO2, 98.293; 93: Perf, 0.755; 94: SpO2, 98.339; 94: Perf, 0.913; 95: SpO2, 98.121; 95: Perf, 1.300; 96: SpO2, 97.695; 96: Perf, 1.225; 97: SpO2, 97.569; 97: Perf, 1.103; 98: SpO2, 98.237; 98: Perf, 0.971; 99: SpO2, 98.254; 99: Perf, 1.076; 100: SpO2, 99.052; 100: Perf, 0.774; 101: SpO2, 99.610; 101: Perf, 0.882; 102: SpO2, 98.707; 102: Perf, 0.931; 103: SpO2, 99.542; 103: Perf, 0.719; 104: SpO2, 99.931; 104: Perf, 1.281; 105: SpO2, 100.0; 105: Perf, 1.238; 106: SpO2, 99.610; 106: Perf, 1.108; 107: SpO2, 99.086; 107: Perf, 0.759; 108: SpO2, 97.636; 108: Perf, 0.521; 109: SpO2, 98.611; 110: SpO2, 98.966; 110: Perf, 0.720; 111: SpO2, 99.593; 111: Perf, 0.645; 112: SpO2, 99.707; 112: Perf, 0.756; 113: SpO2, 98.966; 113: Perf, 0.805; 114: SpO2, 98.690; 114: Perf, 0.62; 115: RBC MORPHOLOGY (SLIDE REVIEW), Abnormal; 115: PROTEIN TOTAL, 7.6 g/dL; 115: ANION GAP, 11 mmol/L; 115: ALT (SGPT), 12 U/L; 115: BLOOD UREA NITROGEN (BUN), 9 mg/dL; 115: GLUCOSE, 132 mg/dL; 115: AST (SGOT), 16 U/L; 115: EGFR REFIT WITHOUT RACE (2021), 44 mL/min/1.73 m2; 115: GLOBULIN, 4.0 g/dL; 115: CHLORIDE, 105 mmol/L; 115: CORRECTED CALCIUM, 8.4 mg/dL; 115: SODIUM, 142 mmol/L; 115: ALKALINE PHOSPHATASE, 82 U/L; 115: POTASSIUM, 3.5 mmol/L; 115: CO2, 26 mmol/L; 115: CALCIUM, 8.1 mg/dL; 115: BILIRUBIN TOTAL, 0.2 mg/dL; 115: EGFR FOR AFRICAN AMERICAN, 51 mL/min/1.73 m2; 115: ALBUMIN, 3.6 g/dL; 115: CREATININE, 1.52 mg/dL; 115: RED CELL DISTRIBUTION WIDTH (RDW), 18.8 %; 115: HEMATOCRIT (HCT), 24.7 %; 115: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 17.9 pg; 115: WHITE BLOOD CELLS (WBC), 8.5 K/uL; 115: HEMOGLOBIN (HGB), 6.4 g/dL; 115: PLATELET COUNT (PLT), 369 K/uL; 115: MEAN CORPUSCULAR VOLUME (MCV), 69.0 fL; 115: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 25.9 g/dL; 115: RED BLOOD CELLS (RBC), 3.58 MIL/uL; 115: NEUTROPHILS BANDS % (MANUAL DIFF), 0.0 %; 115: LYMPHOCYTES % (MANUAL DIFF), 10.4 %; 115: EOSINOPHILS ABSOLUTE (MANUAL DIFF), 0.14 K/uL; 115: MONOCYTES ABSOLUTE (MANUAL DIFF), 0.30 K/uL; 115: EOSINOPHILS % (MANUAL DIFF), 1.7 %; 115: NEUTROPHILS ABSOLUTE (MANUAL DIFF) (SEGS+BANDS), 7.19 K/uL; 115: LYMPHOCYTES ABSOLUTE (MANUAL DIFF), 0.89 K/uL; 115: MONOCYTES % (MANUAL DIFF), 3.5 %; 115: NEUTROPHILS SEGMENTED % (MANUAL DIFF), 84.4 %; 115: SpO2, 98.576; 115: Perf, 0.578; 116: SpO2, 98.136; 116: Perf, 0.589; 117: SpO2, 98.414; 117: Perf, 0.684; 118: SpO2, 98.508; 118: Perf, 1.111; 119: SpO2, 98.593; 119: Perf, 1.259; 0: Age, 33; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 37.4; 0: Triage HR, 124.0; 0: Triage RR, 18.0; 0: Triage SBP, 123.0; 0: Triage DBP, 85.0; 0: Triage acuity, 3-Urgent; 0: CC, FEVER,EMESIS,DIARRHEA",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I checked whether key vital signs (heart rate, blood pressure, lactate, and WBC count) met septic criteria; although the patient is tachycardic, other measures are not indicative of sepsis. Next, I assessed potential organ dysfunction, including kidney function, but the mildly elevated creatinine alone was insufficient evidence of sepsis. Then, I looked for infection markers (fever, high lactate, altered mental status) and found no strong signs. Consequently, the patient does not appear to be at high risk of developing sepsis within 12 hours.",
        "claims": [
            "Key vital signs were assessed to determine if they met septic criteria.",
            "The patient is tachycardic.",
            "Other vital sign measures are not indicative of sepsis.",
            "Potential organ dysfunction was assessed, including kidney function.",
            "The creatinine level was mildly elevated.",
            "The mildly elevated creatinine level alone was insufficient evidence of sepsis.",
            "Infection markers were checked, including fever, high lactate, and altered mental status.",
            "No strong signs of infection were found.",
            "The patient does not appear to be at high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "Key vital signs were assessed to determine if they met septic criteria.",
            "The patient is tachycardic."
        ],
        "alignment_scores": [
            0.5,
            0.8
        ],
        "alignment_category": [
            4,
            2
        ],
        "alignment_reasonings": [
            "The claim refers to the assessment of key vital signs to determine septic criteria. The NEWS score involves evaluating vital signs to predict deterioration consistent with sepsis. However, the claim does not specify if a NEWS score was calculated or if particular thresholds were met, leading to a moderate alignment rating.",
            "Tachycardia (heart rate > 90 bpm) is one of the specific criteria mentioned under the SIRS category used to identify systemic inflammation consistent with early sepsis. The alignment rating is high because tachycardia is directly listed as a SIRS criterion, but the final SIRS positivity requires meeting at least two criteria, so it is not a perfect alignment by itself."
        ],
        "final_alignment_score": 0.65,
        "accuracy": 1
    },
    {
        "input": "13: HR, 128.0; 13: RR, 18.0; 13: SpO2, 99.0; 13: SBP, 120.0; 13: DBP, 51.0; 13: MAP, 74.0; 13: Temp, 99.5; 59: HR, 117.362; 59: RR, 23.914; 59: Perf, 0.43; 59: 1min HRV, 6.545; 60: HR, 117.915; 60: RR, 23.441; 60: SpO2, 100.0; 60: 1min HRV, 7.644; 61: HR, 119.576; 61: RR, 23.373; 61: SpO2, 99.610; 61: Perf, 0.551; 61: 1min HRV, 6.043; 61: 5min HRV, 7.955; 62: HR, 120.086; 62: RR, 23.328; 62: SpO2, 99.310; 62: Perf, 0.769; 62: 1min HRV, 4.305; 63: HR, 121.153; 63: RR, 25.085; 63: SpO2, 99.153; 63: Perf, 0.875; 63: 1min HRV, 4.458; 64: HR, 121.810; 64: RR, 24.466; 64: SpO2, 98.931; 64: Perf, 0.934; 64: 1min HRV, 3.305; 65: HR, 122.034; 65: RR, 22.525; 65: SpO2, 99.305; 65: Perf, 0.970; 65: 1min HRV, 7.228; 66: HR, 122.542; 66: RR, 25.068; 66: SpO2, 99.407; 66: Perf, 1.144; 66: 1min HRV, 9.828; 66: 5min HRV, 7.036; 67: HR, 121.397; 67: RR, 23.034; 67: SpO2, 99.621; 67: Perf, 1.108; 67: 1min HRV, 15.414; 68: HR, 121.966; 68: RR, 22.949; 68: SpO2, 99.780; 68: Perf, 0.948; 68: 1min HRV, 4.909; 69: HR, 121.517; 69: RR, 22.776; 69: SpO2, 99.017; 69: Perf, 1.183; 69: 1min HRV, 13.828; 70: HR, 122.475; 70: RR, 25.169; 70: SpO2, 99.203; 70: Perf, 1.144; 70: 1min HRV, 3.591; 71: HR, 123.259; 71: RR, 24.966; 71: SpO2, 99.810; 71: Perf, 1.064; 71: 1min HRV, 4.648; 71: 5min HRV, 10.297; 72: HR, 122.034; 72: RR, 23.254; 72: SpO2, 99.508; 72: Perf, 0.958; 72: 1min HRV, 10.127; 72: SBP, 102.0; 72: DBP, 58.0; 72: MAP, 72.667; 73: HR, 121.237; 73: RR, 24.169; 73: SpO2, 99.525; 73: Perf, 1.137; 73: 1min HRV, 4.810; 74: HR, 122.638; 74: RR, 24.983; 74: SpO2, 99.828; 74: Perf, 1.003; 74: 1min HRV, 3.128; 75: HR, 122.458; 75: RR, 24.254; 75: SpO2, 99.644; 75: Perf, 0.895; 75: 1min HRV, 8.975; 76: HR, 121.638; 76: RR, 25.379; 76: SpO2, 99.690; 76: Perf, 0.811; 76: 1min HRV, 12.485; 76: 5min HRV, 8.911; 77: HR, 122.915; 77: RR, 25.085; 77: SpO2, 99.729; 77: Perf, 0.893; 77: 1min HRV, 3.437; 78: HR, 123.034; 78: RR, 24.644; 78: SpO2, 99.915; 78: Perf, 0.860; 78: 1min HRV, 3.121; 79: HR, 122.190; 79: RR, 20.793; 79: SpO2, 99.759; 79: Perf, 0.882; 79: 1min HRV, 8.052; 80: HR, 119.610; 80: RR, 19.559; 80: SpO2, 99.322; 80: Perf, 0.682; 80: 1min HRV, 15.067; 81: HR, 119.586; 81: RR, 17.759; 81: SpO2, 98.586; 81: Perf, 0.478; 81: 1min HRV, 21.346; 81: 5min HRV, 14.003; 82: HR, 121.678; 82: RR, 23.390; 82: SpO2, 98.2; 82: Perf, 0.48; 82: 1min HRV, 7.006; 83: HR, 120.729; 83: RR, 22.237; 83: SpO2, 99.677; 83: Perf, 0.48; 83: 1min HRV, 10.215; 84: HR, 122.069; 84: RR, 25.603; 84: SpO2, 99.845; 84: Perf, 0.596; 84: 1min HRV, 2.628; 85: HR, 123.051; 85: RR, 24.407; 85: SpO2, 99.949; 85: Perf, 0.599; 85: 1min HRV, 4.199; 86: HR, 123.224; 86: RR, 24.138; 86: SpO2, 100.0; 86: Perf, 0.641; 86: 1min HRV, 6.186; 86: 5min HRV, 7.510; 87: HR, 120.254; 87: RR, 31.0; 87: SpO2, 99.939; 87: Perf, 0.620; 87: 1min HRV, 11.018; 87: SBP, 106.0; 87: DBP, 63.0; 87: MAP, 77.333; 88: HR, 118.186; 88: RR, 23.068; 88: SpO2, 99.949; 88: Perf, 0.555; 88: 1min HRV, 17.155; 89: HR, 119.828; 89: RR, 23.569; 89: SpO2, 99.789; 89: Perf, 0.579; 89: 1min HRV, 11.270; 90: HR, 118.927; 90: RR, 22.322; 90: SpO2, 99.641; 90: Perf, 0.542; 90: 1min HRV, 4.142; 91: HR, 122.190; 91: RR, 26.397; 91: Perf, 0.54; 91: 1min HRV, 5.678; 91: 5min HRV, 13.005; 92: HR, 122.339; 92: RR, 26.288; 92: 1min HRV, 12.070; 93: HR, 119.102; 93: RR, 23.966; 93: SpO2, 100.0; 93: Perf, 0.37; 93: 1min HRV, 17.897; 94: HR, 117.983; 94: RR, 25.293; 94: SpO2, 99.948; 94: Perf, 0.498; 94: 1min HRV, 11.574; 95: HR, 117.847; 95: RR, 23.915; 95: SpO2, 100.0; 95: Perf, 0.695; 95: 1min HRV, 13.356; 96: HR, 118.776; 96: RR, 22.707; 96: SpO2, 99.966; 96: Perf, 0.776; 96: 1min HRV, 3.920; 96: 5min HRV, 13.245; 97: HR, 118.102; 97: RR, 24.627; 97: SpO2, 99.102; 97: Perf, 0.695; 97: 1min HRV, 5.616; 98: HR, 120.102; 98: RR, 23.339; 98: SpO2, 98.661; 98: Perf, 0.927; 98: 1min HRV, 2.730; 99: HR, 121.190; 99: RR, 24.052; 99: SpO2, 99.759; 99: Perf, 0.931; 99: 1min HRV, 8.752; 100: HR, 121.864; 100: RR, 24.424; 100: SpO2, 100.0; 100: Perf, 1.029; 100: 1min HRV, 2.311; 101: HR, 122.828; 101: RR, 24.672; 101: SpO2, 99.655; 101: Perf, 1.052; 101: 1min HRV, 3.685; 101: 5min HRV, 8.392; 101: SBP, 105.0; 101: DBP, 61.0; 101: MAP, 75.667; 102: HR, 121.576; 102: RR, 24.915; 102: SpO2, 99.407; 102: Perf, 1.066; 102: 1min HRV, 3.417; 102: SBP, 105.0; 102: DBP, 61.0; 102: MAP, 75.667; 103: HR, 123.224; 103: RR, 24.828; 103: SpO2, 98.897; 103: Perf, 1.087; 103: 1min HRV, 2.370; 104: HR, 123.661; 104: RR, 26.085; 104: SpO2, 98.915; 104: Perf, 1.184; 104: 1min HRV, 3.678; 105: HR, 124.390; 105: RR, 25.390; 105: SpO2, 98.983; 105: Perf, 1.227; 105: 1min HRV, 2.959; 106: HR, 124.707; 106: RR, 23.983; 106: SpO2, 98.914; 106: Perf, 1.160; 106: 1min HRV, 6.864; 106: 5min HRV, 6.006; 107: SARS-COV-2 RNA, Not Detected; 107: HR, 124.390; 107: RR, 27.017; 107: SpO2, 99.034; 107: Perf, 1.212; 107: 1min HRV, 3.047; 108: HR, 124.897; 108: RR, 28.0; 108: SpO2, 99.103; 108: Perf, 1.169; 108: 1min HRV, 12.130; 109: HR, 124.339; 109: RR, 24.322; 109: SpO2, 99.288; 109: Perf, 0.893; 109: 1min HRV, 10.818; 110: HR, 124.271; 110: RR, 26.475; 110: SpO2, 98.949; 110: Perf, 0.796; 110: 1min HRV, 11.932; 111: HR, 123.069; 111: RR, 24.259; 111: SpO2, 99.845; 111: Perf, 0.678; 111: 1min HRV, 11.822; 111: 5min HRV, 10.934; 112: HR, 120.864; 112: RR, 28.068; 112: SpO2, 99.442; 112: Perf, 0.482; 112: 1min HRV, 24.982; 113: HR, 123.190; 113: RR, 27.034; 113: SpO2, 97.909; 113: Perf, 0.26; 113: 1min HRV, 8.670; 114: HR, 122.153; 114: RR, 26.780; 114: Perf, 0.26; 114: 1min HRV, 6.498; 115: HR, 123.627; 115: RR, 27.017; 115: SpO2, 98.0; 115: Perf, 0.224; 115: 1min HRV, 11.989; 116: HR, 123.948; 116: RR, 28.414; 116: 1min HRV, 4.802; 116: 5min HRV, 14.052; 117: HR, 122.932; 117: RR, 27.763; 117: 1min HRV, 4.905; 117: SBP, 110.0; 117: DBP, 58.0; 117: MAP, 75.333; 118: HR, 123.897; 118: RR, 25.638; 118: SpO2, 95.0; 118: 1min HRV, 3.633; 119: HR, 121.847; 119: RR, 32.153; 119: 1min HRV, 16.656; 0: Age, 44; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.5; 0: Triage HR, 128.0; 0: Triage RR, 18.0; 0: Triage SBP, 120.0; 0: Triage DBP, 51.0; 0: Triage acuity, 2-Emergent; 0: CC, WOUND CHECK",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, I checked whether the patient has signs of localized infection or a high-risk source, which is suggested by the \u201cWOUND CHECK.\u201d Next, I evaluated whether the patient meets SIRS criteria (such as HR > 90 and RR > 20), finding consistent tachycardia (HR > 120) and tachypnea (RR > 22). I then noted periods of borderline hypotension and low DBP. Combining these factors indicates a high likelihood of sepsis within 12 hours.",
        "claims": [
            "The patient has signs of localized infection or a high-risk source.",
            "The presence of signs of localized infection or a high-risk source is suggested by the \"WOUND CHECK.\"",
            "I evaluated whether the patient meets SIRS criteria.",
            "SIRS criteria include HR > 90 and RR > 20.",
            "The patient has consistent tachycardia with HR > 120.",
            "The patient has tachypnea with RR > 22.",
            "I noted periods of borderline hypotension.",
            "The patient has low DBP.",
            "Combining these factors indicates a high likelihood of sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The presence of signs of localized infection or a high-risk source is suggested by the \"WOUND CHECK.\"",
            "I evaluated whether the patient meets SIRS criteria.",
            "SIRS criteria include HR > 90 and RR > 20.",
            "The patient has consistent tachycardia with HR > 120.",
            "The patient has tachypnea with RR > 22.",
            "I noted periods of borderline hypotension.",
            "The patient has low DBP."
        ],
        "alignment_scores": [
            0.4,
            0.7,
            1.0,
            0.8,
            1.0,
            0.7,
            0.5
        ],
        "alignment_category": [
            9,
            2,
            2,
            2,
            3,
            7,
            6
        ],
        "alignment_reasonings": [
            "This claim implies the presence or investigation of an infection, which could lead to a clinician's suspicion of serious infection. However, without explicit mention of immediate actions like antibiotics administration or blood culture draws, it indirectly suggests the need for further assessment, thus providing a partial but not complete alignment with this category.",
            "The claim directly references the evaluation of SIRS criteria, which pertains to this category. However, it does not state whether the patient actually meets the criteria, suggesting a potential but not confirmed alignment. Therefore, there is a notable connection, but it remains indirect due to lack of detail on the outcome of the evaluation.",
            "The claim directly references specific criteria (heart rate > 90 bpm, respiratory rate > 20/min) that are explicitly listed under the SIRS criteria. This exact match indicates a perfect alignment with the category, as it fully describes the elements used to identify systemic inflammation consistent with early sepsis.",
            "Tachycardia (heart rate > 90 bpm) is a specific criterion of SIRS. The fact that the heart rate is considerably higher than 90 bpm (consistent HR > 120) suggests a strong alignment with this category, indicating systemic inflammation consistent with early sepsis. However, since SIRS requires at least two criteria to fully confirm, the alignment rating is slightly less than perfect.",
            "The claim states that the patient has tachypnea with a respiratory rate greater than 22 breaths per minute. This directly aligns with the qSOFA criterion of respiratory rate \u2265 22/min, indicating a high risk of sepsis-related organ dysfunction and mortality. Therefore, the alignment is perfect.",
            "\"Periods of borderline hypotension\" suggests the presence of low blood pressure, which aligns with sepsis-associated hypotension criteria. However, the claim does not provide specific values such as SBP <90 mmHg or MAP <70 mmHg, or a specific degree of drop, so the alignment is present but not fully confirmed.",
            "Low diastolic blood pressure (DBP) can contribute to an increased shock index, which reflects hemodynamic instability. However, the claim does not provide enough detail to directly calculate the shock index or confirm the \u22651.0 threshold. Since low DBP is a factor in the shock index related to severe sepsis risk, the alignment is moderate."
        ],
        "final_alignment_score": 0.7285714285714286,
        "accuracy": 1
    },
    {
        "input": "3: HR, 83.0; 3: RR, 22.0; 3: SpO2, 97.0; 3: SBP, 132.0; 3: DBP, 70.0; 3: MAP, 90.667; 3: Temp, 101.8; 26: ACETAMINOPHEN, 500 MG PO TABS; 58: SpO, 2: 95.778; 58: SBP, 138.0; 58: DBP, 104.0; 58: MAP, 115.333; 59: SpO2, 96.0; 60: SpO2, 96.135; 61: HR, 78.4; 61: RR, 37.636; 61: SpO2, 96.966; 61: Perf, 2.613; 61: 1min HRV, 54.137; 61: 5min HRV, 54.137; 62: HR, 80.552; 62: RR, 22.569; 62: SpO2, 96.759; 62: Perf, 2.475; 62: 1min HRV, 31.869; 63: HR, 84.203; 63: RR, 22.576; 63: SpO2, 96.288; 63: Perf, 2.57; 63: 1min HRV, 24.486; 64: HR, 86.881; 64: RR, 16.373; 64: SpO2, 95.407; 64: Perf, 2.217; 64: 1min HRV, 12.052; 65: HR, 83.121; 65: RR, 15.793; 65: SpO2, 95.552; 65: Perf, 1.664; 65: 1min HRV, 63.931; 66: HR, 81.746; 66: RR, 19.051; 66: SpO2, 96.559; 66: Perf, 2.129; 66: 1min HRV, 99.476; 66: 5min HRV, 58.807; 67: HR, 81.707; 67: RR, 25.707; 67: SpO2, 96.638; 67: Perf, 2.599; 67: 1min HRV, 47.917; 68: HR, 84.153; 68: RR, 21.271; 68: Perf, 2.62; 68: 1min HRV, 47.688; 69: HR, 83.983; 69: RR, 21.390; 69: SpO2, 95.0; 69: 1min HRV, 44.754; 70: HR, 80.034; 70: RR, 20.845; 70: SpO2, 95.0; 70: Perf, 1.500; 70: 1min HRV, 105.585; 71: HR, 78.288; 71: RR, 18.814; 71: SpO2, 94.475; 71: Perf, 1.42; 71: 1min HRV, 14.070; 71: 5min HRV, 63.502; 72: HR, 82.414; 72: RR, 22.397; 72: SpO2, 95.345; 72: Perf, 1.442; 72: 1min HRV, 15.649; 73: HR, 80.0; 73: RR, 22.983; 73: SpO2, 95.397; 73: Perf, 1.507; 73: 1min HRV, 74.428; 74: HR, 80.237; 74: RR, 22.458; 74: SpO2, 96.898; 74: Perf, 1.717; 74: 1min HRV, 58.426; 75: HR, 80.322; 75: RR, 20.932; 75: SpO2, 97.085; 75: Perf, 1.729; 75: 1min HRV, 50.628; 76: HR, 81.763; 76: RR, 23.610; 76: SpO2, 96.213; 76: Perf, 1.724; 76: 1min HRV, 64.968; 76: 5min HRV, 58.062; 77: HR, 84.811; 77: RR, 20.515; 77: SpO2, 95.467; 77: 1min HRV, 16.010; 78: SpO2, 94.261; 78: 1min HRV, 1.0; 79: SpO2, 92.0; 79: 1min HRV, 187.650; 80: HR, 75.95; 80: SpO2, 94.136; 80: 1min HRV, 104.821; 81: HR, 75.271; 81: SpO2, 98.936; 81: Perf, 2.756; 81: 1min HRV, 26.686; 81: 5min HRV, 78.357; 82: HR, 74.276; 82: SpO2, 98.707; 82: Perf, 2.544; 82: 1min HRV, 16.525; 83: HR, 71.458; 83: SpO2, 98.847; 83: Perf, 2.519; 83: 1min HRV, 28.946; 84: HR, 69.414; 84: SpO2, 99.5; 84: Perf, 2.354; 84: 1min HRV, 23.730; 85: HR, 68.025; 85: SpO2, 98.322; 85: Perf, 2.74; 85: 1min HRV, 14.451; 86: SpO2, 98.678; 86: Perf, 2.871; 86: 1min HRV, 12.582; 86: 5min HRV, 34.479; 87: SpO2, 97.793; 87: Perf, 2.800; 88: SpO2, 97.75; 88: Perf, 2.76; 89: HR, 78.973; 89: SpO2, 97.0; 89: 1min HRV, 28.399; 90: HR, 74.571; 90: SpO2, 97.591; 90: 1min HRV, 59.356; 91: HR, 74.508; 91: SpO2, 93.556; 91: 1min HRV, 30.373; 91: 5min HRV, 46.173; 92: HR, 74.293; 92: 1min HRV, 33.253; 93: HR, 74.881; 93: SpO2, 97.2; 93: 1min HRV, 77.865; 94: HR, 79.25; 94: RR, 19.0; 94: SpO2, 97.237; 94: 1min HRV, 26.789; 95: HR, 82.949; 95: RR, 24.492; 95: 1min HRV, 51.157; 96: HR, 78.288; 96: RR, 18.915; 96: SpO2, 96.062; 96: 1min HRV, 72.650; 96: 5min HRV, 65.329; 97: HR, 76.759; 97: RR, 19.587; 97: SpO2, 98.155; 97: 1min HRV, 66.829; 98: HR, 75.814; 98: RR, 21.102; 98: SpO2, 98.305; 98: Perf, 1.928; 98: 1min HRV, 37.754; 99: HR, 82.397; 99: RR, 21.052; 99: SpO2, 99.0; 99: Perf, 2.0; 99: 1min HRV, 63.652; 99: SBP, 143.0; 99: DBP, 115.0; 99: MAP, 124.333; 99: NS IV BOLUS -, 1000 ML; 100: HR:, 86.508; 100: RR, 15.407; 100: 1min HRV, 139.471; 101: HR, 87.254; 101: RR, 17.712; 101: SpO2, 100.0; 101: Perf, 3.762; 101: 1min HRV, 96.572; 101: 5min HRV, 100.532; 102: HR, 81.672; 102: RR, 20.103; 102: SpO2, 100.0; 102: Perf, 4.789; 102: 1min HRV, 123.858; 103: HR, 81.186; 103: RR, 23.678; 103: SpO2, 99.542; 103: Perf, 3.881; 103: 1min HRV, 52.570; 104: HR, 79.5; 104: RR, 19.879; 104: SpO2, 97.5; 104: Perf, 1.252; 104: 1min HRV, 53.142; 105: HR, 78.542; 105: RR, 20.729; 105: SpO2, 97.525; 105: Perf, 1.479; 105: 1min HRV, 22.765; 106: SARS-COV-2 RNA, Detected; 106: INFLUENZA A, Not Detected; 106: RSV, Not Detected; 106: INFLUENZA A, Not Detected; 106: INFLUENZA B, Not Detected; 106: SARS-COV-2 RNA, Detected; 106: INFLUENZA B, Not Detected; 106: RSV, Not Detected; 106: HR, 79.830; 106: RR, 13.413; 106: SpO2, 98.328; 106: Perf, 2.225; 106: 1min HRV, 44.293; 106: 5min HRV, 71.117; 107: HR, 75.844; 107: RR, 21.462; 107: SpO2, 98.525; 107: Perf, 2.288; 107: 1min HRV, 83.852; 108: HR, 74.729; 108: RR, 19.932; 108: SpO2, 98.932; 108: Perf, 3.335; 108: 1min HRV, 28.074; 109: HR, 77.534; 109: RR, 25.509; 109: SpO2, 99.138; 109: Perf, 5.675; 109: 1min HRV, 62.654; 110: HR, 75.316; 110: SpO2, 98.438; 110: Perf, 5.76; 110: 1min HRV, 170.130; 111: HR, 72.448; 111: Perf, 5.76; 111: 1min HRV, 100.507; 111: 5min HRV, 94.140; 112: HR, 68.186; 112: SpO2, 96.0; 112: Perf, 5.714; 112: 1min HRV, 25.196; 113: HR, 71.562; 113: SpO2, 94.286; 113: Perf, 5.58; 113: 1min HRV, 132.946; 114: HR, 71.25; 114: Perf, 5.58; 114: 1min HRV, 148.337; 115: HR, 73.971; 115: 1min HRV, 142.429; 116: SpO2, 100.0; 116: 5min HRV, 102.586; 117: SpO2, 22.583; 118: SpO2, 100.0; 119: SpO2, 98.558; 0: Age, 66; 0: Gender, F; 0: Race, Black or African American; 0: Means of arrival, Self; 0: Triage Temp, 38.8; 0: Triage HR, 83.0; 0: Triage RR, 22.0; 0: Triage SBP, 132.0; 0: Triage DBP, 70.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER,COUGH,SHORTNESS OF BREATH",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I checked whether the patient\u2019s vital signs and labs suggested shock or organ dysfunction (e.g., persistent hypotension or significantly decreased oxygen saturation), and they did not. Next, I evaluated whether more subtle indicators\u2014like elevated respiratory rate or spiking fever\u2014placed them in immediate danger, but their blood pressure and heart rate remained largely stable. Finally, noting that although the patient has a documented infection (COVID-19) and transiently elevated RR, the overall data do not strongly indicate imminent septic deterioration.",
        "claims": [
            "The patient's vital signs and labs were checked to see if they suggested shock or organ dysfunction.",
            "The patient's vital signs and labs did not suggest shock or organ dysfunction.",
            "More subtle indicators, like elevated respiratory rate or spiking fever, were evaluated.",
            "The patient's blood pressure remained largely stable.",
            "The patient's heart rate remained largely stable.",
            "The patient has a documented infection (COVID-19).",
            "The patient has a transiently elevated respiratory rate (RR).",
            "The overall data do not strongly indicate imminent septic deterioration."
        ],
        "relevant_claims": [
            "The patient's vital signs and labs were checked to see if they suggested shock or organ dysfunction.",
            "More subtle indicators, like elevated respiratory rate or spiking fever, were evaluated.",
            "The patient has a documented infection (COVID-19).",
            "The patient has a transiently elevated respiratory rate (RR)."
        ],
        "alignment_scores": [
            0.7,
            0.8,
            0.5,
            0.7
        ],
        "alignment_category": [
            8,
            2,
            9,
            2
        ],
        "alignment_reasonings": [
            "The claim involves checking vital signs and labs for shock or organ dysfunction, which is aligned with the purpose of the SOFA score\u2014identifying new organ dysfunction. While the claim does not pinpoint a specific change in SOFA score components, it suggests an assessment consistent with evaluating changes related to organ dysfunction and potential sepsis risk. Hence, there is a moderate alignment.",
            "The claim mentions \"elevated respiratory rate\" and \"spiking fever,\" both of which are directly related to the SIRS criteria (temperature\u202f>\u202f38\u202f\u00b0C for fever and respiratory\u202frate\u202f>\u202f20\u202f/min for elevated respiratory rate). These indicators are used to identify systemic inflammation and early sepsis, thus strongly aligning with this category. The only reason the alignment is not a full 1.0 is that the claim does not entirely confirm the presence of these indicators exceeding the specified thresholds, but both elements suggest the relevance of SIRS.",
            "The claim mentions a documented infection (COVID-19), which implies suspicion of a serious infection that could elevate sepsis risk. However, the claim does not describe specific clinical actions (e.g., early antibiotic administration or blood cultures) that are directly addressed by this category. Despite the lack of concrete action, awareness of a documented infection like COVID-19 suggests the need for further investigation, aligning moderately with this category.",
            "The claim mentions an elevated respiratory rate, which is one of the SIRS criteria (RR > 20/min). Although the term \"transiently\" suggests it may not be sustained, this still closely aligns with the systemic inflammatory response criteria relevant in early sepsis detection. Therefore, it merits a fairly high alignment rating."
        ],
        "final_alignment_score": 0.675,
        "accuracy": 1
    },
    {
        "input": "2: HR, 135.0; 2: RR, 18.0; 2: SpO2, 100.0; 2: SBP, 148.0; 2: DBP, 93.0; 2: MAP, 111.333; 2: Temp, 97.5; 12: Pain, 0.0; 51: HR, 128.0; 51: 1min HRV, 19.943; 52: HR, 128.946; 52: RR, 22.490; 52: SpO2, 99.0; 52: 1min HRV, 4.637; 52: 5min HRV, 5.984; 52: SBP, 168.0; 52: DBP, 90.0; 52: MAP, 116.0; 53: HR, 128.136; 53: RR, 22.153; 53: SpO2, 98.746; 53: Perf, 0.575; 53: 1min HRV, 7.372; 54: HR, 127.397; 54: RR, 21.259; 54: SpO2, 98.810; 54: Perf, 0.537; 54: 1min HRV, 7.201; 55: HR, 128.407; 55: RR, 26.441; 55: SpO2, 98.153; 55: Perf, 0.493; 55: 1min HRV, 7.224; 56: HR, 126.897; 56: RR, 22.017; 56: SpO2, 98.793; 56: Perf, 0.455; 56: 1min HRV, 3.731; 57: HR, 126.379; 57: RR, 19.310; 57: SpO2, 98.552; 57: Perf, 0.399; 57: 1min HRV, 4.321; 57: 5min HRV, 6.676; 58: HR, 127.407; 58: RR, 19.593; 58: SpO2, 98.712; 58: Perf, 0.374; 58: 1min HRV, 3.207; 59: HR, 127.5; 59: RR, 19.966; 59: SpO2, 99.0; 59: Perf, 0.362; 59: 1min HRV, 3.383; 59: SBP, 168.0; 59: DBP, 93.0; 59: MAP, 118.0; 60: HR, 128.0; 60: RR, 23.085; 60: SpO2, 98.966; 60: Perf, 0.370; 60: 1min HRV, 4.359; 61: HR, 126.190; 61: RR, 22.966; 61: SpO2, 98.966; 61: Perf, 0.390; 61: 1min HRV, 5.101; 62: HR, 126.475; 62: RR, 26.017; 62: SpO2, 99.0; 62: Perf, 0.407; 62: 1min HRV, 3.753; 62: 5min HRV, 4.820; 63: HR, 125.746; 63: RR, 24.881; 63: SpO2, 98.898; 63: Perf, 0.429; 63: 1min HRV, 6.197; 64: HR, 125.828; 64: RR, 19.931; 64: SpO2, 99.0; 64: Perf, 0.400; 64: 1min HRV, 5.279; 64: LR IV BOLUS -, 1000 ML; 65: HR:, 125.915; 65: RR, 20.831; 65: SpO2, 99.0; 65: Perf, 0.416; 65: 1min HRV, 4.462; 66: HR, 126.569; 66: RR, 21.259; 66: SpO2, 99.0; 66: Perf, 0.439; 66: 1min HRV, 4.439; 67: HR, 126.155; 67: RR, 17.017; 67: SpO2, 99.0; 67: Perf, 0.456; 67: 1min HRV, 7.104; 67: 5min HRV, 5.712; 68: HR, 125.102; 68: RR, 16.831; 68: SpO2, 99.0; 68: Perf, 0.495; 68: 1min HRV, 7.596; 69: HR, 127.259; 69: RR, 23.638; 69: SpO2, 99.0; 69: Perf, 0.476; 69: 1min HRV, 5.688; 69: FAMOTIDINE (PF), 20 MG/2 ML IV SOLN; 70: HR:, 125.949; 70: RR, 22.576; 70: SpO2, 99.0; 70: Perf, 0.472; 70: 1min HRV, 4.833; 70: SBP, 168.0; 70: DBP, 93.0; 70: MAP, 118.0; 71: HR, 124.931; 71: RR, 20.845; 71: SpO2, 99.0; 71: Perf, 0.459; 71: 1min HRV, 6.740; 72: HR, 125.729; 72: RR, 18.881; 72: SpO2, 99.0; 72: Perf, 0.45; 72: 1min HRV, 4.659; 72: 5min HRV, 6.808; 72: SBP, 160.0; 72: DBP, 93.0; 72: MAP, 115.333; 73: INFLUENZA A, Not Detected; 73: INFLUENZA B, Not Detected; 73: RSV, Not Detected; 73: SARS-COV-2 RNA, Not Detected; 73: HR, 125.322; 73: RR, 16.864; 73: SpO2, 99.0; 73: Perf, 0.458; 73: 1min HRV, 6.378; 73: SBP, 160.0; 73: DBP, 93.0; 73: MAP, 115.333; 74: HR, 124.397; 74: RR, 18.431; 74: SpO2, 99.172; 74: Perf, 0.450; 74: 1min HRV, 8.981; 75: HR, 124.203; 75: RR, 17.186; 75: SpO2, 99.305; 75: Perf, 0.461; 75: 1min HRV, 7.082; 76: HR, 126.224; 76: RR, 18.759; 76: SpO2, 98.879; 76: Perf, 0.458; 76: 1min HRV, 7.494; 77: HR, 123.228; 77: RR, 18.439; 77: SpO2, 99.386; 77: Perf, 0.438; 77: 1min HRV, 5.823; 77: 5min HRV, 7.821; 78: HR, 124.55; 78: RR, 18.867; 78: SpO2, 99.133; 78: Perf, 0.445; 78: 1min HRV, 7.017; 79: HR, 122.614; 79: RR, 17.561; 79: SpO2, 99.0; 79: Perf, 0.436; 79: 1min HRV, 8.683; 80: HR, 125.017; 80: RR, 19.133; 80: SpO2, 99.05; 80: Perf, 0.435; 80: 1min HRV, 15.972; 81: HR, 125.690; 81: RR, 19.207; 81: SpO2, 99.310; 81: Perf, 0.393; 81: 1min HRV, 11.273; 82: HR, 124.475; 82: RR, 18.017; 82: SpO2, 99.576; 82: Perf, 0.411; 82: 1min HRV, 9.940; 82: 5min HRV, 11.653; 83: HR, 124.458; 83: RR, 20.898; 83: SpO2, 99.390; 83: Perf, 0.430; 83: 1min HRV, 6.755; 84: HR, 124.053; 84: RR, 20.544; 84: SpO2, 99.0; 84: Perf, 0.41; 84: 1min HRV, 12.448; 85: HR, 123.85; 85: RR, 21.683; 85: SpO2, 99.317; 85: Perf, 0.401; 85: 1min HRV, 9.913; 86: HR, 126.456; 86: RR, 22.053; 86: SpO2, 99.123; 86: Perf, 0.385; 86: 1min HRV, 7.107; 87: HR, 117.224; 87: RR, 25.190; 87: SpO2, 98.397; 87: Perf, 0.39; 87: 1min HRV, 72.391; 87: 5min HRV, 33.854; 88: HR, 132.881; 88: RR, 22.322; 88: SpO2, 99.3; 88: Perf, 0.401; 88: 1min HRV, 64.352; 89: WAM DIFTYP, AUTO; 89: EOSINOPHIL % (AUTO DIFF), 0.1 %; 89: HEMATOCRIT (HCT), 49.6 %; 89: BASOPHIL % (AUTO DIFF), 0.7 %; 89: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.24 K/uL; 89: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 89: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.5 g/dL; 89: RED CELL DISTRIBUTION WIDTH (RDW), 13.2 %; 89: NEUTROPHIL % (AUTO DIFF), 81.2 %; 89: NEUTROPHIL ABSOLUTE (AUTO DIFF), 14.28 K/uL; 89: RED BLOOD CELLS (RBC), 4.73 MIL/uL; 89: NRBC PERCENT (HEMATOLOGY), 0.0 %; 89: HEMOGLOBIN (HGB), 15.6 g/dL; 89: BASOPHIL ABSOLUTE (AUTO DIFF), 0.12 K/uL; 89: MONOCYTE % (AUTO DIFF), 7.8 %; 89: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.55 K/uL; 89: MONOCYTE ABSOLUTE (AUTO DIFF), 1.38 K/uL; 89: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.4 %; 89: MEAN CORPUSCULAR VOLUME (MCV), 104.9 fL; 89: LYMPHOCYTE % (AUTO DIFF), 8.8 %; 89: WHITE BLOOD CELLS (WBC), 17.6 K/uL; 89: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 33.0 pg; 89: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 89: PLATELET COUNT (PLT), 291 K/uL; 89: HR, 137.879; 89: RR, 22.241; 89: SpO2, 99.224; 89: Perf, 0.513; 89: 1min HRV, 13.514; 90: HR, 133.712; 90: RR, 24.831; 90: SpO2, 99.0; 90: Perf, 0.515; 90: 1min HRV, 17.901; 91: HR, 129.291; 91: RR, 27.667; 91: SpO2, 99.0; 91: Perf, 0.474; 91: 1min HRV, 9.513; 92: 5min HRV, 36.740; 107: LORAZEPAM, 2 MG/ML INJ SOLN; 0: Age:, 58; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 36.4; 0: Triage HR, 135.0; 0: Triage RR, 18.0; 0: Triage SBP, 148.0; 0: Triage DBP, 93.0; 0: Triage acuity, 3-Urgent; 0: CC, SHORTNESS OF BREATH",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, I checked whether the patient is tachycardic by comparing the heart rate (consistently above 120 bpm) to normal values; it is. Next, I reviewed lab results, noticing a high white blood cell count (17.6 K/uL), which suggests a possible infection. Then, I confirmed that meeting two SIRS criteria (elevated HR and WBC) could indicate a risk of sepsis, especially with the clinical presentation (shortness of breath). Based on these observations, the patient is at high risk of developing sepsis within 12 hours.",
        "claims": [
            "The heart rate is consistently above 120 bpm.",
            "The patient is tachycardic.",
            "The lab results show a high white blood cell count of 17.6 K/uL.",
            "A high white blood cell count suggests a possible infection.",
            "The patient meets two SIRS criteria: elevated heart rate and high white blood cell count.",
            "Meeting two SIRS criteria could indicate a risk of sepsis.",
            "The patient's clinical presentation includes shortness of breath.",
            "Based on these observations, the patient is at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The heart rate is consistently above 120 bpm.",
            "The patient is tachycardic.",
            "The lab results show a high white blood cell count of 17.6 K/uL.",
            "A high white blood cell count suggests a possible infection.",
            "The patient meets two SIRS criteria: elevated heart rate and high white blood cell count.",
            "Meeting two SIRS criteria could indicate a risk of sepsis.",
            "The patient's clinical presentation includes shortness of breath.",
            "Based on these observations, the patient is at high risk of developing sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.7,
            0.8,
            1.0,
            1.0,
            1.0,
            1.0,
            0.5,
            0.4
        ],
        "alignment_category": [
            2,
            2,
            2,
            2,
            2,
            2,
            3,
            4
        ],
        "alignment_reasonings": [
            "The SIRS criteria include a heart rate >90 bpm as one of the indicators for systemic inflammation consistent with early sepsis. A heart rate consistently above 120 bpm far exceeds this threshold, making it relevant to this category. Nonetheless, since only one SIRS criterion is provided and the criteria require two or more for strong alignment, it doesn't fully meet the definition, resulting in a partial alignment.",
            "Tachycardia (heart rate > 90 bpm) is one of the specific criteria mentioned under the SIRS category used to identify systemic inflammation consistent with early sepsis. The alignment rating is high because tachycardia is directly listed as a SIRS criterion, but the final SIRS positivity requires meeting at least two criteria, so it is not a perfect alignment by itself.",
            "The claim indicates an elevated white blood cell count, which is directly listed under the SIRS criteria. Specifically, a WBC count >12,000/\u00b5L is one of the parameters for identifying systemic inflammation consistent with early sepsis. Therefore, the alignment is perfect.",
            "The claim explicitly mentions a high white blood cell count, which is directly listed under the SIRS criteria for identifying systemic inflammation consistent with early sepsis. This represents a perfect alignment with the SIRS Positivity category.",
            "The claim explicitly states that the patient meets two SIRS criteria",
            "The claim directly refers to meeting two SIRS criteria, which the category identifies as indicative of systemic inflammation consistent with early sepsis. This matches perfectly with the specified category, leading to a high alignment rating.",
            "Shortness of breath is not explicitly quantified in the criteria but can relate to the qSOFA's respiratory rate criterion (\u226522 breaths/min), suggesting potential respiratory distress. While it doesn't directly specify the respiratory rate, shortness of breath conceptually aligns with elements of the qSOFA that indicate high risk of sepsis-related complications. The alignment is moderate as it implies, rather than confirms, a qSOFA criterion.",
            "The claim is general and discusses high risk without specific observations or data points. Elevated NEWS scores usually incorporate multiple vital signs that predict clinical deterioration, aligning somewhat with an overall \"high risk\" prediction. However, the claim lacks specifics (e.g., scores, specific criteria), resulting in only a moderate alignment."
        ],
        "final_alignment_score": 0.8,
        "accuracy": 1
    },
    {
        "input": "6: HR, 107.0; 6: RR, 22.0; 6: SpO2, 98.0; 6: SBP, 150.0; 6: DBP, 92.0; 6: MAP, 111.333; 6: Temp, 98.1; 8: Pain, 6.0; 35: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 39: NS IV BOLUS -, 1000 ML; 40: SBP, 146.0; 40: DBP, 103.0; 40: MAP, 117.333; 43: SBP, 145.0; 43: DBP, 100.0; 43: MAP, 115.0; 44: SpO2, 99.0; 45: SpO2, 98.471; 46: SpO2, 98.593; 46: Perf, 5.352; 47: SpO2, 98.780; 47: Perf, 5.709; 48: SpO2, 98.632; 48: Perf, 5.135; 49: WAM DIFTYP, AUTO; 49: WHITE BLOOD CELLS (WBC), 13.3 K/uL; 49: NRBC PERCENT (HEMATOLOGY), 0.0 %; 49: PLATELET COUNT (PLT), 394 K/uL; 49: HEMOGLOBIN (HGB), 14.0 g/dL; 49: BASOPHIL % (AUTO DIFF), 0.2 %; 49: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.06 K/uL; 49: HEMATOCRIT (HCT), 44.5 %; 49: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.22 K/uL; 49: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.5 %; 49: LYMPHOCYTE % (AUTO DIFF), 14.6 %; 49: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 49: RED CELL DISTRIBUTION WIDTH (RDW), 17.6 %; 49: MONOCYTE % (AUTO DIFF), 9.4 %; 49: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.5 g/dL; 49: MONOCYTE ABSOLUTE (AUTO DIFF), 1.25 K/uL; 49: NEUTROPHIL % (AUTO DIFF), 73.6 %; 49: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 20.9 pg; 49: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 49: MEAN CORPUSCULAR VOLUME (MCV), 66.4 fL; 49: RED BLOOD CELLS (RBC), 6.70 MIL/uL; 49: NEUTROPHIL ABSOLUTE (AUTO DIFF), 9.80 K/uL; 49: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.94 K/uL; 49: EOSINOPHIL % (AUTO DIFF), 1.7 %; 49: SpO2, 98.814; 49: Perf, 5.578; 50: SpO2, 98.621; 50: Perf, 2.859; 51: SpO2, 98.0; 51: Perf, 3.014; 52: SpO2, 98.864; 52: Perf, 2.384; 53: SpO2, 98.259; 53: Perf, 4.219; 54: SpO2, 98.407; 54: Perf, 4.476; 55: SpO2, 99.017; 55: Perf, 3.234; 56: SpO2, 99.153; 56: Perf, 3.459; 57: SpO2, 99.169; 57: Perf, 4.327; 58: SpO2, 98.554; 58: Perf, 3.131; 58: SBP, 146.0; 58: DBP, 90.0; 58: MAP, 108.667; 59: SpO2, 98.948; 59: Perf, 3.605; 60: SpO2, 98.544; 60: Perf, 4.458; 61: SpO2, 98.508; 61: Perf, 4.895; 62: SpO2, 98.483; 62: Perf, 4.893; 63: SpO2, 98.810; 63: Perf, 3.064; 64: SpO2, 98.831; 64: Perf, 4.203; 65: SpO2, 98.759; 65: Perf, 5.463; 66: SpO2, 99.0; 66: Perf, 6.117; 67: INR, 1.0; 67: PROTHROMBIN TIME, 13.2 seconds; 67: PART. THROMBOPLASTIN TIME, 29.8 seconds; 67: SpO2, 98.458; 67: Perf, 7.107; 68: SARS-COV-2 RNA, Not Detected; 68: INFLUENZA B, Not Detected; 68: INFLUENZA A, Not Detected; 68: SpO2, 98.655; 68: Perf, 4.515; 69: SpO2, 99.102; 69: Perf, 5.877; 70: SpO2, 99.088; 70: Perf, 5.058; 71: SpO2, 98.661; 71: Perf, 5.588; 72: SpO2, 98.897; 72: Perf, 5.861; 73: SpO2, 99.324; 73: Perf, 6.02; 74: SpO2, 98.672; 74: Perf, 5.988; 75: SpO2, 98.322; 75: Perf, 5.623; 76: SpO2, 98.305; 76: Perf, 4.111; 77: SpO2, 98.155; 77: Perf, 2.146; 78: SpO2, 97.983; 78: Perf, 2.190; 79: SpO2, 98.203; 79: Perf, 2.648; 80: EGFR FOR AFRICAN AMERICAN, 156 mL/min/1.73 m2; 80: ALBUMIN, 4.7 g/dL; 80: BLOOD UREA NITROGEN (BUN), 10 mg/dL; 80: CALCIUM, 9.8 mg/dL; 80: EGFR REFIT WITHOUT RACE (2021), 135 mL/min/1.73 m2; 80: AST (SGOT), 37 U/L; 80: ALKALINE PHOSPHATASE, 50 U/L; 80: ANION GAP, 13 mmol/L; 80: SODIUM, 138 mmol/L; 80: LIPASE, 33 U/L; 80: ALT (SGPT), 76 U/L; 80: GLOBULIN, 3.2 g/dL; 80: GLUCOSE, 140 mg/dL; 80: CREATININE, 0.61 mg/dL; 80: CHLORIDE, 101 mmol/L; 80: CORRECTED CALCIUM, 9.2 mg/dL; 80: POTASSIUM, 3.8 mmol/L; 80: CO2, 24 mmol/L; 80: BILIRUBIN TOTAL, 0.6 mg/dL; 80: PROTEIN TOTAL, 7.9 g/dL; 80: SpO2, 98.397; 80: Perf, 1.753; 81: SpO2, 98.5; 81: Perf, 1.938; 82: SpO2, 97.862; 82: Perf, 4.743; 83: SpO2, 98.356; 83: Perf, 3.823; 84: SpO2, 99.0; 84: Perf, 4.239; 85: SpO2, 98.879; 85: Perf, 3.032; 86: SpO2, 99.086; 86: Perf, 2.513; 87: SpO2, 99.458; 87: Perf, 2.665; 88: SpO2, 99.746; 88: Perf, 1.855; 89: SpO2, 99.525; 89: Perf, 2.494; 90: SpO2, 98.966; 90: Perf, 3.134; 91: SpO2, 98.763; 91: Perf, 2.510; 92: SpO2, 99.246; 92: Perf, 1.828; 93: SpO2, 99.534; 93: Perf, 1.934; 94: SpO2, 99.1; 94: Perf, 1.72; 95: SpO2, 97.860; 95: Perf, 1.700; 96: SpO2, 99.322; 96: Perf, 1.862; 97: POC GLUCOSE BY METER, 143 mg/dL; 97: SpO2, 99.379; 97: Perf, 2.176; 98: SpO2, 98.948; 98: Perf, 1.813; 99: SpO2, 99.695; 99: Perf, 2.000; 100: POC PH (V) ISTAT, 7.41; 100: POC HCO3 (V) ISTAT, 26.2 mmol/L; 100: POC BASE EXCESS ISTAT, 2 mmol/L; 100: POC PO2 (V) ISTAT, 28 mmHg; 100: POC LACTATE ISTAT, 1.44 mmol/L; 100: POC O2 SATURATION ISTAT VENOUS, 53 %; 100: POC PCO2 (V) ISTAT, 41.5 mmHg; 100: POC TCO2 (V) ISTAT, 27 mmol/L; 100: SpO2, 99.407; 100: Perf, 2.821; 101: SpO2, 99.186; 101: Perf, 2.667; 102: SpO2, 98.860; 102: Perf, 2.243; 103: SpO2, 98.729; 103: Perf, 3.206; 104: SpO2, 98.345; 104: Perf, 3.29; 105: SpO2, 98.695; 105: Perf, 3.340; 106: SpO2, 98.203; 106: Perf, 3.875; 107: SpO2, 98.368; 107: Perf, 4.513; 108: SpO2, 98.678; 108: Perf, 4.579; 109: SpO2, 98.103; 109: Perf, 4.212; 110: SpO2, 98.707; 110: Perf, 2.987; 111: SpO2, 99.153; 111: Perf, 2.532; 112: SpO2, 98.5; 112: Perf, 2.301; 113: SpO2, 98.0; 113: Perf, 1.517; 114: SpO2, 98.0; 114: Perf, 1.459; 115: SpO2, 98.475; 115: Perf, 1.668; 116: SpO2, 98.729; 116: Perf, 2.262; 117: SpO2, 98.431; 117: Perf, 2.479; 118: SpO2, 98.797; 118: Perf, 2.42; 119: SpO2, 98.621; 119: Perf, 2.42; 0: Age, 31; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 107.0; 0: Triage RR, 22.0; 0: Triage SBP, 150.0; 0: Triage DBP, 92.0; 0: Triage acuity, 2-Emergent; 0: CC, BLOOD IN VOMIT",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I confirmed the presence of any abnormal vital signs at ED arrival, noting mild tachycardia (HR 107) and slightly elevated respiratory rate (RR 22) but normal temperature and blood pressure. Next, I checked the lab results, such as WBC count (13.3 K/uL), which is only mildly elevated, and lactate level (1.44 mmol/L), which is within normal limits. Finally, I assessed for clinical indicators of organ dysfunction or severe infection (e.g., hypotension, significant acidosis), but none were evident. Therefore, the overall risk of sepsis within 12 hours appears low.",
        "claims": [
            "There were abnormal vital signs present at ED arrival.",
            "Mild tachycardia was noted, with a heart rate of 107.",
            "The respiratory rate was slightly elevated at 22.",
            "The temperature was normal at ED arrival.",
            "The blood pressure was normal at ED arrival.",
            "The WBC count was 13.3 K/uL, which is only mildly elevated.",
            "The lactate level was 1.44 mmol/L, which is within normal limits.",
            "Clinical indicators of organ dysfunction or severe infection were assessed.",
            "No signs of hypotension were evident.",
            "No significant acidosis was evident.",
            "The overall risk of developing sepsis within 12 hours appears low."
        ],
        "relevant_claims": [
            "There were abnormal vital signs present at ED arrival.",
            "Mild tachycardia was noted, with a heart rate of 107.",
            "The respiratory rate was slightly elevated at 22."
        ],
        "alignment_scores": [
            0.7,
            0.8,
            0.8
        ],
        "alignment_category": [
            4,
            2,
            3
        ],
        "alignment_reasonings": [
            "The claim of abnormal vital signs at ED arrival suggests potential clinical deterioration that aligns with assessing NEWS, which uses vital sign abnormalities to predict deterioration, including sepsis risk. However, the claim does not specify the number or severity of abnormalities, limiting alignment strength.",
            "The claim mentions mild tachycardia with a heart rate of 107 bpm, which surpasses the threshold for one of the SIRS criteria (heart rate\u202f>\u202f90\u202fbpm). This aligns well with the SIRS criteria as it identifies a sign of systemic inflammation consistent with early sepsis. However, since it only addresses one aspect of the SIRS without the presence of additional criteria, the alignment is strong but not perfect.",
            "The claim mentions a respiratory rate of 22, which aligns directly with the qSOFA criterion of respiratory rate \u2265 22/min. This suggests a significant risk factor for sepsis-related complications. While it matches precisely one element of the qSOFA criteria, a qSOFA score of \u22652 is needed to indicate a high risk of sepsis. Therefore, the alignment is strong but not perfect."
        ],
        "final_alignment_score": 0.7666666666666666,
        "accuracy": 1
    },
    {
        "input": "3: HR, 95.0; 3: RR, 18.0; 3: SpO2, 98.0; 3: SBP, 144.0; 3: DBP, 71.0; 3: MAP, 95.333; 3: Temp, 99.7; 5: Pain, 0.0; 28: SpO2, 98.576; 28: SBP, 123.0; 28: DBP, 80.0; 28: MAP, 94.333; 29: SpO2, 98.763; 29: Perf, 8.052; 30: SpO2, 98.534; 30: Perf, 7.895; 31: SpO2, 99.0; 31: Perf, 6.956; 32: SpO2, 99.0; 32: Perf, 6.084; 33: SpO2, 98.897; 33: Perf, 6.188; 33: SBP, 123.0; 33: DBP, 78.0; 33: MAP, 93.0; 34: SpO2, 99.0; 34: Perf, 5.995; 35: SpO2, 99.103; 35: Perf, 4.756; 36: SpO2, 99.017; 36: Perf, 4.286; 37: SpO2, 99.034; 37: Perf, 4.279; 38: SpO2, 98.864; 38: Perf, 4.909; 39: SpO2, 99.136; 39: Perf, 3.534; 40: SpO2, 98.776; 40: Perf, 3.986; 41: SpO2, 98.712; 41: Perf, 7.136; 42: SpO2, 99.0; 42: Perf, 8.326; 43: SpO2, 98.741; 43: Perf, 7.809; 44: SpO2, 98.695; 44: Perf, 8.455; 45: SpO2, 98.983; 45: Perf, 7.046; 46: SpO2, 98.593; 46: Perf, 7.803; 47: SpO2, 98.586; 47: Perf, 7.997; 48: SpO2, 98.729; 48: Perf, 8.226; 49: SpO2, 99.220; 49: Perf, 6.527; 50: SpO2, 98.966; 50: Perf, 5.83; 51: SpO2, 99.0; 51: Perf, 6.004; 52: SpO2, 99.0; 52: Perf, 4.165; 53: SpO2, 99.0; 53: Perf, 2.851; 54: SpO2, 98.966; 54: Perf, 3.823; 55: POC PH (V) ISTAT, 7.41; 55: POC BASE EXCESS ISTAT, 0 mmol/L; 55: POC TCO2 (V) ISTAT, 26 mmol/L; 55: POC PCO2 (V) ISTAT, 39.4 mmHg; 55: POC O2 SATURATION ISTAT VENOUS, 96 %; 55: POC PO2 (V) ISTAT, 79 mmHg; 55: POC LACTATE ISTAT, 0.68 mmol/L; 55: POC HCO3 (V) ISTAT, 24.9 mmol/L; 55: SpO2, 98.828; 55: Perf, 5.279; 56: SpO2, 99.034; 56: Perf, 6.270; 57: SpO2, 99.288; 57: Perf, 5.352; 58: SpO2, 99.0; 58: Perf, 6.585; 59: SpO2, 98.915; 59: Perf, 6.762; 60: INFLUENZA B, Not Detected; 60: RSV, Not Detected; 60: INFLUENZA A, Not Detected; 60: SARS-COV-2 RNA, Not Detected; 60: SpO2, 99.0; 60: Perf, 7.976; 61: SpO2, 98.898; 61: Perf, 7.899; 62: HR, 88.0; 62: SpO2, 98.898; 62: Perf, 6.503; 62: SBP, 118.0; 62: DBP, 76.0; 62: MAP, 90.0; 63: SpO2, 99.193; 63: Perf, 4.902; 63: SBP, 118.0; 63: DBP, 76.0; 63: MAP, 90.0; 64: SpO2, 99.0; 64: Perf, 5.622; 65: WAM DIFTYP, AUTO; 65: MONOCYTE ABSOLUTE (AUTO DIFF), 0.80 K/uL; 65: MEAN CORPUSCULAR VOLUME (MCV), 101.6 fL; 65: PLATELET COUNT (PLT), 264 K/uL; 65: MONOCYTE % (AUTO DIFF), 8.8 %; 65: WHITE BLOOD CELLS (WBC), 9.1 K/uL; 65: RED BLOOD CELLS (RBC), 3.12 MIL/uL; 65: NRBC ABSOLUTE (HEMATOLOGY), 0.02 K/uL; 65: BASOPHIL % (AUTO DIFF), 0.3 %; 65: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.48 K/uL; 65: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.12 K/uL; 65: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.4 g/dL; 65: LYMPHOCYTE % (AUTO DIFF), 16.4 %; 65: NEUTROPHIL ABSOLUTE (AUTO DIFF), 6.54 K/uL; 65: RED CELL DISTRIBUTION WIDTH (RDW), 11.9 %; 65: HEMATOCRIT (HCT), 31.7 %; 65: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 34.0 pg; 65: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 65: EOSINOPHIL % (AUTO DIFF), 0.9 %; 65: HEMOGLOBIN (HGB), 10.6 g/dL; 65: NRBC PERCENT (HEMATOLOGY), 0.2 %; 65: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.3 %; 65: NEUTROPHIL % (AUTO DIFF), 72.3 %; 65: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.08 K/uL; 65: SpO2, 99.0; 65: Perf, 6.659; 66: SpO2, 99.0; 66: Perf, 6.964; 67: SpO2, 98.695; 67: Perf, 6.546; 68: SpO2, 99.052; 68: Perf, 5.081; 69: SpO2, 99.034; 69: Perf, 5.156; 70: SpO2, 98.690; 70: Perf, 3.570; 71: SpO2, 98.034; 71: Perf, 1.72; 72: SpO2, 97.638; 72: Perf, 1.801; 73: SpO2, 98.424; 73: Perf, 2.185; 74: SpO2, 98.966; 74: Perf, 3.629; 75: SpO2, 98.810; 75: Perf, 3.656; 76: SpO2, 98.186; 76: Perf, 3.903; 77: SpO2, 99.052; 77: Perf, 6.108; 78: SpO2, 99.068; 78: Perf, 6.196; 79: SpO2, 98.424; 79: Perf, 6.029; 80: SpO2, 98.190; 80: Perf, 5.042; 81: SpO2, 98.35; 81: Perf, 5.184; 82: SpO2, 98.845; 82: Perf, 6.514; 83: SpO2, 98.797; 83: Perf, 6.342; 84: SpO2, 96.0; 84: Perf, 6.15; 89: ANION GAP, 12 mmol/L; 89: CORRECTED CALCIUM, 9.0 mg/dL; 89: GLUCOSE, 105 mg/dL; 89: POTASSIUM, 4.0 mmol/L; 89: BLOOD UREA NITROGEN (BUN), 13 mg/dL; 89: GLOBULIN, 2.9 g/dL; 89: ALKALINE PHOSPHATASE, 145 U/L; 89: ALBUMIN, 4.0 g/dL; 89: PROTEIN TOTAL, 6.9 g/dL; 89: SODIUM, 139 mmol/L; 89: AST (SGOT), 30 U/L; 89: ALT (SGPT), 55 U/L; 89: CALCIUM, 9.0 mg/dL; 89: CREATININE, 0.60 mg/dL; 89: BILIRUBIN TOTAL, 0.2 mg/dL; 89: EGFR REFIT WITHOUT RACE (2021), 123 mL/min/1.73 m2; 89: CHLORIDE, 105 mmol/L; 89: CO2, 22 mmol/L; 100: SpO2, 98.448; 100: SBP, 113.0; 100: DBP, 78.0; 100: MAP, 89.667; 101: SpO2, 98.254; 101: Perf, 5.693; 102: SpO2, 98.690; 102: Perf, 5.617; 103: SpO2, 98.780; 103: Perf, 4.489; 104: SpO2, 98.776; 104: Perf, 4.781; 105: SpO2, 98.915; 105: Perf, 5.713; 106: SpO2, 98.898; 106: Perf, 6.084; 107: SpO2, 98.931; 107: Perf, 6.246; 108: SpO2, 98.621; 108: Perf, 5.710; 109: SpO2, 99.0; 109: Perf, 5.128; 110: SpO2, 98.797; 110: Perf, 4.415; 111: SpO2, 98.254; 111: Perf, 5.385; 112: SpO2, 98.345; 112: Perf, 5.914; 113: SpO2, 98.356; 113: Perf, 6.226; 114: SpO2, 98.0; 114: Perf, 6.491; 115: SpO2, 98.0; 115: Perf, 7.201; 116: SpO2, 98.0; 116: Perf, 7.171; 117: SpO2, 98.241; 117: Perf, 7.102; 118: SpO2, 99.169; 118: Perf, 6.303; 119: SpO2, 98.828; 119: Perf, 6.511; 0: Age, 30; 0: Gender, F; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 37.6; 0: Triage HR, 95.0; 0: Triage RR, 18.0; 0: Triage SBP, 144.0; 0: Triage DBP, 71.0; 0: Triage acuity, 3-Urgent; 0: CC, FEVER",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I looked at vital signs such as blood pressure, heart rate, respiration rate, and temperature to see if they showed signs of severe infection or shock\u2014these were relatively stable. Next, I checked lab results (including lactate, WBC count, and other inflammatory markers) to see if they indicated infection or organ dysfunction\u2014these were largely normal. Finally, I examined clinical factors like oxygen saturation and perfusion, which also remained within acceptable ranges. Because no clear evidence of sepsis or high-risk trends appeared, the overall conclusion is that the patient is not at high risk of sepsis in the next 12 hours.",
        "claims": [
            "I looked at vital signs such as blood pressure, heart rate, respiration rate, and temperature. The vital signs showed no signs of severe infection or shock. The vital signs were relatively stable. I checked lab results that included lactate, WBC count, and other inflammatory markers. The lab results largely appeared normal. I examined clinical factors such as oxygen saturation and perfusion. The clinical factors remained within acceptable ranges. No clear evidence of sepsis appeared. No high-risk trends were observed. The overall conclusion is that the patient is not at high risk of sepsis in the next 12 hours."
        ],
        "relevant_claims": [
            "I looked at vital signs such as blood pressure, heart rate, respiration rate, and temperature. The vital signs showed no signs of severe infection or shock. The vital signs were relatively stable. I checked lab results that included lactate, WBC count, and other inflammatory markers. The lab results largely appeared normal. I examined clinical factors such as oxygen saturation and perfusion. The clinical factors remained within acceptable ranges. No clear evidence of sepsis appeared. No high-risk trends were observed. The overall conclusion is that the patient is not at high risk of sepsis in the next 12 hours."
        ],
        "alignment_scores": [
            0.7
        ],
        "alignment_category": [
            4
        ],
        "alignment_reasonings": [
            "The claim describes a comprehensive review of vital signs, lab results, and clinical factors, and concludes stability and no evidence of severe infection or shock. This aligns with assessing clinical stability, which is what the NEWS score is intended to evaluate. A normal/low NEWS score would indicate low sepsis risk. However, the claim does not explicitly mention the NEWS score or provide detailed values to calculate it, hence the alignment is not perfect but still relevant."
        ],
        "final_alignment_score": 0.7,
        "accuracy": 1
    },
    {
        "input": "1: SpO2, 98.630; 1: Perf, 3.019; 1: SBP, 152.0; 1: DBP, 96.0; 1: MAP, 114.667; 2: HR, 143.083; 2: RR, 16.192; 2: SpO2, 98.810; 2: Perf, 3.446; 2: 1min HRV, 2.178; 3: HR, 141.678; 3: RR, 24.271; 3: SpO2, 98.322; 3: Perf, 3.714; 3: 1min HRV, 2.554; 3: 5min HRV, 3.429; 4: HR, 140.724; 4: RR, 27.379; 4: SpO2, 96.655; 4: Perf, 3.744; 4: 1min HRV, 2.447; 5: HR, 138.881; 5: RR, 36.847; 5: SpO2, 94.780; 5: Perf, 3.694; 5: 1min HRV, 5.014; 6: HR, 136.017; 6: RR, 37.0; 6: SpO2, 94.576; 6: Perf, 4.768; 6: 1min HRV, 2.594; 7: HR, 136.638; 7: RR, 27.707; 7: SpO2, 94.828; 7: Perf, 4.575; 7: 1min HRV, 3.223; 8: HR, 136.288; 8: RR, 35.712; 8: SpO2, 94.831; 8: Perf, 5.021; 8: 1min HRV, 2.220; 8: 5min HRV, 6.473; 9: HR, 137.220; 9: RR, 35.932; 9: SpO2, 93.847; 9: Perf, 4.974; 9: 1min HRV, 3.275; 10: HR, 135.517; 10: RR, 37.828; 10: SpO2, 94.224; 10: Perf, 4.255; 10: 1min HRV, 2.338; 10: SBP, 148.0; 10: DBP, 88.0; 10: MAP, 108.0; 10: Pain, 2.0; 10: Temp, 98.2; 11: HR, 136.237; 11: RR, 35.797; 11: SpO2, 93.644; 11: Perf, 4.098; 11: 1min HRV, 1.728; 11: SBP, 148.0; 11: DBP, 88.0; 11: MAP, 108.0; 12: HR, 136.362; 12: RR, 34.328; 12: SpO2, 93.138; 12: Perf, 3.829; 12: 1min HRV, 1.689; 13: HR, 136.814; 13: RR, 33.814; 13: SpO2, 93.068; 13: Perf, 3.642; 13: 1min HRV, 2.513; 13: 5min HRV, 3.005; 14: HR, 133.508; 14: RR, 35.390; 14: SpO2, 94.0; 14: Perf, 3.389; 14: 1min HRV, 5.601; 14: SBP, 145.0; 14: DBP, 85.0; 14: MAP, 105.0; 15: HR, 135.707; 15: RR, 29.966; 15: SpO2, 93.259; 15: Perf, 3.463; 15: 1min HRV, 1.602; 16: HR, 135.831; 16: RR, 35.068; 16: SpO2, 92.644; 16: Perf, 3.218; 16: 1min HRV, 2.306; 17: HR, 137.483; 17: RR, 28.017; 17: SpO2, 92.483; 17: Perf, 2.914; 17: 1min HRV, 2.149; 18: HR, 139.525; 18: RR, 33.695; 18: SpO2, 93.831; 18: Perf, 3.005; 18: 1min HRV, 4.277; 18: 5min HRV, 7.611; 19: HR, 140.5; 19: RR, 30.155; 19: SpO2, 94.276; 19: Perf, 3.315; 19: 1min HRV, 2.195; 20: HR, 142.136; 20: RR, 26.153; 20: SpO2, 93.983; 20: Perf, 3.305; 20: 1min HRV, 4.383; 21: HR, 138.356; 21: RR, 39.475; 21: SpO2, 93.780; 21: Perf, 3.03; 21: 1min HRV, 3.559; 22: HR, 137.534; 22: RR, 24.172; 22: SpO2, 94.103; 22: Perf, 3.151; 22: 1min HRV, 4.053; 23: HR, 138.203; 23: RR, 26.0; 23: SpO2, 94.407; 23: Perf, 3.031; 23: 1min HRV, 3.148; 23: 5min HRV, 6.289; 23: SBP, 160.0; 23: DBP, 84.0; 23: MAP, 109.333; 24: HR, 138.379; 24: RR, 27.431; 24: SpO2, 95.414; 24: Perf, 2.772; 24: 1min HRV, 2.778; 24: SBP, 160.0; 24: DBP, 84.0; 24: MAP, 109.333; 25: HR, 138.424; 25: RR, 30.458; 25: SpO2, 94.610; 25: Perf, 2.843; 25: 1min HRV, 4.149; 26: HR, 137.729; 26: RR, 30.288; 26: SpO2, 94.593; 26: Perf, 2.971; 26: 1min HRV, 3.643; 27: HR, 136.034; 27: RR, 34.276; 27: SpO2, 94.431; 27: Perf, 3.723; 27: 1min HRV, 4.158; 28: HR, 135.525; 28: RR, 36.847; 28: SpO2, 94.322; 28: Perf, 3.027; 28: 1min HRV, 3.855; 28: 5min HRV, 5.509; 29: HR, 133.897; 29: RR, 37.845; 29: SpO2, 94.862; 29: Perf, 2.952; 29: 1min HRV, 2.374; 30: HR, 134.424; 30: RR, 36.119; 30: SpO2, 94.492; 30: Perf, 2.938; 30: 1min HRV, 2.384; 31: HR, 133.915; 31: RR, 35.661; 31: SpO2, 94.119; 31: Perf, 2.657; 31: 1min HRV, 3.336; 32: HR, 132.431; 32: RR, 29.241; 32: SpO2, 94.845; 32: Perf, 2.761; 32: 1min HRV, 29.569; 33: HR, 140.0; 33: RR, 40.0; 33: SpO2, 94.0; 33: 5min HRV, 14.178; 33: SBP, 140.0; 33: DBP, 93.0; 33: MAP, 108.667; 42: NORMOSOL-R IV BOLUS -, 500 ML; 43: POC CREATININE,ISTAT: .6 mg/dL; 43: POC EGFR REFIT WITHOUT RACE (2021), 102 mL/min/1.73 m2; 43: POC EGFR FOR AFRICAN AMERICAN, 118 mL/min/1.73 m2; 43: HR, 130.0; 43: RR, 34.0; 43: SpO2, 95.0; 43: SBP, 139.0; 43: DBP, 81.0; 43: MAP, 100.333; 53: HR, 131.0; 53: RR, 37.0; 53: SpO2, 96.0; 53: SBP, 154.0; 53: DBP, 85.0; 53: MAP, 108.0; 56: AZITHROMYCIN, 500 MG IN D5W 250 ML IVPB; 61: CEFEPIME, 2 GRAM/20 ML IV PUSH; 63: HR, 130.0; 63: RR, 38.0; 63: SpO2, 96.0; 63: SBP, 122.0; 63: DBP, 109.0; 63: MAP, 113.333; 73: HR, 134.0; 73: RR, 25.0; 73: SpO2, 95.0; 83: HR, 132.0; 83: RR, 23.0; 83: SpO2, 96.0; 83: SBP, 145.0; 83: DBP, 76.0; 83: MAP, 99.0; 93: HR, 129.0; 93: RR, 35.0; 93: SpO2, 96.0; 93: SBP, 138.0; 93: DBP, 82.0; 93: MAP, 100.667; 103: HR, 127.0; 103: RR, 36.0; 103: SpO2, 95.0; 103: SBP, 118.0; 103: DBP, 92.0; 103: MAP, 100.667; 112: ALBUMIN, 3.7 g/dL; 112: GLUCOSE, 197 mg/dL; 112: ALKALINE PHOSPHATASE, 450 U/L; 112: BLOOD UREA NITROGEN (BUN), 11 mg/dL; 112: POTASSIUM, 3.7 mmol/L; 112: GLOBULIN, 3.1 g/dL; 112: EGFR REFIT WITHOUT RACE (2021), 100 mL/min/1.73 m2; 112: CREATININE, 0.65 mg/dL; 112: CHLORIDE, 101 mmol/L; 112: LIPASE, 24 U/L; 112: AST (SGOT), 83 U/L; 112: PROTEIN TOTAL, 6.8 g/dL; 112: ANION GAP, 12 mmol/L; 112: SODIUM, 135 mmol/L; 112: MAGNESIUM, 1.9 mg/dL; 112: CALCIUM, 8.7 mg/dL; 112: BILIRUBIN TOTAL, 0.6 mg/dL; 112: CORRECTED CALCIUM, 8.9 mg/dL; 112: CO2, 22 mmol/L; 112: ALT (SGPT), 29 U/L; 112: EGFR FOR AFRICAN AMERICAN, 115 mL/min/1.73 m2; 112: TSH, 1.65 uIU/mL; 113: HR, 123.0; 113: RR, 29.0; 113: SpO2, 95.0; 113: SBP, 121.0; 113: DBP, 67.0; 113: MAP, 85.0; 114: TROPONIN I, <.017 ng/mL; 0: Age, 56; 0: Gender, F; 0: Race, Other; 0: Means of arrival, EMS; 0: Triage Temp, 36.8; 0: Triage HR, 136.0; 0: Triage RR, 36.0; 0: Triage SBP, 148.0; 0: Triage DBP, 88.0; 0: Triage acuity, 2-Emergent; 0: CC, SHORTNESS OF BREATH",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, I checked whether the patient was persistently tachycardic and tachypneic, both of which remained high through multiple time points. Next, I noted that the patient received broad-spectrum antibiotics, indicating suspected infection. Finally, I concluded that the ongoing respiratory distress, elevated heart rate, and antibiotic treatment suggest a high risk of sepsis within 12 hours.",
        "claims": [
            "The patient was persistently tachycardic.",
            "The patient was persistently tachypneic.",
            "Heart rate remained high through multiple time points.",
            "The patient received broad-spectrum antibiotics.",
            "The administration of broad-spectrum antibiotics indicates suspected infection.",
            "Ongoing respiratory distress was observed in the patient.",
            "The elevated heart rate suggests a high risk of sepsis.",
            "The antibiotic treatment suggests a high risk of sepsis.",
            "The combination of ongoing respiratory distress, elevated heart rate, and antibiotic treatment suggests a high risk of sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient was persistently tachycardic.",
            "The patient was persistently tachypneic.",
            "Heart rate remained high through multiple time points.",
            "The patient received broad-spectrum antibiotics.",
            "The administration of broad-spectrum antibiotics indicates suspected infection.",
            "Ongoing respiratory distress was observed in the patient.",
            "The elevated heart rate suggests a high risk of sepsis.",
            "The antibiotic treatment suggests a high risk of sepsis.",
            "The combination of ongoing respiratory distress, elevated heart rate, and antibiotic treatment suggests a high risk of sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.8,
            0.7,
            0.6,
            0.9,
            0.9,
            0.7,
            0.7,
            0.8,
            0.8
        ],
        "alignment_category": [
            2,
            2,
            6,
            9,
            9,
            3,
            2,
            9,
            3
        ],
        "alignment_reasonings": [
            "Tachycardia, defined as a heart rate >90 bpm, is explicitly one of the SIRS criteria used to identify systemic inflammation likely linked to early sepsis. The alignment is quite strong as tachycardia directly contributes to SIRS positivity, though it is just one part of the \u22652 criteria required to be fully categorized under SIRS.",
            "Tachypnea is explicitly one of the SIRS criteria, with a respiratory rate >20/min indicating systemic inflammation consistent with early sepsis. Although the claim does not specify the exact respiratory rate or whether other criteria are met, the persistent nature of the tachypnea suggests a significant concern, justifying a strong but not perfect alignment.",
            "A persistently high heart rate could indicate hemodynamic instability, which relates conceptually to a high Shock Index, suggesting a probability of severe sepsis. However, without information on systolic blood pressure to calculate the Shock Index, the match is partial and indirect.",
            "The administration of broad-spectrum antibiotics is a key indicator of clinician suspicion of a serious infection, which this category targets. However, without specific timing information (such as whether this occurred within two hours), it slightly reduces the alignment strength, preventing a perfect score.",
            "The claim specifically mentions the administration of broad-spectrum antibiotics, signifying a clinician's suspicion of a serious infection. This aligns closely with the category that focuses on early antibiotic administration as an actionable sepsis risk assessment. However, it doesn't specify the timing of the antibiotic administration to be within 2 hours, which would have made the alignment perfect.",
            "The claim mentions \"ongoing respiratory distress,\" which aligns with part of the qSOFA criteria involving respiratory rate (\u226522/min). Although the claim does not specify the respiratory rate, respiratory distress often correlates with increased respiratory rate. The alignment is indirect but suggests a possible high risk for sepsis-related complications.",
            "An elevated heart rate is specifically listed in the SIRS criteria (heart rate >90 bpm) as a factor indicative of systemic inflammation associated with early sepsis. However, the claim only mentions the elevated heart rate and does not provide additional SIRS criteria or detail about how high the heart rate is, reducing alignment strength slightly.",
            "The claim mentions antibiotic treatment, indicating a strong suspicion of serious infection, which is aligned with initiating early antibiotic treatment as per the expert sepsis category. However, the claim does not specify the timing of the antibiotic administration (e.g., within 2 hours), slightly reducing the alignment strength.",
            "The claim mentions ongoing respiratory distress and elevated heart rate, which align with qSOFA criteria (respiratory rate and altered mentation can be inferred from distress; elevated heart rate often coexists in such physiological states). While qSOFA does not include antibiotic treatment, the mention of it suggests clinician awareness of possible infection, supporting the sepsis risk focus. The alignment is strong with the risk factors of respiratory distress and tachycardia contributing to possible organ dysfunction as indicated by a high qSOFA score."
        ],
        "final_alignment_score": 0.7666666666666666,
        "accuracy": 1
    },
    {
        "input": "7: HR, 91.596; 7: RR, 24.462; 7: SpO2, 96.562; 7: Perf, 0.259; 7: 1min HRV, 72.990; 8: POC PH (V) ISTAT, 7.25; 8: POC GLUCOSE ISTAT, 100 mg/dL; 8: POC SODIUM ISTAT, 141 mmol/L; 8: POC HGB (CALC) ISTAT, 11.6 g/dL; 8: POC POTASSIUM ISTAT, 4.1 mmol/L; 8: POC HCT ISTAT, 34 %; 8: POC HCO3 (V) ISTAT, 30.1 mmol/L; 8: POC BASE EXCESS ISTAT, 3 mmol/L; 8: POC TCO2 (V) ISTAT, 32 mmol/L; 8: POC LACTATE ISTAT, 0.83 mmol/L; 8: POC O2 SATURATION ISTAT VENOUS, 21 %; 8: POC PO2 (V) ISTAT, 19 mmHg; 8: POC PCO2 (V) ISTAT, 68.9 mmHg; 8: HR, 92.434; 8: RR, 24.623; 8: SpO2, 96.519; 8: Perf, 0.241; 8: 1min HRV, 51.204; 8: 5min HRV, 63.099; 9: HR, 93.135; 9: RR, 19.731; 9: SpO2, 95.95; 9: Perf, 0.217; 9: 1min HRV, 56.604; 10: HR, 91.208; 10: RR, 21.585; 10: SpO2, 96.679; 10: Perf, 0.21; 10: 1min HRV, 41.598; 11: HR, 92.302; 11: RR, 21.321; 11: Perf, 0.21; 11: 1min HRV, 56.135; 12: HR, 92.481; 12: RR, 20.827; 12: SpO2, 97.778; 12: Perf, 0.21; 12: 1min HRV, 33.525; 13: HR, 97.585; 13: RR, 25.849; 13: SpO2, 96.811; 13: Perf, 0.21; 13: 1min HRV, 41.248; 13: 5min HRV, 50.267; 14: HR, 105.887; 14: RR, 21.642; 14: SpO2, 95.947; 14: 1min HRV, 52.404; 15: HR, 104.755; 15: RR, 16.019; 15: SpO2, 97.0; 15: 1min HRV, 15.021; 16: HR, 99.509; 16: RR, 22.623; 16: SpO2, 97.868; 16: Perf, 0.806; 16: 1min HRV, 6.890; 17: HR, 99.327; 17: RR, 19.538; 17: SpO2, 98.462; 17: Perf, 1.002; 17: 1min HRV, 45.299; 18: HR, 98.204; 18: RR, 25.833; 18: SpO2, 98.5; 18: Perf, 0.96; 18: 1min HRV, 7.606; 18: 5min HRV, 37.717; 19: HR, 98.538; 19: RR, 26.731; 19: SpO2, 98.0; 19: Perf, 0.96; 19: 1min HRV, 21.760; 19: SBP, 171.0; 19: DBP, 137.0; 19: MAP, 148.333; 20: HR, 97.667; 20: RR, 20.407; 20: SpO2, 97.824; 20: Perf, 0.96; 20: 1min HRV, 38.205; 21: HR, 97.887; 21: RR, 21.245; 21: SpO2, 98.302; 21: Perf, 0.96; 21: 1min HRV, 38.711; 22: HR, 96.212; 22: RR, 21.673; 22: SpO2, 99.0; 22: Perf, 0.96; 22: 1min HRV, 15.498; 23: HR, 95.679; 23: RR, 23.340; 23: SpO2, 98.041; 23: Perf, 0.959; 23: 1min HRV, 12.652; 23: 5min HRV, 29.080; 23: SBP, 171.0; 23: DBP, 137.0; 23: MAP, 148.333; 23: LPM O2, 2.0; 23: Pain, 1.0; 23: Temp, 101.3; 24: HR, 95.058; 24: RR, 23.654; 24: SpO2, 97.385; 24: Perf, 0.820; 24: 1min HRV, 17.024; 25: HR, 94.755; 25: RR, 22.038; 25: SpO2, 96.925; 25: Perf, 0.358; 25: 1min HRV, 13.002; 26: HR, 93.923; 26: RR, 20.442; 26: SpO2, 96.981; 26: Perf, 0.331; 26: 1min HRV, 17.608; 27: HR, 93.5; 27: RR, 22.519; 27: SpO2, 96.704; 27: Perf, 0.344; 27: 1min HRV, 10.366; 27: SBP, 125.0; 27: DBP, 33.0; 27: MAP, 63.667; 27: LPM O2, 2.0; 28: HR, 93.887; 28: RR, 23.151; 28: SpO2, 96.302; 28: Perf, 0.353; 28: 1min HRV, 4.850; 28: 5min HRV, 13.955; 29: HR, 94.5; 29: RR, 25.077; 29: SpO2, 96.077; 29: Perf, 0.371; 29: 1min HRV, 42.092; 30: HR, 92.208; 30: RR, 29.113; 30: SpO2, 95.660; 30: Perf, 0.388; 30: 1min HRV, 19.633; 31: HR, 93.0; 31: RR, 22.519; 31: SpO2, 94.808; 31: Perf, 0.391; 31: 1min HRV, 28.109; 32: HR, 92.593; 32: RR, 20.204; 32: SpO2, 95.185; 32: Perf, 0.455; 32: 1min HRV, 18.466; 33: 5min HRV, 29.373; 38: ABO/RH, B Positive; 39: ANTIBODY SCREEN 3, NEG; 44: PH.SER/PLAS, 7.22; 44: CALCIUM IONIZED, 1.14 mmol/L; 45: WAM DIFTYP, AUTO; 45: RED CELL DISTRIBUTION WIDTH (RDW), 15.3 %; 45: WHITE BLOOD CELLS (WBC), 11.9 K/uL; 45: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.3 g/dL; 45: NRBC PERCENT (HEMATOLOGY), 0.0 %; 45: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.07 K/uL; 45: HEMOGLOBIN (HGB), 10.0 g/dL; 45: LYMPHOCYTE % (AUTO DIFF), 8.1 %; 45: BASOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 45: MEAN CORPUSCULAR VOLUME (MCV), 110.3 fL; 45: HEMATOCRIT (HCT), 32.0 %; 45: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.96 K/uL; 45: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 45: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 45: PLATELET COUNT (PLT), 185 K/uL; 45: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 34.5 pg; 45: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.08 K/uL; 45: EOSINOPHIL % (AUTO DIFF), 0.4 %; 45: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.7 %; 45: NEUTROPHIL % (AUTO DIFF), 84.7 %; 45: MONOCYTE % (AUTO DIFF), 6.0 %; 45: RED BLOOD CELLS (RBC), 2.90 MIL/uL; 45: BASOPHIL % (AUTO DIFF), 0.1 %; 45: MONOCYTE ABSOLUTE (AUTO DIFF), 0.71 K/uL; 46: ACETAMINOPHEN, 1 000 MG/100 ML (10 MG/ML) IV SOLN; 58: CEFTRIAXONE, 1 GRAM/10 ML IV PUSH (VIAL ONLY); 63: HR, 91.0; 63: SpO2, 100.0; 63: SBP, 109.0; 63: DBP, 44.0; 63: MAP, 65.667; 63: LPM O2, 2.0; 63: VANCOMYCIN-WATER INJECT (PEG), 2 GRAM/400 ML IV PGBK; 69: INR:, 1.1; 69: THROMBIN TIME, 20.9 seconds; 69: PART. THROMBOPLASTIN TIME, 40.8 seconds; 69: FIBRINOGEN, 654 mg/dL; 69: D-DIMER, 1.40 ug/mL FEU; 69: PROTHROMBIN TIME, 13.4 seconds; 70: SARS-COV-2 RNA, Detected; 70: INFLUENZA B, Not Detected; 70: INFLUENZA A, Not Detected; 70: SARS-COV-2 RNA, Detected; 70: INFLUENZA B, Not Detected; 70: INFLUENZA A, Not Detected; 71: BLOOD TYPE VERIFICATION-MANUAL, B Positive; 75: MAGNESIUM, 2.1 mg/dL; 75: PHOSPHORUS, 2.6 mg/dL; 75: BNP NT-PRO, 2986 pg/mL; 88: TROPONIN I, 0.020 ng/mL; 116: KETONE, URINE (UA): Negative; 116: NITRITE, URINE (UA): Negative; 116: SPECIFIC GRAVITY, URINE (UA): 1.020; 116: PH, URINE (UA): 5.0; 116: GLUCOSE, URINE (UA): Negative; 116: LEUKOCYTE ESTERASE, URINE (UA): Negative; 0: Age, 81; 0: Gender, F; 0: Race, Native Hawaiian or Other Pacific Islander; 0: Means of arrival, EMS; 0: Triage Temp, 38.5; 0: Triage HR, 94.0; 0: Triage RR, 23.0; 0: Triage SBP, 171.0; 0: Triage DBP, 137.0; 0: Triage acuity, 2-Emergent; 0: CC, ALTERED MENTAL STATUS",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "I am not a medical professional. First, I assessed whether there were signs of infection, such as fever and positive SARS-COV-2 results; the patient does show these. Next, I looked for indications of organ dysfunction, including altered mental status and fluctuating blood pressure, which suggest compromised physiology. Finally, combining these findings with the administration of broad-spectrum antibiotics indicates a high risk for sepsis within 12 hours.",
        "claims": [
            "I am not a medical professional.",
            "Signs of infection were assessed.",
            "Signs of infection include fever and positive SARS-COV-2 results.",
            "The patient shows signs of infection.",
            "Indications of organ dysfunction were looked for.",
            "Indications of organ dysfunction include altered mental status and fluctuating blood pressure.",
            "Altered mental status suggests compromised physiology.",
            "Fluctuating blood pressure suggests compromised physiology.",
            "The findings of infection and organ dysfunction were combined.",
            "The administration of broad-spectrum antibiotics indicates a high risk for sepsis within 12 hours.",
            "Combining these findings suggests a high risk for sepsis within 12 hours."
        ],
        "relevant_claims": [
            "Signs of infection were assessed.",
            "Signs of infection include fever and positive SARS-COV-2 results.",
            "The patient shows signs of infection.",
            "Indications of organ dysfunction include altered mental status and fluctuating blood pressure.",
            "Altered mental status suggests compromised physiology.",
            "Fluctuating blood pressure suggests compromised physiology.",
            "The findings of infection and organ dysfunction were combined.",
            "The administration of broad-spectrum antibiotics indicates a high risk for sepsis within 12 hours.",
            "Combining these findings suggests a high risk for sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.3,
            0.7,
            0.3,
            0.9,
            0.8,
            0.5,
            0.8,
            1.0,
            0.3
        ],
        "alignment_category": [
            9,
            2,
            9,
            3,
            3,
            6,
            8,
            9,
            4
        ],
        "alignment_reasonings": [
            "The claim mentions assessing signs of infection, which is related to the clinician's suspicion of infection and could lead to actions such as ordering antibiotics or blood cultures. However, the claim lacks specifics about these actions being taken, making the alignment weak.",
            "The presence of fever is directly part of the SIRS criteria, making it partially aligned with this category. While SARS-COV-2 positivity indicates infection, which can support suspicion of sepsis, it does not independently meet any SIRS criteria. The fever, however, is a strong indicator, leading to a relatively high alignment score.",
            "The claim generally indicates that there are signs of infection, which might lead a clinician to consider early antibiotics or culture orders. However, there is no explicit mention of these actions or any specific criteria being met, so the alignment with a concrete category is weak.",
            "The claim directly mentions \"altered mental status\" and \"fluctuating blood pressure.\" Altered mentation is one of the criteria for a qSOFA score, and while fluctuating blood pressure aligns with hemodynamic instability, it strongly resonates with the qSOFA emphasis on organ dysfunction (altered mentation) and potential blood pressure changes. The alignment is strong but not perfect because it doesn't fully specify all qSOFA components, yet it importantly indicates organ dysfunction risk associated with sepsis.",
            "Altered mentation is one of the criteria directly mentioned under the qSOFA score, which is used to flag risks of sepsis-related complications. The claim aligns well with this category, although it doesn\u2019t specify meeting the full score threshold. Hence, the alignment is high but not absolute.",
            "Fluctuating blood pressure can indicate hemodynamic instability and compromised physiology, which relates to the Elevated Shock Index category. However, the claim doesn't provide exact values or calculate the shock index, leading to an indirect association and hence a moderate alignment rating.",
            "The claim refers to the combination of infection findings with organ dysfunction, which aligns closely with the SOFA Score Increase category. The SOFA score assesses organ dysfunction and is used to identify patients at high risk of sepsis. While the claim does not specifically mention an increase in SOFA score, the mention of organ dysfunction strongly suggests a relevant factor in sepsis risk assessment, hence a strong but not perfect alignment.",
            "The claim directly references the administration of broad-spectrum antibiotics, which is explicitly mentioned in this category. Such administration is a strong indicator of clinician suspicion of serious infection and a key action in assessing sepsis risk, resulting in perfect alignment with the category.",
            "The claim mentions a high risk of sepsis within 12 hours without specifying which clinical findings are involved. The reference to combining findings suggests evaluating multiple vital signs or indicators, aligning best with the NEWS Score, which integrates various vital parameters to predict clinical deterioration. The lack of specific metrics or thresholds lowers the alignment rating, as it is more suggestive than definitive."
        ],
        "final_alignment_score": 0.6222222222222222,
        "accuracy": 1
    },
    {
        "input": "3: HR, 114.0; 3: RR, 18.0; 3: SpO2, 100.0; 3: SBP, 150.0; 3: DBP, 95.0; 3: MAP, 113.333; 3: Temp, 98.4; 74: RR, 42.2; 74: SpO2, 99.878; 74: Perf, 0.56; 74: SBP, 149.0; 74: DBP, 103.0; 74: MAP, 118.333; 75: HR, 100.725; 75: RR, 21.948; 75: SpO2, 100.0; 75: Perf, 0.532; 75: 1min HRV, 10.091; 76: HR, 99.814; 76: RR, 18.746; 76: SpO2, 100.0; 76: Perf, 0.793; 76: 1min HRV, 14.214; 77: HR, 99.552; 77: RR, 20.517; 77: SpO2, 100.0; 77: Perf, 0.815; 77: 1min HRV, 11.457; 78: HR, 100.847; 78: RR, 18.288; 78: SpO2, 100.0; 78: Perf, 0.925; 78: 1min HRV, 4.612; 79: HR, 98.254; 79: RR, 17.763; 79: SpO2, 100.0; 79: Perf, 1.615; 79: 1min HRV, 3.239; 79: 5min HRV, 11.448; 80: HR, 96.466; 80: RR, 17.534; 80: SpO2, 100.0; 80: Perf, 1.863; 80: 1min HRV, 4.446; 80: SBP, 146.0; 80: DBP, 104.0; 80: MAP, 118.0; 81: HR, 95.373; 81: RR, 18.085; 81: SpO2, 100.0; 81: Perf, 1.857; 81: 1min HRV, 5.160; 82: HR, 95.897; 82: RR, 17.828; 82: SpO2, 100.0; 82: Perf, 2.077; 82: 1min HRV, 2.885; 83: HR, 95.237; 83: RR, 17.305; 83: SpO2, 100.0; 83: Perf, 2.075; 83: 1min HRV, 2.467; 84: HR, 95.407; 84: RR, 16.441; 84: SpO2, 100.0; 84: Perf, 2.015; 84: 1min HRV, 14.413; 84: 5min HRV, 7.621; 85: HR, 95.966; 85: RR, 18.534; 85: SpO2, 100.0; 85: Perf, 1.242; 85: 1min HRV, 6.758; 86: HR, 94.441; 86: RR, 17.661; 86: SpO2, 100.0; 86: Perf, 1.800; 86: 1min HRV, 7.076; 87: HR, 94.638; 87: RR, 18.810; 87: SpO2, 100.0; 87: Perf, 1.988; 87: 1min HRV, 6.194; 88: HR, 94.864; 88: RR, 18.305; 88: SpO2, 100.0; 88: Perf, 1.841; 88: 1min HRV, 6.704; 89: HR, 95.729; 89: RR, 18.712; 89: SpO2, 100.0; 89: Perf, 1.769; 89: 1min HRV, 11.545; 89: 5min HRV, 8.848; 90: HR, 97.345; 90: RR, 20.569; 90: SpO2, 100.0; 90: Perf, 1.424; 90: 1min HRV, 14.899; 91: HR, 97.220; 91: RR, 18.932; 91: SpO2, 100.0; 91: Perf, 1.581; 91: 1min HRV, 23.578; 92: HR, 95.431; 92: RR, 17.138; 92: SpO2, 100.0; 92: Perf, 1.650; 92: 1min HRV, 5.315; 93: HR, 94.322; 93: RR, 17.017; 93: SpO2, 100.0; 93: Perf, 1.803; 93: 1min HRV, 21.750; 94: HR, 94.864; 94: RR, 15.186; 94: SpO2, 100.0; 94: Perf, 1.650; 94: 1min HRV, 4.707; 94: 5min HRV, 17.740; 95: HR, 94.948; 95: RR, 15.845; 95: SpO2, 99.932; 95: Perf, 1.643; 95: 1min HRV, 7.039; 95: SBP, 153.0; 95: DBP, 101.0; 95: MAP, 118.333; 96: HR, 96.915; 96: RR, 19.593; 96: SpO2, 100.0; 96: Perf, 1.13; 96: 1min HRV, 6.773; 97: HR, 97.172; 97: RR, 20.759; 97: SpO2, 100.0; 97: Perf, 1.264; 97: 1min HRV, 5.834; 98: HR, 97.559; 98: RR, 17.458; 98: SpO2, 100.0; 98: Perf, 1.547; 98: 1min HRV, 3.804; 99: HR, 97.119; 99: RR, 19.627; 99: SpO2, 100.0; 99: Perf, 1.605; 99: 1min HRV, 4.123; 99: 5min HRV, 7.908; 100: HR, 96.310; 100: RR, 19.621; 100: SpO2, 100.0; 100: Perf, 1.606; 100: 1min HRV, 6.912; 101: HR, 96.492; 101: RR, 18.508; 101: SpO2, 100.0; 101: Perf, 1.390; 101: 1min HRV, 18.678; 102: HR, 95.1; 102: RR, 17.190; 102: SpO2, 100.0; 102: Perf, 1.610; 102: 1min HRV, 14.997; 103: HR, 96.356; 103: RR, 18.424; 103: SpO2, 100.0; 103: Perf, 1.005; 103: 1min HRV, 30.601; 104: HR, 100.322; 104: RR, 17.831; 104: SpO2, 99.186; 104: Perf, 0.591; 104: 1min HRV, 48.953; 104: 5min HRV, 32.817; 105: HR, 99.5; 105: RR, 21.069; 105: SpO2, 99.121; 105: Perf, 0.519; 105: 1min HRV, 17.292; 106: HR, 97.661; 106: RR, 18.966; 106: SpO2, 99.542; 106: Perf, 0.567; 106: 1min HRV, 11.182; 107: HR, 99.810; 107: RR, 19.362; 107: SpO2, 99.310; 107: Perf, 0.503; 107: 1min HRV, 8.945; 108: HR, 97.017; 108: RR, 23.593; 108: SpO2, 99.186; 108: Perf, 0.460; 108: 1min HRV, 11.619; 109: HR, 97.483; 109: RR, 20.138; 109: SpO2, 100.0; 109: Perf, 0.639; 109: 1min HRV, 13.210; 109: 5min HRV, 13.786; 110: HR, 95.559; 110: RR, 17.644; 110: SpO2, 100.0; 110: Perf, 0.806; 110: 1min HRV, 5.844; 111: HR, 93.966; 111: RR, 16.576; 111: SpO2, 100.0; 111: Perf, 0.747; 111: 1min HRV, 9.589; 112: HR, 96.672; 112: RR, 21.828; 112: SpO2, 100.0; 112: Perf, 0.716; 112: 1min HRV, 6.406; 113: HR, 96.712; 113: RR, 18.034; 113: SpO2, 100.0; 113: Perf, 0.719; 113: 1min HRV, 31.059; 114: HR, 94.207; 114: RR, 18.534; 114: SpO2, 100.0; 114: Perf, 0.779; 114: 1min HRV, 7.562; 114: 5min HRV, 17.005; 115: POC PH (V) ISTAT, 7.42; 115: POC HCO3 (V) ISTAT, 30.2 mmol/L; 115: POC PO2 (V) ISTAT, 48 mmHg; 115: POC O2 SATURATION ISTAT VENOUS, 83 %; 115: POC TCO2 (V) ISTAT, 32 mmol/L; 115: POC PCO2 (V) ISTAT, 46.3 mmHg; 115: POC LACTATE ISTAT, 2.32 mmol/L; 115: POC BASE EXCESS ISTAT, 6 mmol/L; 115: HR, 97.220; 115: RR, 18.339; 115: SpO2, 100.0; 115: Perf, 0.886; 115: 1min HRV, 8.098; 116: HR, 96.237; 116: RR, 18.847; 116: SpO2, 100.0; 116: Perf, 0.819; 116: 1min HRV, 6.137; 117: HR, 95.034; 117: RR, 17.190; 117: SpO2, 100.0; 117: Perf, 1.051; 117: 1min HRV, 16.127; 118: HR, 95.475; 118: RR, 15.831; 118: SpO2, 100.0; 118: Perf, 1.116; 118: 1min HRV, 8.013; 119: HR, 92.862; 119: RR, 18.155; 119: SpO2, 100.0; 119: Perf, 0.879; 119: 1min HRV, 9.869; 119: 5min HRV, 14.104; 0: Age, 71; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 36.9; 0: Triage HR, 114.0; 0: Triage RR, 18.0; 0: Triage SBP, 150.0; 0: Triage DBP, 95.0; 0: Triage acuity, 3-Urgent; 0: CC, DEHYDRATION,CHEST PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I checked whether the patient had persistent fever or hypotension, and those readings were largely normal. Next, I examined whether the respiratory rate stayed severely elevated and if lactate was markedly high; the lactate value was borderline elevated (2.32 mmol/L), but not definitively in septic range. Then, I looked for clear evidence of infection or multiple abnormal vital signs consistent with sepsis. Considering these subquestions, the patient\u2019s vitals and labs together do not strongly indicate a high risk of sepsis in the next 12 hours.",
        "claims": [
            "The patient did not have persistent fever or hypotension.",
            "The readings for persistent fever and hypotension were largely normal.",
            "The respiratory rate did not stay severely elevated.",
            "The lactate value was borderline elevated at 2.32 mmol/L.",
            "The lactate value was not definitively in septic range.",
            "There was no clear evidence of infection.",
            "There were no multiple abnormal vital signs consistent with sepsis.",
            "The patient\u2019s vitals and labs together do not strongly indicate a high risk of sepsis in the next 12 hours."
        ],
        "relevant_claims": [
            "The patient did not have persistent fever or hypotension.",
            "The lactate value was borderline elevated at 2.32 mmol/L.",
            "There was no clear evidence of infection.",
            "The patient\u2019s vitals and labs together do not strongly indicate a high risk of sepsis in the next 12 hours."
        ],
        "alignment_scores": [
            0.3,
            0.9,
            0.3,
            0.3
        ],
        "alignment_category": [
            2,
            5,
            9,
            4
        ],
        "alignment_reasonings": [
            "The claim mentions \"persistent fever\" and \"hypotension,\" both of which relate to SIRS criteria\u2014a temperature deviation and blood pressure concerns can signify systemic inflammation linked to early sepsis. However, the absence of persistent symptoms reduces the relevance, warranting a low alignment rating.",
            "The claim states that the lactate value is borderline elevated at 2.32 mmol/L, which surpasses the threshold of 2 mmol/L for this category. This situation is a direct indication of tissue hypoperfusion, aligning strongly with the category. As the value slightly exceeds the threshold, the alignment is very strong (though not perfect due to its borderline nature), justifying a 0.9 rating.",
            "The claim suggests the absence of definitive infection evidence, which indirectly relates to clinician actions like ordering antibiotics or cultures due to suspicion of infection. While this highlights a lack of sepsis overt signs, it suggests potential clinical decision-making scenarios considered in this category. However, the alignment is weak as there's no explicit action indicative of suspected sepsis risk.",
            "The claim suggests that a comprehensive assessment of the patient's vitals and labs does not indicate a high sepsis risk. While this could relate to several categories, it most closely aligns with the concept of a NEWS score, which is derived from vitals and helps predict clinical deterioration. However, since the claim indicates a lack of high risk (which corresponds to a score below the threshold), the alignment is indirect and weak, thus the low alignment rating."
        ],
        "final_alignment_score": 0.45,
        "accuracy": 1
    },
    {
        "input": "3: SpO2, 97.5; 4: HR, 101.16; 4: RR, 25.739; 4: SpO2, 94.5; 4: 1min HRV, 6.414; 5: HR, 100.797; 5: RR, 24.475; 5: SpO2, 94.441; 5: Perf, 0.655; 5: 1min HRV, 35.949; 5: SBP, 158.0; 5: DBP, 97.0; 5: MAP, 117.333; 6: HR, 100.593; 6: RR, 23.966; 6: SpO2, 94.0; 6: Perf, 0.625; 6: 1min HRV, 17.024; 6: SBP, 158.0; 6: DBP, 97.0; 6: MAP, 117.333; 6: Temp, 98.8; 7: HR, 101.293; 7: RR, 22.828; 7: SpO2, 94.103; 7: Perf, 0.608; 7: 1min HRV, 37.928; 7: 5min HRV, 29.475; 8: HR, 100.593; 8: RR, 23.407; 8: SpO2, 94.186; 8: Perf, 0.596; 8: 1min HRV, 24.883; 9: HR, 99.707; 9: RR, 23.276; 9: SpO2, 93.172; 9: Perf, 0.576; 9: 1min HRV, 32.870; 10: HR, 99.847; 10: RR, 22.966; 10: SpO2, 93.644; 10: Perf, 0.543; 10: 1min HRV, 44.265; 11: HR, 100.051; 11: RR, 22.881; 11: SpO2, 93.271; 11: Perf, 0.491; 11: 1min HRV, 49.237; 12: HR, 99.776; 12: RR, 22.983; 12: SpO2, 93.845; 12: Perf, 0.489; 12: 1min HRV, 44.707; 12: 5min HRV, 40.246; 13: HR, 102.051; 13: RR, 21.831; 13: SpO2, 92.610; 13: Perf, 0.493; 13: 1min HRV, 37.201; 14: HR, 101.362; 14: RR, 23.224; 14: SpO2, 93.534; 14: Perf, 0.498; 14: 1min HRV, 58.304; 15: HR, 99.831; 15: RR, 23.186; 15: SpO2, 93.169; 15: Perf, 0.568; 15: 1min HRV, 33.361; 16: HR, 101.475; 16: RR, 19.525; 16: SpO2, 93.729; 16: Perf, 0.573; 16: 1min HRV, 54.280; 17: HR, 100.276; 17: RR, 22.017; 17: SpO2, 93.397; 17: Perf, 0.525; 17: 1min HRV, 41.692; 17: 5min HRV, 45.910; 18: HR, 100.271; 18: RR, 23.475; 18: SpO2, 92.932; 18: Perf, 0.523; 18: 1min HRV, 45.637; 19: HR, 99.724; 19: RR, 23.017; 19: SpO2, 93.552; 19: Perf, 0.519; 19: 1min HRV, 42.902; 20: HR, 100.203; 20: RR, 22.051; 20: SpO2, 93.492; 20: Perf, 0.52; 20: 1min HRV, 41.013; 21: HR, 100.186; 21: RR, 22.542; 21: SpO2, 93.271; 21: Perf, 0.513; 21: 1min HRV, 48.040; 22: HR, 101.069; 22: RR, 23.276; 22: SpO2, 93.483; 22: Perf, 0.511; 22: 1min HRV, 43.514; 22: 5min HRV, 44.399; 23: HR, 99.559; 23: RR, 24.441; 23: SpO2, 94.644; 23: Perf, 0.644; 23: 1min HRV, 36.599; 24: HR, 97.759; 24: RR, 21.293; 24: SpO2, 95.828; 24: Perf, 0.823; 24: 1min HRV, 42.457; 25: HR, 98.746; 25: RR, 20.220; 25: SpO2, 95.814; 25: Perf, 0.754; 25: 1min HRV, 75.012; 26: HR, 97.119; 26: RR, 20.695; 26: SpO2, 96.271; 26: Perf, 0.757; 26: 1min HRV, 44.336; 26: LPM O2, 2.0; 27: HR, 97.034; 27: RR, 19.276; 27: SpO2, 97.0; 27: Perf, 0.730; 27: 1min HRV, 55.894; 27: 5min HRV, 52.824; 28: HR, 98.305; 28: RR, 21.271; 28: SpO2, 97.627; 28: Perf, 0.694; 28: 1min HRV, 39.777; 29: HR, 96.069; 29: RR, 20.448; 29: SpO2, 97.914; 29: Perf, 0.660; 29: 1min HRV, 50.570; 30: HR, 94.949; 30: RR, 19.746; 30: SpO2, 97.576; 30: Perf, 0.699; 30: 1min HRV, 70.984; 31: HR, 94.707; 31: RR, 19.845; 31: SpO2, 97.655; 31: Perf, 0.726; 31: 1min HRV, 65.348; 32: HR, 94.780; 32: RR, 20.0; 32: SpO2, 98.0; 32: Perf, 0.718; 32: 1min HRV, 59.486; 32: 5min HRV, 58.790; 33: HR, 94.712; 33: RR, 19.712; 33: SpO2, 98.0; 33: Perf, 0.696; 33: 1min HRV, 44.407; 34: HR, 96.828; 34: RR, 21.931; 34: SpO2, 97.724; 34: Perf, 0.615; 34: 1min HRV, 56.587; 35: HR, 99.254; 35: RR, 20.797; 35: SpO2, 98.119; 35: Perf, 0.565; 35: 1min HRV, 41.004; 36: WAM DIFTYP, AUTO; 36: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 36: MONOCYTE % (AUTO DIFF), 5.1 %; 36: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.60 K/uL; 36: WHITE BLOOD CELLS (WBC), 9.4 K/uL; 36: NRBC PERCENT (HEMATOLOGY), 0.0 %; 36: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.9 g/dL; 36: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.4 pg; 36: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 36: MEAN CORPUSCULAR VOLUME (MCV), 92.2 fL; 36: HEMOGLOBIN (HGB), 11.6 g/dL; 36: RED BLOOD CELLS (RBC), 3.95 MIL/uL; 36: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 36: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.03 K/uL; 36: MONOCYTE ABSOLUTE (AUTO DIFF), 0.48 K/uL; 36: RED CELL DISTRIBUTION WIDTH (RDW), 15.2 %; 36: PLATELET COUNT (PLT), 320 K/uL; 36: LYMPHOCYTE % (AUTO DIFF), 6.4 %; 36: NEUTROPHIL ABSOLUTE (AUTO DIFF), 8.24 K/uL; 36: HEMATOCRIT (HCT), 36.4 %; 36: BASOPHIL % (AUTO DIFF), 0.2 %; 36: NEUTROPHIL % (AUTO DIFF), 88.0 %; 36: EOSINOPHIL % (AUTO DIFF), 0.0 %; 36: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 36: HR, 96.517; 36: RR, 21.103; 36: SpO2, 98.948; 36: Perf, 0.573; 36: 1min HRV, 47.855; 37: HR, 96.814; 37: RR, 21.475; 37: SpO2, 98.797; 37: Perf, 0.501; 37: 1min HRV, 33.828; 37: 5min HRV, 45.940; 38: HR, 96.847; 38: RR, 21.085; 38: SpO2, 98.797; 38: Perf, 0.480; 38: 1min HRV, 51.357; 39: HR, 97.931; 39: RR, 22.310; 39: SpO2, 99.0; 39: Perf, 0.461; 39: 1min HRV, 18.436; 40: HR, 96.627; 40: RR, 21.424; 40: SpO2, 98.475; 40: Perf, 0.442; 40: 1min HRV, 59.154; 41: HR, 97.724; 41: RR, 22.190; 41: SpO2, 98.483; 41: Perf, 0.406; 41: 1min HRV, 20.682; 42: HR, 97.169; 42: RR, 23.458; 42: SpO2, 98.085; 42: Perf, 0.421; 42: 1min HRV, 42.586; 42: 5min HRV, 41.790; 43: HR, 98.814; 43: RR, 24.136; 43: SpO2, 98.254; 43: Perf, 0.396; 43: 1min HRV, 40.306; 44: HR, 96.845; 44: RR, 22.017; 44: SpO2, 98.603; 44: Perf, 0.434; 44: 1min HRV, 71.813; 45: HR, 95.847; 45: RR, 20.678; 45: SpO2, 97.831; 45: Perf, 0.465; 45: 1min HRV, 33.861; 47: 5min HRV, 52.008; 67: INR, 1.0; 67: PROTHROMBIN TIME, 13.0 seconds; 68: PART. THROMBOPLASTIN TIME, 30.7 seconds; 73: ABO/RH (AUTOMATION), A Positive; 73: ANTIBODY SCREEN 3, NEG; 77: SARS-COV-2 RNA, Not Detected; 77: INFLUENZA A, Not Detected; 77: INFLUENZA B, Not Detected; 100: TROPONIN I, <.017 ng/mL; 118: EGFR FOR AFRICAN AMERICAN, 119 mL/min/1.73 m2; 118: CO2, 18 mmol/L; 118: ANION GAP, 18 mmol/L; 118: BLOOD UREA NITROGEN (BUN), 15 mg/dL; 118: CORRECTED CALCIUM, 9.5 mg/dL; 118: GLUCOSE, 97 mg/dL; 118: ALBUMIN, 3.5 g/dL; 118: BILIRUBIN TOTAL, 0.4 mg/dL; 118: MAGNESIUM, 1.8 mg/dL; 118: CREATININE, 0.38 mg/dL; 118: SODIUM, 141 mmol/L; 118: PROTEIN TOTAL, 6.5 g/dL; 118: LIPASE, 20 U/L; 118: POTASSIUM, 5.3 mmol/L; 118: AST (SGOT), 63 U/L; 118: ALT (SGPT), 9 U/L; 118: CALCIUM, 9.1 mg/dL; 118: ALKALINE PHOSPHATASE, 63 U/L; 118: GLOBULIN, 3.0 g/dL; 118: EGFR REFIT WITHOUT RACE (2021), 103 mL/min/1.73 m2; 118: CHLORIDE, 105 mmol/L; 0: Age, 78; 0: Gender, F; 0: Race, Other; 0: Means of arrival, EMS; 0: Triage Temp, 37.1; 0: Triage HR, 100.0; 0: Triage RR, 24.0; 0: Triage SBP, 158.0; 0: Triage DBP, 97.0; 0: Triage acuity, 3-Urgent; 0: CC, EMESIS",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "First, we check vital signs such as heart rate and respiratory rate for abnormal values that might indicate systemic infection; although mildly elevated, they remain relatively stable. Next, we look for laboratory markers consistent with sepsis (e.g., high WBC count, lactic acidosis), which do not appear significantly abnormal in these data. Then, we note that the patient\u2019s blood pressure remains within normal limits and oxygen saturations improve with minimal supplemental oxygen. Finally, the presence of a normal WBC count and relatively stable vitals over time argues against a high risk of sepsis developing in the next 12 hours.",
        "claims": [
            "Vital signs such as heart rate and respiratory rate are checked for abnormal values that might indicate systemic infection.",
            "The heart rate and respiratory rate are mildly elevated but remain relatively stable.",
            "Laboratory markers consistent with sepsis include high WBC count and lactic acidosis.",
            "The laboratory markers do not appear significantly abnormal in these data.",
            "The patient\u2019s blood pressure remains within normal limits.",
            "Oxygen saturations improve with minimal supplemental oxygen.",
            "The presence of a normal WBC count argues against a high risk of sepsis developing in the next 12 hours.",
            "Relatively stable vital signs over time argue against a high risk of sepsis developing in the next 12 hours."
        ],
        "relevant_claims": [
            "The laboratory markers do not appear significantly abnormal in these data.",
            "The presence of a normal WBC count argues against a high risk of sepsis developing in the next 12 hours."
        ],
        "alignment_scores": [
            0.2,
            0.6
        ],
        "alignment_category": [
            5,
            2
        ],
        "alignment_reasonings": [
            "The claim suggests that laboratory markers are not significantly abnormal, which implies standard markers for sepsis risk are not evident. Elevated serum lactate is a laboratory marker used to assess sepsis risk. While the claim indicates that no significant abnormalities are noted, it indirectly touches upon the absence of concerning levels, such as elevated serum lactate, suggesting no elevated sepsis risk. The alignment is weak, as the claim is about normalcy rather than specific lack of elevation.",
            "A normal white blood cell (WBC) count can be relevant to the SIRS criteria, as it suggests the absence of an elevated or decreased WBC, both of which are part of the criteria for identifying systemic inflammation consistent with early sepsis. The claim argues against the presence of systemic inflammation, indirectly referencing SIRS criteria. Hence, the category match is somewhat relevant but not a direct fit, leading to a moderate alignment rating."
        ],
        "final_alignment_score": 0.4,
        "accuracy": 0
    },
    {
        "input": "2: HR, 100.0; 2: RR, 18.0; 2: SpO2, 99.0; 2: SBP, 92.0; 2: DBP, 49.0; 2: MAP, 63.333; 2: Pain, 10.0; 2: Temp, 97.5; 21: SpO2, 96.0; 22: HR, 109.821; 22: RR, 16.308; 22: SpO2, 95.831; 22: Perf, 0.709; 22: 1min HRV, 55.738; 22: SBP, 113.0; 22: DBP, 64.0; 22: MAP, 80.333; 23: HR, 109.412; 23: RR, 21.983; 23: SpO2, 95.897; 23: Perf, 1.001; 23: 1min HRV, 2.469; 24: HR, 109.655; 24: RR, 15.407; 24: SpO2, 97.678; 24: Perf, 0.791; 24: 1min HRV, 47.215; 25: HR, 105.810; 25: RR, 12.259; 25: SpO2, 98.0; 25: Perf, 0.890; 25: 1min HRV, 62.161; 25: 5min HRV, 51.744; 26: HR, 105.322; 26: RR, 14.644; 26: SpO2, 96.034; 26: Perf, 1.468; 26: 1min HRV, 66.515; 26: SBP, 111.0; 26: DBP, 64.0; 26: MAP, 79.667; 27: HR, 103.915; 27: RR, 13.644; 27: SpO2, 96.254; 27: Perf, 1.285; 27: 1min HRV, 50.293; 28: HR, 103.603; 28: RR, 18.483; 28: SpO2, 96.414; 28: Perf, 1.205; 28: 1min HRV, 56.883; 29: HR, 104.356; 29: RR, 16.508; 29: SpO2, 96.712; 29: Perf, 0.952; 29: 1min HRV, 74.698; 30: HR, 105.678; 30: RR, 17.475; 30: SpO2, 96.831; 30: Perf, 0.944; 30: 1min HRV, 41.682; 30: 5min HRV, 59.934; 31: HR, 105.345; 31: RR, 18.379; 31: SpO2, 97.276; 31: Perf, 0.855; 31: 1min HRV, 71.599; 32: HR, 104.492; 32: RR, 16.729; 32: SpO2, 96.898; 32: Perf, 1.194; 32: 1min HRV, 62.066; 33: HR, 105.069; 33: RR, 16.621; 33: SpO2, 96.397; 33: Perf, 1.545; 33: 1min HRV, 80.449; 34: HR, 104.746; 34: RR, 18.983; 34: SpO2, 95.983; 34: Perf, 1.803; 34: 1min HRV, 73.898; 35: HR, 105.576; 35: RR, 16.322; 35: SpO2, 95.729; 35: Perf, 1.834; 35: 1min HRV, 61.796; 35: 5min HRV, 70.356; 36: HR, 104.983; 36: RR, 15.448; 36: SpO2, 96.069; 36: Perf, 1.99; 36: 1min HRV, 83.070; 37: HR, 104.034; 37: RR, 16.475; 37: SpO2, 95.610; 37: Perf, 2.194; 37: 1min HRV, 102.005; 38: HR, 104.966; 38: RR, 15.845; 38: SpO2, 95.759; 38: Perf, 2.007; 38: 1min HRV, 69.008; 39: HR, 103.780; 39: RR, 14.119; 39: SpO2, 95.254; 39: Perf, 2.145; 39: 1min HRV, 83.238; 40: HR, 103.881; 40: RR, 19.559; 40: SpO2, 94.847; 40: Perf, 2.348; 40: 1min HRV, 76.667; 40: 5min HRV, 83.563; 40: SBP, 111.0; 40: DBP, 64.0; 40: MAP, 79.667; 41: HR, 102.759; 41: RR, 14.621; 41: SpO2, 95.552; 41: Perf, 2.174; 41: 1min HRV, 86.573; 41: SBP, 111.0; 41: DBP, 64.0; 41: MAP, 79.667; 42: HR, 102.576; 42: RR, 17.508; 42: SpO2, 95.102; 42: Perf, 2.320; 42: 1min HRV, 82.545; 43: HR, 102.966; 43: RR, 14.897; 43: SpO2, 94.948; 43: Perf, 2.434; 43: 1min HRV, 91.755; 44: HR, 103.017; 44: RR, 16.254; 44: SpO2, 94.712; 44: Perf, 2.529; 44: 1min HRV, 70.841; 45: HR, 103.898; 45: RR, 15.186; 45: SpO2, 95.305; 45: Perf, 2.507; 45: 1min HRV, 75.420; 45: 5min HRV, 82.383; 46: HR, 103.431; 46: RR, 17.828; 46: SpO2, 96.103; 46: Perf, 2.182; 46: 1min HRV, 83.408; 47: HR, 102.203; 47: RR, 19.492; 47: SpO2, 94.017; 47: Perf, 1.954; 47: 1min HRV, 77.013; 48: HR, 104.759; 48: RR, 18.517; 48: SpO2, 95.448; 48: Perf, 1.667; 48: 1min HRV, 72.746; 49: HR, 104.153; 49: RR, 17.983; 49: SpO2, 95.0; 49: Perf, 1.693; 49: 1min HRV, 76.780; 50: HR, 103.017; 50: RR, 17.397; 50: SpO2, 94.759; 50: Perf, 2.124; 50: 1min HRV, 79.480; 50: 5min HRV, 78.245; 51: HR, 104.136; 51: RR, 19.288; 51: SpO2, 95.254; 51: Perf, 2.163; 51: 1min HRV, 92.776; 52: HR, 103.847; 52: RR, 18.390; 52: SpO2, 97.542; 52: Perf, 1.824; 52: 1min HRV, 83.089; 53: HR, 103.034; 53: RR, 18.431; 53: SpO2, 97.328; 53: Perf, 1.928; 53: 1min HRV, 76.756; 54: HR, 102.508; 54: RR, 14.390; 54: SpO2, 96.424; 54: Perf, 2.107; 54: 1min HRV, 85.108; 55: HR, 104.121; 55: RR, 12.517; 55: SpO2, 95.310; 55: Perf, 2.358; 55: 1min HRV, 81.613; 55: 5min HRV, 83.963; 56: HR, 103.407; 56: RR, 18.271; 56: SpO2, 96.0; 56: Perf, 1.747; 56: 1min HRV, 82.473; 56: SBP, 117.0; 56: DBP, 67.0; 56: MAP, 83.667; 57: HR, 103.085; 57: RR, 16.525; 57: SpO2, 95.0; 57: Perf, 1.738; 57: 1min HRV, 90.579; 58: HR, 103.983; 58: RR, 15.431; 58: SpO2, 95.017; 58: Perf, 1.492; 58: 1min HRV, 82.048; 59: HR, 103.169; 59: RR, 14.203; 59: SpO2, 96.0; 59: Perf, 1.310; 59: 1min HRV, 69.464; 60: HR, 103.052; 60: RR, 19.690; 60: SpO2, 95.879; 60: Perf, 1.244; 60: 1min HRV, 78.540; 60: 5min HRV, 81.043; 61: HR, 104.271; 61: RR, 15.153; 61: SpO2, 97.153; 61: Perf, 1.157; 61: 1min HRV, 82.632; 65: 5min HRV, 82.632; 86: SARS-COV-2 RNA, Not Detected; 95: WAM DIFTYP, AUTO; 95: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.40 K/uL; 95: NRBC ABSOLUTE (HEMATOLOGY), 0.04 K/uL; 95: RED CELL DISTRIBUTION WIDTH (RDW), 19.4 %; 95: NEUTROPHIL % (AUTO DIFF), 91.0 %; 95: HEMATOCRIT (HCT), 30.8 %; 95: NEUTROPHIL ABSOLUTE (AUTO DIFF), 21.21 K/uL; 95: EOSINOPHIL % (AUTO DIFF), 0.1 %; 95: WHITE BLOOD CELLS (WBC), 23.3 K/uL; 95: NRBC PERCENT (HEMATOLOGY), 0.2 %; 95: LYMPHOCYTE % (AUTO DIFF), 3.3 %; 95: PLATELET COUNT (PLT), 666 K/uL; 95: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 95: MEAN CORPUSCULAR VOLUME (MCV), 60.0 fL; 95: RED BLOOD CELLS (RBC), 5.13 MIL/uL; 95: BASOPHIL % (AUTO DIFF), 0.1 %; 95: HEMOGLOBIN (HGB), 9.2 g/dL; 95: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.7 %; 95: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 29.9 g/dL; 95: MONOCYTE % (AUTO DIFF), 3.8 %; 95: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 95: MONOCYTE ABSOLUTE (AUTO DIFF), 0.88 K/uL; 95: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.78 K/uL; 95: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 17.9 pg; 97: INR, 1.5; 97: PROTHROMBIN TIME, 17.6 seconds; 97: PART. THROMBOPLASTIN TIME, 34.5 seconds; 100: HR, 98.0; 100: RR, 17.0; 100: SpO2, 98.0; 100: SBP, 115.0; 100: DBP, 76.0; 100: MAP, 89.0; 0: Age, 74; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.4; 0: Triage HR, 100.0; 0: Triage RR, 18.0; 0: Triage SBP, 92.0; 0: Triage DBP, 49.0; 0: Triage acuity, 2-Emergent; 0: CC, FALL,ALTERED MENTAL STATUS,BACK PAIN",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, I check whether the patient\u2019s vital signs show hypotension (SBP ~90) and tachycardia (HR ~100), which they do. Next, I note the significant laboratory abnormalities, especially the elevated WBC of 23.3 K/uL with a high neutrophil percentage, suggesting infection. Then, I consider other risk factors such as advanced age, altered mental status, and potential organ dysfunction. Putting all of these factors together, I conclude that the patient is at high risk for sepsis within the next 12 hours.",
        "claims": [
            "The patient's vital signs show hypotension with an SBP of approximately 90.",
            "The patient's vital signs show tachycardia with a heart rate of approximately 100.",
            "The laboratory results indicate a significant abnormality with an elevated WBC of 23.3 K/uL.",
            "The high neutrophil percentage suggests infection.",
            "Other risk factors include the patient's advanced age.",
            "Other risk factors include the patient's altered mental status.",
            "Other risk factors include potential organ dysfunction.",
            "Putting all of these factors together, I conclude that the patient is at high risk for sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient's vital signs show hypotension with an SBP of approximately 90.",
            "The patient's vital signs show tachycardia with a heart rate of approximately 100.",
            "The laboratory results indicate a significant abnormality with an elevated WBC of 23.3 K/uL.",
            "The high neutrophil percentage suggests infection.",
            "Other risk factors include the patient's advanced age.",
            "Other risk factors include the patient's altered mental status.",
            "Other risk factors include potential organ dysfunction.",
            "Putting all of these factors together, I conclude that the patient is at high risk for sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            0.9,
            0.7,
            1.0,
            0.7,
            0.9,
            0.7,
            0.7,
            0.2
        ],
        "alignment_category": [
            7,
            2,
            2,
            2,
            1,
            3,
            8,
            4
        ],
        "alignment_reasonings": [
            "The claim indicates the patient has a systolic blood pressure (SBP) of approximately 90, suggesting potential sepsis-associated hypotension. This closely aligns with the category, which identifies an SBP <90 mmHg as a marker of progressing toward septic shock. Although the SBP is not definitively below 90 mmHg, the description is close enough to reflect a high alignment.",
            "Tachycardia is directly aligned with one of the SIRS criteria, which includes a heart rate >90 bpm. The claim indicates a heart rate of approximately 100, which surpasses the SIRS threshold for heart rate, thus aligning well with the SIRS Positivity category. However, SIRS requires \u22652 criteria, so while this claim aligns with one SIRS criterion, it doesn't directly confirm SIRS positivity by itself, resulting in a slightly less than perfect alignment.",
            "The claim specifies an elevated white blood cell count, which is explicitly listed under the SIRS criteria (WBC\u202f>\u202f12,000/\u00b5L). This directly correlates with identifying systemic inflammation consistent with early sepsis, resulting in perfect alignment with the category.",
            "An elevated neutrophil percentage suggests an inflammatory response often associated with infection, which aligns conceptually with SIRS criteria involving systemic inflammation. Although the claim does not directly meet a specific SIRS criterion, it is strongly suggestive of conditions often associated with meeting these criteria. The alignment is not perfect but is significant due to the connection with systemic inflammatory responses.",
            "The claim mentions \"the patient's advanced age\" as a risk factor. This aligns strongly with the Elderly Susceptibility category, given that advanced age is a recognized risk factor for sepsis. However, without specifying an age of \u226565, it slightly lessens the certainty that this perfectly fits the category, resulting in a slightly less than perfect alignment rating.",
            "Altered mentation is explicitly one of the components used in calculating the qSOFA score, which indicates a high risk of sepsis-related organ dysfunction and mortality. The claim directly references one part of the qSOFA criteria but does not mention the other components needed for a qSOFA score of \u22652. Hence, while the alignment is meaningful, the scoring isn't complete with the provided information, resulting in a slightly less than perfect alignment rating.",
            "The claim mentions \"potential organ dysfunction,\" which is conceptually related to a SOFA score increase, as this category assesses for new organ dysfunction as part of sepsis risk evaluation. The term \"potential\" indicates a preliminary stage, thus not specifying a confirmed \u22652 points increase. This results in a partial but relevant alignment.",
            "The claim refers to an overall assessment that leads to a conclusion of high sepsis risk. The Elevated NEWS Score category best represents an aggregate evaluation of clinical deterioration, but the claim lacks specific information to support a higher alignment rating. It does not specify any of the underlying vital signs or observations that would correspond directly to NEWS or other structured metrics. Thus, the alignment is broad and generalized, warranting a low alignment rating."
        ],
        "final_alignment_score": 0.725,
        "accuracy": 1
    },
    {
        "input": "6: Pain, 5.0; 11: HR, 102.0; 11: RR, 18.0; 11: SpO2, 99.0; 11: SBP, 100.0; 11: DBP, 65.0; 11: MAP, 76.667; 11: Pain, 5.0; 11: Temp, 98.2; 30: HR, 111.25; 30: RR, 14.657; 30: SpO2, 100.0; 30: 1min HRV, 81.817; 31: HR, 102.414; 31: RR, 16.914; 31: SpO2, 100.0; 31: Perf, 0.753; 31: 1min HRV, 98.629; 31: SBP, 110.0; 31: DBP, 75.0; 31: MAP, 86.667; 32: HR, 103.237; 32: RR, 17.898; 32: SpO2, 100.0; 32: Perf, 1.658; 32: 1min HRV, 78.261; 33: HR, 97.517; 33: RR, 15.517; 33: SpO2, 100.0; 33: Perf, 1.683; 33: 1min HRV, 150.061; 33: 5min HRV, 109.610; 34: HR, 80.729; 34: RR, 18.966; 34: SpO2, 99.926; 34: Perf, 2.32; 34: 1min HRV, 122.922; 34: SBP, 91.0; 34: DBP, 52.0; 34: MAP, 65.0; 35: HR, 89.085; 35: RR, 16.661; 35: SpO2, 100.0; 35: Perf, 2.199; 35: 1min HRV, 78.485; 36: HR, 92.931; 36: RR, 17.672; 36: SpO2, 100.0; 36: Perf, 2.005; 36: 1min HRV, 93.865; 37: HR, 85.085; 37: RR, 19.864; 37: SpO2, 100.0; 37: Perf, 2.101; 37: 1min HRV, 84.424; 38: HR, 91.086; 38: RR, 20.397; 38: SpO2, 100.0; 38: Perf, 1.374; 38: 1min HRV, 77.182; 38: 5min HRV, 98.481; 39: HR, 89.237; 39: RR, 17.610; 39: SpO2, 100.0; 39: Perf, 2.134; 39: 1min HRV, 48.857; 40: HR, 96.373; 40: RR, 19.288; 40: SpO2, 100.0; 40: Perf, 2.359; 40: 1min HRV, 75.919; 41: HR, 99.724; 41: RR, 14.759; 41: SpO2, 100.0; 41: Perf, 1.386; 41: 1min HRV, 88.768; 42: HR, 95.814; 42: RR, 16.593; 42: SpO2, 100.0; 42: Perf, 1.323; 42: 1min HRV, 64.111; 43: HR, 103.603; 43: RR, 14.776; 43: SpO2, 100.0; 43: Perf, 1.383; 43: 1min HRV, 67.070; 43: 5min HRV, 76.235; 44: HR, 102.017; 44: RR, 13.475; 44: SpO2, 100.0; 44: Perf, 1.581; 44: 1min HRV, 90.454; 45: HR, 90.586; 45: RR, 18.483; 45: SpO2, 100.0; 45: Perf, 2.140; 45: 1min HRV, 117.585; 46: HR, 86.678; 46: RR, 14.729; 46: SpO2, 100.0; 46: Perf, 1.606; 46: 1min HRV, 109.479; 47: HR, 88.390; 47: RR, 15.915; 47: SpO2, 99.898; 47: Perf, 1.572; 47: 1min HRV, 82.073; 48: HR, 92.207; 48: RR, 19.259; 48: SpO2, 100.0; 48: Perf, 1.086; 48: 1min HRV, 70.404; 48: 5min HRV, 102.281; 49: HR, 89.458; 49: RR, 14.542; 49: SpO2, 100.0; 49: Perf, 0.949; 49: 1min HRV, 91.342; 49: SBP, 120.0; 49: DBP, 91.0; 49: MAP, 100.667; 50: HR, 89.345; 50: RR, 21.069; 50: SpO2, 100.0; 50: Perf, 1.104; 50: 1min HRV, 58.674; 51: HR, 93.746; 51: RR, 17.288; 51: SpO2, 100.0; 51: Perf, 1.145; 51: 1min HRV, 52.221; 52: HR, 94.814; 52: RR, 13.254; 52: SpO2, 100.0; 52: Perf, 0.876; 52: 1min HRV, 103.907; 53: HR, 90.397; 53: RR, 16.0; 53: SpO2, 100.0; 53: Perf, 0.88; 53: 1min HRV, 81.909; 53: 5min HRV, 81.277; 54: HR, 86.441; 54: RR, 16.119; 54: SpO2, 100.0; 54: Perf, 0.841; 54: 1min HRV, 85.111; 55: HR, 92.845; 55: RR, 16.897; 55: SpO2, 100.0; 55: Perf, 1.127; 55: 1min HRV, 66.007; 56: HR, 96.271; 56: RR, 17.542; 56: SpO2, 100.0; 56: Perf, 1.338; 56: 1min HRV, 73.784; 57: HR, 100.729; 57: RR, 18.814; 57: SpO2, 100.0; 57: Perf, 1.393; 57: 1min HRV, 88.383; 58: HR, 88.517; 58: RR, 17.069; 58: SpO2, 100.0; 58: Perf, 1.814; 58: 1min HRV, 76.327; 58: 5min HRV, 85.133; 59: HR, 81.674; 59: RR, 17.568; 59: SpO2, 100.0; 59: Perf, 1.497; 59: 1min HRV, 79.274; 63: 5min HRV, 79.274; 72: NS IV BOLUS -, 1000 ML; 73: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 88: WAM DIFTYP, AUTO; 88: MONOCYTE ABSOLUTE (AUTO DIFF), 0.45 K/uL; 88: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 88: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.71 K/uL; 88: RED BLOOD CELLS (RBC), 4.81 MIL/uL; 88: BASOPHIL % (AUTO DIFF), 0.7 %; 88: LYMPHOCYTE % (AUTO DIFF), 24.8 %; 88: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 88: NEUTROPHIL % (AUTO DIFF), 67.0 %; 88: EOSINOPHIL % (AUTO DIFF), 0.3 %; 88: RED CELL DISTRIBUTION WIDTH (RDW), 16.5 %; 88: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.1 g/dL; 88: NEUTROPHIL ABSOLUTE (AUTO DIFF), 4.61 K/uL; 88: HEMATOCRIT (HCT), 36.7 %; 88: BASOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 88: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 23.7 pg; 88: PLATELET COUNT (PLT), 346 K/uL; 88: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.05 K/uL; 88: HEMOGLOBIN (HGB), 11.4 g/dL; 88: MEAN CORPUSCULAR VOLUME (MCV), 76.3 fL; 88: MONOCYTE % (AUTO DIFF), 6.5 %; 88: NRBC PERCENT (HEMATOLOGY), 0.0 %; 88: WHITE BLOOD CELLS (WBC), 6.9 K/uL; 88: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.7 %; 107: SARS-COV-2 RNA, Not Detected; 107: RSV, Not Detected; 107: INFLUENZA A, Not Detected; 107: INFLUENZA B, Not Detected; 118: GLUCOSE, URINE (UA): Negative; 118: SPECIFIC GRAVITY, URINE (UA): 1.024; 118: PH, URINE (UA): 5.0; 118: NITRITE, URINE (UA): Negative; 118: PROTEIN, URINE (UA): Negative; 118: PROTEIN TOTAL, 8.2 g/dL; 118: SODIUM, 133 mmol/L; 118: ALT (SGPT), 13 U/L; 118: CO2, 13 mmol/L; 118: CHLORIDE, 98 mmol/L; 118: GLUCOSE, 64 mg/dL; 118: EGFR REFIT WITHOUT RACE (2021), 132 mL/min/1.73 m2; 118: BILIRUBIN TOTAL, 0.7 mg/dL; 118: ALBUMIN, 5.5 g/dL; 118: CREATININE, 0.61 mg/dL; 118: ALKALINE PHOSPHATASE, 58 U/L; 118: GLOBULIN, 2.7 g/dL; 118: CALCIUM, 9.9 mg/dL; 118: EGFR FOR AFRICAN AMERICAN, 152 mL/min/1.73 m2; 118: BLOOD UREA NITROGEN (BUN), 8 mg/dL; 118: CORRECTED CALCIUM, 8.7 mg/dL; 118: ANION GAP, 22 mmol/L; 118: POTASSIUM, 3.7 mmol/L; 118: AST (SGOT), 22 U/L; 0: Age, 20; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.8; 0: Triage HR, 102.0; 0: Triage RR, 18.0; 0: Triage SBP, 100.0; 0: Triage DBP, 65.0; 0: Triage acuity, 3-Urgent; 0: CC, EMESIS",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I check if the vital signs (such as heart rate, blood pressure, and temperature) indicate consistent fever, persistent tachycardia, or hypotension suggestive of severe infection. Next, I review labs (especially white blood cell count and organ function markers) to see if there is evidence of systemic infection or organ dysfunction. Finally, the normal temperature, normal WBC count, and overall stabilization of vitals after IV fluids indicate no high risk of sepsis within 12 hours.",
        "claims": [
            "The vital signs include heart rate, blood pressure, and temperature.",
            "I check if the vital signs indicate consistent fever.",
            "I check if the vital signs indicate persistent tachycardia.",
            "I check if the vital signs indicate hypotension suggestive of severe infection.",
            "I review lab results, especially the white blood cell count and organ function markers.",
            "I look for evidence of systemic infection in the lab results.",
            "I look for evidence of organ dysfunction in the lab results.",
            "A normal temperature indicates no high risk of sepsis.",
            "A normal white blood cell count indicates no high risk of sepsis.",
            "Overall stabilization of vitals after IV fluids indicates no high risk of sepsis within 12 hours.",
            "The presence of persistent tachycardia or hypotension suggests a high risk of infection.",
            "The presence of evidence of systemic infection or organ dysfunction indicates a high risk of sepsis."
        ],
        "relevant_claims": [
            "The presence of persistent tachycardia or hypotension suggests a high risk of infection."
        ],
        "alignment_scores": [
            0.8
        ],
        "alignment_category": [
            6
        ],
        "alignment_reasonings": [
            "The claim references persistent tachycardia and hypotension, both of which contribute to an elevated shock index and signal haemodynamic instability, a strong indicator of severe sepsis. While persistent tachycardia on its own may not fully justify Severe Sepsis, hypotension strongly aligns with this category. However, since shock index calculation or specific thresholds aren't given, the alignment is significant but not perfect."
        ],
        "final_alignment_score": 0.8,
        "accuracy": 1
    },
    {
        "input": "14: HR, 156.0; 14: RR, 22.0; 14: SpO2, 93.0; 14: SBP, 184.0; 14: DBP, 168.0; 14: MAP, 173.333; 14: Temp, 97.3; 35: HR, 73.452; 35: RR, 33.366; 35: 1min HRV, 88.112; 36: HR, 70.379; 36: RR, 41.362; 36: 1min HRV, 83.043; 37: HR, 70.136; 37: RR, 39.831; 37: 1min HRV, 83.907; 38: HR, 71.271; 38: RR, 37.661; 38: 1min HRV, 104.463; 39: HR, 69.610; 39: RR, 38.0; 39: 1min HRV, 87.117; 39: 5min HRV, 90.988; 40: HR, 70.379; 40: RR, 38.190; 40: 1min HRV, 113.496; 41: HR, 70.678; 41: RR, 40.169; 41: 1min HRV, 117.322; 42: HR, 69.776; 42: RR, 37.0; 42: 1min HRV, 115.847; 43: HR, 68.390; 43: RR, 40.169; 43: 1min HRV, 110.946; 44: HR, 70.373; 44: RR, 41.017; 44: 1min HRV, 121.203; 44: 5min HRV, 116.373; 45: HR, 64.345; 45: RR, 38.948; 45: 1min HRV, 6.663; 46: HR, 62.780; 46: RR, 39.864; 46: 1min HRV, 92.436; 47: HR, 73.276; 47: RR, 24.948; 47: 1min HRV, 154.990; 48: HR, 69.915; 48: RR, 25.254; 48: 1min HRV, 110.643; 49: HR, 75.483; 49: RR, 23.448; 49: 1min HRV, 131.734; 49: 5min HRV, 125.448; 50: HR, 77.559; 50: RR, 23.831; 50: 1min HRV, 147.393; 51: HR, 76.407; 51: RR, 30.068; 51: 1min HRV, 107.678; 51: Temp, 100.6; 52: HR, 74.534; 52: RR, 38.569; 52: 1min HRV, 124.051; 53: HR, 71.661; 53: RR, 33.695; 53: 1min HRV, 122.241; 54: HR, 71.759; 54: RR, 36.5; 54: 1min HRV, 130.296; 54: 5min HRV, 130.490; 55: HR, 71.729; 55: RR, 36.305; 55: 1min HRV, 135.077; 56: HR, 68.153; 56: RR, 37.983; 56: 1min HRV, 125.658; 57: HR, 63.828; 57: RR, 36.776; 57: 1min HRV, 103.130; 58: HR, 65.407; 58: RR, 37.729; 58: 1min HRV, 103.953; 59: HR, 66.466; 59: RR, 38.414; 59: 1min HRV, 135.229; 59: 5min HRV, 127.500; 60: HR, 70.102; 60: RR, 31.085; 60: 1min HRV, 142.860; 61: HR, 68.017; 61: RR, 31.305; 61: 1min HRV, 147.320; 62: HR, 69.914; 62: RR, 31.121; 62: 1min HRV, 141.935; 63: HR, 67.271; 63: RR, 36.932; 63: 1min HRV, 139.864; 64: HR, 68.155; 64: RR, 38.310; 64: 1min HRV, 163.649; 64: 5min HRV, 147.753; 65: HR, 69.441; 65: RR, 34.898; 65: 1min HRV, 157.793; 66: HR, 69.780; 66: RR, 37.508; 66: SpO2, 97.0; 66: 1min HRV, 148.174; 67: HR, 66.0; 67: RR, 38.224; 67: 1min HRV, 146.767; 68: HR, 66.203; 68: RR, 36.678; 68: 1min HRV, 137.768; 69: HR, 64.672; 69: RR, 40.121; 69: 1min HRV, 136.136; 69: 5min HRV, 149.031; 70: HR, 63.220; 70: RR, 38.797; 70: 1min HRV, 133.571; 71: HR, 70.814; 71: RR, 38.542; 71: 1min HRV, 157.983; 72: HR, 65.414; 72: RR, 38.466; 72: 1min HRV, 144.074; 73: HR, 64.254; 73: RR, 34.102; 73: 1min HRV, 140.864; 74: HR, 68.517; 74: RR, 29.448; 74: 1min HRV, 137.646; 74: 5min HRV, 148.502; 75: HR, 68.627; 75: RR, 29.271; 75: 1min HRV, 140.437; 76: HR, 69.322; 76: RR, 30.797; 76: 1min HRV, 153.600; 77: HR, 69.052; 77: RR, 34.431; 77: 1min HRV, 154.615; 78: HR, 67.407; 78: RR, 35.729; 78: 1min HRV, 139.424; 79: HR, 69.086; 79: RR, 26.397; 79: 1min HRV, 140.216; 79: 5min HRV, 146.596; 80: HR, 64.390; 80: RR, 38.661; 80: 1min HRV, 146.641; 81: SARS-COV-2 RNA, Not Detected; 81: HR, 66.190; 81: RR, 35.707; 81: 1min HRV, 129.707; 82: HR, 65.186; 82: RR, 38.034; 82: 1min HRV, 128.806; 83: HR, 68.983; 83: RR, 34.644; 83: 1min HRV, 144.160; 84: HR, 70.931; 84: RR, 37.103; 84: 1min HRV, 154.379; 84: 5min HRV, 144.235; 85: HR, 68.661; 85: RR, 35.610; 85: 1min HRV, 154.297; 86: HR, 69.931; 86: RR, 37.397; 86: 1min HRV, 151.109; 87: HR, 70.390; 87: RR, 39.305; 87: 1min HRV, 156.446; 88: HR, 69.475; 88: RR, 36.949; 88: 1min HRV, 151.355; 89: HR, 67.793; 89: RR, 34.845; 89: 1min HRV, 149.483; 89: 5min HRV, 153.149; 90: HR, 65.017; 90: RR, 33.831; 90: SpO2, 96.0; 90: 1min HRV, 131.283; 91: HR, 67.5; 91: RR, 30.017; 91: 1min HRV, 139.116; 92: HR, 70.949; 92: RR, 38.763; 92: SpO2, 97.0; 92: 1min HRV, 174.120; 93: HR, 76.407; 93: RR, 32.576; 93: SpO2, 97.0; 93: 1min HRV, 141.376; 94: HR, 73.017; 94: RR, 34.138; 94: 1min HRV, 135.197; 94: 5min HRV, 152.108; 95: HR, 71.915; 95: RR, 36.458; 95: 1min HRV, 138.877; 96: HR, 71.190; 96: RR, 39.517; 96: 1min HRV, 156.430; 97: HR, 66.492; 97: RR, 34.322; 97: 1min HRV, 132.356; 98: HR, 69.119; 98: RR, 30.983; 98: 1min HRV, 147.886; 99: HR, 69.190; 99: RR, 34.5; 99: 1min HRV, 144.492; 99: 5min HRV, 145.686; 100: HR, 71.492; 100: RR, 38.237; 100: 1min HRV, 150.561; 101: HR, 71.293; 101: RR, 37.793; 101: 1min HRV, 138.640; 102: HR, 68.424; 102: RR, 38.237; 102: 1min HRV, 133.726; 103: HR, 67.881; 103: RR, 38.288; 103: 1min HRV, 135.745; 104: HR, 69.310; 104: RR, 39.690; 104: 1min HRV, 134.999; 104: 5min HRV, 139.607; 105: HR, 69.356; 105: RR, 40.051; 105: SpO2, 96.0; 105: 1min HRV, 160.859; 106: HR, 74.793; 106: RR, 39.690; 106: 1min HRV, 165.740; 107: HR, 66.797; 107: RR, 34.356; 107: SpO2, 94.5; 107: 1min HRV, 141.305; 108: HR, 65.424; 108: RR, 35.186; 108: SpO2, 94.0; 108: 1min HRV, 133.033; 109: HR, 67.914; 109: RR, 38.517; 109: SpO2, 94.889; 109: 1min HRV, 148.623; 109: 5min HRV, 153.681; 110: HR, 69.254; 110: RR, 36.085; 110: 1min HRV, 146.020; 111: HR, 69.397; 111: RR, 35.603; 111: SpO2, 100.0; 111: 1min HRV, 152.806; 111: SBP, 102.0; 111: DBP, 52.0; 111: MAP, 68.667; 112: HR, 68.237; 112: RR, 27.881; 112: 1min HRV, 181.621; 113: HR, 71.5; 113: RR, 30.466; 113: 1min HRV, 139.520; 114: HR, 66.407; 114: RR, 38.373; 114: SpO2, 93.2; 114: 1min HRV, 139.131; 114: 5min HRV, 152.803; 115: HR, 69.661; 115: RR, 34.288; 115: 1min HRV, 139.376; 115: SBP, 106.0; 115: DBP, 63.0; 115: MAP, 77.333; 116: HR, 69.448; 116: RR, 35.690; 116: 1min HRV, 141.771; 117: HR, 66.407; 117: RR, 37.017; 117: 1min HRV, 123.354; 118: HR, 67.810; 118: RR, 34.707; 118: 1min HRV, 144.249; 119: HR, 66.746; 119: RR, 34.610; 119: 1min HRV, 138.079; 119: 5min HRV, 138.635; 0: Age, 88; 0: Gender, F; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 36.3; 0: Triage HR, 156.0; 0: Triage RR, 22.0; 0: Triage SBP, 184.0; 0: Triage DBP, 168.0; 0: Triage acuity, 3-Urgent; 0: CC, REFERRAL",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, I check whether the patient has a significantly elevated heart rate. The triage HR of 156 indicates the patient is tachycardic. Next, I look for other sepsis indicators such as fever and high respiratory rate; the data shows a fever of 100.6\u00b0F and persistent RR above 30. Then, I note the patient\u2019s advanced age and occasional borderline blood pressure measurements. Combining these factors suggests a high risk for sepsis within the next 12 hours.",
        "claims": [
            "The patient's heart rate is significantly elevated.",
            "The triage heart rate (HR) is 156.",
            "A heart rate of 156 indicates the patient is tachycardic.",
            "Other sepsis indicators include fever and high respiratory rate.",
            "The patient has a fever of 100.6\u00b0F.",
            "The patient's respiratory rate is persistent and above 30.",
            "The patient is of advanced age.",
            "The patient has occasional borderline blood pressure measurements.",
            "Combining these factors suggests a high risk for sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient's heart rate is significantly elevated.",
            "The triage heart rate (HR) is 156.",
            "A heart rate of 156 indicates the patient is tachycardic.",
            "Other sepsis indicators include fever and high respiratory rate.",
            "The patient's respiratory rate is persistent and above 30.",
            "The patient is of advanced age.",
            "The patient has occasional borderline blood pressure measurements.",
            "Combining these factors suggests a high risk for sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            0.8,
            0.7,
            0.7,
            1.0,
            0.9,
            0.8,
            0.3,
            0.3
        ],
        "alignment_category": [
            2,
            6,
            2,
            2,
            3,
            1,
            7,
            4
        ],
        "alignment_reasonings": [
            "An elevated heart rate (>90 bpm) is one of the criteria explicitly listed under SIRS criteria. The claim of a \"significantly elevated\" heart rate suggests meeting this threshold, indicating systemic inflammation consistent with early sepsis. The alignment is strong but could be made stronger if specific heart rate values were given to confirm the criteria threshold.",
            "A heart rate of 156 is significantly high, suggesting potential hemodynamic instability, which is relevant to the Elevated Shock Index category. However, the shock index requires both heart rate and systolic blood pressure data to determine if it meets the specific criteria of \u22651.0. The alignment is thus partial but strong due to the heart rate being a critical component of the shock index calculation, indicating possible high-severity sepsis.",
            "The claim references tachycardia, which aligns with the SIRS criteria of heart rate\u202f>\u202f90\u202fbpm. While the presence of tachycardia alone (as per the claim) does not satisfy the requirement of at least 2 SIRS criteria, it certainly points toward systemic inflammation, making it a noteworthy indicator within this category. The claim's direct mention of tachycardia as a qualifier is a strong match to this criterion, but since additional SIRS criteria are needed for full positivity, the alignment is not absolute, hence a strong but not perfect score.",
            "The claim directly references fever and high respiratory rate, both of which are criteria listed under the SIRS criteria. Having \u22652 SIRS criteria is used to identify systemic inflammation consistent with early sepsis, resulting in perfect alignment with this category.",
            "The claim mentions a high respiratory rate, which is directly relevant to a component of the qSOFA score (respiratory rate\u202f\u2265\u202f22/min). The claim indicates the respiratory rate is significantly above the threshold, suggesting a strong alignment with the qSOFA criteria for assessing the risk of sepsis-related organ dysfunction and mortality. Although the claim doesn't mention the full qSOFA score, the specific criterion about respiratory rate aligns closely.",
            "The claim refers to the patient being of \"advanced age,\" which suggests they are likely in the older age group. Although the exact age is not specified, the term \"advanced age\" generally aligns with the concept of increased age-related sepsis susceptibility described in this category. Therefore, while it strongly hints at the category of Elderly Susceptibility, the lack of precise age information reduces the alignment slightly from a perfect score.",
            "The claim about \"occasional borderline blood pressure measurements\" hints at blood pressure instability, but does not strongly confirm sepsis-associated hypotension as defined by the category (e.g., SBP\u202f<\u202f90\u202fmmHg, MAP\u202f<\u202f70\u202fmmHg, or a\u202f\u2265\u202f40\u202fmmHg drop from baseline). The alignment is weak because it hints at potential concern for blood pressure drops without quantifying the extent necessary for a robust link to sepsis-associated hypotension.",
            "The claim mentions a combination of factors suggesting high sepsis risk. The Elevated NEWS Score considers the combination of multiple deranged vitals, predicting clinical deterioration compatible with sepsis, which aligns conceptually with the idea of multiple risk factors. However, without specific details or metrics provided, the alignment is somewhat vague, leading to a moderate but not strong alignment rating."
        ],
        "final_alignment_score": 0.6875,
        "accuracy": 1
    },
    {
        "input": "5: HR, 148.0; 6: HR, 147.308; 6: RR, 33.12; 6: SpO2, 99.0; 6: 1min HRV, 1.682; 6: SBP, 129.0; 6: DBP, 87.0; 6: MAP, 101.0; 6: LPM O2, 6.0; 6: Pain, 0.0; 6: Temp, 98.2; 7: HR, 147.224; 7: RR, 33.569; 7: 1min HRV, 1.191; 8: HR, 146.763; 8: RR, 30.068; 8: 1min HRV, 2.764; 8: 5min HRV, 2.393; 9: HR, 145.961; 9: RR, 29.65; 9: 1min HRV, 1.375; 9: SBP, 127.0; 9: DBP, 80.0; 9: MAP, 95.667; 10: HR, 146.276; 10: RR, 31.103; 10: 1min HRV, 0.989; 11: HR, 145.441; 11: RR, 28.847; 11: 1min HRV, 2.797; 12: HR, 145.466; 12: RR, 27.776; 12: 1min HRV, 1.743; 13: HR, 145.424; 13: RR, 29.831; 13: 1min HRV, 1.490; 13: 5min HRV, 2.104; 14: HR, 145.610; 14: RR, 29.831; 14: SpO2, 100.0; 14: Perf, 0.57; 14: 1min HRV, 1.934; 15: HR, 147.259; 15: RR, 34.121; 15: SpO2, 100.0; 15: 1min HRV, 3.816; 16: HR, 147.864; 16: RR, 26.898; 16: 1min HRV, 3.060; 17: HR, 147.052; 17: RR, 31.310; 17: SpO2, 99.636; 17: 1min HRV, 4.018; 18: HR, 150.305; 18: RR, 24.373; 18: SpO2, 98.0; 18: 1min HRV, 2.201; 18: 5min HRV, 5.055; 19: HR, 151.169; 19: RR, 33.508; 19: SpO2, 99.062; 19: 1min HRV, 3.213; 20: HR, 147.517; 20: RR, 30.552; 20: SpO2, 99.176; 20: Perf, 0.37; 20: 1min HRV, 2.140; 21: HR, 148.102; 21: RR, 31.305; 21: SpO2, 99.133; 21: Perf, 0.389; 21: 1min HRV, 4.108; 22: HR, 148.052; 22: RR, 33.414; 22: SpO2, 99.0; 22: 1min HRV, 2.972; 23: HR, 146.593; 23: RR, 30.915; 23: SpO2, 99.0; 23: 1min HRV, 1.722; 23: 5min HRV, 5.107; 23: SBP, 128.0; 23: DBP, 83.0; 23: MAP, 98.0; 23: LPM O2, 6.0; 24: HR, 145.881; 24: RR, 31.136; 24: SpO2, 99.592; 24: 1min HRV, 1.097; 24: SBP, 128.0; 24: DBP, 83.0; 24: MAP, 98.0; 25: HR, 146.241; 25: RR, 28.759; 25: SpO2, 98.438; 25: Perf, 0.793; 25: 1min HRV, 1.190; 26: HR, 145.881; 26: RR, 28.119; 26: SpO2, 99.932; 26: Perf, 0.795; 26: 1min HRV, 0.960; 27: HR, 145.138; 27: RR, 28.672; 27: SpO2, 99.017; 27: Perf, 0.723; 27: 1min HRV, 1.042; 28: HR, 145.153; 28: RR, 28.593; 28: SpO2, 99.173; 28: Perf, 0.73; 28: 1min HRV, 1.207; 28: 5min HRV, 1.542; 29: HR, 145.525; 29: RR, 27.407; 29: Perf, 0.73; 29: 1min HRV, 1.633; 30: HR, 145.517; 30: RR, 27.552; 30: 1min HRV, 1.037; 31: HR, 145.915; 31: RR, 29.610; 31: SpO2, 97.195; 31: 1min HRV, 1.695; 32: HR, 147.879; 32: RR, 39.362; 32: SpO2, 97.889; 32: Perf, 0.77; 32: 1min HRV, 3.703; 33: HR, 146.678; 33: RR, 33.051; 33: 1min HRV, 2.117; 33: 5min HRV, 3.198; 66: WAM DIFTYP, AUTO; 66: HEMATOCRIT (HCT), 27.6 %; 66: EOSINOPHIL % (AUTO DIFF), 0.5 %; 66: MONOCYTE ABSOLUTE (AUTO DIFF), 0.60 K/uL; 66: RED BLOOD CELLS (RBC), 2.95 MIL/uL; 66: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 66: MEAN CORPUSCULAR VOLUME (MCV), 93.6 fL; 66: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.03 K/uL; 66: PLATELET COUNT (PLT), 172 K/uL; 66: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.5 %; 66: NEUTROPHIL ABSOLUTE (AUTO DIFF), 4.83 K/uL; 66: LYMPHOCYTE % (AUTO DIFF), 10.6 %; 66: WHITE BLOOD CELLS (WBC), 6.2 K/uL; 66: RED CELL DISTRIBUTION WIDTH (RDW), 19.5 %; 66: HEMOGLOBIN (HGB), 8.3 g/dL; 66: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 66: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 66: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 28.1 pg; 66: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 30.1 g/dL; 66: NEUTROPHIL % (AUTO DIFF), 78.4 %; 66: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.65 K/uL; 66: BASOPHIL % (AUTO DIFF), 0.3 %; 66: NRBC PERCENT (HEMATOLOGY), 0.0 %; 66: MONOCYTE % (AUTO DIFF), 9.7 %; 99: CHLORIDE, 93 mmol/L; 99: ALKALINE PHOSPHATASE, 232 U/L; 99: EGFR REFIT WITHOUT RACE (2021), 155 mL/min/1.73 m2; 99: BLOOD UREA NITROGEN (BUN), 3 mg/dL; 99: POTASSIUM, 4.1 mmol/L; 99: CO2, 37 mmol/L; 99: SODIUM, 135 mmol/L; 99: AST (SGOT), 60 U/L; 99: EGFR FOR AFRICAN AMERICAN, 178 mL/min/1.73 m2; 99: GLOBULIN, 3.4 g/dL; 99: PROTEIN TOTAL, 5.9 g/dL; 99: CORRECTED CALCIUM, 9.9 mg/dL; 99: ANION GAP, 5 mmol/L; 99: BILIRUBIN TOTAL, 0.2 mg/dL; 99: ALBUMIN, 2.5 g/dL; 99: CREATININE, 0.25 mg/dL; 99: ALT (SGPT), 16 U/L; 99: CALCIUM, 8.7 mg/dL; 99: GLUCOSE, 104 mg/dL; 99: BNP NT-PRO, 415 pg/mL; 100: LR IV BOLUS -, 500 ML; 0: Age:, 38; 0: Gender, F; 0: Race, Other; 0: Means of arrival, EMS; 0: Triage Temp, 36.8; 0: Triage HR, 147.0; 0: Triage RR, 29.0; 0: Triage SBP, 129.0; 0: Triage DBP, 87.0; 0: Triage acuity, 2-Emergent; 0: CC, SHORTNESS OF BREATH",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "First, I checked whether the patient\u2019s vital signs met common sepsis-triggering thresholds (e.g., high heart rate, high respiratory rate, potential fever). Then, I asked if there were lab indicators of infection or organ dysfunction (such as elevated white blood cell count) and found them to be unremarkable. Next, I considered fluid administration and vital trends to see if they suggested a suspected infection, but the normal blood pressure and normal to slightly low WBC count did not strongly indicate sepsis. Finally, I noted the persistent tachycardia and tachypnea but no clear sign of infection or significant organ dysfunction, leading me to conclude a low sepsis risk.",
        "claims": [
            "The patient\u2019s vital signs were checked for common sepsis-triggering thresholds.",
            "Common sepsis-triggering thresholds include high heart rate, high respiratory rate, and potential fever.",
            "Lab indicators of infection or organ dysfunction were evaluated.",
            "The lab indicators found were unremarkable.",
            "Fluid administration and vital trends were considered.",
            "Normal blood pressure was observed.",
            "The white blood cell count was normal to slightly low.",
            "Normal blood pressure and normal to slightly low white blood cell count did not strongly indicate sepsis.",
            "Persistent tachycardia was noted.",
            "Persistent tachypnea was noted.",
            "There were no clear signs of infection.",
            "There was no significant organ dysfunction observed.",
            "These observations led to the conclusion of a low sepsis risk."
        ],
        "relevant_claims": [
            "Persistent tachycardia was noted.",
            "Persistent tachypnea was noted."
        ],
        "alignment_scores": [
            0.7,
            0.8
        ],
        "alignment_category": [
            2,
            3
        ],
        "alignment_reasonings": [
            "Tachycardia, defined as a heart rate >90 bpm, is one of the criteria under SIRS, which identifies systemic inflammation and could indicate early sepsis. The claim mentions persistent tachycardia, which strongly aligns with this criterion but does not provide other SIRS criteria\u2014resulting in a high but not perfect alignment rating.",
            "The claim of \"persistent tachypnea\" refers to an elevated respiratory rate, which is a component of the qSOFA score (respiratory rate \u226522/min). This makes it highly relevant to this category, although the exact respiratory rate is not provided. The mention of persistent tachypnea suggests a notable respiratory irregularity that aligns strongly but not perfectly without specific quantification."
        ],
        "final_alignment_score": 0.75,
        "accuracy": 0
    },
    {
        "input": "3: SpO2, 98.0; 5: SpO2, 98.333; 6: HR, 93.0; 6: RR, 28.0; 6: SpO2, 95.75; 6: 1min HRV, 31.387; 6: SBP, 134.0; 6: DBP, 95.0; 6: MAP, 108.0; 6: Pain, 0.0; 6: Temp, 99.0; 7: HR, 84.458; 7: RR, 21.627; 7: SpO2, 98.0; 7: 1min HRV, 104.688; 8: HR, 94.293; 8: RR, 23.052; 8: SpO2, 96.0; 8: 1min HRV, 94.542; 9: HR, 93.038; 9: RR, 24.254; 9: SpO2, 98.083; 9: 1min HRV, 92.495; 10: HR, 90.259; 10: RR, 23.293; 10: SpO2, 97.0; 10: 1min HRV, 112.587; 10: 5min HRV, 101.228; 11: HR, 81.390; 11: RR, 22.051; 11: SpO2, 99.0; 11: 1min HRV, 72.280; 12: HR, 82.881; 12: RR, 22.407; 12: 1min HRV, 129.498; 13: HR, 88.017; 13: RR, 20.914; 13: SpO2, 97.0; 13: 1min HRV, 95.278; 14: HR, 78.102; 14: RR, 19.322; 14: SpO2, 96.667; 14: 1min HRV, 109.998; 15: HR, 82.964; 15: RR, 31.448; 15: SpO2, 96.0; 15: 1min HRV, 31.449; 15: 5min HRV, 113.038; 16: HR, 94.931; 16: RR, 24.847; 16: SpO2, 99.489; 16: 1min HRV, 69.945; 17: HR, 94.678; 17: RR, 25.644; 17: SpO2, 96.759; 17: 1min HRV, 40.994; 18: HR, 85.517; 18: RR, 24.517; 18: SpO2, 96.24; 18: 1min HRV, 93.672; 19: HR, 90.220; 19: RR, 21.763; 19: SpO2, 97.030; 19: 1min HRV, 79.258; 20: HR, 92.0; 20: RR, 19.586; 20: SpO2, 98.0; 20: 1min HRV, 87.822; 20: 5min HRV, 92.999; 21: HR, 82.475; 21: RR, 25.186; 21: SpO2, 95.4; 21: 1min HRV, 109.828; 21: SBP, 123.0; 21: DBP, 94.0; 21: MAP, 103.667; 22: HR, 85.414; 22: RR, 22.0; 22: SpO2, 94.0; 22: 1min HRV, 83.980; 23: HR, 81.847; 23: 1min HRV, 124.486; 24: HR, 94.831; 24: SpO2, 92.737; 24: 1min HRV, 63.324; 25: HR, 87.224; 25: 1min HRV, 86.715; 25: 5min HRV, 103.995; 26: HR, 79.339; 26: SpO2, 94.0; 26: 1min HRV, 94.155; 27: HR, 92.207; 27: 1min HRV, 83.240; 28: HR, 79.220; 28: 1min HRV, 81.363; 29: HR, 86.525; 29: SpO2, 96.0; 29: 1min HRV, 86.182; 30: HR, 92.190; 30: RR, 24.4; 30: SpO2, 84.0; 30: 1min HRV, 80.311; 30: 5min HRV, 98.806; 31: HR, 101.153; 31: RR, 24.610; 31: 1min HRV, 55.800; 32: WAM DIFTYP, AUTO; 32: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 32: RED CELL DISTRIBUTION WIDTH (RDW), 18.7 %; 32: BASOPHIL % (AUTO DIFF), 0.9 %; 32: RED BLOOD CELLS (RBC), 3.85 MIL/uL; 32: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 26.2 pg; 32: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.08 K/uL; 32: NRBC PERCENT (HEMATOLOGY), 0.0 %; 32: NEUTROPHIL ABSOLUTE (AUTO DIFF), 2.49 K/uL; 32: WHITE BLOOD CELLS (WBC), 4.4 K/uL; 32: EOSINOPHIL % (AUTO DIFF), 1.8 %; 32: LYMPHOCYTE % (AUTO DIFF), 32.9 %; 32: NEUTROPHIL % (AUTO DIFF), 56.8 %; 32: MEAN CORPUSCULAR VOLUME (MCV), 86.8 fL; 32: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 32: HEMATOCRIT (HCT), 33.4 %; 32: PLATELET COUNT (PLT), 481 K/uL; 32: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 30.2 g/dL; 32: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.5 %; 32: MONOCYTE ABSOLUTE (AUTO DIFF), 0.31 K/uL; 32: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.02 K/uL; 32: MONOCYTE % (AUTO DIFF), 7.1 %; 32: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.44 K/uL; 32: HEMOGLOBIN (HGB), 10.1 g/dL; 32: HR, 101.455; 32: RR, 25.707; 32: SpO2, 76.0; 32: 1min HRV, 41.524; 33: HR, 94.418; 33: RR, 21.186; 33: SpO2, 85.639; 33: 1min HRV, 75.895; 34: HR, 79.864; 34: RR, 22.492; 34: SpO2, 83.6; 34: 1min HRV, 131.719; 35: HR, 81.966; 35: RR, 27.207; 35: 1min HRV, 94.631; 35: 5min HRV, 112.726; 35: SBP, 126.0; 35: DBP, 99.0; 35: MAP, 108.0; 36: HR, 77.385; 36: RR, 24.644; 36: 1min HRV, 64.092; 36: SBP, 126.0; 36: DBP, 99.0; 36: MAP, 108.0; 37: HR, 81.414; 37: RR, 18.862; 37: 1min HRV, 106.216; 38: HR, 84.932; 38: RR, 19.390; 38: 1min HRV, 120.461; 39: HR, 94.833; 39: RR, 22.524; 39: SpO2, 71.714; 39: 1min HRV, 104.928; 40: HR, 102.116; 40: RR, 28.2; 40: SpO2, 81.0; 40: 1min HRV, 76.230; 40: 5min HRV, 116.478; 41: HR, 100.567; 41: RR, 30.424; 41: SpO2, 84.0; 41: 1min HRV, 146.366; 42: HR, 96.966; 42: RR, 24.475; 42: SpO2, 92.895; 42: 1min HRV, 198.539; 43: HR, 95.579; 43: RR, 29.667; 43: 1min HRV, 31.594; 44: HR, 99.754; 44: RR, 25.74; 44: 1min HRV, 57.814; 45: HR, 96.348; 45: RR, 28.833; 45: 1min HRV, 11.723; 45: 5min HRV, 84.891; 46: HR, 91.780; 46: 1min HRV, 56.944; 47: HR, 88.333; 47: 1min HRV, 38.182; 48: HR, 88.205; 48: 1min HRV, 140.676; 49: HR, 89.158; 49: 1min HRV, 118.585; 50: HR, 98.868; 50: 1min HRV, 41.762; 50: 5min HRV, 81.611; 60: SpO2, 71.0; 61: Pain, 0.0; 62: HIGH SENSITIVITY TROPONIN, 24 ng/L; 63: BLOOD UREA NITROGEN (BUN), 22 mg/dL; 63: CHLORIDE, 106 mmol/L; 63: ALBUMIN, 3.1 g/dL; 63: GLOBULIN, 4.1 g/dL; 63: CREATININE, 0.80 mg/dL; 63: ANION GAP, 9 mmol/L; 63: CORRECTED CALCIUM, 9.2 mg/dL; 63: POTASSIUM, 3.6 mmol/L; 63: GLUCOSE, 103 mg/dL; 63: ALKALINE PHOSPHATASE, 168 U/L; 63: PROTEIN TOTAL, 7.2 g/dL; 63: ALT (SGPT), 100 U/L; 63: AST (SGOT), 40 U/L; 63: SODIUM, 139 mmol/L; 63: EGFR REFIT WITHOUT RACE (2021), 110 mL/min/1.73 m2; 63: CALCIUM, 8.5 mg/dL; 63: BILIRUBIN TOTAL, 0.8 mg/dL; 63: CO2, 24 mmol/L; 63: BNP NT-PRO, 17298 pg/mL; 73: SpO2, 86.714; 82: HR, 88.833; 82: 1min HRV, 108.601; 83: HR, 79.333; 83: 1min HRV, 112.306; 84: HR, 74.733; 84: 1min HRV, 114.475; 85: 5min HRV, 121.752; 0: Age, 47; 0: Gender, M; 0: Race, White; 0: Means of arrival, EMS; 0: Triage Temp, 37.2; 0: Triage HR, 105.0; 0: Triage RR, 19.0; 0: Triage SBP, 134.0; 0: Triage DBP, 95.0; 0: Triage acuity, 3-Urgent; 0: CC, CHEST PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I checked if there were classic infection indicators, such as fever or a very high or low WBC count, and found none. Next, although the patient had tachycardia and tachypnea, there was no strong evidence of hypotension or organ dysfunction typical of sepsis. Finally, the patient\u2019s labs (e.g., normal WBC) and relatively stable vitals over time suggest no clear infectious process driving systemic inflammation. Therefore, the risk of developing sepsis in the next 12 hours appears low.",
        "claims": [
            "There were no classic infection indicators, such as fever or a very high or low WBC count.",
            "The patient had tachycardia.",
            "The patient had tachypnea.",
            "There was no strong evidence of hypotension in the patient.",
            "There was no strong evidence of organ dysfunction typical of sepsis in the patient.",
            "The patient\u2019s labs showed a normal WBC count.",
            "The patient\u2019s vitals were relatively stable over time.",
            "The stable vitals and normal labs suggest no clear infectious process driving systemic inflammation.",
            "The risk of developing sepsis in the next 12 hours appears low."
        ],
        "relevant_claims": [
            "There were no classic infection indicators, such as fever or a very high or low WBC count.",
            "The patient had tachycardia.",
            "The patient had tachypnea.",
            "There was no strong evidence of hypotension in the patient.",
            "There was no strong evidence of organ dysfunction typical of sepsis in the patient.",
            "The stable vitals and normal labs suggest no clear infectious process driving systemic inflammation."
        ],
        "alignment_scores": [
            0.7,
            0.8,
            0.7,
            0.7,
            0.8,
            0.3
        ],
        "alignment_category": [
            2,
            2,
            2,
            7,
            8,
            2
        ],
        "alignment_reasonings": [
            "The claim mentions the absence of fever and abnormal WBC counts, both of which are SIRS criteria. Although the claim discusses the lack of these criteria rather than their presence, it still relates to the SIRS framework. The alignment is moderate because the focus is on the absence of SIRS indicators, not their presence.",
            "Tachycardia (heart rate >90 bpm) is explicitly one of the criteria for SIRS. Although meeting one SIRS criterion does not complete the condition of having \u22652 criteria for full SIRS positivity, tachycardia directly aligns with the category requirements. Therefore, the alignment is strong but not perfect, as one more SIRS criterion is needed.",
            "Tachypnea, which is an increased respiratory rate, is directly listed under the SIRS criteria (respiratory rate >20/min). This alignment is strong, but since the claim only mentions tachypnea without additional information on meeting other SIRS criteria (such as heart rate or temperature), it does not fully satisfy the conditions for SIRS positivity by itself.",
            "The claim directly references the absence of hypotension, which is related to sepsis-associated hypotension. Although the claim indicates a lack of evidence rather than confirmation of hypotension, it still relates to the criteria outlined in this category. The alignment is relatively strong because the claim addresses a key factor in sepsis risk assessment, but the absence of hypotension suggests a lower risk, thus the imperfect alignment.",
            "The claim discusses the absence of typical organ dysfunction, which directly references the SOFA score criteria used for identifying organ dysfunction related to sepsis. If this dysfunction were present, it would indicate an increased sepsis risk. The absence of this evidence makes the claim align strongly with the criterion for assessing organ dysfunction related to sepsis, but the focus on the absence rather than the presence of dysfunction slightly lowers the alignment.",
            "The claim about stable vitals and normal labs is indirectly related to the absence of SIRS criteria, which would include signs of systemic inflammation such as abnormal temperature, heart rate, respiratory rate, or white blood cell count. While the claim suggests the lack of systemic inflammation, it does not specifically reference any SIRS criteria results. Thus, the alignment is weak but notable since the SIRS criteria are relevant for identifying systemic inflammation."
        ],
        "final_alignment_score": 0.6666666666666666,
        "accuracy": 1
    },
    {
        "input": "5: HR, 113.0; 5: RR, 18.0; 5: SpO2, 96.0; 5: SBP, 125.0; 5: DBP, 73.0; 5: MAP, 90.333; 5: Temp, 97.9; 37: HR, 110.0; 37: RR, 21.0; 37: SpO2, 97.0; 37: SBP, 127.0; 37: DBP, 72.0; 37: MAP, 90.333; 38: SpO2, 96.5; 39: SpO2, 96.9; 39: 1min HRV, 0.0; 40: HR, 110.833; 40: RR, 21.52; 40: SpO2, 97.695; 40: Perf, 1.694; 40: 1min HRV, 12.659; 41: HR, 110.759; 41: RR, 16.879; 41: SpO2, 97.810; 41: Perf, 2.023; 41: 1min HRV, 6.433; 42: HR, 109.864; 42: RR, 19.441; 42: SpO2, 98.305; 42: Perf, 1.888; 42: 1min HRV, 6.731; 43: HR, 111.224; 43: RR, 22.052; 43: SpO2, 98.466; 43: Perf, 1.622; 43: 1min HRV, 11.941; 43: 5min HRV, 10.269; 44: HR, 110.695; 44: RR, 21.695; 44: SpO2, 99.644; 44: Perf, 0.866; 44: 1min HRV, 5.987; 45: HR, 109.847; 45: RR, 22.831; 45: SpO2, 99.017; 45: Perf, 0.763; 45: 1min HRV, 3.764; 46: HR, 109.810; 46: RR, 22.034; 46: SpO2, 99.0; 46: Perf, 0.810; 46: 1min HRV, 6.749; 46: SBP, 121.0; 46: DBP, 79.0; 46: MAP, 93.0; 47: HR, 110.220; 47: RR, 20.356; 47: SpO2, 99.169; 47: Perf, 0.666; 47: 1min HRV, 6.619; 48: HR, 108.931; 48: RR, 22.259; 48: SpO2, 99.793; 48: Perf, 0.478; 48: 1min HRV, 6.830; 48: 5min HRV, 6.697; 49: HR, 109.254; 49: RR, 20.305; 49: SpO2, 100.0; 49: Perf, 0.428; 49: 1min HRV, 2.846; 50: HR, 109.793; 50: RR, 19.017; 50: SpO2, 100.0; 50: Perf, 0.474; 50: 1min HRV, 2.873; 51: HR, 109.780; 51: RR, 19.390; 51: SpO2, 100.0; 51: Perf, 0.514; 51: 1min HRV, 12.912; 52: HR, 109.559; 52: RR, 20.712; 52: SpO2, 100.0; 52: Perf, 0.488; 52: 1min HRV, 3.660; 53: HR, 110.793; 53: RR, 18.552; 53: SpO2, 99.552; 53: Perf, 0.612; 53: 1min HRV, 36.775; 53: 5min HRV, 17.866; 54: HR, 109.525; 54: RR, 18.915; 54: SpO2, 99.4; 54: Perf, 0.701; 54: 1min HRV, 6.136; 55: HR, 109.707; 55: RR, 20.276; 55: SpO2, 99.483; 55: Perf, 0.681; 55: 1min HRV, 8.137; 56: HR, 110.407; 56: RR, 19.593; 56: SpO2, 99.0; 56: Perf, 0.909; 56: 1min HRV, 3.681; 57: HR, 110.881; 57: RR, 21.932; 57: SpO2, 99.0; 57: Perf, 0.878; 57: 1min HRV, 4.624; 58: HR, 111.069; 58: RR, 21.224; 58: SpO2, 99.0; 58: Perf, 0.896; 58: 1min HRV, 3.577; 58: 5min HRV, 6.241; 59: HR, 111.220; 59: RR, 19.932; 59: SpO2, 99.288; 59: Perf, 0.800; 59: 1min HRV, 3.403; 60: HR, 111.190; 60: RR, 19.862; 60: SpO2, 99.241; 60: Perf, 0.764; 60: 1min HRV, 4.661; 61: HR, 110.983; 61: RR, 20.542; 61: SpO2, 99.271; 61: Perf, 0.727; 61: 1min HRV, 2.780; 61: SBP, 116.0; 61: DBP, 74.0; 61: MAP, 88.0; 62: HR, 110.695; 62: RR, 18.847; 62: SpO2, 99.305; 62: Perf, 0.716; 62: 1min HRV, 4.893; 63: HR, 109.862; 63: RR, 19.569; 63: SpO2, 99.534; 63: Perf, 0.562; 63: 1min HRV, 4.713; 63: 5min HRV, 4.639; 64: HR, 111.356; 64: RR, 19.847; 64: SpO2, 99.763; 64: Perf, 0.669; 64: 1min HRV, 4.143; 65: POC, BHCG, ISTAT QUANTITATIVE: 14.7 IU/L; 65: HR, 110.741; 65: RR, 18.259; 65: SpO2, 99.655; 65: Perf, 0.701; 65: 1min HRV, 4.586; 66: HR, 109.949; 66: RR, 19.051; 66: SpO2, 99.305; 66: Perf, 0.851; 66: 1min HRV, 4.560; 67: POC PH (V) ISTAT, 7.41; 67: POC BASE EXCESS ISTAT, 7 mmol/L; 67: POC LACTATE ISTAT, 0.59 mmol/L; 67: POC O2 SATURATION ISTAT VENOUS, 69 %; 67: POC HCO3 (V) ISTAT, 31.9 mmol/L; 67: POC TCO2 (V) ISTAT, 33 mmol/L; 67: POC PCO2 (V) ISTAT, 50.1 mmHg; 67: POC PO2 (V) ISTAT, 36 mmHg; 67: HR, 109.508; 67: RR, 18.390; 67: SpO2, 99.305; 67: Perf, 0.799; 67: 1min HRV, 5.604; 68: HR, 110.586; 68: RR, 18.241; 68: SpO2, 99.966; 68: Perf, 0.647; 68: 1min HRV, 5.464; 68: 5min HRV, 5.615; 69: HR, 110.576; 69: RR, 18.847; 69: SpO2, 99.822; 69: Perf, 0.63; 69: 1min HRV, 3.598; 69: SBP, 116.0; 69: DBP, 74.0; 69: MAP, 88.0; 70: HR, 110.207; 70: RR, 19.724; 70: SpO2, 99.879; 70: Perf, 0.533; 70: 1min HRV, 8.213; 71: HR, 112.5; 71: RR, 22.538; 71: SpO2, 99.0; 71: Perf, 0.54; 71: 1min HRV, 8.868; 73: 5min HRV, 7.325; 76: HR, 108.0; 76: RR, 20.0; 76: SpO2, 100.0; 99: ABO/RH (AUTOMATION), AB Positive; 99: ANTIBODY SCREEN 3, NEG; 109: WAM DIFTYP, AUTO; 109: WHITE BLOOD CELLS (WBC), 23.3 K/uL; 109: LYMPHOCYTE % (AUTO DIFF), 3.9 %; 109: RED CELL DISTRIBUTION WIDTH (RDW), 24.1 %; 109: HEMOGLOBIN (HGB), 8.4 g/dL; 109: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.90 K/uL; 109: EOSINOPHIL % (AUTO DIFF), 1.4 %; 109: PLATELET COUNT (PLT), 415 K/uL; 109: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 109: NRBC PERCENT (HEMATOLOGY), 0.0 %; 109: BASOPHIL ABSOLUTE (AUTO DIFF), 0.06 K/uL; 109: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 25.8 pg; 109: MEAN CORPUSCULAR VOLUME (MCV), 82.8 fL; 109: HEMATOCRIT (HCT), 26.9 %; 109: BASOPHIL % (AUTO DIFF), 0.3 %; 109: NEUTROPHIL % (AUTO DIFF), 79.9 %; 109: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.62 K/uL; 109: MONOCYTE % (AUTO DIFF), 11.8 %; 109: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.33 K/uL; 109: MONOCYTE ABSOLUTE (AUTO DIFF), 2.75 K/uL; 109: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.2 g/dL; 109: RED BLOOD CELLS (RBC), 3.25 MIL/uL; 109: NEUTROPHIL ABSOLUTE (AUTO DIFF), 18.61 K/uL; 109: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 2.7 %; 0: Age, 33; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.6; 0: Triage HR, 113.0; 0: Triage RR, 18.0; 0: Triage SBP, 125.0; 0: Triage DBP, 73.0; 0: Triage acuity, 2-Emergent; 0: CC, BLOOD IN VOMIT",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I checked for signs of systemic inflammatory response (such as HR or RR abnormalities). The heart rate and WBC count do meet SIRS criteria, but next I considered whether there was evidence of infection, such as fever or elevated lactate, which was not present. Then I checked if there was any hypotension or organ dysfunction suggesting sepsis progression, which did not appear in the data. Given this analysis, the overall picture does not suggest high sepsis risk within the next 12 hours.",
        "claims": [
            "I checked for signs of systemic inflammatory response.",
            "I looked for heart rate or respiratory rate abnormalities.",
            "The heart rate meets SIRS criteria.",
            "The WBC count meets SIRS criteria.",
            "I considered whether there was evidence of infection.",
            "I looked for signs such as fever or elevated lactate.",
            "No evidence of fever or elevated lactate was present.",
            "I checked for hypotension or organ dysfunction suggesting sepsis progression.",
            "No hypotension or organ dysfunction appeared in the data.",
            "The overall picture does not suggest high sepsis risk within the next 12 hours."
        ],
        "relevant_claims": [
            "The heart rate meets SIRS criteria.",
            "No hypotension or organ dysfunction appeared in the data."
        ],
        "alignment_scores": [
            1.0,
            0.7
        ],
        "alignment_category": [
            2,
            7
        ],
        "alignment_reasonings": [
            "The claim states that the heart rate meets SIRS criteria, which directly aligns with the SIRS Positivity category. The SIRS criteria include a heart rate >90 bpm, making this a perfect alignment with the category's definition.",
            "The claim mentions the absence of hypotension and organ dysfunction. Category 7 involves hypotension as an indicator of sepsis, so its exclusion is relevant to the claim. Moreover, organ dysfunction's absence indirectly relates to categories involving dysfunction without directly mapping to a specific criterion. The alignment is moderate since the focus is on reassurance from absence rather than direct risk indication."
        ],
        "final_alignment_score": 0.85,
        "accuracy": 1
    },
    {
        "input": "4: HR, 65.0; 4: RR, 16.0; 4: SpO2, 99.0; 4: SBP, 108.0; 4: DBP, 54.0; 4: MAP, 72.0; 4: Pain, 0.0; 4: Temp, 101.1; 15: SpO2, 97.0; 16: SpO2, 96.797; 16: Perf, 3.364; 17: SpO2, 96.5; 17: Perf, 4.262; 18: SpO2, 97.424; 18: Perf, 4.689; 18: SBP, 107.0; 18: DBP, 60.0; 18: MAP, 75.667; 19: SpO2, 96.169; 19: Perf, 6.684; 20: SpO2, 95.845; 20: Perf, 6.728; 21: SpO2, 95.847; 21: Perf, 5.936; 22: SpO2, 95.897; 22: Perf, 6.207; 23: SpO2, 96.0; 23: Perf, 5.800; 24: SpO2, 95.763; 24: Perf, 5.422; 25: SpO2, 95.879; 25: Perf, 4.448; 26: SpO2, 96.881; 26: Perf, 3.318; 27: SpO2, 96.897; 27: Perf, 3.804; 28: SpO2, 96.373; 28: Perf, 4.445; 29: SpO2, 96.153; 29: Perf, 4.615; 30: SpO2, 96.362; 30: Perf, 4.2; 31: SpO2, 96.119; 31: Perf, 4.233; 32: SpO2, 96.155; 32: Perf, 2.824; 33: SpO2, 96.797; 33: Perf, 2.251; 34: SpO2, 96.864; 34: Perf, 2.579; 35: SpO2, 96.879; 35: Perf, 2.442; 36: SpO2, 96.661; 36: Perf, 3.264; 37: SpO2, 96.207; 37: Perf, 3.824; 38: SpO2, 95.831; 38: Perf, 4.185; 39: SpO2, 97.068; 39: Perf, 4.148; 40: SpO2, 96.707; 40: Perf, 4.992; 41: HR, 66.0; 41: SpO2, 96.322; 41: Perf, 2.957; 41: SBP, 105.0; 41: DBP, 60.0; 41: MAP, 75.0; 42: SpO2, 96.793; 42: Perf, 2.268; 42: SBP, 105.0; 42: DBP, 60.0; 42: MAP, 75.0; 43: SpO2, 95.983; 43: Perf, 2.158; 44: SpO2, 96.276; 44: Perf, 1.960; 45: SpO2, 95.864; 45: Perf, 2.225; 46: SpO2, 96.085; 46: Perf, 2.727; 47: SpO2, 96.052; 47: Perf, 2.607; 48: SpO2, 95.712; 48: Perf, 2.585; 49: SpO2, 96.552; 49: Perf, 2.895; 50: SpO2, 97.0; 50: Perf, 3.872; 51: POC PH (V) ISTAT, 7.43; 51: POC LACTATE ISTAT, 1.50 mmol/L; 51: POC TCO2 (V) ISTAT, 28 mmol/L; 51: POC BASE EXCESS ISTAT, 2 mmol/L; 51: POC PO2 (V) ISTAT, 33 mmHg; 51: POC HCO3 (V) ISTAT, 26.7 mmol/L; 51: POC PCO2 (V) ISTAT, 40.1 mmHg; 51: POC O2 SATURATION ISTAT VENOUS, 65 %; 51: SpO2, 96.119; 51: Perf, 4.245; 52: SpO2, 95.379; 52: Perf, 4.339; 53: SpO2, 95.203; 53: Perf, 4.983; 54: SpO2, 95.414; 54: Perf, 4.544; 55: SpO2, 95.339; 55: Perf, 3.686; 56: SpO2, 95.492; 56: Perf, 2.525; 57: SpO2, 95.690; 57: Perf, 2.330; 58: SpO2, 96.322; 58: Perf, 2.288; 59: SpO2, 96.879; 59: Perf, 2.320; 60: SpO2, 96.576; 60: Perf, 2.423; 61: SpO2, 96.271; 61: Perf, 2.796; 62: SpO2, 96.603; 62: Perf, 2.776; 63: SpO2, 96.322; 63: Perf, 2.685; 64: SpO2, 96.569; 64: Perf, 2.665; 65: HR, 68.0; 65: RR, 18.0; 65: SpO2, 97.034; 65: Perf, 2.549; 65: Pain, 0.0; 65: Temp, 98.8; 66: SpO2, 96.153; 66: Perf, 3.064; 67: SpO2, 96.0; 67: Perf, 3.010; 68: SpO2, 96.0; 68: Perf, 3.140; 69: SpO2, 95.862; 69: Perf, 2.665; 70: SpO2, 96.017; 70: Perf, 2.534; 71: SpO2, 96.373; 71: Perf, 2.460; 72: SpO2, 95.724; 72: Perf, 2.733; 73: SpO2, 96.5; 73: Perf, 2.844; 74: SpO2, 97.475; 74: Perf, 2.574; 75: SpO2, 97.339; 75: Perf, 3.392; 76: SpO2, 96.776; 76: Perf, 3.584; 77: SpO2, 96.017; 77: Perf, 3.487; 78: SpO2, 96.102; 78: Perf, 3.156; 79: SpO2, 96.897; 79: Perf, 2.657; 80: SpO2, 97.356; 80: Perf, 1.940; 81: SpO2, 96.931; 81: Perf, 2.155; 82: SpO2, 97.254; 82: Perf, 3.481; 83: SpO2, 97.0; 83: Perf, 3.891; 84: SpO2, 96.948; 84: Perf, 4.301; 85: SpO2, 96.746; 85: Perf, 4.189; 86: SpO2, 96.879; 86: Perf, 4.32; 87: SpO2, 97.0; 87: Perf, 3.467; 88: SpO2, 97.0; 88: Perf, 3.842; 89: SpO2, 96.586; 89: Perf, 4.186; 90: SpO2, 97.288; 90: Perf, 2.210; 91: SpO2, 97.414; 91: Perf, 2.020; 92: SpO2, 97.627; 92: Perf, 2.045; 93: SpO2, 97.586; 93: Perf, 2.665; 94: SpO2, 97.102; 94: Perf, 2.485; 95: SpO2, 97.169; 95: Perf, 2.391; 96: SpO2, 97.741; 96: Perf, 1.804; 97: SpO2, 98.458; 97: Perf, 1.764; 98: INR, 1.3; 98: PROTHROMBIN TIME, 16.2 seconds; 98: SpO2, 97.724; 98: Perf, 1.940; 99: PART. THROMBOPLASTIN TIME, 40.6 seconds; 99: SpO2, 97.475; 99: Perf, 2.127; 100: SpO2, 97.220; 100: Perf, 2.529; 101: SpO2, 97.466; 101: Perf, 2.502; 102: SpO2, 98.0; 102: Perf, 2.511; 102: SBP, 102.0; 102: DBP, 60.0; 102: MAP, 74.0; 103: SpO2, 98.259; 103: Perf, 2.868; 104: SpO2, 97.237; 104: Perf, 3.350; 105: SpO2, 97.339; 105: Perf, 2.797; 106: SpO2, 97.138; 106: Perf, 2.413; 107: SpO2, 97.339; 107: Perf, 1.779; 108: SpO2, 97.172; 108: Perf, 2.104; 109: SpO2, 96.949; 109: Perf, 2.225; 110: SpO2, 97.169; 110: Perf, 1.982; 111: SpO2, 96.845; 111: Perf, 2.225; 112: ALKALINE PHOSPHATASE, 83 U/L; 112: GLUCOSE, 98 mg/dL; 112: POTASSIUM, 3.9 mmol/L; 112: BLOOD UREA NITROGEN (BUN), 14 mg/dL; 112: CHLORIDE, 103 mmol/L; 112: CALCIUM, 9.1 mg/dL; 112: EGFR FOR AFRICAN AMERICAN, 102 mL/min/1.73 m2; 112: ALBUMIN, 3.9 g/dL; 112: ALT (SGPT), 30 U/L; 112: EGFR REFIT WITHOUT RACE (2021), 88 mL/min/1.73 m2; 112: CORRECTED CALCIUM, 9.2 mg/dL; 112: GLOBULIN, 2.9 g/dL; 112: BILIRUBIN TOTAL, 0.8 mg/dL; 112: CO2, 25 mmol/L; 112: ANION GAP, 10 mmol/L; 112: PROTEIN TOTAL, 6.8 g/dL; 112: SODIUM, 138 mmol/L; 112: CREATININE, 0.97 mg/dL; 112: AST (SGOT), 37 U/L; 112: SpO2, 97.271; 112: Perf, 2.201; 113: SpO2, 97.069; 113: Perf, 2.263; 114: SpO2, 97.441; 114: Perf, 2.106; 115: SpO2, 97.153; 115: Perf, 2.087; 116: SpO2, 97.638; 116: Perf, 1.803; 117: SpO2, 97.712; 117: Perf, 2.006; 118: SpO2, 97.621; 118: Perf, 3.632; 119: SpO2, 96.831; 119: Perf, 2.841; 0: Age, 52; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 38.4; 0: Triage HR, 65.0; 0: Triage RR, 16.0; 0: Triage SBP, 108.0; 0: Triage DBP, 54.0; 0: Triage acuity, 3-Urgent; 0: CC, FEVER",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I checked whether the patient\u2019s vital signs\u2014such as heart rate, respiratory rate, and blood pressure\u2014were substantially abnormal, and they were relatively stable. Next, I looked at labs for signs of organ dysfunction or elevated lactate, but these values (like lactate at 1.5 mmol/L) were within normal limits. Then, I assessed the presence of persistent fever or other indicators of deteriorating infection status, but the temperature and subsequent vitals did not suggest impending sepsis. Thus, overall, the evidence does not meet the threshold for high sepsis risk within 12 hours.",
        "claims": [
            "The patient's vital signs were checked for abnormalities.",
            "The patient's vital signs included heart rate, respiratory rate, and blood pressure.",
            "The patient's vital signs were relatively stable.",
            "Labs were checked for signs of organ dysfunction or elevated lactate.",
            "The lactate level was measured at 1.5 mmol/L.",
            "The lactate level of 1.5 mmol/L was within normal limits.",
            "The presence of persistent fever or other indicators of deteriorating infection status was assessed.",
            "The temperature did not suggest impending sepsis.",
            "Subsequent vital signs did not suggest impending sepsis.",
            "Overall, the evidence does not meet the threshold for high sepsis risk within 12 hours."
        ],
        "relevant_claims": [
            "The lactate level was measured at 1.5 mmol/L.",
            "The lactate level of 1.5 mmol/L was within normal limits."
        ],
        "alignment_scores": [
            0.3,
            0.1
        ],
        "alignment_category": [
            5,
            5
        ],
        "alignment_reasonings": [
            "The claim mentions a lactate level, which directly relates to the \"Elevated Serum Lactate\" category. However, the level of 1.5 mmol/L does not meet the threshold of \u22652 mmol/L required for significant concern in this category. Thus, the alignment is minimal but present as it pertains to the concept of measuring lactate to assess sepsis risk.",
            "The claim focuses on a lactate level, which directly relates to the \"Elevated Serum Lactate\" category. However, the level is below the threshold of \u22652 mmol/L that significantly elevates sepsis mortality risk. Therefore, while the claim is conceptually linked to the category due to the reference to lactate, the alignment is minimal because the level is normal and does not suggest increased sepsis risk."
        ],
        "final_alignment_score": 0.2,
        "accuracy": 1
    },
    {
        "input": "2: HR, 84.0; 2: RR, 24.0; 2: SpO2, 100.0; 2: SBP, 143.0; 2: DBP, 55.0; 2: MAP, 84.333; 2: Temp, 97.2; 80: HR, 94.548; 80: RR, 31.238; 80: 1min HRV, 56.958; 80: SBP, 148.0; 80: DBP, 61.0; 80: MAP, 90.0; 81: HR, 90.729; 81: RR, 33.898; 81: SpO2, 97.882; 81: 1min HRV, 103.265; 82: HR, 90.517; 82: RR, 30.293; 82: SpO2, 97.259; 82: Perf, 0.19; 82: 1min HRV, 62.996; 82: 5min HRV, 79.552; 82: SBP, 145.0; 82: DBP, 74.0; 82: MAP, 97.667; 83: HR, 89.898; 83: RR, 24.949; 83: SpO2, 98.316; 83: Perf, 0.153; 83: 1min HRV, 117.529; 83: SBP, 145.0; 83: DBP, 74.0; 83: MAP, 97.667; 84: HR, 90.914; 84: RR, 27.017; 84: SpO2, 98.941; 84: Perf, 0.186; 84: 1min HRV, 40.962; 85: HR, 90.729; 85: RR, 24.831; 85: SpO2, 98.957; 85: Perf, 0.170; 85: 1min HRV, 93.212; 86: HR, 92.017; 86: RR, 35.576; 86: SpO2, 99.842; 86: Perf, 0.17; 86: 1min HRV, 106.341; 87: HR, 90.569; 87: RR, 31.672; 87: SpO2, 98.661; 87: Perf, 0.17; 87: 1min HRV, 77.268; 87: 5min HRV, 90.692; 88: HR, 90.712; 88: RR, 29.339; 88: SpO2, 97.970; 88: Perf, 0.166; 88: 1min HRV, 39.251; 89: HR, 88.483; 89: RR, 30.345; 89: SpO2, 98.3; 89: Perf, 0.160; 89: 1min HRV, 59.194; 90: HR, 87.559; 90: RR, 32.051; 90: SpO2, 98.788; 90: Perf, 0.152; 90: 1min HRV, 83.922; 91: HR, 87.052; 91: RR, 28.690; 91: SpO2, 98.783; 91: Perf, 0.181; 91: 1min HRV, 16.064; 92: HR, 87.356; 92: RR, 25.373; 92: SpO2, 98.952; 92: Perf, 0.177; 92: 1min HRV, 32.678; 92: 5min HRV, 52.812; 93: HR, 88.407; 93: RR, 26.610; 93: SpO2, 98.837; 93: Perf, 0.163; 93: 1min HRV, 63.430; 94: HR, 87.483; 94: RR, 30.086; 94: SpO2, 99.463; 94: Perf, 0.168; 94: 1min HRV, 49.410; 95: HR, 87.153; 95: RR, 30.525; 95: SpO2, 98.5; 95: Perf, 0.163; 95: 1min HRV, 68.312; 96: HR, 88.203; 96: RR, 28.644; 96: SpO2, 98.310; 96: Perf, 0.16; 96: 1min HRV, 62.534; 97: HR, 89.052; 97: RR, 31.224; 97: SpO2, 99.0; 97: Perf, 0.16; 97: 1min HRV, 45.705; 97: 5min HRV, 58.445; 98: HR, 92.508; 98: RR, 31.339; 98: SpO2, 98.955; 98: Perf, 0.154; 98: 1min HRV, 58.106; 99: HR, 90.155; 99: RR, 30.672; 99: SpO2, 99.111; 99: Perf, 0.181; 99: 1min HRV, 72.588; 100: HR, 89.034; 100: RR, 29.610; 100: SpO2, 99.0; 100: Perf, 0.181; 100: 1min HRV, 74.885; 101: HR, 88.649; 101: RR, 27.345; 101: Perf, 0.18; 101: 1min HRV, 82.167; 102: HR, 86.345; 102: RR, 27.931; 102: 1min HRV, 85.908; 102: 5min HRV, 76.514; 103: HR, 84.678; 103: RR, 27.695; 103: SpO2, 98.889; 103: 1min HRV, 99.837; 104: HR, 86.576; 104: RR, 28.983; 104: SpO2, 95.444; 104: 1min HRV, 63.969; 105: HR, 84.949; 105: RR, 28.441; 105: SpO2, 98.944; 105: Perf, 0.18; 105: 1min HRV, 91.749; 106: HR, 84.508; 106: RR, 28.051; 106: SpO2, 98.429; 106: Perf, 0.18; 106: 1min HRV, 95.686; 107: HR, 84.759; 107: RR, 27.293; 107: SpO2, 97.095; 107: Perf, 0.171; 107: 1min HRV, 90.017; 107: 5min HRV, 89.852; 108: HR, 86.627; 108: RR, 28.305; 108: SpO2, 99.1; 108: Perf, 0.17; 108: 1min HRV, 9.485; 109: HR, 87.224; 109: RR, 27.241; 109: SpO2, 98.0; 109: Perf, 0.17; 109: 1min HRV, 47.279; 110: HR, 88.847; 110: RR, 26.644; 110: SpO2, 96.938; 110: Perf, 0.177; 110: 1min HRV, 95.307; 111: HR, 85.593; 111: RR, 28.102; 111: SpO2, 97.339; 111: Perf, 0.196; 111: 1min HRV, 28.518; 112: HR, 85.931; 112: RR, 27.5; 112: SpO2, 98.245; 112: Perf, 0.21; 112: 1min HRV, 34.042; 112: 5min HRV, 52.342; 113: HR, 84.814; 113: RR, 27.508; 113: SpO2, 98.389; 113: Perf, 0.208; 113: 1min HRV, 53.801; 114: HR, 87.328; 114: RR, 25.897; 114: SpO2, 99.2; 114: Perf, 0.17; 114: 1min HRV, 13.145; 115: HR, 86.102; 115: RR, 26.559; 115: SpO2, 98.188; 115: Perf, 0.18; 115: 1min HRV, 11.984; 116: HR, 86.569; 116: RR, 29.0; 116: SpO2, 97.333; 116: Perf, 0.19; 116: 1min HRV, 7.712; 117: HR, 86.085; 117: RR, 27.458; 117: SpO2, 98.857; 117: Perf, 0.174; 117: 1min HRV, 48.261; 117: 5min HRV, 33.786; 118: HR, 85.559; 118: RR, 27.322; 118: SpO2, 98.462; 118: Perf, 0.17; 118: 1min HRV, 13.360; 119: HR, 86.897; 119: RR, 28.741; 119: SpO2, 99.0; 119: Perf, 0.17; 119: 1min HRV, 48.790; 0: Age, 85; 0: Gender, F; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 36.2; 0: Triage HR, 84.0; 0: Triage RR, 24.0; 0: Triage SBP, 143.0; 0: Triage DBP, 55.0; 0: Triage acuity, 3-Urgent; 0: CC, ABDOMINAL PAIN",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "First, I checked whether the patient\u2019s vitals indicated severe abnormalities such as very high heart rate or very low blood pressure; they did not. Next, I noted the patient\u2019s respiratory rate is elevated, but their heart rate and blood pressure are relatively stable and there is no evidence of fever. Then, I considered whether multiple clinical criteria (e.g., qSOFA) would be met; they are not. Thus, integrating these findings, the patient does not appear to be at high risk of developing sepsis in the next 12 hours.",
        "claims": [
            "The patient's vitals do not indicate severe abnormalities.",
            "The patient does not have a very high heart rate.",
            "The patient does not have very low blood pressure.",
            "The patient's respiratory rate is elevated.",
            "The patient\u2019s heart rate is relatively stable.",
            "The patient\u2019s blood pressure is relatively stable.",
            "There is no evidence of fever in the patient.",
            "Multiple clinical criteria, such as qSOFA, are not met.",
            "The patient does not appear to be at high risk of developing sepsis in the next 12 hours."
        ],
        "relevant_claims": [
            "The patient does not have very low blood pressure.",
            "There is no evidence of fever in the patient."
        ],
        "alignment_scores": [
            0.3,
            0.3
        ],
        "alignment_category": [
            7,
            2
        ],
        "alignment_reasonings": [
            "The claim indicates the absence of very low blood pressure, which might suggest the patient doesn't meet thresholds indicating sepsis-associated hypotension. While it doesn't directly address the presence of sepsis-specific criteria, it indirectly relates to stabilization of blood pressure as it pertains to hypoperfusion and septic shock risk, albeit with marginal relevance.",
            "The absence of fever is relevant to the SIRS criteria for systemic inflammation, as fever is one of the elements assessed. However, it being \"no evidence of fever\" suggests the absence of one potential SIRS indicator without providing information on other criteria, thus showing weak alignment with early sepsis detection."
        ],
        "final_alignment_score": 0.3,
        "accuracy": 0
    },
    {
        "input": "2: HR, 100.0; 2: RR, 18.0; 2: SpO2, 100.0; 2: SBP, 129.0; 2: DBP, 90.0; 2: MAP, 103.0; 2: Temp, 97.5; 32: POC, HCG, ISTAT QUALITATIVE: Negative; 32: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 42: SpO2, 100.0; 42: SBP, 121.0; 42: DBP, 84.0; 42: MAP, 96.333; 43: SpO2, 100.0; 43: Perf, 1.407; 44: SpO2, 100.0; 44: Perf, 1.549; 45: SpO2, 99.949; 45: Perf, 1.471; 45: SBP, 139.0; 45: DBP, 90.0; 45: MAP, 106.333; 46: SpO2, 100.0; 46: Perf, 1.485; 47: SpO2, 100.0; 47: Perf, 1.395; 48: SpO2, 100.0; 48: Perf, 1.493; 49: SpO2, 100.0; 49: Perf, 1.580; 50: SpO2, 100.0; 50: Perf, 1.320; 51: SpO2, 100.0; 51: Perf, 1.367; 52: SpO2, 100.0; 52: Perf, 1.446; 53: SpO2, 100.0; 53: Perf, 1.679; 54: SpO2, 100.0; 54: Perf, 1.779; 55: SpO2, 100.0; 55: Perf, 1.764; 56: SpO2, 99.845; 56: Perf, 1.48; 57: SpO2, 100.0; 57: Perf, 1.282; 58: SpO2, 100.0; 58: Perf, 1.390; 59: SpO2, 100.0; 59: Perf, 1.111; 60: SpO2, 100.0; 60: Perf, 1.357; 60: SBP, 148.0; 60: DBP, 91.0; 60: MAP, 110.0; 61: SpO2, 99.759; 61: Perf, 1.514; 62: SpO2, 99.915; 62: Perf, 1.576; 63: SpO2, 99.898; 63: Perf, 1.522; 64: SpO2, 99.914; 64: Perf, 1.142; 65: SpO2, 99.763; 65: Perf, 1.102; 66: WAM DIFTYP, AUTO; 66: BASOPHIL % (AUTO DIFF), 0.5 %; 66: MONOCYTE ABSOLUTE (AUTO DIFF), 0.38 K/uL; 66: HEMATOCRIT (HCT), 32.5 %; 66: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.05 K/uL; 66: RED CELL DISTRIBUTION WIDTH (RDW), 14.7 %; 66: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.5 pg; 66: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.37 K/uL; 66: NEUTROPHIL ABSOLUTE (AUTO DIFF), 6.03 K/uL; 66: MONOCYTE % (AUTO DIFF), 4.6 %; 66: RED BLOOD CELLS (RBC), 3.38 MIL/uL; 66: EOSINOPHIL % (AUTO DIFF), 4.7 %; 66: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 66: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.39 K/uL; 66: MEAN CORPUSCULAR VOLUME (MCV), 96.2 fL; 66: WHITE BLOOD CELLS (WBC), 8.3 K/uL; 66: LYMPHOCYTE % (AUTO DIFF), 16.6 %; 66: PLATELET COUNT (PLT), 349 K/uL; 66: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 66: NRBC PERCENT (HEMATOLOGY), 0.0 %; 66: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.6 %; 66: HEMOGLOBIN (HGB), 10.3 g/dL; 66: NEUTROPHIL % (AUTO DIFF), 73.0 %; 66: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.7 g/dL; 66: SpO2, 100.0; 66: Perf, 1.377; 67: SpO2, 99.898; 67: Perf, 1.314; 68: SpO2, 99.864; 68: Perf, 1.382; 69: SpO2, 99.293; 69: Perf, 1.647; 70: SpO2, 99.864; 70: Perf, 1.749; 71: SpO2, 99.897; 71: Perf, 1.719; 72: SpO2, 100.0; 72: Perf, 1.875; 73: SpO2, 100.0; 73: Perf, 2.066; 74: SpO2, 99.828; 74: Perf, 1.824; 75: SpO2, 100.0; 75: Perf, 1.525; 75: SBP, 145.0; 75: DBP, 94.0; 75: MAP, 111.0; 76: SpO2, 100.0; 76: Perf, 1.591; 77: SpO2, 98.949; 77: Perf, 1.554; 78: SpO2, 99.793; 78: Perf, 1.474; 79: SpO2, 100.0; 79: Perf, 1.346; 80: SpO2, 100.0; 80: Perf, 1.755; 81: SpO2, 99.914; 81: Perf, 1.211; 82: SARS-COV-2 RNA, Not Detected; 82: SpO2, 100.0; 82: Perf, 1.267; 83: SpO2, 99.879; 83: Perf, 1.263; 84: SpO2, 99.983; 84: Perf, 1.283; 85: SpO2, 100.0; 85: Perf, 1.625; 86: SpO2, 99.914; 86: Perf, 1.966; 87: SpO2, 100.0; 87: Perf, 1.905; 88: SpO2, 100.0; 88: Perf, 1.642; 89: SpO2, 100.0; 89: Perf, 1.408; 90: SpO2, 100.0; 90: Perf, 1.682; 90: SBP, 156.0; 90: DBP, 109.0; 90: MAP, 124.667; 91: SpO2, 100.0; 91: Perf, 1.419; 92: SpO2, 99.932; 92: Perf, 1.327; 93: SpO2, 99.828; 93: Perf, 1.536; 94: SpO2, 100.0; 94: Perf, 1.546; 95: SpO2, 99.525; 95: Perf, 1.69; 96: SpO2, 99.293; 96: Perf, 1.753; 97: SpO2, 100.0; 97: Perf, 1.554; 98: SpO2, 100.0; 98: Perf, 1.802; 99: SpO2, 100.0; 99: Perf, 1.849; 100: SpO2, 99.390; 100: Perf, 1.844; 101: SpO2, 99.897; 101: Perf, 1.603; 102: SpO2, 100.0; 102: Perf, 1.579; 103: SpO2, 99.897; 103: Perf, 1.589; 104: SpO2, 100.0; 104: Perf, 1.547; 105: SpO2, 100.0; 105: Perf, 1.587; 105: SBP, 168.0; 105: DBP, 155.0; 105: MAP, 159.333; 106: SpO2, 100.0; 106: Perf, 1.513; 107: SpO2, 100.0; 107: Perf, 1.597; 107: SBP, 149.0; 107: DBP, 98.0; 107: MAP, 115.0; 108: SpO2, 100.0; 108: Perf, 1.563; 109: SpO2, 100.0; 109: Perf, 1.600; 110: SpO2, 99.845; 110: Perf, 1.718; 111: SpO2, 100.0; 111: Perf, 1.665; 112: SpO2, 100.0; 112: Perf, 1.813; 113: SpO2, 99.931; 113: Perf, 1.657; 114: SpO2, 100.0; 114: Perf, 1.736; 115: SpO2, 99.793; 115: Perf, 1.530; 116: ALKALINE PHOSPHATASE, 72 U/L; 116: CORRECTED CALCIUM, 8.5 mg/dL; 116: BILIRUBIN TOTAL, 0.2 mg/dL; 116: EGFR REFIT WITHOUT RACE (2021), 63 mL/min/1.73 m2; 116: ALT (SGPT), 6 U/L; 116: PROTEIN TOTAL, 7.0 g/dL; 116: CO2, 18 mmol/L; 116: CHLORIDE, 102 mmol/L; 116: SODIUM, 136 mmol/L; 116: GLOBULIN, 3.1 g/dL; 116: AST (SGOT), 12 U/L; 116: GLUCOSE, 237 mg/dL; 116: ALBUMIN, 3.9 g/dL; 116: POTASSIUM, 4.3 mmol/L; 116: CALCIUM, 8.4 mg/dL; 116: BLOOD UREA NITROGEN (BUN), 15 mg/dL; 116: LIPASE, 16 U/L; 116: ANION GAP, 16 mmol/L; 116: EGFR FOR AFRICAN AMERICAN, 73 mL/min/1.73 m2; 116: CREATININE, 1.05 mg/dL; 116: SpO2, 100.0; 116: Perf, 2.034; 117: SpO2, 100.0; 117: Perf, 1.921; 118: SpO2, 99.897; 118: Perf, 1.865; 119: SpO2, 99.932; 119: Perf, 1.826; 0: Age, 47; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.4; 0: Triage HR, 100.0; 0: Triage RR, 18.0; 0: Triage SBP, 129.0; 0: Triage DBP, 90.0; 0: Triage acuity, 3-Urgent; 0: CC, ABDOMINAL PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I checked if the patient's vital signs demonstrate consistent fever, tachycardia, hypotension, or tachypnea, and found them largely stable. Next, I assessed lab results for signs of infection or organ dysfunction, such as abnormal WBC or elevated creatinine, and concluded that they are within normal limits. Based on this information, there are no strong indicators of sepsis or early organ dysfunction. Therefore, the patient appears at low risk and is unlikely to develop sepsis within 12 hours.",
        "claims": [
            "The patient's vital signs demonstrate consistent fever, tachycardia, hypotension, or tachypnea.",
            "The patient's vital signs were largely stable.",
            "I assessed lab results for signs of infection or organ dysfunction.",
            "The lab results showed no signs of infection or organ dysfunction.",
            "The abnormal WBC and elevated creatinine levels are within normal limits.",
            "There are no strong indicators of sepsis.",
            "There are no strong indicators of early organ dysfunction.",
            "The patient appears to be at low risk of developing sepsis.",
            "The patient is unlikely to develop sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The lab results showed no signs of infection or organ dysfunction.",
            "There are no strong indicators of early organ dysfunction."
        ],
        "alignment_scores": [
            0.2,
            0.7
        ],
        "alignment_category": [
            8,
            8
        ],
        "alignment_reasonings": [
            "The claim mentions \"no signs of infection or organ dysfunction,\" which is nominally opposite to what SOFA score increase indicates\u2014namely, new organ dysfunction. Although it aligns weakly since the absence of these signs suggests no risk increase per this criterion, the claim technically serves as confirmation of no acute sepsis risk, albeit indirectly.",
            "The claim suggests an absence of significant early organ dysfunction. The SOFA score is used to track organ dysfunction and new organ dysfunction would result in an increase of \u22652 points. The statement about the absence of strong indicators correlates with this category, though in a negative form (indicating low risk of sepsis). The alignment is somewhat strong because the absence of indicators relates directly to a lack of new organ dysfunction."
        ],
        "final_alignment_score": 0.44999999999999996,
        "accuracy": 1
    },
    {
        "input": "5: HR, 108.0; 5: RR, 18.0; 5: SpO2, 95.0; 5: SBP, 150.0; 5: DBP, 70.0; 5: MAP, 96.667; 5: Temp, 100.6; 47: POC PH (V) ISTAT, 7.41; 47: POC PO2 (V) ISTAT, 14 mmHg; 47: POC HCO3 (V) ISTAT, 28.3 mmol/L; 47: POC O2 SATURATION ISTAT VENOUS, 18 %; 47: POC LACTATE ISTAT, 0.82 mmol/L; 47: POC TCO2 (V) ISTAT, 30 mmol/L; 47: POC PCO2 (V) ISTAT, 44.7 mmHg; 47: POC BASE EXCESS ISTAT, 4 mmol/L; 69: SpO2, 95.082; 69: Perf, 6.772; 70: SpO2, 95.159; 70: Perf, 7.448; 70: SBP, 126.0; 70: DBP, 55.0; 70: MAP, 78.667; 72: HR, 92.64; 72: RR, 27.7; 72: 1min HRV, 57.204; 73: HR, 92.593; 73: RR, 24.898; 73: 1min HRV, 53.127; 74: HR, 93.281; 74: RR, 22.719; 74: SpO2, 96.0; 74: 1min HRV, 43.048; 74: 5min HRV, 50.360; 74: SBP, 126.0; 74: DBP, 55.0; 74: MAP, 78.667; 74: Pain, 0.0; 74: Temp, 100.0; 75: WAM DIFTYP, AUTO; 75: LYMPHOCYTE % (AUTO DIFF), 8.1 %; 75: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 26.2 pg; 75: RED BLOOD CELLS (RBC), 4.61 MIL/uL; 75: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.32 K/uL; 75: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.08 K/uL; 75: MEAN CORPUSCULAR VOLUME (MCV), 85.2 fL; 75: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 75: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.5 %; 75: MONOCYTE % (AUTO DIFF), 6.6 %; 75: HEMOGLOBIN (HGB), 12.1 g/dL; 75: BASOPHIL % (AUTO DIFF), 0.3 %; 75: RED CELL DISTRIBUTION WIDTH (RDW), 14.9 %; 75: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 30.8 g/dL; 75: NEUTROPHIL ABSOLUTE (AUTO DIFF), 13.50 K/uL; 75: HEMATOCRIT (HCT), 39.3 %; 75: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.24 K/uL; 75: MONOCYTE ABSOLUTE (AUTO DIFF), 1.08 K/uL; 75: NRBC PERCENT (HEMATOLOGY), 0.0 %; 75: WHITE BLOOD CELLS (WBC), 16.3 K/uL; 75: PLATELET COUNT (PLT), 277 K/uL; 75: EOSINOPHIL % (AUTO DIFF), 1.5 %; 75: BASOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 75: NEUTROPHIL % (AUTO DIFF), 83.0 %; 75: HR, 93.356; 75: RR, 27.746; 75: 1min HRV, 40.677; 76: HR, 91.914; 76: RR, 27.259; 76: 1min HRV, 8.585; 77: HR, 92.525; 77: RR, 27.780; 77: 1min HRV, 6.611; 78: HR, 92.661; 78: RR, 29.102; 78: 1min HRV, 7.071; 79: HR, 92.579; 79: RR, 27.789; 79: 1min HRV, 9.463; 79: 5min HRV, 19.702; 80: HR, 91.949; 80: RR, 27.085; 80: 1min HRV, 5.027; 81: HR, 91.138; 81: RR, 26.931; 81: 1min HRV, 4.219; 82: HR, 91.373; 82: RR, 27.576; 82: 1min HRV, 6.705; 83: HR, 92.158; 83: RR, 25.351; 83: 1min HRV, 9.338; 84: HR, 90.492; 84: RR, 25.271; 84: SpO2, 97.0; 84: 1min HRV, 9.232; 84: 5min HRV, 8.128; 84: SBP, 118.0; 84: DBP, 55.0; 84: MAP, 76.0; 85: HR, 90.085; 85: RR, 26.864; 85: 1min HRV, 59.939; 85: SBP, 118.0; 85: DBP, 55.0; 85: MAP, 76.0; 86: HR, 91.509; 86: RR, 27.386; 86: 1min HRV, 5.108; 87: HR, 90.017; 87: RR, 27.034; 87: 1min HRV, 10.785; 88: HR, 91.276; 88: RR, 27.017; 88: 1min HRV, 6.485; 89: HR, 90.034; 89: RR, 27.254; 89: 1min HRV, 41.373; 89: 5min HRV, 33.336; 90: HR, 90.949; 90: RR, 27.254; 90: 1min HRV, 7.295; 91: HR, 91.684; 91: RR, 28.228; 91: 1min HRV, 38.357; 92: HR, 90.593; 92: RR, 27.661; 92: 1min HRV, 14.779; 92: CEFEPIME, 2 GRAM/20 ML IV PUSH; 93: HR:, 91.034; 93: RR, 28.259; 93: 1min HRV, 5.225; 94: HR, 91.203; 94: RR, 27.831; 94: 1min HRV, 33.017; 94: 5min HRV, 24.101; 95: HR, 90.175; 95: RR, 28.053; 95: 1min HRV, 4.054; 96: HR, 90.085; 96: RR, 28.119; 96: 1min HRV, 9.153; 97: HR, 89.254; 97: RR, 28.356; 97: 1min HRV, 40.998; 98: HR, 91.983; 98: RR, 19.879; 98: 1min HRV, 13.356; 99: HR, 92.328; 99: RR, 25.224; 99: 1min HRV, 19.558; 99: 5min HRV, 23.573; 100: HR, 95.119; 100: RR, 19.356; 100: 1min HRV, 38.958; 100: SBP, 118.0; 100: DBP, 55.0; 100: MAP, 76.0; 100: LR IV BOLUS -, 1000 ML; 101: HR:, 92.828; 101: RR, 24.724; 101: 1min HRV, 7.677; 102: CO2, 27 mmol/L; 102: AST (SGOT), 20 U/L; 102: ALT (SGPT), 21 U/L; 102: CORRECTED CALCIUM, 9.8 mg/dL; 102: EGFR REFIT WITHOUT RACE (2021), 57 mL/min/1.73 m2; 102: CREATININE, 1.37 mg/dL; 102: SODIUM, 138 mmol/L; 102: BLOOD UREA NITROGEN (BUN), 20 mg/dL; 102: ANION GAP, 9 mmol/L; 102: GLUCOSE, 143 mg/dL; 102: GLOBULIN, 3.3 g/dL; 102: BILIRUBIN TOTAL, 0.2 mg/dL; 102: CALCIUM, 9.8 mg/dL; 102: ALBUMIN, 4.0 g/dL; 102: PROTEIN TOTAL, 7.3 g/dL; 102: ALKALINE PHOSPHATASE, 96 U/L; 102: POTASSIUM, 4.0 mmol/L; 102: CHLORIDE, 102 mmol/L; 102: HR, 92.780; 102: RR, 22.237; 102: 1min HRV, 7.634; 103: HR, 93.121; 103: RR, 23.086; 103: 1min HRV, 57.319; 104: HR, 91.729; 104: RR, 24.271; 104: 1min HRV, 9.637; 104: 5min HRV, 32.482; 105: HR, 92.414; 105: RR, 22.241; 105: 1min HRV, 3.310; 106: HR, 92.847; 106: RR, 23.424; 106: 1min HRV, 15.807; 107: HR, 92.845; 107: RR, 25.362; 107: 1min HRV, 9.563; 108: HR, 91.259; 108: RR, 25.034; 108: 1min HRV, 7.513; 109: INR, 1.2; 109: PART. THROMBOPLASTIN TIME, 30.9 seconds; 109: PROTHROMBIN TIME, 15.8 seconds; 109: HR, 90.627; 109: RR, 25.949; 109: 1min HRV, 7.505; 109: 5min HRV, 11.746; 110: HR, 94.879; 110: RR, 24.690; 110: 1min HRV, 19.871; 111: HR, 93.345; 111: RR, 28.793; 111: 1min HRV, 45.103; 112: HR, 91.661; 112: RR, 25.695; 112: 1min HRV, 6.633; 113: HR, 90.293; 113: RR, 25.155; 113: 1min HRV, 45.384; 114: HR, 89.881; 114: RR, 26.780; 114: 1min HRV, 42.987; 114: 5min HRV, 38.858; 115: HR, 89.789; 115: RR, 26.123; 115: 1min HRV, 8.617; 116: HR, 88.0; 116: RR, 28.0; 119: SARS-COV-2 RNA, Not Detected; 119: 5min HRV, 8.617; 0: Age, 65; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 38.1; 0: Triage HR, 108.0; 0: Triage RR, 18.0; 0: Triage SBP, 150.0; 0: Triage DBP, 70.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER",
        "answer": false,
        "llm_answer": "Yes",
        "llm_explanation": "First, we consider whether the patient shows signs of infection, noting fever and a high WBC count. Next, we assess vital signs and laboratory results, including tachycardia, elevated respiratory rate, and mild hypotension. Then, we check for possible organ dysfunction signs, such as the slight renal impairment apparent in the creatinine and eGFR values. Because these findings align with sepsis criteria and suggest a high risk of progression, we label the patient as Yes.",
        "claims": [
            "The patient shows signs of infection.",
            "The patient has a fever.",
            "The patient has a high white blood cell (WBC) count.",
            "Vital signs and laboratory results are assessed.",
            "The patient exhibits tachycardia.",
            "The patient has an elevated respiratory rate.",
            "The patient has mild hypotension.",
            "Possible signs of organ dysfunction are checked.",
            "There is slight renal impairment apparent in the creatinine values.",
            "There is slight renal impairment apparent in the eGFR values.",
            "These findings align with sepsis criteria.",
            "These findings suggest a high risk of progression to sepsis.",
            "The patient is labeled as Yes for high risk of developing sepsis."
        ],
        "relevant_claims": [
            "The patient shows signs of infection.",
            "The patient has a fever.",
            "The patient has a high white blood cell (WBC) count.",
            "The patient exhibits tachycardia.",
            "The patient has an elevated respiratory rate.",
            "The patient has mild hypotension.",
            "Possible signs of organ dysfunction are checked.",
            "There is slight renal impairment apparent in the creatinine values.",
            "There is slight renal impairment apparent in the eGFR values.",
            "These findings align with sepsis criteria.",
            "These findings suggest a high risk of progression to sepsis."
        ],
        "alignment_scores": [
            0.3,
            0.5,
            1.0,
            0.5,
            0.7,
            0.7,
            0.7,
            0.7,
            0.7,
            0.3,
            0.3
        ],
        "alignment_category": [
            9,
            2,
            2,
            2,
            3,
            7,
            8,
            8,
            8,
            2,
            4
        ],
        "alignment_reasonings": [
            "The claim generally indicates that there are signs of infection, which might lead a clinician to consider early antibiotics or culture orders. However, there is no explicit mention of these actions or any specific criteria being met, so the alignment with a concrete category is weak.",
            "The claim mentions fever, which directly relates to the SIRS criteria. However, fever alone does not fulfill the requirement of having \u22652 SIRS criteria. Therefore, the alignment is moderate as it partially supports the criteria for systemic inflammation consistent with early sepsis.",
            "A high white blood cell count is explicitly listed as one of the criteria for SIRS positivity, which is used to identify systemic inflammation consistent with early sepsis. The claim perfectly aligns with this category.",
            "Tachycardia alone is one of the criteria listed under the Systemic Inflammatory Response Syndrome (SIRS), which includes a heart\u202frate of\u202f>\u202f90\u202fbpm. While the presence of tachycardia alone does not fulfill the requirement of SIRS (which needs at least two criteria), it is still directly related to the SIRS criteria, warranting a moderate alignment rating.",
            "An elevated respiratory rate is a specific criterion included in the qSOFA score (respiratory rate \u226522/min), which flags a high risk of sepsis-related complications. However, without the specific respiratory rate provided, it is unclear if it meets the threshold of \u226522/min, resulting in a strong but not perfect alignment.",
            "The claim of \"mild hypotension\" relates to the concept of sepsis-associated hypotension outlined in category 7. However, \"mild\" is a vague descriptor and does not specify whether the systolic blood pressure is <90 mmHg, mean arterial pressure is <70 mmHg, or if there is a \u226540 mmHg drop from baseline. Due to this lack of specificity, the alignment is partial but significant, as mild hypotension can be an early indicator of worsening hemodynamics as described in this category.",
            "The claim mentions \"possible signs of organ dysfunction,\" which aligns conceptually with the SOFA Score Increase category. The SOFA score specifically measures organ dysfunction, and checking for signs of organ dysfunction implies concern about sepsis risk. The alignment is strong but not perfect, as the claim does not specify a score increase of \u22652 points.",
            "Renal impairment is directly related to the SOFA score because creatinine levels are one of the components used to assess for organ dysfunction within the SOFA scoring system. The mention of creatinine implies possible new organ dysfunction, making this category a relevant choice. The alignment is strong but not perfect, as the claim does not indicate a specific score increase threshold (\u22652 points as specified in the category).",
            "The claim regarding slight renal impairment, inferred from eGFR values, aligns conceptually with the SOFA category, which includes creatinine levels as an indicator of renal function. While the claim mentions renal impairment, it does not quantify it to confirm an increase in SOFA score by \u22652 points. Nonetheless, the renal function deterioration is relevant to SOFA criteria, indicating a moderate to strong alignment.",
            "The claim is vague and does not specify which sepsis criteria are being met. However, SIRS criteria are often informally referred to as \"sepsis criteria.\" The match is indirect and weak due to the lack of detail, hence the low alignment rating.",
            "The claim suggests a potential for progression to sepsis but lacks specific detail to strongly align with any particular category. The Elevated NEWS Score relates to predicting imminent clinical deterioration, which conceptually matches the idea of high risk of progression. However, without specific information on vital signs or scores, the alignment is weak. Other categories might touch on risk, but none provide a closer match without further specifics."
        ],
        "final_alignment_score": 0.5818181818181818,
        "accuracy": 0
    },
    {
        "input": "8: HR, 119.0; 8: RR, 18.0; 8: SpO2, 95.0; 8: SBP, 169.0; 8: DBP, 103.0; 8: MAP, 125.0; 8: Pain, 6.0; 8: Temp, 95.0; 33: POC PH (V) ISTAT, 7.45; 33: POC O2 SATURATION ISTAT VENOUS, 55 %; 33: POC LACTATE ISTAT, 1.54 mmol/L; 33: POC HCO3 (V) ISTAT, 29.1 mmol/L; 33: POC PO2 (V) ISTAT, 28 mmHg; 33: POC BASE EXCESS ISTAT, 5 mmol/L; 33: POC TCO2 (V) ISTAT, 30 mmol/L; 33: POC PCO2 (V) ISTAT, 42.3 mmHg; 44: HR, 88.590; 44: RR, 18.406; 44: SpO2, 99.0; 44: 1min HRV, 20.500; 44: 5min HRV, 20.500; 45: HR, 92.305; 45: RR, 15.068; 45: SpO2, 98.797; 45: Perf, 0.735; 45: 1min HRV, 15.914; 46: HR, 94.085; 46: RR, 17.729; 46: SpO2, 98.542; 46: Perf, 0.682; 46: 1min HRV, 20.121; 47: HR, 94.931; 47: RR, 12.603; 47: SpO2, 97.980; 47: Perf, 0.69; 47: 1min HRV, 17.878; 48: HR, 88.931; 48: RR, 11.190; 48: SpO2, 98.604; 48: Perf, 0.69; 48: 1min HRV, 25.098; 49: HR, 90.576; 49: RR, 14.102; 49: SpO2, 98.881; 49: Perf, 0.691; 49: 1min HRV, 22.655; 49: 5min HRV, 26.130; 50: HR, 88.254; 50: RR, 13.356; 50: SpO2, 99.797; 50: Perf, 0.768; 50: 1min HRV, 20.065; 51: HR, 85.797; 51: RR, 12.881; 51: SpO2, 99.847; 51: Perf, 0.780; 51: 1min HRV, 25.433; 51: NORMOSOL-R IV BOLUS -, 1000 ML; 52: HR:, 87.828; 52: RR, 14.483; 52: SpO2, 99.0; 52: Perf, 0.801; 52: 1min HRV, 17.872; 53: HR, 87.492; 53: RR, 13.441; 53: SpO2, 98.424; 53: Perf, 0.752; 53: 1min HRV, 14.349; 54: HR, 87.259; 54: RR, 12.741; 54: SpO2, 98.552; 54: Perf, 0.726; 54: 1min HRV, 21.211; 54: 5min HRV, 21.158; 54: SBP, 194.0; 54: DBP, 112.0; 54: MAP, 139.333; 55: HR, 87.797; 55: RR, 16.271; 55: SpO2, 98.909; 55: Perf, 0.696; 55: 1min HRV, 20.357; 55: SBP, 194.0; 55: DBP, 112.0; 55: MAP, 139.333; 56: HR, 88.542; 56: RR, 11.136; 56: SpO2, 99.164; 56: Perf, 0.578; 56: 1min HRV, 21.854; 56: SBP, 191.0; 56: DBP, 107.0; 56: MAP, 135.0; 56: Temp, 99.0; 57: HR, 85.724; 57: RR, 12.897; 57: SpO2, 98.638; 57: Perf, 0.604; 57: 1min HRV, 23.184; 57: SBP, 191.0; 57: DBP, 107.0; 57: MAP, 135.0; 58: HR, 86.508; 58: RR, 14.508; 58: SpO2, 99.409; 58: Perf, 0.57; 58: 1min HRV, 24.025; 59: HR, 85.845; 59: RR, 17.259; 59: SpO2, 99.310; 59: Perf, 0.546; 59: 1min HRV, 35.505; 59: 5min HRV, 27.028; 60: HR, 93.741; 60: RR, 23.621; 60: SpO2, 98.707; 60: Perf, 0.559; 60: 1min HRV, 31.804; 61: HR, 96.627; 61: RR, 13.831; 61: SpO2, 98.458; 61: Perf, 0.563; 61: 1min HRV, 16.269; 62: HR, 97.305; 62: RR, 14.695; 62: SpO2, 97.0; 62: Perf, 0.586; 62: 1min HRV, 13.340; 63: INR, 1.0; 63: PROTHROMBIN TIME, 12.6 seconds; 63: PART. THROMBOPLASTIN TIME, 27.5 seconds; 63: HR, 97.220; 63: RR, 14.390; 63: SpO2, 97.305; 63: Perf, 0.606; 63: 1min HRV, 40.075; 64: HR, 93.259; 64: RR, 13.259; 64: SpO2, 98.586; 64: Perf, 0.716; 64: 1min HRV, 16.946; 64: 5min HRV, 29.308; 64: SBP, 178.0; 64: DBP, 99.0; 64: MAP, 125.333; 65: HR, 89.305; 65: RR, 12.458; 65: SpO2, 99.153; 65: Perf, 0.709; 65: 1min HRV, 14.345; 65: SBP, 178.0; 65: DBP, 99.0; 65: MAP, 125.333; 66: HR, 89.914; 66: RR, 15.5; 66: SpO2, 99.069; 66: Perf, 0.746; 66: 1min HRV, 11.732; 67: HR, 89.983; 67: RR, 15.492; 67: SpO2, 98.881; 67: Perf, 0.7; 67: 1min HRV, 12.711; 68: HR, 90.356; 68: RR, 18.373; 68: SpO2, 98.610; 68: Perf, 0.700; 68: 1min HRV, 21.647; 69: HR, 88.190; 69: RR, 14.379; 69: SpO2, 98.828; 69: Perf, 0.804; 69: 1min HRV, 16.146; 69: 5min HRV, 16.123; 70: HR, 88.695; 70: RR, 13.322; 70: SpO2, 98.576; 70: Perf, 0.778; 70: 1min HRV, 12.567; 71: HR, 89.517; 71: RR, 14.190; 71: SpO2, 97.586; 71: Perf, 0.757; 71: 1min HRV, 18.283; 72: HR, 90.831; 72: RR, 13.034; 72: SpO2, 97.712; 72: Perf, 0.781; 72: 1min HRV, 30.201; 73: HR, 89.441; 73: RR, 13.441; 73: SpO2, 97.763; 73: Perf, 0.792; 73: 1min HRV, 17.698; 74: HR, 90.052; 74: RR, 15.517; 74: SpO2, 97.552; 74: Perf, 0.767; 74: 1min HRV, 18.816; 74: 5min HRV, 21.222; 75: AST (SGOT), 38 U/L; 75: EGFR FOR AFRICAN AMERICAN, 88 mL/min/1.73 m2; 75: CHLORIDE, 101 mmol/L; 75: EGFR REFIT WITHOUT RACE (2021), 76 mL/min/1.73 m2; 75: CORRECTED CALCIUM, 9.4 mg/dL; 75: ALBUMIN, 4.4 g/dL; 75: CO2, 27 mmol/L; 75: ANION GAP, 13 mmol/L; 75: GLOBULIN, 2.5 g/dL; 75: CALCIUM, 9.7 mg/dL; 75: POTASSIUM, 3.7 mmol/L; 75: BILIRUBIN TOTAL, 0.6 mg/dL; 75: CREATININE, 0.85 mg/dL; 75: ALT (SGPT), 75 U/L; 75: BLOOD UREA NITROGEN (BUN), 16 mg/dL; 75: ALKALINE PHOSPHATASE, 136 U/L; 75: PROTEIN TOTAL, 6.9 g/dL; 75: GLUCOSE, 134 mg/dL; 75: SODIUM, 141 mmol/L; 75: MAGNESIUM, 2.2 mg/dL; 75: C-REACTIVE PROTEIN (CRP), 12.9 mg/dL; 75: HR, 92.576; 75: RR, 15.492; 75: SpO2, 97.458; 75: Perf, 0.738; 75: 1min HRV, 15.039; 75: LABETALOL, 5 MG/ML IV SOLN; 76: HR:, 91.172; 76: RR, 14.914; 76: SpO2, 98.086; 76: Perf, 0.761; 76: 1min HRV, 22.991; 77: HR, 92.593; 77: RR, 12.966; 77: SpO2, 97.847; 77: Perf, 0.732; 77: 1min HRV, 12.759; 78: HR, 90.322; 78: RR, 11.407; 78: SpO2, 97.763; 78: Perf, 0.629; 78: 1min HRV, 29.457; 79: HR, 81.672; 79: RR, 11.603; 79: SpO2, 96.724; 79: Perf, 0.630; 79: 1min HRV, 12.557; 79: 5min HRV, 39.153; 80: SBP, 160.0; 80: DBP, 140.0; 80: MAP, 146.667; 98: PROCALCITONIN, 3.91 ng/mL; 100: ESR (AUTOMATED), 112 mm/hr; 110: TROPONIN I, 0.028 ng/mL; 0: Age, 57; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, nan; 0: Triage HR, 119.0; 0: Triage RR, 18.0; 0: Triage SBP, 169.0; 0: Triage DBP, 103.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER",
        "answer": false,
        "llm_answer": "Yes",
        "llm_explanation": "First, I looked for immediate indicators of infection, such as elevated heart rate and fever, and noted the consistently high heart rate. Next, I examined labs like procalcitonin and CRP, both of which were significantly elevated, suggesting a bacterial infection. Then, I considered whether the patient showed early signs of organ dysfunction or hemodynamic instability, noticing changes in blood pressure and heart rate that could signal progression. Putting these findings together, the elevated inflammatory markers and vital sign abnormalities indicate a high risk for sepsis within 12 hours.",
        "claims": [
            "Immediate indicators of infection were sought, such as elevated heart rate and fever.",
            "The heart rate was consistently high.",
            "Labs like procalcitonin and CRP were examined.",
            "Procalcitonin and CRP levels were significantly elevated.",
            "The elevated procalcitonin and CRP levels suggest a bacterial infection.",
            "Early signs of organ dysfunction or hemodynamic instability were considered.",
            "Changes in blood pressure and heart rate were observed.",
            "Changes in blood pressure and heart rate could signal progression.",
            "The elevated inflammatory markers indicate a high risk for sepsis.",
            "The vital sign abnormalities indicate a high risk for sepsis.",
            "There is a high risk for sepsis within 12 hours."
        ],
        "relevant_claims": [
            "Immediate indicators of infection were sought, such as elevated heart rate and fever.",
            "The heart rate was consistently high.",
            "Labs like procalcitonin and CRP were examined.",
            "Procalcitonin and CRP levels were significantly elevated.",
            "The elevated procalcitonin and CRP levels suggest a bacterial infection.",
            "Early signs of organ dysfunction or hemodynamic instability were considered.",
            "Changes in blood pressure and heart rate were observed.",
            "Changes in blood pressure and heart rate could signal progression.",
            "The elevated inflammatory markers indicate a high risk for sepsis.",
            "The vital sign abnormalities indicate a high risk for sepsis.",
            "There is a high risk for sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.8,
            0.7,
            0.3,
            0.7,
            0.6,
            0.7,
            0.7,
            0.7,
            0.7,
            0.8,
            0.3
        ],
        "alignment_category": [
            2,
            2,
            9,
            2,
            9,
            8,
            6,
            6,
            2,
            4,
            4
        ],
        "alignment_reasonings": [
            "The claim mentions elevated heart rate and fever, both of which are part of the SIRS criteria. SIRS (Systemic Inflammatory Response Syndrome) positivity requires the presence of two or more criteria, and while the claim suggests seeking these indicators rather than confirming them, it strongly aligns with the SIRS criteria used to identify systemic inflammation associated with early sepsis. This indirect reference to potential SIRS criteria warrants a high alignment rating, though not a perfect one since it doesn't confirm both criteria are met.",
            "A consistently high heart rate aligns with one of the SIRS criteria, as a heart rate >90 bpm is used to identify systemic inflammation consistent with early sepsis. While the claim doesn't specify whether the heart rate meets the threshold for SIRS, the implication is strong due to the word \"consistently,\" thus suggesting potential fulfillment of this SIRS criterion.",
            "The examination of markers such as procalcitonin and CRP suggests an underlying suspicion of infection, which aligns with sepsis risk assessment. However, the category focuses on proactive clinical actions like administering antibiotics or drawing cultures rather than just examining lab tests. Therefore, while there is some relevant alignment in terms of investigating infection risk, it is indirect and weak.",
            "Both procalcitonin and CRP are biomarkers indicative of an inflammatory response or infection. They are not explicitly mentioned under SIRS criteria, but they align with the concept of systemic inflammation consistent with early sepsis. Thus, they indirectly relate to SIRS Positivity. The alignment rating reflects this indirect, yet significant, connection.",
            "Elevated procalcitonin and CRP levels are indicators of a bacterial infection, which aligns with clinical suspicion of serious infection. However, the claim doesn\u2019t specify immediate clinical actions such as antibiotics or cultures, which would have warranted a stronger alignment. Thus, it fits the category moderately well, so a rating of 0.6 is assigned.",
            "The claim mentions \"early signs of organ dysfunction\" which directly aligns with the concept of SOFA Score Increase, as this category focuses on assessing new organ dysfunction. Although the claim does not explicitly quantify or reference specific SOFA components, the general notion of organ dysfunction aligns well. Hemodynamic instability could also relate to changes in SOFA score components like blood pressure or related organ dysfunction, adding to the relevance. Thus, the alignment is fairly strong but lacks explicit quantification or specifics.",
            "Changes in blood pressure and heart rate are directly related to the concept of Shock Index, which involves heart rate divided by systolic blood pressure. While the claim doesn't specify if the shock index itself is elevated, fluctuations in these parameters suggest relevance to this category, making the alignment moderately strong.",
            "The claim references changes in blood pressure and heart rate, which are directly related to the shock index\u2014a measure of hemodynamic instability that is calculated using heart rate and systolic blood pressure. Although the claim does not provide specific values, the mention of changes in these parameters suggests a consideration of increased shock index and potential progression towards severe sepsis. The alignment is moderately strong due to the conceptual relationship but lacks specific index or value changes that would be necessary for a full match.",
            "SIRS criteria involve systemic inflammatory markers, and the claim directly references elevated inflammatory markers. While the claim does not specify the exact markers or thresholds met, it aligns conceptually with the criteria used to identify systemic inflammation in early sepsis as per the SIRS criteria. However, due to the lack of specific details, the alignment is not perfect, warranting a 0.7 rating.",
            "The claim references \"vital sign abnormalities\" indicating a high risk for sepsis, which strongly aligns with the Elevated NEWS Score category. This score is derived from deranged vitals and is used to predict imminent clinical deterioration related to sepsis. Although the claim does not specify a NEWS score, its focus on abnormal vitals and high sepsis risk strongly parallels the purpose of the NEWS criteria, resulting in a high alignment rating.",
            "The claim generally addresses a 'high risk for sepsis,' implying a prediction of potential clinical deterioration. The most fitting category would be one that uses current physiological data to predict such deterioration, which aligns with the purpose of the NEWS score. However, because the claim lacks specific clinical data to suggest a direct alignment with an elevated NEWS score, the alignment rating is low."
        ],
        "final_alignment_score": 0.6363636363636362,
        "accuracy": 0
    },
    {
        "input": "2: SpO2, 98.912; 3: HR, 127.55; 3: RR, 25.833; 3: SpO2, 99.0; 3: 1min HRV, 9.900; 3: 5min HRV, 9.900; 3: SBP, 112.0; 3: DBP, 60.0; 3: MAP, 77.333; 4: HR, 123.810; 4: RR, 14.64; 4: SpO2, 93.6; 4: 1min HRV, 8.630; 5: HR, 123.759; 5: RR, 20.083; 5: SpO2, 100.0; 5: Perf, 0.17; 5: 1min HRV, 9.799; 6: HR, 121.237; 6: RR, 20.864; 6: SpO2, 100.0; 6: Perf, 0.173; 6: 1min HRV, 8.424; 7: HR, 122.534; 7: RR, 18.897; 7: SpO2, 99.806; 7: Perf, 0.180; 7: 1min HRV, 10.581; 8: HR, 122.237; 8: RR, 21.153; 8: SpO2, 100.0; 8: Perf, 0.165; 8: 1min HRV, 11.457; 8: 5min HRV, 10.763; 8: SBP, 112.0; 8: DBP, 60.0; 8: MAP, 77.333; 8: Pain, 0.0; 8: Temp, 99.1; 9: HR, 121.466; 9: RR, 22.138; 9: SpO2, 99.711; 9: Perf, 0.17; 9: 1min HRV, 12.729; 10: HR, 120.085; 10: RR, 18.373; 10: SpO2, 99.826; 10: Perf, 0.17; 10: 1min HRV, 8.977; 11: HR, 121.356; 11: RR, 20.847; 11: SpO2, 99.96; 11: Perf, 0.159; 11: 1min HRV, 6.412; 13: 5min HRV, 10.151; 20: POC PH (V) ISTAT, 7.35; 20: POC TCO2 (V) ISTAT, 32 mmol/L; 20: POC O2 SATURATION ISTAT VENOUS, 28 %; 20: POC PCO2 (V) ISTAT, 54.3 mmHg; 20: POC HCO3 (V) ISTAT, 30.1 mmol/L; 20: POC LACTATE ISTAT, 0.86 mmol/L; 20: POC BASE EXCESS ISTAT, 5 mmol/L; 20: POC PO2 (V) ISTAT, 20 mmHg; 27: ABO/RH (AUTOMATION), AB Positive; 27: ANTIBODY SCREEN 3, NEG; 29: HR, 117.0; 29: RR, 20.0; 29: SpO2, 100.0; 29: SBP, 104.0; 29: DBP, 67.0; 29: MAP, 79.333; 40: WAM DIFTYP, AUTO; 40: PLATELET COUNT (PLT), 300 K/uL; 40: HEMATOCRIT (HCT), 29.4 %; 40: HEMOGLOBIN (HGB), 9.7 g/dL; 40: MONOCYTE ABSOLUTE (AUTO DIFF), 1.06 K/uL; 40: MEAN CORPUSCULAR VOLUME (MCV), 85.2 fL; 40: NEUTROPHIL ABSOLUTE (AUTO DIFF), 12.92 K/uL; 40: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.06 K/uL; 40: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 40: RED BLOOD CELLS (RBC), 3.45 MIL/uL; 40: EOSINOPHIL % (AUTO DIFF), 0.0 %; 40: BASOPHIL % (AUTO DIFF), 0.1 %; 40: NEUTROPHIL % (AUTO DIFF), 87.3 %; 40: MONOCYTE % (AUTO DIFF), 7.2 %; 40: NRBC PERCENT (HEMATOLOGY), 0.0 %; 40: WHITE BLOOD CELLS (WBC), 14.8 K/uL; 40: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.74 K/uL; 40: BASOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 40: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 40: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.0 g/dL; 40: RED CELL DISTRIBUTION WIDTH (RDW), 17.3 %; 40: LYMPHOCYTE % (AUTO DIFF), 5.0 %; 40: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 28.1 pg; 40: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 43: HR, 114.0; 43: RR, 27.0; 43: SpO2, 100.0; 43: SBP, 107.0; 43: DBP, 62.0; 43: MAP, 77.0; 50: INR, 1.1; 50: PROTHROMBIN TIME, 14.4 seconds; 51: PART. THROMBOPLASTIN TIME, 33.5 seconds; 56: ETOMIDATE, 2 MG/ML IV SOLN; 58: SUCCINYLCHOLINE CHLORIDE, 20 MG/ML INJ SOLN; 60: ALT (SGPT), 47 U/L; 60: ANION GAP, 8 mmol/L; 60: ALBUMIN, 3.4 g/dL; 60: EGFR FOR AFRICAN AMERICAN, 150 mL/min/1.73 m2; 60: CALCIUM, 8.6 mg/dL; 60: CREATININE, 0.42 mg/dL; 60: GLUCOSE, 120 mg/dL; 60: CORRECTED CALCIUM, 9.1 mg/dL; 60: GLOBULIN, 3.2 g/dL; 60: BILIRUBIN TOTAL, 0.3 mg/dL; 60: EGFR REFIT WITHOUT RACE (2021), 130 mL/min/1.73 m2; 60: SODIUM, 130 mmol/L; 60: PROTEIN TOTAL, 6.6 g/dL; 60: ALKALINE PHOSPHATASE, 95 U/L; 60: BLOOD UREA NITROGEN (BUN), 10 mg/dL; 60: AST (SGOT), 33 U/L; 60: CHLORIDE, 95 mmol/L; 60: CO2, 27 mmol/L; 60: POTASSIUM, 4.6 mmol/L; 63: HR, 59.0; 63: RR, 18.0; 63: SBP, 117.0; 63: DBP, 100.0; 63: MAP, 105.667; 68: HR, 59.0; 68: RR, 20.0; 68: SBP, 100.0; 68: DBP, 49.0; 68: MAP, 66.0; 69: HR, 59.0; 69: RR, 23.0; 69: SBP, 72.0; 69: DBP, 45.0; 69: MAP, 54.0; 69: PHENYLEPHRINE HCL IN, 0.9% NACL 0.5 MG/5 ML (100 MCG/ML) IV SYRG; 70: RR:, 24.0; 70: SBP, 87.0; 70: DBP, 54.0; 70: MAP, 65.0; 71: PHENYLEPHRINE HCL IN, 0.9% NACL 0.5 MG/5 ML (100 MCG/ML) IV SYRG; 72: TRANEXAMIC ACID, 100 MG/ML NEBULIZED INHALATION; 73: RR, 18.0; 73: SBP, 89.0; 73: DBP, 63.0; 73: MAP, 71.667; 74: HR, 140.0; 74: RR, 21.0; 74: SBP, 139.0; 74: DBP, 86.0; 74: MAP, 103.667; 74: NOREPINEPHRINE BITARTRATE-NACL, 4 MG/250 ML (16 MCG/ML) IV SOLN; 76: CALCIUM GLUCONATE IN, 0.9% NACL 1 GRAM/50 ML IV SOLN; 78: HR, 138.0; 78: RR, 16.0; 78: SpO2, 100.0; 78: SBP, 167.0; 78: DBP, 91.0; 78: MAP, 116.333; 82: HR, 138.0; 82: RR, 24.0; 82: SpO2, 100.0; 82: SBP, 118.0; 82: DBP, 89.0; 82: MAP, 98.667; 83: HR, 133.0; 83: RR, 14.0; 83: SpO2, 100.0; 83: SBP, 140.0; 83: DBP, 76.0; 83: MAP, 97.333; 85: PROPOFOL, 10 MG/ML IV INFUSION; 87: FENTANYL CITRATE (PF), 50 MCG/ML INJ SOLN (WRAPPER RECORD); 88: HR, 125.0; 88: RR, 13.0; 88: SpO2, 100.0; 88: SBP, 105.0; 88: DBP, 47.0; 88: MAP, 66.333; 93: HR, 119.0; 93: RR, 20.0; 93: SpO2, 99.0; 93: SBP, 133.0; 93: DBP, 50.0; 93: MAP, 77.667; 98: HR, 109.0; 98: RR, 21.0; 98: SpO2, 99.0; 98: FENTANYL CITRATE (PF), 50 MCG/ML INJ SOLN (WRAPPER RECORD); 102: POC PH (A), ISTAT: 7.21; 102: POC BASE EXCESS ISTAT, -11 mmol/L; 102: POC LACTATE ISTAT, 7.13 mmol/L; 102: POC HCO3 (A) ISTAT, 16.6 mmol/L; 102: POC O2 SATURATION ISTAT, 98 %; 102: POC PO2 (A) ISTAT, 122 mmHg; 102: POC TCO2 (A) ISTAT, 18 mmol/L; 102: POC PCO2 (A) ISTAT, 41.2 mmHg; 108: HR, 105.0; 108: RR, 20.0; 108: SpO2, 98.0; 113: HR, 89.0; 113: RR, 21.0; 113: SpO2, 100.0; 118: HR, 103.0; 118: RR, 20.0; 118: SpO2, 100.0; 118: Pain, 0.0; 118: Pain, 1.0; 0: Age, 37; 0: Gender, F; 0: Race, Asian; 0: Means of arrival, EMS; 0: Triage Temp, 37.3; 0: Triage HR, 118.0; 0: Triage RR, 22.0; 0: Triage SBP, 112.0; 0: Triage DBP, 60.0; 0: Triage acuity, 2-Emergent; 0: CC, BLOOD IN VOMIT",
        "answer": false,
        "llm_answer": "Yes",
        "llm_explanation": "First, I checked whether the patient\u2019s vital signs indicated an abnormal physiology (e.g., elevated heart rate, low blood pressure). Next, I examined laboratory values, noting the elevated lactate and signs of acidosis that suggest possible infection and poor tissue perfusion. Then, I confirmed that the patient required vasopressors, another clear indicator of severe hemodynamic instability. Putting these factors together, it indicates a high risk for sepsis within 12 hours.",
        "claims": [
            "The patient\u2019s vital signs were checked for abnormal physiology.",
            "Abnormal physiology includes elevated heart rate and low blood pressure.",
            "Laboratory values were examined for signs of infection.",
            "The lactate level was elevated.",
            "Elevated lactate suggests possible infection.",
            "Signs of acidosis were noted.",
            "Acidosis indicates poor tissue perfusion.",
            "The patient required vasopressors.",
            "The requirement for vasopressors is a clear indicator of severe hemodynamic instability.",
            "Putting these factors together indicates a high risk for sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient\u2019s vital signs were checked for abnormal physiology.",
            "Abnormal physiology includes elevated heart rate and low blood pressure.",
            "Laboratory values were examined for signs of infection.",
            "Elevated lactate suggests possible infection.",
            "Signs of acidosis were noted.",
            "Acidosis indicates poor tissue perfusion.",
            "The patient required vasopressors.",
            "The requirement for vasopressors is a clear indicator of severe hemodynamic instability."
        ],
        "alignment_scores": [
            0.3,
            0.8,
            0.3,
            0.7,
            0.7,
            0.7,
            0.9,
            0.8
        ],
        "alignment_category": [
            4,
            6,
            9,
            5,
            5,
            5,
            7,
            6
        ],
        "alignment_reasonings": [
            "Checking vital signs for abnormal physiology aligns somewhat with the NEWS Score, which assesses deranged vitals to predict clinical deterioration compatible with sepsis. However, the claim lacks specificity or detail about the values of those vital signs, making the alignment weak but not entirely irrelevant.",
            "The claim mentions an elevated heart rate and low blood pressure, which directly relate to the Shock Index, a ratio involving heart rate and systolic blood pressure. This strongly suggests hemodynamic instability, although the claim does not provide exact values needed to calculate or confirm the elevated Shock Index definitively. However, the combination of these factors is a clear indicator of potential severe sepsis as described in this category.",
            "The claim involves examining laboratory values for signs of infection, which suggests an underlying suspicion of infection similar to the rationale for obtaining cultures or starting antibiotics. However, the claim does not specify any actual interventions like ordering antibiotics or cultures, making the alignment indirect and relatively weak.",
            "The claim references elevated lactate, directly relating to this category, which highlights lactate levels as an indication of potential tissue hypoperfusion and sepsis risk. However, it doesn't specify the degree of elevation or explicitly connect to the threshold (\u22652 mmol/L), so the alignment is strong but not perfect.",
            "Acidosis often indicates an increase in lactate levels, which aligns with the category of Elevated Serum Lactate. While acidosis isn't exclusively tied to lactate, lactate elevation is a common cause of metabolic acidosis in the context of sepsis, suggesting a significant but indirect association with this category. The alignment with elevated serum lactate is strong but not definitive, warranting a 0.7 rating.",
            "Acidosis, often resulting from lactic acid buildup, suggests tissue hypoperfusion, which aligns with the rationale behind elevated serum lactate levels as an indicator of sepsis risk. While the claim doesn't explicitly mention serum lactate levels, the association of acidosis with poor tissue perfusion connects conceptually to this category, leading to a strong but indirect alignment.",
            "The use of vasopressors is typically associated with addressing hypotension, especially in the context of sepsis. This aligns closely with the category of sepsis-associated hypotension indicating progression toward septic shock. However, the claim does not provide specific blood pressure values or confirm hypotension precisely as outlined in the category, resulting in a slight deduction from a perfect score.",
            "The claim about the requirement for vasopressors highlights severe hemodynamic instability. While vasopressor use itself is not explicitly stated in the Elevated Shock Index criterion, it is closely related since vasopressors are used to manage hemodynamic instability similar to what an elevated shock index indicates. The alignment is strong though not perfect because it mentions the treatment (vasopressors) rather than the measurement (shock index)."
        ],
        "final_alignment_score": 0.65,
        "accuracy": 0
    },
    {
        "input": "1: HR, 79.882; 1: RR, 18.0; 1: SpO2, 92.348; 1: Perf, 2.965; 1: 1min HRV, 16.865; 2: HR, 79.475; 2: RR, 17.102; 2: SpO2, 92.459; 2: Perf, 3.261; 2: 1min HRV, 12.250; 2: 5min HRV, 13.874; 2: SBP, 91.0; 2: DBP, 56.0; 2: MAP, 67.667; 3: HR, 79.603; 3: RR, 17.552; 3: SpO2, 92.167; 3: Perf, 4.201; 3: 1min HRV, 9.150; 3: SBP, 89.0; 3: DBP, 54.0; 3: MAP, 65.667; 4: HR, 80.017; 4: RR, 19.814; 4: SpO2, 91.797; 4: Perf, 4.437; 4: 1min HRV, 7.918; 5: HR, 79.483; 5: RR, 17.897; 5: SpO2, 92.466; 5: Perf, 4.719; 5: 1min HRV, 19.889; 6: HR, 77.898; 6: RR, 17.203; 6: SpO2, 93.034; 6: Perf, 4.849; 6: 1min HRV, 8.734; 7: HR, 77.305; 7: RR, 17.915; 7: SpO2, 94.172; 7: Perf, 4.749; 7: 1min HRV, 29.252; 7: 5min HRV, 20.200; 7: SBP, 82.0; 7: DBP, 58.0; 7: MAP, 66.0; 8: HR, 77.603; 8: RR, 19.879; 8: SpO2, 94.845; 8: Perf, 4.85; 8: 1min HRV, 15.192; 9: HR, 77.932; 9: RR, 18.898; 9: SpO2, 95.729; 9: Perf, 5.131; 9: 1min HRV, 12.593; 10: HR, 77.845; 10: RR, 16.397; 10: SpO2, 96.293; 10: Perf, 4.86; 10: 1min HRV, 16.278; 10: SBP, 82.0; 10: DBP, 56.0; 10: MAP, 64.667; 11: HR, 77.458; 11: RR, 19.085; 11: SpO2, 96.492; 11: Perf, 5.061; 11: 1min HRV, 23.636; 12: HR, 77.441; 12: RR, 19.458; 12: SpO2, 96.0; 12: Perf, 4.676; 12: 1min HRV, 26.166; 12: 5min HRV, 19.846; 13: HR, 77.086; 13: RR, 19.672; 13: SpO2, 96.517; 13: Perf, 4.590; 13: 1min HRV, 27.453; 14: HR, 78.068; 14: RR, 20.780; 14: SpO2, 97.119; 14: Perf, 4.273; 14: 1min HRV, 29.638; 15: HR, 78.259; 15: RR, 18.069; 15: SpO2, 96.017; 15: Perf, 4.582; 15: 1min HRV, 26.424; 16: HR, 77.0; 16: RR, 21.712; 16: SpO2, 95.831; 16: Perf, 4.953; 16: 1min HRV, 21.531; 17: HR, 74.655; 17: RR, 19.983; 17: SpO2, 96.0; 17: Perf, 5.045; 17: 1min HRV, 32.942; 17: 5min HRV, 30.473; 18: HR, 76.627; 18: RR, 18.644; 18: SpO2, 96.881; 18: Perf, 4.553; 18: 1min HRV, 42.603; 18: SBP, 86.0; 18: DBP, 56.0; 18: MAP, 66.0; 19: HR, 76.746; 19: RR, 20.695; 19: SpO2, 96.085; 19: Perf, 4.913; 19: 1min HRV, 22.919; 20: HR, 75.914; 20: RR, 19.672; 20: SpO2, 96.810; 20: Perf, 4.996; 20: 1min HRV, 15.346; 21: HR, 75.695; 21: RR, 21.186; 21: SpO2, 96.068; 21: Perf, 4.31; 21: 1min HRV, 18.165; 22: HR, 75.0; 22: RR, 19.897; 22: SpO2, 96.0; 22: Perf, 5.584; 22: 1min HRV, 15.242; 22: 5min HRV, 26.758; 23: SpO2, 95.627; 23: Perf, 6.732; 24: SpO2, 95.847; 24: Perf, 6.377; 25: SpO2, 95.103; 25: Perf, 5.538; 26: SpO2, 95.271; 26: Perf, 4.859; 27: SpO2, 94.431; 27: Perf, 3.054; 28: SpO2, 97.0; 28: Perf, 3.627; 29: SpO2, 95.644; 29: Perf, 3.088; 30: SpO2, 96.862; 30: Perf, 2.077; 31: SpO2, 96.068; 31: Perf, 2.325; 32: SpO2, 97.759; 32: Perf, 1.248; 33: SpO2, 97.068; 33: Perf, 0.830; 33: SBP, 110.0; 33: DBP, 71.0; 33: MAP, 84.0; 34: SpO2, 97.949; 34: Perf, 0.764; 34: NORMOSOL-R IV BOLUS -, 1000 ML; 35: HR:, 75.0; 35: RR, 20.0; 35: SpO2, 96.828; 35: Perf, 0.739; 35: SBP, 110.0; 35: DBP, 71.0; 35: MAP, 84.0; 36: POC PH (V) ISTAT, 7.42; 36: POC PCO2 (V) ISTAT, 35.1 mmHg; 36: POC PO2 (V) ISTAT, 37 mmHg; 36: POC HCO3 (V) ISTAT, 22.7 mmol/L; 36: POC O2 SATURATION ISTAT VENOUS, 73 %; 36: POC LACTATE ISTAT, 1.78 mmol/L; 36: POC TCO2 (V) ISTAT, 24 mmol/L; 36: POC BASE EXCESS ISTAT, -2 mmol/L; 36: HR, 73.935; 36: RR, 26.932; 36: SpO2, 95.593; 36: Perf, 1.088; 36: 1min HRV, 15.067; 37: HR, 76.224; 37: RR, 22.655; 37: SpO2, 97.5; 37: Perf, 1.012; 37: 1min HRV, 13.381; 37: 5min HRV, 18.055; 38: HR, 78.051; 38: RR, 28.356; 38: SpO2, 97.932; 38: Perf, 0.629; 38: 1min HRV, 16.546; 39: HR, 80.0; 39: RR, 25.254; 39: SpO2, 98.390; 39: Perf, 0.600; 39: 1min HRV, 21.224; 40: HR, 81.121; 40: RR, 23.741; 40: SpO2, 98.810; 40: Perf, 0.593; 40: 1min HRV, 13.943; 41: HR, 83.542; 41: RR, 26.373; 41: SpO2, 98.0; 41: Perf, 0.600; 41: 1min HRV, 19.886; 42: HR, 83.897; 42: RR, 29.414; 42: SpO2, 98.086; 42: Perf, 0.639; 42: 1min HRV, 17.444; 42: 5min HRV, 26.739; 43: HR, 84.475; 43: RR, 28.780; 43: SpO2, 98.661; 43: Perf, 0.669; 43: 1min HRV, 13.889; 44: HR, 85.712; 44: RR, 26.424; 44: SpO2, 98.644; 44: Perf, 0.677; 44: 1min HRV, 17.314; 47: 5min HRV, 16.253; 62: INR, 1.3; 62: PROTHROMBIN TIME, 15.6 seconds; 63: PART. THROMBOPLASTIN TIME, 35.1 seconds; 71: PIPERACILLIN-TAZOBACTAM-DEXTRS, 4.5 GRAM/100 ML IV PGBK; 74: LIPASE:, 3 U/L; 77: EGFR REFIT WITHOUT RACE (2021), 71 mL/min/1.73 m2; 77: ALT (SGPT), 20 U/L; 77: PROTEIN TOTAL, 5.4 g/dL; 77: CREATININE, 1.01 mg/dL; 77: POTASSIUM, 4.2 mmol/L; 77: GLOBULIN, 2.7 g/dL; 77: AST (SGOT), 62 U/L; 77: ALKALINE PHOSPHATASE, 362 U/L; 77: GLUCOSE, 194 mg/dL; 77: BILIRUBIN TOTAL, 2.1 mg/dL; 77: EGFR FOR AFRICAN AMERICAN, 82 mL/min/1.73 m2; 77: CORRECTED CALCIUM, 8.5 mg/dL; 77: ANION GAP, 11 mmol/L; 77: ALBUMIN, 2.7 g/dL; 77: SODIUM, 133 mmol/L; 77: CALCIUM, 7.5 mg/dL; 77: BLOOD UREA NITROGEN (BUN), 23 mg/dL; 77: CO2, 23 mmol/L; 77: CHLORIDE, 99 mmol/L; 118: HEMOGLOBIN (HGB), 11.1 g/dL; 118: WHITE BLOOD CELLS (WBC), 2.9 K/uL; 118: PLATELET COUNT (PLT), 47 K/uL; 118: HEMATOCRIT (HCT), 33.3 %; 118: RED CELL DISTRIBUTION WIDTH (RDW), 15.4 %; 118: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.3 g/dL; 118: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 32.4 pg; 118: RED BLOOD CELLS (RBC), 3.43 MIL/uL; 118: MEAN CORPUSCULAR VOLUME (MCV), 97.1 fL; 118: LYMPHOCYTES % (MANUAL DIFF), 6.0 %; 118: NEUTROPHILS SEGMENTED % (MANUAL DIFF), 78.0 %; 118: MONOCYTES % (MANUAL DIFF), 0.0 %; 118: NEUTROPHILS ABSOLUTE (MANUAL DIFF) (SEGS+BANDS), 2.75 K/uL; 118: NEUTROPHILS BANDS % (MANUAL DIFF), 16.0 %; 118: LYMPHOCYTES ABSOLUTE (MANUAL DIFF), 0.18 K/uL; 0: Age, 80; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, EMS; 0: Triage Temp, 38.2; 0: Triage HR, 77.0; 0: Triage RR, 16.0; 0: Triage SBP, 92.0; 0: Triage DBP, 53.0; 0: Triage acuity, 3-Urgent; 0: CC, GENERAL WEAKNESS",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, I checked the patient\u2019s vital signs and noted hypotension (SBP in the 80\u201390 range) and fever (38.2\u00b0C). Next, I examined laboratory results, which show low platelets, leukopenia with bandemia, and mild bilirubin elevation, suggesting end organ effects. Then, I looked at treatment signs, including administration of broad-spectrum antibiotics, indicating a strong suspicion of infection. Combining these points, I determined the patient is at high risk for sepsis within 12 hours.",
        "claims": [
            "I checked the patient\u2019s vital signs.",
            "The patient has hypotension with a systolic blood pressure (SBP) in the 80\u201390 range.",
            "The patient has a fever of 38.2\u00b0C.",
            "I examined the laboratory results.",
            "The laboratory results show low platelets.",
            "The laboratory results show leukopenia with bandemia.",
            "The laboratory results show mild bilirubin elevation.",
            "The laboratory results suggest end organ effects.",
            "I looked at treatment signs.",
            "The patient has received administration of broad-spectrum antibiotics.",
            "The administration of broad-spectrum antibiotics indicates a strong suspicion of infection.",
            "Combining these points, I determined the patient is at high risk for sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient has hypotension with a systolic blood pressure (SBP) in the 80\u201390 range.",
            "The patient has a fever of 38.2\u00b0C.",
            "The laboratory results show low platelets.",
            "The laboratory results show leukopenia with bandemia.",
            "The laboratory results show mild bilirubin elevation.",
            "The laboratory results suggest end organ effects.",
            "The patient has received administration of broad-spectrum antibiotics.",
            "The administration of broad-spectrum antibiotics indicates a strong suspicion of infection.",
            "Combining these points, I determined the patient is at high risk for sepsis within 12 hours."
        ],
        "alignment_scores": [
            1.0,
            0.7,
            0.8,
            0.9,
            0.5,
            0.8,
            1.0,
            0.9,
            0.3
        ],
        "alignment_category": [
            7,
            2,
            8,
            2,
            8,
            8,
            9,
            9,
            4
        ],
        "alignment_reasonings": [
            "The claim specifically mentions hypotension with an SBP in the range of 80\u201390 mmHg. This directly aligns with the criteria for sepsis-associated hypotension (SBP <90 mmHg), indicating a perfect alignment between the claim and the chosen category.",
            "The fever of 38.2\u00b0C meets the SIRS criteria for temperature (>38\u00b0C), which helps identify systemic inflammation associated with early sepsis. The alignment is solid as it clearly fits the SIRS temperature criterion. However, to fully meet \"SIRS Positivity,\" at least two criteria are required; this claim only provides temperature information.",
            "The claim about low platelets aligns with the SOFA score components, specifically the platelet count (<100 \u00d7 10\u2079/L), which relates to organ dysfunction and high sepsis risk. The alignment is relatively strong since platelet count is an explicit component of the SOFA score, but the precise platelet value or change is not specified in the claim, preventing a perfect alignment rating.",
            "Leukopenia, or a low white blood cell count (<4,000/\u00b5L), is a specific criterion in the SIRS framework, indicating systemic inflammation potentially due to infection or sepsis. Bandemia further suggests an acute inflammatory response, usually associated with infections. While the claim does not specify the WBC count, the mention of leukopenia directly aligns with one of the SIRS criteria, justifying a high alignment rating. Since bandemia strengthens the indication of infection, the alignment is strong, but not perfect, as it doesn't state fulfillment of a second SIRS criterion.",
            "Mild bilirubin elevation is related to one of the SOFA components (bilirubin\u202f>\u202f2\u202fmg/dL), though the claim does not specify the exact level of elevation. Since an increase in bilirubin is used to assess organ dysfunction in sepsis, the alignment with the SOFA score is relevant, but the lack of specific measurement leads to a moderate alignment rating.",
            "The claim mentions \"end organ effects,\" which closely relates to the SOFA score components that measure organ dysfunction, like PaO\u2082/FiO\u2082 ratio, platelet count, bilirubin level, creatinine level, and Glasgow Coma Scale score. Although the claim is general and does not specify which particular organ dysfunctions are present, it strongly aligns with the concept of organ dysfunction in the SOFA score. Thus, the alignment is substantial but not perfect due to the lack of specificity.",
            "The claim explicitly mentions the administration of broad-spectrum antibiotics, which is directly described in category 9 as an indicator of clinician suspicion of serious infection and an anchor for sepsis risk assessment. This is a perfect alignment with the category.",
            "The claim highlights the administration of broad-spectrum antibiotics, directly indicative of a clinician's strong suspicion of serious infection, which aligns well with this category. However, it is not explicitly stated that the administration happened within 2 hours, which slightly reduces the alignment from perfect.",
            "The claim references a combined assessment leading to a high-risk determination. Among the categories, an Elevated NEWS Score aggregates different deranged vitals to predict deterioration, aligning conceptually. However, the claim's lack of specificity or mention of NEWS limit the alignment strength."
        ],
        "final_alignment_score": 0.7666666666666667,
        "accuracy": 1
    },
    {
        "input": "24: HR, 67.0; 24: RR, 21.0; 24: SpO2, 100.0; 24: SBP, 150.0; 24: DBP, 75.0; 24: MAP, 100.0; 24: Pain, 4.0; 24: Temp, 98.1; 72: SpO2, 96.85; 73: HR, 73.429; 73: SpO2, 97.448; 73: 1min HRV, 39.770; 74: HR, 76.576; 74: RR, 24.111; 74: SpO2, 97.847; 74: 1min HRV, 79.227; 74: 5min HRV, 75.764; 75: HR, 73.879; 75: RR, 24.069; 75: SpO2, 99.052; 75: 1min HRV, 64.406; 76: HR, 72.508; 76: RR, 22.203; 76: SpO2, 100.0; 76: 1min HRV, 40.756; 77: HR, 73.593; 77: RR, 22.881; 77: SpO2, 100.0; 77: 1min HRV, 84.321; 78: HR, 71.828; 78: RR, 26.414; 78: 1min HRV, 66.034; 79: HR, 71.915; 79: RR, 24.475; 79: SpO2, 99.0; 79: 1min HRV, 68.889; 79: 5min HRV, 66.426; 80: HR, 73.241; 80: RR, 26.810; 80: 1min HRV, 49.479; 81: HR, 72.729; 81: RR, 27.203; 81: 1min HRV, 70.379; 82: HR, 70.390; 82: RR, 27.136; 82: SpO2, 88.647; 82: 1min HRV, 80.163; 83: HR, 72.052; 83: RR, 27.034; 83: SpO2, 100.0; 83: 1min HRV, 56.723; 84: HR, 72.051; 84: RR, 24.610; 84: SpO2, 100.0; 84: 1min HRV, 74.728; 84: 5min HRV, 68.300; 85: HR, 71.586; 85: RR, 24.569; 85: SpO2, 99.909; 85: 1min HRV, 38.538; 86: HR, 70.627; 86: RR, 23.847; 86: SpO2, 100.0; 86: 1min HRV, 67.076; 87: POC PH (V) ISTAT, 7.30; 87: POC PCO2 (V) ISTAT, 51.4 mmHg; 87: POC O2 SATURATION ISTAT VENOUS, 30 %; 87: POC PO2 (V) ISTAT, 21 mmHg; 87: POC BASE EXCESS ISTAT, -1 mmol/L; 87: POC LACTATE ISTAT, 1.03 mmol/L; 87: POC TCO2 (V) ISTAT, 27 mmol/L; 87: POC HCO3 (V) ISTAT, 25.2 mmol/L; 87: HR, 70.966; 87: RR, 24.017; 87: SpO2, 100.0; 87: 1min HRV, 47.630; 88: HR, 70.305; 88: RR, 24.085; 88: SpO2, 100.0; 88: 1min HRV, 27.826; 89: HR, 70.034; 89: RR, 21.017; 89: SpO2, 100.0; 89: 1min HRV, 54.584; 89: 5min HRV, 49.265; 90: HR, 72.414; 90: RR, 21.862; 90: SpO2, 100.0; 90: 1min HRV, 61.558; 91: HR, 71.169; 91: RR, 22.051; 91: 1min HRV, 60.250; 92: HR, 71.121; 92: RR, 29.707; 92: SpO2, 99.957; 92: 1min HRV, 82.983; 93: HR, 71.661; 93: RR, 28.237; 93: SpO2, 99.569; 93: 1min HRV, 52.021; 94: HR, 72.932; 94: RR, 27.034; 94: SpO2, 99.322; 94: 1min HRV, 61.645; 94: 5min HRV, 65.404; 95: HR, 70.897; 95: RR, 23.328; 95: SpO2, 97.931; 95: 1min HRV, 83.476; 96: HR, 70.915; 96: RR, 22.610; 96: SpO2, 96.0; 96: 1min HRV, 129.629; 97: HR, 73.069; 97: RR, 22.310; 97: 1min HRV, 81.351; 98: HR, 70.983; 98: RR, 26.610; 98: SpO2, 96.923; 98: 1min HRV, 77.855; 99: HR, 72.441; 99: RR, 24.322; 99: SpO2, 97.844; 99: 1min HRV, 65.983; 99: 5min HRV, 85.807; 100: HR, 72.948; 100: RR, 31.707; 100: 1min HRV, 60.048; 101: HR, 70.661; 101: RR, 28.932; 101: SpO2, 96.357; 101: 1min HRV, 75.586; 102: HR, 71.569; 102: RR, 29.517; 102: SpO2, 98.471; 102: 1min HRV, 50.917; 103: HR, 71.983; 103: RR, 29.288; 103: SpO2, 98.017; 103: 1min HRV, 37.331; 104: HR, 72.390; 104: RR, 24.695; 104: SpO2, 96.373; 104: 1min HRV, 57.989; 104: 5min HRV, 58.190; 105: HR, 72.534; 105: RR, 29.086; 105: SpO2, 97.172; 105: 1min HRV, 42.429; 106: HR, 72.576; 106: RR, 29.508; 106: SpO2, 97.254; 106: 1min HRV, 54.927; 107: HR, 73.741; 107: RR, 26.862; 107: SpO2, 97.0; 107: 1min HRV, 34.070; 108: WAM DIFTYP, AUTO; 108: HEMATOCRIT (HCT), 32.9 %; 108: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 108: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 27.0 pg; 108: NRBC PERCENT (HEMATOLOGY), 0.0 %; 108: RED CELL DISTRIBUTION WIDTH (RDW), 14.5 %; 108: MONOCYTE % (AUTO DIFF), 7.9 %; 108: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.50 K/uL; 108: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.11 K/uL; 108: NEUTROPHIL ABSOLUTE (AUTO DIFF), 3.91 K/uL; 108: LYMPHOCYTE % (AUTO DIFF), 35.1 %; 108: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.02 K/uL; 108: WHITE BLOOD CELLS (WBC), 7.1 K/uL; 108: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 108: MONOCYTE ABSOLUTE (AUTO DIFF), 0.56 K/uL; 108: EOSINOPHIL % (AUTO DIFF), 1.5 %; 108: RED BLOOD CELLS (RBC), 4.08 MIL/uL; 108: BASOPHIL % (AUTO DIFF), 0.4 %; 108: NEUTROPHIL % (AUTO DIFF), 54.8 %; 108: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 108: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.4 g/dL; 108: HEMOGLOBIN (HGB), 11.0 g/dL; 108: PLATELET COUNT (PLT), 181 K/uL; 108: MEAN CORPUSCULAR VOLUME (MCV), 80.6 fL; 108: HR, 73.237; 108: RR, 24.119; 108: SpO2, 96.424; 108: 1min HRV, 72.738; 109: HR, 73.610; 109: RR, 23.203; 109: SpO2, 96.0; 109: 1min HRV, 54.247; 109: 5min HRV, 53.550; 110: HR, 75.207; 110: RR, 22.914; 110: SpO2, 96.0; 110: 1min HRV, 47.829; 111: HR, 80.424; 111: RR, 25.814; 111: 1min HRV, 65.162; 112: HR, 81.845; 112: RR, 25.655; 112: SpO2, 96.0; 112: 1min HRV, 56.303; 113: HR, 79.576; 113: RR, 24.695; 113: SpO2, 96.405; 113: 1min HRV, 69.113; 114: HR, 79.864; 114: RR, 23.610; 114: SpO2, 97.0; 114: 1min HRV, 58.916; 114: 5min HRV, 62.870; 114: SBP, 162.0; 114: DBP, 89.0; 114: MAP, 113.333; 114: LPM O2, 2.0; 114: Pain, 4.0; 115: HR, 75.241; 115: RR, 26.397; 115: SpO2, 97.0; 115: 1min HRV, 74.272; 115: SBP, 162.0; 115: DBP, 89.0; 115: MAP, 113.333; 116: HR, 76.746; 116: RR, 30.831; 116: SpO2, 96.932; 116: 1min HRV, 60.360; 117: HR, 76.017; 117: RR, 29.034; 117: SpO2, 97.771; 117: 1min HRV, 54.618; 118: HR, 75.661; 118: RR, 28.203; 118: SpO2, 97.812; 118: 1min HRV, 64.985; 119: HR, 75.379; 119: RR, 25.707; 119: SpO2, 97.86; 119: 1min HRV, 44.094; 119: 5min HRV, 60.569; 0: Age, 90; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 67.0; 0: Triage RR, 21.0; 0: Triage SBP, 150.0; 0: Triage DBP, 75.0; 0: Triage acuity, 2-Emergent; 0: CC, MULTIPLE COMPLAINTS",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I checked the vital signs (HR, BP, Temp) and found no clear signs of instability or fever. Next, I looked at laboratory markers, including lactate (1.03 mmol/L) and WBC (7.1 K/uL), which are within normal limits and do not suggest severe infection or organ dysfunction. Finally, although the respiratory rate is elevated at times, on balance there is insufficient evidence of high sepsis risk based on these clinical and lab findings.",
        "claims": [
            "I checked the vital signs, which include heart rate, blood pressure, and temperature.",
            "I found no clear signs of instability in the vital signs.",
            "I found no signs of fever in the vital signs.",
            "I looked at laboratory markers, including lactate and white blood cell count.",
            "The lactate level is 1.03 mmol/L.",
            "The white blood cell count is 7.1 K/uL.",
            "The lactate level is within normal limits.",
            "The white blood cell count is within normal limits.",
            "The laboratory markers do not suggest severe infection.",
            "The laboratory markers do not suggest organ dysfunction.",
            "The respiratory rate is elevated at times.",
            "Overall, there is insufficient evidence of high sepsis risk based on the clinical and lab findings."
        ],
        "relevant_claims": [
            "I found no signs of fever in the vital signs.",
            "The lactate level is 1.03 mmol/L.",
            "The laboratory markers do not suggest severe infection."
        ],
        "alignment_scores": [
            0.3,
            0.1,
            0.3
        ],
        "alignment_category": [
            2,
            5,
            9
        ],
        "alignment_reasonings": [
            "Absence of fever is relevant to the SIRS criteria, which include temperature thresholds as signs of systemic inflammation. However, the claim specifies a lack of fever entirely, offering a weaker, inverse alignment with the normal temperature range\u2014hence a lower alignment rating.",
            "The claim references serum lactate levels, which directly pertains to the Elevated Serum Lactate category. However, the lactate level of 1.03 mmol/L is well below the threshold of 2 mmol/L, which would indicate a sepsis risk according to this category. The claim's lactate level doesn't signal tissue hypoperfusion and has minimal alignment with this specific criterion, resulting in a low alignment rating.",
            "The claim refers to laboratory markers, which suggests assessment of infection severity. While it doesn\u2019t mention specific clinical action, such as administering antibiotics or obtaining cultures, it relates to infection evaluation. This makes the category slightly relevant but with weak alignment due to the absence of direct clinical actions indicating suspected severe infection."
        ],
        "final_alignment_score": 0.2333333333333333,
        "accuracy": 1
    },
    {
        "input": "6: HR, 113.0; 6: RR, 18.0; 6: SpO2, 100.0; 6: SBP, 129.0; 6: DBP, 99.0; 6: MAP, 109.0; 6: Pain, 8.0; 6: Temp, 97.5; 14: SpO2, 98.0; 14: Perf, 3.832; 15: SpO2, 98.0; 15: Perf, 2.722; 16: SpO2, 97.828; 16: Perf, 2.920; 17: SpO2, 98.797; 17: Perf, 4.697; 18: SpO2, 97.949; 18: Perf, 5.500; 19: SpO2, 97.776; 19: Perf, 4.514; 20: SpO2, 98.186; 20: Perf, 3.809; 21: SpO2, 98.0; 21: Perf, 5.181; 22: POC, HCG, ISTAT QUALITATIVE: Negative; 22: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 22: SpO2, 97.237; 22: Perf, 5.756; 23: POC PH (V) ISTAT, 7.44; 23: POC O2 SATURATION ISTAT VENOUS, 76 %; 23: POC BASE EXCESS ISTAT, 0 mmol/L; 23: POC LACTATE ISTAT, 1.46 mmol/L; 23: POC PO2 (V) ISTAT, 39 mmHg; 23: POC PCO2 (V) ISTAT, 36.1 mmHg; 23: POC HCO3 (V) ISTAT, 24.6 mmol/L; 23: POC TCO2 (V) ISTAT, 26 mmol/L; 23: SpO2, 98.051; 23: Perf, 3.662; 24: SpO2, 97.190; 24: Perf, 4.291; 25: SpO2, 97.559; 25: Perf, 2.529; 26: SpO2, 97.534; 26: Perf, 2.696; 27: SpO2, 98.780; 27: Perf, 3.376; 28: SpO2, 98.85; 28: Perf, 4.125; 38: HR, 96.0; 38: SpO2, 99.0; 38: SBP, 130.0; 38: DBP, 89.0; 38: MAP, 102.667; 38: Pain, 8.0; 40: SpO2, 98.781; 40: HYDROMORPHONE, 1 MG/ML INJ SYRG; 40: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 41: SpO2, 98.552; 41: Perf, 1.926; 42: SpO2, 97.983; 42: Perf, 1.936; 43: SpO2, 97.793; 43: Perf, 1.598; 44: SpO2, 98.186; 44: Perf, 1.330; 45: SpO2, 97.627; 45: Perf, 4.355; 46: SpO2, 95.948; 46: Perf, 6.526; 47: SpO2, 95.814; 47: Perf, 7.211; 48: SpO2, 94.897; 48: Perf, 7.489; 49: SpO2, 94.949; 49: Perf, 7.38; 50: SpO2, 95.288; 50: Perf, 6.922; 51: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.4 pg; 51: RED CELL DISTRIBUTION WIDTH (RDW), 15.7 %; 51: PLATELET COUNT (PLT), 237 K/uL; 51: RED BLOOD CELLS (RBC), 4.69 MIL/uL; 51: WHITE BLOOD CELLS (WBC), 14.3 K/uL; 51: HEMOGLOBIN (HGB), 13.8 g/dL; 51: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.8 g/dL; 51: HEMATOCRIT (HCT), 40.8 %; 51: MEAN CORPUSCULAR VOLUME (MCV), 87.0 fL; 51: SpO2, 95.534; 51: Perf, 6.612; 52: SpO2, 95.136; 52: Perf, 6.263; 53: SpO2, 95.724; 53: Perf, 5.561; 54: SpO2, 96.712; 54: Perf, 4.76; 55: SpO2, 97.237; 55: Perf, 5.833; 56: SpO2, 96.362; 56: Perf, 4.918; 57: SpO2, 95.847; 57: Perf, 3.894; 58: SpO2, 97.052; 58: Perf, 3.035; 59: SpO2, 97.932; 59: Perf, 1.960; 60: SpO2, 97.508; 60: Perf, 1.363; 61: SpO2, 98.621; 61: Perf, 0.817; 62: SpO2, 98.441; 62: Perf, 0.831; 63: SpO2, 97.811; 63: Perf, 0.81; 64: SpO2, 97.457; 64: Perf, 0.933; 65: SpO2, 98.0; 65: Perf, 1.696; 66: SpO2, 97.017; 66: Perf, 2.477; 67: SpO2, 97.0; 67: Perf, 2.975; 68: SpO2, 96.293; 68: Perf, 3.856; 69: SpO2, 97.017; 69: Perf, 2.624; 70: BILIRUBIN TOTAL, 0.8 mg/dL; 70: BLOOD UREA NITROGEN (BUN), 16 mg/dL; 70: EGFR FOR AFRICAN AMERICAN, 83 mL/min/1.73 m2; 70: CALCIUM, 8.7 mg/dL; 70: EGFR REFIT WITHOUT RACE (2021), 72 mL/min/1.73 m2; 70: ALT (SGPT), 35 U/L; 70: CHLORIDE, 104 mmol/L; 70: PROTEIN TOTAL, 6.4 g/dL; 70: GLOBULIN, 3.0 g/dL; 70: SODIUM, 137 mmol/L; 70: CO2, 23 mmol/L; 70: ANION GAP, 10 mmol/L; 70: POTASSIUM, 4.2 mmol/L; 70: CORRECTED CALCIUM, 9.2 mg/dL; 70: GLUCOSE, 197 mg/dL; 70: CREATININE, 1.04 mg/dL; 70: AST (SGOT), 58 U/L; 70: ALBUMIN, 3.4 g/dL; 70: ALKALINE PHOSPHATASE, 152 U/L; 70: SpO2, 96.458; 70: Perf, 3.956; 71: SpO2, 95.983; 71: Perf, 3.871; 72: SpO2, 97.136; 72: Perf, 2.959; 73: SpO2, 97.552; 73: Perf, 1.859; 74: SpO2, 96.831; 74: Perf, 1.531; 75: SpO2, 96.672; 75: Perf, 2.519; 76: SpO2, 96.034; 76: Perf, 4.384; 77: SpO2, 96.068; 77: Perf, 5.572; 78: SpO2, 96.259; 78: Perf, 5.864; 79: SpO2, 96.339; 79: Perf, 4.983; 80: SpO2, 95.948; 80: Perf, 4.156; 81: SpO2, 96.0; 81: Perf, 6.151; 82: SpO2, 95.322; 82: Perf, 6.860; 83: SpO2, 95.569; 83: Perf, 6.102; 84: SpO2, 97.542; 84: Perf, 2.928; 85: SpO2, 97.603; 85: Perf, 2.236; 86: SpO2, 97.407; 86: Perf, 1.993; 87: SpO2, 97.763; 87: Perf, 2.127; 88: SpO2, 98.517; 88: Perf, 1.963; 89: SpO2, 98.163; 89: Perf, 2.272; 90: SpO2, 97.983; 90: Perf, 1.775; 91: SpO2, 98.712; 91: Perf, 1.189; 92: SpO2, 98.136; 92: Perf, 1.692; 93: SpO2, 98.0; 93: Perf, 1.553; 94: SpO2, 97.695; 94: Perf, 1.424; 95: SpO2, 97.828; 95: Perf, 1.935; 96: SpO2, 97.864; 96: Perf, 2.417; 97: SpO2, 97.424; 97: Perf, 3.952; 98: SpO2, 97.948; 98: Perf, 2.007; 98: Pain, 8.0; 98: HYDROMORPHONE, 1 MG/ML INJ SYRG; 99: SpO, 2: 97.407; 99: Perf, 1.745; 100: SpO2, 97.207; 100: Perf, 2.058; 101: SpO2, 98.475; 101: Perf, 1.515; 102: SpO2, 96.559; 102: Perf, 4.064; 103: SpO2, 95.672; 103: Perf, 6.009; 104: SpO2, 95.797; 104: Perf, 6.499; 105: LIPASE, 3 U/L; 105: SpO2, 96.690; 105: Perf, 6.050; 106: SpO2, 96.085; 106: Perf, 4.536; 107: HR, 100.0; 107: RR, 16.0; 107: SpO2, 96.103; 107: Perf, 3.992; 107: SBP, 122.0; 107: DBP, 83.0; 107: MAP, 96.0; 107: Pain, 7.0; 107: LR IV BOLUS -, 1000 ML; 108: SpO, 2: 95.830; 108: Perf, 4.809; 109: SpO2, 96.593; 109: Perf, 2.287; 110: SpO2, 96.862; 110: Perf, 3.286; 111: SpO2, 96.814; 111: Perf, 5.008; 112: SpO2, 96.155; 112: Perf, 6.273; 113: SpO2, 96.0; 113: Perf, 7.343; 114: SpO2, 96.0; 114: Perf, 8.217; 115: SpO2, 96.0; 115: Perf, 8.392; 116: SpO2, 96.0; 116: Perf, 8.23; 117: SpO2, 96.0; 117: Perf, 7.856; 118: SpO2, 96.186; 118: Perf, 7.616; 119: SpO2, 96.254; 119: Perf, 5.937; 0: Age, 30; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.4; 0: Triage HR, 113.0; 0: Triage RR, 18.0; 0: Triage SBP, 129.0; 0: Triage DBP, 99.0; 0: Triage acuity, 2-Emergent; 0: CC, ABDOMINAL PAIN",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "First I check the vital signs for immediate sepsis indicators, noticing mild tachycardia but no fever or hypotension. Next I assess the labs for signs of infection, noting a slightly elevated WBC but a normal lactate and no major abnormalities. Then I review the patient\u2019s response to interventions and see stable hemodynamics and oxygenation. Based on these steps, the patient is not at high risk of developing sepsis within 12 hours.",
        "claims": [
            "I check the vital signs for immediate sepsis indicators.",
            "I notice mild tachycardia.",
            "There is no fever.",
            "There is no hypotension.",
            "I assess the labs for signs of infection.",
            "I note a slightly elevated WBC.",
            "The lactate level is normal.",
            "There are no major abnormalities in the labs.",
            "I review the patient\u2019s response to interventions.",
            "I see stable hemodynamics.",
            "I see stable oxygenation.",
            "Based on these assessments, the patient is not at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "There is no fever.",
            "There is no hypotension."
        ],
        "alignment_scores": [
            0.3,
            0.2
        ],
        "alignment_category": [
            2,
            7
        ],
        "alignment_reasonings": [
            "The absence of fever is related to the SIRS criteria, as fever (temperature\u202f>\u202f38\u202f\u00b0C) is one of the indicators for systemic inflammation under SIRS. However, \"no fever\" indicates that this specific criterion is not met, which lowers the relevance. Nonetheless, it still relates to the category as it defines an exception.",
            "The claim directly addresses hypotension, or rather the absence of it, which is related to this category. However, the absence of hypotension suggests the patient is not exhibiting this risk factor for sepsis. Therefore, the claim only weakly interacts with the category since it highlights a non-issue in terms of sepsis risk."
        ],
        "final_alignment_score": 0.25,
        "accuracy": 0
    },
    {
        "input": "4: HR, 82.0; 4: RR, 16.0; 4: SpO2, 100.0; 4: SBP, 146.0; 4: DBP, 98.0; 4: MAP, 114.0; 4: Pain, 7.0; 4: Temp, 98.1; 7: Pain, 7.0; 33: WAM DIFTYP, AUTO; 33: NEUTROPHIL % (AUTO DIFF), 62.5 %; 33: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.31 K/uL; 33: NRBC PERCENT (HEMATOLOGY), 0.0 %; 33: MONOCYTE % (AUTO DIFF), 7.0 %; 33: PLATELET COUNT (PLT), 367 K/uL; 33: HEMATOCRIT (HCT), 38.3 %; 33: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.6 pg; 33: BASOPHIL % (AUTO DIFF), 0.3 %; 33: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 33: HEMOGLOBIN (HGB), 13.4 g/dL; 33: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 33: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.5 %; 33: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.07 K/uL; 33: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 3.79 K/uL; 33: NEUTROPHIL ABSOLUTE (AUTO DIFF), 8.63 K/uL; 33: MONOCYTE ABSOLUTE (AUTO DIFF), 0.96 K/uL; 33: EOSINOPHIL % (AUTO DIFF), 2.2 %; 33: MEAN CORPUSCULAR VOLUME (MCV), 90.3 fL; 33: RED CELL DISTRIBUTION WIDTH (RDW), 11.2 %; 33: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 35.0 g/dL; 33: LYMPHOCYTE % (AUTO DIFF), 27.5 %; 33: WHITE BLOOD CELLS (WBC), 13.8 K/uL; 33: RED BLOOD CELLS (RBC), 4.24 MIL/uL; 38: HR, 80.0; 38: SpO2, 99.0; 38: SBP, 162.0; 38: DBP, 101.0; 38: MAP, 121.333; 39: HR, 83.0; 39: SpO2, 98.407; 39: Perf, 2.286; 39: SBP, 159.0; 39: DBP, 107.0; 39: MAP, 124.333; 40: SpO2, 98.793; 40: Perf, 1.983; 41: SpO2, 99.017; 41: Perf, 1.678; 42: SpO2, 98.831; 42: Perf, 1.288; 43: SpO2, 99.103; 43: Perf, 1.572; 44: SpO2, 98.773; 44: Perf, 2.47; 44: SBP, 142.0; 44: DBP, 97.0; 44: MAP, 112.0; 45: SpO2, 99.310; 45: Perf, 2.105; 46: SpO2, 98.525; 46: Perf, 2.503; 47: PH, URINE (UA): 6.0; 47: KETONE, URINE (UA): Negative; 47: SPECIFIC GRAVITY, URINE (UA): 1.010; 47: PROTEIN, URINE (UA): Negative; 47: LEUKOCYTE ESTERASE, URINE (UA): Negative; 47: NITRITE, URINE (UA): Negative; 47: GLUCOSE, URINE (UA): Negative; 47: SpO2, 98.169; 47: Perf, 2.853; 48: HR, 79.0; 48: RR, 18.0; 48: SpO2, 98.138; 48: Perf, 2.775; 48: SBP, 142.0; 48: DBP, 97.0; 48: MAP, 112.0; 49: SpO2, 98.695; 49: Perf, 3.093; 50: SpO2, 98.621; 50: Perf, 3.136; 51: SpO2, 97.881; 51: Perf, 3.083; 52: SpO2, 98.222; 52: Perf, 2.428; 60: SODIUM, 137 mmol/L; 60: BLOOD UREA NITROGEN (BUN), 9 mg/dL; 60: ALT (SGPT), 95 U/L; 60: BILIRUBIN TOTAL, 0.4 mg/dL; 60: ALBUMIN, 4.5 g/dL; 60: PROTEIN TOTAL, 8.5 g/dL; 60: CALCIUM, 9.7 mg/dL; 60: CHLORIDE, 101 mmol/L; 60: CORRECTED CALCIUM, 9.3 mg/dL; 60: GLOBULIN, 4.0 g/dL; 60: GLUCOSE, 167 mg/dL; 60: CREATININE, 0.44 mg/dL; 60: ALKALINE PHOSPHATASE, 96 U/L; 60: AST (SGOT), 58 U/L; 60: POTASSIUM, 3.7 mmol/L; 60: ANION GAP, 12 mmol/L; 60: CO2, 24 mmol/L; 60: EGFR REFIT WITHOUT RACE (2021), 132 mL/min/1.73 m2; 66: SpO2, 98.273; 66: SBP, 138.0; 66: DBP, 91.0; 66: MAP, 106.667; 67: SpO2, 98.119; 67: Perf, 1.559; 68: HR, 79.0; 68: SpO2, 98.776; 68: Perf, 2.141; 68: SBP, 138.0; 68: DBP, 91.0; 68: MAP, 106.667; 69: SpO2, 98.102; 69: Perf, 2.627; 70: SpO2, 97.431; 70: Perf, 2.77; 71: SpO2, 97.424; 71: Perf, 2.602; 72: SpO2, 98.138; 72: Perf, 1.685; 73: SpO2, 98.203; 73: Perf, 1.359; 74: SpO2, 98.542; 74: Perf, 1.387; 75: SpO2, 97.017; 75: Perf, 1.193; 76: SpO2, 99.658; 76: Perf, 1.508; 77: SpO2, 99.052; 77: Perf, 4.531; 78: SpO2, 99.458; 78: Perf, 3.426; 79: SpO2, 98.797; 79: Perf, 3.575; 80: SpO2, 98.276; 80: Perf, 2.550; 81: SpO2, 97.102; 81: Perf, 2.810; 82: SpO2, 95.966; 82: Perf, 2.693; 83: SpO2, 98.203; 83: Perf, 1.976; 84: SpO2, 97.356; 84: Perf, 2.381; 85: SpO2, 97.362; 85: Perf, 2.297; 86: SpO2, 95.390; 86: Perf, 2.546; 87: SpO2, 95.190; 87: Perf, 2.503; 88: SpO2, 95.932; 88: Perf, 2.038; 89: SpO2, 95.593; 89: Perf, 1.964; 90: SpO2, 98.121; 90: Perf, 1.987; 91: SpO2, 98.593; 91: Perf, 1.973; 92: SpO2, 99.121; 92: Perf, 2.620; 93: SpO2, 97.0; 93: Perf, 3.478; 94: SpO2, 93.322; 94: Perf, 3.164; 95: SpO2, 98.707; 95: Perf, 1.441; 96: SpO2, 97.729; 96: Perf, 1.631; 97: SpO2, 99.0; 97: Perf, 1.952; 98: SpO2, 99.102; 98: Perf, 2.415; 99: SpO2, 98.695; 99: Perf, 2.855; 100: SpO2, 98.5; 100: Perf, 3.036; 101: SpO2, 98.237; 101: Perf, 2.378; 102: SpO2, 98.241; 102: Perf, 2.211; 103: SpO2, 98.797; 103: Perf, 3.313; 104: SpO2, 98.845; 104: Perf, 2.617; 105: SpO2, 98.559; 105: Perf, 2.219; 106: SpO2, 98.492; 106: Perf, 1.441; 107: SpO2, 98.483; 107: Perf, 1.413; 108: SpO2, 98.356; 108: Perf, 1.123; 109: HIGH SENSITIVITY TROPONIN, <4 ng/L; 109: SpO2, 97.897; 109: Perf, 1.762; 110: SpO2, 97.966; 110: Perf, 2.066; 111: SpO2, 98.339; 111: Perf, 4.271; 112: SpO2, 98.724; 112: Perf, 4.038; 113: SpO2, 98.678; 113: Perf, 3.599; 114: SpO2, 98.879; 114: Perf, 5.345; 115: SpO2, 99.169; 115: Perf, 4.547; 116: SpO2, 98.627; 116: Perf, 4.874; 117: INFLUENZA B, Not Detected; 117: RSV, Not Detected; 117: SARS-COV-2 RNA, Not Detected; 117: INFLUENZA A, Not Detected; 117: SpO2, 98.397; 117: Perf, 2.488; 118: HR, 74.0; 118: RR, 16.0; 118: SpO2, 99.339; 118: Perf, 2.690; 118: SBP, 138.0; 118: DBP, 90.0; 118: MAP, 106.0; 119: SpO2, 98.897; 119: Perf, 4.056; 0: Age, 33; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 82.0; 0: Triage RR, 16.0; 0: Triage SBP, 146.0; 0: Triage DBP, 98.0; 0: Triage acuity, 3-Urgent; 0: CC, HEADACHE",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I look at the patient\u2019s vital signs for any clear indications of sepsis, such as fever or hypotension, but they appear relatively normal. Next, I check laboratory values for significant abnormalities suggesting infection or organ dysfunction, noting only a mildly elevated white blood cell count without other concerning findings. Then, I confirm there are no major changes in blood pressure, heart rate, or respiratory rate over time that would imply early sepsis. Lastly, although the patient reports pain (headache), I see no additional evidence that would elevate concern for sepsis within 12 hours. Combining these considerations, the overall clinical picture does not indicate a high risk of sepsis.",
        "claims": [
            "I look at the patient\u2019s vital signs for indications of sepsis.",
            "I look for signs of fever or hypotension in the vital signs.",
            "The patient\u2019s vital signs appear relatively normal.",
            "I check laboratory values for abnormalities suggesting infection or organ dysfunction.",
            "I note only a mildly elevated white blood cell count in the laboratory values.",
            "There are no other concerning findings in the laboratory values.",
            "I confirm there are no major changes in blood pressure over time.",
            "I confirm there are no major changes in heart rate over time.",
            "I confirm there are no major changes in respiratory rate over time.",
            "The absence of major changes in vital signs implies no early sepsis.",
            "The patient reports experiencing headache.",
            "I see no additional evidence that would elevate concern for sepsis within 12 hours.",
            "Combining these considerations, the overall clinical picture does not indicate a high risk of sepsis."
        ],
        "relevant_claims": [
            "The absence of major changes in vital signs implies no early sepsis."
        ],
        "alignment_scores": [
            0.3
        ],
        "alignment_category": [
            4
        ],
        "alignment_reasonings": [
            "The claim suggests that there are no major changes in vital signs, implying stability and thus a low score in the NEWS, which is used to predict clinical deterioration. While the claim does not explicitly mention the NEWS system, lack of changes in vital signs is more relevant to this category than others, as a stable or low NEWS score often indicates low potential for sepsis risk. The alignment is indirect, hence the moderate rating."
        ],
        "final_alignment_score": 0.3,
        "accuracy": 1
    },
    {
        "input": "6: SpO2, 100.0; 6: 1min HRV, 0.0; 6: 5min HRV, 0.0; 7: HR, 89.619; 7: RR, 22.685; 7: SpO2, 99.944; 7: 1min HRV, 11.931; 7: SBP, 121.0; 7: DBP, 79.0; 7: MAP, 93.0; 7: Pain, 0.0; 7: Temp, 99.2; 8: HR, 85.983; 8: RR, 17.322; 8: SpO2, 98.407; 8: Perf, 1.51; 8: 1min HRV, 15.479; 9: HR, 85.186; 9: RR, 17.966; 9: SpO2, 99.610; 9: Perf, 1.854; 9: 1min HRV, 12.859; 10: HR, 82.138; 10: RR, 21.569; 10: SpO2, 99.983; 10: Perf, 3.417; 10: 1min HRV, 8.644; 10: SBP, 121.0; 10: DBP, 79.0; 10: MAP, 93.0; 11: HR, 80.610; 11: RR, 20.407; 11: SpO2, 98.983; 11: Perf, 3.693; 11: 1min HRV, 9.208; 11: 5min HRV, 28.237; 12: HR, 80.879; 12: RR, 20.310; 12: SpO2, 99.724; 12: Perf, 3.354; 12: 1min HRV, 7.965; 12: SBP, 126.0; 12: DBP, 74.0; 12: MAP, 91.333; 13: HR, 80.627; 13: RR, 19.339; 13: SpO2, 99.407; 13: Perf, 4.203; 13: 1min HRV, 21.634; 14: HR, 83.407; 14: RR, 19.881; 14: SpO2, 100.0; 14: Perf, 3.270; 14: 1min HRV, 14.516; 15: HR, 83.828; 15: RR, 20.741; 15: SpO2, 100.0; 15: Perf, 2.916; 15: 1min HRV, 13.868; 16: HR, 82.780; 16: RR, 20.559; 16: SpO2, 100.0; 16: Perf, 3.216; 16: 1min HRV, 14.416; 16: 5min HRV, 18.190; 17: HR, 83.379; 17: RR, 19.776; 17: SpO2, 99.914; 17: Perf, 3.048; 17: 1min HRV, 12.498; 18: HR, 83.593; 18: RR, 18.475; 18: SpO2, 99.780; 18: Perf, 3.221; 18: 1min HRV, 9.845; 19: HR, 83.483; 19: RR, 18.414; 19: SpO2, 100.0; 19: Perf, 3.773; 19: 1min HRV, 15.395; 20: HR, 82.102; 20: RR, 17.627; 20: SpO2, 100.0; 20: Perf, 4.452; 20: 1min HRV, 12.347; 21: HR, 80.983; 21: RR, 21.644; 21: SpO2, 100.0; 21: Perf, 4.297; 21: 1min HRV, 8.791; 21: 5min HRV, 14.222; 22: HR, 81.534; 22: RR, 22.586; 22: SpO2, 100.0; 22: Perf, 4.374; 22: 1min HRV, 10.385; 23: HR, 81.695; 23: RR, 21.814; 23: SpO2, 100.0; 23: Perf, 4.000; 23: 1min HRV, 8.485; 24: HR, 84.0; 24: RR, 18.103; 24: SpO2, 99.828; 24: Perf, 3.904; 24: 1min HRV, 17.086; 25: HR, 80.932; 25: RR, 21.949; 25: SpO2, 99.898; 25: Perf, 2.998; 25: 1min HRV, 14.699; 26: HR, 79.661; 26: RR, 23.542; 26: SpO2, 100.0; 26: Perf, 3.536; 26: 1min HRV, 11.626; 26: 5min HRV, 18.159; 27: HR, 80.069; 27: RR, 19.241; 27: SpO2, 100.0; 27: Perf, 3.759; 27: 1min HRV, 11.552; 28: HR, 81.407; 28: RR, 21.831; 28: SpO2, 100.0; 28: Perf, 4.380; 28: 1min HRV, 42.345; 29: HR, 80.741; 29: RR, 23.379; 29: SpO2, 99.281; 29: Perf, 4.449; 29: 1min HRV, 15.668; 30: HR, 86.542; 30: RR, 24.441; 30: SpO2, 98.974; 30: Perf, 4.22; 30: 1min HRV, 10.281; 31: HR, 80.729; 31: RR, 22.153; 31: SpO2, 99.068; 31: Perf, 4.201; 31: 1min HRV, 41.651; 31: 5min HRV, 37.735; 32: HR, 77.362; 32: RR, 20.603; 32: SpO2, 98.741; 32: Perf, 4.049; 32: 1min HRV, 74.029; 33: HR, 78.610; 33: RR, 22.712; 33: SpO2, 99.0; 33: Perf, 3.340; 33: 1min HRV, 21.139; 34: HR, 79.241; 34: RR, 20.379; 34: SpO2, 99.793; 34: Perf, 2.175; 34: 1min HRV, 30.534; 35: HR, 77.492; 35: RR, 22.356; 35: SpO2, 100.0; 35: Perf, 1.999; 35: 1min HRV, 34.039; 36: HR, 78.0; 36: RR, 15.576; 36: SpO2, 100.0; 36: Perf, 2.634; 36: 1min HRV, 21.351; 36: 5min HRV, 41.722; 37: HR, 78.241; 37: RR, 23.914; 37: SpO2, 100.0; 37: Perf, 2.585; 37: 1min HRV, 27.046; 38: HR, 78.254; 38: RR, 23.542; 38: SpO2, 100.0; 38: Perf, 2.801; 38: 1min HRV, 22.826; 38: NS IV BOLUS -, 1000 ML; 39: HR:, 80.776; 39: RR, 20.483; 39: SpO2, 100.0; 39: Perf, 2.416; 39: 1min HRV, 23.835; 39: ACETAMINOPHEN, 500 MG PO TABS; 40: HR:, 82.458; 40: RR, 18.847; 40: SpO2, 100.0; 40: Perf, 1.982; 40: 1min HRV, 21.585; 41: HR, 83.915; 41: RR, 22.644; 41: SpO2, 99.203; 41: Perf, 1.928; 41: 1min HRV, 31.481; 41: 5min HRV, 34.632; 42: HR, 80.259; 42: RR, 25.103; 42: SpO2, 99.586; 42: Perf, 1.913; 42: 1min HRV, 22.326; 42: SBP, 127.0; 42: DBP, 98.0; 42: MAP, 107.667; 43: HR, 77.593; 43: RR, 25.203; 43: SpO2, 100.0; 43: Perf, 3.700; 43: 1min HRV, 23.540; 44: HR, 77.241; 44: RR, 23.707; 44: SpO2, 100.0; 44: Perf, 4.000; 44: 1min HRV, 17.694; 45: HR, 78.949; 45: RR, 19.847; 45: SpO2, 99.746; 45: Perf, 3.578; 45: 1min HRV, 71.802; 46: 5min HRV, 40.598; 54: WAM DIFTYP, AUTO; 54: MONOCYTE % (AUTO DIFF), 17.1 %; 54: NEUTROPHIL ABSOLUTE (AUTO DIFF), 1.40 K/uL; 54: PLATELET COUNT (PLT), 251 K/uL; 54: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.20 K/uL; 54: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.2 %; 54: HEMATOCRIT (HCT), 30.9 %; 54: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.04 K/uL; 54: MONOCYTE ABSOLUTE (AUTO DIFF), 0.56 K/uL; 54: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 54: LYMPHOCYTE % (AUTO DIFF), 36.6 %; 54: BASOPHIL % (AUTO DIFF), 1.8 %; 54: EOSINOPHIL % (AUTO DIFF), 0.6 %; 54: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 35.3 g/dL; 54: WHITE BLOOD CELLS (WBC), 3.3 K/uL; 54: MEAN CORPUSCULAR VOLUME (MCV), 86.3 fL; 54: RED BLOOD CELLS (RBC), 3.58 MIL/uL; 54: NEUTROPHIL % (AUTO DIFF), 42.7 %; 54: RED CELL DISTRIBUTION WIDTH (RDW), 16.8 %; 54: NRBC PERCENT (HEMATOLOGY), 0.0 %; 54: HEMOGLOBIN (HGB), 10.9 g/dL; 54: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 54: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.4 pg; 54: BASOPHIL ABSOLUTE (AUTO DIFF), 0.06 K/uL; 95: HR, 89.0; 95: RR, 20.0; 95: SpO2, 99.0; 95: SBP, 135.0; 95: DBP, 73.0; 95: MAP, 93.667; 95: GABAPENTIN, 600 MG PO TABS; 111: TROPONIN I: <., 017 ng/mL; 0: Age, 71; 0: Gender, M; 0: Race, Black or African American; 0: Means of arrival, EMS; 0: Triage Temp, 37.3; 0: Triage HR, 81.0; 0: Triage RR, 18.0; 0: Triage SBP, 121.0; 0: Triage DBP, 79.0; 0: Triage acuity, 3-Urgent; 0: CC, RAPID HEART RATE",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I check whether the patient\u2019s vitals (heart rate, blood pressure, respiratory rate, and temperature) show signs of shock or severe infection. Next, I assess the lab results (particularly the WBC count of 3.3 K/uL) to see if they indicate a serious infection or organ dysfunction. Then, I look at any treatments provided (e.g., IV fluids, medications) and whether they suggest concern for sepsis. Although the WBC is slightly low and there are occasional mild elevations in respiratory rate, the patient\u2019s blood pressure and heart rate remain relatively stable. Therefore, the overall picture does not strongly suggest a high risk of sepsis within 12 hours.",
        "claims": [
            "I check whether the patient\u2019s vitals show signs of shock or severe infection.",
            "The patient's vitals include heart rate, blood pressure, respiratory rate, and temperature.",
            "I assess the lab results to see if they indicate a serious infection or organ dysfunction.",
            "The WBC count is 3.3 K/uL.",
            "A WBC count of 3.3 K/uL is considered slightly low.",
            "I look at any treatments provided to see if they suggest concern for sepsis.",
            "Treatments may include IV fluids and medications.",
            "There are occasional mild elevations in respiratory rate.",
            "The patient's blood pressure remains relatively stable.",
            "The patient's heart rate remains relatively stable.",
            "The overall clinical picture does not strongly suggest a high risk of sepsis within 12 hours."
        ],
        "relevant_claims": [
            "A WBC count of 3.3 K/uL is considered slightly low."
        ],
        "alignment_scores": [
            1.0
        ],
        "alignment_category": [
            2
        ],
        "alignment_reasonings": [
            "A white blood cell (WBC) count less than 4,000/\u00b5L is explicitly listed as part of the SIRS criteria, which are used to identify systemic inflammation consistent with early sepsis. Therefore, the claim of a WBC count of 3.3 K/uL (or 3,300/\u00b5L) perfectly aligns with the SIRS Positivity category."
        ],
        "final_alignment_score": 1.0,
        "accuracy": 1
    },
    {
        "input": "2: HR, 117.0; 2: RR, 18.0; 2: SpO2, 97.0; 2: SBP, 127.0; 2: DBP, 74.0; 2: MAP, 91.667; 2: Temp, 101.0; 11: Pain, 4.0; 25: RR, 18.0; 28: POC PH (V) ISTAT, 7.45; 28: POC BASE EXCESS ISTAT, 6 mmol/L; 28: POC PO2 (V) ISTAT, 20 mmHg; 28: POC O2 SATURATION ISTAT VENOUS, 33 %; 28: POC LACTATE ISTAT, 1.05 mmol/L; 28: POC HCO3 (V) ISTAT, 30.4 mmol/L; 28: POC PCO2 (V) ISTAT, 44.3 mmHg; 28: POC TCO2 (V) ISTAT, 32 mmol/L; 30: ACETAMINOPHEN, 500 MG PO TABS; 55: INR:, 1.0; 55: PROTHROMBIN TIME, 14.0 seconds; 56: PART. THROMBOPLASTIN TIME, 30.6 seconds; 61: SARS-COV-2 RNA, Not Detected; 72: HR, 109.543; 72: RR, 14.92; 72: 1min HRV, 10.910; 72: SBP, 125.0; 72: DBP, 77.0; 72: MAP, 93.0; 73: HR, 108.661; 73: RR, 20.322; 73: SpO2, 98.0; 73: 1min HRV, 9.919; 73: 5min HRV, 10.791; 73: SBP, 125.0; 73: DBP, 77.0; 73: MAP, 93.0; 73: Pain, 6.0; 73: Temp, 97.2; 74: HR, 109.780; 74: RR, 15.373; 74: 1min HRV, 9.975; 75: HR, 107.241; 75: RR, 18.914; 75: 1min HRV, 13.266; 76: HR, 105.356; 76: RR, 21.169; 76: 1min HRV, 8.440; 77: CREATININE, 0.89 mg/dL; 77: PROTEIN TOTAL, 8.4 g/dL; 77: BLOOD UREA NITROGEN (BUN), 11 mg/dL; 77: AST (SGOT), 46 U/L; 77: CO2, 27 mmol/L; 77: ALT (SGPT), 31 U/L; 77: BILIRUBIN TOTAL, 0.8 mg/dL; 77: ANION GAP, 11 mmol/L; 77: CHLORIDE, 95 mmol/L; 77: POTASSIUM, 4.2 mmol/L; 77: EGFR REFIT WITHOUT RACE (2021), 102 mL/min/1.73 m2; 77: GLUCOSE, 112 mg/dL; 77: CALCIUM, 8.8 mg/dL; 77: GLOBULIN, 4.1 g/dL; 77: CORRECTED CALCIUM, 8.6 mg/dL; 77: SODIUM, 133 mmol/L; 77: ALBUMIN, 4.3 g/dL; 77: ALKALINE PHOSPHATASE, 73 U/L; 77: LIPASE, 27 U/L; 77: HR, 107.517; 77: RR, 19.690; 77: 1min HRV, 13.170; 78: HR, 104.915; 78: RR, 19.475; 78: 1min HRV, 7.905; 78: 5min HRV, 13.380; 79: HR, 106.678; 79: RR, 23.237; 79: 1min HRV, 10.356; 80: HR, 106.966; 80: RR, 19.397; 80: 1min HRV, 10.673; 81: HR, 107.102; 81: RR, 21.559; 81: 1min HRV, 22.506; 82: HR, 105.466; 82: RR, 19.345; 82: 1min HRV, 10.033; 83: HR, 105.288; 83: RR, 18.017; 83: 1min HRV, 16.411; 83: 5min HRV, 15.158; 84: HR, 104.847; 84: RR, 18.441; 84: 1min HRV, 15.242; 85: HR, 105.603; 85: RR, 12.879; 85: 1min HRV, 14.937; 86: HR, 103.780; 86: RR, 20.780; 86: 1min HRV, 11.609; 87: HR, 105.857; 87: RR, 17.079; 87: 1min HRV, 23.708; 88: HR, 106.169; 88: RR, 18.333; 88: 1min HRV, 11.407; 88: 5min HRV, 16.147; 89: HR, 104.897; 89: RR, 20.810; 89: 1min HRV, 18.039; 90: HR, 104.621; 90: RR, 15.621; 90: 1min HRV, 10.529; 91: HR, 105.695; 91: RR, 19.712; 91: 1min HRV, 22.887; 92: HR, 106.069; 92: RR, 21.328; 92: 1min HRV, 19.021; 93: HR, 104.0; 93: RR, 17.542; 93: 1min HRV, 7.265; 93: 5min HRV, 17.503; 94: HR, 102.845; 94: RR, 21.983; 94: 1min HRV, 10.541; 95: HR, 102.102; 95: RR, 21.593; 95: 1min HRV, 11.068; 96: HR, 104.576; 96: RR, 23.237; 96: 1min HRV, 11.313; 97: HR, 104.759; 97: RR, 21.138; 97: 1min HRV, 19.620; 98: HR, 102.559; 98: RR, 21.288; 98: 1min HRV, 11.768; 98: 5min HRV, 14.812; 99: HR, 103.246; 99: RR, 22.807; 99: 1min HRV, 22.341; 100: HEMATOCRIT (HCT), 43.7 %; 100: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.0 pg; 100: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.1 g/dL; 100: RED CELL DISTRIBUTION WIDTH (RDW), 10.9 %; 100: WHITE BLOOD CELLS (WBC), 7.0 K/uL; 100: RED BLOOD CELLS (RBC), 4.80 MIL/uL; 100: MEAN CORPUSCULAR VOLUME (MCV), 91.0 fL; 100: PLATELET COUNT (PLT), 199 K/uL; 100: HEMOGLOBIN (HGB), 14.9 g/dL; 100: NEUTROPHILS SEGMENTED % (MANUAL DIFF), 35.7 %; 100: LYMPHOCYTES VARIANT ABSOLUTE (MANUAL DIFF), 0.06 K/uL; 100: EOSINOPHILS % (MANUAL DIFF), 0.9 %; 100: NEUTROPHILS BANDS % (MANUAL DIFF), 36.4 %; 100: NEUTROPHILS ABSOLUTE (MANUAL DIFF) (SEGS+BANDS), 5.08 K/uL; 100: MONOCYTES ABSOLUTE (MANUAL DIFF), 0.73 K/uL; 100: BASOPHILS % (MANUAL DIFF), 0.9 %; 100: MONOCYTES % (MANUAL DIFF), 10.4 %; 100: LYMPHOCYTES VARIANT % (MANUAL DIFF), 0.9 %; 100: LYMPHOCYTES % (MANUAL DIFF), 14.8 %; 100: EOSINOPHILS ABSOLUTE (MANUAL DIFF), 0.06 K/uL; 100: BASOPHILS ABSOLUTE (MANUAL DIFF), 0.06 K/uL; 100: LYMPHOCYTES ABSOLUTE (MANUAL DIFF), 1.04 K/uL; 100: HR, 103.576; 100: RR, 20.627; 100: 1min HRV, 14.543; 101: HR, 102.746; 101: RR, 25.254; 101: 1min HRV, 13.129; 102: HR, 108.08; 102: RR, 20.714; 102: 1min HRV, 31.538; 103: HR, 105.153; 103: RR, 10.763; 103: 1min HRV, 17.801; 103: 5min HRV, 22.944; 104: HR, 101.862; 104: RR, 16.569; 104: 1min HRV, 9.539; 104: SBP, 122.0; 104: DBP, 83.0; 104: MAP, 96.0; 105: HR, 102.441; 105: RR, 18.356; 105: 1min HRV, 22.460; 106: HR, 100.254; 106: RR, 22.322; 106: 1min HRV, 10.142; 107: HR, 104.276; 107: RR, 26.655; 107: 1min HRV, 19.422; 108: HR, 99.552; 108: RR, 17.017; 108: 1min HRV, 14.436; 108: 5min HRV, 19.297; 109: HR, 100.879; 109: RR, 17.431; 109: 1min HRV, 18.475; 110: HR, 100.983; 110: RR, 15.661; 110: 1min HRV, 17.022; 111: HR, 102.424; 111: RR, 16.0; 111: 1min HRV, 21.414; 111: LR IV BOLUS -, 1000 ML; 112: HR:, 101.5; 112: RR, 19.879; 112: 1min HRV, 23.754; 113: HR, 99.153; 113: RR, 18.525; 113: 1min HRV, 11.421; 113: 5min HRV, 19.897; 114: HR, 99.812; 114: RR, 16.667; 114: 1min HRV, 11.782; 118: 5min HRV, 11.782; 0: Age, 53; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 38.3; 0: Triage HR, 117.0; 0: Triage RR, 18.0; 0: Triage SBP, 127.0; 0: Triage DBP, 74.0; 0: Triage acuity, 2-Emergent; 0: CC, ABDOMINAL PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I identified whether the vital signs met common criteria for concern, such as high heart rate or fever. Next, I examined lab results for abnormalities like elevated lactate or WBC count that might indicate sepsis risk; these were normal in this case. Then, I looked for signs of organ dysfunction or hypotension, which also did not appear abnormal here. Finally, I concluded that although there are some mild abnormal vital signs (e.g., tachycardia, fever), there is insufficient evidence to label this patient as high risk for sepsis within 12 hours.",
        "claims": [
            "I identified whether the vital signs met common criteria for concern.",
            "Common criteria for concern include high heart rate or fever.",
            "I examined lab results for abnormalities that might indicate sepsis risk.",
            "Abnormalities in lab results include elevated lactate or WBC count.",
            "In this case, the lab results were normal.",
            "I looked for signs of organ dysfunction or hypotension.",
            "Signs of organ dysfunction or hypotension did not appear abnormal in this case.",
            "There are mild abnormal vital signs present.",
            "Mild abnormal vital signs include tachycardia and fever.",
            "There is insufficient evidence to label this patient as high risk for sepsis within 12 hours."
        ],
        "relevant_claims": [
            "Common criteria for concern include high heart rate or fever.",
            "Mild abnormal vital signs include tachycardia and fever."
        ],
        "alignment_scores": [
            0.8,
            0.9
        ],
        "alignment_category": [
            2,
            2
        ],
        "alignment_reasonings": [
            "The claim mentions two criteria\u2014high heart rate and fever\u2014that are part of the SIRS criteria used to identify systemic inflammation in early sepsis. While the specific thresholds aren't stated, both are directly relevant to the SIRS category, indicating a strong but not absolute alignment given the absence of specific measurements.",
            "The presence of tachycardia and fever both align with the SIRS criteria for identifying systemic inflammation, which can indicate early sepsis. SIRS criteria include heart rate\u202f>\u202f90\u202fbpm (tachycardia) and temperature >38\u202f\u00b0C (fever). Assuming the specifics of these abnormalities align with SIRS thresholds, there is strong alignment with this category. However, without the exact values, the confidence isn't absolute, hence not a full 1.0 rating."
        ],
        "final_alignment_score": 0.8500000000000001,
        "accuracy": 1
    },
    {
        "input": "4: HR, 107.811; 4: RR, 20.453; 4: SpO2, 97.875; 4: 1min HRV, 98.468; 5: HR, 103.660; 5: RR, 17.604; 5: SpO2, 95.154; 5: 1min HRV, 130.891; 5: 5min HRV, 117.559; 5: SBP, 109.0; 5: DBP, 67.0; 5: MAP, 81.0; 5: Temp, 97.7; 6: HR, 103.808; 6: RR, 18.712; 6: SpO2, 94.0; 6: 1min HRV, 119.633; 7: HR, 101.774; 7: RR, 22.0; 7: SpO2, 94.0; 7: 1min HRV, 106.343; 8: HR, 102.558; 8: RR, 17.635; 8: SpO2, 98.775; 8: 1min HRV, 142.784; 9: HR, 106.604; 9: RR, 20.283; 9: SpO2, 98.818; 9: 1min HRV, 114.243; 10: HR, 110.170; 10: RR, 19.623; 10: SpO2, 97.115; 10: 1min HRV, 130.733; 10: 5min HRV, 125.114; 11: HR, 105.981; 11: RR, 21.327; 11: SpO2, 97.545; 11: 1min HRV, 110.793; 12: HR, 97.075; 12: RR, 18.962; 12: SpO2, 99.139; 12: 1min HRV, 154.971; 13: HR, 105.923; 13: RR, 19.308; 13: SpO2, 98.674; 13: 1min HRV, 121.821; 14: HR, 102.08; 14: RR, 23.057; 14: SpO2, 99.053; 14: Perf, 0.24; 14: 1min HRV, 127.983; 15: HR, 107.358; 15: RR, 19.962; 15: SpO2, 99.729; 15: Perf, 0.255; 15: 1min HRV, 142.063; 15: 5min HRV, 135.303; 16: HR, 105.404; 16: RR, 19.48; 16: SpO2, 99.654; 16: Perf, 0.268; 16: 1min HRV, 131.069; 16: SBP, 108.0; 16: DBP, 72.0; 16: MAP, 84.0; 17: HR, 102.113; 17: RR, 21.333; 17: SpO2, 99.5; 17: Perf, 0.287; 17: 1min HRV, 118.922; 18: HR, 107.404; 18: RR, 22.25; 18: SpO2, 99.25; 18: Perf, 0.292; 18: 1min HRV, 136.870; 19: HR, 105.396; 19: RR, 19.660; 19: SpO2, 99.020; 19: Perf, 0.297; 19: 1min HRV, 112.584; 20: HR, 104.755; 20: RR, 18.279; 20: SpO2, 99.06; 20: Perf, 0.268; 20: 1min HRV, 145.764; 20: 5min HRV, 130.300; 21: HR, 105.942; 21: RR, 22.827; 21: SpO2, 99.913; 21: Perf, 0.25; 21: 1min HRV, 160.123; 22: HR, 107.887; 22: RR, 24.566; 22: SpO2, 99.0; 22: Perf, 0.25; 22: 1min HRV, 97.245; 23: HR, 107.404; 23: RR, 18.673; 23: Perf, 0.25; 23: 1min HRV, 100.277; 24: HR, 107.16; 24: RR, 22.472; 24: Perf, 0.25; 24: 1min HRV, 50.432; 25: HR, 109.396; 25: RR, 19.453; 25: SpO2, 98.679; 25: 1min HRV, 151.744; 25: 5min HRV, 130.502; 26: HR, 98.442; 26: RR, 18.8; 26: SpO2, 98.312; 26: 1min HRV, 145.506; 27: HR, 104.396; 27: RR, 18.717; 27: SpO2, 96.943; 27: Perf, 0.498; 27: 1min HRV, 123.708; 28: HR, 104.385; 28: RR, 23.7; 28: SpO2, 98.282; 28: Perf, 0.492; 28: 1min HRV, 128.235; 29: HR, 104.660; 29: RR, 17.019; 29: SpO2, 98.0; 29: Perf, 0.49; 29: 1min HRV, 135.629; 30: HR, 107.936; 30: RR, 26.5; 30: SpO2, 97.933; 30: Perf, 0.481; 30: 1min HRV, 148.137; 30: 5min HRV, 137.295; 31: HR, 102.453; 31: RR, 19.388; 31: SpO2, 97.849; 31: Perf, 0.506; 31: 1min HRV, 146.413; 31: SBP, 107.0; 31: DBP, 76.0; 31: MAP, 86.333; 32: HR, 106.038; 32: RR, 19.491; 32: SpO2, 97.226; 32: Perf, 0.482; 32: 1min HRV, 113.776; 33: HR, 101.851; 33: RR, 21.538; 33: SpO2, 99.419; 33: Perf, 0.433; 33: 1min HRV, 146.124; 34: HR, 107.151; 34: RR, 17.962; 34: SpO2, 98.293; 34: Perf, 0.418; 34: 1min HRV, 115.549; 35: HR, 106.904; 35: RR, 18.519; 35: SpO2, 98.0; 35: Perf, 0.41; 35: 1min HRV, 112.346; 35: 5min HRV, 126.538; 36: HR, 100.914; 36: RR, 22.019; 36: Perf, 0.41; 36: 1min HRV, 61.116; 37: HR, 108.041; 37: RR, 15.395; 37: Perf, 0.41; 37: 1min HRV, 132.412; 38: HR, 105.7; 38: RR, 21.02; 38: SpO2, 98.682; 38: Perf, 0.412; 38: 1min HRV, 134.087; 39: HR, 103.717; 39: RR, 19.906; 39: SpO2, 97.769; 39: Perf, 0.465; 39: 1min HRV, 134.831; 40: HR, 98.962; 40: RR, 19.744; 40: SpO2, 98.636; 40: Perf, 0.478; 40: 1min HRV, 183.842; 40: 5min HRV, 150.445; 41: WAM DIFTYP, AUTO; 41: LYMPHOCYTE % (AUTO DIFF), 7.7 %; 41: NRBC PERCENT (HEMATOLOGY), 0.0 %; 41: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 28.4 pg; 41: BASOPHIL % (AUTO DIFF), 0.1 %; 41: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 41: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 41: PLATELET COUNT (PLT), 195 K/uL; 41: HEMOGLOBIN (HGB), 11.5 g/dL; 41: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 41: WHITE BLOOD CELLS (WBC), 16.4 K/uL; 41: NEUTROPHIL % (AUTO DIFF), 87.1 %; 41: NEUTROPHIL ABSOLUTE (AUTO DIFF), 14.27 K/uL; 41: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.07 K/uL; 41: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 30.6 g/dL; 41: HEMATOCRIT (HCT), 37.6 %; 41: MEAN CORPUSCULAR VOLUME (MCV), 92.8 fL; 41: RED BLOOD CELLS (RBC), 4.05 MIL/uL; 41: RED CELL DISTRIBUTION WIDTH (RDW), 16.4 %; 41: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.26 K/uL; 41: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 41: MONOCYTE ABSOLUTE (AUTO DIFF), 0.76 K/uL; 41: EOSINOPHIL % (AUTO DIFF), 0.1 %; 41: MONOCYTE % (AUTO DIFF), 4.6 %; 41: HR, 103.824; 41: RR, 19.275; 41: SpO2, 96.981; 41: Perf, 0.493; 41: 1min HRV, 149.126; 45: 5min HRV, 149.126; 68: ALT (SGPT), 63 U/L; 68: BLOOD UREA NITROGEN (BUN), 31 mg/dL; 68: CO2, 21 mmol/L; 68: PROTEIN TOTAL, 6.4 g/dL; 68: CHLORIDE, 106 mmol/L; 68: ALKALINE PHOSPHATASE, 107 U/L; 68: ANION GAP, 12 mmol/L; 68: EGFR FOR AFRICAN AMERICAN, 62 mL/min/1.73 m2; 68: AST (SGOT), 82 U/L; 68: BILIRUBIN TOTAL, 0.4 mg/dL; 68: SODIUM, 139 mmol/L; 68: GLUCOSE, 239 mg/dL; 68: POTASSIUM, 4.3 mmol/L; 68: CORRECTED CALCIUM, 10.5 mg/dL; 68: EGFR REFIT WITHOUT RACE (2021), 54 mL/min/1.73 m2; 68: CREATININE, 0.88 mg/dL; 68: GLOBULIN, 3.2 g/dL; 68: CALCIUM, 9.9 mg/dL; 68: ALBUMIN, 3.2 g/dL; 89: SARS-COV-2 RNA, Not Detected; 91: LIPASE, 25 U/L; 91: BNP NT-PRO, 28823 pg/mL; 107: TROPONIN I, 0.665 ng/mL; 107: TROPONIN I, 0.665 ng/mL; 0: Age, 90; 0: Gender, F; 0: Race, Other; 0: Means of arrival, EMS; 0: Triage Temp, 36.5; 0: Triage HR, 91.0; 0: Triage RR, 13.0; 0: Triage SBP, 109.0; 0: Triage DBP, 67.0; 0: Triage acuity, 2-Emergent; 0: CC, FATIGUE,IRREGULAR HEART BEAT,ARM SWELLING",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, I note that the patient\u2019s HR frequently exceeds 100 bpm, RR often exceeds 22 breaths/min, and WBC is elevated above 12 K/uL, satisfying multiple SIRS criteria. Next, I consider whether there is suspicion of infection, which is supported by the high neutrophil count and the clinical context. Finally, I check if there could be organ dysfunction, noting potential concerns such as elevated BUN and borderline kidney function. Putting these findings together, the data suggest a high risk for developing sepsis within 12 hours.",
        "claims": [
            "The patient\u2019s heart rate frequently exceeds 100 bpm.",
            "The patient's respiratory rate often exceeds 22 breaths/min.",
            "The patient's white blood cell count is elevated above 12 K/uL.",
            "The patient satisfies multiple SIRS criteria.",
            "There is suspicion of infection based on clinical context.",
            "The high neutrophil count supports the suspicion of infection.",
            "There are potential concerns regarding organ dysfunction.",
            "The patient's blood urea nitrogen (BUN) is elevated.",
            "The patient has borderline kidney function.",
            "The findings suggest a high risk for developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient\u2019s heart rate frequently exceeds 100 bpm.",
            "The patient's respiratory rate often exceeds 22 breaths/min.",
            "The patient's white blood cell count is elevated above 12 K/uL.",
            "The patient satisfies multiple SIRS criteria.",
            "There is suspicion of infection based on clinical context.",
            "The high neutrophil count supports the suspicion of infection.",
            "There are potential concerns regarding organ dysfunction.",
            "The patient's blood urea nitrogen (BUN) is elevated.",
            "The patient has borderline kidney function.",
            "The findings suggest a high risk for developing sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.8,
            0.7,
            1.0,
            1.0,
            0.3,
            0.8,
            0.7,
            0.3,
            0.7,
            0.3
        ],
        "alignment_category": [
            2,
            3,
            2,
            2,
            9,
            2,
            8,
            8,
            8,
            3
        ],
        "alignment_reasonings": [
            "The claim indicates a heart rate exceeding 100 bpm, which fits within the SIRS criteria of heart rate >90 bpm. This suggests systemic inflammatory response and aligns well with the category, but the claim alone does not show two or more SIRS criteria to fully meet the category's requirements, so the alignment is strong but not perfect.",
            "The claim about respiratory rate exceeding 22 breaths per minute directly aligns with one of the elements of the qSOFA score, which flags a high risk of sepsis-related organ dysfunction and mortality. However, qSOFA requires at least two criteria, so while it strongly indicates a risk factor, it by itself does not meet the full qSOFA score criteria, leading to a slightly reduced rating.",
            "The claim explicitly mentions an elevated white blood cell count above 12 K/uL, which directly matches one of the criteria for SIRS positivity. SIRS is used to identify systemic inflammation consistent with early sepsis. Thus, the alignment is perfect with this category.",
            "The claim explicitly states that the patient satisfies multiple SIRS criteria, which perfectly aligns with Category 2, SIRS Positivity. The presence of two or more SIRS criteria is a direct indicator of systemic inflammation consistent with early sepsis, leading to a full alignment rating.",
            "The claim expresses a suspicion of infection, which is foundational for considering early antibiotic or culture orders. However, it does not mention actual clinical actions (like ordering antibiotics or cultures), which are needed to fully match this category. As such, the alignment is weak.",
            "A high neutrophil count is indicative of an inflammatory or infectious process, which aligns conceptually with SIRS criteria that include elevated white blood cells. While the claim does not specifically mention exceeding the WBC SIRS threshold, it strongly suggests an inflammatory response consistent with systemic inflammation (a SIRS indicator). The alignment is strong but not perfect since the direct SIRS criteria threshold is not explicitly met.",
            "The claim mentions potential concerns regarding organ dysfunction, which is directly related to the concept of increasing SOFA scores that indicate new or worsening organ dysfunction. While the claim is somewhat vague and does not specify an exact SOFA score increase, the reference to organ dysfunction aligns with the criteria used in SOFA scoring, making category 8 the most relevant. The alignment rating reflects the conceptual connection even though specifics are not given.",
            "Elevated blood urea nitrogen (BUN) suggests renal dysfunction, which can infer an increase in creatinine, a SOFA component. However, BUN itself is not directly listed in SOFA, making the alignment minimal but relevant to the renal function aspect.",
            "Borderline kidney function suggests potential renal impairment, which can significantly impact the SOFA score through the creatinine measurement. While the claim does not specify a SOFA-style increase in creatinine, impaired kidney function is directly relevant and strongly associated with the concept of SOFA score increases. Hence, there is a meaningful, though not explicit, alignment.",
            "The claim is general and mentions a high risk for developing sepsis within 12 hours, but it doesn't specify the criteria or findings leading to this conclusion. The high qSOFA score is designed to identify patients at high risk of sepsis-related complications, which somewhat aligns with the mentioned high risk, though it is more specific in its criteria. The alignment is weak due to the lack of specific clinical indicators provided in the claim."
        ],
        "final_alignment_score": 0.6599999999999999,
        "accuracy": 1
    },
    {
        "input": "8: Pain, 7.0; 27: HR, 120.0; 27: RR, 22.0; 27: SpO2, 95.0; 27: SBP, 81.0; 27: DBP, 55.0; 27: MAP, 63.667; 27: LPM O2, 3.0; 27: Temp, 98.1; 56: POC, HCG, ISTAT QUALITATIVE: Negative; 56: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 65: SpO2, 87.3; 65: SBP, 88.0; 65: DBP, 64.0; 65: MAP, 72.0; 66: SpO2, 86.370; 66: SBP, 94.0; 66: DBP, 62.0; 66: MAP, 72.667; 67: SpO2, 92.661; 67: Perf, 0.203; 68: HR, 118.385; 68: RR, 15.385; 68: SpO2, 94.729; 68: Perf, 0.220; 68: 1min HRV, 64.080; 69: HR, 117.793; 69: RR, 22.241; 69: SpO2, 95.897; 69: Perf, 0.259; 69: 1min HRV, 9.480; 69: SBP, 94.0; 69: DBP, 62.0; 69: MAP, 72.667; 69: LPM O2, 4.0; 69: Temp, 98.3; 70: HR, 117.559; 70: RR, 24.136; 70: SpO2, 96.492; 70: Perf, 0.284; 70: 1min HRV, 10.843; 70: 5min HRV, 30.738; 71: HR, 116.224; 71: RR, 27.121; 71: SpO2, 97.017; 71: Perf, 0.290; 71: 1min HRV, 14.608; 72: HR, 114.831; 72: RR, 30.288; 72: SpO2, 97.966; 72: Perf, 0.360; 72: 1min HRV, 4.378; 73: HR, 116.862; 73: RR, 27.328; 73: SpO2, 97.0; 73: Perf, 0.743; 73: 1min HRV, 5.068; 74: HR, 117.119; 74: RR, 22.373; 74: SpO2, 96.746; 74: Perf, 0.788; 74: 1min HRV, 9.255; 75: HR, 117.373; 75: RR, 23.390; 75: SpO2, 96.3; 75: Perf, 0.743; 75: 1min HRV, 16.879; 75: 5min HRV, 11.855; 76: HR, 117.175; 76: RR, 25.877; 76: SpO2, 96.035; 76: Perf, 0.527; 76: 1min HRV, 4.554; 77: HR, 117.167; 77: RR, 22.95; 77: SpO2, 96.417; 77: Perf, 0.435; 77: 1min HRV, 7.411; 78: HR, 117.983; 78: RR, 23.345; 78: SpO2, 97.534; 78: Perf, 0.455; 78: 1min HRV, 8.065; 79: HR, 118.559; 79: RR, 18.492; 79: SpO2, 97.610; 79: Perf, 0.357; 79: 1min HRV, 1.958; 80: HR, 119.051; 80: RR, 19.610; 80: SpO2, 97.508; 80: Perf, 0.352; 80: 1min HRV, 2.552; 80: 5min HRV, 6.305; 80: SBP, 93.0; 80: DBP, 64.0; 80: MAP, 73.667; 80: LPM O2, 4.0; 81: HR, 118.448; 81: RR, 22.879; 81: SpO2, 96.759; 81: Perf, 0.407; 81: 1min HRV, 5.158; 81: SBP, 93.0; 81: DBP, 64.0; 81: MAP, 73.667; 82: HR, 117.492; 82: RR, 24.661; 82: SpO2, 96.712; 82: Perf, 0.428; 82: 1min HRV, 11.514; 83: HR, 115.707; 83: RR, 28.534; 83: SpO2, 96.966; 83: Perf, 0.454; 83: 1min HRV, 2.751; 84: HR, 115.661; 84: RR, 26.186; 84: SpO2, 97.797; 84: Perf, 0.500; 84: 1min HRV, 20.359; 85: PART. THROMBOPLASTIN TIME, 31.0 seconds; 85: HR, 115.559; 85: RR, 29.542; 85: SpO2, 96.966; 85: Perf, 0.760; 85: 1min HRV, 4.553; 85: 5min HRV, 11.994; 86: HR, 115.690; 86: RR, 27.034; 86: SpO2, 96.414; 86: Perf, 0.943; 86: 1min HRV, 2.962; 87: HR, 116.339; 87: RR, 26.288; 87: SpO2, 96.0; 87: Perf, 1.029; 87: 1min HRV, 4.366; 88: HR, 116.362; 88: RR, 23.948; 88: SpO2, 96.448; 88: Perf, 0.671; 88: 1min HRV, 4.347; 89: HR, 116.237; 89: RR, 24.593; 89: SpO2, 97.610; 89: Perf, 0.564; 89: 1min HRV, 8.873; 90: HR, 116.915; 90: RR, 25.898; 90: SpO2, 97.169; 90: Perf, 0.406; 90: 1min HRV, 5.612; 90: 5min HRV, 6.027; 91: HR, 116.603; 91: RR, 22.534; 91: SpO2, 96.862; 91: Perf, 0.308; 91: 1min HRV, 8.173; 92: HR, 115.4; 92: RR, 25.944; 92: SpO2, 97.702; 92: Perf, 0.309; 92: 1min HRV, 2.095; 93: POC PH (V) ISTAT, 7.32; 93: POC O2 SATURATION ISTAT VENOUS, 76 %; 93: POC HCO3 (V) ISTAT, 10.5 mmol/L; 93: POC LACTATE ISTAT, 0.73 mmol/L; 93: POC PCO2 (V) ISTAT, 20.6 mmHg; 93: POC BASE EXCESS ISTAT, -16 mmol/L; 93: POC TCO2 (V) ISTAT, 11 mmol/L; 93: POC PO2 (V) ISTAT, 43 mmHg; 95: 5min HRV, 7.487; 96: INR, 1.4; 96: PROTHROMBIN TIME, 16.8 seconds; 102: BILIRUBIN TOTAL, 1.0 mg/dL; 102: GLUCOSE, 105 mg/dL; 102: CREATININE, 2.37 mg/dL; 102: POTASSIUM, 5.5 mmol/L; 102: ALKALINE PHOSPHATASE, 99 U/L; 102: AST (SGOT), 95 U/L; 102: GLOBULIN, 4.4 g/dL; 102: BLOOD UREA NITROGEN (BUN), 41 mg/dL; 102: CHLORIDE, 105 mmol/L; 102: EGFR REFIT WITHOUT RACE (2021), 27 mL/min/1.73 m2; 102: CORRECTED CALCIUM, 9.3 mg/dL; 102: ALBUMIN, 3.5 g/dL; 102: SODIUM, 131 mmol/L; 102: ALT (SGPT), 395 U/L; 102: PROTEIN TOTAL, 7.9 g/dL; 102: CO2, 12 mmol/L; 102: CALCIUM, 8.9 mg/dL; 102: ANION GAP, 14 mmol/L; 102: BNP NT-PRO, 16041 pg/mL; 106: RBC MORPHOLOGY (SLIDE REVIEW), Abnormal; 106: HEMOGLOBIN (HGB), 10.4 g/dL; 106: RED BLOOD CELLS (RBC), 4.59 MIL/uL; 106: RED CELL DISTRIBUTION WIDTH (RDW), 19.9 %; 106: MEAN CORPUSCULAR VOLUME (MCV), 75.4 fL; 106: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 30.1 g/dL; 106: WHITE BLOOD CELLS (WBC), 11.4 K/uL; 106: PLATELET COUNT (PLT), 292 K/uL; 106: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 22.7 pg; 106: HEMATOCRIT (HCT), 34.6 %; 106: NEUTROPHILS ABSOLUTE (MANUAL DIFF) (SEGS+BANDS), 9.25 K/uL; 106: LYMPHOCYTES VARIANT ABSOLUTE (MANUAL DIFF), 0.11 K/uL; 106: NEUTROPHILS SEGMENTED % (MANUAL DIFF), 78.0 %; 106: LYMPHOCYTES VARIANT % (MANUAL DIFF), 1.0 %; 106: NEUTROPHILS BANDS % (MANUAL DIFF), 3.0 %; 106: LYMPHOCYTES ABSOLUTE (MANUAL DIFF), 1.26 K/uL; 106: MONOCYTES ABSOLUTE (MANUAL DIFF), 0.69 K/uL; 106: LYMPHOCYTES % (MANUAL DIFF), 11.0 %; 106: EOSINOPHILS % (MANUAL DIFF), 1.0 %; 106: EOSINOPHILS ABSOLUTE (MANUAL DIFF), 0.11 K/uL; 106: MONOCYTES % (MANUAL DIFF), 6.0 %; 112: IOPAMIDOL, 76 % IV SOLN (RADIOLOGY) 500 ML; 0: Age:, 32; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 120.0; 0: Triage RR, 22.0; 0: Triage SBP, 81.0; 0: Triage DBP, 55.0; 0: Triage acuity, 2-Emergent; 0: CC, ABDOMINAL PAIN,SHORTNESS OF BREATH",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, I checked the vital signs, noting hypotension (SBP ~80 mmHg), tachycardia (HR >115), and an elevated respiratory rate. Next, I looked at the labs for possible organ dysfunction, seeing elevated creatinine (2.37 mg/dL) and metabolic acidosis (low bicarbonate). Then I asked whether these findings, in the context of abdominal pain and shortness of breath, suggest a high likelihood of sepsis. Based on the persistent hemodynamic abnormalities and laboratory derangements, the patient is at high risk of developing sepsis within 12 hours.",
        "claims": [
            "I checked the vital signs.",
            "The vital signs showed hypotension with a systolic blood pressure of approximately 80 mmHg.",
            "The vital signs showed tachycardia with a heart rate greater than 115 beats per minute.",
            "The vital signs showed an elevated respiratory rate.",
            "I looked at the labs for possible organ dysfunction.",
            "The labs showed elevated creatinine levels of 2.37 mg/dL.",
            "The labs indicated metabolic acidosis with low bicarbonate levels.",
            "The findings include abdominal pain and shortness of breath.",
            "These findings suggest a high likelihood of sepsis.",
            "The patient has persistent hemodynamic abnormalities.",
            "The patient has laboratory derangements.",
            "Based on these factors, the patient is at high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The vital signs showed hypotension with a systolic blood pressure of approximately 80 mmHg.",
            "The vital signs showed tachycardia with a heart rate greater than 115 beats per minute.",
            "The vital signs showed an elevated respiratory rate.",
            "I looked at the labs for possible organ dysfunction.",
            "The labs showed elevated creatinine levels of 2.37 mg/dL.",
            "The labs indicated metabolic acidosis with low bicarbonate levels.",
            "The findings include abdominal pain and shortness of breath.",
            "These findings suggest a high likelihood of sepsis.",
            "The patient has persistent hemodynamic abnormalities.",
            "The patient has laboratory derangements.",
            "Based on these factors, the patient is at high risk of developing sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            1.0,
            0.8,
            0.8,
            0.5,
            1.0,
            0.7,
            0.3,
            0.3,
            0.7,
            0.3,
            0.3
        ],
        "alignment_category": [
            7,
            2,
            2,
            8,
            8,
            8,
            3,
            4,
            6,
            8,
            4
        ],
        "alignment_reasonings": [
            "The claim directly references a systolic blood pressure of approximately 80 mmHg, which is below the threshold of 90 mmHg. This perfectly aligns with the criteria of sepsis-associated hypotension, indicating progression toward septic shock.",
            "The claim mentions tachycardia with a heart rate greater than 115 beats per minute. One of the SIRS criteria includes a heart rate greater than 90 beats per minute. While this claim directly aligns with one of the SIRS criteria, it does not mention any additional SIRS criteria, which prevents a perfect alignment rating. Therefore, it's highly aligned but not fully comprehensive against the complete set of SIRS criteria, resulting in a high alignment rating of 0.8.",
            "An elevated respiratory rate is a specific parameter listed in the SIRS criteria (respiratory rate\u202f>\u202f20\u202f/min). The claim directly refers to one of the SIRS criteria components, suggesting early sepsis due to systemic inflammation. Although the exact value isn't provided, the alignment is strong since the category directly includes respiratory rate as a factor.",
            "The claim references looking at labs for potential organ dysfunction, which implies a search for lab results that might indicate an increased SOFA score (a measure used to evaluate organ dysfunction). While no specific SOFA component increase is mentioned, the focus on organ dysfunction aligns with the SOFA score criteria. The alignment is indirect, as no explicit increase in SOFA components is mentioned, so a moderate rating is appropriate.",
            "The claim mentions elevated creatinine levels of 2.37 mg/dL, which is directly mentioned as a criterion in the SOFA score (creatinine >2 mg/dL). This directly relates to an increase in SOFA score, indicating new organ dysfunction and a high sepsis risk. The alignment is perfect.",
            "Metabolic acidosis and low bicarbonate levels could imply kidney dysfunction, which is one of the organ systems evaluated by the SOFA score (as indicated by elevated creatinine). While the claim doesn't directly state a SOFA score increase or specific criteria such as creatinine levels, it does suggest potential organ dysfunction, aligning moderately well with this category.",
            "Shortness of breath can be associated with a respiratory rate \u226522/min, which is part of the qSOFA criteria. However, the claim does not provide specific vital sign values to confirm this, nor does it clearly align abdominal pain with any sepsis criteria. Therefore, the alignment is weak and indirect.",
            "The claim vaguely indicates a high sepsis likelihood without specifying any clinical details or measurements. The mention of a \"high likelihood of sepsis\" generally aligns with monitoring tools predicting clinical deterioration, like the NEWS score, but without specifics, it's a weak alignment.",
            "Hemodynamic abnormalities often imply issues like instability in blood pressure or heart rate. The Elevated Shock Index is directly concerned with hemodynamic instability as it involves heart rate and systolic blood pressure, making it the most appropriate category. However, the claim does not provide specific details like actual heart rate or blood pressure measurements, so the alignment, while relevant, is not perfect.",
            "The term \"laboratory derangements\" is too vague to be directly attributable to any specific category. However, the SOFA Score involves laboratory measures that indicate organ dysfunction (e.g., PaO\u2082/FiO\u2082, platelets, bilirubin, creatinine). Therefore, there is a weak but conceivable alignment with SOFA Score Increase due to the general implication of abnormal labs potentially impacting organ function.",
            "The claim is vague and does not provide specific clinical indicators. It generally implies a high risk of sepsis, which aligns more with a scoring system like NEWS that predicts imminent clinical deterioration. However, the absence of specific parameters or values results in a low alignment rating."
        ],
        "final_alignment_score": 0.6090909090909091,
        "accuracy": 1
    },
    {
        "input": "3: HR, 99.0; 3: RR, 20.0; 3: SpO2, 100.0; 3: SBP, 140.0; 3: DBP, 85.0; 3: MAP, 103.333; 3: Pain, nan; 3: Temp, 98.0; 4: SpO2, 100.0; 5: HR, 96.625; 5: RR, 26.391; 5: SpO2, 100.0; 5: 1min HRV, 65.045; 6: HR, 93.655; 6: RR, 13.828; 6: SpO2, 81.8; 6: 1min HRV, 14.901; 6: SBP, 140.0; 6: DBP, 85.0; 6: MAP, 103.333; 7: HR, 95.102; 7: RR, 16.983; 7: SpO2, 100.0; 7: 1min HRV, 27.905; 8: HR, 92.271; 8: RR, 19.763; 8: SpO2, 100.0; 8: Perf, 3.422; 8: 1min HRV, 26.209; 8: 5min HRV, 33.677; 9: HR, 87.948; 9: RR, 14.483; 9: SpO2, 100.0; 9: Perf, 3.304; 9: 1min HRV, 14.298; 10: HR, 88.508; 10: RR, 14.475; 10: SpO2, 100.0; 10: Perf, 3.767; 10: 1min HRV, 24.175; 11: HR, 87.966; 11: RR, 17.793; 11: SpO2, 100.0; 11: Perf, 2.893; 11: 1min HRV, 14.373; 12: HR, 90.017; 12: RR, 16.220; 12: SpO2, 100.0; 12: Perf, 1.955; 12: 1min HRV, 14.858; 13: HR, 88.322; 13: RR, 13.339; 13: SpO2, 100.0; 13: Perf, 1.784; 13: 1min HRV, 16.979; 13: 5min HRV, 18.750; 14: HR, 85.466; 14: RR, 13.983; 14: SpO2, 100.0; 14: Perf, 1.337; 14: 1min HRV, 41.162; 15: HR, 85.915; 15: RR, 8.089; 15: SpO2, 100.0; 15: Perf, 1.305; 15: 1min HRV, 47.027; 16: HR, 87.034; 16: RR, 14.241; 16: SpO2, 99.034; 16: Perf, 1.554; 16: 1min HRV, 13.824; 17: HR, 86.881; 17: RR, 19.322; 17: SpO2, 99.780; 17: Perf, 1.531; 17: 1min HRV, 16.674; 18: HR, 88.424; 18: RR, 22.508; 18: SpO2, 100.0; 18: Perf, 1.917; 18: 1min HRV, 18.220; 18: 5min HRV, 32.184; 19: HR, 86.328; 19: RR, 17.862; 19: SpO2, 99.879; 19: Perf, 2.174; 19: 1min HRV, 30.876; 19: SBP, 132.0; 19: DBP, 94.0; 19: MAP, 106.667; 20: HR, 84.864; 20: RR, 17.627; 20: SpO2, 100.0; 20: Perf, 2.211; 20: 1min HRV, 12.137; 21: HR, 84.966; 21: RR, 18.914; 21: SpO2, 99.879; 21: Perf, 2.119; 21: 1min HRV, 16.061; 22: HR, 87.203; 22: RR, 17.814; 22: SpO2, 100.0; 22: Perf, 1.934; 22: 1min HRV, 19.905; 23: HR, 91.586; 23: RR, 16.621; 23: SpO2, 100.0; 23: Perf, 1.638; 23: 1min HRV, 33.288; 23: 5min HRV, 29.349; 24: HR, 85.695; 24: RR, 20.085; 24: SpO2, 100.0; 24: Perf, 2.043; 24: 1min HRV, 43.239; 25: HR, 89.186; 25: RR, 16.644; 25: SpO2, 100.0; 25: Perf, 1.875; 25: 1min HRV, 20.964; 26: HR, 91.586; 26: RR, 17.0; 26: SpO2, 100.0; 26: Perf, 1.781; 26: 1min HRV, 12.019; 27: HR, 95.576; 27: RR, 16.966; 27: SpO2, 100.0; 27: Perf, 1.809; 27: 1min HRV, 24.570; 28: HR, 95.207; 28: RR, 20.759; 28: SpO2, 99.914; 28: Perf, 2.004; 28: 1min HRV, 12.423; 28: 5min HRV, 36.506; 29: HR, 93.038; 29: RR, 21.583; 29: SpO2, 99.966; 29: Perf, 2.114; 29: 1min HRV, 17.322; 30: SpO2, 99.763; 30: Perf, 2.112; 31: SpO2, 100.0; 31: Perf, 1.998; 32: SpO2, 100.0; 32: Perf, 2.940; 33: SpO2, 100.0; 33: Perf, 4.336; 33: 5min HRV, 17.322; 34: SpO2, 100.0; 34: Perf, 3.641; 34: SBP, 141.0; 34: DBP, 128.0; 34: MAP, 132.333; 35: SpO2, 100.0; 35: Perf, 3.437; 36: SpO2, 100.0; 36: Perf, 2.395; 37: SpO2, 100.0; 37: Perf, 1.783; 38: SpO2, 100.0; 38: Perf, 1.336; 39: WAM DIFTYP, AUTO; 39: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.2 pg; 39: PLATELET COUNT (PLT), 212 K/uL; 39: NEUTROPHIL ABSOLUTE (AUTO DIFF), 3.26 K/uL; 39: BASOPHIL % (AUTO DIFF), 0.9 %; 39: HEMOGLOBIN (HGB), 13.0 g/dL; 39: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.7 g/dL; 39: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 39: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.01 K/uL; 39: MONOCYTE ABSOLUTE (AUTO DIFF), 0.72 K/uL; 39: RED BLOOD CELLS (RBC), 4.17 MIL/uL; 39: LYMPHOCYTE % (AUTO DIFF), 32.2 %; 39: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.2 %; 39: NEUTROPHIL % (AUTO DIFF), 51.2 %; 39: MEAN CORPUSCULAR VOLUME (MCV), 89.9 fL; 39: BASOPHIL ABSOLUTE (AUTO DIFF), 0.06 K/uL; 39: WHITE BLOOD CELLS (WBC), 6.4 K/uL; 39: RED CELL DISTRIBUTION WIDTH (RDW), 13.3 %; 39: MONOCYTE % (AUTO DIFF), 11.3 %; 39: NRBC PERCENT (HEMATOLOGY), 0.0 %; 39: EOSINOPHIL % (AUTO DIFF), 4.2 %; 39: HEMATOCRIT (HCT), 37.5 %; 39: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.05 K/uL; 39: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.27 K/uL; 39: SpO2, 99.864; 39: Perf, 1.502; 40: SpO2, 100.0; 40: Perf, 1.656; 41: SpO2, 100.0; 41: Perf, 1.606; 42: SpO2, 100.0; 42: Perf, 1.024; 43: SpO2, 100.0; 43: Perf, 0.829; 44: SpO2, 100.0; 44: Perf, 0.882; 45: SpO2, 100.0; 45: Perf, 0.867; 46: SpO2, 100.0; 46: Perf, 0.679; 47: SpO2, 100.0; 47: Perf, 0.640; 48: SpO2, 100.0; 48: Perf, 0.650; 49: SpO2, 99.943; 49: Perf, 0.674; 49: SBP, 142.0; 49: DBP, 95.0; 49: MAP, 110.667; 56: BLOOD TYPE VERIFICATION-AUTOMATION, O Positive; 56: ANTIBODY SCREEN 3, NEG; 56: ABO/RH (AUTOMATION), O Positive; 60: PART. THROMBOPLASTIN TIME, 30.7 seconds; 61: INR, 1.2; 61: PROTHROMBIN TIME, 14.5 seconds; 83: HR, 84.0; 83: SpO2, 100.0; 83: SBP, 141.0; 83: DBP, 95.0; 83: MAP, 110.333; 83: Pain, 8.0; 91: MORPHINE, 4 MG/ML IV SYRG; 96: LR IV BOLUS -, 1000 ML; 97: CEFAZOLIN IV PUSH (, 1 GRAM VIAL + NS VIAL); 108: HR:, 85.0; 108: RR, 16.0; 108: SpO2, 100.0; 108: SBP, 170.0; 108: DBP, 98.0; 108: MAP, 122.0; 108: Pain, 0.0; 108: Pain, 0.0; 0: Age, 60; 0: Gender, M; 0: Race, Black or African American; 0: Means of arrival, EMS; 0: Triage Temp, 36.7; 0: Triage HR, 99.0; 0: Triage RR, 20.0; 0: Triage SBP, 140.0; 0: Triage DBP, 85.0; 0: Triage acuity, 2-Emergent; 0: CC, LEG INJURY",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I considered whether the patient\u2019s vitals were showing abnormal patterns (e.g., fever, hypotension, tachycardia) suggesting possible sepsis, but overall, the temperatures remained near normal and blood pressures stayed stable or even elevated. Next, I looked at laboratory results (such as WBC count), which were generally within normal limits and did not indicate infection-related abnormalities. After that, I evaluated whether there were signs of end-organ dysfunction (e.g., significantly low oxygen saturation or markedly elevated respiratory rate), but the patient\u2019s oxygen levels were mostly high and respiratory rate was only briefly elevated. Based on these findings, the patient does not appear to be at high risk of developing sepsis within the next 12 hours.",
        "claims": [
            "The patient's vitals were considered for abnormal patterns suggesting possible sepsis.",
            "The patient's temperatures remained near normal.",
            "The patient's blood pressures stayed stable or even elevated.",
            "Laboratory results, such as WBC count, were generally within normal limits.",
            "The laboratory results did not indicate infection-related abnormalities.",
            "Signs of end-organ dysfunction were evaluated.",
            "There were no significantly low oxygen saturation levels in the patient.",
            "The patient's respiratory rate was only briefly elevated.",
            "The patient's oxygen levels were mostly high.",
            "Based on these findings, the patient does not appear to be at high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient's blood pressures stayed stable or even elevated.",
            "The laboratory results did not indicate infection-related abnormalities.",
            "There were no significantly low oxygen saturation levels in the patient."
        ],
        "alignment_scores": [
            0.2,
            0.3,
            0.3
        ],
        "alignment_category": [
            7,
            9,
            8
        ],
        "alignment_reasonings": [
            "The claim indicates that the patient's blood pressures are stable or elevated, which is contrary to what the category describes (hypotension is an indicator of sepsis progression). There is only an indirect relevance as stable or elevated blood pressures imply that hypotension\u2014and thus the typical warning sign of sepsis\u2014is not present. Hence, the alignment is minimal.",
            "The claim mentions that laboratory results did not indicate infection-related abnormalities. This suggests an absence of concrete indicators for infection. While it doesn't explicitly involve early antibiotic administration or culture orders, the negative laboratory findings are relevant to infection assessment. The alignment is weak since the claim only implies an absence of customary infection markers rather than a proactive clinical action for infection suspicion.",
            "The claim references oxygen saturation levels, which relate indirectly to the SOFA component measuring impaired oxygenation (specifically PaO\u2082/FiO\u2082 ratios). While the absence of low oxygen saturation suggests stable oxygenation, the claim does not directly address any measurements or criteria used in the SOFA score determination. Thus, the alignment is weak and conceptual, not meeting the criteria but somewhat related in context."
        ],
        "final_alignment_score": 0.26666666666666666,
        "accuracy": 1
    },
    {
        "input": "16: Pain, 0.0; 18: HR, 117.0; 18: RR, 16.0; 18: SpO2, 100.0; 18: SBP, 103.0; 18: DBP, 74.0; 18: MAP, 83.667; 18: LPM O2, 2.0; 18: Temp, 97.7; 67: POC PH (V) ISTAT, 7.33; 67: POC PCO2 (V) ISTAT, 61.8 mmHg; 67: POC HCO3 (V) ISTAT, 32.6 mmol/L; 67: POC BASE EXCESS ISTAT, 7 mmol/L; 67: POC O2 SATURATION ISTAT VENOUS, 20 %; 67: POC TCO2 (V) ISTAT, 34 mmol/L; 67: POC PO2 (V) ISTAT, 17 mmHg; 67: POC LACTATE ISTAT, 2.77 mmol/L; 71: SpO2, 100.0; 71: Perf, 0.388; 72: HR, 114.091; 72: RR, 27.833; 72: SpO2, 100.0; 72: Perf, 0.453; 72: 1min HRV, 5.252; 72: SBP, 116.0; 72: DBP, 90.0; 72: MAP, 98.667; 72: LPM O2, 2.0; 73: HR, 113.862; 73: RR, 27.0; 73: SpO2, 99.943; 73: Perf, 0.43; 73: 1min HRV, 4.683; 74: HR, 114.983; 74: RR, 26.542; 74: SpO2, 100.0; 74: Perf, 0.382; 74: 1min HRV, 6.631; 75: HR, 115.356; 75: RR, 25.407; 75: SpO2, 100.0; 75: Perf, 0.301; 75: 1min HRV, 2.988; 76: HR, 115.224; 76: RR, 25.172; 76: SpO2, 100.0; 76: Perf, 0.226; 76: 1min HRV, 3.239; 76: 5min HRV, 5.415; 76: SBP, nan; 76: DBP, nan; 76: MAP, nan; 77: HR, 115.627; 77: RR, 25.254; 77: SpO2, 100.0; 77: Perf, 0.193; 77: 1min HRV, 8.700; 78: HR, 115.305; 78: RR, 27.966; 78: SpO2, 100.0; 78: Perf, 0.199; 78: 1min HRV, 5.428; 79: HR, 121.586; 79: RR, 29.397; 79: SpO2, 100.0; 79: 1min HRV, 6.808; 80: HR, 126.0; 80: RR, 33.339; 80: SpO2, 100.0; 80: Perf, 0.239; 80: 1min HRV, 11.828; 81: HR, 121.310; 81: RR, 27.914; 81: SpO2, 100.0; 81: Perf, 0.251; 81: 1min HRV, 11.118; 81: 5min HRV, 19.998; 82: HR, 117.305; 82: RR, 28.763; 82: SpO2, 100.0; 82: Perf, 0.367; 82: 1min HRV, 9.659; 83: HR, 117.017; 83: RR, 26.627; 83: SpO2, 99.915; 83: Perf, 0.396; 83: 1min HRV, 5.729; 84: HR, 116.534; 84: RR, 25.293; 84: SpO2, 99.674; 84: Perf, 0.363; 84: 1min HRV, 6.921; 85: HR, 116.833; 85: RR, 29.647; 85: SpO2, 99.085; 85: 1min HRV, 9.961; 86: HR, 116.741; 86: RR, 27.552; 86: SpO2, 100.0; 86: Perf, 0.321; 86: 1min HRV, 4.353; 86: 5min HRV, 7.542; 87: HR, 114.610; 87: RR, 23.576; 87: SpO2, 100.0; 87: Perf, 0.332; 87: 1min HRV, 7.569; 88: HR, 114.831; 88: RR, 25.373; 88: SpO2, 100.0; 88: Perf, 0.202; 88: 1min HRV, 13.931; 89: HR, 117.069; 89: RR, 30.741; 89: SpO2, 100.0; 89: Perf, 0.278; 89: 1min HRV, 16.662; 90: WAM DIFTYP, AUTO; 90: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.13 K/uL; 90: LYMPHOCYTE % (AUTO DIFF), 19.4 %; 90: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 90: MONOCYTE ABSOLUTE (AUTO DIFF), 1.26 K/uL; 90: EOSINOPHIL % (AUTO DIFF), 1.2 %; 90: RED CELL DISTRIBUTION WIDTH (RDW), 18.2 %; 90: NEUTROPHIL ABSOLUTE (AUTO DIFF), 11.82 K/uL; 90: NEUTROPHIL % (AUTO DIFF), 70.8 %; 90: MONOCYTE % (AUTO DIFF), 7.6 %; 90: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.5 g/dL; 90: NRBC PERCENT (HEMATOLOGY), 0.0 %; 90: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.20 K/uL; 90: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 26.6 pg; 90: HEMATOCRIT (HCT), 44.7 %; 90: PLATELET COUNT (PLT), 472 K/uL; 90: MEAN CORPUSCULAR VOLUME (MCV), 84.3 fL; 90: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 3.23 K/uL; 90: WHITE BLOOD CELLS (WBC), 16.7 K/uL; 90: HEMOGLOBIN (HGB), 14.1 g/dL; 90: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 90: BASOPHIL % (AUTO DIFF), 0.2 %; 90: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.8 %; 90: RED BLOOD CELLS (RBC), 5.30 MIL/uL; 90: HR, 115.475; 90: RR, 23.610; 90: SpO2, 100.0; 90: Perf, 0.508; 90: 1min HRV, 6.293; 91: HR, 111.569; 91: RR, 21.431; 91: SpO2, 100.0; 91: Perf, 0.309; 91: 1min HRV, 21.705; 91: 5min HRV, 17.493; 92: HR, 111.254; 92: RR, 22.220; 92: SpO2, 100.0; 92: Perf, 0.163; 92: 1min HRV, 30.123; 93: HR, 116.879; 93: RR, 23.310; 93: SpO2, 100.0; 93: Perf, 0.206; 93: 1min HRV, 22.858; 94: HR, 108.288; 94: RR, 20.068; 94: SpO2, 100.0; 94: Perf, 0.269; 94: 1min HRV, 42.586; 95: HR, 117.898; 95: RR, 23.373; 95: SpO2, 100.0; 95: Perf, 0.270; 95: 1min HRV, 9.268; 96: HR, 110.034; 96: RR, 21.431; 96: SpO2, 100.0; 96: Perf, 0.355; 96: 1min HRV, 31.907; 96: 5min HRV, 32.721; 97: HR, 116.644; 97: RR, 24.763; 97: SpO2, 100.0; 97: Perf, 0.210; 97: 1min HRV, 12.208; 98: HR, 115.414; 98: RR, 21.086; 98: SpO2, 100.0; 98: Perf, 0.311; 98: 1min HRV, 13.967; 99: HR, 110.627; 99: RR, 21.593; 99: SpO2, 100.0; 99: Perf, 0.155; 99: 1min HRV, 30.190; 100: HR, 114.186; 100: RR, 23.339; 100: SpO2, 100.0; 100: Perf, 0.215; 100: 1min HRV, 10.330; 101: HR, 109.569; 101: RR, 22.655; 101: SpO2, 100.0; 101: Perf, 0.227; 101: 1min HRV, 24.137; 101: 5min HRV, 22.116; 102: HR, 117.085; 102: RR, 25.593; 102: SpO2, 100.0; 102: Perf, 0.183; 102: 1min HRV, 12.517; 103: HR, 115.603; 103: RR, 22.310; 103: SpO2, 100.0; 103: Perf, 0.356; 103: 1min HRV, 8.259; 104: HR, 114.559; 104: RR, 20.492; 104: SpO2, 100.0; 104: Perf, 0.360; 104: 1min HRV, 6.277; 105: HR, 114.542; 105: RR, 22.119; 105: SpO2, 100.0; 105: Perf, 0.311; 105: 1min HRV, 8.614; 106: HR, 114.483; 106: RR, 20.293; 106: SpO2, 100.0; 106: Perf, 0.302; 106: 1min HRV, 6.211; 106: 5min HRV, 9.837; 107: HR, 113.763; 107: RR, 20.237; 107: SpO2, 100.0; 107: Perf, 0.289; 107: 1min HRV, 7.220; 108: HR, 113.638; 108: RR, 21.931; 108: SpO2, 100.0; 108: Perf, 0.341; 108: 1min HRV, 6.759; 109: HR, 113.373; 109: RR, 21.864; 109: SpO2, 100.0; 109: Perf, 0.333; 109: 1min HRV, 5.955; 110: HR, 114.121; 110: RR, 20.603; 110: SpO2, 100.0; 110: Perf, 0.326; 110: 1min HRV, 8.640; 111: HR, 115.678; 111: RR, 24.254; 111: SpO2, 100.0; 111: Perf, 0.299; 111: 1min HRV, 4.160; 111: 5min HRV, 7.704; 112: HR, 113.322; 112: RR, 23.966; 112: SpO2, 100.0; 112: Perf, 0.428; 112: 1min HRV, 8.932; 113: HR, 114.017; 113: RR, 21.207; 113: SpO2, 100.0; 113: Perf, 0.405; 113: 1min HRV, 6.271; 114: HR, 112.797; 114: RR, 21.695; 114: SpO2, 100.0; 114: Perf, 0.374; 114: 1min HRV, 8.015; 115: HR, 113.288; 115: RR, 21.085; 115: SpO2, 100.0; 115: Perf, 0.393; 115: 1min HRV, 7.768; 116: HR, 113.586; 116: RR, 23.466; 116: SpO2, 100.0; 116: Perf, 0.332; 116: 1min HRV, 10.202; 116: 5min HRV, 8.462; 117: HR, 112.898; 117: RR, 20.695; 117: SpO2, 100.0; 117: Perf, 0.350; 117: 1min HRV, 5.507; 118: HR, 112.552; 118: RR, 20.552; 118: SpO2, 100.0; 118: Perf, 0.328; 118: 1min HRV, 9.157; 119: HR, 112.424; 119: RR, 20.814; 119: SpO2, 100.0; 119: Perf, 0.293; 119: 1min HRV, 7.331; 0: Age, 56; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.5; 0: Triage HR, 117.0; 0: Triage RR, 16.0; 0: Triage SBP, 103.0; 0: Triage DBP, 74.0; 0: Triage acuity, 2-Emergent; 0: CC, ABNORMAL LAB",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, I consider whether the patient has vital sign abnormalities such as elevated heart rate or respiratory rate. Next, I look for lab indicators like elevated lactate and high white blood cell count, which point toward a possible infection and inflammatory response. Finally, I assess whether these signs and labs together suggest a high risk of sepsis within 12 hours, and the persistent tachycardia, tachypnea, leukocytosis, and elevated lactate collectively indicate that risk.",
        "claims": [
            "I consider whether the patient has vital sign abnormalities.",
            "Vital sign abnormalities include elevated heart rate.",
            "Vital sign abnormalities include elevated respiratory rate.",
            "I look for lab indicators.",
            "Lab indicators include elevated lactate.",
            "Lab indicators include high white blood cell count.",
            "Elevated lactate points toward a possible infection.",
            "High white blood cell count points toward a possible infection.",
            "Lab indicators suggest an inflammatory response.",
            "I assess whether the signs and labs suggest a high risk of sepsis.",
            "The signs and labs together suggest a high risk of sepsis within 12 hours.",
            "Persistent tachycardia indicates a risk of sepsis.",
            "Tachypnea indicates a risk of sepsis.",
            "Leukocytosis indicates a risk of sepsis.",
            "Elevated lactate indicates a risk of sepsis.",
            "Persistent tachycardia, tachypnea, leukocytosis, and elevated lactate collectively indicate that risk."
        ],
        "relevant_claims": [
            "I consider whether the patient has vital sign abnormalities.",
            "Vital sign abnormalities include elevated heart rate.",
            "Vital sign abnormalities include elevated respiratory rate.",
            "Lab indicators include elevated lactate.",
            "Elevated lactate points toward a possible infection.",
            "High white blood cell count points toward a possible infection.",
            "Lab indicators suggest an inflammatory response.",
            "I assess whether the signs and labs suggest a high risk of sepsis.",
            "The signs and labs together suggest a high risk of sepsis within 12 hours.",
            "Persistent tachycardia indicates a risk of sepsis.",
            "Tachypnea indicates a risk of sepsis.",
            "Leukocytosis indicates a risk of sepsis.",
            "Elevated lactate indicates a risk of sepsis.",
            "Persistent tachycardia, tachypnea, leukocytosis, and elevated lactate collectively indicate that risk."
        ],
        "alignment_scores": [
            0.6,
            0.7,
            0.8,
            1.0,
            0.8,
            1.0,
            0.7,
            0.3,
            0.5,
            0.8,
            0.7,
            1.0,
            1.0,
            0.8
        ],
        "alignment_category": [
            4,
            2,
            3,
            5,
            5,
            2,
            2,
            9,
            4,
            2,
            3,
            2,
            5,
            2
        ],
        "alignment_reasonings": [
            "The claim references vital sign abnormalities, which relate to assessments like the National Early Warning Score (NEWS) that use deranged vitals for sepsis prediction. While the claim isn't specific enough to confirm an elevated NEWS score, the concept aligns well with monitoring vital signs to predict clinical deterioration. Thus, there is a moderate level of alignment.",
            "An elevated heart rate is directly mentioned as one of the criteria for SIRS (heart rate >90 bpm). The claim specifically highlights this vital sign abnormality, which aligns with the SIRS criteria used to detect systemic inflammation, possibly indicating early sepsis. However, since only one SIRS criterion is mentioned without any additional criteria met, the alignment is not perfect but still strong.",
            "The claim of an elevated respiratory rate is closely aligned with the criteria for the qSOFA score, which includes a respiratory rate of \u226522/min as one of its components. While the claim does not specify the exact rate, the mention of an elevated rate suggests a potential alignment with this scoring system. It is not a direct hit (e.g., no exact rate provided), but it strongly suggests a linkage, hence the high rating.",
            "The claim directly references elevated lactate levels, which is explicitly listed under the category \"Elevated Serum Lactate (\u22652 mmol/L).\" Elevated lactate is a clear and strong indicator of tissue hypoperfusion and a significant risk factor for sepsis, creating perfect alignment with this category.",
            "The claim references elevated lactate, which is explicitly mentioned in this category as a marker of tissue hypoperfusion and increased sepsis risk. However, the claim does not specify the lactate level (e.g., \u22652 mmol/L), which leaves some uncertainty about the extent of risk according to the expert categories. Despite this, the mention of elevated lactate is strongly aligned with the category's description.",
            "A high white blood cell count is explicitly mentioned as one of the SIRS criteria, used to assess systemic inflammation consistent with early sepsis. The claim directly indicates a potential infection, meeting the SIRS criteria for possible sepsis risk assessment, resulting in perfect alignment.",
            "The mention of an \"inflammatory response\" broadly aligns with the concept of SIRS, which identifies systemic inflammatory responses related to early sepsis. However, the claim does not specify which lab indicators meet the specific SIRS criteria (e.g., WBC count), so the alignment isn't perfect but still notably relevant.",
            "The claim broadly indicates an assessment for sepsis risk, which aligns vaguely with the clinical judgment involved in early sepsis suspicion and management (such as ordering antibiotics or cultures). However, it does not mention any specific actions or indicators that strongly align with the expert categories. Therefore, the alignment is weak and indirect.",
            "The claim implies an integrated assessment of multiple signs and lab results suggesting a high sepsis risk. The Elevated NEWS Score is designed to summarize various deranged vital signs into a single predictive measure, which resonates with the idea of combining different indicators to assess risk. However, the claim is not specific enough to verify it meets or exceeds the NEWS threshold, thus it receives a moderate alignment rating.",
            "Tachycardia, defined as a heart rate\u202f>\u202f90\u202fbpm, is one of the criteria listed under SIRS (Systemic Inflammatory Response Syndrome). While the claim doesn\u2019t specify that more than one SIRS criterion is present, persistent tachycardia aligns well with the concept of systemic inflammation that could suggest early sepsis, making it highly relevant but not fully definitive without additional SIRS criteria.",
            "Tachypnea (increased respiratory rate) is a key component in the calculation of a qSOFA score, as it directly contributes to a score if the respiratory rate is \u226522/min. While the claim does not specify the exact respiratory rate, the mention of tachypnea indicates alignment with qSOFA criteria due to its focus on respiratory distress. However, without detailed information confirming a qSOFA score of \u22652, the alignment is strong but not absolute.",
            "Leukocytosis, or an elevated white blood cell count, is explicitly one of the SIRS criteria used to identify systemic inflammation and early signs of sepsis. This claim directly corresponds to the SIRS Positivity category, indicating a strong alignment.",
            "The claim directly refers to elevated lactate levels being an indicator of sepsis risk. This perfectly aligns with the category that identifies elevated serum lactate as a strong predictor of sepsis due to tissue hypoperfusion. The alignment is direct and complete.",
            "The claim refers to tachycardia (elevated heart rate), tachypnea (increased respiratory rate), and leukocytosis (high white blood cell count), all of which are part of the SIRS criteria, thus demonstrating systemic inflammation consistent with early sepsis. However, it also mentions elevated lactate, which aligns with a different category regarding tissue hypoperfusion (Category 5, Elevated Serum Lactate). While the SIRS criteria are the most aligned, the inclusion of elevated lactate slightly diversifies the main category focus, resulting in a slightly less than perfect alignment."
        ],
        "final_alignment_score": 0.7642857142857142,
        "accuracy": 1
    },
    {
        "input": "5: SBP, 154.0; 5: DBP, 59.0; 5: MAP, 90.667; 6: HR, 109.0; 6: RR, 24.0; 6: SpO2, 86.4; 6: SBP, 154.0; 6: DBP, 59.0; 6: MAP, 90.667; 6: LPM O2, 2.0; 6: Pain, 10.0; 6: Temp, 102.7; 7: SpO2, 93.186; 7: Perf, 0.338; 8: SpO2, 95.897; 8: Perf, 0.303; 9: SpO2, 99.492; 9: Perf, 0.292; 10: SpO2, 99.833; 10: Perf, 0.281; 11: SpO2, 99.667; 11: Perf, 0.23; 12: SpO2, 100.0; 12: Perf, 0.244; 13: SpO2, 100.0; 13: Perf, 0.268; 14: SpO2, 99.853; 14: Perf, 0.239; 15: SpO2, 99.0; 15: Perf, 0.23; 17: SpO2, 98.833; 18: SpO2, 99.25; 18: Perf, 0.273; 19: SpO2, 96.306; 19: Perf, 0.232; 20: SpO2, 98.294; 20: Perf, 0.191; 24: SpO2, 99.0; 24: Perf, 0.15; 25: SpO2, 98.481; 25: Perf, 0.146; 26: SpO2, 99.667; 26: Perf, 0.157; 29: SpO2, 94.727; 29: Perf, 0.12; 30: SpO2, 97.0; 30: Perf, 0.13; 31: SpO2, 97.643; 31: Perf, 0.14; 32: SpO2, 98.333; 32: Perf, 0.143; 33: SpO2, 97.047; 33: Perf, 0.167; 34: SpO2, 94.625; 34: Perf, 0.175; 35: SpO2, 98.143; 35: Perf, 0.149; 36: SpO2, 98.321; 36: Perf, 0.145; 38: SpO2, 97.625; 38: Perf, 0.195; 39: SpO2, 97.818; 39: Perf, 0.2; 40: SpO2, 98.5; 40: Perf, 0.228; 41: SpO2, 96.922; 41: Perf, 0.204; 42: SpO2, 96.756; 42: Perf, 0.2; 43: SpO2, 98.595; 43: Perf, 0.2; 44: SpO2, 97.765; 44: Perf, 0.2; 45: SpO2, 99.407; 46: SpO2, 99.776; 46: Perf, 0.282; 47: SpO2, 99.362; 47: Perf, 0.349; 48: SpO2, 98.814; 48: Perf, 0.31; 49: SpO2, 99.424; 49: Perf, 0.279; 50: SpO2, 99.690; 50: Perf, 0.335; 50: ACETAMINOPHEN, 500 MG PO TABS; 51: POC PH (V), ISTAT: 7.37; 51: POC HCO3 (V) ISTAT, 28.5 mmol/L; 51: POC LACTATE ISTAT, 2.34 mmol/L; 51: POC TCO2 (V) ISTAT, 30 mmol/L; 51: POC BASE EXCESS ISTAT, 3 mmol/L; 51: POC PCO2 (V) ISTAT, 49.8 mmHg; 51: POC PO2 (V) ISTAT, 19 mmHg; 51: POC O2 SATURATION ISTAT VENOUS, 28 %; 51: SpO2, 97.780; 51: Perf, 0.297; 52: SpO2, 99.08; 52: Perf, 0.267; 53: SpO2, 99.224; 53: Perf, 0.257; 54: SpO2, 99.679; 54: Perf, 0.240; 55: SpO2, 99.26; 55: Perf, 0.221; 56: SpO2, 99.244; 56: Perf, 0.211; 57: SpO2, 97.9; 57: Perf, 0.213; 58: SpO2, 98.714; 58: Perf, 0.22; 59: SpO2, 99.0; 59: Perf, 0.22; 60: SpO2, 99.0; 60: Perf, 0.19; 61: SpO2, 99.12; 61: Perf, 0.205; 62: SpO2, 99.727; 62: Perf, 0.21; 63: SpO2, 98.524; 63: Perf, 0.206; 64: SpO2, 98.727; 64: Perf, 0.224; 65: SpO2, 98.981; 65: Perf, 0.262; 66: SpO2, 98.644; 66: Perf, 0.277; 67: SpO2, 99.667; 67: Perf, 0.278; 68: SpO2, 99.254; 68: Perf, 0.27; 69: POC, BHCG, ISTAT QUANTITATIVE: 17.6 IU/L; 69: SpO2, 99.537; 69: Perf, 0.286; 70: SpO2, 99.169; 70: Perf, 0.317; 71: SpO2, 98.068; 71: Perf, 0.315; 72: SpO2, 99.328; 72: Perf, 0.351; 73: SpO2, 99.797; 73: Perf, 0.553; 74: SpO2, 99.345; 74: Perf, 0.623; 75: SpO2, 98.288; 75: Perf, 0.858; 79: HR, 96.0; 79: RR, 22.0; 79: SpO2, 100.0; 79: SBP, 139.0; 79: DBP, 76.0; 79: MAP, 97.0; 82: NORMOSOL-R IV BOLUS -, 1000 ML; 106: WAM, DIFTYP: AUTO; 106: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 106: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.17 K/uL; 106: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 25.4 pg; 106: RED BLOOD CELLS (RBC), 4.06 MIL/uL; 106: MONOCYTE ABSOLUTE (AUTO DIFF), 0.74 K/uL; 106: NEUTROPHIL % (AUTO DIFF), 85.0 %; 106: MEAN CORPUSCULAR VOLUME (MCV), 84.2 fL; 106: WHITE BLOOD CELLS (WBC), 21.5 K/uL; 106: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 30.1 g/dL; 106: MONOCYTE % (AUTO DIFF), 3.4 %; 106: BASOPHIL ABSOLUTE (AUTO DIFF), 0.06 K/uL; 106: HEMATOCRIT (HCT), 34.2 %; 106: PLATELET COUNT (PLT), 209 K/uL; 106: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.0 %; 106: HEMOGLOBIN (HGB), 10.3 g/dL; 106: LYMPHOCYTE % (AUTO DIFF), 10.1 %; 106: EOSINOPHIL % (AUTO DIFF), 0.2 %; 106: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 106: RED CELL DISTRIBUTION WIDTH (RDW), 17.2 %; 106: BASOPHIL % (AUTO DIFF), 0.3 %; 106: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.22 K/uL; 106: NEUTROPHIL ABSOLUTE (AUTO DIFF), 18.31 K/uL; 106: NRBC PERCENT (HEMATOLOGY), 0.0 %; 112: CEFEPIME, 2 GRAM/20 ML IV PUSH; 115: POTASSIUM:, 3.6 mmol/L; 115: BLOOD UREA NITROGEN (BUN), 10 mg/dL; 115: BILIRUBIN TOTAL, 1.2 mg/dL; 115: EGFR FOR AFRICAN AMERICAN, 64 mL/min/1.73 m2; 115: CORRECTED CALCIUM, 8.8 mg/dL; 115: ANION GAP, 10 mmol/L; 115: PROTEIN TOTAL, 7.0 g/dL; 115: ALT (SGPT), 17 U/L; 115: CHLORIDE, 95 mmol/L; 115: CO2, 24 mmol/L; 115: AST (SGOT), 30 U/L; 115: GLOBULIN, 3.4 g/dL; 115: CREATININE, 1.14 mg/dL; 115: ALKALINE PHOSPHATASE, 83 U/L; 115: ALBUMIN, 3.6 g/dL; 115: GLUCOSE, 97 mg/dL; 115: SODIUM, 129 mmol/L; 115: CALCIUM, 8.5 mg/dL; 115: EGFR REFIT WITHOUT RACE (2021), 55 mL/min/1.73 m2; 115: C-REACTIVE PROTEIN (CRP), 21.1 mg/dL; 116: NORMOSOL-R IV BOLUS -, 500 ML; 0: Age:, 51; 0: Gender, F; 0: Race, White; 0: Means of arrival, EMS; 0: Triage Temp, 39.3; 0: Triage HR, 109.0; 0: Triage RR, 24.0; 0: Triage SBP, 154.0; 0: Triage DBP, 59.0; 0: Triage acuity, 2-Emergent; 0: CC, LEG PAIN,FEVER,CHILLS",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, I check if the patient meets systemic inflammatory response criteria, noting tachycardia (HR 109), tachypnea (RR 24), and fever (39.3\u00b0C). Next, I confirm suspicion of infection based on the presenting complaint (fever, chills, high WBC count) and lactate level of 2.34 mmol/L. Then, I evaluate whether these signs and labs suggest organ dysfunction and an increased risk of rapid deterioration. Considering these findings together, the patient appears to be at high risk of developing sepsis within the next 12 hours.",
        "claims": [
            "The patient meets systemic inflammatory response criteria.",
            "The patient exhibits tachycardia with a heart rate of 109.",
            "The patient exhibits tachypnea with a respiratory rate of 24.",
            "The patient has a fever of 39.3\u00b0C.",
            "The suspicion of infection is confirmed based on the presenting complaint.",
            "The presenting complaint includes fever, chills, and a high white blood cell count.",
            "The patient's lactate level is 2.34 mmol/L.",
            "The signs and labs suggest possible organ dysfunction.",
            "The signs and labs indicate an increased risk of rapid deterioration.",
            "Considering these findings, the patient appears to be at high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient meets systemic inflammatory response criteria.",
            "The patient exhibits tachycardia with a heart rate of 109.",
            "The patient exhibits tachypnea with a respiratory rate of 24.",
            "The patient has a fever of 39.3\u00b0C.",
            "The suspicion of infection is confirmed based on the presenting complaint.",
            "The presenting complaint includes fever, chills, and a high white blood cell count.",
            "The patient's lactate level is 2.34 mmol/L.",
            "The signs and labs suggest possible organ dysfunction.",
            "The signs and labs indicate an increased risk of rapid deterioration.",
            "Considering these findings, the patient appears to be at high risk of developing sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            1.0,
            0.8,
            0.8,
            1.0,
            0.6,
            1.0,
            1.0,
            0.7,
            0.7,
            0.3
        ],
        "alignment_category": [
            2,
            2,
            3,
            2,
            9,
            2,
            5,
            8,
            4,
            4
        ],
        "alignment_reasonings": [
            "The claim explicitly states that the patient meets systemic inflammatory response criteria, directly aligning with the SIRS Positivity category. SIRS criteria are specifically designed to identify systemic inflammation consistent with early sepsis, indicating perfect alignment with this category.",
            "Tachycardia, defined as a heart rate greater than 90 bpm, is one of the specific criteria for SIRS positivity. The claim of a heart rate of 109 bpm clearly meets this criterion, indicating systemic inflammation consistent with early sepsis. Therefore, this claim aligns well with the SIRS category, but since it is only one part of the criteria (\u22652 required), the alignment is strong but not complete.",
            "Tachypnea, defined here by a respiratory rate of 24, aligns with the high qSOFA score criteria of a respiratory rate of \u226522/min. While tachypnea alone does not fulfill the full criteria of a qSOFA score \u22652, it is one of the significant factors. Thus, the alignment rating is high but not perfect.",
            "The claim explicitly states a fever of 39.3\u00b0C, which exceeds the SIRS criterion of temperature >38\u00b0C. This directly aligns with the SIRS Positivity category, as fever is one of the criteria used to assess systemic inflammation consistent with early sepsis. The alignment is perfect.",
            "The claim of a confirmed suspicion of infection aligns conceptually with clinician actions in response to suspected infections, such as ordering antibiotics or cultures. While the claim does not mention these specific actions directly, this category reflects the clinician's mindset during the assessment of sepsis risk. Therefore, it exhibits a moderate level of alignment with the category.",
            "The claim explicitly mentions fever and a high white blood cell count, both of which are criteria used to identify SIRS. Presence of these signs indicates systemic inflammation consistent with early sepsis, fitting the category perfectly.",
            "The claim specifies a lactate level of 2.34 mmol/L, which is directly above the threshold of 2 mmol/L mentioned in the category. An elevated serum lactate level is a strong indicator of tissue hypoperfusion and significantly increases the risk of sepsis-related mortality, providing perfect alignment with this category.",
            "The claim of \"possible organ dysfunction\" aligns most closely with the SOFA Score Increase category, which tracks organ dysfunction as part of indicating increased sepsis risk. Although the claim lacks specific SOFA component criteria (e.g., PaO\u2082/FiO\u2082\u202f<\u202f300, platelets\u202f<\u202f100\u202f\u00d7\u202f10\u2079/L, etc.), the general reference to organ dysfunction makes this category relevant, justifying a moderate alignment rating.",
            "The claim's reference to \"increased risk of rapid deterioration\" aligns with the purpose of the NEWS score, which predicts imminent clinical decline consistent with sepsis. However, the claim does not specify any NEWS score or component, so it aligns conceptually rather than explicitly. Thus, the alignment is notable but not complete.",
            "The claim broadly mentions a high risk of developing sepsis without specific details, but implies imminent clinical deterioration, which aligns conceptually with the Elevated NEWS Score category's focus. However, because no direct clinical measurements or actions are described in the claim, the alignment is weak."
        ],
        "final_alignment_score": 0.79,
        "accuracy": 1
    },
    {
        "input": "11: Pain, 8.0; 18: HR, 114.0; 18: RR, 22.0; 18: SpO2, 95.0; 18: SBP, 101.0; 18: DBP, 62.0; 18: MAP, 75.0; 18: LPM O2, 2.0; 18: Temp, 102.2; 21: ACETAMINOPHEN, 500 MG PO TABS; 29: POC PH (V), ISTAT: 7.44; 29: POC PCO2 (V) ISTAT, 45.7 mmHg; 29: POC HCO3 (V) ISTAT, 30.9 mmol/L; 29: POC O2 SATURATION ISTAT VENOUS, 57 %; 29: POC LACTATE ISTAT, 1.00 mmol/L; 29: POC PO2 (V) ISTAT, 29 mmHg; 29: POC TCO2 (V) ISTAT, 32 mmol/L; 29: POC BASE EXCESS ISTAT, 7 mmol/L; 40: SpO2, 89.769; 40: Perf, 1.475; 40: SBP, 110.0; 40: DBP, nan; 40: MAP, nan; 41: HR, 109.95; 41: SpO2, 88.828; 41: Perf, 1.977; 41: 1min HRV, 14.576; 42: HR, 110.525; 42: SpO2, 90.525; 42: Perf, 2.646; 42: 1min HRV, 16.205; 43: HR, 109.678; 43: SpO2, 91.881; 43: Perf, 3.402; 43: 1min HRV, 21.374; 43: 5min HRV, 18.328; 44: HR, 109.672; 44: SpO2, 95.172; 44: Perf, 3.964; 44: 1min HRV, 21.182; 45: HR, 108.390; 45: SpO2, 95.153; 45: Perf, 4.616; 45: 1min HRV, 21.246; 46: HR, 108.569; 46: SpO2, 94.914; 46: Perf, 4.833; 46: 1min HRV, 17.993; 47: HR, 107.085; 47: SpO2, 95.017; 47: Perf, 5.151; 47: 1min HRV, 18.946; 48: HR, 108.356; 48: SpO2, 95.373; 48: Perf, 5.283; 48: 1min HRV, 19.931; 48: 5min HRV, 20.167; 49: HR, 107.138; 49: SpO2, 95.155; 49: Perf, 5.190; 49: 1min HRV, 17.870; 50: HR, 106.424; 50: SpO2, 96.0; 50: Perf, 5.102; 50: 1min HRV, 19.279; 51: HR, 106.241; 51: SpO2, 96.0; 51: Perf, 4.463; 51: 1min HRV, 16.673; 52: HR, 107.186; 52: SpO2, 96.068; 52: Perf, 4.564; 52: 1min HRV, 20.341; 53: HR, 105.525; 53: RR, 17.0; 53: SpO2, 96.0; 53: Perf, 5.102; 53: 1min HRV, 18.524; 53: 5min HRV, 18.733; 54: HR, 106.276; 54: SpO2, 96.0; 54: Perf, 5.207; 54: 1min HRV, 18.691; 55: HR, 108.814; 55: SpO2, 94.339; 55: Perf, 5.860; 55: 1min HRV, 19.011; 56: HR, 108.017; 56: SpO2, 93.828; 56: Perf, 5.531; 56: 1min HRV, 17.191; 57: HR, 108.102; 57: SpO2, 93.831; 57: Perf, 5.456; 57: 1min HRV, 20.965; 58: HR, 107.322; 58: SpO2, 93.627; 58: Perf, 5.796; 58: 1min HRV, 18.570; 58: 5min HRV, 19.512; 59: HR, 107.897; 59: SpO2, 93.328; 59: Perf, 5.545; 59: 1min HRV, 18.361; 60: HR, 107.508; 60: SpO2, 95.729; 60: Perf, 4.673; 60: 1min HRV, 16.617; 61: HR, 106.672; 61: SpO2, 95.310; 61: Perf, 4.716; 61: 1min HRV, 18.259; 62: HR, 106.797; 62: SpO2, 95.678; 62: Perf, 4.453; 62: 1min HRV, 17.616; 63: HR, 107.831; 63: SpO2, 96.322; 63: Perf, 3.808; 63: 1min HRV, 23.819; 63: 5min HRV, 19.307; 64: HR, 105.172; 64: SpO2, 96.0; 64: Perf, 4.299; 64: 1min HRV, 23.239; 65: HR, 106.254; 65: RR, 22.056; 65: SpO2, 95.915; 65: Perf, 4.105; 65: 1min HRV, 17.162; 66: HR, 104.517; 66: SpO2, 95.828; 66: Perf, 4.427; 66: 1min HRV, 18.875; 67: HR, 104.085; 67: SpO2, 96.0; 67: Perf, 4.424; 67: 1min HRV, 17.668; 68: HR, 105.525; 68: SpO2, 95.017; 68: Perf, 5.536; 68: 1min HRV, 17.378; 68: 5min HRV, 19.579; 69: HR, 104.914; 69: SpO2, 94.0; 69: Perf, 5.951; 69: 1min HRV, 15.239; 70: HR, 104.695; 70: SpO2, 93.797; 70: Perf, 6.006; 70: 1min HRV, 14.047; 71: HR, 104.810; 71: SpO2, 93.224; 71: Perf, 5.726; 71: 1min HRV, 12.730; 72: HR, 103.288; 72: RR, 29.375; 72: SpO2, 93.661; 72: Perf, 5.810; 72: 1min HRV, 10.750; 73: HR, 103.431; 73: RR, 14.259; 73: SpO2, 94.0; 73: Perf, 5.949; 73: 1min HRV, 15.137; 73: 5min HRV, 14.475; 74: HR, 102.508; 74: RR, 18.593; 74: SpO2, 93.576; 74: Perf, 5.645; 74: 1min HRV, 18.665; 75: HR, 104.203; 75: RR, 18.559; 75: SpO2, 94.085; 75: Perf, 5.729; 75: 1min HRV, 19.603; 76: HR, 104.931; 76: RR, 19.655; 76: SpO2, 94.828; 76: Perf, 6.026; 76: 1min HRV, 17.125; 77: HR, 102.932; 77: RR, 20.729; 77: SpO2, 95.627; 77: Perf, 5.371; 77: 1min HRV, 16.380; 78: HR, 101.224; 78: RR, 20.241; 78: SpO2, 96.0; 78: Perf, 5.247; 78: 1min HRV, 17.340; 78: 5min HRV, 19.426; 79: HR, 100.607; 79: RR, 20.898; 79: SpO2, 95.424; 79: Perf, 4.697; 79: 1min HRV, 12.174; 80: HR, 100.847; 80: RR, 21.186; 80: SpO2, 95.136; 80: Perf, 4.427; 80: 1min HRV, 16.551; 83: INFLUENZA B, Not Detected; 83: SARS-COV-2 RNA, Not Detected; 83: RSV, Not Detected; 83: INFLUENZA A, Not Detected; 83: 5min HRV, 14.374; 98: PART. THROMBOPLASTIN TIME, 37.6 seconds; 103: INR, 1.3; 103: WAM DIFTYP, AUTO; 103: PROTHROMBIN TIME, 16.4 seconds; 103: MONOCYTE ABSOLUTE (AUTO DIFF), 1.80 K/uL; 103: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.45 K/uL; 103: RED BLOOD CELLS (RBC), 2.91 MIL/uL; 103: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.14 K/uL; 103: NEUTROPHIL % (AUTO DIFF), 64.1 %; 103: LYMPHOCYTE % (AUTO DIFF), 8.7 %; 103: HEMOGLOBIN (HGB), 8.8 g/dL; 103: EOSINOPHIL % (AUTO DIFF), 15.1 %; 103: BASOPHIL % (AUTO DIFF), 0.5 %; 103: MEAN CORPUSCULAR VOLUME (MCV), 92.8 fL; 103: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 103: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.63 K/uL; 103: EOSINOPHIL ABSOLUTE (AUTO DIFF), 2.50 K/uL; 103: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.8 %; 103: NRBC PERCENT (HEMATOLOGY), 0.0 %; 103: WHITE BLOOD CELLS (WBC), 16.6 K/uL; 103: PLATELET COUNT (PLT), 637 K/uL; 103: HEMATOCRIT (HCT), 27.0 %; 103: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.2 pg; 103: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.6 g/dL; 103: MONOCYTE % (AUTO DIFF), 10.8 %; 103: RED CELL DISTRIBUTION WIDTH (RDW), 13.5 %; 103: BASOPHIL ABSOLUTE (AUTO DIFF), 0.08 K/uL; 0: Age, 39; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, nan; 0: Triage HR, 114.0; 0: Triage RR, 22.0; 0: Triage SBP, 101.0; 0: Triage DBP, 62.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER",
        "answer": false,
        "llm_answer": "Yes",
        "llm_explanation": "First, I checked whether the vital signs meet typical abnormal thresholds for sepsis risk (tachycardia, fever, tachypnea). Next, I evaluated whether there is a likely source of infection, noting the fever complaint and high WBC count of 16.6 K/uL. Then, I combined these clinical findings\u2014fever of 102.2\u00b0F, HR consistently over 100, RR over 20, and elevated WBC\u2014to assess overall sepsis risk. Because multiple concerning criteria are present, the patient is at high risk for developing sepsis within 12 hours.",
        "claims": [
            "The vital signs were checked for typical abnormal thresholds associated with sepsis risk.",
            "The evaluation focused on tachycardia, fever, and tachypnea.",
            "A likely source of infection was evaluated.",
            "The patient had a fever complaint.",
            "The patient's white blood cell (WBC) count was 16.6 K/uL.",
            "Clinical findings included a fever of 102.2\u00b0F.",
            "The heart rate (HR) was consistently over 100.",
            "The respiratory rate (RR) was over 20.",
            "The WBC count was elevated.",
            "The overall sepsis risk was assessed based on the combined clinical findings.",
            "Multiple concerning criteria were present in the patient's condition.",
            "The patient is at high risk for developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The vital signs were checked for typical abnormal thresholds associated with sepsis risk.",
            "The evaluation focused on tachycardia, fever, and tachypnea.",
            "The patient had a fever complaint.",
            "The patient's white blood cell (WBC) count was 16.6 K/uL.",
            "Clinical findings included a fever of 102.2\u00b0F.",
            "The heart rate (HR) was consistently over 100.",
            "The respiratory rate (RR) was over 20.",
            "The WBC count was elevated.",
            "The overall sepsis risk was assessed based on the combined clinical findings.",
            "Multiple concerning criteria were present in the patient's condition.",
            "The patient is at high risk for developing sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            0.6,
            1.0,
            0.5,
            1.0,
            0.9,
            0.8,
            0.9,
            1.0,
            0.3,
            0.5,
            0.4
        ],
        "alignment_category": [
            4,
            2,
            2,
            2,
            2,
            2,
            2,
            2,
            4,
            4,
            4
        ],
        "alignment_reasonings": [
            "The claim refers to checking vital signs for abnormal thresholds, which aligns with the assessment of a NEWS score, as it involves evaluating deranged vitals for sepsis prediction. However, no specific score or result is mentioned, so the alignment is somewhat general and indirect.",
            "The claim mentions tachycardia, fever, and tachypnea, which are directly related to the SIRS criteria (heart rate >90 bpm, temperature >38\u00b0C, and respiratory rate >20/min). The presence of two or more of these criteria strongly suggests systemic inflammation consistent with early sepsis. This aligns perfectly with the category, resulting in the maximum alignment rating.",
            "A fever is a component of the SIRS criteria when the temperature is >38\u00b0C. The claim mentions a fever complaint but does not provide explicit details to confirm it meets the exact SIRS threshold. However, it still suggests potential systemic inflammation linked to early sepsis, leading to moderate alignment.",
            "The claim directly references an elevated white blood cell count (16.6 K/uL), which exceeds the SIRS criterion of WBC > 12,000/\u00b5L. This is a specific indicator of systemic inflammation, aligning perfectly with the SIRS Positivity category used for early sepsis detection.",
            "A fever of 102.2\u00b0F corresponds to a temperature of approximately 39\u00b0C, which meets one of the SIRS criteria for systemic inflammation consistent with early sepsis (temperature > 38\u00b0C). This is a strong indication of SIRS positivity, so the alignment rating is high but not perfect as other criteria would need to be evaluated for full SIRS positivity.",
            "A heart rate greater than 90 bpm is directly referenced in the SIRS criteria, which identify systemic inflammation consistent with early sepsis. Since the heart rate in the claim is consistently over 100 bpm, it strongly aligns with the SIRS criterion, though not perfectly since only one SIRS criterion is mentioned rather than the required two.",
            "A respiratory rate over 20 is one of the specified criteria for SIRS positivity, which is used to identify systemic inflammation that is consistent with early sepsis. The claim aligns very closely with the SIRS criteria, but since only the respiratory rate is provided and not the complete set of criteria (\u22652), the alignment rating is slightly less than perfect.",
            "An elevated white blood cell (WBC) count is explicitly mentioned as one of the criteria under the SIRS category, which identifies systemic inflammation consistent with early sepsis. The claim directly aligns with this category, resulting in a perfect alignment score.",
            "The claim mentions an overall assessment of sepsis risk based on combined clinical findings, which aligns broadly with the concept of a NEWS score that integrates various vitals to predict clinical deterioration. However, the claim is vague and does not specifically mention a NEWS score or its components, resulting in a low alignment rating.",
            "The claim mentions \"multiple concerning criteria,\" which suggests a broader assessment of overall patient status, possibly indicative of a scoring system. While not explicit, this aligns moderately with the NEWS score concept, as elevated NEWS involves multiple parameters reflecting clinical deterioration consistent with sepsis. The lack of specific criteria mentioned in the claim limits the full alignment, reflecting a moderate connection.",
            "The claim broadly indicates a high risk of sepsis, which could result from various factors including deranged vital signs that the NEWS score captures. However, it lacks specifics on any parameters such as vital sign deterioration needed to clearly align with the NEWS category. While the elevated NEWS score is a strong predictor of imminent clinical deterioration, the claim does not provide sufficient detail to strongly support any expert category, thus a moderate alignment rating is appropriate."
        ],
        "final_alignment_score": 0.7181818181818183,
        "accuracy": 0
    },
    {
        "input": "4: HR, 110.0; 4: RR, 18.0; 4: SpO2, 100.0; 4: SBP, 157.0; 4: DBP, 87.0; 4: MAP, 110.333; 4: Temp, 97.0; 12: Pain, 8.0; 52: SpO2, 98.0; 53: SpO2, 94.484; 53: Perf, 0.343; 54: SpO2, 93.154; 54: Perf, 0.300; 55: SpO2, 91.959; 55: Perf, 0.278; 56: SpO2, 93.019; 56: Perf, 0.450; 57: SpO2, 96.132; 57: Perf, 0.738; 58: SpO2, 97.0; 58: Perf, 0.945; 59: SpO2, 95.849; 59: Perf, 0.823; 60: SpO2, 94.981; 60: Perf, 0.576; 61: SpO2, 96.528; 61: Perf, 0.527; 62: SpO2, 95.509; 62: Perf, 0.607; 63: SpO2, 95.346; 63: Perf, 0.519; 64: SpO2, 95.604; 64: Perf, 0.626; 65: SpO2, 95.537; 65: Perf, 0.59; 66: SpO2, 94.458; 66: Perf, 0.586; 67: SpO2, 94.265; 67: Perf, 0.579; 68: SpO2, 95.0; 68: Perf, 0.574; 69: SpO2, 95.774; 69: Perf, 0.547; 70: SpO2, 95.774; 70: Perf, 0.425; 71: SpO2, 96.192; 71: Perf, 0.397; 72: HR, 111.0; 72: SpO2, 97.226; 72: Perf, 0.378; 72: SBP, 158.0; 72: DBP, 100.0; 72: MAP, 119.333; 73: SpO2, 97.0; 73: Perf, 0.373; 73: SBP, 158.0; 73: DBP, 100.0; 73: MAP, 119.333; 74: SpO2, 96.906; 74: Perf, 0.377; 75: SpO2, 96.5; 75: Perf, 0.406; 75: Pain, 0.0; 76: SpO2, 96.192; 76: Perf, 0.429; 77: SpO2, 96.415; 77: Perf, 0.455; 78: SpO2, 96.75; 78: Perf, 0.47; 79: SpO2, 97.377; 79: Perf, 0.436; 80: SpO2, 96.0; 80: Perf, 0.454; 81: SpO2, 95.308; 81: Perf, 0.439; 82: SpO2, 97.547; 82: Perf, 0.467; 83: SpO2, 97.942; 83: Perf, 0.528; 84: HR, 108.562; 84: RR, 23.333; 84: SpO2, 97.415; 84: Perf, 0.52; 84: 1min HRV, 6.283; 84: SBP, 146.0; 84: DBP, 95.0; 84: MAP, 112.0; 85: HR, 107.315; 85: RR, 18.796; 85: SpO2, 98.148; 85: Perf, 0.52; 85: 1min HRV, 9.190; 86: HR, 107.75; 86: RR, 22.269; 86: SpO2, 98.308; 86: Perf, 0.52; 86: 1min HRV, 7.709; 87: HR, 106.396; 87: RR, 16.415; 87: SpO2, 97.094; 87: Perf, 0.487; 87: 1min HRV, 8.475; 87: 5min HRV, 9.826; 88: HR, 106.115; 88: RR, 17.192; 88: SpO2, 96.75; 88: Perf, 0.403; 88: 1min HRV, 8.518; 89: HR, 108.278; 89: RR, 20.204; 89: SpO2, 95.852; 89: Perf, 0.376; 89: 1min HRV, 7.594; 90: HR, 109.377; 90: RR, 17.302; 90: SpO2, 95.321; 90: Perf, 0.383; 90: 1min HRV, 3.874; 91: HR, 109.135; 91: RR, 17.923; 91: SpO2, 96.673; 91: Perf, 0.398; 91: 1min HRV, 6.186; 92: HR, 105.509; 92: RR, 17.604; 92: SpO2, 97.0; 92: Perf, 0.399; 92: 1min HRV, 2.008; 92: 5min HRV, 10.216; 93: HR, 107.769; 93: RR, 18.365; 93: SpO2, 97.0; 93: Perf, 0.384; 93: 1min HRV, 5.526; 94: HR, 108.642; 94: RR, 19.679; 94: SpO2, 96.396; 94: Perf, 0.349; 94: 1min HRV, 5.896; 95: HR, 107.615; 95: RR, 19.865; 95: SpO2, 96.827; 95: Perf, 0.360; 95: 1min HRV, 6.318; 96: HR, 107.811; 96: RR, 19.604; 96: SpO2, 96.887; 96: Perf, 0.342; 96: 1min HRV, 9.593; 97: HR, 107.833; 97: RR, 17.630; 97: SpO2, 96.926; 97: Perf, 0.343; 97: 1min HRV, 8.945; 97: 5min HRV, 7.989; 98: HR, 109.115; 98: RR, 16.962; 98: SpO2, 96.365; 98: Perf, 0.352; 98: 1min HRV, 4.041; 99: HR, 108.132; 99: RR, 17.679; 99: SpO2, 96.057; 99: Perf, 0.367; 99: 1min HRV, 8.423; 100: HR, 111.019; 100: RR, 15.231; 100: SpO2, 96.442; 100: Perf, 0.388; 100: 1min HRV, 3.575; 101: HR, 110.585; 101: RR, 16.189; 101: SpO2, 96.943; 101: Perf, 0.372; 101: 1min HRV, 3.269; 102: HR, 110.226; 102: RR, 14.868; 102: SpO2, 96.472; 102: Perf, 0.343; 102: 1min HRV, 7.359; 102: 5min HRV, 7.762; 103: HR, 110.192; 103: RR, 17.404; 103: SpO2, 96.904; 103: Perf, 0.35; 103: 1min HRV, 6.722; 104: HR, 110.660; 104: RR, 18.623; 104: SpO2, 96.113; 104: Perf, 0.352; 104: 1min HRV, 5.132; 105: HR, 110.288; 105: RR, 17.885; 105: SpO2, 96.5; 105: Perf, 0.466; 105: 1min HRV, 7.060; 106: HR, 111.434; 106: RR, 16.811; 106: SpO2, 98.094; 106: Perf, 0.522; 106: 1min HRV, 29.379; 107: HR, 109.887; 107: RR, 16.623; 107: SpO2, 97.943; 107: Perf, 0.512; 107: 1min HRV, 6.777; 107: 5min HRV, 14.634; 108: HR, 111.75; 108: RR, 19.442; 108: SpO2, 97.981; 108: Perf, 0.464; 108: 1min HRV, 4.427; 108: SBP, 138.0; 108: DBP, 96.0; 108: MAP, 110.0; 109: HR, 110.113; 109: RR, 16.415; 109: SpO2, 96.811; 109: Perf, 0.469; 109: 1min HRV, 4.230; 110: HR, 108.358; 110: RR, 17.170; 110: SpO2, 97.642; 110: Perf, 0.568; 110: 1min HRV, 7.919; 111: HR, 109.226; 111: RR, 17.925; 111: SpO2, 97.472; 111: Perf, 0.575; 111: 1min HRV, 4.075; 112: HR, 109.340; 112: RR, 13.604; 112: SpO2, 96.887; 112: Perf, 0.533; 112: 1min HRV, 5.584; 112: 5min HRV, 7.998; 113: HR, 109.566; 113: RR, 12.717; 113: SpO2, 97.113; 113: Perf, 0.497; 113: 1min HRV, 6.331; 113: SBP, 139.0; 113: DBP, 88.0; 113: MAP, 105.0; 114: HR, 108.962; 114: RR, 18.830; 114: SpO2, 97.415; 114: Perf, 0.552; 114: 1min HRV, 10.085; 115: LACTATE.WHOLE BLD, 1.6 mmol/L; 115: HR, 109.115; 115: RR, 22.096; 115: SpO2, 94.069; 115: Perf, 0.574; 115: 1min HRV, 5.739; 116: HR, 109.038; 116: RR, 20.528; 116: SpO2, 95.778; 116: 1min HRV, 3.933; 117: HR, 109.774; 117: RR, 19.698; 117: 1min HRV, 5.480; 117: 5min HRV, 6.848; 118: HR, 109.154; 118: RR, 22.981; 118: 1min HRV, 4.851; 119: HR, 110.434; 119: RR, 22.302; 119: 1min HRV, 4.683; 0: Age, 59; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.1; 0: Triage HR, 110.0; 0: Triage RR, 18.0; 0: Triage SBP, 157.0; 0: Triage DBP, 87.0; 0: Triage acuity, 3-Urgent; 0: CC, MALE GENITAL PROBLEM,SHORTNESS OF BREATH",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, I checked whether the patient\u2019s vital signs (heart rate, respiratory rate, blood pressure, and temperature) indicated abnormal values that might suggest sepsis. Then I looked for clear signs of infection or organ dysfunction, such as an elevated lactate level or hypotension, which were not present. Next, I assessed whether the patient\u2019s trends (mild tachycardia but normal lactate and stable blood pressure) raised immediate concern for sepsis. Finally, I found that the evidence did not support a high sepsis risk within 12 hours. Therefore, I concluded that the patient is not at high risk of developing sepsis.",
        "claims": [
            "The patient's vital signs were checked for abnormal values.",
            "Abnormal vital signs may suggest sepsis.",
            "The assessment included heart rate, respiratory rate, blood pressure, and temperature.",
            "Clear signs of infection or organ dysfunction were looked for.",
            "Elevated lactate level can indicate infection or organ dysfunction.",
            "Hypotension can indicate infection or organ dysfunction.",
            "There were no signs of elevated lactate or hypotension present.",
            "The patient's trends were assessed for immediate concern for sepsis.",
            "The patient exhibited mild tachycardia.",
            "The patient's lactate level was normal.",
            "The patient's blood pressure was stable.",
            "The evidence did not support a high sepsis risk within 12 hours.",
            "The conclusion was made that the patient is not at high risk of developing sepsis."
        ],
        "relevant_claims": [
            "Abnormal vital signs may suggest sepsis.",
            "The patient exhibited mild tachycardia."
        ],
        "alignment_scores": [
            0.7,
            0.7
        ],
        "alignment_category": [
            4,
            2
        ],
        "alignment_reasonings": [
            "The claim mentions \"abnormal vital signs,\" which is a key component evaluated by the National Early Warning Score (NEWS) that predicts clinical deterioration compatible with sepsis. While the claim does not specify a NEWS score or exactly how the vitals are abnormal, the link to evaluating abnormal vitals aligns most closely with this category, given NEWS is specifically designed to assess risk by aggregating derangements in vital signs.",
            "Tachycardia, defined as a heart rate >90 bpm, is one of the SIRS criteria. While the claim notes \"mild\" tachycardia, it still aligns well with the criteria for SIRS, indicating systemic inflammation consistent with early sepsis. Therefore, the alignment is significant but not absolute, given the \"mild\" qualifier."
        ],
        "final_alignment_score": 0.7,
        "accuracy": 1
    }
]